GSK plc F-3ASR, filed Mar 25, 2024
GSK plc (GSK)
Table of Contents
As filed with the Securities and Exchange Commission on March 25, 2024
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM F-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
| GSK plc | GlaxoSmithKline Capital Inc. | GlaxoSmithKline Capital plc | ||
| (Exact name of Registrant as specified in its charter) |
(Exact name of Registrant as specified in its charter) |
(Exact name of Registrant as specified in its charter) |
| England and Wales | Delaware | England and Wales | ||
| (State or other jurisdiction of
98-0607772 (I.R.S. Employer Identification No.)
980 Great West Road, Brentford Middlesex TW8 9GS, England +44 (0) 20 8047 5000 (Address and telephone number of |
(State or other jurisdiction of
51-0332587 (I.R.S. Employer Identification No.)
1100 North Market Street, 4th Floor, Suite 4056 Wilmington, Delaware 19890 +1 (302) 651-8319 (Address and telephone number of |
(State or other jurisdiction of
Not Applicable (I.R.S. Employer Identification No.)
980 Great West Road, Brentford Middlesex TW8 9GS, England +44 (0) 20 8047 5000 (Address and telephone number of |
GlaxoSmithKline Capital Inc.
1100 North Market Street, 4th Floor, Suite 4056 Wilmington,
Delaware 19890
+1 (302) 651-8319
(Name, address and telephone number of agent for service)
Copies to:
| Justin Huang Senior Counsel, Business Development & Corporate US Legal |
Sebastian R. Sperber, Esq Sarah E. Lewis Harthan, Esq. |
Edward F. Petrosky, Esq. Robert A. Ryan, Esq. Kostian Ciko, Esq. | ||
| GlaxoSmithKline LLC 1250 South Collegeville Road, Mail Code UP4110 Collegeville, PA 19426 Philadelphia, PA 19112 +1 (215) 751 5893 |
Cleary Gottlieb Steen & Hamilton LLP 2 London Wall Place London EC2Y 5AU, England +44 (0) 20 7614 2200 |
Sidley Austin LLP 787 Seventh Avenue New York, NY 10019 +1 (212) 839 5300 | ||
Approximate date of commencement of proposed sale to the public: From time to time after this Registration Statement becomes effective.
If only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a registration statement pursuant to General Instruction I.C. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☒
If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.
Emerging growth company ☐
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
† The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
Table of Contents
PROSPECTUS
GSK plc
Debt Securities
GlaxoSmithKline Capital Inc.
Debt Securities
Fully and Unconditionally Guaranteed by
GSK plc
GlaxoSmithKline Capital plc
Debt Securities
Fully and Unconditionally Guaranteed by
GSK plc
We may offer and sell debt securities from time to time in one or more series through this prospectus. The debt securities will be issued by GSK plc or through one of our finance subsidiaries, GlaxoSmithKline Capital Inc. or GlaxoSmithKline Capital plc. Any debt securities issued through GlaxoSmithKline Capital Inc. and GlaxoSmithKline Capital plc will be fully and unconditionally guaranteed by GSK plc.
This prospectus describes certain of the general terms that may apply to the securities we may offer and sell and the general manner in which they may be offered. Each time we offer securities pursuant to this prospectus, we will provide the specific terms of the debt securities we offer in one or more supplements to this prospectus. You should read this prospectus and any related prospectus supplement carefully before you make a decision to invest. Our debt securities may be denominated in U.S. dollars or in any other currencies, currency units or composite currencies as we may designate.
We may offer these debt securities through underwriters, agents or dealers or directly to institutional purchasers. The accompanying prospectus supplement will set forth the names of any underwriters or agents and any applicable commissions or discounts. The prospectus supplement will also set forth the proceeds we will receive from any sale of debt securities.
Investing in our debt securities involves certain risks. See “Risk Factors” on page 1 to read about certain factors you should consider before making a decision to invest in our debt securities.
Neither the Securities and Exchange Commission nor any state securities commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus or any accompanying prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus is March 25, 2024.
Table of Contents
| Page | ||||
| ii | ||||
| ii | ||||
| ii | ||||
| iii | ||||
| 1 | ||||
| 1 | ||||
| 4 | ||||
| 5 | ||||
| 5 | ||||
| 5 | ||||
| 6 | ||||
| 9 | ||||
| 21 | ||||
| 22 | ||||
| 23 | ||||
| 23 | ||||
| 23 | ||||
| 23 | ||||
You should rely only on the information incorporated by reference or provided in this prospectus or any prospectus supplement. We have not authorized anyone else to provide you with different or additional information. You should not assume that the information in this prospectus or any prospectus supplement is accurate as of any date other than the date on the front of these documents. We are not making an offer of these securities in any state or other jurisdiction where the offer or sale is not permitted.
i
Table of Contents
This prospectus is part of a registration statement that we filed with the U.S. Securities and Exchange Commission, or the SEC, under the Securities Act of 1933, as amended, or the Securities Act, using a “shelf” registration process. Under this shelf process, we may sell any combination of the debt securities described in this prospectus in one or more offerings.
This prospectus provides you with a general description of the debt securities we may offer and sell from time to time in one or more offerings as described in this prospectus. Each time we sell debt securities, we will provide a prospectus supplement, attached to the front of this prospectus, that will contain specific information about the terms of that offering and the offered debt securities. Those terms may vary from the terms described in this prospectus. As a result, the summary description of the debt securities in this prospectus is subject to, and qualified by reference to, the descriptions of the particular terms of any debt securities contained in any related prospectus supplement. The prospectus supplement may also add, update or change information contained in this prospectus. You should read both this prospectus and any related prospectus supplement together with the additional information described under the headings “Where You Can Find More Information” and “Incorporation of Certain Documents by Reference.”
This prospectus does not include all of the information contained in the registration statement of which it is a part. We refer you to the registration statement and the related exhibits for a more complete understanding of our debt securities and the shelf registration process.
As used in this prospectus, the term “finance subsidiaries” refers to GlaxoSmithKline Capital Inc., a Delaware corporation, and GlaxoSmithKline Capital plc, an English public limited company. Any debt securities issued by one of the finance subsidiaries will be fully and unconditionally guaranteed by GSK plc, an English public limited company (which we refer to as “GSK” and formerly known as “GlaxoSmithKline plc”). The term “guarantor” refers to GSK in its capacity as guarantor of the debt securities issued by GlaxoSmithKline Capital Inc. and/ or GlaxoSmithKline Capital plc. Unless the context requires otherwise, the terms “we,” “our,” “us” and “Group” refer to GSK and its consolidated subsidiaries.
WHERE YOU CAN FIND MORE INFORMATION
We file annual reports and other information with the SEC. You may obtain documents we file with the SEC on the SEC website at www.sec.gov. The address of the SEC’s internet site is provided solely for the information of prospective investors and is not intended to be an active link. Reports and other information concerning our business may also be inspected at the offices of the New York Stock Exchange at 20 Broad Street, New York, New York 10005.
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The SEC allows us to “incorporate by reference” the information we file with the SEC, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is an important part of this prospectus, and information that we file later with the SEC and that is incorporated by reference will automatically update and supersede information in this prospectus and information previously incorporated by reference herein.
Each document incorporated by reference is current only as of the date of such document, and the incorporation by reference of such documents shall not create any implication that there has been no change in our affairs since the date thereof or that the information contained therein is current as of any time subsequent to its date. Any statement contained in such incorporated documents shall be deemed to be modified or superseded
ii
Table of Contents
for the purpose of this prospectus to the extent that a subsequent statement contained in another document we incorporate by reference at a later date modifies or supersedes that statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.
We hereby incorporate by reference our annual report on Form 20-F for the year ended December 31, 2023 (File No. 001-15170). We also incorporate by reference any future annual reports on Form 20-F we file with the SEC under the Securities Exchange Act of 1934, as amended, or the Exchange Act, after the date of this prospectus and prior to the time we sell all of the debt securities described in this prospectus, and any future reports on Form 6-K we furnish to the SEC during such period that are identified in such reports as being incorporated by reference in this prospectus.
You may request a copy of these filings, at no cost, by writing or telephoning us at our principal executive offices at the following address: GSK plc, 980 Great West Road, Brentford, Middlesex TW8 9GS, England, telephone +44 (0) 20 8047 5000, Attention: Company Secretary. Our Internet address is www.gsk.com. We are not incorporating the contents of our website into this prospectus.
PRESENTATION OF FINANCIAL INFORMATION
We present our consolidated financial statements in pounds sterling and in accordance with International Financial Reporting Standards as adopted by the European Union and also with International Financial Reporting Standards as issued by the International Accounting Standards Board, which we refer to collectively as “IFRS.” When we refer to “£,” we mean pounds sterling. When we refer to “$,” we mean U.S. dollars. Except where noted, all financial information is presented in accordance with IFRS.
iii
Table of Contents
Investing in our debt securities involves certain risks. You should read “Risk Factors” on pages 254-260 of our annual report on Form 20-F for the year ended December 31, 2023, which is incorporated by reference in this prospectus, or similar sections in subsequent filings incorporated by reference in this prospectus, for a discussion of certain factors you should consider before making a decision to invest in our debt securities.
This prospectus and the information incorporated by reference in this prospectus and the applicable prospectus supplement may contain forward-looking statements. Forward-looking statements give the Group’s current expectations or forecasts of future events. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, dividend payments and financial results. You should not place undue reliance on these statements as no assurance can be given that any particular expectation or forecast will be met. In addition, in the future we, and others on our behalf, may make statements that constitute forward-looking statements and, except as may be required by applicable legal or regulatory obligations, we undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking statements may include, without limitation, statements relating to the following:
| • | our plans, objectives and goals; |
| • | our future economic performance and prospects; |
| • | the potential effect on our future performance of certain contingencies; and |
| • | assumptions underlying any such statements. |
You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. Words such as “believes,” “anticipates,” “expects,” “intends,” “estimates,” “plans,” “will,” “projects” and “targets” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance are intended to identify forward-looking statements but these are not the exclusive means of identifying such statements.
Forward-looking statements are subject to assumptions, inherent risks and uncertainties, many of which relate to factors that are beyond our control or precise estimate. We caution you that a number of important factors could cause actual results to differ materially from those expressed or implied in any forward-looking statement. Some of the factors that could cause actual results or events to differ from current expectations include the following:
| • | significant product innovations, technical advances or the intensification of price competition by our competitors, and any failure on our part to adequately respond to any such price competition or to develop commercially successful products or to deliver additional uses for existing products, including after significant resources have been invested; |
| • | changes in, and any failure to comply with, applicable law and regulation governing the pharmaceutical and vaccines industries and affecting the cost of product development and the time required to reach the market and the uncertainty of successfully doing so; |
| • | the outcome of, or provisions made for or costs incurred in relation to, litigation and government investigations, including those with respect to product liability, anti-trust matters and sales and marketing; |
| • | failure to appropriately collect, review, follow up or report human safety information, including adverse events from all potential sources, and to act on any relevant findings in a timely manner, which |
1
Table of Contents
| could compromise our ability to effectively collect, manage and analyze safety information associated with our products and enable us to conduct robust safety signal detection activities, and to ensure we make decisions based on the most up-to-date risk/benefit profile of our products; |
| • | competition from producers of proprietary and generic pharmaceutical products, especially upon the expiry or loss of patent protection for our products, challenges to the validity or enforceability of a patent or assertions of non-infringement by competitors, and the bringing of anti-trust claims by government entities or private parties following patent infringement actions and settlements; |
| • | failure to ensure appropriate controls and governance of quality in product development; |
| • | failure to comply with good manufacturing or good distribution practice regulations in commercial or clinical trials’ manufacturing and distribution activities; |
| • | failure to comply with the terms of our product licenses and supporting regulatory activities; |
| • | failure to deliver a continuous supply of compliant finished product and inability to respond effectively to a crisis incident in a timely manner to recover and sustain critical operations; |
| • | failure to report accurate financial information in compliance with accounting standards and applicable legislation; |
| • | failure to comply with current tax laws, or incurring significant losses due to treasury activities; |
| • | failure to comply with applicable and international anti-bribery and corruption legislation; |
| • | commercial or scientific activities that are inconsistent with the law, industry regulations, or the Group’s requirements relating to sales and promotion of our medicines and vaccines, including inappropriate interactions with healthcare professionals, organizations and patients and illegitimate and nontransparent transfers of value; |
| • | failure to comply with pricing and antitrust regulations in commercial practices, including trade channel activities and tendering for business; |
| • | failure to conduct objective, ethical preclinical and clinical trials, in which we protect and inform patients involved in human clinical trials, manage human biological samples according to established ethical standards and regulatory expectations, treat animals ethically and practice good animal welfare, appropriately disclose human subject research for medicinal products and maintain the integrity of our research data and regulatory filings; |
| • | failure in management of the execution of hazardous activities, our physical assets and infrastructure; the handling and processing of hazardous chemicals and biological agents and the control of releases of substances harmful to the environment in both the short and long term, leading to incidents which could disrupt our R&D and supply activities, harm employees, harm the communities and harm the local environment in which we operate; |
| • | failure in the management of physical climate and environmental risks, current and future regulatory requirements for environmental policies and taxes, and delivery and performance of management environmental objectives; |
| • | failure to collect, secure, use and destroy personal information in accordance with data privacy laws, which can lead to harm to individuals, including financial harm, stress and prejudice, and to us, including fines and operational, financial and reputational harm; |
| • | unauthorized disclosure, theft, unavailability or corruption of our information or key information systems may lead to harm to our patients, workforce and customers, disruption to our business and/or the loss of commercial or strategic advantage, damage to our reputation or regulatory sanctions; and |
| • | new and possibly increasing levels of price controls, pricing pressures or price restrictions with respect to our products in various markets. |
2
Table of Contents
We caution you that the foregoing list of important factors is not exhaustive. When evaluating forward-looking statements, you should carefully consider the foregoing factors and other uncertainties and events, as well as the risk factors set forth in our annual report on Form 20-F for the year ended December 31, 2023 and subsequent annual reports on Form 20-F and other documents filed with the SEC and incorporated by reference in this prospectus and any risk factors relating to us or a particular offering set forth or incorporated by reference in the applicable prospectus supplement.
3
Table of Contents
Unless we tell you otherwise in a prospectus supplement, we will use the net proceeds from the sale of the debt securities described in this prospectus for our general corporate purposes, including to refinance existing indebtedness. We may also invest the net proceeds in marketable securities as part of our liquidity management process.
4
Table of Contents
GSK is a public limited company incorporated under the laws of England and Wales. Our Ordinary shares are listed on the London Stock Exchange and our American Depositary Shares are listed on the New York Stock Exchange. On December 27, 2000, GSK acquired Glaxo Wellcome plc and SmithKline Beecham plc (now known as SmithKline Beecham Limited), both English public limited companies, through a merger of the two companies.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. Our corporate head office is in the London area at 980 Great West Road, Brentford, Middlesex, TW8 9GS, England, and our telephone number is +44 (0) 20 8047 5000.
GlaxoSmithKline Capital Inc. is a Delaware corporation. It is a 100% owned subsidiary of GSK, and it exists for the purpose of issuing debt securities, the proceeds of which will be invested by it in marketable securities or advanced to, or otherwise invested in, subsidiaries or affiliates of GSK. The principal executive offices of GlaxoSmithKline Capital Inc. are located at 1100 North Market Street, 4th Floor, Suite 4056, Wilmington, Delaware 19890. Its telephone number is +1 (302) 651-8319.
GlaxoSmithKline Capital plc is a public limited company incorporated under the laws of England and Wales. It is a 100% owned subsidiary of GSK, and it exists for the purpose of issuing debt securities, the proceeds of which will be invested by it in marketable securities or advanced to, or otherwise invested in, subsidiaries or affiliates of GSK. The principal executive offices of GlaxoSmithKline Capital plc are located at 980 Great West Road, Brentford, Middlesex TW8 9GS, England. Its telephone number is +44 (0) 20 8047 5000.
5
Table of Contents
LEGAL OWNERSHIP OF DEBT SECURITIES
“Street Name” and Other Indirect Holders
We generally will not recognize investors who hold debt securities in accounts at banks or brokers as legal holders of those debt securities. Holding securities in accounts at banks or brokers is called holding in “street name.” If an investor holds debt securities in street name, we recognize only the bank or broker or the financial institution the bank or broker uses to hold the debt securities. These intermediary banks, brokers and other financial institutions pass along principal, interest and other payments on the debt securities, either because they agree to do so in their customer agreements or because they are legally required to do so. If you hold debt securities in street name, you should check with your own institution to find out:
| • | how it handles payments and notices with respect to securities; |
| • | whether it imposes fees or charges; |
| • | how it would handle voting if ever required; |
| • | how and when you should notify it to exercise on your behalf any rights or options that may exist under the debt securities; |
| • | whether and how you can instruct it to send you securities registered in your own name so you can be a direct holder as described below; and |
| • | how it would pursue rights under the debt securities if there were a default or other event triggering the need for holders to act to protect their interests. |
Registered Holders
Our obligations, as well as the obligations of the trustee and those of any third parties employed by us or the trustee, extend only to persons who are registered as holders of debt securities. As noted above, we do not have obligations directly to you if you hold in street name or through other indirect means, either because you choose to hold debt securities in that manner or because the debt securities are issued in the form of global securities as described below. For example, once we make payment to the registered holder, we have no further responsibility for the payment even if that holder is legally required to pass the payment along to you but does not do so.
Global Securities
A global security is a special type of indirectly held security. If we choose to issue debt securities in the form of global securities, the ultimate beneficial owners of the debt securities will be indirect holders. We do this by requiring that the global security be registered in the name of a financial institution we select and by requiring that the debt securities represented by the global security not be registered in the name of any other holder except in the special situations described below. The financial institution that acts as the sole registered holder of the global security is called the depositary. Any person wishing to own a debt security may do so indirectly through an account with a broker, bank or other financial institution that in turn has an account with the depositary. The prospectus supplement will indicate whether your series of debt securities will be issued only as global securities.
Transfers of debt securities represented by the global security will be made only on the records of the depositary or its nominee by transferring such debt securities from the account of one broker, bank or financial institution to the account of another broker, bank or financial institution. These transfers are made electronically only and are also known as book-entry transfers. Securities in global form are sometimes also referred to as being in book-entry form.
As an indirect holder, your rights relating to a global security will be governed by the account rules of your broker, bank or financial institution and of the depositary, as well as general laws relating to securities transfers. We will not recognize you as a holder of debt securities and instead will deal only with the depositary that holds the global security.
6
Table of Contents
You should be aware that if debt securities are issued only in the form of a global security:
| • | except in very limited circumstances described below, you will not have any right to have debt securities registered in your own name; |
| • | you cannot receive physical certificates for your interest in the debt securities; |
| • | you will be a street name holder and must look to your own broker, bank or financial institution for payments on the debt securities and protection of your legal rights relating to the debt securities; |
| • | you may not be able to sell interests in the debt securities to some insurance companies and other institutions that are required by law to own securities in the form of physical certificates; |
| • | the depositary’s policies will govern payments, transfers, exchanges and other matters relating to your indirect interest in the global security. We and the trustee will have no responsibility for any aspect of the depositary’s actions or for its records of ownership interests in the global security. We and the trustee also will not supervise the depositary in any way; and |
| • | the depositary will require that indirect interests in the global security be purchased or sold within its system using same-day funds for settlement. |
In a few special circumstances described below, the global security will terminate and the indirect interests in it will be exchanged for registered debt securities represented by physical certificates. After that exchange, the choice of whether to hold debt securities in registered form or in street name will be up to you. You must consult your broker, bank or financial institution to find out how to have your interests in debt securities transferred to your name, so that you will be a registered holder of the debt securities.
Unless we specify otherwise in the prospectus supplement, the special circumstances for termination of a global security are:
| • | when the depositary notifies us that it is unwilling or unable to continue as depositary and we do not or cannot appoint a successor depositary within 90 days; |
| • | the depositary ceases to be a clearing agency registered under the Exchange Act and we do not appoint a successor depositary within 90 days; |
| • | an event of default has occurred and is continuing and beneficial owners representing a majority in principal amount of the applicable series of debt securities have advised the depositary to cease acting as the depositary; or |
| • | we decide we do not want to have the debt securities of that series represented by a global security. |
The prospectus supplement may also list additional circumstances for terminating a global security that would apply only to the particular series of debt securities covered by the prospectus supplement. When a global security terminates, the depositary (and not us or the trustee) is responsible for deciding the names of the institutions that will be the initial registered holders.
The Term “Holder” as Used in this Prospectus and Elsewhere
In the descriptions of the debt securities included in this prospectus and any prospectus supplement, when we refer to the “holder” of a given debt security as being entitled to certain rights or payments, or being permitted to take certain actions, we are in all cases referring to the registered holder of the debt security.
While you would be the registered holder if you held a certificated security registered in your name, it is likely that the holder will actually be either the broker, bank or other financial institution where you have your street name account or, in the case of a global security, the depositary. If you are an indirect holder, you will need to coordinate with the institution through which you hold your interest in a debt security in order to determine
7
Table of Contents
how the provisions involving holders described in this prospectus and any prospectus supplement will actually apply to you. For example, if the debt security in which you hold a beneficial interest in street name can be repaid at the option of the holder, you cannot exercise the option yourself by following the procedures described in the prospectus supplement. Instead, you would need to cause the institution through which you hold your interest to take those actions on your behalf. Your institution may have procedures and deadlines different from or additional to those described in the prospectus supplement relating to the debt security.
8
Table of Contents
DESCRIPTION OF DEBT SECURITIES
This section describes the general terms that will apply to any debt securities that we may offer pursuant to this prospectus, other than as noted otherwise in this section. The specific terms of any offered debt securities, and the extent to which the general terms described in this section apply to those debt securities, will be described in the related prospectus supplement at the time of the offer.
General
As used in this prospectus, “debt securities” means the debentures, notes, bonds, guarantees and other evidences of indebtedness that GSK issues or that a finance subsidiary issues and GSK fully and unconditionally guarantees and, in each case, the trustee authenticates and delivers under the applicable indenture. The debt securities will be our direct unsecured obligations and will rank equally and ratably without preference among themselves and at least equally with all of our other unsecured and unsubordinated indebtedness.
The debt securities will be issued in one or more series under an indenture dated as of March 4, 2008 between GSK and Deutsche Bank Trust Company Americas, as trustee (the “trustee”) (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among GSK, the trustee and Law Debenture Trust Company of New York), as supplemented by a first supplemental indenture dated as of March 21, 2014 between GSK and the trustee (the “GSK plc Indenture”), an indenture dated as of April 6, 2004 among GlaxoSmithKline Capital plc, GSK, as guarantor, and the trustee (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among GlaxoSmithKline Capital plc, the trustee and Law Debenture Trust Company of New York), as supplemented by a first supplemental indenture dated as of March 21, 2014 among GlaxoSmithKline Capital plc, the guarantor and the trustee and a second supplemental indenture dated as of May 15, 2018 among GlaxoSmithKline Capital plc, the guarantor and the trustee (the “GSK Capital plc Indenture”), or an indenture dated as of April 6, 2004 among GlaxoSmithKline Capital Inc., the guarantor and the trustee (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017, among GlaxoSmithKline Capital Inc., the trustee and Law Debenture Trust Company of New York), as supplemented by a first supplemental indenture dated as of March 18, 2013 among GlaxoSmithKline Capital Inc., the guarantor and the trustee, a second supplemental indenture dated as of March 21, 2014 among GlaxoSmithKline Capital Inc., the guarantor and the trustee and a third supplemental indenture dated as of May 15, 2018 among GlaxoSmithKline Capital Inc., the guarantor and the trustee (the “GSK Capital Inc. Indenture”). Each of the GSK plc Indenture, the GSK Capital plc Indenture and the GSK Capital Inc. Indenture has been qualified under the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”). In the following discussion, we sometimes refer to these indentures collectively as the “indentures.”
This prospectus briefly outlines the provisions of the indentures and is qualified in its entirety by reference to the indentures. The terms of the indentures will include both those stated in the indentures and those made part of the indentures by the Trust Indenture Act. The indentures have been filed as exhibits to the registration statement of which this prospectus forms a part, and you should read the indentures for provisions that may be important to you.
The indentures do not contain any covenants or other provisions designed to protect holders of the debt securities against a reduction in the creditworthiness of GSK or the finance subsidiaries in the event of a highly leveraged transaction or that would prohibit other transactions that might adversely affect holders of the debt securities.
Issuances in Series
The indentures do not limit the amount of debt securities that may be issued. The debt securities may be issued in one or more series with the same or various maturities, at a price of 100% of their principal amount or
9
Table of Contents
at a premium or a discount. Not all debt securities of any one series need be issued at the same time, and, unless otherwise provided, any series may be reopened, without the consents of the holders of debt securities of that series, for issuances of additional debt securities of that series. Except in the limited circumstances described below under “—Covenants—Limitation on Liens,” the debt securities will not be secured by any property or assets of GSK, as issuer or guarantor, or the finance subsidiaries.
The terms of any authorized series of debt securities will be described in a prospectus supplement. These terms will include some or all of the following:
| • | the title, aggregate principal amount and denominations of the debt securities; |
| • | the date or dates on which principal will be payable; |
| • | the percentage of the principal amount at which the debt securities will be issued and whether the debt securities will be “original issue discount” securities for U.S. federal income tax purposes. If original issue discount debt securities are issued (generally, any security that provides for an amount less than the principal amount thereof to be due and payable upon a declaration of acceleration of the maturity), the special U.S. federal income tax and other considerations of a purchase of original issue discount debt securities will be described; |
| • | the rate or rates, which may be fixed or variable, at which the debt securities will bear interest; |
| • | the interest payment dates; |
| • | any optional or mandatory redemption terms; |
| • | whether any sinking fund is required; |
| • | the currency in which the debt securities will be denominated or principal, premium, interest or any additional amounts will be payable, if other than U.S. dollars; |
| • | whether the debt securities are to be issued as individual certificates to each holder or in the form of global certificates held by a depositary on behalf of beneficial owners; |
| • | information describing any book-entry features; |
| • | the names and duties of any co-trustees, depositaries, authenticating agents, paying agents, transfer agents or registrars for any series; |
| • | provisions for the defeasance, which provisions may modify the provisions described in this prospectus; |
| • | any deletions from, modifications of or additions to the events of default or covenants with respect to the debt securities; and |
| • | any other terms of the debt securities. |
The prospectus supplement relating to any series of debt securities may add to or change statements contained in this prospectus. The prospectus supplement may also include, if applicable, a discussion of certain U.S. federal income tax and U.K. income tax considerations.
GSK Guarantees
Debt securities issued by the finance subsidiaries will be fully and unconditionally guaranteed by GSK. If for any reason the applicable finance subsidiary does not make any required payment in respect of its debt securities when due, whether on the normal due date, on acceleration, redemption or otherwise, GSK will cause the payment to be made to or to the order of the trustee. The holder of a guaranteed debt security will be entitled to payment under the applicable guarantee of GSK without taking any action whatsoever against the finance subsidiary.
10
Table of Contents
Payment and Transfer
The debt securities will be issued only as registered securities, which means that the name of the holder will be entered in a register that will be kept by the trustee or another agent appointed by us. Unless stated otherwise in a prospectus supplement, and except as described under “—Book-Entry System” below, payments of principal, interest and additional amounts, if any, will be made at the office of the paying agent or agents named in the prospectus supplement or by check mailed to you at your address as it appears in the register.
Unless other procedures are described in a prospectus supplement and except as described under “—Book Entry System” below, you will be able to transfer registered debt securities at the office of the transfer agent or agents named in the prospectus supplement. You may also exchange registered debt securities at the office of the transfer agent for an equal aggregate principal amount of registered debt securities of the same series having the same maturity date, interest rate and other terms as long as the debt securities are issued in authorized denominations.
Neither we nor the trustee will impose any service charge for any transfer or exchange of a debt security; however, we may ask you to pay any taxes or other governmental charges in connection with a transfer or exchange of debt securities.
Book-Entry System
Debt securities may be issued under a book-entry system in the form of one or more global securities. The global securities will be registered in the name of a depositary or its nominee and deposited with that depositary or its custodian. Unless stated otherwise in the prospectus supplement, the Depository Trust Company, or DTC, will be the depositary if a depositary is used.
DTC has advised us as follows:
| • | DTC is a limited-purpose trust company organized under the New York Banking Law, a “banking organization” within the meaning of the New York Banking Law, a member of the Federal Reserve System, a “clearing corporation” within the meaning of the New York Uniform Commercial Code and a “clearing agency” registered pursuant to the provisions of Section 17A of the Exchange Act; |
| • | DTC was created to hold securities of its participants and to facilitate the clearance and settlement of securities transactions, such as through transfers and pledges, among its participants in such securities through electronic computerized book-entry changes to accounts of its participants, thereby eliminating the need for physical movement of securities certificates; |
| • | DTC’s participants include securities brokers and dealers, banks, trust companies, clearing corporations and certain other organizations, some of whom (and/or their representatives) own DTC; and |
| • | access to DTC’s book-entry system is also available to others, such as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a participant, either directly or indirectly. |
According to DTC, the foregoing information with respect to DTC has been provided to the financial community for informational purposes only and is not intended to serve as a representation, warranty or contract modification of any kind.
Following the issuance of a global security in registered form, the depositary will credit the accounts of its participants with the debt securities upon our instructions. Only persons who hold directly or indirectly through financial institutions that are participants in the depositary can hold beneficial interests in the global securities. Since the laws of some jurisdictions require certain types of purchasers to take physical delivery of such securities in definitive form, you may encounter difficulties in your ability to own, transfer or pledge beneficial interests in a global security.
11
Table of Contents
So long as the depositary or its nominee is the registered owner of a global security, we and the trustee will treat the depositary as the sole owner or holder of the debt securities for purposes of the applicable indenture. Therefore, except as set forth below, you will not be entitled to have debt securities registered in your name or to receive physical delivery of certificates representing the debt securities. Accordingly, you will have to rely on the procedures of the depositary and the participant in the depositary through whom you hold your beneficial interest in order to exercise any rights of a holder under the indenture. We understand that under existing practices, the depositary would act upon the instructions of a participant or authorize that participant to take any action that a holder is entitled to take.
We will make all payments of principal, interest and additional amounts, if any, on the debt securities to the depositary. It is expected that the depositary will then credit participants’ accounts proportionately with these payments on the payment date and that the participants will in turn credit their customers’ accounts in accordance with their customary practices. Neither we nor the trustee will be responsible for making any payments to participants or customers of participants or for maintaining any records relating to the holdings of or payments to participants and their customers, and you will have to rely on the procedures of the depositary and its participants.
Global securities are generally not transferable. Physical certificates will be issued to beneficial owners in lieu of a global security only in the special situations described in the sixth paragraph under the heading “Legal Ownership of Debt Securities—Global Securities” above.
Consolidation, Merger or Sale
We and the finance subsidiaries have agreed in the indentures not to consolidate with or merge with or into any other person or convey or transfer all or substantially all of our respective properties and assets to any person (except that the finance subsidiaries may merge into us), unless:
| • | we or the applicable finance subsidiary, as the case may be, are the continuing person, or the successor expressly assumes by supplemental indenture our obligations under the applicable indenture; |
| • | the continuing person is a U.S. or U.K. company or is organized and validly existing under the laws of a jurisdiction that is a member country of the Organisation for Economic Cooperation and Development (or any successor) and, if it is not a U.S. or U.K. company, the continuing person agrees by supplemental indenture to be bound by a covenant comparable to that described below under “—Covenants—Payment of Additional Amounts” with respect to taxes imposed in the continuing person’s jurisdiction of organization (in which case the continuing person will benefit from a redemption option comparable to that described below under “—Optional Redemption for Tax Reasons” in the event of changes in taxes in that jurisdiction after the date of the consolidation, merger or sale); |
| • | immediately after the transaction, no default under the debt securities has occurred and is continuing; and |
| • | we deliver to the trustee an officer’s certificate and, if neither we nor the applicable subsidiary are the continuing person, an opinion of counsel, in each case stating, among other things, that the transaction and the supplemental indenture, if required, comply with these provisions and the indenture. |
Covenants
Payment of Additional Amounts
Payments made by us under or with respect to the debt securities will be free and clear of and without withholding or deduction for or on account of any present or future tax, duty, levy, impost, assessment or other governmental charge of any nature whatsoever imposed or levied by or on behalf of (i) the government of the
12
Table of Contents
United Kingdom or of any territory of the United Kingdom or by any authority or agency therein or thereof having the power to tax or (ii) solely with respect to debt securities issued under the GSK Capital Inc. Indenture, the government of the United States or any state or territory of the United States or by any authority or agency therein or thereof having the power to tax, which we refer to collectively as “Taxes,” unless we are required to withhold or deduct Taxes by law or by the interpretation or administration thereof.
If we are required to withhold or deduct any amount for or on account of Taxes from any payment made with respect to the debt securities, we will pay such additional amounts as may be necessary so that the net amount received by each holder (including additional amounts) after such withholding or deduction will not be less than the amount the holder would have received if the Taxes had not been withheld or deducted; provided that no additional amounts will be payable with respect to Taxes:
| • | that would not have been imposed but for the existence of any present or former connection between such holder or beneficial owner of the debt securities (or between a fiduciary, settlor, beneficiary, member or shareholder of, or possessor of a power over, such holder or beneficial owner, if such holder or beneficial owner is an estate, trust, partnership or corporation) and the United Kingdom or, solely with respect to debt securities issued under the GSK Capital Inc. Indenture, the United States or, as applicable, any political subdivision or territory or possession thereof or therein or area subject to its jurisdiction, including, without limitation, such holder or beneficial owner (or such fiduciary, settlor, beneficiary, member, shareholder or possessor) being or having been a citizen or resident thereof or treated as a resident thereof or domiciled thereof or a national thereof or being or having been present or engaged in trade or business therein or having or having had a permanent establishment therein; |
| • | that are estate, inheritance, gift, sales, transfer, personal property, wealth or similar taxes, duties, assessments or other governmental charges; |
| • | payable other than by withholding from payments of principal of or interest on the debt securities; |
| • | that would not have been imposed but for the failure of the applicable recipient of such payment to comply with any certification, identification, information, documentation or other reporting requirement to the extent such compliance is required by applicable law or administrative practice or an applicable treaty as a precondition to exemption from, or reduction in, the rate of deduction or withholding of such Taxes; |
| • | that would not have been imposed but for the presentation of a debt security (where presentation is required) for payment on a date more than 30 days after the date on which such payment became due and payable or the date on which payment thereof was duly provided for, whichever occurred later; |
| • | solely with respect to debt securities issued under the GSK plc Indenture, that are imposed on a payment to an individual and are required to be made pursuant to European Council Directive 2003/48/EC or any other Directive implementing the conclusions of the ECOFIN Council meeting of November 26-27, 2000 on the taxation of savings income, or any law implementing or complying with, or introduced in order to conform to, such Directive; |
| • | that would not have been imposed if presentation for payment of the relevant debt securities had been made to a paying agent other than the paying agent to which the presentation was made; |
| • | that would not have been imposed but for a failure by the holder or beneficial owner (or any financial institution through which the holder or beneficial owner holds any debt security through which payment on the debt security is made) to comply with any certification, information, identification, documentation or other reporting requirements (including entering into and complying with an agreement with the U.S. Internal Revenue Service or any other governmental authority) imposed pursuant to Sections 1471 through 1474 of the U.S. Internal Revenue Code as in effect on the date of issuance of the Notes or any successor or amended version of such provisions, or, solely with respect to debt securities issued under the GSK plc Indenture, any agreement entered into pursuant to Section 1471(b) of the U.S. Internal Revenue Code, or any fiscal or regulatory legislation, rules or |
13
Table of Contents
| practices adopted pursuant to any intergovernmental agreement entered into in connection with the implementation of such Sections of the U.S. Internal Revenue Code (or any law implementing such intergovernmental agreement); |
| • | solely with respect to debt securities issued under the GSK Capital Inc. Indenture and the GSK Capital plc Indenture, that are imposed solely by reason of the holder or beneficial owner owning or having owned, actually or constructively, 10% or more of the total combined voting power of all classes of the Company’s stock entitled to vote; or |
| • | any combination of the foregoing items; |
nor shall additional amounts be paid with respect to any payment of the principal of or interest on any debt security to any such holder who is a fiduciary or a partnership or a beneficial owner who is other than the sole beneficial owner of such payment to the extent a beneficiary or settlor with respect to such fiduciary or a member of such partnership or a beneficial owner would not have been entitled to such additional amounts had it been the holder of the debt security.
We have agreed in each indenture that at least one paying agent for each outstanding series of debt securities will be located outside the United Kingdom. Solely with respect to debt securities issued under the GSK plc Indenture, we have also agreed that if we maintain a paying agent with respect to a particular series of debt securities in any member state of the European Union, we will maintain a paying agent in at least one member state that will not be obliged to withhold or deduct taxes pursuant to any law implementing European Council Directive 2003/48/EC or any other Directive implementing the conclusions of the ECOFIN Council meeting of November 26-27, 2000 on the taxation of savings income, provided there is at least one member state that does not require a paying agent to withhold or deduct pursuant to such Directive.
Our obligation to pay additional amounts, if and when due, will survive the termination of the indentures and the payment of all amounts in respect of the debt securities.
Limitation on Liens
We have agreed in the indentures not to incur or assume (or permit any of our subsidiaries to incur or assume) any lien on or with respect to any of our or our subsidiaries’ property, assets or revenues, present or future, to secure any relevant indebtedness (as this term is defined below) without making (or causing our subsidiaries to make) effective provision for securing the debt securities equally and ratably with such relevant indebtedness as to such property, assets or revenues, for as long as such relevant indebtedness is so secured.
The restrictions on liens will not apply to:
| • | liens arising by operation of law; |
| • | liens on property, assets or revenues of any person, which liens are existing at the time such person becomes a subsidiary; and |
| • | liens on property, assets or revenues of a person existing at the time such person is merged with or into or amalgamated or consolidated with us or any of our subsidiaries or at the time of a sale, lease or other disposition to us of the properties of a corporation as an entirety or substantially as an entirety. |
For purposes of the limitation on liens covenant, the term “relevant indebtedness” means any of our debt that:
| • | is in the form of or represented by bonds, notes, loan stock, depositary receipts or other securities issued (otherwise than to constitute or represent advances made by banks or other lending institutions); |
14
Table of Contents
| • | is denominated in, or confers any right of payment by reference to, any currency other than the currency of the country in which the issuer of the indebtedness has its principal place of business, or is denominated in or by reference to the currency of such country but more than 20% of which is placed or offered for subscription or sale by or on behalf of, or by agreement with, the issuer outside such country; and |
| • | at its date of issue is, or is intended by the issuer to become, quoted, listed, traded or dealt in on any stock exchange, over-the-counter market or other securities market. |
Additional Covenants
We may be subject to additional covenants, including restrictive covenants in respect of a particular series of debt securities. Such additional covenants will be set forth in the applicable prospectus supplement and, to the extent necessary, in the supplemental indenture or board resolution relating to that series of debt securities.
Optional Redemption for Tax Reasons
We may redeem any series of debt securities in whole but not in part at any time, solely with respect to debt securities issued under the GSK plc Indenture, on giving not less than 30 nor more than 60 days’ notice of such redemption, or, solely with respect to debt securities issued under the GSK Capital Inc. Indenture and GSK Capital plc Indenture, on giving not less than 15 nor more than 60 days’ notice of such redemption, at the applicable redemption price, together with accrued interest, if any, to the date fixed for redemption, if:
| • | we determine that, as a result of any change in or amendment to the laws or any regulations or rulings promulgated thereunder of the United Kingdom (or of any political subdivision or taxing authority thereof) or, solely with respect to debt securities issued under the GSK Capital Inc. Indenture, the United States (or of any political subdivision or taxing authority thereof), or any change in the application or official interpretation of such laws, regulations or rulings, or any change in the application or official interpretation of, or any execution of or amendment to, any treaty or treaties affecting taxation to which any such jurisdiction is a party, which change, execution or amendment becomes effective on or after the issue date or such other date specified in the debt securities of that series: |
| • | we would be required to pay additional amounts (as described under “—Covenants––Payment of Additional Amounts” above) with respect to that series of debt securities on the next succeeding interest payment date and the payment of such additional amounts cannot be avoided by the use of reasonable measures available to us; or |
| • | solely with respect to debt securities issued under the GSK Capital plc Indenture and the GSK Capital Inc. Indenture, withholding tax has been or would be required to be withheld with respect to interest income received or receivable by the applicable finance subsidiary directly from the guarantor (or any affiliate) and such withholding tax obligation cannot be avoided by the use of reasonable measures available to the applicable finance subsidiary or the guarantor (or any affiliate); or |
| • | solely with respect to debt securities issued under the GSK plc Indenture, withholding tax has been or would be required to be withheld with respect to interest income received or receivable by GSK directly from any affiliate and such withholding tax obligation cannot be avoided by the use of reasonable measures available to GSK (or any affiliate); or |
| • | we determine, based upon an opinion of independent counsel of recognized standing that, as a result of any action taken by any legislative body of, taxing authority of, or any action brought in a court of competent jurisdiction in, the United Kingdom (or any political subdivision or taxing authority thereof) or, solely with respect to debt securities issued under the GSK Capital Inc. Indenture, the United States (or any political subdivision or taxing authority thereof) (whether or not such action was taken or |
15
Table of Contents
| brought with respect to GSK, as issuer or guarantor, or the applicable finance subsidiary, as the case may be), which action is taken or brought on or after the issue date or such other date specified in the debt securities of that series, there is a substantial probability that the circumstances described above would exist; provided, however, that no such notice of redemption may be given earlier than 90 days prior to the earliest date on which we would be obligated to pay such additional amounts. |
We will also pay to each holder, or make available for payment to each such holder, on the redemption date any additional amounts resulting from the payment of such redemption price. Prior to the delivery of any notice of redemption, we will deliver to the trustee:
| • | an officer’s certificate stating that we are entitled to effect a redemption and setting forth a statement of facts showing that the conditions precedent of the right so to redeem have occurred; or |
| • | an opinion of counsel to the effect that the conditions specified above have been satisfied. |
Any notice of redemption will be irrevocable once we deliver the officer’s certificate to the trustee.
Events of Default
Unless otherwise specified in a prospectus supplement, an event of default with respect to a series of debt securities occurs upon:
| • | default in payment of all or any part of the principal (or premium, if any) of any debt security of that series when due and payable (including as a sinking fund installment), and, in the case of technical or administrative difficulties, the continuance of that default for more than two business days; |
| • | default in payment of interest on, or any additional amounts payable in respect of, any debt security of that series when due and payable, and the continuance of that default for 30 days; |
| • | default in performing any other covenant in the indenture applicable to that series for 90 days after the receipt of written notice specifying such default from the trustee or from the holders of 25% in principal amount of the debt securities of that series; |
| • | default under any bond, debenture, note or other evidence of indebtedness for money borrowed of GSK or either finance subsidiary, as the case may be (not including any indebtedness for which recourse is limited to property purchased), having in any particular case an outstanding principal amount in excess of £100,000,000 (or its equivalent in any other currency) where any such failure results in such indebtedness being accelerated and becoming due and payable prior to its stated maturity and such acceleration shall not have been rescinded or annulled or such indebtedness shall not have been discharged; provided that there shall not be deemed to be an Event of Default if such acceleration is rescinded or annulled or such payment is made within 10 days after there has been given to GSK and either finance subsidiary by the trustee or to either finance subsidiary, GSK and the trustee by the holders of 25% or more in aggregate principal amount of the debt securities of such series a written notice specifying such default and requiring it to be remedied and stating that such notice is a “Notice of Default” hereunder; |
| • | certain events of bankruptcy, insolvency or reorganization of GSK or either finance subsidiary, as the case may be; |
| • | any other event of default provided with respect to that particular series of debt securities. |
Any additional or different events of default applicable to a particular series of debt securities will be described in the prospectus supplement relating to such series.
An event of default with respect to a particular series of debt securities will not necessarily constitute an event of default with respect to any other series of debt securities.
16
Table of Contents
If an event of default occurs and continues, the trustee or the holders of the aggregate principal amount of the debt securities specified below may require us to repay immediately, or accelerate:
| • | the entire principal of the debt securities of such series; or |
| • | if the debt securities are original issue discount securities, such portion of the principal as may be described in the applicable prospectus supplement. |
If the event of default occurs because of a default in a payment of principal or interest on the debt securities of any series, then the trustee or the holders of at least 25% of the aggregate principal amount of debt securities of that series can accelerate that series of debt securities. If the event of default occurs because of a failure to perform any other covenant in the applicable indenture or any covenant for the benefit of one or more, but not all, of the series of debt securities, then the trustee or the holders of at least 25% of the aggregate principal amount of debt securities of all series affected, voting as one class, can accelerate all of the affected series of debt securities. If the event of default occurs because of bankruptcy proceedings, then all of the debt securities under the indenture will be accelerated automatically. Therefore, except in the case of a default on a payment of principal or interest on the debt securities of your series or a default due to our bankruptcy or insolvency, it is possible that you may not be able to accelerate the debt securities of your series because of the failure of holders of other series to take action.
The holders of a majority of the aggregate principal amount of the debt securities of all affected series, voting as one class, can rescind this accelerated payment requirement or waive any past default or event of default or allow noncompliance with any provision of the applicable indenture. However, they cannot waive a default in payment of principal of, premium, if any, or interest on, or additional amounts in respect of, any of the debt securities when due otherwise than as a result of acceleration.
After an event of default, the trustee must exercise the same degree of care a prudent person would exercise under the circumstances in the conduct of her or his own affairs. Subject to these requirements, the trustee is not obligated to exercise any of its rights or powers under the applicable indenture at the request, order or direction of any holders, unless the holders offer the trustee indemnity satisfactory to it. If they provide this indemnity, the holders of a majority in principal amount of all affected series of debt securities, voting as one class, may direct the time, method and place of conducting any proceeding for any remedy available to the trustee, or exercising any power conferred upon the trustee, for any series of debt securities. However, the trustee may refuse to follow any direction that conflicts with law or the indenture or is unduly prejudicial to the rights of other holders.
No holder will be entitled to pursue any remedy with respect to the indenture unless the trustee fails to act for 60 days after it is given:
| • | notice of default by that holder; |
| • | a written request to enforce the indenture by the holders of not less than 25% in principal amount of all outstanding debt securities of any affected series; and |
| • | an indemnity to the trustee, reasonably satisfactory to the trustee; |
and during this 60-day period the holders of a majority in principal amount of all outstanding debt securities of such affected series do not give a direction to the trustee that is inconsistent with the enforcement request. These provisions will not prevent any holder of debt securities from enforcing payment of the principal of (and premium, if any) and interest on, or additional amounts payable in respect of, the debt securities at the relevant due dates.
If an event of default with respect to a series of debt securities occurs and is continuing, the trustee will mail to the holders of those debt securities a notice of the event of default within 90 days after it occurs. However, except in the case of a default in any payment in respect of a series of debt securities, the trustee shall be protected in
17
Table of Contents
withholding notice of an event of default if it determines in good faith that this is in the interests of the holders of the relevant debt securities. A default is any event that is, or after notice or passage of time or both would be, an event of default.
Modification of the Indentures
In general, rights and obligations of us and the holders under the indentures may be modified if the holders of a majority in aggregate principal amount of the outstanding debt securities of each series affected by the modification consent to such modification. However, each of the indentures provides that, unless each affected holder agrees, an amendment cannot:
| • | make any adverse change to any payment term of a debt security such as extending the maturity date, extending the date on which we have to pay interest or make a sinking fund payment, reducing the interest rate, reducing the amount of principal we have to repay, changing the currency in which we have to make any payment of principal, premium, interest or additional amount, modifying any redemption or repurchase right, or right to convert or exchange any debt security, to the detriment of the holder and impairing any right of a holder to bring suit for payment; |
| • | waive any payment default; |
| • | reduce the percentage of the aggregate principal amount of debt securities needed to make any amendment to the applicable indenture or to waive any covenant or default; or |
| • | make any other change to the amendment provisions of the applicable indenture. |
However, if we and the trustee agree, the applicable indenture may be amended without notifying any holders or seeking their consent if the amendment does not materially and adversely affect any holder. We and the trustee are permitted to make modifications and amendments to the applicable indenture without the consent of any holder of debt securities for any of the following purposes:
| • | to cure any ambiguity, defect or inconsistency in the indenture; |
| • | to comply with sections of the indenture governing when we may merge and substitute obligors; |
| • | to comply with any requirements of the SEC in connection with the qualification of the indenture under the Trust Indenture Act; |
| • | to evidence and provide for the acceptance by a successor trustee of appointment under the indenture with respect to the debt securities of any or all series; |
| • | to establish the form or forms or terms of the debt securities of any series or of the coupons appertaining to such debt securities as permitted under the indenture; |
| • | to provide for uncertificated debt securities and to make all appropriate changes for such purpose; |
| • | to provide for a further guarantee from a third party on outstanding debt securities of any series and the debt securities of any series that may be issued under the indenture; |
| • | to change or eliminate any provision of the indenture; provided that any such change or elimination will become effective only when there are no outstanding debt securities of any series created prior to the execution of such supplemental indenture that is entitled to the benefit of such provision; |
| • | to supplement any of the provisions of the indenture to such extent as will be necessary to permit or facilitate the defeasance and discharge of any series of debt securities pursuant to the indenture; provided that any such action will not adversely affect the interests of the holders of such or any other series of debt securities in any material respect; or |
| • | to make any change that does not materially and adversely affect the rights of any holder of the debt securities. |
18
Table of Contents
Defeasance
The term defeasance means discharge from some or all of the obligations under the indentures. If we deposit with the trustee sufficient cash or government securities (if government securities, as deemed sufficient in the opinion of a nationally recognized firm of public accountants) to pay the principal, interest, any premium and any other sums due to the stated maturity date or a redemption date of the debt securities of a particular series, then at our option:
| • | we will be discharged from our respective obligations with respect to the debt securities of such series; or |
| • | we will no longer be under any obligation to comply with the restrictive covenants, if any, contained in the applicable indenture and any supplemental indenture or board resolution with respect to the debt securities of such series, and the events of default relating to failures to comply with covenants will no longer apply to us. |
If this happens, the holders of the debt securities of the affected series will not be entitled to the benefits of the applicable indenture except for registration of transfer and exchange of debt securities and replacement of lost, stolen or mutilated debt securities. Instead, the holders will only be able to rely on the deposited funds or obligations for payment.
Unless the debt securities of the respective series mature within one year or all such securities are to be called for redemption within one year under arrangements satisfactory to the trustee for giving the notice of redemption, we must deliver to the trustee an opinion of counsel to the effect that the deposit and related defeasance would not cause the holders of the debt securities to recognize income, gain or loss for U.S. federal income tax purposes. We may, in lieu of an opinion of counsel, deliver a ruling to such effect from the U.S. Internal Revenue Service.
Substitution of Issuer
We may at our option at any time, without the consent of any holders of debt securities, cause GSK or any other subsidiary of GSK to assume the obligations of the applicable finance subsidiary under any series of debt securities, provided that the new obligor executes a supplemental indenture in which it agrees to be bound by the terms of those debt securities and the relevant indenture. If the new obligor is not a U.S. or U.K. company, it must be organized and validly existing under the laws of a jurisdiction that is a member country of the Organisation for Economic Cooperation and Development (or any successor) and it must also agree in the supplemental indenture to be bound by a covenant comparable to that described above under “—Covenants—Payment of Additional Amounts” with respect to taxes imposed in its jurisdiction of organization (in which case the new obligor will benefit from a redemption option comparable to that described above under “—Optional Redemption for Tax Reasons” in the event of changes in taxes in that jurisdiction after the date of the substitution). In the case of such a substitution, the applicable finance subsidiary will be relieved of any further obligation under the assumed series of debt securities.
Information Concerning the Trustee
Deutsche Bank Trust Company Americas, 60 Wall Street, 24th Floor, New York, NY 10005, will be the trustee. The trustee will be required to perform only those duties that are specifically set forth in the indentures, except when a default has occurred and is continuing with respect to the debt securities. After a default, the trustee must exercise the same degree of care that a prudent person would exercise under the circumstances in the conduct of her or his own affairs. Subject to these requirements, the trustee will be under no obligation to exercise any of the powers vested in it by the indentures at the request of any holder of debt securities unless the holder offers the trustee indemnity satisfactory to it against the costs, expenses and liabilities that might be incurred by exercising those powers.
19
Table of Contents
Governing Law
The debt securities, the related guarantees and the indentures will be governed by and construed in accordance with the laws of the State of New York.
20
Table of Contents
The applicable prospectus supplement will describe certain U.K. tax considerations in connection with the acquisition, ownership and disposal of debt securities for investors who are not resident in the United Kingdom for U.K. tax purposes at any material time (including Eligible U.S. Investors) and who meet certain other requirements. Such considerations will include whether the payment by us of principal (and premium, if any) and interest will be subject to U.K. withholding tax. For this purpose, “Eligible U.S. Investors” are investors who qualify for benefits under the income tax convention between the United States and the United Kingdom (the “Treaty”), who are residents of the United States for the purposes of the Treaty, and who are not resident in the United Kingdom for U.K. tax purposes at any material time.
The applicable prospectus supplement will also describe certain U.S. federal income tax considerations relevant to a particular series of debt securities.
21
Table of Contents
We may sell our debt securities through agents, underwriters, dealers or directly to purchasers. Our agents may solicit offers to purchase the debt securities.
| • | We will name any agent involved in offering or selling our securities, and any commissions that we will pay to the agent, in the prospectus supplement. |
| • | Unless we indicate otherwise in the prospectus supplement, our agents will act on a best efforts basis for the period of their appointment. |
| • | Our agents may be deemed to be underwriters under the Securities Act of any of our securities that they offer or sell. |
We may use an underwriter or underwriters in the offer or sale of the debt securities.
| • | If we use an underwriter or underwriters, we will execute an underwriting agreement with the underwriter or underwriters at the time that we reach an agreement for the sale of the debt securities. |
| • | We will include the names of the specific managing underwriter or underwriters, as well as any other underwriters, and the terms of the transactions, including the compensation the underwriters and dealers will receive, in the prospectus supplement. |
| • | The underwriters will use the prospectus supplement to sell our securities. |
| • | If we use an underwriter or underwriters, the underwriter or underwriters will acquire our securities for their own account and may resell the debt securities in one or more transactions, including negotiated transactions. These sales will be made at a fixed price or at varying prices determined at the time of the sale. |
We may use a dealer to sell the debt securities.
| • | If we use a dealer, we, as principal, will sell the debt securities to the dealer. |
| • | The dealer will then sell the debt securities to the public at varying prices that the dealer will determine at the time it sells the debt securities. |
| • | We will include the name of the dealer and the terms of our transactions with the dealer in the prospectus supplement. |
We may solicit directly offers to purchase the debt securities, and we may directly sell the debt securities to institutional or other investors. We will describe the terms of our direct sales in the prospectus supplement.
We may indemnify agents, underwriters and dealers against certain liabilities, including liabilities under the Securities Act. Our agents, underwriters and dealers, or their affiliates, may be customers of, engage in transactions with or perform services for, us or our subsidiaries and affiliates in the ordinary course of business.
We may authorize our agents and underwriters to solicit offers by certain institutions to purchase the debt securities at the public offering price under delayed delivery contracts.
| • | If we use delayed delivery contracts, we will disclose that we are using them in the prospectus supplement and will tell you when we will demand payment and delivery of the securities under the delayed delivery contracts. |
| • | These delayed delivery contracts will be subject only to the conditions that we set forth in the prospectus supplement. |
| • | We will indicate in the prospectus supplements the commission that underwriters and agents soliciting purchases of the debt securities under delayed delivery contracts will be entitled to receive. |
22
Table of Contents
Cleary Gottlieb Steen & Hamilton LLP, our U.S. and English counsel, will pass upon the validity of the debt securities and guarantees as to matters of U.S. and English law. Certain matters of U.S. law and English law will be passed upon by Sidley Austin LLP for any agents or underwriters. Cleary Gottlieb Steen & Hamilton LLP and Sidley Austin LLP regularly provide legal services to us and our subsidiaries and affiliates.
The financial statements of the Group incorporated by reference in this prospectus, and the effectiveness of the Group’s internal control over financial reporting have been audited by Deloitte LLP, an independent registered public accounting firm, as stated in their reports. Such financial statements are incorporated by reference in reliance upon the reports of such firm, given their authority as experts in accounting and auditing.
LIMITATIONS ON ENFORCEMENT OF U.S. LAWS
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. Many of our directors and executive officers (as well as certain directors, managers and executive officers of the finance subsidiaries), and certain experts named in this prospectus, reside outside the United States, and all or a substantial portion of our assets and the assets of such persons are located outside the United States. As a result, it may be difficult for you to serve legal process on us or our directors and executive officers (as well as certain directors, managers and executive officers of the finance subsidiaries) or have any of them appear in a U.S. court. There is some doubt as to the enforceability in the United Kingdom, in original actions or in actions for enforcement of judgments of U.S. courts, of civil liabilities based solely on the federal securities laws of the United States. In addition, awards for punitive damages in actions brought in the United States or elsewhere may be unenforceable in the United Kingdom.
Under the U.K. Companies Act 2006, a safe harbor limits the liability of GSK’s directors in respect of statements in and omissions from certain sections of GSK’s annual report on Form 20-F (namely the strategic report, the director’s report and the director’s remuneration report). Under U.K. law, a director would only be liable to GSK in respect of such reports if they were to contain errors as a result of knowing or reckless misstatement or dishonest concealment of a material fact by that director, but would not otherwise be liable to GSK or any third party.
European Economic Area
In relation to each Member State of the European Economic Area (“EEA” and each, a “Member State”), each underwriter has represented and agreed, and each further underwriter will be required to represent and agree that an offer of debt securities to the public in that Member State, which are the subject of the offering contemplated by this prospectus (as completed by the prospectus supplement in relation thereto) will only be made to a legal entity which is a qualified investor (“EU Qualified Investor”) as defined under the EU Prospectus Regulation as defined below. Accordingly any person making or intending to make an offer in the EEA of debt securities which are the subject of the offering contemplated by this prospectus (as completed by the prospectus supplement in relation thereto) may only do so with respect to EU Qualified Investors. Neither we nor the underwriters have authorized, nor do we or they authorize, the making of any offer of debt securities other than to EU Qualified Investors. The expression “EU Prospectus Regulation” means Regulation (EU) 2017/1129 (as amended).
23
Table of Contents
Prohibition of Sales to EEA Retail Investors
The debt securities are not intended to be offered, sold or otherwise made available to, and should not be offered, sold or otherwise made available to, any EEA Retail Investor in the EEA. For these purposes, “EEA Retail Investor” means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, “MiFID II”) or (ii) a customer within the meaning of Directive (EU) 2016/97 (as amended), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not an EU Qualified Investor, and the expression “offer” includes the communication in any form and by any means of sufficient information on the terms of the offer and the debt securities to be offered so as to enable an investor to decide to purchase or subscribe for the debt securities.
EU PRIIPs/Important – EEA Retail Investors
No key information document required by Regulation (EU) No 1286/2014 (as amended, the “EU PRIIPs Regulation”) for offering or selling the debt securities or otherwise making them available to EEA Retail Investors in the EEA has been prepared and therefore offering or selling the debt securities or otherwise making them available to any EEA Retail Investor in the EEA may be unlawful under the EU PRIIPs Regulation.
United Kingdom
Prohibition of Sales to U.K. Retail Investors
The debt securities are not intended to be offered, sold or otherwise made available to, and should not be offered, sold or otherwise made available to, any UK Retail Investor in the United Kingdom (“UK”). For the purposes of this provision:
| (a) | the expression “UK Retail Investor” means a person who is one (or more) of the following: |
| (i) | a retail client, as defined in point (8) of Article 2 of Commission Delegated Regulation (EU) 2017/565 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (“EUWA”); or |
| (ii) | a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the “FSMA”) and any rules or regulations made under the FSMA (such rules and regulations as amended) to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of UK domestic law by virtue of the EUWA; or |
| (iii) | not a qualified investor as defined in Article 2 of Regulation (EU) 2017/1129 as it forms part of UK domestic law by virtue of the EUWA; and |
| (b) | the expression “an offer” includes the communication in any form and by any means of sufficient information on the terms of the offer and the debt securities to be offered so as to enable an investor to decide to purchase or subscribe for the debt securities. |
Other Regulatory Restrictions
Each dealer, agent or underwriter has represented and agreed, and each further dealer, agent or underwriter appointed to sell the debt securities will be required to represent and agree that:
| (a) | in relation to any debt securities which have a maturity of less than one year (i) it is a person whose ordinary activities involve it in acquiring, holding, managing or disposing of investments (as principal or agent) for the purposes of its business; and (ii) it has not offered or sold and will not offer or sell any debt securities other than to persons whose ordinary activities involve them in acquiring, holding, managing or disposing of investments (as principal or as agent) for the purposes of their businesses or who it is reasonable to expect will acquire, hold, manage or |
24
Table of Contents
| dispose of investments (as principal or agent) for the purposes of their businesses where the issue of the debt securities would otherwise constitute a contravention of Section 19 FSMA by the issuer; |
| (b) | it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the FSMA) received by it in connection with the issue or sale of any debt securities in circumstances in which Section 21(1) of the FSMA does not apply to the issuer or the guarantor; and |
| (c) | it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to any debt securities in, from or otherwise involving the UK. |
25
Table of Contents
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
| Item 8. | Indemnification of Directors and Officers |
GSK and GlaxoSmithKline Capital plc
Article 141 of GSK’s Articles of Association currently provides that GSK shall indemnify every director or former director or other officer of GSK or of any associated company against all costs, charges, losses, expenses and liabilities incurred by them in performing their duties and/or in exercising their powers and/or in supposedly doing these things and/or otherwise in relation to or in connection with their duties, powers or office to the extent permitted by every statute (including any orders, regulations or other subordinate legislation made under it) from time to time in force concerning companies in so far as it applies to GSK.
Article 12 of GlaxoSmithKline Capital plc’s Articles of Association currently provides that GlaxoSmithKline Capital plc shall indemnify directors and officers to the extent permitted by law.
GSK and GlaxoSmithKline Capital plc have agreed with their directors and officers to indemnify them, to the extent permitted by law and subject to certain limitations, against all costs reasonably incurred by any such director or officer in an action or proceeding to which the director or officer was made a party by reason of the director or officer being an officer and/or director of (a) the company or (b) if at the company’s request, an organization of which it is a shareholder or creditor.
GSK maintains insurance relating to certain liabilities of GSK plc and its subsidiaries, including GlaxoSmithKline Capital Inc. and GlaxoSmithKline Capital plc, that its directors and officers may incur in such capacity.
Sections 232 to 236 of the U.K. Companies Act 2006 (as amended) provide as follows:
“232. Provisions protecting directors from liability
(1) Any provision that purports to exempt a director of a company (to any extent) from any liability that would otherwise attach to him in connection with any negligence, default, breach of duty or breach of trust in relation to the company is void.
(2) Any provision by which a company directly or indirectly provides an indemnity (to any extent) for a director of the company, or of an associated company, against any liability attaching to him in connection with any negligence, default, breach of duty or breach of trust in relation to the company of which he is a director is void, except as permitted by—
| (a) | section 233 (provision of insurance), |
| (b) | section 234 (qualifying third party indemnity provision), or |
| (c) | section 235 (qualifying pension scheme indemnity provision). |
(3) This section applies to any provision, whether contained in a company’s articles or in any contract with the company or otherwise.
(4) Nothing in this section prevents a company’s articles from making such provision as has previously been lawful for dealing with conflicts of interest.
233. Provision of insurance
Section 232(2) (voidness of provisions for indemnifying directors) does not prevent a company from purchasing and maintaining for a director of the company, or of an associated company, insurance against any such liability as is mentioned in that subsection.
II-1
Table of Contents
234. Qualifying third party indemnity provision
(1) Section 232(2) (voidness of provisions for indemnifying directors) does not apply to qualifying third party indemnity provision.
(2) Third party indemnity provision means provision for indemnity against liability incurred by the director to a person other than the company or an associated company.
Such provision is qualifying third party indemnity provision if the following requirements are met.
(3) The provision must not provide any indemnity against—
| (a) | any liability of the director to pay— |
| (i) | a fine imposed in criminal proceedings, or |
| (ii) | a sum payable to a regulatory authority by way of a penalty in respect of non-compliance with any requirement of a regulatory nature (however arising); or |
| (b) | any liability incurred by the director— |
| (i) | in defending criminal proceedings in which he is convicted, or |
| (ii) | in defending civil proceedings brought by the company, or an associated company, in which judgment is given against him, or |
| (iii) | in connection with an application for relief (see subsection (6)) in which the court refuses to grant him relief. |
(4) The references in subsection (3)(b) to a conviction, judgment or refusal of relief are to the final decision in the proceedings.
(5) For this purpose—
| (a) | a conviction, judgment or refusal of relief becomes final— |
| (i) | if not appealed against, at the end of the period for bringing an appeal, or |
| (ii) | if appealed against, at the time when the appeal (or any further appeal) is disposed of; and |
| (b) | an appeal is disposed of— |
| (i) | if it is determined and the period for bringing any further appeal has ended, or |
| (ii) | if it is abandoned or otherwise ceases to have effect. |
(6) The reference in subsection (3)(b)(iii) to an application for relief is to an application for relief under section 661 (3) or (4) (power of court to grant relief in case of acquisition of shares by innocent nominee), or section 1157 (general power of court to grant relief in case of honest and reasonable conduct).
235. Qualifying pension scheme indemnity provision
(1) Section 232(2) (voidness of provisions for indemnifying directors) does not apply to qualifying pension scheme indemnity provision.
(2) Pension scheme indemnity provision means provision indemnifying a director of a company that is a trustee of an occupational pension scheme against liability incurred in connection with the company’s activities as trustee of the scheme.
Such provision is qualifying pension scheme indemnity provision if the following requirements are met.
II-2
Table of Contents
(3) The provision must not provide any indemnity against—
| (a) | any liability of the director to pay— |
| (i) | a fine imposed in criminal proceedings, or |
| (ii) | a sum payable to a regulatory authority by way of a penalty in respect of non-compliance with any requirement of a regulatory nature (however arising); or |
| (b) | any liability incurred by the director in defending criminal proceedings in which he is convicted. |
(4) The reference in subsection (3)(b) to a conviction is to the final decision in the proceedings.
(5) For this purpose—
| (a) | a conviction becomes final— |
| (i) | if not appealed against, at the end of the period for bringing an appeal, or |
| (ii) | if appealed against, at the time when the appeal (or any further appeal) is disposed of; and |
| (b) | an appeal is disposed of— |
| (i) | if it is determined and the period for bringing any further appeal has ended, or |
| (ii) | if it is abandoned or otherwise ceases to have effect. |
(6) In this section “occupational pension scheme” means an occupational pension scheme as defined in section 150(5) of the Finance Act 2004 (c 12) that is established under a trust.
236. Qualifying indemnity provision to be disclosed in directors’ report
(1) This section requires disclosure in the directors’ report of—
| (a) | qualifying third party indemnity provision, and |
| (b) | qualifying pension scheme indemnity provision. |
Such provision is referred to in this section as “qualifying indemnity provision.”
(2) If when a directors’ report is approved any qualifying indemnity provision (whether made by the company or otherwise) is in force for the benefit of one or more directors of the company, the report must state that such provision is in force.
(3) If at any time during the financial year to which a directors’ report relates any such provision was in force for the benefit of one or more persons who were then directors of the company, the report must state that such provision was in force.
(4) If when a directors’ report is approved qualifying indemnity provision made by the company is in force for the benefit of one or more directors of an associated company, the report must state that such provision is in force.
(5) If at any time during the financial year to which a directors’ report relates any such provision was in force for the benefit of one or more persons who were then directors of an associated company, the report must state that such provision was in force.”
Section 1157 of the U.K. Companies Act 2006 (as amended) provides as follows:
“1157. Power of court to grant relief in certain cases:
(1) If in proceedings for negligence, default, breach of duty or breach of trust against—
II-3
Table of Contents
| (a) | an officer of a company, or |
| (b) | a person employed by a company as auditor (whether he is or is not an officer of the company). |
it appears to the court hearing the case that the officer or person is or may be liable but that he acted honestly and reasonably, and that having regard to all the circumstances of the case (including those connected with his appointment) he ought fairly to be excused, the court may relieve him, either wholly or in part, from his liability on such terms as it thinks fit.
(2) If any such officer or person has reason to apprehend that a claim will or might be made against him in respect of negligence, default, breach of duty or breach of trust—
| (a) | he may apply to the court for relief, and |
| (b) | the court has the same power to relieve him as it would have had if it had been a court before which proceedings against him for negligence, default, breach of duty or breach of trust, had been brought. |
(3) Where a case to which subsection (1) applies is being tried by a judge with a jury, the judge, after hearing the evidence may, if he is satisfied that the defendant (in Scotland, the defender) ought in pursuance of that subsection to be relieved either in whole or in part from the liability sought to be enforced against him, withdraw the case from the jury and forthwith direct judgment to be entered for the defendant (in Scotland, grant decree of absolvitor) on such terms as to costs (in Scotland, expenses) or otherwise as the judge may think proper.”
GlaxoSmithKline Capital Inc.
Section 7 of Article 7 of GlaxoSmithKline Capital Inc.’s By-Laws currently provides that GlaxoSmithKline Capital Inc. shall indemnify officers, directors, employees and agents to the extent permitted by the Delaware General Corporation Law.
Under the bylaws of GlaxoSmithKline Capital Inc., officers, directors, employees and agents of GlaxoSmithKline Capital Inc. are indemnified, to the extent permitted by law and subject to certain limitations, against all costs reasonably incurred by any such officer, director, employee or agent in an action or proceeding to which he or she was made a party by reason of being an officer, director, employee and/or agent of (a) GlaxoSmithKline Capital Inc. or (b) if at GlaxoSmithKline Capital Inc.’s request, another organization.
Section 145 of the Delaware General Corporation Law provides that a corporation may indemnify directors and officers, as well as other employees and individuals, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with any threatened, pending or completed actions, suits or proceedings in which such person was or is made a party by reason of such person being or having been a director, officer, employee or agent of such corporation or serving or having served at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, provided that the person acted in good faith and in a manner the person reasonably believed was (i) in, or not opposed to, the best interests of the corporation and (ii), with respect to any criminal action or proceeding, not unlawful, and provided also that no indemnification is made in respect of any claim, issue or matter as to which such person is adjudged to be liable to the corporation unless, and only to the extent, otherwise determined by the court. The statute provides that it is not exclusive of other rights to which those seeking indemnification may be entitled under any by-law, agreement, vote of stockholders or disinterested directors or otherwise.
II-4
Table of Contents
| Item 9. | Exhibits |
| Exhibit |
Description of Document | |
| 1.1 | Form of Underwriting Agreement between GSK plc and the Representatives of the Underwriters. | |
| 1.2 | Form of Underwriting Agreement among GlaxoSmithKline Capital Inc., as Issuer, GSK plc, as guarantor, and the Representatives of the Underwriters. | |
| 1.3 | Form of Underwriting Agreement among GlaxoSmithKline Capital plc, as Issuer, GSK plc, as guarantor, and the Representatives of the Underwriters. | |
| 4.1 | Indenture, dated as of March 4, 2008, between GSK plc, as issuer, and Deutsche Bank Trust Company Americas, as trustee (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among GSK plc, as issuer, Deutsche Bank Trust Company Americas and Law Debenture Trust Company of New York) (incorporated by reference to Exhibit 4.1 of the Registrants’ Registration Statement on Form F-3 (File Nos. 333-149531, 333-149531-01 and 333-149531-02), filed with the Securities and Exchange Commission on March 4, 2008). | |
| 4.2 | First Supplemental Indenture, dated as of March 21, 2014, between GSK plc, as issuer, and the trustee (incorporated by reference to Exhibit 4.2 of the Registrants’ Registration Statement on Form F-3 (File Nos. 333-217125, 333-217125-01 and 333-217125-02), filed with the Securities and Exchange Commission on April 3, 2017). | |
| 4.3 | Indenture, dated as of April 6, 2004, among GlaxoSmithKline Capital Inc., GSK plc, as guarantor, and Deutsche Bank Trust Company Americas, as trustee (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among GlaxoSmithKline Capital Inc., as issuer, GSK plc, as guarantor, Deutsche Bank Trust Company Americas and Law Debenture Trust Company of New York) (incorporated by reference to Exhibit 4.3 of the Registrants’ Report of Foreign Issuer on Form 6-K (File No. 001-15170), filed with the Securities and Exchange Commission on April 7, 2004). | |
| 4.4 | First Supplemental Indenture, dated as of March 18, 2013, among GlaxoSmithKline Capital Inc., GSK plc, as guarantor, and the trustee (incorporated by reference to Exhibit 4.1 of the Registrants’ Report of Foreign Issuer on Form 6-K (File No. 001-15170 / Film No. 13696882), filed with the Securities and Exchange Commission on March 18, 2013). | |
| 4.5 | Second Supplemental Indenture, dated as of March 21, 2014, among GlaxoSmithKline Capital Inc., as issuer, GSK plc, as guarantor, and the trustee (incorporated by reference to Exhibit 4.5 of the Registrants’ Registration Statement on Form F-3 (File Nos. 333-217125, 333-217125-01 and 333-217125-02), filed with the Securities and Exchange Commission on April 3, 2017). | |
| 4.6 | Third Supplemental Indenture, dated as of May 15, 2018, among GlaxoSmithKline Capital Inc., as issuer, GSK plc, as guarantor, and the trustee (incorporated by reference to Exhibit 4.2 of the Registrants’ Registration Statement on Form 6-K (File No. 001-34068 / Film No. 18836324), filed with the Securities and Exchange Commission on May 15, 2018). | |
| 4.7 | Indenture, dated as of April 6, 2004, among GlaxoSmithKline Capital plc, as issuer, GSK plc, as guarantor, and Deutsche Bank Trust Company Americas, as trustee (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among GlaxoSmithKline Capital plc, as issuer, GSK plc, as guarantor, Deutsche Bank Trust Company Americas and Law Debenture Trust Company of New York), (incorporated by reference to Exhibit 4.4 of the Registrants’ Report of Foreign Issuer on Form 6-K (File No. 001-15170), filed with the Securities and Exchange Commission on April 7, 2004). | |
II-5
Table of Contents
| Exhibit |
Description of Document | |
| 4.8 | First Supplemental Indenture, dated as of March 21, 2014, among GlaxoSmithKline Capital plc, as issuer, GSK plc, as guarantor, and the trustee (incorporated by reference to Exhibit 4.7 of the Registrants’ Registration Statement on Form F-3 (File Nos. 333-217125, 333-217125-01 and 333-217125-02), filed with the Securities and Exchange Commission on April 3, 2017). | |
| 4.9 | Second Supplemental Indenture, dated as of May 15, 2018, among GlaxoSmithKline Capital plc, as issuer, GSK plc, as guarantor, and the trustee (incorporated by reference to Exhibit 4.1 of the Registrants’ Registration Statement on Form 6-K (File No. 001-35541 / Film No. 18836326), filed with the Securities and Exchange Commission on May 15, 2018). | |
| 4.10 | Form of Debt Security of GSK plc (incorporated by reference to Exhibit 4.8 of the Registrants’ Registration Statement on Form F-3 (File Nos. 333-217125, 333-217125-01 and 333-217125-02), filed with the Securities and Exchange Commission on April 3, 2017). | |
| 4.11 | Form of Guaranteed Debt Security of GlaxoSmithKline Capital Inc. (incorporated by reference to Exhibit 4.9 of the Registrants’ Registration Statement on Form F-3 (File Nos. 333-217125, 333-217125-01 and 333-217125-02), filed with the Securities and Exchange Commission on April 3, 2017). | |
| 4.12 | Form of Guaranteed Debt Security of GlaxoSmithKline Capital plc (incorporated by reference to Exhibit 4.10 of the Registrants’ Registration Statement on Form F-3 (File Nos. 333-217125, 333-217125-01 and 333-217125-02), filed with the Securities and Exchange Commission on April 3, 2017). | |
| 5.1 | Opinion of Cleary Gottlieb Steen & Hamilton LLP, special U.S. counsel to GSK plc, GlaxoSmithKline Capital Inc. and GlaxoSmithKline Capital plc. | |
| 5.2 | Opinion of Cleary Gottlieb Steen & Hamilton LLP, special English counsel to GSK plc, GlaxoSmithKline Capital Inc. and GlaxoSmithKline Capital plc. | |
| 22 | List of subsidiary issuers of guaranteed securities. | |
| 23.1 | Consent of Cleary Gottlieb Steen & Hamilton LLP (included in Exhibit 5.1). | |
| 23.2 | Consent of Cleary Gottlieb Steen & Hamilton LLP (included in Exhibit 5.2). | |
| 23.3 | Consent of Deloitte LLP. | |
| 24 | Powers of Attorney (included on the signature pages of this registration statement). | |
| 25.1 | Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Deutsche Bank Trust Company Americas, as trustee, under the GSK plc Indenture. | |
| 25.2 | Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Deutsche Bank Trust Company Americas, as trustee, under the GlaxoSmithKline Capital Inc. Indenture. | |
| 25.3 | Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Deutsche Bank Trust Company Americas, as trustee, under the GlaxoSmithKline Capital plc Indenture. | |
| 107 | Filing Fee Table. | |
| Item 10. | Undertakings |
(a) The undersigned Registrants hereby undertake:
(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement;
(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;
II-6
Table of Contents
(ii) To reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement;
(iii) To include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in this registration statement;
provided, however, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by GSK pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of this registration statement.
(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(4) In the case of GSK, to file a post-effective amendment to this registration statement to include any financial statements required by Item 8.A. of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Securities Act need not be furnished, provided, that GSK includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3) of the Securities Act or Item 8.A. of Form 20-F if such financial statements and information are contained in periodic reports filed with or furnished to the SEC by GSK pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this registration statement.
(5) That, for the purpose of determining liability under the Securities Act to any purchaser:
(i) Each prospectus filed by the Registrants pursuant to Rule 424(b)(3) shall be deemed to be part of this registration statement as of the date the filed prospectus was deemed part of and included in this registration statement; and
II-7
Table of Contents
(ii) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act shall be deemed to be part of and included in this registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of this registration statement relating to the securities in this registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of this registration statement or made in a document incorporated or deemed incorporated by reference into this registration statement or prospectus that is part of this registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in this registration statement or prospectus that was part of this registration statement or made in any such document immediately prior to such effective date.
(6) That, for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned Registrants undertake that in a primary offering of securities of the undersigned Registrants pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned Registrants will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
(i) Any preliminary prospectus or prospectus of the undersigned Registrants relating to the offering required to be filed pursuant to Rule 424;
(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrants or used or referred to by the undersigned Registrants;
(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned Registrants or their securities provided by or on behalf of the undersigned Registrants; and
(iv) Any other communication that is an offer in the offering made by the undersigned Registrants to the purchaser.
(b) The undersigned Registrants hereby undertake that, for purposes of determining any liability under the Securities Act, each filing of GSK’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrants pursuant to the foregoing provisions, or otherwise, the Registrants have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrants of expenses incurred or paid by a director, officer or controlling person of the Registrants in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrants will, unless in the opinion of their counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by them is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
II-8
Table of Contents
INDEX TO EXHIBITS
Table of Contents
Table of Contents
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in London, England, on the 25th day of March, 2024.
| GSK plc | ||
| By: | /s/ Julie Brown | |
| Name: | Julie Brown | |
| Title: | Chief Financial Officer and Executive Director | |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENT, that each person whose signature appears below hereby constitutes and appoints Victoria A. Whyte and Justin Huang, jointly and severally, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments, including post-effective amendments, and supplements to this Registration Statement on Form F-3 (and any and all additional registration statements, including registration statements filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed below by the following persons in the capacities indicated, on March 25, 2024.
| Signature |
Title | |
| /s/ Sir Jonathan Symonds |
Chairman of the Board of Directors | |
| Sir Jonathan Symonds | ||
| /s/ Dame Emma Walmsley |
Chief Executive Officer (principal executive officer) and Executive Director | |
| Dame Emma Walmsley | ||
| /s/ Julie Brown |
Chief Financial Officer (principal financial and accounting officer) and Executive Director | |
| Julie Brown | ||
| /s/ Elizabeth McKee Anderson |
Independent Non-Executive Director | |
| Elizabeth McKee Anderson | ||
| /s/ Charles Bancroft |
Senior Independent Non-Executive Director | |
| Charles Bancroft | ||
| /s/ Dr. Hal Barron |
Non-Executive Director | |
| Dr. Hal Barron | ||
|
|
Independent Non-Executive Director | |
| Dr. Anne Beal | ||
| /s/ Wendy Becker |
Independent Non-Executive Director | |
| Wendy Becker | ||
Table of Contents
| Signature |
Title | |
| /s/ Dr Harry C Dietz |
Independent Non-Executive Director | |
| Dr Harry C Dietz | ||
| /s/ Dr Jesse Goodman |
Independent Non-Executive Director | |
| Dr Jesse Goodman | ||
| /s/ Jeannie Lee |
Independent Non-Executive Director | |
| Jeannie Lee | ||
| /s/ Urs Rohner |
Independent Non-Executive Director | |
| Urs Rohner | ||
| /s/ Dr Vishal Sikka |
Independent Non-Executive Director | |
| Dr Vishal Sikka | ||
| /s/ Justin Huang |
Senior Counsel (Business Development & Corporate US Legal) and Authorized Representative in the United States | |
| Justin Huang | ||
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in London, England, on the 25th day of March, 2024.
| GLAXOSMITHKLINE CAPITAL INC. | ||
| By: | /s/ Gabriel Millan | |
| Name: | Gabriel Millan | |
| Title: | Director and President | |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENT, that each person whose signature appears below hereby constitutes and appoints Victoria A. Whyte and Justin Huang, jointly and severally, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments, including post-effective amendments, and supplements to this Registration Statement on Form F-3 (and any and all additional registration statements, including registration statements filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities indicated, on March 25, 2024.
| Signature |
Title | |
| /s/ Gabriel Millan |
Director and President (principal executive officer, principal financial and accounting officer) | |
| Gabriel Millan | ||
| /s/ Richard J. Latchford |
Director and Vice President | |
| Richard J. Latchford | ||
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in London, England, on the 25th day of March, 2024.
| GLAXOSMITHKLINE CAPITAL PLC | ||
| By: | /s/ Julie Brown | |
| Name: | Julie Brown | |
| Title: | Director | |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENT, that each person whose signature appears below hereby constitutes and appoints Victoria A. Whyte and Justin Huang, jointly and severally, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments, including post-effective amendments, and supplements to this Registration Statement on Form F-3 (and any and all additional registration statements, including registration statements filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended), and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities indicated, on March 25, 2024.
| Signature |
Title | |
| /s/ Julie Brown Julie Brown |
Director and President (principal executive officer, principal financial and accounting officer) | |
| /s/ Ciara Lynch Ciara Lynch, for and on behalf of Edinburgh Pharmaceutical Industries Limited |
Corporate Director | |
| /s/ Adam Walker Adam Walker, for and on behalf of Glaxo Group Limited |
Corporate Director | |
| /s/ Justin Huang Justin Huang |
Senior Counsel (Business Development & Corporate US Legal) and Authorized Representative in the United States | |
Exhibit 1.1
UNDERWRITING AGREEMENT
between
GSK plc
as Issuer
and
[ ]
as Representatives of the Underwriters
Dated as of [ ], 20[ ]
TABLE OF CONTENTS
| Page | ||||||
| 1. |
Representations and Warranties |
2 | ||||
| 2. |
Purchase and Sale |
5 | ||||
| 3. |
Delivery and Payment |
5 | ||||
| 4. |
Payment of Expenses |
5 | ||||
| 5. |
Agreements |
6 | ||||
| 6. |
Conditions to the Obligations of the Underwriters |
8 | ||||
| 7. |
Reimbursement of Underwriters’ Expenses |
10 | ||||
| 8. |
Indemnification and Contribution |
10 | ||||
| 9. |
Default by an Underwriter |
13 | ||||
| 10. |
Termination |
13 | ||||
| 11. |
Representations and Indemnities to Survive |
14 | ||||
| 12. |
Notices |
14 | ||||
| 13. |
Successors |
14 | ||||
| 14. |
Applicable Law |
14 | ||||
| 15. |
Counterparts |
14 | ||||
| 16. |
Headings |
14 | ||||
| 17. |
No Fiduciary Duty |
14 | ||||
| 18. |
Consent to Jurisdiction; Appointment of Agent to Accept Service of Process |
15 | ||||
| 19. |
Recognition of the U.S. Special Resolution Regimes |
16 | ||||
| 20. |
Definitions |
16 | ||||
SCHEDULES
| Schedule I |
Terms of the Debt Securities | |
| Schedule II |
Underwriting Commitments | |
| Schedule III |
Schedule of Free Writing Prospectuses included in the Disclosure Package | |
| Schedule IV |
Form of Pricing Term Sheet | |
| Schedule V |
Schedule of Selling Agents |
EXHIBITS
| Exhibit A-1 |
Form of Opinion of U.S. Counsel to the Company | |
| Exhibit A-2 |
Form of Opinion of U.K. Counsel to the Company | |
| Exhibit B |
Form of Letter of Counsel to the Company |
i
GSK plc
[ ] Notes Due 20[ ]
Underwriting Agreement
[ ], 20[ ]
[ ]
as Representatives of the
several Underwriters named
in Schedule II hereto
Ladies and Gentlemen:
GSK plc, a public limited company incorporated in England and Wales (the “Company”), proposes to sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the principal amount of its securities identified in Schedule I hereto (the “Securities”), to be issued under an indenture dated as of March 4, 2008 (as amended, modified or supplemented by the First Supplemental Indenture dated as of March 21, 2014, the “Indenture”), between the Company and Deutsche Bank Trust Company Americas, as trustee (the “Trustee”) (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among the Company, the Trustee and Law Debenture Trust Company of New York).
Any reference herein to the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Final Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 6 of Form F-3 that were filed under the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations of the U.S. Securities and Exchange Commission (the “Commission”) thereunder (collectively, the “Exchange Act”), on or before the Effective Date of the Registration Statement or the issue date of the Base Prospectus, any Preliminary Prospectus or the Final Prospectus, as the case may be; and any reference herein to the terms “amend,” “amendment” or “supplement” with respect to the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Final Prospectus shall be deemed to refer to and include the filing of any document under the Exchange Act after the Effective Date of the Registration Statement or the issue date of the Base Prospectus, any Preliminary Prospectus or the Final Prospectus, as the case may be, deemed to be incorporated therein by reference. Certain terms used herein are defined in Section 19 hereof.
1. Representations and Warranties. The Company represents and warrants to, and agrees with, each Underwriter as follows:
(a) Registration Statement Effective. The Company meets the requirements for use of Form F-3 under the U.S. Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Securities Act”) and has filed with the Commission an automatic shelf registration statement, as defined in Rule 405 (No. 333-[ ]) on Form F-3, including a related Base Prospectus, for registration under the Securities Act of the offering and sale from time to time of certain debt securities, including the Securities. Such Registration Statement, including any amendments thereto filed prior to the Execution Time, became effective upon filing. The Company may have filed with the Commission, as part of an amendment to the Registration Statement or pursuant to Rule 424(b), one or more preliminary prospectus supplements relating to the Securities, each of which will have previously been furnished to you. The Company will file with the Commission a final prospectus supplement relating to the Securities in accordance with Rule 424(b). As filed, such final prospectus supplement shall contain all information required by the Securities Act, and, except to the extent the Representatives shall agree in writing to a modification, shall be in all substantive respects in the form furnished to you prior to the Execution Time or, to the extent not completed at the Execution Time, shall contain only such specific additional information and other changes (beyond that contained in the Base Prospectus and any Preliminary Prospectus) as the Company has advised you, prior to the Execution Time, will be included or made therein. The Registration Statement, at the Execution Time, meets the requirements set forth in Rule 415(a)(1)(x). No stop order suspending the effectiveness of the Registration Statement has been issued and no proceeding for that purpose has been instituted or, to the knowledge of the Company, threatened by the Commission.
(b) Registration Statement Not Misleading. On each Effective Date, the Registration Statement complied in all material respects with the applicable requirements of the Securities Act; on each Effective Date and at the Execution Time, the Registration Statement did not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein not misleading; and on its date as reflected in any filing pursuant to Rule 424(b) under the Securities Act and on the Closing Date (as defined below), the Final Prospectus (together with any supplement thereto) will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the Company makes no representation or warranty as to (i) the Statement of Eligibility and Qualification of the Trustee under the Trust Indenture Act (Form T-1), which is included in the Registration Statement, or (ii) the information contained in or omitted from the Registration Statement or the Final Prospectus (or any supplement thereto) in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of any Underwriter through the Representatives specifically for inclusion in the Registration Statement or the Final Prospectus (or any supplement thereto), it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8(b) hereof.
2
(c) Disclosure Package. At the Execution Time, (i) the Disclosure Package and (ii) each electronic road show, if any, when taken together as a whole with the Disclosure Package, do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The preceding sentence does not apply to statements in or omissions from the Disclosure Package based upon and in conformity with written information furnished to the Company by any Underwriter through the Representatives specifically for use therein, it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8(b) hereof.
(d) Well-Known Seasoned Issuer. (i) At the time of filing the Registration Statement, (ii) at the time of the most recent amendment thereto for the purposes of complying with Section 10(a)(3) of the Securities Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Sections 13 or 15(d) of the Exchange Act or form of prospectus) and (iii) at the time the Company or any person acting on their behalf (within the meaning, for this clause only, of Rule 163(c)) made any offer relating to the Securities in reliance on the exemption in Rule 163, the Company was or is (as the case may be) a “well-known seasoned issuer” as defined in Rule 405. The Company agrees to pay the fees required by the Commission relating to the Securities within the time required by Rule 456(b)(1) without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r).
(e) Not an Ineligible Issuer. (i) At the earliest time after the filing of the Registration Statement that the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2)) of the Securities and (ii) as of the Execution Time (with such date being used as the determination date for purposes of this clause (ii)) the Company was not and is not an Ineligible Issuer (as defined in Rule 405), without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary to consider whether the Company would be considered an Ineligible Issuer.
(f) Issuer Free Writing Prospectus. Each Issuer Free Writing Prospectus (including the final term sheet prepared and filed pursuant to Section 5(c) hereof) does not include any information that conflicts with the information contained in the Registration Statement, including any document incorporated therein by reference and any prospectus supplement deemed to be a part thereof that has not been superseded or modified. The foregoing sentence does not apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to the Company by any Underwriter through the Representatives specifically for use therein, it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8(b) hereof.
(g) Authorization of Indenture and Securities. The Indenture has been duly authorized, executed and delivered by the Company and has been duly qualified under the U.S. Trust Indenture Act of 1939, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Trust Indenture Act”); the Securities have been duly authorized by the Company, and when the Securities are delivered and paid for pursuant to this Agreement on the Closing Date, the Securities will have been duly executed, authenticated, issued and delivered and will constitute valid and legally binding
3
obligations of the Company, enforceable in accordance with their terms, subject to bankruptcy, insolvency and similar laws affecting creditors’ rights generally and to general principles of equity; and, when the Securities have been duly executed, authenticated, issued and delivered, the Securities will conform in all material respects to the description thereof contained in the Disclosure Package and the Final Prospectus.
(h) Organization of the Company. The Company is organized and validly existing as a public limited company under the laws of England and Wales, with power and authority to own its properties and conduct its business as described in the Disclosure Package and the Final Prospectus.
(i) No Consents. No consent, approval, authorization, or order of, or filing with, any governmental agency or body or any court is required for the consummation by the Company of the transactions contemplated by this Agreement in connection with the issuance and sale of the Securities by the Company, except such as have been obtained or made under the Securities Act, the Exchange Act and the Trust Indenture Act and such as may be required under state securities laws or the securities laws of any jurisdiction outside the United States in which the Securities are offered and sold.
(j) No Breach or Default. The execution, delivery and performance by the Company of the Indenture, this Agreement and the issuance and sale of the Securities and compliance with the terms and provisions thereof by the Company will not result in a breach or violation of any of the terms and provisions of, or constitute a default under (i) any law or regulation of the jurisdiction of incorporation of the Company, (ii) any material agreement or instrument to which the Company or any of the Company’s subsidiaries is a party or by which the Company or the Company’s subsidiaries is bound or to which any of their respective properties is subject, or (iii) the charter or by-laws of the Company, except in the cases of clauses (i) and (ii) above for such breaches, violations or defaults that would not affect the validity, binding nature or enforceability of the Indenture or the Securities or have a material adverse effect on the financial condition, earnings, business or properties of the Company and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business.
(k) Investment Company Act. The Company is not, nor, after giving effect to the offering and sale of the Securities and the application of the proceeds therefrom as described in the Disclosure Package and the Final Prospectus, will be an “investment company” as defined in the U.S. Investment Company Act of 1940, as amended.
(l) Disclosure Controls. The Company and its subsidiaries maintain “disclosure controls and procedures” (as such term is defined in Rule 13a-15(e) under the Exchange Act); such disclosure controls and procedures are effective.
Any certificate signed by any officer of the Company and delivered to the Representatives or counsel for the Underwriters in connection with the offering of the Securities shall be deemed a representation and warranty by the Company, as to matters covered thereby, to each Underwriter.
4
2. Purchase and Sale. Subject to the terms and conditions and in reliance upon the representations and warranties herein set forth, the Company agrees to sell to each Underwriter, and each Underwriter agrees, severally and not jointly, to purchase from the Company, at the purchase price set forth in Schedule I hereto the principal amount of the Securities set forth opposite such Underwriter’s name in Schedule II hereto.
3. Delivery and Payment. Delivery of and payment for the Securities shall be made on the date and at the time specified in Schedule I hereto or on such other date and at such other time as the Company and the Representatives may agree (such date and time of delivery and payment for the Securities being herein called the “Closing Date”). For purposes of this Agreement, “Business Day” shall mean any day other than a Saturday, Sunday or legal holiday or day on which banking institutions or trust companies are authorized or obligated by law to close in New York City or London.
Delivery of the Securities shall be made to the Representatives for the respective accounts of the several Underwriters against payment by the several Underwriters through the Representatives of the purchase price thereof to or upon the order of the Company by wire transfer payable in same-day funds to an account specified by the Company. Delivery of the Securities shall be made through the facilities of The Depository Trust Company unless the Representatives shall otherwise instruct.
4. Payment of Expenses. The Company agrees to pay or cause to be paid the following: (i) except as provided in the proviso contained in Section 5(g) hereof, the fees, disbursements and expenses of counsel and accountants of the Company in connection with the registration of the Securities under the Securities Act and the qualification of any indenture related to the Securities under the Trust Indenture Act and all other expenses in connection with the preparation, printing and filing of the Registration Statement, the Base Prospectus, any Preliminary Prospectus, the Prospectus and amendments and supplements thereto, the Disclosure Package and any Issuer Free Writing Prospectus and the mailing and delivering of copies thereof to the Underwriters; (ii) the cost of printing or producing this Agreement, the Disclosure Package, any indenture related to the Securities, any Blue Sky and legal investment memoranda and any other documents in connection with the offering, purchase, sale and delivery of the Securities; (iii) any fees charged by securities rating services for rating the Securities; (iv) any filing fees incident to any required review by the Financial Industry Regulatory Authority, Inc. of the terms of the sale of the Securities; (v) the cost of preparing the Securities and of the delivery of the Securities to the Underwriters; (vi) the reasonable fees and expenses of any Trustee and any agent of any Trustee and the reasonable fees and disbursements of counsel for any Trustee in connection with the Indenture and the Securities; and (vii) except as provided in the proviso contained in Section 5(g) hereof, all other reasonable costs and expenses incident to the performance of their obligations hereunder which are not otherwise specifically provided for in this Section. It is understood, however, that, except as provided in this Section, Section 7 and Section 8 hereof, the Underwriters will pay all of their own costs and expenses, including, but not limited to, the fees of their counsel, transfer taxes, documentary or stamp taxes (including United Kingdom stamp duty or stamp duty reserve tax) on resale of any of the Securities by them, and any advertising expenses connected with any offers they may make.
5
5. Agreements. The Company agrees with the several Underwriters as follows:
(a) File Prospectus. The Company will file the Final Prospectus with the Commission pursuant to and in accordance with Rule 424(b) under the Securities Act within the time period prescribed.
(b) Amendments to Registration Statement or Prospectus; Stop Orders. The Company will advise the Representatives promptly of any proposal to amend the Registration Statement or file any supplement (including the Final Prospectus or any Preliminary Prospectus) to the Base Prospectus and will afford the Representatives a reasonable opportunity to comment on any such proposed amendment or supplement. The Company will promptly advise the Representatives of the filing of any such amendment or supplement and of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or the institution or threatening of any proceeding for that purpose. The Company will use its reasonable best efforts to prevent the issuance of any such stop order and, if issued, to obtain as soon as possible the withdrawal thereof.
(c) Final Term Sheet. The Company will prepare a final term sheet, containing solely a description of final terms of the Securities and the offering thereof, in the form approved by you and attached as Schedule IV hereto and to file such term sheet pursuant to Rule 433(d) within the time required by such Rule.
(d) Amendment of Disclosure Package. If, at any time prior to the filing of the Final Prospectus pursuant to Rule 424(b), any event occurs as a result of which the Disclosure Package would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein in the light of the circumstances under which they were made or the circumstances then prevailing not misleading, the Company will (i) notify promptly the Representatives so that any use of the Disclosure Package may cease until it is amended or supplemented; (ii) amend or supplement the Disclosure Package to correct such statement or omission; and (iii) supply any amendment or supplement to you in such quantities as you may reasonably request.
(e) Material Changes. If, at any time when a prospectus relating to the Securities is required to be delivered under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172), any event occurs as a result of which the Final Prospectus as then supplemented would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, or if it shall be necessary to amend the Registration Statement or supplement the Final Prospectus to comply with the Securities Act or the Exchange Act, the Company will promptly notify the Representatives of such event and prepare and file with the Commission an amendment or supplement that will correct such statement or omission or effect such compliance.
6
(f) Delivery of Earnings Statement. As soon as practicable, the Company will make generally available to its security holders an earnings statement or statements of the Company and its subsidiaries that will satisfy the provisions of Section 11(a) of the Securities Act and Rule 158.
(g) Delivery of Registration Statement and Prospectus. The Company will furnish to the Representatives copies of the Registration Statement and, so long as delivery of a prospectus by an Underwriter or dealer may be required by the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172), as many copies of each Preliminary Prospectus, the Final Prospectus and each Issuer Free Writing Prospectus and any supplement to any of the foregoing as the Representatives may reasonably request. The Company will pay the expenses of preparation, printing or other production of all documents relating to the offering; provided that, if any Underwriter is required to deliver a Final Prospectus in connection with sales of Securities at any time six months or more after the date of the Final Prospectus, the expenses relating to such Final Prospectus shall be paid by such Underwriter.
(h) Qualification of Securities. The Company will use its reasonable best efforts to arrange, if necessary, for the qualification of the Securities for sale under the laws of such jurisdictions as the Representatives may reasonably designate, will maintain such qualifications in effect so long as required for the distribution of the Securities and will pay any fee of the Financial Industry Regulatory Authority, Inc. in connection with its review of the offering; provided that in no event shall the Company be obligated to qualify to do business in any jurisdiction where it is not now so qualified, to take any action that would subject it to service of process in suits, other than those arising out of the offering or sale of the Securities, in any jurisdiction where it is not now so subject or to subject itself to taxation as doing business in any such jurisdiction.
(i) No Other Offering Materials. The Company agrees that, unless it has or shall have obtained the prior written consent of the Representatives, and each Underwriter, severally and not jointly, agrees with the Company that, unless it has or shall have obtained, as the case may be, the prior written consent of the Company, it has not made and will not make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405) required to be filed by the Company with the Commission or retained by the Company under Rule 433, other than a free writing prospectus containing the information contained in the final term sheet prepared and filed pursuant to Section 5(c) hereof; provided that the prior written consent of the parties hereto shall be deemed to have been given in respect of the Free Writing Prospectuses included in Schedule III hereto and any electronic road show. Any such free writing prospectus consented to by the Representatives and the Company is hereinafter referred to as a “Permitted Free Writing Prospectus.” The Company agrees that (x) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus and (y) it has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping.
7
(j) Lock-up. The Company will not, without the prior written consent of the Representatives, which consent shall not be unreasonably withheld, offer, sell, contract to sell, pledge, or otherwise dispose of, directly or indirectly, including the filing (or participation in the filing) of a registration statement with the Commission in respect of, any U.S. dollar-denominated debt securities issued or guaranteed by the Company (other than the Securities), which mature more than one year after the Closing Date and which are substantially similar to the Securities, until the Business Day set forth on Schedule I hereto.
(k) Stabilization. The Company will not take, directly or indirectly, any action that is designed to or that constitutes, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities.
(l) Listing. The Company will use reasonable best efforts to have the Securities listed and admitted to trading on the [ ] Stock Exchange or another “recognised stock exchange” (as defined in Section 1005 of the United Kingdom Income Tax Act 2007), and satisfactory evidence of such actions shall have been provided to the Representatives.
6. Conditions to the Obligations of the Underwriters. The obligations of the Underwriters to purchase the Securities shall be subject to the accuracy of the representations and warranties on the part of the Company contained herein as of the Execution Time and as of the Closing Date, to the accuracy of the statements of the Company made in any certificates pursuant to the provisions hereof, to the performance by the Company of its obligations hereunder and to the following additional conditions:
(a) Prospectus Filed; No Stop Order. The Final Prospectus, and any supplement thereto, shall have been filed in the manner and within the time period required by Rule 424(b); the final term sheet contemplated by Section 5(c) hereof, and any other material required to be filed by the Company pursuant to Rule 433(d), shall have been filed with the Commission within the applicable time periods prescribed for such filings by Rule 433; and no stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall have been instituted or, to the knowledge of the Company or any Underwriter, threatened.
(b) Opinions of Counsel to the Company. On the Closing Date, the Representatives, on behalf of the Underwriters, shall have received an opinion or opinions of Cleary Gottlieb Steen & Hamilton LLP, counsel to the Company, dated such date, substantially to the effect set forth in Exhibits A-1 and A-2 hereto.
(c) Letter of Counsel to the Company. On the Closing Date, the Representatives, on behalf of the Underwriters, shall have received a letter of Cleary Gottlieb Steen & Hamilton LLP, counsel to the Company, dated such date, substantially in the form set forth in Exhibit B hereto.
8
(d) Opinion of Counsel to the Underwriters. The Representatives, on behalf of the Underwriters, shall have received from Sidley Austin LLP, counsel for the Underwriters, such opinion or opinions, dated the Closing Date and addressed to the Representatives, on behalf of the Underwriters, with respect to the issuance and sale of the Securities, the Indenture, the Registration Statement, the Disclosure Package and the Final Prospectus (together with any supplement thereto) and other related matters as the Representatives may reasonably require, and the Company shall have furnished to such counsel such documents as they reasonably request for the purpose of enabling them to pass upon such matters.
(e) Certificate of the Company. The Company shall have furnished to the Representatives, on behalf of the Underwriters, a certificate of officers of the Company reasonably satisfactory to the Representatives, dated the Closing Date, to the effect that the signers of such certificate have carefully examined the Registration Statement, the Disclosure Package, the Final Prospectus and any supplements or amendments thereto, as well as each electronic road show used in connection with the offering of the Securities, and this Agreement and that:
(i) the representations and warranties of the Company in this Agreement are true and correct on and as of the Closing Date with the same effect as if made on the Closing Date and the Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior to the Closing Date;
(ii) no stop order suspending the effectiveness of the Registration Statement has been issued and no proceedings for that purpose have been instituted or, to the knowledge of the Company, threatened; and
(iii) since the date of the most recent financial statements included or incorporated by reference in the Disclosure Package and the Final Prospectus (in each case, exclusive of any supplement thereto after the date hereof), there has been no material adverse effect or any development which in the reasonable judgment of the Company will result in any material adverse effect on the financial condition, earnings, business or properties of the Company and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Disclosure Package and the Final Prospectus (in each case, exclusive of any supplement thereto after the date hereof) or as described in such certificate.
(f) Accountants’ Comfort Letters. The Company shall have requested and caused Deloitte LLP to have furnished to the Representatives, on behalf of the Underwriters, and to the affiliates of the Underwriters at the addresses set forth in Schedule V, at the Execution Time and on the Closing Date, letters (which may refer to letters previously delivered to one or more of the Representatives), dated respectively as of the date hereof and as of the Closing Date, in form and substance satisfactory to the Representatives, containing statements and information of the type
9
ordinarily included in accountants’ “comfort letters” to underwriters with respect to the financial statements and certain financial information included or incorporated by reference in the Registration Statement, the Preliminary Prospectus and the Final Prospectus.
(g) No Material Adverse Change. Subsequent to the Execution Time, there shall not have been (i) any change, or any development which in the reasonable judgment of the Company will result in any change, in or affecting the financial condition, earnings, business or properties of the Company and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Disclosure Package and the Final Prospectus (in each case, exclusive of any supplement thereto after the date hereof) or (ii) any decrease in the rating of any of the Company’s debt securities by any “nationally recognized statistical rating organization” (as defined for purposes of Rule 436(g)) or any notice given of any intended or potential decrease in any such rating or of a possible change in any such rating that does not indicate the direction of the possible change, the effect of which, in any case referred to in clause (i) or (ii) above, is, in the judgment of a majority in interest of the Representatives, so material and adverse as to make it impractical or inadvisable to proceed with the offering or delivery of the Securities as contemplated by the Registration Statement, the Disclosure Package and the Final Prospectus (in each case, exclusive of any supplement thereto after the date hereof).
The Representatives may in their sole discretion waive on behalf of the Underwriters compliance with any conditions to the obligations of the Underwriters under this Agreement.
The documents required to be delivered by this Section 6 shall be delivered at the office of Sidley Austin LLP, counsel for the Underwriters, at 787 Seventh Avenue, New York, New York 10019 or 70 St Mary Axe, London EC3A 8BE, United Kingdom, on the Closing Date.
7. Reimbursement of Underwriters’ Expenses. If the sale of the Securities provided for herein is not consummated because any condition to the obligations of the Underwriters set forth in Section 6 hereof is not satisfied or because of any refusal, inability or failure on the part of the Company to perform any agreement herein or comply with any provision hereof other than by reason of a default by any of the Underwriters, the Company will reimburse the Underwriters severally through the Representatives on demand for all out-of-pocket expenses (including reasonable fees and disbursements of counsel) that shall have been reasonably incurred by them in connection with the proposed purchase and sale of the Securities.
8. Indemnification and Contribution.
(a) Indemnification of the Underwriters by the Company. The Company agrees to indemnify and hold harmless each Underwriter, the directors, officers, employees and agents of each Underwriter and each person who controls any Underwriter within the meaning of either the Securities Act or the Exchange Act against any and all losses, claims, damages or liabilities, joint or several, to which they or any of
10
them may become subject under the Securities Act, the Exchange Act or other U.S. federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement as originally filed or in any amendment thereof, or in the Base Prospectus, any Preliminary Prospectus or any other preliminary prospectus supplement relating to the Securities, the Final Prospectus, or any Issuer Free Writing Prospectus or the information contained in the final term sheet required to be prepared and filed pursuant to Section 5(c) hereof, or in any amendment thereof or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and agrees to reimburse each such indemnified party, as incurred, for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the Company will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with written information furnished to the Company by or on behalf of any Underwriter through the Representatives specifically for inclusion therein. This indemnity agreement will be in addition to any liability that the Company may otherwise have.
(b) Indemnification of the Company by the Underwriters. Each Underwriter severally and not jointly agrees to indemnify and hold harmless the Company, each of its directors, each of its officers who signs the Registration Statement, and each person who controls the Company within the meaning of either the Securities Act or the Exchange Act, to the same extent as the foregoing indemnity from the Company to each Underwriter, but only with reference to written information relating to such Underwriter furnished to the Company by or on behalf of such Underwriter through the Representatives specifically for inclusion in the documents referred to in the foregoing indemnity. This indemnity agreement will be in addition to any liability that any Underwriter may otherwise have. The Company acknowledges that the statements set forth in [ ] constitute the only information furnished in writing by or on behalf of the several Underwriters for inclusion in any Preliminary Prospectus, the Final Prospectus or any Issuer Free Writing Prospectus.
(c) Actions Against Parties; Notification. Promptly after receipt by an indemnified party under this Section 8 of notice of the commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against the indemnifying party under this Section 8, notify the indemnifying party in writing of the commencement thereof; but the failure so to notify the indemnifying party (i) will not relieve it from liability under paragraph (a) or (b) above unless and to the extent it did not otherwise learn of such action and such failure results in the forfeiture by the indemnifying party of substantial rights and defenses and (ii) will not, in any event, relieve the indemnifying party from any obligations to any indemnified party other than the indemnification obligation provided in paragraph (a) or (b) above. The indemnifying party shall be entitled to appoint counsel of the indemnifying party’s choice at the indemnifying party’s expense to represent the indemnified party in any action for which
11
indemnification is sought (in which case the indemnifying party shall not thereafter be responsible for the fees and expenses of any separate counsel retained by the indemnified party or parties except as set forth below); provided, however, that such counsel shall be reasonably satisfactory to the indemnified party. Notwithstanding the indemnifying party’s election to appoint counsel to represent the indemnified party in an action, the indemnified party shall have the right to employ a single separate counsel, and the indemnifying party shall bear the reasonable fees, costs and expenses of such separate counsel, if the use of counsel chosen by the indemnifying party to represent the indemnified party would present such counsel with a conflict of interest. An indemnifying party shall not, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding. The indemnifying party shall not be liable for any settlement of any such action, suit or proceeding effected without its written consent.
(d) Contribution. In the event that the indemnity provided in paragraph (a) or (b) of this Section 8 is unavailable to or insufficient to hold harmless an indemnified party for any reason, the Company and the Underwriters severally agree to contribute to the aggregate losses, claims, damages and liabilities (including legal or other expenses reasonably incurred in connection with investigating or defending the same) (collectively “Losses”) to which the Company and one or more of the Underwriters may be subject in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and by the Underwriters on the other from the offering of the Securities; provided, however, that in no case shall any Underwriter (except as may be provided in any agreement among underwriters relating to the offering of the Securities) be responsible for any amount in excess of the underwriting discount or commission applicable to the Securities purchased by such Underwriter hereunder. If the allocation provided by the immediately preceding sentence is unavailable for any reason, the Company and the Underwriters severally shall contribute in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company on the one hand and of the Underwriters on the other in connection with the statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. Benefits received by the Company shall be deemed to be equal to the total net proceeds from the offering (before deducting expenses) received by it, and benefits received by the Underwriters shall be deemed to be equal to the total underwriting discounts and commissions, in each case as set forth on the cover page of the Final Prospectus. Relative fault shall be determined by reference to, among other things, whether any untrue or any alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information provided by the Company on the one hand or the Underwriters on the other, the relative intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The Company and the Underwriters agree that it would not be just and equitable if contribution were determined by pro rata allocation or any other method of allocation
12
that does not take account of the equitable considerations referred to above. Notwithstanding the provisions of this paragraph (d), no person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 8, each person who controls an Underwriter within the meaning of either the Securities Act or the Exchange Act and each director, officer, employee and agent of an Underwriter shall have the same rights to contribution as such Underwriter, and each person who controls the Company within the meaning of either the Securities Act or the Exchange Act, each officer of the Company who shall have signed the Registration Statement and each director of the Company shall have the same rights to contribution as the Company, subject in each case to the applicable terms and conditions of this paragraph (d).
9. Default by an Underwriter. If any one or more Underwriters shall fail to purchase and pay for any of the Securities agreed to be purchased by such Underwriter or Underwriters hereunder and such failure to purchase shall constitute a default in the performance of its or their obligations under this Agreement, the remaining Underwriters shall be obligated severally to take up and pay for (in the respective proportions which the principal amount of Securities set forth opposite their names in Schedule II hereto bears to the aggregate principal amount of Securities set forth opposite the names of all the remaining Underwriters) the Securities that the defaulting Underwriter or Underwriters agreed but failed to purchase; provided, however, that in the event that the aggregate principal amount of Securities that the defaulting Underwriter or Underwriters agreed but failed to purchase shall exceed 10% of the aggregate principal amount of Securities set forth in Schedule II hereto, the remaining Underwriters shall have the right to purchase all, but shall not be under any obligation to purchase any, of the Securities, and if arrangements satisfactory to the Representatives and the Company for the purchase of such Securities by other persons are not made within 36 hours after such default, this Agreement will terminate without liability to any nondefaulting Underwriter or the Company. In the event of a default by any Underwriter as set forth in this Section 9, the Closing Date shall be postponed for such period, not exceeding five Business Days, as the Representatives shall determine in order that the required changes in the Registration Statement and the Final Prospectus or in any other documents or arrangements may be effected. Nothing contained in this Agreement shall relieve any defaulting Underwriter of its liability, if any, to the Company and any nondefaulting Underwriter for damages occasioned by its default hereunder.
10. Termination. This Agreement shall be subject to termination in the absolute discretion of the Representatives, by notice given to the Company prior to delivery of and payment for the Securities, if at any time prior to such time (i) trading in the Company’s Common Stock shall have been suspended by the London Stock Exchange or trading in the Company’s American Depositary Shares shall have been suspended by the Commission or the New York Stock Exchange or trading in securities generally on the New York Stock Exchange or the London Stock Exchange shall have been suspended or materially limited, (ii) a banking moratorium shall have been declared either by U.S. federal or New York State authorities or (iii) there shall have occurred any outbreak or escalation of hostilities, declaration by the United States of a national emergency or war, or other calamity or crisis the effect of which on financial markets is such as to make it, in the reasonable judgment of the Representatives, after consultation with the Company, impractical or inadvisable to proceed with the offering or delivery of the Securities as contemplated by any Preliminary Prospectus or the Final Prospectus (in each case, exclusive of any amendment or supplement thereto).
13
11. Representations and Indemnities to Survive. The respective agreements, representations, warranties, indemnities and other statements of the Company or its officers and of the Underwriters set forth in or made pursuant to this Agreement shall remain in full force and effect, regardless of any investigation made by or on behalf of any Underwriter, the Company or any of the officers, directors, employees, agents or controlling persons referred to in Section 8 hereof, and shall survive delivery of and payment for the Securities. The provisions of Sections 7, 8, 14 and 18 hereof shall survive the termination or cancellation of this Agreement.
12. Notices. All communications hereunder shall be in writing and effective only on receipt, and, (i) if sent to the Representatives, shall be mailed, electronically mailed or delivered to [ ] attention:[ ] or, (ii) if sent to the Company, shall be mailed, electronically mailed or delivered to 980 Great West Road, Brentford, Middlesex, TW8 9GS, England, email: [ ], attention: The Company Secretary.
13. Successors. This Agreement will inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers, directors, employees, agents and controlling persons referred to in Section 8 hereof, and no other person will have any right or obligation hereunder.
14. Applicable Law. This Agreement will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed within the State of New York.
15. Counterparts. This Agreement may be signed by manual or electronic signature (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) in one or more counterparts, each of which shall constitute an original and all of which together shall constitute one and the same agreement. Counterparts may be delivered via electronic mail or other electronic format (i.e., “pdf,” “tif” or “jpg”) transmission or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.
16. Headings. The section headings used herein are for convenience only and shall not affect the construction hereof.
17. No Fiduciary Duty. The Company hereby acknowledges that (a) the purchase and sale of the Securities pursuant to this Agreement is an arm’s-length commercial transaction between the Company, on the one hand, and the Underwriters and any affiliate through which any of them may be acting, on the other hand, (b) the Underwriters are acting as principal and not as an agent or fiduciary of the Company and (c) the Company’s engagements of the Underwriters in connection with the offering and the process leading up to the offering is as independent contractors and not in any other capacity. Furthermore, the Company agrees that it is solely responsible for making its own judgments in connection with the offering
14
(irrespective of whether any of the Underwriters has advised or is currently advising the Company on related or other matters). The Company agrees that it will not claim that the Underwriters have rendered advisory services of any nature or respect in connection with the offering of the Securities, or owe an agency, fiduciary or similar duty to the Company, in connection with such transaction or the process leading thereto.
18. Consent to Jurisdiction; Appointment of Agent to Accept Service of Process.
(a) The Company irrevocably consents and agrees that any legal action, suit or proceeding against it with respect to any matter arising out of or based upon this Agreement may be brought in the courts of the State of New York located in The City of New York or the courts of the United States of America located in The City of New York and hereby irrevocably consents and submits to the non-exclusive jurisdiction of each such court in personam, generally and unconditionally with respect to any such action, suit or proceeding.
(b) The Company hereby irrevocably designates, appoints, and empowers [ ], with offices currently at [ ], as its designee, appointee and agent to receive, accept and acknowledge for and on its behalf, service of any and all legal process, summons, notices and documents that may be served in any action, suit or proceeding brought against the Company in any such United States or State court with respect to any matter arising out of or based upon this Agreement and that may be made on such designee, appointee and agent in accordance with legal procedures prescribed for such courts. The Company further hereby irrevocably consents and agrees to the service of any and all legal process, summons, notices and documents in any such action, suit or proceeding against it by serving a copy thereof upon the relevant agent for service of process referred to in this Section 18 (whether or not the appointment of such agent shall for any reason prove to be ineffective or such agent shall accept or acknowledge such service). The Company agrees that the failure of any such designee, appointee and agent to give any notice of such service to it shall not impair or affect in any way the validity of such service or any judgment rendered in any such action or proceeding based thereon. Nothing herein shall in any way be deemed to limit the ability of the Underwriters to serve such legal process, summons, notices and documents in any other manner permitted by applicable law or to obtain jurisdiction over the Company or bring actions, suits or proceedings against the Company in such other jurisdictions, and in such manner, as may be permitted by applicable law. The Company hereby irrevocably and unconditionally waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of venue of any of the aforesaid actions, suits or proceedings arising out of or based upon this Agreement brought in the United States federal courts located in The City of New York or the courts of the State of New York located in The City of New York and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum.
15
19. Recognition of the U.S. Special Resolution Regimes. In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime.
In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime.
For purposes of foregoing two paragraphs, “BHC Act Affiliate” has the meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k); “Covered Entity” means any of the following: (i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b), (ii) a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b) or (iii) a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b); “Default Right” has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable; and “U.S. Special Resolution Regime” means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
20. Definitions. The terms that follow, when used in this Agreement, shall have the meanings indicated.
“Base Prospectus” shall mean the base prospectus referred to in Section 1(a) above contained in the Registration Statement at the Execution Time.
“Disclosure Package” shall mean (i) the Base Prospectus, (ii) the Preliminary Prospectus used most recently prior to the Execution Time, (iii) the Issuer Free Writing Prospectuses, if any, identified in Schedule III hereto, (iv) the final term sheet prepared and filed pursuant to Section 5(c) hereof, if any, and (v) any other Free Writing Prospectus that the parties hereto shall hereafter expressly agree in writing to treat as part of the Disclosure Package.
“Effective Date” shall mean each date and time that the Registration Statement and any post-effective amendment or amendments thereto became or becomes effective.
“Execution Time” shall mean the date and time that this Agreement is executed and delivered by the parties hereto.
“Final Prospectus” shall mean the prospectus supplement relating to the Securities that was first filed pursuant to Rule 424(b) after the Execution Time, together with the Base Prospectus.
“Free Writing Prospectus” shall mean a free writing prospectus, as defined in Rule 405.
“Issuer Free Writing Prospectus” shall mean an issuer free writing prospectus, as defined in Rule 433.
16
“Preliminary Prospectus” shall mean any preliminary prospectus supplement to the Base Prospectus referred to in Section 1(a) above which is used prior to the filing of the Final Prospectus, together with the Base Prospectus.
“Registration Statement” shall mean the registration statement referred to in Section 1(a) above, including exhibits and financial statements and any prospectus supplement relating to the Securities that is filed with the Commission pursuant to Rule 424(b) and deemed part of such registration statement pursuant to Rule 430B, as amended on each Effective Date and, in the event any post-effective amendment thereto becomes effective prior to the Closing Date, shall also mean such registration statement as so amended.
“Rule 158”, “Rule 163”, “Rule 164”, “Rule 172”, “Rule 405”, “Rule 415”, “Rule 424”, “Rule 430B”, “Rule 433”, “Rule 436”, “Rule 456” and “Rule 457” refer to such rules under the Securities Act.
17
If the foregoing is in accordance with your understanding of our agreement, please sign and return to us the enclosed duplicate hereof, whereupon this letter and your acceptance shall represent a binding agreement among the Company and the several Underwriters.
| VERY TRULY YOURS, | ||
| GSK plc | ||
| By: | ||
| Name: | ||
| Title: | ||
The foregoing Agreement is hereby confirmed and accepted as of the date specified in Schedule I hereto.
| [ ] | ||
| By: |
||
| Name: | ||
| Title: | ||
For themselves and the other several Underwriters, if any, named in Schedule II to the foregoing Agreement.
SCHEDULE I
Terms of the Debt Securities
Underwriting Agreement dated [ ]
Registration Statement Nos. 333-[ ]
Representatives: [ ]
Title, Purchase Price and Description of Securities:
Title: [ ]
Principal amount: $[ ]
Purchase price (include accrued interest or amortization, if any): $[ ]
Sinking fund provisions: [ ]
Redemption provisions: [ ]
Other provisions: As described in the applicable prospectus supplement referred to in this Agreement.
| Closing Date, Time and Location: | [ ] at [ ]a.m./p.m., simultaneously, at Sidley Austin LLP, 787 Seventh Avenue, New York, New York 10019 and 70 St Mary Axe, London EC3A 8BE, United Kingdom |
Type of Offering: Non-delayed.
Date referred to in Section 5(j) after which the Company may offer or sell debt securities issued or guaranteed by the Company without the consent of the Representatives: [ ].
I-1
SCHEDULE II
Underwriting Commitments
| Underwriters |
Principal Amount of Securities to be Purchased |
|||
| [Names of Underwriters] |
||||
| Total |
$ | |||
|
|
|
|||
II-1
SCHEDULE III
Schedule of Free Writing Prospectuses included in the Disclosure Package
III-1
SCHEDULE IV
Pricing Term Sheet
IV-1
Filed Pursuant to Rule 433
Registration Nos. 333-[ ]
[ ], 20[ ]
FORM OF PRICING TERM SHEET
GSK plc
[•]% Notes due 20[•]
| Issuer: | GSK plc | |||
| Principal Amount: | $[•] | |||
| Trade Date | [•], 20[•] | |||
| Maturity Date: | [•], 20[•] | |||
| Coupon: | [•]% | |||
| Interest Payment Dates: | [•], commencing [•] | |||
| Price to Public: | [•]% | |||
| Gross Proceeds to Issuer: | $[•] | |||
| Underwriting Discount and Commissions: | [•]% | |||
| Net Proceeds to Issuer: | $[•] | |||
| Benchmark Treasury: | [•] | |||
| Benchmark Treasury Yield: | [•]% | |||
| Spread to Benchmark Treasury: | + [•]bp | |||
| Yield to Maturity: | [•]% | |||
| Make-Whole Call: | [•] | |||
| CUSIP: | [•] | |||
IV-2
| ISIN: | [•] | |||
| Expected Settlement Date: | [•], 20[•] | |||
| Day Count Fraction: | [•] | |||
| Business Day: | New York and London | |||
| Expected Listing: | [•] | |||
| Denominations: | [•] | |||
| Anticipated Ratings: | [•] by [Moody’s Investors Service, Inc.] [•] by [Standard & Poor’s Ratings Services] | |||
| Joint Book-Running Managers: | [•] | |||
| Co-Managers: | [•] | |||
Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
No PRIIPs KID. No PRIIPs key information document (KID) has been prepared as the Notes are not available to retail clients in the EEA or the UK.
The issuer has filed a registration statement (including a prospectus) and a preliminary prospectus supplement with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering.
You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and the preliminary prospectus supplement if you request it by calling [ ]toll-free at [ ] or [ ].
IV-3
SCHEDULE V
Schedule of Selling Agents
V-1
EXHIBIT A-1
[Form of Opinion of U.S. Counsel to the Company]
A-1-1
EXHIBIT A-2
[Form of Opinion of U.K. Counsel to the Company]
A-2-1
EXHIBIT B
[Form of Letter of Counsel to the Company]
B-1
Exhibit 1.2
UNDERWRITING AGREEMENT
among
GLAXOSMITHKLINE CAPITAL Inc.
as Issuer
GSK plc
as Guarantor
and
[ ]
as Representatives of the Underwriters
Dated as of [ ], 20[ ]
TABLE OF CONTENTS
| Page | ||||||
| 1. | Representations and Warranties |
2 | ||||
| 2. | Purchase and Sale |
5 | ||||
| 3. | Delivery and Payment |
5 | ||||
| 4. | Payment of Expenses |
6 | ||||
| 5. | Agreements |
6 | ||||
| 6. | Conditions to the Obligations of the Underwriters |
9 | ||||
| 7. | Reimbursement of Underwriters’ Expenses |
11 | ||||
| 8. | Indemnification and Contribution |
11 | ||||
| 9. | Default by an Underwriter |
14 | ||||
| 10. | Termination |
14 | ||||
| 11. | Representations and Indemnities to Survive |
14 | ||||
| 12. | Notices |
15 | ||||
| 13. | Successors |
15 | ||||
| 14. | Applicable Law |
15 | ||||
| 15. | Counterparts |
15 | ||||
| 16. | Headings |
15 | ||||
| 17. | No Fiduciary Duty |
15 | ||||
| 18. | Consent to Jurisdiction; Appointment of Agent to Accept Service of Process |
15 | ||||
| 19. | Recognition of the U.S. Special Resolution Regimes |
16 | ||||
| 20. | Definitions |
17 | ||||
SCHEDULES
| Schedule I | Terms of the Debt Securities | |
| Schedule II | Underwriting Commitments | |
| Schedule III | Schedule of Free Writing Prospectuses included in the Disclosure Package | |
| Schedule IV | Form of Pricing Term Sheet | |
| Schedule V | Schedule of Selling Agents |
EXHIBITS
| Exhibit A-1 | Form of Opinion of U.S. Counsel to the Company and the Guarantor | |
| Exhibit A-2 | Form of Opinion of U.K. Counsel to the Company and the Guarantor | |
| Exhibit B | Form of Letter of Counsel to the Company and the Guarantor |
i
GlaxoSmithKline Capital Inc.
[ ] Notes Due 20[ ]
Fully and Unconditionally Guaranteed by
GSK plc
Underwriting Agreement
[ ], 20[ ]
[ ]
as Representatives of the
several Underwriters named
in Schedule II hereto
Ladies and Gentlemen:
GlaxoSmithKline Capital Inc., a corporation organized under the laws of the State of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the principal amount of its securities identified in Schedule I hereto (the “Debt Securities”), to be issued under an indenture dated as of April 6, 2004 (as amended, modified or supplemented by the First Supplemental Indenture dated as of March 18, 2013, and as further amended, modified or supplemented by the Second Supplemental Indenture dated as of March 21, 2014 and a Third Supplemental Indenture dated as of May 15, 2018, the “Indenture”), among the Company, GSK plc, as guarantor (the “Guarantor”), and Deutsche Bank Trust Company Americas (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among the Company, the Guarantor, Deutsche Bank Trust Company Americas and Law Debenture Trust Company of New York), as trustee (the “Trustee”). The Debt Securities will be fully and unconditionally guaranteed by the Guarantor as to payment of principal, premium, if any, and interest (the “Guarantees” and, together with the Debt Securities, the “Securities”).
Any reference herein to the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Final Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 6 of Form F-3 that were filed under the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations of the U.S. Securities and Exchange Commission (the “Commission”) thereunder (collectively, the “Exchange Act”), on or before the Effective Date of the Registration Statement or the issue date of the Base Prospectus, any Preliminary Prospectus or the Final Prospectus, as the case may be; and any reference herein to the terms “amend,” “amendment” or “supplement” with respect to the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Final Prospectus shall be deemed to refer to and include the filing of any document under the Exchange Act after the Effective Date of the Registration Statement or the issue date of the Base Prospectus, any Preliminary Prospectus or the Final Prospectus, as the case may be, deemed to be incorporated therein by reference. Certain terms used herein are defined in Section 19 hereof.
1. Representations and Warranties. The Company and the Guarantor jointly and severally represent and warrant to, and agree with, each Underwriter as follows:
(a) Registration Statement Effective. The Company and the Guarantor meet the requirements for use of Form F-3 under the U.S. Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Securities Act”) and have filed with the Commission an automatic shelf registration statement, as defined in Rule 405 (No. 333-[ ]) on Form F-3, including a related Base Prospectus, for registration under the Securities Act of the offering and sale from time to time of certain debt securities, including the Securities. Such Registration Statement, including any amendments thereto filed prior to the Execution Time, became effective upon filing. The Company and the Guarantor may have filed with the Commission, as part of an amendment to the Registration Statement or pursuant to Rule 424(b), one or more preliminary prospectus supplements relating to the Securities, each of which will have previously been furnished to you. The Company and the Guarantor will file with the Commission a final prospectus supplement relating to the Securities in accordance with Rule 424(b). As filed, such final prospectus supplement shall contain all information required by the Securities Act, and, except to the extent the Representatives shall agree in writing to a modification, shall be in all substantive respects in the form furnished to you prior to the Execution Time or, to the extent not completed at the Execution Time, shall contain only such specific additional information and other changes (beyond that contained in the Base Prospectus and any Preliminary Prospectus) as the Company and the Guarantor have advised you, prior to the Execution Time, will be included or made therein. The Registration Statement, at the Execution Time, meets the requirements set forth in Rule 415(a)(1)(x). No stop order suspending the effectiveness of the Registration Statement has been issued and no proceeding for that purpose has been instituted or, to the knowledge of the Company or the Guarantor, threatened by the Commission.
(b) Registration Statement Not Misleading. On each Effective Date, the Registration Statement complied in all material respects with the applicable requirements of the Securities Act; on each Effective Date and at the Execution Time, the Registration Statement did not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein not misleading; and on its date as reflected in any filing pursuant to Rule 424(b) under the Securities Act and on the Closing Date (as defined below), the Final Prospectus (together with any supplement thereto) will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the Company and the Guarantor make no representation or warranty as to (i) the Statement of Eligibility and Qualification of the Trustee under the Trust Indenture Act (Form T-1), which is included in the Registration Statement, or (ii) the information contained in or omitted from the Registration Statement or the Final Prospectus (or any supplement thereto) in reliance upon and in conformity with information furnished in writing to the Company or the Guarantor by or on behalf of any Underwriter through the Representatives
2
specifically for inclusion in the Registration Statement or the Final Prospectus (or any supplement thereto), it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8(b) hereof.
(c) Disclosure Package. At the Execution Time, (i) the Disclosure Package and (ii) each electronic road show, if any, when taken together as a whole with the Disclosure Package, do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The preceding sentence does not apply to statements in or omissions from the Disclosure Package based upon and in conformity with written information furnished to the Company or the Guarantor by any Underwriter through the Representatives specifically for use therein, it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8(b) hereof.
(d) Well-Known Seasoned Issuer. (i) At the time of filing the Registration Statement, (ii) at the time of the most recent amendment thereto for the purposes of complying with Section 10(a)(3) of the Securities Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Sections 13 or 15(d) of the Exchange Act or form of prospectus) and (iii) at the time the Company, the Guarantor or any person acting on their behalf (within the meaning, for this clause only, of Rule 163(c)) made any offer relating to the Securities in reliance on the exemption in Rule 163, each of the Company and the Guarantor was or is (as the case may be) a “well-known seasoned issuer” as defined in Rule 405. The Company and the Guarantor agrees to pay the fees required by the Commission relating to the Securities within the time required by Rule 456(b)(1) without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r).
(e) Not an Ineligible Issuer. (i) At the earliest time after the filing of the Registration Statement that the Company, the Guarantor or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2)) of the Securities and (ii) as of the Execution Time (with such date being used as the determination date for purposes of this clause (ii)), neither the Company nor the Guarantor was or is an Ineligible Issuer (as defined in Rule 405), without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary to consider whether the Company or the Guarantor would be considered an Ineligible Issuer.
(f) Issuer Free Writing Prospectus. Each Issuer Free Writing Prospectus (including the final term sheet prepared and filed pursuant to Section 5(c) hereof) does not include any information that conflicts with the information contained in the Registration Statement, including any document incorporated therein by reference and any prospectus supplement deemed to be a part thereof that has not been superseded or modified. The foregoing sentence does not apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to the Company or the Guarantor by any Underwriter through the Representatives specifically for use therein, it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8(b) hereof.
3
(g) Authorization of Indenture and Securities. The Indenture has been duly authorized, executed and delivered by the Company and the Guarantor and has been duly qualified under the U.S. Trust Indenture Act of 1939, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Trust Indenture Act”); the Debt Securities have been duly authorized by the Company, and when the Debt Securities are delivered and paid for pursuant to this Agreement on the Closing Date, the Debt Securities will have been duly executed, authenticated, issued and delivered and will constitute valid and legally binding obligations of the Company, enforceable in accordance with their terms, subject to bankruptcy, insolvency and similar laws affecting creditors’ rights generally and to general principles of equity; the Guarantees have been duly authorized by the Guarantor and, upon due issuance, authentication and delivery of the Securities and due endorsement of the Guarantees, the Guarantees will have been duly executed, issued and delivered and will constitute valid and legally binding obligations of the Guarantor, enforceable in accordance with their terms, subject to bankruptcy, insolvency and similar laws affecting creditors’ rights generally and to general principles of equity; and, when the Debt Securities have been duly executed, authenticated, issued and delivered and when the Guarantees have been duly endorsed, the Securities will conform in all material respects to the description thereof contained in the Disclosure Package and the Final Prospectus.
(h) Organization of the Company and the Guarantor. The Company is organized and validly existing as a corporation under the laws of the State of Delaware, with power and authority to own its properties and conduct its business as described in the Disclosure Package and the Final Prospectus. The Guarantor is organized and validly existing as a public limited company under the laws of England and Wales, with power and authority to own its properties and conduct its business as described in the Disclosure Package and the Final Prospectus.
(i) No Consents. No consent, approval, authorization, or order of, or filing with, any governmental agency or body or any court is required for the consummation by the Company or the Guarantor of the transactions contemplated by this Agreement in connection with the issuance and sale of the Securities by the Company, except such as have been obtained or made under the Securities Act, the Exchange Act and the Trust Indenture Act and such as may be required under state securities laws or the securities laws of any jurisdiction outside the United States in which the Securities are offered and sold.
(j) No Breach or Default. The execution, delivery and performance by the Company and the Guarantor of the Indenture, this Agreement and the issuance and sale of the Securities and compliance with the terms and provisions thereof by the Company and the Guarantor will not result in a breach or violation of any of the terms and provisions of, or constitute a default under, (i) any law or regulation of the jurisdiction of incorporation of the Company or the Guarantor, (ii) any material agreement or instrument to which the Company or the Guarantor is a party or by which the
4
Company or the Guarantor is bound or to which any of their respective properties is subject, or (iii) the charter or by-laws of the Company or the Guarantor, except in the cases of clauses (i) and (ii) above for such breaches, violations or defaults that would not affect the validity, binding nature or enforceability of the Indenture or the Securities or have a material adverse effect on the financial condition, earnings, business or properties of the Guarantor and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business.
(k) Investment Company Act. Neither the Company nor the Guarantor is nor, after giving effect to the offering and sale of the Securities and the application of the proceeds therefrom as described in the Disclosure Package and the Final Prospectus, will be an “investment company” as defined in the U.S. Investment Company Act of 1940, as amended.
(l) Disclosure Controls. The Guarantor and its subsidiaries maintain “disclosure controls and procedures” (as such term is defined in Rule 13a-15(e) under the Exchange Act); such disclosure controls and procedures are effective.
Any certificate signed by any officer of the Company or the Guarantor and delivered to the Representatives or counsel for the Underwriters in connection with the offering of the Securities shall be deemed a representation and warranty by the Company or the Guarantor, as the case may be, as to matters covered thereby, to each Underwriter.
2. Purchase and Sale. Subject to the terms and conditions and in reliance upon the representations and warranties herein set forth, the Company agrees to sell to each Underwriter, and each Underwriter agrees, severally and not jointly, to purchase from the Company, at the purchase price set forth in Schedule I hereto the principal amount of the Securities set forth opposite such Underwriter’s name in Schedule II hereto.
3. Delivery and Payment. Delivery of and payment for the Securities shall be made on the date and at the time specified in Schedule I hereto or on such other date and at such other time as the Company and the Representatives may agree (such date and time of delivery and payment for the Securities being herein called the “Closing Date”). For purposes of this Agreement, “Business Day” shall mean any day other than a Saturday, Sunday or legal holiday or day on which banking institutions or trust companies are authorized or obligated by law to close in New York City or London.
Delivery of the Securities shall be made to the Representatives for the respective accounts of the several Underwriters against payment by the several Underwriters through the Representatives of the purchase price thereof to or upon the order of the Company by wire transfer payable in same-day funds to an account specified by the Company. Delivery of the Securities shall be made through the facilities of The Depository Trust Company unless the Representatives shall otherwise instruct.
5
4. Payment of Expenses. The Company and the Guarantor jointly agree to pay or cause to be paid the following: (i) except as provided in the proviso contained in Section 5(g) hereof, the fees, disbursements and expenses of counsel and accountants of the Company and the Guarantor in connection with the registration of the Securities under the Securities Act and the qualification of any indenture related to the Securities under the Trust Indenture Act and all other expenses in connection with the preparation, printing and filing of the Registration Statement, the Base Prospectus, any Preliminary Prospectus, the Prospectus and amendments and supplements thereto, the Disclosure Package and any Issuer Free Writing Prospectus and the mailing and delivering of copies thereof to the Underwriters; (ii) the cost of printing or producing this Agreement, the Disclosure Package, any indenture related to the Securities, any Blue Sky and legal investment memoranda and any other documents in connection with the offering, purchase, sale and delivery of the Securities; (iii) any fees charged by securities rating services for rating the Securities; (iv) any filing fees incident to any required review by the Financial Industry Regulatory Authority, Inc. of the terms of the sale of the Securities; (v) the cost of preparing the Securities and of the delivery of the Securities to the Underwriters; (vi) the reasonable fees and expenses of any Trustee and any agent of any Trustee and the reasonable fees and disbursements of counsel for any Trustee in connection with the Indenture and the Securities; and (vii) except as provided in the proviso contained in Section 5(g) hereof, all other reasonable costs and expenses incident to the performance of their obligations hereunder which are not otherwise specifically provided for in this Section. It is understood, however, that, except as provided in this Section, Section 7 and Section 8 hereof, the Underwriters will pay all of their own costs and expenses, including, but not limited to, the fees of their counsel, transfer taxes, documentary or stamp taxes (including United Kingdom stamp duty or stamp duty reserve tax) on resale of any of the Securities by them, and any advertising expenses connected with any offers they may make.
5. Agreements. The Company and the Guarantor agree with the several Underwriters as follows:
(a) File Prospectus. The Company and the Guarantor will file the Final Prospectus with the Commission pursuant to and in accordance with Rule 424(b) under the Securities Act within the time period prescribed.
(b) Amendments to Registration Statement or Prospectus; Stop Orders. The Company and the Guarantor will advise the Representatives promptly of any proposal to amend the Registration Statement or file any supplement (including the Final Prospectus or any Preliminary Prospectus) to the Base Prospectus and will afford the Representatives a reasonable opportunity to comment on any such proposed amendment or supplement. The Company and the Guarantor will promptly advise the Representatives of the filing of any such amendment or supplement and of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or the institution or threatening of any proceeding for that purpose. The Company and the Guarantor will use their reasonable best efforts to prevent the issuance of any such stop order and, if issued, to obtain as soon as possible the withdrawal thereof.
(c) Final Term Sheet. The Company and the Guarantor will prepare a final term sheet, containing solely a description of final terms of the Securities and the offering thereof, in the form approved by you and attached as Schedule IV hereto and to file such term sheet pursuant to Rule 433(d) within the time required by such Rule.
6
(d) Amendment of Disclosure Package. If, at any time prior to the filing of the Final Prospectus pursuant to Rule 424(b), any event occurs as a result of which the Disclosure Package would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein in the light of the circumstances under which they were made or the circumstances then prevailing not misleading, the Company and the Guarantor will (i) notify promptly the Representatives so that any use of the Disclosure Package may cease until it is amended or supplemented; (ii) amend or supplement the Disclosure Package to correct such statement or omission; and (iii) supply any amendment or supplement to you in such quantities as you may reasonably request.
(e) Material Changes. If, at any time when a prospectus relating to the Securities is required to be delivered under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172), any event occurs as a result of which the Final Prospectus as then supplemented would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, or if it shall be necessary to amend the Registration Statement or supplement the Final Prospectus to comply with the Securities Act or the Exchange Act, the Company and the Guarantor will promptly notify the Representatives of such event and prepare and file with the Commission an amendment or supplement that will correct such statement or omission or effect such compliance.
(f) Delivery of Earnings Statement. As soon as practicable, the Guarantor will make generally available to its security holders an earnings statement or statements of the Guarantor and its subsidiaries that will satisfy the provisions of Section 11(a) of the Securities Act and Rule 158.
(g) Delivery of Registration Statement and Prospectus. The Company and the Guarantor will furnish to the Representatives copies of the Registration Statement and, so long as delivery of a prospectus by an Underwriter or dealer may be required by the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172), as many copies of each Preliminary Prospectus, the Final Prospectus and each Issuer Free Writing Prospectus and any supplement to any of the foregoing as the Representatives may reasonably request. The Company and the Guarantor will pay the expenses of preparation, printing or other production of all documents relating to the offering; provided that, if any Underwriter is required to deliver a Final Prospectus in connection with sales of Securities at any time six months or more after the date of the Final Prospectus, the expenses relating to such Final Prospectus shall be paid by such Underwriter.
(h) Qualification of Securities. The Company and the Guarantor will use their reasonable best efforts to arrange, if necessary, for the qualification of the Securities for sale under the laws of such jurisdictions as the Representatives may reasonably designate, will maintain such qualifications in effect so long as required for the distribution of the Securities and will pay any fee of the Financial Industry Regulatory Authority, Inc. in connection with its review of the offering; provided that in no event shall the Company or the Guarantor be obligated to qualify to do business in any jurisdiction where it is not now so qualified, to take any action that would subject it to service of process in suits, other than those arising out of the offering or sale of the Securities, in any jurisdiction where it is not now so subject or to subject itself to taxation as doing business in any such jurisdiction.
7
(i) No Other Offering Materials. Each of the Company and the Guarantor agrees that, unless it has or shall have obtained the prior written consent of the Representatives, and each Underwriter, severally and not jointly, agrees with the Company and the Guarantor that, unless it has or shall have obtained, as the case may be, the prior written consent of the Company and the Guarantor, it has not made and will not make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405) required to be filed by the Company or the Guarantor with the Commission or retained by the Company or the Guarantor under Rule 433, other than a free writing prospectus containing the information contained in the final term sheet prepared and filed pursuant to Section 5(c) hereof; provided that the prior written consent of the parties hereto shall be deemed to have been given in respect of the Free Writing Prospectuses included in Schedule III hereto and any electronic road show. Any such free writing prospectus consented to by the Representatives, the Company and the Guarantor is hereinafter referred to as a “Permitted Free Writing Prospectus.” Each of the Company and the Guarantor agrees that (x) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus and (y) it has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping.
(j) Lock-up. Neither the Company nor the Guarantor will, without the prior written consent of the Representatives, which consent shall not be unreasonably withheld, offer, sell, contract to sell, pledge, or otherwise dispose of, directly or indirectly, including the filing (or participation in the filing) of a registration statement with the Commission in respect of, any U.S. dollar-denominated debt securities issued or guaranteed by the Company or the Guarantor (other than the Securities), which mature more than one year after the Closing Date and which are substantially similar to the Securities, until the Business Day set forth on Schedule I hereto.
(k) Stabilization. Neither the Company nor the Guarantor will take, directly or indirectly, any action that is designed to or that constitutes, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company or the Guarantor to facilitate the sale or resale of the Securities.
(l) Listing. The Company and the Guarantor will use reasonable best efforts to have the Securities listed and admitted to trading on the [ ] Stock Exchange or another “recognised stock exchange” (as defined in Section 1005 of the United Kingdom Income Tax Act 2007), and satisfactory evidence of such actions shall have been provided to the Representatives.
8
6. Conditions to the Obligations of the Underwriters. The obligations of the Underwriters to purchase the Securities shall be subject to the accuracy of the representations and warranties on the part of the Company and the Guarantor contained herein as of the Execution Time and as of the Closing Date, to the accuracy of the statements of the Company and the Guarantor made in any certificates pursuant to the provisions hereof, to the performance by the Company and the Guarantor of their obligations hereunder and to the following additional conditions:
(a) Prospectus Filed; No Stop Order. The Final Prospectus, and any supplement thereto, shall have been filed in the manner and within the time period required by Rule 424(b); the final term sheet contemplated by Section 5(c) hereof, and any other material required to be filed by the Company and the Guarantor pursuant to Rule 433(d), shall have been filed with the Commission within the applicable time periods prescribed for such filings by Rule 433; and no stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall have been instituted or, to the knowledge of the Company, the Guarantor or any Underwriter, threatened.
(b) Opinions of Counsel to the Company and the Guarantor. On the Closing Date, the Representatives, on behalf of the Underwriters, shall have received an opinion or opinions of Cleary Gottlieb Steen & Hamilton LLP, counsel to the Company and the Guarantor, dated such date, substantially to the effect set forth in Exhibits A-1 and A-2 hereto.
(c) Letter of Counsel to the Company and the Guarantor. On the Closing Date, the Representatives, on behalf of the Underwriters, shall have received a letter of Cleary Gottlieb Steen & Hamilton LLP, counsel to the Company and the Guarantor, dated such date, substantially in the form set forth in Exhibit B hereto.
(d) Opinion of Counsel to the Underwriters. The Representatives, on behalf of the Underwriters, shall have received from Sidley Austin LLP, counsel for the Underwriters, such opinion or opinions, dated the Closing Date and addressed to the Representatives, on behalf of the Underwriters, with respect to the issuance and sale of the Securities, the Indenture, the Registration Statement, the Disclosure Package and the Final Prospectus (together with any supplement thereto) and other related matters as the Representatives may reasonably require, and the Company and the Guarantor shall have furnished to such counsel such documents as they reasonably request for the purpose of enabling them to pass upon such matters.
(e) Certificate of the Company and the Guarantor. The Company and the Guarantor shall have furnished to the Representatives, on behalf of the Underwriters, a certificate of officers of the Company and the Guarantor reasonably satisfactory to the Representatives, dated the Closing Date, to the effect that the signers of such certificate have carefully examined the Registration Statement, the Disclosure Package, the Final Prospectus and any supplements or amendments thereto, as well as each electronic road show used in connection with the offering of the Securities, and this Agreement and that:
9
(i) the representations and warranties of the Company and the Guarantor in this Agreement are true and correct on and as of the Closing Date with the same effect as if made on the Closing Date and each of the Company and the Guarantor has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior to the Closing Date;
(ii) no stop order suspending the effectiveness of the Registration Statement has been issued and no proceedings for that purpose have been instituted or, to the knowledge of the Company or the Guarantor, threatened; and
(iii) since the date of the most recent financial statements included or incorporated by reference in the Disclosure Package and the Final Prospectus (in each case, exclusive of any supplement thereto after the date hereof), there has been no material adverse effect or any development which in the reasonable judgment of the Company or the Guarantor will result in any material adverse effect on the financial condition, earnings, business or properties of the Guarantor and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Disclosure Package and the Final Prospectus (in each case, exclusive of any supplement thereto after the date hereof) or as described in such certificate.
(f) Accountants’ Comfort Letters. The Company shall have requested and caused Deloitte LLP to have furnished to the Representatives, on behalf of the Underwriters, and to the affiliates of the Underwriters at the addresses set forth in Schedule V, at the Execution Time and on the Closing Date, letters (which may refer to letters previously delivered to one or more of the Representatives), dated respectively as of the date hereof and as of the Closing Date, in form and substance satisfactory to the Representatives, containing statements and information of the type ordinarily included in accountants’ “comfort letters” to underwriters with respect to the financial statements and certain financial information included or incorporated by reference in the Registration Statement, the Preliminary Prospectus and the Final Prospectus.
(g) No Material Adverse Change. Subsequent to the Execution Time, there shall not have been (i) any change, or any development which in the reasonable judgment of the Company or the Guarantor will result in any change, in or affecting the financial condition, earnings, business or properties of the Guarantor and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Disclosure Package and the Final Prospectus (in each case, exclusive of any supplement thereto after the date hereof) or (ii) any decrease in the rating of any of the Guarantor’s debt securities by any “nationally recognized statistical rating organization” (as defined for purposes of Rule 436(g)) or any notice given of any intended or potential decrease in any such rating or of a possible change in any such rating that does not indicate the direction of the possible change, the effect of which, in any case referred to in clause (i) or (ii) above, is, in the judgment of a majority in interest of the Representatives, so material and adverse as to make it impractical or inadvisable to proceed with the offering or delivery of the Securities as contemplated by the Registration Statement, the Disclosure Package and the Final Prospectus (in each case, exclusive of any supplement thereto after the date hereof).
10
The Representatives may in their sole discretion waive on behalf of the Underwriters compliance with any conditions to the obligations of the Underwriters under this Agreement.
The documents required to be delivered by this Section 6 shall be delivered at the office of Sidley Austin LLP, counsel for the Underwriters, at 787 Seventh Avenue, New York, New York 10019 or 70 St Mary Axe, London EC3A 8BE, United Kingdom, on the Closing Date.
7. Reimbursement of Underwriters’ Expenses. If the sale of the Securities provided for herein is not consummated because any condition to the obligations of the Underwriters set forth in Section 6 hereof is not satisfied or because of any refusal, inability or failure on the part of the Company or the Guarantor to perform any agreement herein or comply with any provision hereof other than by reason of a default by any of the Underwriters, the Company and the Guarantor will reimburse the Underwriters severally through the Representatives on demand for all out-of-pocket expenses (including reasonable fees and disbursements of counsel) that shall have been reasonably incurred by them in connection with the proposed purchase and sale of the Securities.
8. Indemnification and Contribution.
(a) Indemnification of the Underwriters by the Company and the Guarantor. The Company and the Guarantor jointly and severally agree to indemnify and hold harmless each Underwriter, the directors, officers, employees and agents of each Underwriter and each person who controls any Underwriter within the meaning of either the Securities Act or the Exchange Act against any and all losses, claims, damages or liabilities, joint or several, to which they or any of them may become subject under the Securities Act, the Exchange Act or other U.S. federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement as originally filed or in any amendment thereof, or in the Base Prospectus, any Preliminary Prospectus or any other preliminary prospectus supplement relating to the Securities, the Final Prospectus, or any Issuer Free Writing Prospectus or the information contained in the final term sheet required to be prepared and filed pursuant to Section 5(c) hereof, or in any amendment thereof or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and agrees to reimburse each such indemnified party, as incurred, for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that neither the Company nor the Guarantor will be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with written information furnished to the Company or the Guarantor by or on behalf of any Underwriter through the Representatives specifically for inclusion therein. This indemnity agreement will be in addition to any liability that the Company or the Guarantor may otherwise have.
11
(b) Indemnification of the Company and the Guarantor by the Underwriters. Each Underwriter severally and not jointly agrees to indemnify and hold harmless each of the Company and the Guarantor, each of their respective directors, each of their respective officers who signs the Registration Statement, and each person who controls the Company or the Guarantor within the meaning of either the Securities Act or the Exchange Act, to the same extent as the foregoing indemnity from the Company and the Guarantor to each Underwriter, but only with reference to written information relating to such Underwriter furnished to the Company or the Guarantor by or on behalf of such Underwriter through the Representatives specifically for inclusion in the documents referred to in the foregoing indemnity. This indemnity agreement will be in addition to any liability that any Underwriter may otherwise have. The Company and the Guarantor acknowledge that the statements set forth in [ ] constitute the only information furnished in writing by or on behalf of the several Underwriters for inclusion in any Preliminary Prospectus, the Final Prospectus or any Issuer Free Writing Prospectus.
(c) Actions Against Parties; Notification. Promptly after receipt by an indemnified party under this Section 8 of notice of the commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against the indemnifying party under this Section 8, notify the indemnifying party in writing of the commencement thereof; but the failure so to notify the indemnifying party (i) will not relieve it from liability under paragraph (a) or (b) above unless and to the extent it did not otherwise learn of such action and such failure results in the forfeiture by the indemnifying party of substantial rights and defenses and (ii) will not, in any event, relieve the indemnifying party from any obligations to any indemnified party other than the indemnification obligation provided in paragraph (a) or (b) above. The indemnifying party shall be entitled to appoint counsel of the indemnifying party’s choice at the indemnifying party’s expense to represent the indemnified party in any action for which indemnification is sought (in which case the indemnifying party shall not thereafter be responsible for the fees and expenses of any separate counsel retained by the indemnified party or parties except as set forth below); provided, however, that such counsel shall be reasonably satisfactory to the indemnified party. Notwithstanding the indemnifying party’s election to appoint counsel to represent the indemnified party in an action, the indemnified party shall have the right to employ a single separate counsel, and the indemnifying party shall bear the reasonable fees, costs and expenses of such separate counsel, if the use of counsel chosen by the indemnifying party to represent the indemnified party would present such counsel with a conflict of interest. An indemnifying party shall not, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding. The indemnifying party shall not be liable for any settlement of any such action, suit or proceeding effected without its written consent.
12
(d) Contribution. In the event that the indemnity provided in paragraph (a) or (b) of this Section 8 is unavailable to or insufficient to hold harmless an indemnified party for any reason, the Company, the Guarantor and the Underwriters severally agree to contribute to the aggregate losses, claims, damages and liabilities (including legal or other expenses reasonably incurred in connection with investigating or defending the same) (collectively “Losses”) to which the Company, the Guarantor and one or more of the Underwriters may be subject in such proportion as is appropriate to reflect the relative benefits received by the Company and the Guarantor on the one hand and by the Underwriters on the other from the offering of the Securities; provided, however, that in no case shall any Underwriter (except as may be provided in any agreement among underwriters relating to the offering of the Securities) be responsible for any amount in excess of the underwriting discount or commission applicable to the Securities purchased by such Underwriter hereunder. If the allocation provided by the immediately preceding sentence is unavailable for any reason, the Company, the Guarantor and the Underwriters severally shall contribute in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company or the Guarantor on the one hand and of the Underwriters on the other in connection with the statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. Benefits received by the Company and the Guarantor shall be deemed to be equal to the total net proceeds from the offering (before deducting expenses) received by it, and benefits received by the Underwriters shall be deemed to be equal to the total underwriting discounts and commissions, in each case as set forth on the cover page of the Final Prospectus. Relative fault shall be determined by reference to, among other things, whether any untrue or any alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information provided by the Company and the Guarantor on the one hand or the Underwriters on the other, the relative intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The Company, the Guarantor and the Underwriters agree that it would not be just and equitable if contribution were determined by pro rata allocation or any other method of allocation that does not take account of the equitable considerations referred to above. Notwithstanding the provisions of this paragraph (d), no person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 8, each person who controls an Underwriter within the meaning of either the Securities Act or the Exchange Act and each director, officer, employee and agent of an Underwriter shall have the same rights to contribution as such Underwriter, and each person who controls the Company or the Guarantor within the meaning of either the Securities Act or the Exchange Act, each officer of the Company or the Guarantor who shall have signed the Registration Statement and each director of the Company or the Guarantor shall have the same rights to contribution as the Company or the Guarantor, as the case may be, subject in each case to the applicable terms and conditions of this paragraph (d).
13
9. Default by an Underwriter. If any one or more Underwriters shall fail to purchase and pay for any of the Securities agreed to be purchased by such Underwriter or Underwriters hereunder and such failure to purchase shall constitute a default in the performance of its or their obligations under this Agreement, the remaining Underwriters shall be obligated severally to take up and pay for (in the respective proportions which the principal amount of Securities set forth opposite their names in Schedule II hereto bears to the aggregate principal amount of Securities set forth opposite the names of all the remaining Underwriters) the Securities that the defaulting Underwriter or Underwriters agreed but failed to purchase; provided, however, that in the event that the aggregate principal amount of Securities that the defaulting Underwriter or Underwriters agreed but failed to purchase shall exceed 10% of the aggregate principal amount of Securities set forth in Schedule II hereto, the remaining Underwriters shall have the right to purchase all, but shall not be under any obligation to purchase any, of the Securities, and if arrangements satisfactory to the Representatives, the Company and the Guarantor for the purchase of such Securities by other persons are not made within 36 hours after such default, this Agreement will terminate without liability to any nondefaulting Underwriter, the Company or the Guarantor. In the event of a default by any Underwriter as set forth in this Section 9, the Closing Date shall be postponed for such period, not exceeding five Business Days, as the Representatives shall determine in order that the required changes in the Registration Statement and the Final Prospectus or in any other documents or arrangements may be effected. Nothing contained in this Agreement shall relieve any defaulting Underwriter of its liability, if any, to the Company, the Guarantor and any nondefaulting Underwriter for damages occasioned by its default hereunder.
10. Termination. This Agreement shall be subject to termination in the absolute discretion of the Representatives, by notice given to the Company and the Guarantor prior to delivery of and payment for the Securities, if at any time prior to such time (i) trading in the Guarantor’s Common Stock shall have been suspended by the London Stock Exchange or trading in the Guarantor’s American Depositary Shares shall have been suspended by the Commission or the New York Stock Exchange or trading in securities generally on the New York Stock Exchange or the London Stock Exchange shall have been suspended or materially limited, (ii) a banking moratorium shall have been declared either by U.S. federal or New York State authorities or (iii) there shall have occurred any outbreak or escalation of hostilities, declaration by the United States of a national emergency or war, or other calamity or crisis the effect of which on financial markets is such as to make it, in the reasonable judgment of the Representatives, after consultation with the Guarantor, impractical or inadvisable to proceed with the offering or delivery of the Securities as contemplated by any Preliminary Prospectus or the Final Prospectus (in each case, exclusive of any amendment or supplement thereto).
11. Representations and Indemnities to Survive. The respective agreements, representations, warranties, indemnities and other statements of the Company and the Guarantor or their respective officers and of the Underwriters set forth in or made pursuant to this Agreement shall remain in full force and effect, regardless of any investigation made by or on behalf of any Underwriter, the Company or the Guarantor or any of the officers, directors, employees, agents or controlling persons referred to in Section 8 hereof, and shall survive delivery of and payment for the Securities. The provisions of Sections 7, 8, 14 and 18 hereof shall survive the termination or cancellation of this Agreement.
14
12. Notices. All communications hereunder shall be in writing and effective only on receipt, and, (i) if sent to the Representatives, shall be mailed, electronically mailed or delivered to [ ] attention:[ ] or, (ii) if sent to the Company or the Guarantor, shall be mailed, electronically mailed or delivered to 980 Great West Road, Brentford, Middlesex, TW8 9GS, England, email: company.secretary@gsk.com, attention: The Company Secretary.
13. Successors. This Agreement will inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers, directors, employees, agents and controlling persons referred to in Section 8 hereof, and no other person will have any right or obligation hereunder.
14. Applicable Law. This Agreement will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed within the State of New York.
15. Counterparts. This Agreement may be signed by manual or electronic signature (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) in one or more counterparts, each of which shall constitute an original and all of which together shall constitute one and the same agreement. Counterparts may be delivered via electronic mail or other electronic format (i.e., “pdf,” “tif” or “jpg”) transmission or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.
16. Headings. The section headings used herein are for convenience only and shall not affect the construction hereof.
17. No Fiduciary Duty. The Company and the Guarantor hereby acknowledge that (a) the purchase and sale of the Securities pursuant to this Agreement is an arm’s-length commercial transaction between the Company and the Guarantor, on the one hand, and the Underwriters and any affiliate through which any of them may be acting, on the other hand, (b) the Underwriters are acting as principal and not as an agent or fiduciary of the Company or the Guarantor and (c) the Company’s and the Guarantor’s engagements of the Underwriters in connection with the offering and the process leading up to the offering is as independent contractors and not in any other capacity. Furthermore, each of the Company and the Guarantor agrees that it is solely responsible for making its own judgments in connection with the offering (irrespective of whether any of the Underwriters has advised or is currently advising the Company or the Guarantor on related or other matters). Each of the Company and the Guarantor agrees that it will not claim that the Underwriters have rendered advisory services of any nature or respect in connection with the offering of the Securities, or owe an agency, fiduciary or similar duty to the Company or the Guarantor, in connection with such transaction or the process leading thereto.
15
18. Consent to Jurisdiction; Appointment of Agent to Accept Service of Process.
(a) The Guarantor irrevocably consents and agrees that any legal action, suit or proceeding against it with respect to any matter arising out of or based upon this Agreement may be brought in the courts of the State of New York located in The City of New York or the courts of the United States of America located in The City of New York and hereby irrevocably consents and submits to the non-exclusive jurisdiction of each such court in personam, generally and unconditionally with respect to any such action, suit or proceeding.
(b) The Guarantor hereby irrevocably designates, appoints, and empowers the Company, with offices currently at 1100 North Market Street, 4th Floor, Suite 4056, Wilmington, Delaware, 19890, as its designee, appointee and agent to receive, accept and acknowledge for and on its behalf, service of any and all legal process, summons, notices and documents that may be served in any action, suit or proceeding brought against the Guarantor in any such United States or State court with respect to any matter arising out of or based upon this Agreement and that may be made on such designee, appointee and agent in accordance with legal procedures prescribed for such courts. The Guarantor further hereby irrevocably consents and agrees to the service of any and all legal process, summons, notices and documents in any such action, suit or proceeding against it by serving a copy thereof upon the relevant agent for service of process referred to in this Section 18 (whether or not the appointment of such agent shall for any reason prove to be ineffective or such agent shall accept or acknowledge such service). The Guarantor agrees that the failure of any such designee, appointee and agent to give any notice of such service to it shall not impair or affect in any way the validity of such service or any judgment rendered in any such action or proceeding based thereon. Nothing herein shall in any way be deemed to limit the ability of the Underwriters to serve such legal process, summons, notices and documents in any other manner permitted by applicable law or to obtain jurisdiction over the Guarantor or bring actions, suits or proceedings against the Guarantor in such other jurisdictions, and in such manner, as may be permitted by applicable law. The Guarantor hereby irrevocably and unconditionally waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of venue of any of the aforesaid actions, suits or proceedings arising out of or based upon this Agreement brought in the United States federal courts located in The City of New York or the courts of the State of New York located in The City of New York and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum.
19. Recognition of the U.S. Special Resolution Regimes. In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime.
In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime.
16
For purposes of foregoing two paragraphs, “BHC Act Affiliate” has the meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k); “Covered Entity” means any of the following: (i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b), (ii) a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b) or (iii) a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b); “Default Right” has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable; and “U.S. Special Resolution Regime” means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
20. Definitions. The terms that follow, when used in this Agreement, shall have the meanings indicated.
“Base Prospectus” shall mean the base prospectus referred to in Section 1(a) above contained in the Registration Statement at the Execution Time.
“Disclosure Package” shall mean (i) the Base Prospectus, (ii) the Preliminary Prospectus used most recently prior to the Execution Time, (iii) the Issuer Free Writing Prospectuses, if any, identified in Schedule III hereto, (iv) the final term sheet prepared and filed pursuant to Section 5(c) hereof, if any, and (v) any other Free Writing Prospectus that the parties hereto shall hereafter expressly agree in writing to treat as part of the Disclosure Package.
“Effective Date” shall mean each date and time that the Registration Statement and any post-effective amendment or amendments thereto became or becomes effective.
“Execution Time” shall mean the date and time that this Agreement is executed and delivered by the parties hereto.
“Final Prospectus” shall mean the prospectus supplement relating to the Securities that was first filed pursuant to Rule 424(b) after the Execution Time, together with the Base Prospectus.
“Free Writing Prospectus” shall mean a free writing prospectus, as defined in Rule 405.
“Issuer Free Writing Prospectus” shall mean an issuer free writing prospectus, as defined in Rule 433.
“Preliminary Prospectus” shall mean any preliminary prospectus supplement to the Base Prospectus referred to in Section 1(a) above which is used prior to the filing of the Final Prospectus, together with the Base Prospectus.
17
“Registration Statement” shall mean the registration statement referred to in Section 1(a) above, including exhibits and financial statements and any prospectus supplement relating to the Securities that is filed with the Commission pursuant to Rule 424(b) and deemed part of such registration statement pursuant to Rule 430B, as amended on each Effective Date and, in the event any post-effective amendment thereto becomes effective prior to the Closing Date, shall also mean such registration statement as so amended.
“Rule 158”, “Rule 163”, “Rule 164”, “Rule 172”, “Rule 405”, “Rule 415”, “Rule 424”, “Rule 430B”, “Rule 433”, “Rule 436”, “Rule 456” and “Rule 457” refer to such rules under the Securities Act.
18
If the foregoing is in accordance with your understanding of our agreement, please sign and return to us the enclosed duplicate hereof, whereupon this letter and your acceptance shall represent a binding agreement among the Company, the Guarantor and the several Underwriters.
| VERY TRULY YOURS, | ||
| GLAXOSMITHKLINE CAPITAL Inc. | ||
| By: |
| |
| Name: | ||
| Title: | ||
| GSK plc | ||
| By: |
| |
| Name: | ||
| Title: | ||
The foregoing Agreement is hereby confirmed and accepted
as of the date specified in Schedule I hereto.
[ ]
| By: |
| |
| Name: | ||
| Title: |
For themselves and the other several Underwriters, if any,
named in Schedule II to the foregoing Agreement.
SCHEDULE I
Terms of the Debt Securities
Underwriting Agreement dated [ ]
Registration Statement Nos. 333-[ ]
Representatives: [ ]
Title, Purchase Price and Description of Securities:
Title: [ ]
Principal amount: $[ ]
Purchase price (include accrued interest or amortization, if any): $[ ]
Sinking fund provisions: [ ]
Redemption provisions: [ ]
Other provisions: As described in the applicable prospectus supplement referred to in this Agreement.
| Closing Date, Time and Location: | [ ] at [ ]a.m./p.m., simultaneously, at Sidley Austin LLP, 787 Seventh Avenue, New York, New York 10019 and 70 St Mary Axe, London EC3A 8BE, United Kingdom |
Type of Offering: Non-delayed.
Date referred to in Section 5(j) after which the Company and the Guarantor may offer or sell debt securities issued or guaranteed by the Company or the Guarantor without the consent of the Representatives: [ ].
I-1
SCHEDULE II
Underwriting Commitments
| Underwriters |
Principal Amount of Securities to be Purchased |
|||
| [Names of Underwriters] |
||||
| Total |
$ | |||
|
|
|
|||
II-2
SCHEDULE III
Schedule of Free Writing Prospectuses included in the Disclosure Package
III-1
SCHEDULE IV
Pricing Term Sheet
IV-1
Filed Pursuant to Rule 433
Registration Nos. 333-[ ]
[ ], 20[ ]
FORM OF PRICING TERM SHEET
GlaxoSmithKline Capital Inc.
[•]% Notes due 20[•]
Fully and unconditionally guaranteed by
GSK plc
| Issuer: | GlaxoSmithKline Capital Inc. | |
| Guarantor: | GSK plc | |
| Principal Amount: |
$[•] | |
| Trade Date |
[•], 20[•] | |
| Maturity Date: |
[•], 20[•] | |
| Coupon: |
[•]% | |
| Interest Payment Dates: |
[•], commencing [•] | |
| Price to Public: |
[•]% | |
| Gross Proceeds to Issuer: |
$[•] | |
| Underwriting Discount and Commissions: |
[•]% | |
| Net Proceeds to Issuer: |
$[•] | |
| Benchmark Treasury: |
[•] | |
| Benchmark Treasury Yield: |
[•]% | |
| Spread to Benchmark Treasury: |
+ [•]bp | |
| Yield to Maturity: |
[•]% | |
IV-2
| Make-Whole Call: |
[•] | |
| CUSIP: |
[•] | |
| ISIN: |
[•] | |
| Expected Settlement Date: |
[•], 20[•] | |
| Day Count Fraction: |
[•] | |
| Business Day: |
New York and London | |
| Expected Listing: |
[•] | |
| Denominations: |
[•] | |
| Anticipated Ratings: |
[•] by [Moody’s Investors Service, Inc.] [•] by [Standard & Poor’s Ratings Services] | |
| Joint Book-Running Managers: |
[•] | |
| Co-Managers: |
[•] | |
Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
No PRIIPs KID. No PRIIPs key information document (KID) has been prepared as the Notes are not available to retail clients in the EEA or the UK.
The issuer and the guarantor have filed a registration statement (including a prospectus) and a preliminary prospectus supplement with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and other documents the issuer and the guarantor have filed with the SEC for more complete information about the issuer, the guarantor and this offering.
You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and the preliminary prospectus supplement if you request it by calling [ ]toll-free at [ ] or [ ].
IV-3
SCHEDULE V
Schedule of Selling Agents
V-1
EXHIBIT A-1
[Form of Opinion of U.S. Counsel to the Company and the Guarantor]
A-1-1
EXHIBIT A-2
[Form of Opinion of U.K. Counsel to the Company and the Guarantor]
A-2-1
EXHIBIT B
[Form of Letter of Counsel to the Company and the Guarantor]
B-1
Exhibit 1.3
UNDERWRITING AGREEMENT
among
GLAXOSMITHKLINE CAPITAL plc
as Issuer
GSK plc
as Guarantor
and
[ ]
as Representatives of the Underwriters
Dated as of [ ], 20[ ]
TABLE OF CONTENTS
| Page | ||||||
| 1. |
Representations and Warranties |
2 | ||||
| 2. |
Purchase and Sale |
5 | ||||
| 3. |
Delivery and Payment |
5 | ||||
| 4. |
Payment of Expenses |
5 | ||||
| 5. |
Agreements |
6 | ||||
| 6. |
Conditions to the Obligations of the Underwriters |
9 | ||||
| 7. |
Reimbursement of Underwriters’ Expenses |
11 | ||||
| 8. |
Indemnification and Contribution |
11 | ||||
| 9. |
Default by an Underwriter |
13 | ||||
| 10. |
Termination |
14 | ||||
| 11. |
Representations and Indemnities to Survive |
14 | ||||
| 12. |
Notices |
14 | ||||
| 13. |
Successors |
15 | ||||
| 14. |
Applicable Law |
15 | ||||
| 15. |
Counterparts |
15 | ||||
| 16. |
Headings |
15 | ||||
| 17. |
No Fiduciary Duty |
15 | ||||
| 18. |
Consent to Jurisdiction; Appointment of Agent to Accept Service of Process |
15 | ||||
| 19. |
Recognition of the U.S. Special Resolution Regimes |
16 | ||||
| 20. |
Definitions |
17 | ||||
| SCHEDULES | ||
| Schedule I |
Terms of the Debt Securities | |
| Schedule II |
Underwriting Commitments | |
| Schedule III |
Schedule of Free Writing Prospectuses included in the Disclosure Package | |
| Schedule IV |
Form of Pricing Term Sheet | |
| Schedule V |
Schedule of Selling Agents | |
| EXHIBITS | ||
| Exhibit A-1 |
Form of Opinion of U.S. Counsel to the Company and the Guarantor | |
| Exhibit A-2 |
Form of Opinion of U.K. Counsel to the Company and the Guarantor | |
| Exhibit B |
Form of Letter of Counsel to the Company and the Guarantor | |
i
GlaxoSmithKline Capital plc
[ ] Notes Due 20[ ]
Fully and Unconditionally Guaranteed by
GSK plc
Underwriting Agreement
[ ], 20[ ]
[ ]
as Representatives of the
several Underwriters named
in Schedule II hereto
Ladies and Gentlemen:
GlaxoSmithKline Capital plc, a public limited company incorporated in England and Wales (the “Company”), proposes to sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the principal amount of its securities identified in Schedule I hereto (the “Debt Securities”), to be issued under an indenture dated as of April 6, 2004 (as amended, modified or supplemented by the First Supplemental Indenture dated as of March 21, 2014 and as further supplemented by the Second Supplemental Indenture dated as of May 15, 2018, the “Indenture”), among the Company, GSK plc, as guarantor (the “Guarantor”), and Deutsche Bank Trust Company Americas (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among the Company, the Guarantor, Deutsche Bank Trust Company Americas and Law Debenture Trust Company of New York), as trustee (the “Trustee”). The Debt Securities will be fully and unconditionally guaranteed by the Guarantor as to payment of principal, premium, if any, and interest (the “Guarantees” and, together with the Debt Securities, the “Securities”).
Any reference herein to the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Final Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 6 of Form F-3 that were filed under the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations of the U.S. Securities and Exchange Commission (the “Commission”) thereunder (collectively, the “Exchange Act”), on or before the Effective Date of the Registration Statement or the issue date of the Base Prospectus, any Preliminary Prospectus or the Final Prospectus, as the case may be; and any reference herein to the terms “amend,” “amendment” or “supplement” with respect to the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Final Prospectus shall be deemed to refer to and include the filing of any document under the Exchange Act after the Effective Date of the Registration Statement or the issue date of the Base Prospectus, any Preliminary Prospectus or the Final Prospectus, as the case may be, deemed to be incorporated therein by reference. Certain terms used herein are defined in Section 19 hereof.
1. Representations and Warranties. The Company and the Guarantor jointly and severally represent and warrant to, and agree with, each Underwriter as follows:
(a) Registration Statement Effective. The Company and the Guarantor meet the requirements for use of Form F-3 under the U.S. Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Securities Act”) and have filed with the Commission an automatic shelf registration statement, as defined in Rule 405 (No. 333-[ ]) on Form F-3, including a related Base Prospectus, for registration under the Securities Act of the offering and sale from time to time of certain debt securities, including the Securities. Such Registration Statement, including any amendments thereto filed prior to the Execution Time, became effective upon filing. The Company and the Guarantor may have filed with the Commission, as part of an amendment to the Registration Statement or pursuant to Rule 424(b), one or more preliminary prospectus supplements relating to the Securities, each of which will have previously been furnished to you. The Company and the Guarantor will file with the Commission a final prospectus supplement relating to the Securities in accordance with Rule 424(b). As filed, such final prospectus supplement shall contain all information required by the Securities Act, and, except to the extent the Representatives shall agree in writing to a modification, shall be in all substantive respects in the form furnished to you prior to the Execution Time or, to the extent not completed at the Execution Time, shall contain only such specific additional information and other changes (beyond that contained in the Base Prospectus and any Preliminary Prospectus) as the Company and the Guarantor have advised you, prior to the Execution Time, will be included or made therein. The Registration Statement, at the Execution Time, meets the requirements set forth in Rule 415(a)(1)(x). No stop order suspending the effectiveness of the Registration Statement has been issued and no proceeding for that purpose has been instituted or, to the knowledge of the Company or the Guarantor, threatened by the Commission.
(b) Registration Statement Not Misleading. On each Effective Date, the Registration Statement complied in all material respects with the applicable requirements of the Securities Act; on each Effective Date and at the Execution Time, the Registration Statement did not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein not misleading; and on its date as reflected in any filing pursuant to Rule 424(b) under the Securities Act and on the Closing Date (as defined below), the Final Prospectus (together with any supplement thereto) will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the Company and the Guarantor make no representation or warranty as to (i) the Statement of Eligibility and Qualification of the Trustee under the Trust Indenture Act (Form T-1), which is included in the Registration Statement, or (ii) the information contained in or omitted from the Registration Statement or the Final Prospectus (or any supplement thereto) in reliance upon and in conformity with information furnished in writing to the Company or the Guarantor by or on behalf of any Underwriter through the Representatives specifically for inclusion in the Registration Statement or the Final Prospectus (or any supplement thereto), it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8(b) hereof.
2
(c) Disclosure Package. At the Execution Time, (i) the Disclosure Package and (ii) each electronic road show, if any, when taken together as a whole with the Disclosure Package, do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The preceding sentence does not apply to statements in or omissions from the Disclosure Package based upon and in conformity with written information furnished to the Company or the Guarantor by any Underwriter through the Representatives specifically for use therein, it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8(b) hereof.
(d) Well-Known Seasoned Issuer. (i) At the time of filing the Registration Statement, (ii) at the time of the most recent amendment thereto for the purposes of complying with Section 10(a)(3) of the Securities Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Sections 13 or 15(d) of the Exchange Act or form of prospectus) and (iii) at the time the Company, the Guarantor or any person acting on their behalf (within the meaning, for this clause only, of Rule 163(c)) made any offer relating to the Securities in reliance on the exemption in Rule 163, each of the Company and the Guarantor was or is (as the case may be) a “well-known seasoned issuer” as defined in Rule 405. The Company and the Guarantor agrees to pay the fees required by the Commission relating to the Securities within the time required by Rule 456(b)(1) without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r).
(e) Not an Ineligible Issuer. (i) At the earliest time after the filing of the Registration Statement that the Company, the Guarantor or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2)) of the Securities and (ii) as of the Execution Time (with such date being used as the determination date for purposes of this clause (ii)), neither the Company nor the Guarantor was or is an Ineligible Issuer (as defined in Rule 405), without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary to consider whether the Company or the Guarantor would be considered an Ineligible Issuer.
(f) Issuer Free Writing Prospectus. Each Issuer Free Writing Prospectus (including the final term sheet prepared and filed pursuant to Section 5(c) hereof) does not include any information that conflicts with the information contained in the Registration Statement, including any document incorporated therein by reference and any prospectus supplement deemed to be a part thereof that has not been superseded or modified. The foregoing sentence does not apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to the Company or the Guarantor by any Underwriter through the Representatives specifically for use therein, it being understood and agreed that the only such information furnished by or on behalf of any Underwriter consists of the information described as such in Section 8(b) hereof.
3
(g) Authorization of Indenture and Securities. The Indenture has been duly authorized, executed and delivered by the Company and the Guarantor and has been duly qualified under the U.S. Trust Indenture Act of 1939, as amended, and the rules and regulations of the Commission thereunder (collectively, the “Trust Indenture Act”); the Debt Securities have been duly authorized by the Company, and when the Debt Securities are delivered and paid for pursuant to this Agreement on the Closing Date, the Debt Securities will have been duly executed, authenticated, issued and delivered and will constitute valid and legally binding obligations of the Company, enforceable in accordance with their terms, subject to bankruptcy, insolvency and similar laws affecting creditors’ rights generally and to general principles of equity; the Guarantees have been duly authorized by the Guarantor and, upon due issuance, authentication and delivery of the Securities and due endorsement of the Guarantees, the Guarantees will have been duly executed, issued and delivered and will constitute valid and legally binding obligations of the Guarantor, enforceable in accordance with their terms, subject to bankruptcy, insolvency and similar laws affecting creditors’ rights generally and to general principles of equity; and, when the Debt Securities have been duly executed, authenticated, issued and delivered and when the Guarantees have been duly endorsed, the Securities will conform in all material respects to the description thereof contained in the Disclosure Package and the Final Prospectus.
(h) Organization of the Company and the Guarantor. Each of the Company and the Guarantor is organized and validly existing as a public limited company under the laws of England and Wales, with power and authority to own its properties and conduct its business as described in the Disclosure Package and the Final Prospectus.
(i) No Consents. No consent, approval, authorization, or order of, or filing with, any governmental agency or body or any court is required for the consummation by the Company or the Guarantor of the transactions contemplated by this Agreement in connection with the issuance and sale of the Securities by the Company, except such as have been obtained or made under the Securities Act, the Exchange Act and the Trust Indenture Act and such as may be required under state securities laws or the securities laws of any jurisdiction outside the United States in which the Securities are offered and sold.
(j) No Breach or Default. The execution, delivery and performance by the Company and the Guarantor of the Indenture, this Agreement and the issuance and sale of the Securities and compliance with the terms and provisions thereof by the Company and the Guarantor will not result in a breach or violation of any of the terms and provisions of, or constitute a default under, (i) any law or regulation of the jurisdiction of incorporation of the Company or the Guarantor, (ii) any material agreement or instrument to which the Company or the Guarantor is a party or by which the Company or the Guarantor is bound or to which any of their respective properties is subject, or (iii) the charter or by-laws of the Company or the Guarantor, except in the cases of clauses (i) and (ii) above for such breaches, violations or defaults that would not affect the validity, binding nature or enforceability of the Indenture or the Securities or have a material adverse effect on the financial condition, earnings, business or properties of the Guarantor and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business.
4
(k) Investment Company Act. Neither the Company nor the Guarantor is nor, after giving effect to the offering and sale of the Securities and the application of the proceeds therefrom as described in the Disclosure Package and the Final Prospectus, will be an “investment company” as defined in the U.S. Investment Company Act of 1940, as amended.
(l) Disclosure Controls. The Guarantor and its subsidiaries maintain “disclosure controls and procedures” (as such term is defined in Rule 13a-15(e) under the Exchange Act); such disclosure controls and procedures are effective.
Any certificate signed by any officer of the Company or the Guarantor and delivered to the Representatives or counsel for the Underwriters in connection with the offering of the Securities shall be deemed a representation and warranty by the Company or the Guarantor, as the case may be, as to matters covered thereby, to each Underwriter.
2. Purchase and Sale. Subject to the terms and conditions and in reliance upon the representations and warranties herein set forth, the Company agrees to sell to each Underwriter, and each Underwriter agrees, severally and not jointly, to purchase from the Company, at the purchase price set forth in Schedule I hereto the principal amount of the Securities set forth opposite such Underwriter’s name in Schedule II hereto.
3. Delivery and Payment. Delivery of and payment for the Securities shall be made on the date and at the time specified in Schedule I hereto or on such other date and at such other time as the Company and the Representatives may agree (such date and time of delivery and payment for the Securities being herein called the “Closing Date”). For purposes of this Agreement, “Business Day” shall mean any day other than a Saturday, Sunday or legal holiday or day on which banking institutions or trust companies are authorized or obligated by law to close in New York City or London.
Delivery of the Securities shall be made to the Representatives for the respective accounts of the several Underwriters against payment by the several Underwriters through the Representatives of the purchase price thereof to or upon the order of the Company by wire transfer payable in same-day funds to an account specified by the Company. Delivery of the Securities shall be made through the facilities of The Depository Trust Company unless the Representatives shall otherwise instruct.
4. Payment of Expenses. The Company and the Guarantor jointly agree to pay or cause to be paid the following: (i) except as provided in the proviso contained in Section 5(g) hereof, the fees, disbursements and expenses of counsel and accountants of the Company and the Guarantor in connection with the registration of the Securities under the Securities Act and the qualification of any indenture related to the Securities under the Trust Indenture Act and all other expenses in connection with the preparation, printing and filing of the Registration Statement, the Base Prospectus, any Preliminary Prospectus, the Prospectus and amendments and supplements thereto, the Disclosure Package and any Issuer Free Writing Prospectus and the mailing and delivering of copies thereof to the Underwriters; (ii) the cost of printing or producing this Agreement, the Disclosure Package, any
5
indenture related to the Securities, any Blue Sky and legal investment memoranda and any other documents in connection with the offering, purchase, sale and delivery of the Securities; (iii) any fees charged by securities rating services for rating the Securities; (iv) any filing fees incident to any required review by the Financial Industry Regulatory Authority, Inc. of the terms of the sale of the Securities; (v) the cost of preparing the Securities and of the delivery of the Securities to the Underwriters; (vi) the reasonable fees and expenses of any Trustee and any agent of any Trustee and the reasonable fees and disbursements of counsel for any Trustee in connection with the Indenture and the Securities; and (vii) except as provided in the proviso contained in Section 5(g) hereof, all other reasonable costs and expenses incident to the performance of their obligations hereunder which are not otherwise specifically provided for in this Section. It is understood, however, that, except as provided in this Section, Section 7 and Section 8 hereof, the Underwriters will pay all of their own costs and expenses, including, but not limited to, the fees of their counsel, transfer taxes, documentary or stamp taxes (including United Kingdom stamp duty or stamp duty reserve tax) on resale of any of the Securities by them, and any advertising expenses connected with any offers they may make.
5. Agreements. The Company and the Guarantor agree with the several Underwriters as follows:
(a) File Prospectus. The Company and the Guarantor will file the Final Prospectus with the Commission pursuant to and in accordance with Rule 424(b) under the Securities Act within the time period prescribed.
(b) Amendments to Registration Statement or Prospectus; Stop Orders. The Company and the Guarantor will advise the Representatives promptly of any proposal to amend the Registration Statement or file any supplement (including the Final Prospectus or any Preliminary Prospectus) to the Base Prospectus and will afford the Representatives a reasonable opportunity to comment on any such proposed amendment or supplement. The Company and the Guarantor will promptly advise the Representatives of the filing of any such amendment or supplement and of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or the institution or threatening of any proceeding for that purpose. The Company and the Guarantor will use their reasonable best efforts to prevent the issuance of any such stop order and, if issued, to obtain as soon as possible the withdrawal thereof.
(c) Final Term Sheet. The Company and the Guarantor will prepare a final term sheet, containing solely a description of final terms of the Securities and the offering thereof, in the form approved by you and attached as Schedule IV hereto and to file such term sheet pursuant to Rule 433(d) within the time required by such Rule.
(d) Amendment of Disclosure Package. If, at any time prior to the filing of the Final Prospectus pursuant to Rule 424(b), any event occurs as a result of which the Disclosure Package would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein in the light of the circumstances under which they were made or the circumstances then prevailing not
6
misleading, the Company and the Guarantor will (i) notify promptly the Representatives so that any use of the Disclosure Package may cease until it is amended or supplemented; (ii) amend or supplement the Disclosure Package to correct such statement or omission; and (iii) supply any amendment or supplement to you in such quantities as you may reasonably request.
(e) Material Changes. If, at any time when a prospectus relating to the Securities is required to be delivered under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172), any event occurs as a result of which the Final Prospectus as then supplemented would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, or if it shall be necessary to amend the Registration Statement or supplement the Final Prospectus to comply with the Securities Act or the Exchange Act, the Company and the Guarantor will promptly notify the Representatives of such event and prepare and file with the Commission an amendment or supplement that will correct such statement or omission or effect such compliance.
(f) Delivery of Earnings Statement. As soon as practicable, the Guarantor will make generally available to its security holders an earnings statement or statements of the Guarantor and its subsidiaries that will satisfy the provisions of Section 11(a) of the Securities Act and Rule 158.
(g) Delivery of Registration Statement and Prospectus. The Company and the Guarantor will furnish to the Representatives copies of the Registration Statement and, so long as delivery of a prospectus by an Underwriter or dealer may be required by the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172), as many copies of each Preliminary Prospectus, the Final Prospectus and each Issuer Free Writing Prospectus and any supplement to any of the foregoing as the Representatives may reasonably request. The Company and the Guarantor will pay the expenses of preparation, printing or other production of all documents relating to the offering; provided that, if any Underwriter is required to deliver a Final Prospectus in connection with sales of Securities at any time six months or more after the date of the Final Prospectus, the expenses relating to such Final Prospectus shall be paid by such Underwriter.
(h) Qualification of Securities. The Company and the Guarantor will use their reasonable best efforts to arrange, if necessary, for the qualification of the Securities for sale under the laws of such jurisdictions as the Representatives may reasonably designate, will maintain such qualifications in effect so long as required for the distribution of the Securities and will pay any fee of the Financial Industry Regulatory Authority, Inc. in connection with its review of the offering; provided that in no event shall the Company or the Guarantor be obligated to qualify to do business in any jurisdiction where it is not now so qualified, to take any action that would subject it to service of process in suits, other than those arising out of the offering or sale of the Securities, in any jurisdiction where it is not now so subject or to subject itself to taxation as doing business in any such jurisdiction.
7
(i) No Other Offering Materials. Each of the Company and the Guarantor agrees that, unless it has or shall have obtained the prior written consent of the Representatives, and each Underwriter, severally and not jointly, agrees with the Company and the Guarantor that, unless it has or shall have obtained, as the case may be, the prior written consent of the Company and the Guarantor, it has not made and will not make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in Rule 405) required to be filed by the Company or the Guarantor with the Commission or retained by the Company or the Guarantor under Rule 433, other than a free writing prospectus containing the information contained in the final term sheet prepared and filed pursuant to Section 5(c) hereof; provided that the prior written consent of the parties hereto shall be deemed to have been given in respect of the Free Writing Prospectuses included in Schedule III hereto and any electronic road show. Any such free writing prospectus consented to by the Representatives, the Company and the Guarantor is hereinafter referred to as a “Permitted Free Writing Prospectus.” Each of the Company and the Guarantor agrees that (x) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus and (y) it has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping.
(j) Lock-up. Neither the Company nor the Guarantor will, without the prior written consent of the Representatives, which consent shall not be unreasonably withheld, offer, sell, contract to sell, pledge, or otherwise dispose of, directly or indirectly, including the filing (or participation in the filing) of a registration statement with the Commission in respect of, any U.S. dollar-denominated debt securities issued or guaranteed by the Company or the Guarantor (other than the Securities), which mature more than one year after the Closing Date and which are substantially similar to the Securities, until the Business Day set forth on Schedule I hereto.
(k) Stabilization. Neither the Company nor the Guarantor will take, directly or indirectly, any action that is designed to or that constitutes, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company or the Guarantor to facilitate the sale or resale of the Securities.
(l) Listing. The Company and the Guarantor will use reasonable best efforts to have the Securities listed and admitted to trading on the [ ] Stock Exchange or another “recognised stock exchange” (as defined in Section 1005 of the United Kingdom Income Tax Act 2007), and satisfactory evidence of such actions shall have been provided to the Representatives.
8
6. Conditions to the Obligations of the Underwriters. The obligations of the Underwriters to purchase the Securities shall be subject to the accuracy of the representations and warranties on the part of the Company and the Guarantor contained herein as of the Execution Time and as of the Closing Date, to the accuracy of the statements of the Company and the Guarantor made in any certificates pursuant to the provisions hereof, to the performance by the Company and the Guarantor of their obligations hereunder and to the following additional conditions:
(a) Prospectus Filed; No Stop Order. The Final Prospectus, and any supplement thereto, shall have been filed in the manner and within the time period required by Rule 424(b); the final term sheet contemplated by Section 5(c) hereof, and any other material required to be filed by the Company and the Guarantor pursuant to Rule 433(d), shall have been filed with the Commission within the applicable time periods prescribed for such filings by Rule 433; and no stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall have been instituted or, to the knowledge of the Company, the Guarantor or any Underwriter, threatened.
(b) Opinions of Counsel to the Company and the Guarantor. On the Closing Date, the Representatives, on behalf of the Underwriters, shall have received an opinion or opinions of Cleary Gottlieb Steen & Hamilton LLP, counsel to the Company and the Guarantor, dated such date, substantially to the effect set forth in Exhibits A-1 and A-2 hereto.
(c) Letter of Counsel to the Company and the Guarantor. On the Closing Date, the Representatives, on behalf of the Underwriters, shall have received a letter of Cleary Gottlieb Steen & Hamilton LLP, counsel to the Company and the Guarantor, dated such date, substantially in the form set forth in Exhibit B hereto.
(d) Opinion of Counsel to the Underwriters. The Representatives, on behalf of the Underwriters, shall have received from Sidley Austin LLP, counsel for the Underwriters, such opinion or opinions, dated the Closing Date and addressed to the Representatives, on behalf of the Underwriters, with respect to the issuance and sale of the Securities, the Indenture, the Registration Statement, the Disclosure Package and the Final Prospectus (together with any supplement thereto) and other related matters as the Representatives may reasonably require, and the Company and the Guarantor shall have furnished to such counsel such documents as they reasonably request for the purpose of enabling them to pass upon such matters.
(e) Certificate of the Company and the Guarantor. The Company and the Guarantor shall have furnished to the Representatives, on behalf of the Underwriters, a certificate of officers of the Company and the Guarantor reasonably satisfactory to the Representatives, dated the Closing Date, to the effect that the signers of such certificate have carefully examined the Registration Statement, the Disclosure Package, the Final Prospectus and any supplements or amendments thereto, as well as each electronic road show used in connection with the offering of the Securities, and this Agreement and that:
(i) the representations and warranties of the Company and the Guarantor in this Agreement are true and correct on and as of the Closing Date with the same effect as if made on the Closing Date and each of the Company and the Guarantor has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior to the Closing Date;
9
(ii) no stop order suspending the effectiveness of the Registration Statement has been issued and no proceedings for that purpose have been instituted or, to the knowledge of the Company or the Guarantor, threatened; and
(iii) since the date of the most recent financial statements included or incorporated by reference in the Disclosure Package and the Final Prospectus (in each case, exclusive of any supplement thereto after the date hereof), there has been no material adverse effect or any development which in the reasonable judgment of the Company or the Guarantor will result in any material adverse effect on the financial condition, earnings, business or properties of the Guarantor and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Disclosure Package and the Final Prospectus (in each case, exclusive of any supplement thereto after the date hereof) or as described in such certificate.
(f) Accountants’ Comfort Letters. The Company shall have requested and caused Deloitte LLP to have furnished to the Representatives, on behalf of the Underwriters, and to the affiliates of the Underwriters at the addresses set forth in Schedule V, at the Execution Time and on the Closing Date, letters (which may refer to letters previously delivered to one or more of the Representatives), dated respectively as of the date hereof and as of the Closing Date, in form and substance satisfactory to the Representatives, containing statements and information of the type ordinarily included in accountants’ “comfort letters” to underwriters with respect to the financial statements and certain financial information included or incorporated by reference in the Registration Statement, the Preliminary Prospectus and the Final Prospectus.
(g) No Material Adverse Change. Subsequent to the Execution Time, there shall not have been (i) any change, or any development which in the reasonable judgment of the Company or the Guarantor will result in any change, in or affecting the financial condition, earnings, business or properties of the Guarantor and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Disclosure Package and the Final Prospectus (in each case, exclusive of any supplement thereto after the date hereof) or (ii) any decrease in the rating of any of the Guarantor’s debt securities by any “nationally recognized statistical rating organization” (as defined for purposes of Rule 436(g)) or any notice given of any intended or potential decrease in any such rating or of a possible change in any such rating that does not indicate the direction of the possible change, the effect of which, in any case referred to in clause (i) or (ii) above, is, in the judgment of a majority in interest of the Representatives, so material and adverse as to make it impractical or inadvisable to proceed with the offering or delivery of the Securities as contemplated by the Registration Statement, the Disclosure Package and the Final Prospectus (in each case, exclusive of any supplement thereto after the date hereof).
The Representatives may in their sole discretion waive on behalf of the Underwriters compliance with any conditions to the obligations of the Underwriters under this Agreement.
10
The documents required to be delivered by this Section 6 shall be delivered at the office of Sidley Austin LLP, counsel for the Underwriters, at 787 Seventh Avenue, New York, New York 10019 or 70 St Mary Axe, London EC3A 8BE, United Kingdom, on the Closing Date.
7. Reimbursement of Underwriters’ Expenses. If the sale of the Securities provided for herein is not consummated because any condition to the obligations of the Underwriters set forth in Section 6 hereof is not satisfied or because of any refusal, inability or failure on the part of the Company or the Guarantor to perform any agreement herein or comply with any provision hereof other than by reason of a default by any of the Underwriters, the Company and the Guarantor will reimburse the Underwriters severally through the Representatives on demand for all out-of-pocket expenses (including reasonable fees and disbursements of counsel) that shall have been reasonably incurred by them in connection with the proposed purchase and sale of the Securities.
8. Indemnification and Contribution.
(a) Indemnification of the Underwriters by the Company and the Guarantor. The Company and the Guarantor jointly and severally agree to indemnify and hold harmless each Underwriter, the directors, officers, employees and agents of each Underwriter and each person who controls any Underwriter within the meaning of either the Securities Act or the Exchange Act against any and all losses, claims, damages or liabilities, joint or several, to which they or any of them may become subject under the Securities Act, the Exchange Act or other U.S. federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement as originally filed or in any amendment thereof, or in the Base Prospectus, any Preliminary Prospectus or any other preliminary prospectus supplement relating to the Securities, the Final Prospectus, or any Issuer Free Writing Prospectus or the information contained in the final term sheet required to be prepared and filed pursuant to Section 5(c) hereof, or in any amendment thereof or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and agrees to reimburse each such indemnified party, as incurred, for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that neither the Company nor the Guarantor will be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with written information furnished to the Company or the Guarantor by or on behalf of any Underwriter through the Representatives specifically for inclusion therein. This indemnity agreement will be in addition to any liability that the Company or the Guarantor may otherwise have.
11
(b) Indemnification of the Company and the Guarantor by the Underwriters. Each Underwriter severally and not jointly agrees to indemnify and hold harmless each of the Company and the Guarantor, each of their respective directors, each of their respective officers who signs the Registration Statement, and each person who controls the Company or the Guarantor within the meaning of either the Securities Act or the Exchange Act, to the same extent as the foregoing indemnity from the Company and the Guarantor to each Underwriter, but only with reference to written information relating to such Underwriter furnished to the Company or the Guarantor by or on behalf of such Underwriter through the Representatives specifically for inclusion in the documents referred to in the foregoing indemnity. This indemnity agreement will be in addition to any liability that any Underwriter may otherwise have. The Company and the Guarantor acknowledge that the statements set forth in [ ] constitute the only information furnished in writing by or on behalf of the several Underwriters for inclusion in any Preliminary Prospectus, the Final Prospectus or any Issuer Free Writing Prospectus.
(c) Actions Against Parties; Notification. Promptly after receipt by an indemnified party under this Section 8 of notice of the commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against the indemnifying party under this Section 8, notify the indemnifying party in writing of the commencement thereof; but the failure so to notify the indemnifying party (i) will not relieve it from liability under paragraph (a) or (b) above unless and to the extent it did not otherwise learn of such action and such failure results in the forfeiture by the indemnifying party of substantial rights and defenses and (ii) will not, in any event, relieve the indemnifying party from any obligations to any indemnified party other than the indemnification obligation provided in paragraph (a) or (b) above. The indemnifying party shall be entitled to appoint counsel of the indemnifying party’s choice at the indemnifying party’s expense to represent the indemnified party in any action for which indemnification is sought (in which case the indemnifying party shall not thereafter be responsible for the fees and expenses of any separate counsel retained by the indemnified party or parties except as set forth below); provided, however, that such counsel shall be reasonably satisfactory to the indemnified party. Notwithstanding the indemnifying party’s election to appoint counsel to represent the indemnified party in an action, the indemnified party shall have the right to employ a single separate counsel, and the indemnifying party shall bear the reasonable fees, costs and expenses of such separate counsel, if the use of counsel chosen by the indemnifying party to represent the indemnified party would present such counsel with a conflict of interest. An indemnifying party shall not, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding. The indemnifying party shall not be liable for any settlement of any such action, suit or proceeding effected without its written consent.
12
(d) Contribution. In the event that the indemnity provided in paragraph (a) or (b) of this Section 8 is unavailable to or insufficient to hold harmless an indemnified party for any reason, the Company, the Guarantor and the Underwriters severally agree to contribute to the aggregate losses, claims, damages and liabilities (including legal or other expenses reasonably incurred in connection with investigating or defending the same) (collectively “Losses”) to which the Company, the Guarantor and one or more of the Underwriters may be subject in such proportion as is appropriate to reflect the relative benefits received by the Company and the Guarantor on the one hand and by the Underwriters on the other from the offering of the Securities; provided, however, that in no case shall any Underwriter (except as may be provided in any agreement among underwriters relating to the offering of the Securities) be responsible for any amount in excess of the underwriting discount or commission applicable to the Securities purchased by such Underwriter hereunder. If the allocation provided by the immediately preceding sentence is unavailable for any reason, the Company, the Guarantor and the Underwriters severally shall contribute in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company or the Guarantor on the one hand and of the Underwriters on the other in connection with the statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. Benefits received by the Company and the Guarantor shall be deemed to be equal to the total net proceeds from the offering (before deducting expenses) received by it, and benefits received by the Underwriters shall be deemed to be equal to the total underwriting discounts and commissions, in each case as set forth on the cover page of the Final Prospectus. Relative fault shall be determined by reference to, among other things, whether any untrue or any alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information provided by the Company and the Guarantor on the one hand or the Underwriters on the other, the relative intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The Company, the Guarantor and the Underwriters agree that it would not be just and equitable if contribution were determined by pro rata allocation or any other method of allocation that does not take account of the equitable considerations referred to above. Notwithstanding the provisions of this paragraph (d), no person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section 8, each person who controls an Underwriter within the meaning of either the Securities Act or the Exchange Act and each director, officer, employee and agent of an Underwriter shall have the same rights to contribution as such Underwriter, and each person who controls the Company or the Guarantor within the meaning of either the Securities Act or the Exchange Act, each officer of the Company or the Guarantor who shall have signed the Registration Statement and each director of the Company or the Guarantor shall have the same rights to contribution as the Company or the Guarantor, as the case may be, subject in each case to the applicable terms and conditions of this paragraph (d).
9. Default by an Underwriter. If any one or more Underwriters shall fail to purchase and pay for any of the Securities agreed to be purchased by such Underwriter or Underwriters hereunder and such failure to purchase shall constitute a default in the performance of its or their obligations under this Agreement, the remaining Underwriters shall be obligated severally to take up and pay for (in the respective proportions which the principal amount of Securities set forth opposite their names in Schedule II hereto bears to the aggregate principal amount of Securities set forth opposite the names of all
13
the remaining Underwriters) the Securities that the defaulting Underwriter or Underwriters agreed but failed to purchase; provided, however, that in the event that the aggregate principal amount of Securities that the defaulting Underwriter or Underwriters agreed but failed to purchase shall exceed 10% of the aggregate principal amount of Securities set forth in Schedule II hereto, the remaining Underwriters shall have the right to purchase all, but shall not be under any obligation to purchase any, of the Securities, and if arrangements satisfactory to the Representatives, the Company and the Guarantor for the purchase of such Securities by other persons are not made within 36 hours after such default, this Agreement will terminate without liability to any nondefaulting Underwriter, the Company or the Guarantor. In the event of a default by any Underwriter as set forth in this Section 9, the Closing Date shall be postponed for such period, not exceeding five Business Days, as the Representatives shall determine in order that the required changes in the Registration Statement and the Final Prospectus or in any other documents or arrangements may be effected. Nothing contained in this Agreement shall relieve any defaulting Underwriter of its liability, if any, to the Company, the Guarantor and any nondefaulting Underwriter for damages occasioned by its default hereunder.
10. Termination. This Agreement shall be subject to termination in the absolute discretion of the Representatives, by notice given to the Company and the Guarantor prior to delivery of and payment for the Securities, if at any time prior to such time (i) trading in the Guarantor’s Common Stock shall have been suspended by the London Stock Exchange or trading in the Guarantor’s American Depositary Shares shall have been suspended by the Commission or the New York Stock Exchange or trading in securities generally on the New York Stock Exchange or the London Stock Exchange shall have been suspended or materially limited, (ii) a banking moratorium shall have been declared either by U.S. federal or New York State authorities or (iii) there shall have occurred any outbreak or escalation of hostilities, declaration by the United States of a national emergency or war, or other calamity or crisis the effect of which on financial markets is such as to make it, in the reasonable judgment of the Representatives, after consultation with the Guarantor, impractical or inadvisable to proceed with the offering or delivery of the Securities as contemplated by any Preliminary Prospectus or the Final Prospectus (in each case, exclusive of any amendment or supplement thereto).
11. Representations and Indemnities to Survive. The respective agreements, representations, warranties, indemnities and other statements of the Company and the Guarantor or their respective officers and of the Underwriters set forth in or made pursuant to this Agreement shall remain in full force and effect, regardless of any investigation made by or on behalf of any Underwriter, the Company or the Guarantor or any of the officers, directors, employees, agents or controlling persons referred to in Section 8 hereof, and shall survive delivery of and payment for the Securities. The provisions of Sections 7, 8, 14 and 18 hereof shall survive the termination or cancellation of this Agreement.
12. Notices. All communications hereunder shall be in writing and effective only on receipt, and, (i) if sent to the Representatives, shall be mailed, electronically mailed or delivered to [ ] attention:[ ] or, (ii) if sent to the Company or the Guarantor, shall be mailed, electronically mailed or delivered to 980 Great West Road, Brentford, Middlesex, TW8 9GS, England, email: company.secretary@gsk.com, attention: The Company Secretary.
14
13. Successors. This Agreement will inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers, directors, employees, agents and controlling persons referred to in Section 8 hereof, and no other person will have any right or obligation hereunder.
14. Applicable Law. This Agreement will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed within the State of New York.
15. Counterparts. This Agreement may be signed by manual or electronic signature (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) in one or more counterparts, each of which shall constitute an original and all of which together shall constitute one and the same agreement. Counterparts may be delivered via electronic mail or other electronic format (i.e., “pdf,” “tif” or “jpg”) transmission or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.
16. Headings. The section headings used herein are for convenience only and shall not affect the construction hereof.
17. No Fiduciary Duty. The Company and the Guarantor hereby acknowledge that (a) the purchase and sale of the Securities pursuant to this Agreement is an arm’s-length commercial transaction between the Company and the Guarantor, on the one hand, and the Underwriters and any affiliate through which any of them may be acting, on the other hand, (b) the Underwriters are acting as principal and not as an agent or fiduciary of the Company or the Guarantor and (c) the Company’s and the Guarantor’s engagements of the Underwriters in connection with the offering and the process leading up to the offering is as independent contractors and not in any other capacity. Furthermore, each of the Company and the Guarantor agrees that it is solely responsible for making its own judgments in connection with the offering (irrespective of whether any of the Underwriters has advised or is currently advising the Company or the Guarantor on related or other matters). Each of the Company and the Guarantor agrees that it will not claim that the Underwriters have rendered advisory services of any nature or respect in connection with the offering of the Securities, or owe an agency, fiduciary or similar duty to the Company or the Guarantor, in connection with such transaction or the process leading thereto.
18. Consent to Jurisdiction; Appointment of Agent to Accept Service of Process.
(a) Each of the Company and the Guarantor irrevocably consents and agrees that any legal action, suit or proceeding against it with respect to any matter arising out of or based upon this Agreement may be brought in the courts of the State of New York located in The City of New York or the courts of the United States of America located in The City of New York and hereby irrevocably consents and submits to the non-exclusive jurisdiction of each such court in personam, generally and unconditionally with respect to any such action, suit or proceeding.
15
(b) Each of the Company and the Guarantor hereby irrevocably designates, appoints, and empowers [ ], with offices currently at [ ], as its designee, appointee and agent to receive, accept and acknowledge for and on its behalf, service of any and all legal process, summons, notices and documents that may be served in any action, suit or proceeding brought against the Company or the Guarantor in any such United States or State court with respect to any matter arising out of or based upon this Agreement and that may be made on such designee, appointee and agent in accordance with legal procedures prescribed for such courts. Each of the Company and the Guarantor further hereby irrevocably consents and agrees to the service of any and all legal process, summons, notices and documents in any such action, suit or proceeding against it by serving a copy thereof upon the relevant agent for service of process referred to in this Section 18 (whether or not the appointment of such agent shall for any reason prove to be ineffective or such agent shall accept or acknowledge such service). Each of the Company and the Guarantor agrees that the failure of any such designee, appointee and agent to give any notice of such service to it shall not impair or affect in any way the validity of such service or any judgment rendered in any such action or proceeding based thereon. Nothing herein shall in any way be deemed to limit the ability of the Underwriters to serve such legal process, summons, notices and documents in any other manner permitted by applicable law or to obtain jurisdiction over the Company or the Guarantor or bring actions, suits or proceedings against the Company or the Guarantor in such other jurisdictions, and in such manner, as may be permitted by applicable law. Each of the Company and the Guarantor hereby irrevocably and unconditionally waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of venue of any of the aforesaid actions, suits or proceedings arising out of or based upon this Agreement brought in the United States federal courts located in The City of New York or the courts of the State of New York located in The City of New York and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has been brought in an inconvenient forum.
19. Recognition of the U.S. Special Resolution Regimes. In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime.
In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime.
For purposes of foregoing two paragraphs, “BHC Act Affiliate” has the meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k); “Covered Entity” means any of the following: (i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b), (ii) a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b) or (iii) a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b); “Default Right” has the meaning assigned to that term
16
in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable; and “U.S. Special Resolution Regime” means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
20. Definitions. The terms that follow, when used in this Agreement, shall have the meanings indicated.
“Base Prospectus” shall mean the base prospectus referred to in Section 1(a) above contained in the Registration Statement at the Execution Time.
“Disclosure Package” shall mean (i) the Base Prospectus, (ii) the Preliminary Prospectus used most recently prior to the Execution Time, (iii) the Issuer Free Writing Prospectuses, if any, identified in Schedule III hereto, (iv) the final term sheet prepared and filed pursuant to Section 5(c) hereof, if any, and (v) any other Free Writing Prospectus that the parties hereto shall hereafter expressly agree in writing to treat as part of the Disclosure Package.
“Effective Date” shall mean each date and time that the Registration Statement and any post-effective amendment or amendments thereto became or becomes effective.
“Execution Time” shall mean the date and time that this Agreement is executed and delivered by the parties hereto.
“Final Prospectus” shall mean the prospectus supplement relating to the Securities that was first filed pursuant to Rule 424(b) after the Execution Time, together with the Base Prospectus.
“Free Writing Prospectus” shall mean a free writing prospectus, as defined in Rule 405.
“Issuer Free Writing Prospectus” shall mean an issuer free writing prospectus, as defined in Rule 433.
“Preliminary Prospectus” shall mean any preliminary prospectus supplement to the Base Prospectus referred to in Section 1(a) above which is used prior to the filing of the Final Prospectus, together with the Base Prospectus.
“Registration Statement” shall mean the registration statement referred to in Section 1(a) above, including exhibits and financial statements and any prospectus supplement relating to the Securities that is filed with the Commission pursuant to Rule 424(b) and deemed part of such registration statement pursuant to Rule 430B, as amended on each Effective Date and, in the event any post-effective amendment thereto becomes effective prior to the Closing Date, shall also mean such registration statement as so amended.
“Rule 158”, “Rule 163”, “Rule 164”, “Rule 172”, “Rule 405”, “Rule 415”, “Rule 424”, “Rule 430B”, “Rule 433”, “Rule 436”, “Rule 456” and “Rule 457” refer to such rules under the Securities Act.
17
If the foregoing is in accordance with your understanding of our agreement, please sign and return to us the enclosed duplicate hereof, whereupon this letter and your acceptance shall represent a binding agreement among the Company, the Guarantor and the several Underwriters.
| VERY TRULY YOURS, | ||
| GLAXOSMITHKLINE CAPITAL plc | ||
| By: | ||
| Name: | ||
| Title: | ||
| GSK plc | ||
| By: | ||
| Name: | ||
| Title: | ||
The foregoing Agreement is hereby confirmed and accepted
as of the date specified in Schedule I hereto.
| [ ] | ||
| By: | ||
| Name: | ||
| Title: | ||
For themselves and the other several Underwriters, if any,
named in Schedule II to the foregoing Agreement.
SCHEDULE I
Terms of the Debt Securities
Underwriting Agreement dated [ ]
Registration Statement Nos. 333-[ ]
Representatives: [ ]
Title, Purchase Price and Description of Securities:
Title: [ ]
Principal amount: $[ ]
Purchase price (include accrued interest or amortization, if any): $[ ]
Sinking fund provisions: [ ]
Redemption provisions: [ ]
Other provisions: As described in the applicable prospectus supplement
referred to in this Agreement.
Closing Date, Time and Location: [ ] at [ ]a.m./p.m., simultaneously, at Sidley Austin
LLP, 787 Seventh Avenue, New York, New York 10019
and 70 St Mary Axe, London EC3A 8BE, United Kingdom
Type of Offering: Non-delayed.
Date referred to in Section 5(j) after which the Company and the Guarantor may offer or sell debt securities issued or guaranteed by the Company or the Guarantor without the consent of the Representatives: [ ].
I-1
SCHEDULE II
Underwriting Commitments
| Underwriters |
Principal Amount of Securities to be Purchased |
|||
| [Names of Underwriters] |
||||
| Total |
$ | |||
|
|
|
|||
II-2
SCHEDULE III
Schedule of Free Writing Prospectuses included in the Disclosure Package
III-1
SCHEDULE IV
Pricing Term Sheet
IV-1
Filed Pursuant to Rule 433
Registration Nos. 333-[ ]
[ ], 20[ ]
FORM OF PRICING TERM SHEET
GlaxoSmithKline Capital plc
[•]% Notes due 20[•]
Fully and unconditionally guaranteed by
GSK plc
| Issuer: | GlaxoSmithKline Capital plc | |||
| Guarantor: | GSK plc | |||
| Principal Amount: | $[•] | |||
| Trade Date | [•], 20[•] | |||
| Maturity Date: | [•], 20[•] | |||
| Coupon: | [•]% | |||
| Interest Payment Dates: | [•], commencing [•] | |||
| Price to Public: | [•]% | |||
| Gross Proceeds to Issuer: | $[•] | |||
| Underwriting Discount and Commissions: | [•]% | |||
| Net Proceeds to Issuer: | $[•] | |||
| Benchmark Treasury: | [•] | |||
| Benchmark Treasury Yield: | [•]% | |||
| Spread to Benchmark Treasury: | + [•]bp | |||
| Yield to Maturity: | [•]% | |||
IV-2
| Make-Whole Call: | [•] | |||
| CUSIP: | [•] | |||
| ISIN: | [•] | |||
| Expected Settlement Date: | [•], 20[•] | |||
| Day Count Fraction: | [•] | |||
| Business Day: | New York and London | |||
| Expected Listing: | [•] | |||
| Denominations: | [•] | |||
| Anticipated Ratings: | [•] by [Moody’s Investors Service, Inc.] [•] by [Standard & Poor’s Ratings Services] | |||
| Joint Book-Running Managers: | [•] | |||
| Co-Managers: | [•] | |||
Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
No PRIIPs KID. No PRIIPs key information document (KID) has been prepared as the Notes are not available to retail clients in the EEA or the UK.
The issuer and the guarantor have filed a registration statement (including a prospectus) and a preliminary prospectus supplement with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and other documents the issuer and the guarantor have filed with the SEC for more complete information about the issuer, the guarantor and this offering.
You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and the preliminary prospectus supplement if you request it by calling [ ]toll-free at [ ] or [ ].
IV-3
SCHEDULE V
Schedule of Selling Agents
V-1
EXHIBIT A-1
[Form of Opinion of U.S. Counsel to the Company and the Guarantor]
A-1-1
EXHIBIT A-2
[Form of Opinion of U.K. Counsel to the Company and the Guarantor]
A-2-1
EXHIBIT B
[Form of Letter of Counsel to the Company and the Guarantor]
B-1
Exhibit 5.1
CLEARY GOTTLIEB STEEN & HAMILTON LLP
| AMERICAS NEW YORK SAN FRANCISCO SAO PAULO SILICON VALLEY WASHINGTON, D.C.
ASIA BEIJING HONG KONG SEOUL |
2 London Wall Place London EC2Y 5AU T: + 44 20 7614 2200 T: + 44 20 7600 1698
clearygottlieb.com
D: + 44 20 7614 2237 ssperber@cgsh.com |
EUROPE & MIDDLE EAST ABU DHABI BRUSSELS COLOGNE FRANKFURT LONDON MILAN PARIS ROME |
March 25, 2024
GSK plc
980 Great West Road
Brentford, Middlesex TW8 9GS
England
GlaxoSmithKline Capital Inc.
1100 North Market Street
4th Floor, Suite 4056
Wilmington, Delaware 19890
United States
GlaxoSmithKline Capital plc
980 Great West Road
Brentford, Middlesex TW8 9GS
England
Ladies and Gentlemen:
We have acted as special United States counsel to GSK plc, a public limited company incorporated in England and Wales, GlaxoSmithKline Capital Inc., a Delaware corporation (“GSK Capital Inc.”), and GlaxoSmithKline Capital plc, a public limited company incorporated in England and Wales (“GSK Capital plc”), in connection with the preparation and filing with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”), of a registration statement on Form F-3 (the “Registration Statement”) relating to the offering from time to time, together or separately and in one or more series, of (a) debt securities of GSK plc, (b) debt securities of GSK Capital Inc. and GSK Capital plc, as the case may be, guaranteed by GSK plc, and (c) guarantees of GSK plc in respect of the debt securities of GSK Capital Inc. and GSK Capital plc (the “Guarantees”). The debt securities of GSK plc, GSK Capital Inc. and GSK Capital plc are collectively referred to herein as the “Debt Securities.” The securities being registered under the Registration Statement will be offered on a continuous or delayed basis pursuant to the provisions of Rule 415 under the Securities Act.
Cleary Gottlieb Steen & Hamilton LLP is a Limited Liability Partnership registered in England and Wales Number OC310280. It is authorised and regulated by the Solicitors Regulation Authority. A list of the members and their professional qualifications is open to inspection at the registered office, 2 London Wall Place, London EC 2Y 5AU. Cleary Gottlieb Steen & Hamilton LLP or an affiliated entity has an office in each of the locations listed above.
GSK plc et al., p. 2
Unless otherwise provided in any prospectus supplement forming a part of the Registration Statement relating to a particular series of Debt Securities, the Debt Securities of GSK plc are to be issued under an indenture dated as of March 4, 2008 between GSK plc and Deutsche Bank Trust Company Americas (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among GSK plc, as issuer, Deutsche Bank Trust Company Americas and Law Debenture Trust Company of New York), as trustee (the “Trustee”), as supplemented by the First Supplemental Indenture dated as of March 21, 2014, between GSK plc and the Trustee (as so supplemented, the “GSK plc Indenture”); the Debt Securities of GSK Capital Inc. and the related Guarantees are to be issued under an indenture dated as of April 6, 2004 among GSK Capital Inc., GSK plc and the Trustee (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among GSK Capital Inc., the Trustee and Law Debenture Trust Company of New York), as supplemented by the First Supplemental Indenture dated as of March 18, 2013, among GSK Capital Inc., GSK plc and the Trustee, the Second Supplemental Indenture dated as of March 21, 2014, among GSK Capital Inc., GSK plc and the Trustee, and the Third Supplemental Indenture dated as of May 15, 2018, among GSK Capital Inc., GSK plc and the Trustee (as so supplemented, the “GSK Capital Inc. Indenture”); and the Debt Securities of GSK Capital plc and the related Guarantees are to be issued under an indenture dated as of April 6, 2004 among GSK Capital plc, GSK plc and the Trustee (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among GSK Capital plc, the Trustee and Law Debenture Trust Company of New York), as supplemented by the First Supplemental Indenture dated as of March 21, 2014, among GSK Capital plc, GSK plc and the Trustee, and the Second Supplemental Indenture dated as of May 15, 2018, among GSK Capital plc, GSK plc and the Trustee (as so supplemented, the “GSK Capital plc Indenture” and, together with the GSK plc Indenture and the GSK Capital Inc. Indenture, the “Indentures”).
In arriving at the opinions expressed below, we have reviewed the following documents:
| (a) | the Registration Statement; |
| (b) | an executed copy of the GSK plc Indenture; |
| (c) | an executed copy of the GSK Capital Inc. Indenture; and |
| (d) | an executed copy of the GSK Capital plc Indenture. |
In addition, we have reviewed the originals or copies certified or otherwise identified to our satisfaction of all such corporate records of GSK Capital Inc. and such other documents, and we have made such investigations of law, as we have deemed appropriate as a basis for the opinions expressed below.
In rendering the opinions expressed below, we have assumed the authenticity of all documents submitted to us as originals and the conformity to the originals of all documents submitted to us as copies. In addition, we have assumed and have not verified the accuracy as to factual matters of each document we have reviewed.
GSK plc et al., p. 3
Based on the foregoing, and subject to the further assumptions and qualifications set forth below, it is our opinion that:
1. (a) The Indentures have been duly executed and delivered by GSK plc under the law of the State of New York, (b) the execution and delivery of the GSK Capital Inc. Indenture have been duly authorized by all necessary corporate action of GSK Capital Inc., and the GSK Capital Inc. Indenture has been duly executed and delivered by GSK Capital Inc. and (c) the GSK Capital plc Indenture has been duly executed and delivered by GSK Capital plc under the law of the State of New York.
2. When the Debt Securities and the Guarantees endorsed thereon, as applicable, in the forms filed as Exhibits 4.10, 4.11 and 4.12 to the Registration Statement, have been duly authorized by GSK plc, GSK Capital Inc. and GSK Capital plc, as the case may be, duly executed and authenticated in accordance with the relevant Indenture and duly delivered to and paid for by the purchasers thereof pursuant to a sale in the manner described in the Registration Statement:
| (a) | The Debt Securities of GSK plc will be valid, binding and enforceable obligations of GSK plc, entitled to the benefits of the GSK plc Indenture. |
| (b) | The Debt Securities of GSK Capital Inc. will be valid, binding and enforceable obligations of GSK Capital Inc., entitled to the benefits of the GSK Capital Inc. Indenture. |
| (c) | The Debt Securities of GSK Capital plc will be valid, binding and enforceable obligations of GSK Capital plc, entitled to the benefits of the GSK Capital plc Indenture. |
| (d) | The Guarantees will be valid, binding and enforceable obligations of GSK plc, entitled to the benefits of the GSK Capital Inc. Indenture or the GSK Capital plc Indenture, as the case may be. |
Insofar as the foregoing opinions relate to the validity, binding effect or enforceability of any agreement or obligation of GSK plc, GSK Capital Inc. or GSK Capital plc, (a) we have assumed that each of GSK plc, GSK Capital Inc., GSK Capital plc and each other party to such agreement or obligation has satisfied or, prior to the issuance of the Debt Securities and the Guarantees, will satisfy those legal requirements that are applicable to it to the extent necessary to make such agreement or obligation enforceable against it (except that no such assumption is made as to GSK plc, GSK Capital Inc. or GSK Capital plc regarding matters of the federal law of the United States of America or the law of the State of New York or, solely with respect to GSK Capital Inc., the General Corporation Law of the State of Delaware (the “DGCL”), that in our experience normally would be applicable to general business entities with respect to such agreement or obligation); (b) such opinions are subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally and to general principles of equity; (c) we express no opinion with respect to the effect of any mandatory choice of law rules; and (d) in the case of GSK plc and GSK Capital plc, such opinions are subject to the effect of judicial application of foreign laws or foreign governmental actions affecting creditors’ rights.
In rendering the opinions expressed above, we have further assumed that (a) the Registration Statement and any amendments thereto (including post-effective amendments) will or have become effective and comply with all applicable laws, (b) the Registration Statement and any amendments thereto (including post-effective amendments) will be effective and will comply with all applicable laws at the time the Debt Securities and the Guarantees are offered or issued as contemplated by the Registration Statement, (c) the terms of the Debt Securities and the Guarantees will
GSK plc et al., p. 4
conform to the forms thereof, and the terms of the Debt Securities and the Guarantees will not violate any applicable law, result in a default under or breach of any agreement or instrument binding upon GSK plc, GSK Capital Inc. or GSK Capital plc, as applicable, or violate any requirement or restriction imposed by any court or governmental body having jurisdiction over GSK plc, GSK Capital Inc. or GSK Capital plc, as applicable, (d) the Debt Securities and the Guarantees will be sold and delivered to, and paid for by, the purchasers at the price specified in, and in accordance with the terms of, an agreement or agreements duly authorized, executed and delivered by the parties thereto, (e) GSK plc, GSK Capital Inc. and GSK Capital plc, as the case may be, will duly authorize the offering and issuance of the Debt Securities and the Guarantees, as applicable, will duly authorize, approve and establish the final terms and conditions thereof and will take any other appropriate additional corporate action and (f) certificates, if required, representing the Debt Securities (including the Guarantees endorsed thereon, as applicable) will be duly executed and delivered and, to the extent required by the applicable Indenture, duly authenticated and countersigned.
In rendering the opinions expressed above, we have assumed that each series of Debt Securities issued pursuant to the Registration Statement will be issued with an original aggregate principal amount (or in the case of Debt Securities issued at original issue discount, an aggregate issue price) of U.S.$2,500,000 or more.
The waiver of defenses contained in Section 6.01 of the GSK Capital plc Indenture and the GSK Capital Inc. Indenture may be ineffective to the extent that any such defense involves a matter of public policy in New York.
We note that by statute New York provides that a judgment or decree rendered in a currency other than the currency of the United States shall be converted into U.S. dollars at the rate of exchange prevailing on the date of entry of the judgment or decree. There is no corresponding Federal statute and no controlling Federal court decision on this issue. Accordingly, we express no opinion as to whether a Federal court would award a judgment in a currency other than U.S. dollars or, if it did so, whether it would order conversion of the judgment into U.S. dollars.
We express no opinion as to the enforceability of Section 11.15 of each of the Indentures relating to currency indemnity.
The foregoing opinions are limited to the federal law of the United States of America, the law of the State of New York and the DGCL. With respect to matters governed by the law of England and Wales, we have relied on our opinion dated March 25, 2024, as English counsel to GSK plc, GSK Capital Inc. and GSK Capital plc, which has been filed as Exhibit 5.2 to the Registration Statement.
We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to us under the heading “Validity of Securities” in the prospectus included in the Registration Statement and in any prospectus supplement related thereto. In giving such consent, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.
GSK plc et al., p. 5
The opinions expressed herein are rendered on and as of the date hereof, and we assume no obligation to advise you or any other person, or to make any investigations, as to any legal developments or factual matters arising subsequent to the date hereof that might affect the opinions expressed herein.
| Very truly yours, | ||
| CLEARY GOTTLIEB STEEN & HAMILTON LLP | ||
| By: | /s/ Sebastian R. Sperber | |
| Sebastian R. Sperber, a Partner | ||
Exhibit 5.2
CLEARY GOTTLIEB STEEN & HAMILTON LLP
| AMERICAS NEW YORK SAN FRANCISCO SAO PAULO SILICON VALLEY WASHINGTON, D.C.
ASIA BEIJING HONG KONG SEOUL |
2 London Wall Place London EC2Y 5AU T: + 44 20 7614 2200 T: + 44 20 7600 1698
clearygottlieb.com
D: + 44 20 7614 2224 craja@cgsh.com |
EUROPE & MIDDLE EAST ABU DHABI BRUSSELS COLOGNE FRANKFURT LONDON MILAN PARIS ROME |
March 25, 2024
GSK plc
980 Great West Road
Brentford, Middlesex TW8 9GS
England
GlaxoSmithKline Capital Inc.
Wilmington Trust SP Services, Inc.,
1100 N. Market Street, 4th Floor,
Wilmington, Delaware 19890
United States
GlaxoSmithKline Capital plc
980 Great West Road
Brentford, Middlesex TW8 9GS
England
Ladies and Gentlemen:
We have acted as special English counsel to GSK plc, a public limited company incorporated in England and Wales, GlaxoSmithKline Capital Inc., a Delaware corporation (“GSK Capital Inc.”), and GlaxoSmithKline Capital plc, a public limited company incorporated in England and Wales (“GSK Capital plc”, and together with GSK plc, each a “Company” and together the “Companies”), in connection with the preparation and filing with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”), of a registration statement on Form F-3 (the “Registration Statement”) relating to the offering from time to time, together or separately and in one or more series, of (a) debt securities of GSK Capital Inc. and GSK Capital plc, as the case may be, guaranteed by GSK plc, (b) guarantees of GSK plc in respect of the debt securities of GSK Capital Inc. and GSK Capital plc (the “Guarantees”) and (c) debt securities of GSK plc. The debt securities of GSK Capital Inc., GSK Capital plc and GSK plc are collectively referred to herein as the “Debt Securities.” We understand that the securities being registered under the Registration Statement will be offered on a continuous or delayed basis pursuant to the provisions of Rule 415 under the Securities Act.
Cleary Gottlieb Steen & Hamilton LLP is a Limited Liability Partnership registered in England and Wales Number OC310280. It is authorised and regulated by the Solicitors Regulation Authority. A list of the members and their professional qualifications is open to inspection at the registered office, 2 London Wall Place, London EC 2Y 5AU. Cleary Gottlieb Steen & Hamilton LLP or an affiliated entity has an office in each of the locations listed above.
GSK plc et al., p. 2
Unless otherwise provided in any prospectus supplement forming a part of the Registration Statement relating to a particular series of Debt Securities, the Debt Securities of GSK plc are to be issued under an indenture dated as of March 4, 2008 between GSK plc and Deutsche Bank Trust Company Americas (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among GSK plc, Deutsche Bank Trust Company Americas and Law Debenture Trust Company of New York), as trustee (the “Trustee”), as supplemented by the First Supplemental Indenture dated as of March 21, 2014, between GSK plc and the Trustee (as so supplemented, the “GSK plc Indenture”); the Debt Securities of GSK Capital Inc. and the related Guarantees are to be issued under an indenture dated as of April 6, 2004 among GSK Capital Inc., GSK plc and the Trustee (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among GSK Capital Inc., the Trustee and Law Debenture Trust Company of New York), as supplemented by the First Supplemental Indenture dated as of March 18, 2013, among GSK Capital Inc., GSK plc and the Trustee, the Second Supplemental Indenture dated as of March 21, 2014, among GSK Capital Inc., GSK plc and the Trustee and the Third Supplemental Indenture dated as of May 15, 2018, among GSK Capital Inc., GSK plc and the Trustee (as so supplemented, the “GSK Capital Inc. Indenture”); and the Debt Securities of GSK Capital plc and the related Guarantees are to be issued under an indenture dated as of April 6, 2004 among GSK Capital plc, GSK plc and the Trustee (as successor to Law Debenture Trust Company of New York, pursuant to an Instrument of Resignation, Appointment and Acceptance dated April 12, 2017 among GSK Capital plc., the Trustee and Law Debenture Trust Company of New York), as supplemented by the First Supplemental Indenture dated as of March 21, 2014, among GSK Capital plc, GSK plc and the Trustee and the Second Supplemental Indenture dated as of May 15, 2018, among GSK Capital plc, GSK plc and the Trustee (as so supplemented, the “GSK Capital plc Indenture” and, together with the GSK plc Indenture and the GSK Capital Inc. Indenture, the “Indentures”). References to the Indentures shall be construed as including references to the Guarantees given in the Indentures.
In arriving at the opinions expressed below, we have reviewed copies of the following documents:
| (a) | a Certificate of the Secretary of GSK plc dated March 25, 2024 (the “2024 GSK plc Secretary’s Certificate”) having annexed thereto and certified as true, complete and up-to-date copies as at such date, the following documents: |
| (i) | the Articles of Association of GSK plc; |
| (ii) | an extract from the draft minutes of a meeting of the Board of Directors of GSK plc held on March 6, 2024 and the minutes of a meeting of the Corporate Administration & Transactions Committee of GSK plc held on March 18, 2024 (the “2024 GSK plc Minutes”); |
| (b) | a Certificate of the Secretary of GSK plc dated May 15, 2018 (the “2018 GSK plc Secretary’s Certificate”) having annexed thereto and certified as true, complete and up-to-date copies as at such date of the following documents: |
| (i) | the Articles of Association of GSK plc; and |
GSK plc et al., p. 3
| (ii) | the minutes of the meetings of the Board of Directors of GSK plc held on March 15, 2018 and the Corporate Administration & Transactions Committee of GSK plc held on March 23, 2018, May 10, 2018 and May 11, 2018 (the “2018 GSK plc Minutes”); |
| (c) | a Certificate of the Secretary of GSK plc dated March 21, 2014 (the “2014 GSK plc Secretary’s Certificate”) having annexed thereto and certified as true, complete and up-to-date copies as at such date of the following documents: |
| (i) | the Articles of Association of GSK plc (the “2014 Articles of GSK plc”); and |
| (ii) | the minutes of the meetings of the Board of Directors of GSK plc held on March 19, 2014 and the Corporate Administration & Transactions Committee of GSK plc held on March 19, 2014 (the “2014 GSK plc Minutes”); |
| (d) | a Certificate of the Secretary of GSK plc dated April 6, 2004 (the “2004 GSK plc Secretary’s Certificate”, and together with the 2024 GSK plc Secretary’s Certificate, the 2018 GSK plc Secretary’s Certificate and the 2014 GSK plc Secretary’s Certificate, the “GSK plc Secretary’s Certificates”) having annexed thereto and certified as true, complete and up-to-date copies as at such date of the following documents: |
| (i) | the Memorandum and Articles of Association of GSK plc (the “2004 Memorandum and Articles of GSK plc”); and |
| (ii) | the minutes of the meetings of the Board of Directors of GSK plc held on October 4, 2002 and the Corporate Administration & Transactions Committee of GSK plc held on March 28, 2003, September 2, 2003 and March 26, 2004 (the “2004 GSK plc Minutes”, and together with the 2024 GSK plc Minutes, the 2018 GSK plc Minutes and the 2014 GSK plc Minutes, the “GSK plc Minutes”); |
| (e) | a Certificate of the Secretary of GSK Capital plc dated March 25, 2024 (the “2024 GSK Capital plc Secretary’s Certificate”) having annexed thereto and certified as true, complete and up-to-date copies as at such date, the following documents: |
| (i) | the Articles of Association of GSK Capital plc; and |
| (ii) | the minutes of a meeting of the Board of Directors of GSK Capital plc held on March 19, 2024 (the “2024 GSK Capital plc Minutes”); |
| (f) | a Certificate of the Secretary of GSK Capital plc dated May 15, 2018 (the “2018 GSK Capital plc Secretary’s Certificate”) having annexed thereto and certified as true, complete and up-to-date copies as at such date of the following documents: |
| (i) | the Memorandum and Articles of Association of GSK Capital plc; and |
| (ii) | the minutes of the meetings of the Board of Directors of GSK Capital plc held on May 10, 2018 and May 11, 2018 (the “2018 GSK Capital plc Minutes”); |
GSK plc et al., p. 4
| (g) | a Certificate of the Secretary of GSK Capital plc dated March 21, 2014 (the “2014 GSK Capital plc Secretary’s Certificate”) having annexed thereto and certified as true, complete and up-to-date copies as at such date of the following documents: |
| (i) | the Memorandum and Articles of Association of GSK Capital plc (the “2014 Memorandum and Articles of GSK Capital plc”); and |
| (ii) | the minutes of the meetings of the Board of Directors of GSK Capital plc held on March 20, 2014 (the “2014 GSK Capital plc Minutes”); |
| (h) | a Certificate of the Secretary of GSK Capital plc dated April 6, 2004 (the “2004 GSK Capital plc Secretary’s Certificate”, and together with the 2024 GSK Capital plc Secretary’s Certificate, the 2018 GSK Capital plc Secretary’s Certificate and the 2014 GSK Capital plc Secretary’s Certificate, the “GSK Capital plc Secretary’s Certificates” and, together with the GSK plc Secretary’s Certificates, the “Secretary’s Certificates”) having annexed thereto and certified as true, complete and up-to-date copies as at such date of the following documents: |
| (i) | the Memorandum and Articles of Association of GSK Capital plc the “2004 Memorandum and Articles of GSK Capital plc”); and |
| (ii) | the minutes of the meetings of the Board of Directors of GSK Capital plc held on March 26, 2004 (the “2004 GSK Capital plc Minutes”, and together with the 2024 GSK Capital plc Minutes, the 2018 GSK Capital plc Minutes and the 2014 GSK Capital plc Minutes, the “GSK Capital plc Minutes”); |
| (i) | a form of the Debt Securities to be issued by each of the Companies and GSK Capital Inc. filed as exhibits to the Registration Statement; |
| (j) | the Registration Statement; and |
| (k) | each executed Indenture. |
In addition, we have reviewed the originals, or copies certified or otherwise identified to our satisfaction, of all such other documents, and we have made such investigations of law, as we have deemed appropriate as a basis for the opinions expressed below.
In this opinion letter, the Debt Securities and the Indentures are referred to collectively as the “Transaction Documents” or each individually as a “Transaction Document”.
In rendering the opinions expressed below we have assumed and not verified:
| a) | the genuineness of all signatures, stamps and seals, the authenticity and completeness of all documents supplied to us and the conformity to the originals of all documents supplied to us as photocopies, facsimile or electronic copies; |
| b) | that, where a document has been examined by us in draft, specimen or certificated form, it has been or will be executed in the form of that draft, specimen or certificate and in the case of the Debt Securities, that they will be duly executed, authenticated and delivered in accordance with the terms of the relevant Indenture; |
GSK plc et al., p. 5
| c) | (i) the accuracy as to factual matters of each document we have reviewed, including, without limitation, the accuracy and completeness of all statements in each Secretary’s Certificate as at the date of such Secretary’s Certificate, and (ii) the compliance by each of the parties thereto with their respective obligations under the Transaction Documents; |
| d) | that where a document is required to be delivered, each party to it has delivered the same without it being subject to any escrow or other similar arrangement; |
| e) | that all consents, approvals, notices, filings and registrations that are necessary under any applicable laws or regulations (other than laws or regulations of the United Kingdom) in order to permit the execution, delivery or performance of the Transaction Documents have been or will be duly made or obtained; |
| f) | that each of the Transaction Documents constitutes legal, valid and binding obligations of each of the parties thereto under all applicable laws (including the laws of the State of New York by which the Transaction Documents are expressed to be governed) enforceable in accordance with their terms and have the same meaning and effect as if they were governed by English law; |
| g) | that each of the Transaction Documents has been or will be duly authorized, executed and delivered by or on behalf of each of the parties to such Transaction Document (other than the Companies) and each such party (other than the Companies) has the power, capacity and authority to execute, deliver and perform its obligations contained in each of the Transaction Documents to which it is a party; |
| h) | the absence of any other arrangements between any of the parties to the Transaction Documents which modify or supersede any of the terms of the Transaction Documents; |
| i) | that no law of any jurisdiction outside England and Wales would render the execution, delivery, issue or performance of the terms of the Transaction Documents illegal or ineffective and that, insofar as any obligation under the Transaction Documents falls to be performed in any jurisdiction other than England and Wales, its performance will not be illegal or ineffective by virtue of the laws of that jurisdiction; |
| j) | that any party or prospective party to the Transaction Documents which is subject to the supervision of any regulatory authority in the United Kingdom has complied and will comply with the requirements of such regulatory authority in connection with the offering and sale of the Debt Securities; |
| k) | that there are no provisions of the laws of any jurisdiction outside England and Wales that would have any implication for the opinions we express and that, insofar as the laws of any jurisdiction outside England and Wales may be relevant to this opinion letter, such laws have been and will be complied with; |
| l) | that any limit on borrowings to which each Company is subject has not been exceeded, and that the entry into or the performance of the Transaction Documents will not cause any such limit on borrowings to be exceeded; |
GSK plc et al., p. 6
| m) | that each of the parties to the Transaction Documents has fully complied with its obligations under all applicable money laundering legislation; |
| n) | that the binding effect of the Transaction Documents on the parties thereto is not affected by duress, undue influence or mistake, and no document has been entered into by any of the parties thereto in connection with any unlawful activity; |
| o) | that each of the parties to the Transaction Documents has complied with all applicable provisions of (i) Regulation (EU) No. 2017/1129 of the European Parliament as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020) (“EUWA”), (ii) Regulation (EU) No. 596/2014 of the European Parliament as it forms part of domestic law by virtue of the EUWA, (iii) the Financial Services Act 2012, and (iv) the Financial Services and Markets Act 2000, as amended, (the “FSMA”) and any applicable secondary legislation made under any of the foregoing with respect to anything done by any of them in relation to the Debt Securities in, from or otherwise involving the United Kingdom (including Sections 19, 21 and 85 of FSMA); |
| p) | that the information relating to each of the Companies disclosed by our searches on March 25, 2024 at Companies House at their website at www.companieshouse.gov.uk and by telephone at the Central Registry of Winding Up Petitions at the Companies Court in London in relation to each such Company was then complete, up to date and accurate and has not since then been materially altered and that such searches did not fail to disclose any material information which had been delivered for registration but did not appear on the website or the relevant file in London at the time of our search, and that such oral disclosures did not fail to disclose any material information or any petition for an administration order, dissolution or winding-up order in respect of each such Company that has been presented in England and Wales; |
| q) | that the resolutions referred to in the GSK plc Minutes and the GSK Capital plc Minutes were duly and validly passed and are true records of the proceedings of the meeting, are in full force and effect, and have not been amended, revoked or superseded, and the related Secretary’s Certificates are true and correct as of the date hereof; |
| r) | that each director of each of the Companies has disclosed any interest which he may have in the transactions contemplated by each of the Transaction Documents in accordance with the provisions of the Companies Act 1985 and the Companies Act 2006 and the Articles of Association of each such Company, and that none of the relevant directors of each such Company has any interest in such transactions except to the extent permitted by the Articles of Association of each such Company; and |
| s) | that the execution and delivery of each of the Transaction Documents by each of the Companies and the exercise of their rights and performance of their obligations thereunder will materially benefit each such Company and that the directors of each such Company acted in good faith and in the interests of such Company in approving each of the Transaction Documents and the transactions contemplated thereby; and will not conflict with, or result in a breach of, or constitute a default under, or result in the creation of any mortgage, charge or security interest upon any property or assets of each such Company or its subsidiary undertakings under (A) any agreement to which it is a party or to which any of its properties may be subject or (B) any existing applicable law, rule, regulation, judgment, order or decree of any government, governmental instrumentality or court, having jurisdiction over each such Company or its subsidiary undertakings or any of its properties. |
GSK plc et al., p. 7
Based on the foregoing, and subject to the further qualifications and limitations set forth below, it is our opinion that:
| 1. | Each of the Companies has been duly incorporated as a public limited company under the laws of England and Wales. A search of the records of the Registrar of Companies as made public through the www.companieshouse.gov.uk website on March 25, 2024 and an oral enquiry made to the Central Registry of Winding up Petitions at the Companies Court at approximately 10:01 GMT on March 25, 2024 revealed no petition, order or resolution for the winding up of either Company and no petition for, and no notice of appointment of, a receiver or administrator, provided that: |
| a. | the searches with Companies House referred to above are not conclusively capable of revealing whether or not (i) a winding up order has been made in respect of a company or a resolution passed for the winding up of a company, or (ii) an administration order has been made in respect of a company, or (iii) a receiver, administrative receiver, administrator or liquidator has been appointed in respect of a company, since notice of these matters might not be filed with Companies House immediately and, when filed, might not be made available through the website or entered on the files of Companies House relating to insolvency details with respect to the relevant company immediately. In addition, such searches are not capable of revealing, prior to the making of the relevant order, whether or not a winding up petition or a petition for an administration order has been presented; and |
| b. | the enquiry at the Central Registry of Winding up Petitions at the Companies Court referred to above relates only to a compulsory winding up and is not capable of revealing conclusively whether or not a winding up petition in respect of a compulsory winding up has been presented since details of the petition may not have been entered on the records of the Central Registry of Winding up Petitions immediately or, in the case of a petition presented to a County Court, may not have been notified to the Central Registry and entered on such records at all, and the response to an enquiry only relates to the period of six months prior to the date when the enquiry was made. We have not made enquiries of any County Court as to whether a petition for the appointment of an administrator has been presented to, or an administration order has been made by, any County Court against either Company. |
| 2. | GSK plc has the corporate power to enter into and perform its obligations under each of the Indentures. |
| 3. | GSK Capital plc has the corporate power to enter into and perform its obligations under the GSK Capital plc Indenture. |
| 4. | The GSK plc Indenture has been duly authorized, executed and delivered by GSK plc. |
GSK plc et al., p. 8
| 5. | The GSK Capital plc Indenture has been duly authorized, executed and delivered by each of GSK Capital plc and GSK plc. |
| 6. | The GSK Capital Inc. Indenture has been duly authorized, executed and delivered by GSK plc. |
The foregoing opinions are subject to certain qualifications, in particular, but without limitation:
| (a) | We express no opinion as to matters of fact. |
| (b) | We express no opinion as to any agreement, instrument or other document that may arise or be entered into, or as to any liability to tax or obligation to report to any tax authority that may arise or be incurred as a result of or in connection with the Transaction Documents, including, without limitation, the creation, issue or offer of the Debt Securities or the Guarantees or any other transaction. |
The opinions set out above are given on the basis of, and are limited to, the laws of England and Wales in force as at the date of this opinion letter (taking into account the effect of the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community and the European Union (Withdrawal) Act 2018), as currently applied by the courts in England and Wales, and are given on the basis that this opinion letter will be governed by and construed in accordance with English law.
We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to us under the heading “Validity of Securities” in the prospectus included in the Registration Statement and in any prospectus supplement related thereto. In giving such consent, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.
| Very truly yours, | ||
| CLEARY GOTTLIEB STEEN & HAMILTON LLP | ||
| By: | /s/ Chrishan Raja | |
| Chrishan Raja, a Partner | ||
Exhibit 22
List of Subsidiary Issuers of Guaranteed Securities
As of March 25, 2024, each of the following subsidiaries of GSK plc (the “Guarantor”) is issuer of the following outstanding securities, which are fully and unconditionally guaranteed by the Guarantor:
GlaxoSmithKline Capital Inc.
3.625% Notes due 2025
3.875% Notes due 2028
5.375% Notes due 2034
6.375% Notes due 2038
4.200% Notes due 2043
GlaxoSmithKline Capital plc
3.000% Notes due 2024
3.375% Notes due 2029
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form F-3 of our reports dated 5 March 2024 relating to the financial statements of GSK plc and the effectiveness of GSK plc’s internal control over financial reporting, appearing in the Annual Report on Form 20-F of GSK plc for the year ended 31 December, 2023. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
| /s/ Deloitte LLP |
| London, United Kingdom |
| 25 March 2024 |
Exhibit 25.1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM T-1
STATEMENT OF ELIGIBILITY
UNDER THE TRUST INDENTURE ACT OF 1939
OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE
| ☐ | CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) |
DEUTSCHE BANK TRUST COMPANY AMERICAS
(formerly BANKERS TRUST COMPANY)
(Exact name of trustee as specified in its charter)
| NEW YORK | 13-4941247 | |
| (Jurisdiction of Incorporation or organization if not a U.S. national bank) |
(I.R.S. Employer Identification no.) | |
| 1 COLUMBUS CIRCLE NEW YORK, NEW YORK |
10019 | |
| (Address of principal executive offices) | (Zip Code) | |
Deutsche Bank Trust Company Americas
1 Columbus Circle
New York, New York 10019
(212) 250 – 2500
(Name, address and telephone number of agent for service)
GSK plc
(Exact name of obligor as specified in its charter)
England and Wales
(State or other jurisdiction of incorporation or organization)
98-0607772
(I.R.S. Employer Identification No.)
980 Great West Road, Brentford
Middlesex TW8 9GS, England
+44 (0) 20 8047 5000
(Address and telephone number of Obligor’s principal executive offices)
DEBT SECURITIES OF GSK PLC
(Title of the Indenture securities)
| Item 1. | General Information. |
Furnish the following information as to the trustee.
| (a) | Name and address of each examining or supervising authority to which it is subject. |
| Name |
Address | |
| Federal Reserve Bank (2nd District) | New York, NY | |
| Federal Deposit Insurance Corporation | Washington, D.C. | |
| New York State Banking Department | Albany, NY | |
| (b) | Whether it is authorized to exercise corporate trust powers. |
Yes.
| Item 2. | Affiliations with Obligor. |
If the obligor is an affiliate of the Trustee, describe each such affiliation.
NA
| Item 3. -15. | Not Applicable |
| Item 16. | List of Exhibits. |
| Exhibit 1 - | Restated Organization Certificate of Bankers Trust Company dated August 31, 1998; Certificate of Amendment of the Organization Certificate of Bankers Trust Company dated September 25, 1998; Certificate of Amendment of the Organization Certificate of Bankers Trust Company dated December 18, 1998;Certificate of Amendment of the Organization Certificate of Bankers Trust Company dated September 3, 1999; and Certificate of Amendment of the Organization Certificate of Bankers Trust Company dated March 14, 2002, incorporated herein by reference to Exhibit 1 filed with Form T-1 Statement, Registration No. 333-201810. | |
| Exhibit 2 - | Certificate of Authority to commence business, incorporated herein by reference to Exhibit 2 filed with Form T-1 Statement, Registration No. 333-201810. | |
| Exhibit 3 - | Authorization of the Trustee to exercise corporate trust powers, incorporated herein by reference to Exhibit 3 filed with Form T-1 Statement, Registration No. 333-201810. | |
| Exhibit 4 - | A copy of existing By-Laws of Deutsche Bank Trust Company Americas, dated March 2, 2023 (see attached). | |
| Exhibit 5 - | Not applicable. | |
| Exhibit 6 - | Consent of Bankers Trust Company required by Section 321(b) of the Act, incorporated herein by reference to Exhibit 6 filed with Form T-1 Statement, Registration No. 333-201810. | |
| Exhibit 7 - | A copy of the latest report of condition of the trustee published pursuant to law or the requirements of its supervising or examining authority. | |
| Exhibit 8 - | Not Applicable. | |
| Exhibit 9 - | Not Applicable. | |
SIGNATURE
Pursuant to the requirements of the Trust Indenture Act of 1939, as amended, the trustee, Deutsche Bank Trust Company Americas, a corporation organized and existing under the laws of the State of New York, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in The City of New York, and State of New York, on this 20th day of March , 2024.
| DEUTSCHE BANK TRUST COMPANY AMERICAS | ||
| By: |
/s/ Irina Golovashchuk | |
| Name: Irina Golovashchuk | ||
| Title: Vice President | ||
Exhibit 4
AMENDED AND RESTATED
BY-LAWS
OF
DEUTSCHE BANK TRUST COMPANY AMERICAS
ARTICLE I
STOCKHOLDERS
Section 1.01. Annual Meeting. The annual meeting of the stockholders of Deutsche Bank Trust Company Americas (the “Company”) shall be held in the City of New York within the State of New York within the first four months of the Company’s fiscal year, on such date and at such time and place as the board of directors of the Company (“Board of Directors” or “Board”) may designate in the call or in a waiver of notice thereof, for the purpose of electing directors and for the transaction of such other business as may properly be brought before the meeting.
Section 1.02. Special Meetings. Special meetings of the stockholders of the Company may be called by the Board of Directors or by the President, and shall be called by the President or by the Secretary upon the written request of the holders of record of at least twenty-five percent (25%) of the shares of stock of the Company issued and outstanding and entitled to vote, at such times. If for a period of thirteen months after the last annual meeting, there is a failure to elect a sufficient number of directors to conduct the business of the Company, the Board of Directors shall call a special meeting for the election of directors within two weeks after the expiration of such period; otherwise, holders of record of ten percent (10%) of the shares of stock of the Company entitled to vote in an election of directors may, in writing, demand the call of a special meeting at the office of the Company for the election of directors, specifying the date and month thereof, but not less than two nor more than three months from the date of such call. At any such special meeting called on demand of stockholders, the stockholders attending, in person or by proxy, and entitled to vote in an election of directors shall constitute a quorum for the purpose of electing directors, but not for the transaction of any other business.
Section 1.03. Notice of Meetings. Notice of the time, place and purpose of every meeting of stockholders shall be delivered personally or mailed not less than 10 nor more than 50 days before the date of such meeting (or any other action) to each stockholder of record entitled to vote, at his post office address appearing upon the records of the Company or at such other address as shall be furnished in writing by him to the Secretary of the Company for such purpose. Such further notice shall be given as may be required by law or by these By-Laws. Any meeting may be held without notice if all stockholders entitled to vote are present in person or by proxy, or if notice is waived in writing, either before or after the meeting, by those not present.
Section 1.04. Quorum. The holders of record of at least a majority of the shares of the stock of the Company issued and outstanding and entitled to vote, present in person or by proxy, shall, except as otherwise provided by law, by the Company’s Organization Certificate or by these By-Laws, constitute a quorum at all meetings of the stockholders; if there be no such quorum, the holders of a majority of such shares so present or represented may adjourn the meeting from time to time until a quorum shall have been obtained.
Section 1.05. Organization of Meetings. Meetings of the stockholders shall be presided over by the Chairman of the Board or, if he is not present, by the President or, if he is not present, by a chairman to be chosen at the meeting. The Secretary of the Company, or in his absence an Assistant Secretary, shall act as secretary of the meeting, if present.
- 1 -
Section 1.06. Voting. At each meeting of stockholders, except as otherwise provided by statute, the Company’s Organization Certificate or these By-Laws, every holder of record of stock entitled to vote shall be entitled to one vote in person or by proxy for each share of such stock standing in his name on the records of the Company. Elections of directors shall be determined by a plurality of the votes cast thereat and, except as otherwise provided by statute, the Company’s Organization Certificate or these By-Laws, all other action shall be determined by a majority of the votes cast at such meeting.
At all elections of directors, the voting shall be by ballot or in such other manner as may be determined by the stockholders present in person or by proxy entitled to vote at such election.
Section 1.07. Action by Consent. Except as may otherwise be provided in the Company’s Organization Certificate, any action required or permitted to be taken at any meeting of stockholders may be taken without a meeting, without prior notice and without a vote if, prior to such action, a written consent or consents thereto, setting forth such action, is signed by all the holders of record of shares of the stock of the Company, issued and outstanding and entitled to vote thereon, having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted.
ARTICLE II
DIRECTORS
Section 2.01. Chairman of the Board. Following the election of the Board of Directors at each annual meeting, the elected Board shall appoint one of its members as Chairman. The Chairman of the Board shall preside at all meetings of the Board of Directors and of the stockholders, and he shall perform such other duties and have such other powers as from time to time may be prescribed by the Board of Directors.
Section 2.02. Lead Independent Director. Following the election of the Board of Directors at each annual meeting, the elected Board may appoint one of its independent members as its Lead Independent Director. When the Chairman of the Board is not present at a meeting of the Board of Directors, the Lead Independent Director, if there be one, shall preside.
Section 2.03. Director Emeritus. The Board of Directors may from time to time elect one or more Directors Emeritus. Each Director Emeritus shall be elected for a term expiring on the date of the regular meeting of the Board of Directors following the next annual meeting. No Director Emeritus shall be considered a “director” for purposes of these By-Laws or for any other purpose.
Section 2.04. Powers, Number, Quorum, Term, Vacancies, Removal. The business and affairs of the Company shall be managed by or under the direction of the Board of Directors which may exercise all such powers of the Company and do all such lawful acts and things as are not by statute or by the Company’s Organization Certificate or by these By-Laws required to be exercised or done by the stockholders.
The number of directors may be changed by a resolution passed by a majority of the members of the Board of Directors or by a vote of the holders of record of at least a majority of the shares of stock of the Company issued and outstanding and entitled to vote, but at all times the Board of Directors must consist of not less than seven nor more than thirty directors. No more than one-third of the directors shall be active officers or employees of the Company. At least one-half of the directors must be citizens of the United States at the time of their election and during their continuance in office.
- 2 -
Except as otherwise required by law, rule or regulation, or by the Company’s Organization Certificate, at all meetings of the Board of Directors or any committee thereof, a majority of the entire Board of Directors or a majority of the directors constituting such committee, as the case may be, shall constitute a quorum for the transaction of business and the act of a majority of the directors or committee members present at any meeting at which there is a quorum shall be the act of the Board of Directors, or such committee, as applicable. Any one or more members of the Board may participate in a meeting of the Board by means of a conference telephone or video, or other similar communications equipment allowing all persons participating in the meeting to hear each other at the same time. Participation by such means shall constitute presence in person at a meeting. Whether or not a quorum shall be present at any meeting of the Board of Directors or a committee thereof, a majority of the directors present thereat may adjourn the meeting from time to time; notice of the adjourned meeting shall be given to the directors who were not present at the time of the adjournment, but if the time and place of the adjourned meeting are announced, no additional notice shall be required to be given to the directors present at the time of adjournment.
Directors shall hold office until the next annual election and until their successors shall have been elected and shall have qualified. Director vacancies not exceeding one-third of the whole number of the Board of Directors may be filled by the affirmative vote of a majority of the directors then in office, and the directors so elected shall hold office for the balance of the unexpired term.
Any one or more of the directors of the Company may be removed either with or without cause at any time by a vote of the holders of record of at least a majority of the shares of stock of the Company, issued and outstanding and entitled to vote, and thereupon the term of the director or directors who shall have been so removed shall forthwith terminate and there shall be a vacancy or vacancies in the Board of Directors, to be filled by a vote of the stockholders as provided in these By-Laws.
Section 2.05. Meetings, Notice. Meetings of the Board of Directors shall be held at such place either within or without the State of New York, as may from time to time be fixed by resolution of the Board, or as may be specified in the call or in a waiver of notice thereof. Regular meetings of the Board of Directors and its Executive Committee shall be held as often as may be required under applicable law, and special meetings may be held at any time upon the call of two directors, the Chairman of the Board or the President, by oral, telegraphic or written notice duly served on or sent or mailed to each director not less than two days before such meeting. Any meeting may be held without notice, if all directors are present, or if notice is waived in writing, either before or after the meeting, by those not present.
Section 2.06. Compensation. The Board of Directors may determine, from time to time, the amount of compensation, which shall be paid to its members. The Board of Directors shall also have power, in its discretion, to allow a fixed sum and expenses for attendance at each regular or special meeting of the Board, or of any committee of the Board. The Board of Directors shall also have power, in its discretion, to provide for and pay to directors rendering services to the Company not ordinarily rendered by directors, as such, special compensation appropriate to the value of such services, as determined by the Board from time to time.
ARTICLE III
COMMITTEES
Section 3.01. Executive Committee. There shall be an Executive Committee of the Board who shall be appointed annually by resolution adopted by the majority of the entire Board of Directors. The Chairman of the Board shall preside at meetings of the Executive Committee. In his absence, the Chief Executive Officer or, in his absence, the President or any Co-President or, in their absence, such other member of the Executive Committee as the Executive Committee from time to time may designate shall preside at such meetings.
- 3 -
Section 3.02. Audit and Fiduciary Committee. There shall be an Audit and Fiduciary Committee appointed annually by resolution adopted by a majority of the entire Board of Directors which shall consist of such number of independent directors, as may from time to time be fixed by the Audit and Fiduciary Committee charter adopted by the Board of Directors.
Section 3.03. Other Committees. The Board of Directors shall have the power to appoint any other Committees as may seem necessary, and from time to time to suspend or continue the powers and duties of such Committees. Each Committee appointed pursuant to this Article shall serve at the pleasure of the Board of Directors.
Section 3.04. Limitations. No committee shall have the authority as to the following matters: (i) the submission to stockholders of any action that needs stockholders’ authorization under New York Banking Law; (ii) the filling of vacancies in the Board of Directors or in any such committee; (iii) the fixing of compensation of the directors for serving on the Board of Directors or on any committee; (iv) the amendment or repeal of these By-Laws, or the adoption of new by-laws; (v) the amendment or repeal of any resolution of the Board of Directors which by its terms shall not be so amendable or repealable; or (vi) the taking of action which is expressly required by any provision of New York Banking Law to be taken at a meeting of the Board of Directors or by a specified proportion of the directors.
ARTICLE IV
OFFICERS
Section 4.01. Titles and Election. The officers of the Company, who shall be chosen by the Board of Directors within twenty-five days after each annual meeting of stockholders, shall be a President, Chief Executive Officer, Chief Risk Officer, Chief Financial Officer, Treasurer, Secretary, and a General Auditor. The Board of Directors from time to time may elect one or more Managing Directors, Directors, Vice Presidents, Assistant Secretaries, Assistant Treasurers and such other officers and agents as it shall deem necessary, and may define their powers and duties. Any number of offices may be held by the same person, except the offices of President and Secretary.
Section 4.02. Terms of Office. Each officer shall hold office for the term for which he is elected or appointed, and until his successor has been elected or appointed and qualified.
Section 4.03. Removal. Any officer may be removed, either with or without cause, at any time, by the affirmative vote of a majority of the Board of Directors.
Section 4.04. Resignations. Any officer may resign at any time by giving written notice to the Board of Directors or to the Secretary. Such resignation shall take effect at the time specified therein and, unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective.
Section 4.05. Vacancies. If the office of any officer or agent becomes vacant by reason of death, resignation, retirement, disqualification, removal from office or otherwise, the Board of Directors may choose a successor, who shall hold office for the unexpired term in respect of which such vacancy occurred.
- 4 -
Section 4.06. President. The President shall have general authority to exercise all the powers necessary for the President of the Company. In the absence of the Chairman and the Lead Independent Director, the President shall preside at all meetings of the Board of Directors and of the stockholders. The President shall have the power to execute bonds, mortgages and other contracts, agreements and instruments of the Company, and he shall perform such other duties and have such other powers as may be incident to the office of the president of a corporation and as from time to time may otherwise be prescribed by the Board of Directors.
Section 4.07. Chief Executive Officer. Unless otherwise determined by the Board of Directors, the President shall be the Chief Executive Officer of the Company. The Chief Executive Officer shall exercise the powers and perform the duties usual to the chief executive officer and, subject to the control of the Board of Directors, shall have general management and control of the affairs and business of the Company; he shall appoint and discharge employees and agents of the Company (other than officers elected by the Board of Directors); he shall see that all orders and resolutions of the Board of Directors are carried into effect; he shall have the power to execute bonds, mortgages and other contracts, agreements and instruments of the Company, and he shall perform such other duties and have such other powers as may be incident to the office of the chief executive officer of a corporation and as from time to time may otherwise be prescribed by the Board of Directors.
Section 4.08. Chief Risk Officer. The Chief Risk Officer shall have the responsibility for the risk management and monitoring of the Company. The Chief Risk Officer shall have the power to execute bonds, notes, mortgages and other contracts, agreements and instruments of the Company, and he shall perform such other duties and have such other powers as may be incident to his office and as from time to time may otherwise be prescribed by the Board of Directors.
Section 4.09. Chief Financial Officer. The Chief Financial Officer shall have the responsibility for reporting to the Board of Directors on the financial condition of the Company, preparing and submitting all financial reports required by applicable law, and preparing annual financial statements of the Company and coordinating with qualified third party auditors to ensure such financial statements are audited in accordance with applicable law.
Section 4.10. Treasurer. The Treasurer shall have the custody of the corporate funds and securities and shall keep full and accurate accounts of receipts and disbursements in books belonging to the Company and shall deposit all moneys, and other valuable effects in the name and to the credit of the Company, in such depositories as may be designated by the Board of Directors. He shall disburse the funds of the Company as may be ordered by the Board, taking proper vouchers for such disbursements, and shall render to the directors whenever they may require it an account of all his transactions as Treasurer and of the financial condition of the Company.
Section 4.11. Secretary. The Secretary shall attend all sessions of the Board of Directors and all meetings of the stockholders and record all votes and the minutes of proceedings in records or books to be kept for that purpose. He shall give, or cause to be given, notice of all meetings of the stockholders and of the Board of Directors and shall perform such other duties and have such other powers as may be incident to the office of the secretary of a corporation and as from time to time may otherwise be prescribed by the Board of Directors. The Secretary shall have and be the custodian of the stock records and all other books, records and papers of the Company (other than financial) and shall see that all books, reports, statements, certificates and other documents and records required by law are properly kept and filed.
- 5 -
Section 4.12. General Auditor. The General Auditor shall be responsible, through the Audit and Fiduciary Committee, to the Board of Directors for the determination of the program of the internal audit function and the evaluation of the adequacy of the system of internal controls. Subject to the Board of Directors, the General Auditor shall have and may exercise all the powers and shall perform all the duties usual to such office and shall have such other powers as may be prescribed or assigned to him from time to time by the Board of Directors or vested in him by law or by these By-Laws. He shall perform such other duties and shall make such investigations, examinations and reports as may be prescribed or required by the Audit and Fiduciary Committee. The General Auditor shall have unrestricted access to all records and premises of the Company and shall delegate such authority to his subordinates. He shall have the duty to report to the Audit and Fiduciary Committee on all matters concerning the internal audit program and the adequacy of the system of internal controls of the Company which he deems advisable or which the Audit and Fiduciary Committee may request.
Section 4.13. Managing Directors, Directors and Vice Presidents. If chosen, the Managing Directors, Directors and Vice Presidents, in the order of their seniority, shall, in the absence or disability of the President, exercise all of the powers and duties of the President. Such Managing Directors, Directors and Vice Presidents shall have the power to execute bonds, notes, mortgages and other contracts, agreements and instruments of the Company, and they shall perform such other duties and have such other powers as may be incident to their respective offices and as from time to time may be prescribed by the Board of Directors or the President.
Section 4.14. Duties of Officers may be Delegated. In case of the absence or disability of any officer of the Company, or for any other reason that the Board may deem sufficient, the Board may delegate, for the time being, the powers or duties, or any of them, of such officer to any other officer.
ARTICLE V
INDEMNIFICATION OF DIRECTORS, OFFICERS AND OTHERS
Section 5.01. Power to Indemnify in Actions, Suits or Proceedings other than Those by or in the Right of the Company. Subject to the other provisions of this Article V, and subject to applicable law, the Company shall indemnify any person made or threatened to be made a party to an action or proceeding (other than one by or in the right of the Company to procure a judgment in its favor), whether civil or criminal, including an action by or in the right of any other corporation of any type or kind, domestic or foreign, or any partnership, joint venture, trust, employee benefit plan or other enterprise, which any director or officer of the Company served in any capacity at the request of the Company, by reason of the fact that such person, his or her testator or intestate, was a director or officer of the Company, or served such other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise in any capacity, against judgments, fines, amounts paid in settlement and reasonable expenses, including attorneys’ fees actually and necessarily incurred as a result of such action or proceeding, or any appeal therein, if such director or officer acted, in good faith, for a purpose which such person reasonably believed to be in, or, in the case of service for any other corporation or any partnership, joint venture, trust, employee benefit plan or other enterprise, not opposed to, the best interests of the Company, and had no reasonable cause to believe that such person’s conduct was unlawful.
Section 5.02. Power to Indemnify in Actions, Suits or Proceedings by or in the Right of the Company. Subject to the other provisions of this Article V, and subject to applicable law, the Company shall indemnify any person made, or threatened to be made, a party to an action by or in the right of the Company to procure a judgment in its favor by reason of the fact that such person, his or her testator or intestate, is or was a director or officer of the Company, or is or was serving at the request of the Company as a director or officer of any other corporation of any type or kind, domestic or foreign, of any partnership, joint venture, trust, employee benefit plan or other enterprise, against amounts paid in settlement and reasonable
- 6 -
expenses, including attorneys’ fees, actually and necessarily incurred by such person in connection with the defense or settlement of such action, or in connection with an appeal therein, if such director or officer acted, in good faith, for a purpose which he reasonably believed to be in, or, in the case of service for any other corporation or any partnership, joint venture, trust, employee benefit plan or other enterprise, not opposed to, the best interests of the Company, except that no indemnification under this Section 5.02 shall be made in respect of (a) a threatened action, or a pending action which is settled or otherwise disposed of, or (b) any claim, issue or matter as to which such person shall have been adjudged to be liable to the Company, unless and only to the extent that the court in which the action was brought, or, if no action was brought, any court of competent jurisdiction, determines upon application that, in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such portion of the settlement amount and expenses as the court deems proper.
Section 5.03. Authorization of Indemnification. Any indemnification under this Article V (unless ordered by a court) shall be made by the Company only if authorized in the specific case (i) by the Board acting by a quorum consisting of directors who are not parties to such action or proceeding upon a finding that the director or officer has met the standard of conduct set forth in Section 5.01 or Section 5.02, as the case may be; or (ii) if a quorum is not obtainable or, even if obtainable, a quorum of disinterested directors so directs, (x) by the Board upon the opinion in writing of independent legal counsel that indemnification is proper in the circumstances because the applicable standard of conduct set forth in Section 5.01 or Section 5.02, as the case may be, has been met by such director or officer; or (y) by the stockholders upon a finding that the director or officer has met the applicable standard of conduct set forth in Section 5.01 or Section 5.02, as the case may be. A person who has been successful on the merits or otherwise, in the defense of a civil or criminal action or proceeding of the character described in Sections 5.01 or 5.02, shall be entitled to indemnification as authorized in such section.
Section 5.04. Good Faith Defined. For purposes of any determination under Section 5.03, a person shall be deemed to have acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Company, or to have had no reasonable cause to believe such person’s conduct was unlawful, if such person’s action is based on the records or books of account of the Company or another enterprise, or on information supplied to such person by the officers of the Company or another enterprise in the course of their duties, or on the advice of legal counsel for the Company or another enterprise or on information or records given or reports made to the Company or another enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by the Company or another enterprise. The provisions of this Section 5.04 shall not be deemed to be exclusive or to limit in any way the circumstances in which a person may be deemed to have met the applicable standard of conduct set forth in Section 5.01 or Section 5.02, as the case may be.
Section 5.05. Serving an Employee Benefit Plan on behalf of the Company. For the purpose of this Article V, the Company shall be deemed to have requested a person to serve an employee benefit plan where the performance by such person of his duties to the Company also imposes duties on, or otherwise involves services by, such person to the plan or participants or beneficiaries of the plan; excise taxes assessed on a person with respect to an employee benefit plan pursuant to applicable law shall be considered fines; and action taken or omitted by a person with respect to an employee benefit plan in the performance of such person’s duties for a purpose reasonably believed by such person to be in the interest of the participants and beneficiaries of the plan shall be deemed to be for a purpose which is not opposed to the best interests of the Company.
- 7 -
Section 5.06. Indemnification upon Application to a Court. Notwithstanding the failure of the Company to provide indemnification and despite any contrary resolution of the Board or stockholders under Section 5.03, or in the event that no determination has been made within ninety days after receipt of the Company of a written claim therefor, upon application to a court by a director or officer, indemnification shall be awarded by a court to the extent authorized in Section 5.01 or Section 5.02. Such application shall be upon notice to the Company. Neither a contrary determination in the specific case under Section 5.03 nor the absence of any determination thereunder shall be a defense to such application or create a presumption that the director or officer seeking indemnification has not met any applicable standard of conduct.
Section 5.07. Expenses Payable in Advance. Subject to the other provisions of this Article V, and subject to applicable law, expenses incurred in defending a civil or criminal action or proceeding may be paid by the Company in advance of the final disposition of such action or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount (i) if it shall ultimately be determined that such person is not entitled to be indemnified by the Company as authorized in this Article V, (ii) where indemnification is granted, to the extent expenses so advanced by the Company or allowed by a court exceed the indemnification to which such person is entitled and (iii) upon such other terms and conditions, if any, as the Company deems appropriate. Any such advancement of expenses shall be made in the sole and absolute discretion of the Company only as authorized in the specific case upon a determination made, with respect to a person who is a director or officer at the time of such determination, (i) by the Board acting by a quorum consisting of directors who are not parties to such action or proceeding, or (ii) if a quorum is not obtainable or, even if obtainable, if a quorum of disinterested directors so directs, (x) by the Board upon the opinion in writing of independent legal counsel or (y) by the stockholders and, with respect to former directors and officers, by any person or persons having the authority to act on the matter on behalf of the Company. Without limiting the foregoing, the Company reserves the right in its sole and absolute discretion to revoke at any time any approval previously granted in respect of any such request for the advancement of expenses or to, in its sole and absolute discretion, impose limits or conditions in respect of any such approval.
Section 5.08. Nonexclusivity of Indemnification and Advancement of Expenses. The indemnification and advancement of expenses granted pursuant to, or provided by, this Article V shall not be deemed exclusive of any other rights to which a director or officer seeking indemnification or advancement of expenses may be entitled whether contained in the Company’s Organization Certificate, these By-Laws or, when authorized by the Organization Certificate or these By-Laws, (i) a resolution of stockholders, (ii) a resolution of directors, or (iii) an agreement providing for such indemnification, provided that no indemnification may be made to or on behalf of any director or officer if a judgment or other final adjudication adverse to the director or officer establishes that his acts were committed in bad faith or were the result of active and deliberate dishonesty and were material to the cause of action so adjudicated, or that he personally gained in fact a financial profit or other advantage to which he was not legally entitled. Nothing contained in this Article V shall affect any rights to indemnification to which corporate personnel other than directors and officers may be entitled by contract or otherwise under law.
Section 5.09. Insurance. Subject to the other provisions of this Article V, the Company may purchase and maintain insurance (in a single contract or supplement thereto, but not in a retrospective rated contract): (i) to indemnify the Company for any obligation which it incurs as a result of the indemnification of directors and officers under the provisions of this Article V, (ii) to indemnify directors and officers in instances in which they may be indemnified by the Company under the provisions of this Article V and applicable law, and (iii) to indemnify directors and officers in instances in which they may not otherwise be indemnified by the Company under the provisions of this Article V, provided the contract of insurance covering such directors and officers provides, in a manner acceptable to the New York Superintendent of Financial Services, for a retention amount and for co-insurance. Notwithstanding the foregoing, any such insurance shall be subject to the provisions of, and the Company shall comply with the requirements set forth in, Section 7023 of the New York State Banking Law.
- 8 -
Section 5.10. Limitations on Indemnification and Insurance. All indemnification and insurance provisions contained in this Article V are subject to any limitations and prohibitions under applicable law, including but not limited to Section 7022 (with respect to indemnification, advancement or allowance) and Section 7023 (with respect to insurance) of the New York State Banking Law and the Federal Deposit Insurance Act (with respect to administrative proceedings or civil actions initiated by any federal banking agency). Notwithstanding anything contained in this Article V to the contrary, no indemnification, advancement or allowance shall be made (i) to or on behalf of any director or officer if a judgment or other final adjudication adverse to the director or officer establishes that his acts were committed in bad faith or were the result of active and deliberate dishonesty and were material to the cause of action so adjudicated, or that he personally gained in fact a financial profit or other advantage to which he was not legally entitled, or (ii) in any circumstance where it appears (a) that the indemnification would be inconsistent with a provision of the Company’s Organization Certificate, these By-Laws, a resolution of the Board or of the stockholders, an agreement or other proper corporate action, in effect at the time of the accrual of the alleged cause of action asserted in the threatened or pending action or proceeding in which the expenses were incurred or other amounts were paid, which prohibits or otherwise limits indemnification; or (b) if there has been a settlement approved by the court, that the indemnification would be inconsistent with any condition with respect to indemnification expressly imposed by the court in approving the settlement.
Notwithstanding anything contained in this Article V to the contrary, but subject to any requirements of applicable law, (i) except for proceedings to enforce rights to indemnification (which shall be governed by Section 5.06), the Company shall not be obligated to indemnify any director or officer (or his testators intestate) or advance expenses in connection with a proceeding (or part thereof) initiated by such person unless such proceeding (or part thereof) was authorized or consented to by the Board of Directors of the Company, (ii) with respect to indemnification or advancement of expenses relating to attorneys’ fees under this Article V, counsel for the present or former director or officer must be reasonably acceptable to the Company (and the Company may, in its sole and absolute discretion, establish a panel of approved law firms for such purpose, out of which the present or former director or officer could be required to select an approved law firm to represent him), (iii) indemnification in respect of amounts paid in settlement shall be subject to the prior consent of the Company (not to be unreasonably withheld), (iv) any and all obligations of the Corporation under this Article V shall be subject to applicable law, (v) in no event shall any payments pursuant to this Article V be made if duplicative of any indemnification or advancement of expenses or other reimbursement available to the applicable director or officer (other than for coverage maintained by such person in his individual capacity), and (vi) no indemnification or advancement of expenses shall be provided under these By-Laws to any person in respect of any expenses, judgments, fines or amounts paid in settlement to the extent incurred by such person in his capacity or position with another entity (including, without limitation, an entity that is a stockholder of the Company or any of the branches or affiliates of such stockholder), except as expressly provided in these By-Laws in respect of such person’s capacity and position as a director or officer of the Company or such person is a director or officer of the Company serving at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise.
Section 5.11. Indemnification of Other Persons. The Company may, to the extent authorized from time to time by the Board of Directors, provide rights to indemnification and to the advancement of expenses (whether pursuant to an adoption of a policy or otherwise) to employees and agents of the Company (whether similar to those conferred in this Article V upon directors and officers of the Company or on other terms and conditions authorized from time to time by the Board of Directors), as well as to employees of direct and indirect subsidiaries of the Company and to other persons (or categories of persons) approved from time to time by the Board of Directors.
- 9 -
Section 5.12. Repeal. Any repeal or modification of this Article V shall not adversely affect any rights to indemnification and to the advancement of expenses of a director, officer, employee or agent of the Company existing at the time of such repeal or modification with respect to any acts or omissions occurring prior to such repeal or modification.
ARTICLE VI
CAPITAL STOCK
Section 6.01. Certificates. The interest of each stockholder of the Company shall be evidenced by certificates for shares of stock in such form as the Board of Directors may from time to time prescribe. The certificates of stock shall be signed by the Chairman of the Board or the President or a Managing Director or a Director or a Vice President and by the Secretary, or the Treasurer, or an Assistant Secretary, or an Assistant Treasurer, sealed with the seal of the Company or a facsimile thereof, and countersigned and registered in such manner, if any, as the Board of Directors may by resolution prescribe. Where any such certificate is countersigned by a transfer agent other than the Company or its employee, or registered by a registrar other than the Company or its employee, the signature of any such officer may be a facsimile signature. In case any officer or officers who shall have signed, or whose facsimile signature or signatures shall have been used on, any such certificate or certificates shall cease to be such officer or officers of the Company, whether because of death, resignation, retirement, disqualification, removal or otherwise, before such certificate or certificates shall have been delivered by the Company, such certificate or certificates may nevertheless be adopted by the Company and be issued and delivered as though the person or persons who signed such certificate or certificates or whose facsimile signature or signatures shall have been used thereon had not ceased to be such officer or officers of the Company.
Section 6.02. Transfer. The shares of stock of the Company shall be transferred only upon the books of the Company by the holder thereof in person or by his attorney, upon surrender for cancellation of certificates for the same number of shares, with an assignment and power of transfer endorsed thereon or attached thereto, duly executed, with such proof of the authenticity of the signature as the Company or its agents may reasonably require.
Section 6.03. Record Dates. The Board of Directors may fix in advance a date, not less than 10 nor more than 50 days preceding the date of any meeting of stockholders, or the date for the payment of any dividend, or the date for the distribution or allotment of any rights, or the date when any change, conversion or exchange of capital stock shall go into effect, as a record date for the determination of the stockholders entitled to notice of, and to vote at, any such meeting, or entitled to receive payment of any such dividend, or to receive any distribution or allotment of such rights, or to exercise the rights in respect of any such change, conversion or exchange of capital stock, and in such case only such stockholders as shall be stockholders of record on the date so fixed shall be entitled to such notice of, and to vote at, such meeting, or to receive payment of such dividend, or to receive such distribution or allotment or rights or to exercise such rights, as the case may be, notwithstanding any transfer of any stock on the books of the Company after any such record date fixed as aforesaid.
Section 6.04. Lost Certificates. In the event that any certificate of stock is lost, stolen, destroyed or mutilated, the Board of Directors may authorize the issuance of a new certificate of the same tenor and for the same number of shares in lieu thereof. The Board may in its discretion, before the issuance of such new certificate, require the owner of the lost, stolen, destroyed or mutilated certificate or the legal representative of the owner to make an affidavit or affirmation setting forth such facts as to the loss, destruction or mutilation as it deems necessary and to give the Company a bond in such reasonable sum as it directs to indemnify the Company.
- 10 -
ARTICLE VII
CHECKS, NOTES, ETC.
Section 7.01. Checks, Notes, Etc. All checks and drafts on the Company’s bank accounts and all bills of exchange and promissory notes, and all acceptances, obligations and other instruments for the payment of money, may be signed by the President or any Managing Director or any Director or any Vice President and may also be signed by such other officer or officers, agent or agents, as shall be thereunto authorized from time to time by the Board of Directors.
ARTICLE VIII
MISCELLANEOUS PROVISIONS
Section 8.01. Fiscal Year. The fiscal year of the Company shall be from January 1 to December 31, unless changed by the Board of Directors.
Section 8.02. Books. There shall be kept at such office of the Company as the Board of Directors shall determine, within or without the State of New York, correct books and records of account of all its business and transactions, minutes of the proceedings of its stockholders, Board of Directors and committees, and the stock book, containing the names and addresses of the stockholders, the number of shares held by them, respectively, and the dates when they respectively became the owners of record thereof, and in which the transfer of stock shall be registered, and such other books and records as the Board of Directors may from time to time determine.
Section 8.03. Voting of Stock. Unless otherwise specifically authorized by the Board of Directors, all stock owned by the Company, other than stock of the Company, shall be voted, in person or by proxy, by the President or any Managing Director or any Director or any Vice President of the Company on behalf of the Company.
ARTICLE IX
AMENDMENTS
Section 9.01. Amendments. The vote of the holders of at least a majority of the shares of stock of the Company issued and outstanding and entitled to vote shall be necessary at any meeting of stockholders to amend or repeal these By-Laws or to adopt new by-laws. These By-Laws may also be amended or repealed, or new by-laws adopted, at any meeting of the Board of Directors by the vote of at least a majority of the entire Board, provided that any by-law adopted by the Board may be amended or repealed by the stockholders in the manner set forth above.
Any proposal to amend or repeal these By-Laws or to adopt new by-laws shall be stated in the notice of the meeting of the Board of Directors or the stockholders or in the waiver of notice thereof, as the case may be, unless all of the directors or the holders of record of all of the shares of stock of the Company issued and outstanding and entitled to vote are present at such meeting.
- 11 -
Exhibit 7
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Board of Governors of the Federal Reserve System OMB Number 7100-0036 Federal Deposit Insurance Corporation OMB Number 3064-0052 Office of the Comptroller of the Currency OMB Number 1557-0081 Approval expires August 31, 2026 Page 1 of 86 Federal Financial Institutions Examination Council Consolidated Reports of Condition and Income for a Bank with Domestic Offices Only—FFIEC 041 Report at the close of business December 31, 2023 20231231 (RCON 9999) This report is required by law: 12 U.S.C. § 324 (State member This report form is to be filed by banks with domestic offices only banks); 12 U.S.C. §1817 (State nonmember banks); 12 U.S.C. §161 and total consolidated assets of less than $100 billion, except (National banks); and 12 U.S.C. §1464 (Savings associations). those banks that file the FFIEC 051, and those banks that are advanced approaches institutions for regulatory capital purposes Unless the context indicates otherwise, the term “bank” in this that are required to file the FFIEC 031. report form refers to both banks and savings associations. NOTE: Each bank’s board of directors and senior management are responsible for establishing and maintaining an effective system of internal control, including controls over the Reports of Condition and Income. The Reports of Condition and Income are to be prepared in accordance with federal regulatory authority instructions. The Reports of Condition and Income must be signed by the Chief Financial Officer (CFO) of the reporting bank (or by the individual performing an equivalent function) and attested to by not less than two directors (trustees) for state nonmember banks and three directors for state member banks, national banks, and savings associations. I, the undersigned CFO (or equivalent) of the named bank, attest that the Reports of Condition and Income (including the supporting Signature of Chief Financial Officer (or Equivalent) 01/30/2024 Date of Signature schedules) for this report date have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true and correct to the best of my knowledge and belief. We, the undersigned directors (trustees), attest to the correctness of the Reports of Condition and Income (including the supporting schedules) for this report date and declare that the Reports of Condition and Income have been examined by us and to the best of our knowledge and belief have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true and correct. Director (Trustee) Director (Trustee) Director (Trustee) Submission of Reports Each bank must file its Reports of Condition and Income (Call To fulfill the signature and attestation requirement for the Reports Report) data by either: of Condition and Income for this report date, attach your bank’s completed signature page (or a photocopy or a computer gener-(a) Using computer software to prepare its Call Report and then ated version of this page) to the hard-copy record of the data file submitting the report data directly to the FFIEC’s Central Data submitted to the CDR that your bank must place in its files. Repository (CDR), an Internet-based system for data collection (https://cdr.ffiec.gov/cdr/), or The appearance of your bank’s hard-copy record of the submitted (b) Completing its Call Report in paper form and arranging with a data file need not match exactly the appearance of the FFIEC’s software vendor or another party to convert the data into the sample report forms, but should show at least the caption of each electronic format that can be processed by the CDR. The Call Report item and the reported amount. software vendor or other party then must electronically submit the bank’s data file to the CDR. DEUTSCHE BANK TRUST COMPANY AMERICAS Legal Title of Bank (RSSD 9017) For technical assistance with submissions to the CDR, please contact the CDR Help Desk by telephone at (888) CDR-3111, by New York fax at (703) 774-3946, or by e-mail at cdr.help@cdr.ffiec.gov. City (RSSD 9130) FDIC Certificate Number 623 NY 10019 (RSSD 9050) State Abbreviation (RSSD 9200) Zip Code (RSSD 9220) Legal Entity Identifier (LEI) 8EWQ2UQKS07AKK8ANH81 (Report only if your institution already has an LEI.) (RCON 9224) The estimated average burden associated with this information collection is 54.60 hours per respondent and is expected to vary by institution, depending on individual circumstances. Burden estimates include the time for reviewing instructions, gathering and maintaining data in the required form, and completing the information collection, but exclude the time for compiling and maintaining business records in the normal course of a respondent’s activities. A Federal agency may not conduct or sponsor, and an organization (or a person) is not required to respond to a collection of information, unless it displays a currently valid OMB control number. Comments concerning the accuracy of this burden estimate and suggestions for reducing this burden should be directed to the Office of Information and Regulatory Affairs, Office of Management and Budget, Washington, DC 20503, and to one of the following: Secretary, Board of Governors of the Federal Reserve System, 20th and C Streets, NW, Washington, DC 20551; Legislative and Regulatory Analysis Division, Office of the Comptroller of the Currency, Washington, DC 20219; Assistant Executive Secretary, Federal Deposit Insurance Corporation, Washington, DC 20429. 12/2023 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 2 of 86 Consolidated Reports of Condition and Income for a Bank with Domestic Offices Only Table of Contents Signature Page...................................................................................................................................................................1 Contact Information.................................................................................................... 3, 4 Report of Income Schedule RI—Income Statement........................................RI-1, 2, 3, 4 Schedule RI-A—Changes in Bank Equity Capital......................RI-5 Schedule RI-B—Charge-offs and Recoveries on Loans and Leases and Changes in Allowances for Credit Losses Part I. Charge-offs and Recoveries on Loans and Leases............................................................................................RI-6, 7 Part II. Changes in Allowances for Credit Losses..................RI-8 Schedule RI-C—Disaggregated Data on the Allowance for Loan and Lease Losses (to be completed only by selected banks) Part I. Disaggregated Data on the Allowance for Loan and Lease Losses......................................................................................RI-9 Part II. Disaggregated Data on the Allowances for Credit Losses..........................................................................................RI-10 Schedule RI-E—Explanations..............................................................................................RI-11, 12 Report of Condition Schedule RC—Balance Sheet.......................................................................................................RC-1, 2 Schedule RC-A—Cash and Balances Due from Depository Institutions (to be completed only by selected banks)...........................RC-3 Schedule RC-B—Securities.............................................RC-3, 4, 5, 6, 7 Schedule RC-C—Loans and Lease Financing Receivables: Part I. Loans and Leases........................RC-8, 9, 10, 11, 12, 13 Part II. Loans to Small Businesses and Small Farms................................................................. RC-14,15 Schedule RC-D—Trading Assets and Liabilities (to be completed only by selected banks)...............................................................................……...............RC-16 Schedule RC-E—Deposit Liabilities ............................... .................................................... RC-17, 18, 19 Schedule RC-F—Other Assets.................................................................................RC-20 Schedule RC-G—Other Liabilities..........................................................................................................................RC-20 Schedule RC-K—Quarterly Averages.......................................................................................................................RC-21, 22 Schedule RC-L—Derivatives and Off-Balance-Sheet Items...................................................RC-23, 24, 25, 26 Schedule RC-M—Memoranda.............................................RC-27, 28, 29 Schedule RC-N—Past Due and Nonaccrual Loans, Leases, and Other Assets.....................RC-30, 31, 32, 33, 34 Schedule RC-O—Other Data for Deposit Insurance Assessments..................RC-35, 36, 37, 38, 39, 40 Schedule RC-P—1–4 Family Residential Mortgage Banking Activities (to be completed only by selected banks)........................................................................................................................................................................RC-41 Schedule RC-Q—Assets and Liabilities Measured at Fair Value on a Recurring Basis (to be completed only by selected banks)..........................................................................................................RC-42, 43, 44 Schedule RC-R—Regulatory Capital: Part I. Regulatory Capital Components and Ratios..........................................................................................RC-45, 46, 47, 48 Part II. Risk-Weighted Assets....................................RC-49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62 Schedule RC-S—Servicing, Securitization, and Asset Sale Activities.................................................RC-63, 64 Schedule RC-T—Fiduciary and Related Services..........................................................RC-65, 66, 67, 68 Schedule RC-V—Variable Interest Entities ....................RC-69 Optional Narrative Statement Concerning the Amounts Reported in the Consolidated Reports of Condition and Income..........................................................................RC-70 For information or assistance, national banks, state nonmember banks, and savings associations should contact the FDIC’s Data Collection and Analysis Section, 550 17th Street, NW, Washington, DC 20429, toll free on (800) 688-FDIC(3342), Monday through Friday between 8:00 a.m. and 5:00 p.m., Eastern Time. State member banks should contact their Federal Reserve District Bank. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 3 of 86 Contact Information for the Reports of Condition and Income To facilitate communication between the Agencies and the bank concerning the Reports of Condition and Income, please provide contact information for (1) the Chief Financial Officer (or equivalent) of the bank signing the reports for this quarter, and (2) the person at the bank —other than the Chief Financial Officer (or equivalent) — to whom questions about the reports should be directed. If the Chief Financial Officer (or equivalent) is the primary contact for questions about the reports, please provide contact information for another person at the bank who will serve as a secondary contact for communications between the Agencies and the bank concerning the Reports of Condition and Income. Enter “none” for the contact’s e-mail address or fax number if not available. Contact information for the Reports of Condition and Income is for the confidential use of the Agencies and will not be released to the public. Chief Financial Officer (or Equivalent) Other Person to Whom Questions about the Signing the Reports Reports Should be Directed Mona Nag Scott Iacono Name (TEXT C490) Name (TEXT C495) CFO Director Title (TEXT C491) Title (TEXT C496) mona.nag@db.com Scott.Iacono@db.com E-mail Address (TEXT C492) E-mail Address (TEXT 4086) 212-250-0302 212-250-8948 Area Code / Phone Number / Extension (TEXT C493) Area Code / Phone Number / Extension (TEXT 8902) 212-797-5376 212-797-5376 Area Code / FAX Number (TEXT C494) Area Code / FAX Number (TEXT 9116) Chief Executive Officer Contact Information This information is being requested so the Agencies can distribute notifications about policy initiatives, deposit insurance assessments, and other matters directly to the Chief Executive Officers of reporting institutions. Notifications about other matters may include emergency notifications that may or may not also be sent to the institution’s emergency contacts listed below. Please provide contact information for the Chief Executive Officer of the reporting institution. Enter “none” for the Chief Executive Officer’s e-mail address or fax number if not available. Chief Executive Officer contact information is for the confidential use of the Agencies and will not be released to the public. Chief Executive Officer Arjun Nagarkatti 442075450031 Name (TEXT FT42) Area Code / Phone Number / Extension (TEXT FT43) arjun.nagarkatti@db.com 212-797-4932 E-mail Address (TEXT FT44) Area Code / FAX Number (TEXT FT45) Emergency Contact Information This information is being requested so the Agencies can distribute critical, time-sensitive information to emergency contacts at banks. Please provide primary contact information for a senior official of the bank who has decision-making authority. Also provide information for a secondary contact if available. Enter “none” for the contact’s e-mail address or fax number if not available. Emergency contact information is for the confidential use of the Agencies and will not be released to the public. Primary Contact Secondary Contact Arjun Nagarkatti Michael Connolly Name (TEXT C366) Name (TEXT C371) Managing Director Managing Director Title (TEXT C367) Title (TEXT C372) Arjun.Nagarkatti@db.com Michael.Connolly@db.com E-mail Address (TEXT C368) E-mail Address (TEXT C373) 442075450031 212-250-1483 Area Code / Phone Number / Extension (TEXT C369) Area Code / Phone Number / Extension (TEXT C374) 212-797-4932 212-797-4932 Area Code / FAX Number (TEXT C370) Area Code / FAX Number (TEXT C375) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 4 of 86 USA PATRIOT Act Section 314(a) Anti-Money Laundering Contact Information This information is being requested to identify points-of-contact who are in charge of your bank’s USA PATRIOT Act Section 314(a) information requests. Bank personnel listed could be contacted by law enforcement officers or the Financial Crimes Enforcement Network (FinCEN) for additional information related to specific Section 314(a) search requests or other anti-terrorist financing and anti-money-laundering matters. Communications sent by FinCEN to the bank for purposes other than Section 314(a) notifications will state the intended purpose and should be directed to the appropriate bank personnel for review. Any disclosure of customer records to law enforcement officers or FinCEN must be done in compliance with applicable law, including the Right to Financial Privacy Act (12 U.S.C. 3401 et seq.). Please provide information for a primary and secondary contact. Information for a third and fourth contact may be provided at the bank’s option. Enter “none” for the contact’s e-mail address if not available. This contact information is for the confidential use of the Agencies, FinCEN, and law enforcement officers and will not be released to the public. Primary Contact Secondary Contact Paul Khareyn Joe Evans Name (TEXT C437) Name (TEXT C442) Director Managing Director Title (TEXT C438) Title (TEXT C443) Paul.Khareyn@db.com Joe.Evans@db.com E-mail Address (TEXT C439) E-mail Address (TEXT C444) 212-250-6774 212-250-1213 Area Code / Phone Number / Extension (TEXT C440) Area Code / Phone Number / Extension (TEXT C445) Third Contact Fourth Contact Hatton Hillin Cristian Ilut Name (TEXT C870) Name (TEXT C875) Assistant Vice President Assistant Vice President Title (TEXT C871) Title (TEXT C876) Hatton.Hillin@db.com Cristian.Ilut@db.com E-mail Address (TEXT C872) E-mail Address (TEXT C877) 904-520-5106 347-863-0715 Area Code / Phone Number / Extension (TEXT C873) Area Code / Phone Number / Extension (TEXT C878) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 5 of 86 RI-1 Consolidated Report of Income for the period January 1, 2023–December 31, 2023 Schedule RI—Income Statement Dollar Amounts in Thousands RIAD Amount 1. Interest income: a. Interest and fee income on loans: (1) Loans secured by real estate: (a) Loans secured by 1–4 family residential properties……………………………………….............................. 4435 80,000 1.a.(1)(a) (b) All other loans secured by real estate……………………………………………………….............................. 4436 290,000 1.a.(1)(b) (2) Commercial and industrial loans…………………………………………………………………......................... 4012 122,000 1.a.(2) (3) Loans to individuals for household, family, and other personal expenditures: (a) Credit cards………………………………………………………………………………………….................... B485 0 1.a.(3)(a) (b) Other (includes revolving credit plans other than credit cards, automobile loans, and other consumer loans)……………………………………………………………………..……………………….................. B486 21,000 1.a.(3)(b) (4) Not applicable All other loans 4058 (5) (1)…………………………………………………………............................................................ 436,000 1.a.(5) (6) Total interest and fee income on loans (sum of items 1.a.(1)(a) through 1.a.(5))…………………........................... 4010 949,000 1.a.(6) b. Income from lease financing receivables……………………………………..………..….………............................ 4065 0 1.b. . Interest income on balances due from depository institutions 4115 c (2)……………………………………..................... 712,000 1.c. d. Interest and dividend income on securities: (1) U.S. Treasury securities and U.S. Government agency obligations (excluding mortgage-backed securities)………………………………………………………………………………........................ B488 5,000 1.d.(1) (2) Mortgage-backed securities………………………………………………………………………………......................... B489 0 1.d.(2) (3) All other securities (includes securities issued by states and political subdivisions in the U.S.)……………………………………………………………………………………………....…......................... 4060 0 1.d.(3) e. Not applicable f. Interest income on federal funds sold and securities purchased under agreements to resell………….............. 4020 306,000 1.f. g. Other interest income………………………………………………………………………………............................... 4518 5,000 1.g. h. Total interest income (sum of items 1.a.(6) through 1.g)…………………………………………........................... 4107 1,977,000 1.h. 2. Interest expense: a. Interest on deposits: (1) Transaction accounts (interest-bearing demand deposits, NOW accounts, ATS accounts, and telephone and preauthorized transfer accounts)………………………………………………………………............................ 4508 545,000 2.a.(1) (2) Nontransaction accounts: (a) Savings deposits (includes MMDAs)………………………………………………….............................. 0093 82,000 2.a.(2)(a) (b) Time deposits of $250,000 or less………………………………………………………............................. HK03 0 2.a.(2)(b) (c) Time deposits of more than $250,000………………………………………………………………................. HK04 7,000 2.a.(2)(c) b. Expense of federal funds purchased and securities sold under agreements to repurchase…………............... 4180 0 2.b. c. Interest on trading liabilities and other borrowed money…………………………………...………....................... 4185 29,000 2.c. d. Interest on subordinated notes and debentures............................................................................................................................................................................................. 4200 0 2.d. e. Total interest expense (sum of items 2.a through 2.d)............................................................................................................................................... 4073 663,000 2.e. 3. Net interest income (item 1.h minus 2.e)....................................................................................................................... 4074 1,314,000 3. . Provision for loan and lease losses JJ33 4 (3)..................................................................................................................... (2,000) 4. __________ 1. Includes interest and fee income on “Loans to depository institutions and acceptances of other banks,” “Loans to finance agricultural production and other loans to farmers,” “Obligations (other than securities and leases) of states and political subdivisions in the U.S.,” and “Loans to nondepository financial institutions and other loans.” 2. Includes interest income on time certificates of deposit not held for trading. 3. Institutions that have adopted ASU 2016-13 should report in item 4 the provisions for credit losses on all financial assets and off-balance-sheet credit exposures that fall within the scope of the standard. 12/2023 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 6 of 86 RI-2 Schedule RI—Continued Year-to-date Dollar Amounts in Thousands RIAD Amount 5. Noninterest income: . Income from fiduciary activities 4070 a (1).................................................................................................................................................... 279,000 5.a. b. Service charges on deposit accounts...................................................................................................................……………………………. 4080 140,000 5.b. c. Trading revenue.................................................................................................................................................................…………. A220 0 5.c. d. Income from securities-related and insurance activities: (1)Fees and commissions from securities brokerage..........................................................................................................................................… C886 0 5.d.(1) (2)Investment banking, advisory, and underwriting fees and commissions C888 0 5.d.(2) (3)Fees and commissions from annuity sales.......................................................................................................................................... C887 0 5.d.(3) (4)Underwriting income from insurance and reinsurance activities.......................................................................................................................................... C386 0 5.d.(4) (5)Income from other insurance activities................................................................................................................... C387 0 5.d.(5) e. Venture capital revenue........................................................................................................................................................................................ B491 0 5.e. f. Net servicing fees.................................................................................................................................................................… B492 0 5.f. g. Net securitization income..........................................................................................................................................................................................................................…........… B493 0 5.g. h. Not applicable i. Net gains (losses) on sales of loans and leases....................................................................................................................................… 5416 0 5.i. j. Net gains (losses) on sales of other real estate owned....................................................................................................................................… 5415 0 5.j. . Net gains (losses) on sales of other assets B496 k (2)....................................................................................................................................… 0 5.k. l. Other noninterest income*..............................................................................................................................................................................................................................................… B497 139,000 5.l. m.Total noninterest income (sum of items 5.a through 5.l)………………….…..…..…………….. 4079 558,000 5.m. 6. a. Realized gains (losses) on held-to-maturity securities………………………………..………… 3521 0 6.a. b. Realized gains (losses) on available-for-sale debt securities………………..…..…………………… 3196 0 6.b. 7. Noninterest expense: a. Salaries and employee benefits 4135 122,000 7.a. b. Expenses of premises and fixed assets (net of rental income) (excluding salaries and employee benefits and mortgage interest)....................................................................................................................................… 4217 28,000 7.b. c. (1)Goodwill impairment losses....................................................................................................................................… C216 0 7.c.(1) (2)Amortization expense and impairment losses for other intangible assets....................................................................................................................................… C232 2,000 7.c.(2) d. Other noninterest expense*....................................................................................................................................… 4092 873,000 7.d. e. Total noninterest expense (sum of items 7.a through 7.d)....................................................................................................................................… 4093 1,025,000 7.e. 8. a. Income (loss) before change in net unrealized holding gains (losses) on equity securities not held for trading, applicable income taxes, and discontinued operations (item 3 plus or minus items 4, 5.m, 6.a, 6.b, and 7.e)……..…..…………………………..… HT69 849,000 8.a. b. Change in net unrealized holding gains (losses) on equity securities held for trading HT70 not (3)..…..…………………………..…..…………………………..…..……………………..…..…………………………..…..…………………………..…..…………………… 1,000 8.b c. Income (loss) before applicable income taxes and discontinued operations (sum of items 8.a and 8.b)……..…..…………………………..…..…………………………..…..…………………… 4301 850,000 8.c. 9. Applicable income taxes (on item 8.c)....................................................................................................................................… 4302 219,000 9. 10. Income (loss) before discontinued operations (item 8.c minus item 9)......................................................................................... 4300 631,000 10. 11. Discontinued operations, net of applicable income taxes*........................................................................................................... FT28 0 11. 12. Net income (loss) attributable to bank and noncontrolling (minority) interests (sum of items 10 and 11)....................................................................................................................................… G104 631,000 12. 13. LESS: Net income (loss) attributable to noncontrolling (minority) interests (if net income, report as a positive value; if net loss, report as a negative value)....................................................................................................................................…....................................................................................................................................… G103 0 13. 14. Net income (loss) attributable to bank (item 12 minus item 13)....................................................................................................................................… 4340 631,000 14. __________ * Describe on Schedule RI-E—Explanations. 1. For banks required to complete Schedule RC-T, items 14 through 22, income from fiduciary activities reported in Schedule RI, item 5.a, must equal the amount reported in Schedule RC-T, item 22. 2. Exclude net gains (losses) on sales of trading assets and held-to-maturity and available-for-sale debt securities. 3. Item 8.b is to be completed by all institutions. See the instructions for this item and the Glossary entry for “Securities Activities” for further detail on accounting for investments in equity securities. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 7 of 86 Schedule RI—Continued RI-3 Memoranda Year-to-date Dollar Amounts in Thousands RIAD Amount 1. Interest expense incurred to carry tax-exempt securities, loans, and leases acquired after August 7, 1986, that is not deductible for federal income tax purposes…………………………………................ 4513 0 M.1. Memorandum item 2 is to be completed by banks with $1 billion or more in total assets (1) 2. Income from the sale and servicing of mutual funds and annuities (included in Schedule RI, item 8)……………………………………………………………………………………..................................................... 8431 0 M.2. 3. Income on tax-exempt loans and leases to states and political subdivisions in the U.S. (included in Schedule RI, items 1.a and 1.b)………………………………………………………………………................................... 4313 0 M.3. 4. Income on tax-exempt securities issued by states and political subdivisions in the U.S. (included in Schedule RI, item 1.d.(3))…………………………………………………………………………….................................... 4507 0 M.4. 5. Number of full-time equivalent employees at end of current period Number (round to nearest whole number)………………………………………………………………………………………………………................................... 4150 384 M.5. Memorandum item 6 is to be completed by: (1) • banks with $300 million or more in total assets, and • banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans 6. Interest and fee income on loans to finance agricultural production and other loans to farmers Amount (included in Schedule RI, item 1.a.(5))......................................................................................................................... 4024 0 M.6. 7. If the reporting institution has applied push down accounting this calendar year, report the date RIAD Date the institution’s acquisition (see instructions) 9106 of (2)…………………………......................………..................................... 00000000 M.7. 8. Not applicable Memorandum items 9.a and 9.b are to be completed by banks with $10 billion or more in total assets. (1) 9. Net gains (losses) recognized in earnings on credit derivatives that economically hedge credit exposures held outside the trading account: Amount a. Net gains (losses) on credit derivatives held for trading…………………………………………………….................................. C889 0 M.9.a. b. Net gains (losses) on credit derivatives held for purposes other than trading……………………………................................. C890 0 M.9.b. Memorandum item 10 is to be completed by banks with $300 million or more in total assets. (1) 10. Credit losses on derivatives (see instructions)…………………………………………………………………................................. A251 0 M.10. 11. Does the reporting bank have a Subchapter S election in effect for federal income tax purposes RIAD Yes No for the current tax year?................................................................................................................................................ A530 x M.11. 12. Not applicable __________ 1. The asset-size tests and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 2. Report the date in YYYYMMDD format. For example, a bank acquired on March 1, 2023, would report 20230301. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 8 of 86 Schedule RI—Continued RI-4 Memoranda—Continued Dollar Amounts in Thousands Year-to-date RIAD Amount Memorandum item 13 is to be completed by banks that have elected to account for assets and liabilities under a fair value option. 13. Net gains (losses) recognized in earnings on assets and liabilities that are reported at fair value under a fair value option: a. Net gains (losses) on assets............................................................................................................................................................ F551 0 M.13.a. (1) Estimated net gains (losses) on loans attributable to changes in instrument-specific credit risk................................................................................................................................................................................ F552 0 M.13.a.(1) b. Net gains (losses) on liabilities............................................................................................................................................................ F553 0 M.13.b. (1) Estimated net gains (losses) on liabilities attributable to changes in instrument-specific credit risk................................................................................................................................................................................ F554 0 M.13.b.(1) 14. Other-than-temporary impairment losses on held-to-maturity and available-for-sale debt recognized in earnings (included in Schedule RI, items 6.a and 6.b) J321 securities (1)................................................................................................... NA M.14. Memorandum item 15 is to be completed by institutions with $1 billion or more in total assets (2) that answered “Yes” to Schedule RC-E, Memorandum item 5. 15. Components of service charges on deposit accounts (sum of Memorandum items 15.a through 15.d must equal Schedule RI, item 5.b): a. Consumer overdraft-related service charges levied on those transaction account and nontransaction savings account deposit products intended primarily for individuals for personal, household, or family use H032 NA M.15.a. b. Consumer account periodic maintenance charges levied on those transaction account and nontransaction savings account deposit products intended primarily for individuals for personal, household, or family use H033 NA M.15.b. c. Consumer customer automated teller machine (ATM) fees levied on those transaction account and nontransaction savings account deposit products intended primarily for individuals for personal, household, or family use H034 NA M.15.c. d. All other service charges on deposit accounts ................................................................................................................................................................................................ H035 NA M.15.d. 1. Memorandum item 14 is to be completed only by institutions that have not adopted ASU 2016-13. 2. The $1 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 9 of 86 RI-5 Schedule RI-A—Changes in Bank Equity Capital RIAD Amount Dollar Amounts in Thousands 1. Total bank equity capital most recently reported for the December 31, 2022, Reports of Condition and Income (i.e., after adjustments from amended Reports of Income) 3217 9,479,000 1. 2. Cumulative effect of changes in accounting principles and corrections of material accounting errors*............................................................................................................................................................................................................. B507 0 2. 3. Balance end of previous calendar year as restated (sum of items 1 and 2) B508 9,479,000 3. 4. Net income (loss) attributable to bank (must equal Schedule RI, item 14) 4340 631,000 4. 5. Sale, conversion, acquisition, or retirement of capital stock, net (excluding treasury stock transactions)............................................................................................................................................................ B509 (4,000) 5. 6. Treasury stock transactions, net............................................................................................................................................................ B510 0 6. 7. Changes incident to business combinations, net............................................................................................................................................................ 4356 0 7. 8. LESS: Cash dividends declared on preferred stock............................................................................................................................................................ 4470 0 8. 9. LESS: Cash dividends declared on common stock............................................................................................................................................................ 4460 456,000 9. . Other comprehensive income B511 10 (1)............................................................................................................................................................ 15,000 10. 11. Other transactions with stockholders (including a parent holding company)* (not included in items 5, 6, 8, or 9 above)............................................................................................................................................................ 4415 0 11. 12. Total bank equity capital end of current period (sum of items 3 through 11) (must equal Schedule RC, item 27.a)............................................................................................................................................................ 3210 9,665,000 12. __________ * Describe on Schedule RI-E—Explanations. 1. Includes, but is not limited to, changes in net unrealized holding gains (losses) on available-for-sale debt securities, changes in accumulated net gains (losses) on cash flow hedges, and pension and other postretirement plan-related changes other than net periodic benefit cost. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 10 of 86 Schedule RI-B—Charge-offs and Recoveries on Loans and Leases RI-6 and Changes in Allowances for Credit Losses Part I. Charge-offs and Recoveries on Loans and Leases Part I includes charge-offs and recoveries through (Column A) (Column B) the allocated transfer risk reserve. Charge-offs (1) Recoveries Calendar Year-to-date Dollar Amounts in Thousands RIAD Amount RIAD Amount 1. Loans secured by real estate: a. Construction, land development, and other land loans: (1) 1–4 family residential construction loans………………………………............................. C891 0 C892 0 1.a.(1) (2) Other construction loans and all land development and other land loans………………………………………………………………….............................. C893 0 C894 0 1.a.(2) b. Secured by farmland …………………………………….............................................................. 3584 0 3585 0 1.b. c. Secured by 1–4 family residential properties: (1) Revolving, open-end loans secured by 1–4 family residential properties and extended under lines of credit…………………………............................ 5411 0 5412 0 1.c.(1) (2) Closed-end loans secured by 1–4 family residential properties: (a) Secured by first liens…………………………………………………......................... C234 0 C217 2,000 1.c.(2)(a) (b) Secured by junior liens……………………………………………….......................... C235 0 C218 0 1.c.(2)(b) d. Secured by multifamily (5 or more) residential properties………………………………………………………………… 3588 0 3589 0 1.d. e. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties…………………………………………………………………................................ C895 0 C896 0 1.e.(1) (2) Loans secured by other nonfarm nonresidential properties........................................ C897 0 C898 0 1.e.(2) 2. and 3. Not applicable 4. Commercial and industrial loans………………………………………………………… 4638 0 4608 0 4. 5. Loans to individuals for household, family, and other personal expenditures: a. Credit cards…................................................................................................................................................... B514 0 B515 0 5.a. b. Automobile loans…................................................................................................................................................... K129 0 K133 0 5.b. c. Other (includes revolving credit plans other than credit cards and other consumer loans)…................................................................................................................................................... K205 0 K206 0 5.c. 6. Not applicable . All other loans 4644 4628 7 (2)…................................................................................................................................................... 0 0 7. 8. Lease financing receivables…................................................................................................................................................... 4266 0 4267 0 8. 9. Total (sum of items 1 through 8)…................................................................................................................................................... 4635 0 4605 2,000 9. 1. Include write-downs arising from transfers of loans to a held-for-sale account. 2. Includes charge-offs and recoveries on ”Loans to depository institutions and acceptances of other banks,“ “Loans to finance agricultural production and other loans to farmers,” “Obligations (other than securities and leases) of states and political subdivisions in the U.S.,” and “Loans to nondepository financial institutions and other loans.” 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 11 of 86 RI-7 Schedule RI-B—Continued Memoranda (Column A) (Column B) Charge-offs (1) Recoveries Calendar Year-to-date RIAD Amount RIAD Amount Dollar Amounts in Thousands 1. Loans to finance commercial real estate, construction, and land development activities (not secured by real estate) included in Schedule RI-B, Part I, items 4 and 7, above…................................................................................................................................................... 5409 0 5410 0 M.1. 2. Memorandum items 2.a. through 2.d. are to be completed by banks with $300 million or more in total assets: (2) a. Loans secured by real estate to non-U.S. addressees (domicile) (included in Schedule RI-B, Part I, item 1, above)…................................................................................................................................................... 4652 0 4662 0 M.2.a. b. Not applicable c. Commercial and industrial loans to non-U.S. addressees (domicile) (included in Schedule RI-B, Part I, item 4 above) ......................................................... 4646 0 4618 0 M.2.c. d. Leases to individuals for household, family, and other personal expenditures (included in Schedule RI-B, Part I, item 8, above)…................................................................................................................................................... F185 0 F187 0 M.2.d. Memorandum item 3 is to be completed by: (2) • banks with $300 million or more in total assets, and • banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans: 3. Loans to finance agricultural production and other loans to farmers (included in Schedule RI-B, Part I, item 7, above) ......................................................... 4655 0 4665 0 M.3. Memorandum item 4 is to be completed by banks that (1) together with affiliated institutions, have outstanding credit card receivables (as defined in the instructions) that exceed $500 million as of the report date, or (2) are credit card specialty banks as defined for Uniform Bank Performance Report purposes. Calendar Year-to-date 4. Uncollectible retail credit card fees and finance charges reversed against income RIAD Amount .e., not included in charge-offs against the allowance for loan and lease losses) C388 . (i (3) NA M.4 __________ 1. Include write-downs arising from transfers of loans to a held-for-sale account. 2. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 3. Institutions that have adopted ASU 2016-13 should report in Memorandum item 4 uncollectible retail credit card fees and finance charges reversed against income (i.e., not included in charge-offs against the allowance for credit losses on loans and leases). 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 12 of 86 RI-8 Schedule RI-B—Continued Part II. Changes in Allowances for Credit Losses (1) (Column A) (Column B) (Column C) Loans and Leases Held Held-to-Maturity Available-for-Sale for Investment Debt Securities (2) Debt Securities (2) Dollar Amounts in Thousands RIAD Amount RIAD Amount RIAD Amount 1. Balance most recently reported for the December 31, 2022, Reports of Condition and Income (i.e., after adjustments from amended Reports of Income)........................................................................................................................................ B522 16,000 JH88 0 JH94 0 1. 2. Recoveries (column A must equal Part I, item 9, column B, above) .......................................................................................................................... 4605 2,000 JH89 0 JH95 0 2. 3. LESS: Charge-offs (column A must equal Part I, item 9, column A, above less Schedule RI-B, Part II, item 4, column A) ..................................................................................................................................................................................................................... C079 0 JH92 0 JH98 0 3. 4. LESS: Write-downs arising from transfers of assets 5523 JJ00 JJ01 financial (3).............................................................................................................................................................................................................0 0 0 4. 5. Provisions for credit losses (4, 5)........................................................................................................................................................................ 4230 (2,000) JH90 0 JH96 0 5. 6. Adjustments* (see instructions for this schedule) C233 0 JH91 0 JH97 0 6. 7. Balance end of current period (sum of items 1, 2, 5, and 6, less items 3 and 4) (column A must equal Schedule RC, item 4.c).................................................................................................................................................................. 3123 16,000 JH93 0 JH99 0 7. * Describe on Schedule RI-E—Explanations. 1. Institutions that have not adopted ASU 2016-13 should report changes in the allowance for loan and lease losses in column A. 2. Columns B and C are to be completed only by institutions that have adopted ASU 2016-13. 3. Institutions that have not yet adopted ASU 2016-13 should report write-downs arising from transfers of loans to a held-for-sale account in item 4, column A. 4. Institutions that have not yet adopted ASU 2016-13 should report the provision for loan and lease losses in item 5, column A, and the amount reported must equal Schedule RI, item 4. 5. For institutions that have adopted ASU 2016-13, the sum of item 5, columns A through C, plus schedule RI-B, Part II, Memorandum items 5 and 7, below, must equal Schedule RI, item 4. Memoranda Dollar Amounts in Thousands RIAD Amount 1. Allocated transfer risk reserve included in Schedule RI-B, Part II, item 7,column A, above...................................................................................................................... C435 0 M.1. Memorandum items 2 and 3 are to be completed by banks that (1) together with affiliated institutions, have outstanding credit card receivables (as defined in the instructions) that exceed $500 million as of the report date, or (2) are credit card specialty banks as defined for Uniform Bank Performance Report purposes. 2. Separate valuation allowance for uncollectible retail credit card fees and finance charges......................................................................................... C389 NA M.2. 3. Amount of allowance for loan and lease losses attributable to retail credit card fees and finance C390 charges (1).................................................................................................................................................................................................................................... NA M.3. 4. Amount of allowance for post-acquisition credit losses on purchased credit-impaired loans accounted for in accordance with FASB ASC 310-30 (former AICPA Statement of Position 03-3) in Schedule RI-B, Part II, item 7, column A , above) C781 (included (2).............................................................................................................................................................................. NA M.4. 5. Provisions for credit losses on other financial assets measured at amortized cost (not included in 5, above) JJ02 item (3) 0 M.5. 6. Allowance for credit losses on other financial assets measured at amortized cost (not included in RCON 7, above) JJ03 item (3) 0 M.6. RIAD 7. Provisions for credit losses on off-balance-sheet credit exposures MG93 (3)....................................................................................................................................................................... 0 M.7. 8. Estimated amount of expected recoveries of amounts previously written off included within the allowance for credit losses on loans and leases held for investment (included in item 7, column A, end of current period,” above) MG94 “Balance (3)....................................................................................................................................................................... 0 M.8. 1. Institutions that have adopted ASU 2016-13 should report in Memorandum item 3 the amount of allowance for credit losses on loans and leases attributable to retail credit card fees and finance changes. 2. Memorandum item 4 is to be completed only by institutions that have not yet adopted ASU 2016-13. 3. Memorandum items 5, 6, 7, and 8 are to be completed only by institutions that have adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RI-C—Disaggregated Data on the Allowance for Loan and Lease Losses FFIEC 041 Page 13 of 86 RI-9 Part I. Disaggregated Data on the Allowance for Loan and Lease Losses (1) Schedule RI-C. Part I, is to be completed by institutions with $1 billion or more in total assets. (2) (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) Recorded Investment: Allowance Balance: Recorded Investment: Allowance Balance: Recorded Investment: Allowance Balance: Individually Evaluated Individually Evaluated Collectively Evaluated Collectively Evaluated Purchased Purchased for Impairment and for Impairment and for Impairment for Impairment Credit-Impaired Loans Credit-Impaired Loans Determined to be Impaired Determined to be Impaired (ASC 450-20) (ASC 450-20) (ASC 310-30) (ASC 310-30) (ASC 310-10-35) (ASC 310-10-35) Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount RCON Amount RCON Amount Real estate loans: a. Construction loans………………………………………………………………………….............. M708 NA M709 NA M710 NA M711 NA M712 NA M713 NA 1.a. b. Commercial real estate loans………………………………………………………………………….............. M714 NA M715 NA M716 NA M717 NA M719 NA M720 NA 1.b. c. Residential real estate loans………………………………………………………………………….............. M721 NA M722 NA M723 NA M724 NA M725 NA M726 NA 1.c. M727 M728 M729 M730 M731 M732 Commercial loans (3)………………………………………………………………………….............. NA NA NA NA NA NA 2. Credit cards………………………………………………………………………….............. M733 NA M734 NA M735 NA M736 NA M737 NA M738 NA 3. Other consumer loans………………………………………………………………………….............. M739 NA M740 NA M741 NA M742 NA M743 NA M744 NA 4. Unallocated, if any………………………………………………………………………….............. M745 NA 5. Total (sum of . through 5) M746 M747 M748 M749 M750 M751 items 1.a (4)………………………………………………………………………….............. NA NA NA NA NA NA 6. 1. Only institutions that have not yet adopted ASU 2016-13 are to complete Schedule RI-C, Part I. 2. The $1 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 3. Include all loans and leases not reported as real estate loans, credit cards, or other consumer loans in items 1, 3, or 4 of Schedule RI-C. 4. The sum of item 6, columns B, D, and F, must equal Schedule RC, item 4.c. Item 6, column E, must equal Schedule RC-C, Part I, Memorandum item 7.b. Item 6, column F, must equal Schedule RI-B, Part II, Memorandum item 4. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 14 of 86 RI-10 Schedule RI-C—Continued Part II. Disaggregated Data on the Allowances for Credit Losses (1) Schedule RI-C, Part II, is to be completed by institutions with $1 billion or more in total assets. (2) (Column A) (Column B) Amortized Cost Allowance Balance Dollar Amounts in Thousands RCON Amount RCON Amount Loans and Leases Held for Investment: 1. Real estate loans: a. Construction loans.................................................................................................... JJ04 77,000 JJ12 0 1.a. b. Commercial real estate loans................................................................................................ JJ05 4,452,000 JJ13 3,000 1.b. c. Residential real estate loans................................................................................................ JJ06 2,194,000 JJ14 4,000 1.c. . JJ07 JJ15 2 Commercial loans (3)................................................................................................................................................................................... 9,317,000 8,000 2. 3. Credit cards................................................................................................................................................ JJ08 0 JJ16 0 3. 4. Other consumer loans................................................................................................................................................ JJ09 307,000 JJ17 1,000 4. 5. Unallocated, if any................................................................................................................................................ JJ18 0 5. . Total (sum of items 1 a. through 5) JJ11 JJ19 6 . (4)................................................................................................................................... 16,347,000 16,000 6. Allowance Balance Dollar Amounts in Thousands RCON Amount Held-to-Maturity Securities: 7. Securities issued by states and political subdivisions in the U.S.................................................................... JJ20 0 7. 8. Mortgage-backed securities (MBS) (including CMOs, REMICs, and stripped MBS) JJ21 0 8. 9. Asset-backed securities and structured financial products JJ23 0 9. 10. Other debt securities JJ24 0 10. 11. Total (sum of items 7 through 10) JJ25 (5) 0 11. 1. Only institutions that have adopted ASU 2016-13 are to complete Schedule RI-C, Part II. 2. The $1 billion asset-size test is based on the total assets reported on theJune 30, 2022, Report of Condition. 3. Include all loans and leases not reported as real estate loans, credit cards, or other consumer loans in items 1, 3, or 4 of Schedule RI-C, Part II. 4. Item 6, column B, must equal Schedule RC, item 4.c. 5. Item 11 must equal Schedule RI-B, Part II, item 7, column B. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 15 of 86 RI-11 Schedule RI-E—Explanations Schedule RI-E is to be completed each quarter on a calendar year-to-date basis. Detail all adjustments in Schedule RI-A and RI-B, all discontinued operations in Schedule RI, and all significant items of other noninterest income and other noninterest expense in Schedule RI. (See instructions for details.) Year-to-date Dollar Amounts in Thousands RIAD Amount 1. Other noninterest income (from Schedule RI, item 5.l) Itemize and describe amounts greater than $100,000 that exceed 7 percent of Schedule RI, item 5.l: a. Income and fees from the printing and sale of checks............................................................................................................................................ C013 0 1.a. b. Earnings on/increase in value of cash surrender value of life insurance.................................................................................... C014 0 1.b. c. Income and fees from automated teller machines (ATMs)................................................................................................................ C016 0 1.c. d. Rent and other income from other real estate owned................................................................................................................ 4042 0 1.d. e. Safe deposit box rent........................................................................................................................................................................ C015 0 1.e. f. Bank card and credit card interchange fees................................................................................................................ F555 0 1.f. g. Income and fees from wire transfers not reportable as service charges on deposit accounts……………….T047 0 1.g. TEXT 4461 h. 4461 Revenue from Services rendered to affiliates 165,000 1.h. . TEXT 4462 . i 4462 Net gains (losses) on non-trading derivatives (59,000) 1.i TEXT 4463 j. 4463 Commissions and fees 30,000 1.j. 2. Other noninterest expense (from Schedule RI, item 7.d) Itemize and describe amounts greater than $100,000 that exceed 7 percent of Schedule RI, item 7.d: a. Data processing expenses………………………………………………….…………………………………………............. C017 0 2.a. b. Advertising and marketing expenses………………………………………………….……….……………………................ 0497 0 2.b. c. Directors’ fees………………………………………………….……….………………………………………………............. 4136 0 2.c. d. Printing, stationery, and supplies………………………………………………….……….…………………………............... C018 0 2.d. e. Postage………………………………………………….……….………………………………………………….…................... 8403 0 2.e. f. Legal fees and expenses………………………………………………….……….………………………………….............. 4141 0 2.f. g. FDIC deposit insurance assessments………………………………………………….……….…………………….............. 4146 0 2.g. h. Accounting and auditing expenses………………………………………………….……….………………………................ F556 0 2.h. i. Consulting and advisory expenses………………………………………………….……….……………………….............. F557 0 2.i. j. Automated teller machine (ATM) and interchange expenses………………………………………………….……................. F558 0 2.j. k. Telecommunications expenses………………………………………………….……….……………………………................. F559 0 2.k. l. Other real estate owned expenses..................................................................................................................................... Y923 0 2.l. m. Insurance expenses (not included in employee expenses, premises and fixed asset expenses, and other real estate owned expenses)................................................................................................................................................................................ Y924 0 2.m. . TEXT 4464 . n 4464 Services rendered by affiliates 627,000 2.n o. TEXT 4467 4467 Litigation Expenses 98,000 2.o. p. TEXT 4468 p 4468 0 2. . 3. Discontinued operations and applicable income tax effect (from Schedule RI, item 11) (itemize and describe each discontinued operation): TEXT FT29 a. (1) FT29 0 3.a.(1) (2) Applicable income tax effect………………………………………………….................................. FT30 0 3.a.(2) TEXT FT31 b. (1) FT31 0 3.b.(1) (2) Applicable income tax effect…………………………………………………................................... FT32 0 3.b.(2) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 16 of 86 RI-12 Schedule RI-E—Continued Year-to-date Dollar Amounts in Thousands RIAD Amount 4. Cumulative effect of changes in accounting principles and corrections of material accounting errors (from Schedule RI-A, item 2) (itemize and describe all such effects): a. Effect of adoption of current expected credit losses methodology—ASU 2016-13 (1, 2).............................................................. JJ26 NA 4.a. b. Not applicable TEXT c. B526 . B526 0 4.c TEXT d. B527 d B527 0 4. . 5. Other transactions with stockholders (including a parent holding company) (from Schedule RI-A, item 11) (itemize and describe all such transactions): TEXT a. 4498 . 4498 0 5.a TEXT b. 4499 b 4499 0 5. . 6. Adjustments to allowances for credit losses (3) (from Schedule RI-B, Part II, item 6) (itemize and describe all adjustments): a. Initial allowances for credit losses recognized upon the acquisition of purchased credit-deteriorated assets on or after the effective date of ASU 2016-13 (1).......................................................... JJ27 NA 6.a. b. Effect of adoption of current expected credit losses methodology on allowances for losses JJ28 credit (1, 2)........................................................................................................................................................................................................... 0 6.b. TEXT c. 4521 c 4521 0 6. . TEXT d. 4522 d 4522 0 6. . 7. Other explanations (the space below is provided for the bank to briefly describe, at its option, any other significant items affecting the Report of Income): RIAD Yes No Comments?.................................................................................................................................................................. 4769 x 7. Other explanations (please type or print clearly; 750 character limit): (TEXT 4769) 1. Only institutions that have adopted ASU 2016-13 should report amounts in items 4.a, 6.a, and 6.b, if applicable. 2. An institution should complete item 4.a and item 6.b in the quarter that it adopts ASU 2016-13 and in the quarter-end Call Reports for the remainder of that calendar year only. 3. Institutions that have not adopted ASU 2016-13 should report adjustments to the allowance for loan and lease losses in items 6.c and 6.d, if applicable. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 17 of 86 RC-1 Consolidated Report of Condition for Insured Banks and Savings Associations for December 31, 2023 All schedules are to be reported in thousands of dollars. Unless otherwise indicated, report the amount outstanding as of the last business day of the quarter. Schedule RC—Balance Sheet Dollar Amounts in Thousands RCON Amount Assets 1. Cash and balances due from depository institutions (from Schedule RC-A): . Noninterest-bearing balances and currency and coin 0081 a (1)…………………………….…….…........................ 41,000 1.a. . Interest-bearing balances 0071 b (2)……………………………………………………….................................... 13,556,000 1.b. 2. Securities: a. Held-to-maturity securities (from Schedule RC-B, column A) JJ34 (3)……………………………............................... 0 2.a. b. Available-for-sale debt securities (from Schedule RC-B, column D)…………………….……................................... 1773 378,000 2.b. . Equity securities with readily determinable fair values not held for trading JA22 c (4)…………………………. 0 2.c. 3. Federal funds sold and securities purchased under agreements to resell: a. Federal funds sold………………………………………………………......................................................... B987 0 3.a. . Securities purchased under agreements to resell B989 b (5, 6)………………………….......................................... 5,923,000 3.b. 4. Loans and lease financing receivables (from Schedule RC-C): a. Loans and leases held for sale………………………………………………………..……................................... 5369 0 4.a. b. Loans and leases held for investment……………….................................... B528 16,347,000 4.b. c. LESS: Allowance for loan and lease losses……………....................................... 3123 16,000 4.c. . Loans and leases held for investment, net of allowance (item 4.b minus 4.c) B529 d (7)………............................... 16,331,000 4.d. 5. Trading assets (from Schedule RC-D)…………………………………………………….…….................................. 3545 0 5. 6. Premises and fixed assets (including capitalized leases)…………………………………….................................. 2145 0 6. 7. Other real estate owned (from Schedule RC-M)………………………………………………............................... 2150 4,000 7. 8. Investments in unconsolidated subsidiaries and associated companies……………………............................... 2130 0 8. 9. Direct and indirect investments in real estate ventures...................................……...................................... 3656 0 9. 10. Intangible assets (from Schedule RC-M)………………………………………………………………………………………………………… 2143 2,000 10. . Other assets (from Schedule RC-F) 2160 11 (6)…………………………………………………………….................................. 2,490,000 11. 12. Total assets (sum of items 1 through 11)………………………………………………………....................................... 2170 38,725,000 12. Liabilities 13. Deposits: a. In domestic offices (sum of totals of columns A and C from Schedule RC-E)………………………………................... 2200 26,278,000 13.a. -bearing 6631 (1) Noninterest (8)………………………………………………..………….. 9,337,000 13.a.(1) (2) Interest-bearing……………………………………………………..…………….. 6636 16,941,000 13.a.(2) b. Not applicable 14. Federal funds purchased and securities sold under agreements to repurchase: . Federal funds purchased B993 a (9)………………………………………..…………......................................... 0 14.a. .. Securities sold under agreements to repurchase B995 b (10)………………………………………………..................................... 0 14.b. 15. Trading liabilities (from Schedule RC-D)…………………………………………………..………….............................................. 3548 0 15. 16. Other borrowed money (includes mortgage indebtedness) (from Schedule RC-M)................................. 3190 0 16. 17. and 18. Not applicable 19 Subordinated notes and debentures 3200 . (11)……………………………………………………………………..……………….................. 0 19. __________ 1. Includes cash items in process of collection and unposted debits. 2. Includes time certificates of deposit not held for trading. 3. Institutions that have adopted ASU 2016-13 should report in item 2.a amounts net of any applicable allowance for credit losses, and item 2.a should equal Schedule RC-B, item 8, column A, less Schedule RI-B, Part II, item 7, column B. 4. Item 2.c is to be completed by all institutions. See the instructions for this item and the Glossary entry for “Securities Activities” for further detail on accounting for investments in equity securities. 5. Includes all securities resale agreements, regardless of maturity. 6. Institutions that have adopted ASU 2016-13 should report in items 3.b and 11 amounts net of any applicable allowance for credit losses. 7. Institutions that have adopted ASU 2016-13 should report in item 4.c the allowance for credit losses on loans and leases. 8. Includes noninterest-bearing demand, time, and savings deposits. 9. Report overnight Federal Home Loan Bank advances in Schedule RC, item 16, “Other borrowed money.” 10. Includes all securities repurchase agreements, regardless of maturity. 11. Includes limited-life preferred stock and related surplus. 12/2023 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 18 of 86 RC-2 Schedule RC—Continued Dollar Amounts in Thousands RCON Amount Liabilities—continued 20. Other liabilities (from Schedule RC-G)…………………………………………………………………….………………..................... 2930 2,782,000 20. 21. Total liabilities (sum of items 13 through 20)……………………………………………………………………………….................. 2948 29,060,000 21. 22. Not applicable Equity Capital Bank Equity Capital 23. Perpetual preferred stock and related surplus…………………………………………………………………………….............. 3838 0 23. 24. Common stock……………………………………………………………………………………………….……………….............. 3230 2,127,000 24. 25. Surplus (exclude all surplus related to preferred stock)………………………………………………..………………............... 3839 935,000 25. 26. a.Retained earnings………………………………………………………………………………………..………………............... 3632 6,637,000 26.a. .Accumulated other comprehensive income B530 b (1)………………………………………………………….………………...................... (34,000) 26.b. . Other equity capital components A130 c (2)………………………………………………………………………………………................. 0 26.c. 27. a.Total bank equity capital (sum of items 23 through 26.c)…………………………………………………..…………....................... 3210 9,665,000 27.a. b.Noncontrolling (minority) interests in consolidated subsidiaries…………………………………….……............................ 3000 0 27.b. 28. Total equity capital (sum of items 27.a and 27.b)………………………………………………………..…………....................... G105 9,665,000 28. 29. Total liabilities and equity capital (sum of items 21 and 28)……………………………………………..……….......................... 3300 38,725,000 29. Memoranda To be reported with the March Report of Condition. 1. Indicate in the box at the right the number of the statement below that best describes the most comprehensive level of auditing work performed for the bank by independent external auditors as of RCON Number any date during 2022……………………………………………………………………………………......................... 6724 NA M.1. 1a = An integrated audit of the reporting institution’s financial statements and its internal control over financial reporting conducted in accordance with the standards of the American Institute of Certified Public Accountants (AICPA) or Public Company Accounting Oversight Board (PCAOB) by an independent public accountant that submits a report on the institution 1b =An audit of the reporting institution’s financial statements only conducted in accordance with the auditing standards of the AICPA or the PCAOB by an independent public accountant that submits a report on the institution 2a =An integrated audit of the reporting institution’s parent holding company’s consolidated financial statements and its internal control over financial reporting conducted in accordance with the standards of the AICPA or the PCAOB by an independent public accountant that submits a report on the consolidated holding company (but not on the institution separately) 2b = 3 = 4 = 5 = 6 = 7 = 8 = 9 = An audit of the reporting institution’s parent holding company’s consolidated financial statements only conducted in accordance with the auditing standards of the AICPA or the PCAOB by an independent public accountant that submits a report on the consolidated holding company (but not on the institution separately) This number is not to be used Directors’ examination of the bank conducted in accordance with generally accepted auditing standards by a certified public accounting firm (may be required by state-chartering authority) Directors’ examination of the bank performed by other external auditors (may be required by state-chartering authority) Review of the bank’s financial statements by external auditors Compilation of the bank’s financial statements by external auditors Other audit procedures (excluding tax preparation work) No external audit work To be reported with the March Report of Condition. RCON Date 2. Bank’s fiscal year-end date (report the date in MMDD format)............................................................................................................................................................... 8678 NA M.2. 1. Includes, but is not limited to, net unrealized holding gains (losses) on available-for-sale securities, accumulated net gains (losses) on cash flow hedges, and accumulated defined benefit pension and other postretirement plan adjustments. 2. Includes treasury stock and unearned Employee Stock Ownership Plan shares. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 19 of 86 RC-3 Schedule RC-A—Cash and Balances Due from Depository Institutions Schedule RC-A is to be completed only by banks with $300 million or more in total assets. (1) Exclude assets held for trading. Dollar Amounts in Thousands RCON Amount 1. Cash items in process of collection, unposted debits, and currency and coin: a. Cash items in process of collection and unposted debits...................................................................................... 0020 41,000 1.a. b. Currency and coin............................................................................................................................................................. 0080 0 1.b. 2. Balances due from depository institutions in the U.S............................................................................................... 0082 3,000 2. 3. Balances due from banks in foreign countries and foreign central banks........................................................................................ 0070 0 3. 4. Balances due from Federal Reserve Banks......................................................................................................................... 0090 13,553,000 4. 5. Total (sum of items 1 through 4) (must equal Schedule RC, sum of items 1.a and 1.b)…........................................ 0010 13,597,000 5. __________ 1. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. Schedule RC-B—Securities Exclude assets held for trading. Held-to-maturity Available-for-sale (Column A) (Column B) (Column C) (Column D) Amortized Cost Fair Value Amortized Cost Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount 1. U.S. Treasury securities……................. 0211 0 0213 0 1286 423,000 1287 378,000 1. 2. U.S. Government agency and sponsored agency obligations (exclude mort—backed securities) ………………… HT50 0 HT51 0 HT52 HT53 gage (1) 0 0 2. 3. Securities issued by states and political subdivisions in the U.S 8496 0 8497 0 8498 0 8499 0 3. 1. Includes Small Business Administration “Guaranteed Loan Pool Certificates”; U.S. Maritime Administration obligations; Export-Import Bank participation certificates; and obligations (other than mortgage-backed securities) issued by the Farm Credit System, the Federal Home Loan Bank System, the Federal Home Loan Mortgage Corporation, the Federal National Mortgage Association, the Resolution Funding Corporation, the Student Loan Marketing Association, and the Tennessee Valley Authority. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 20 of 86 RC-4 Schedule RC-B—Continued Held-to-maturity Available-for-sale (Column A) (Column B) (Column C) (Column D) Amortized Cost Fair Value Amortized Cost Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount 4. Mortgage-backed securities (MBS): a. Residential mortgage pass-through securities: (1) Guaranteed by GNMA…………………..……......................... G300 0 G301 0 G302 0 G303 0 4.a.(1) (2) Issued by FNMA and FHLMC…………………........................ G304 0 G305 0 G306 0 G307 0 4.a.(2) (3) Other pass-through securities…………….................... G308 0 G309 0 G310 0 G311 0 4.a.(3) b. Other residential mortgage-backed securities (include CMOs, REMICs, and stripped MBS): (1) Issued or guaranteed by U.S. Government agencies or sponsored G312 G313 G314 G315 agencies (1) ………………………………………………………… 0 0 0 0 4.b.(1) (2) Collateralized by MBS issued or guaranteed by U.S. Government agencies or sponsored G316 G317 G318 G319 agencies (1) ..................................................................... 0 0 0 0 4.b.(2) (3) All other residential MBS................................................. G320 0 G321 0 G322 0 G323 0 4.b.(3) c. Commercial MBS (1) Commercial mortgage pass-through securities: (a) Issued or guaranteed by FNMA, FHLMC, or GNMA…………………… K142 0 K143 0 K144 0 K145 0 4.c.(1)(a) (b) Other pass-through securities………… K146 0 K147 0 K148 0 K149 0 4.c.(1)(b) 1. U.S. Government agencies include, but are not limited to, such agencies as the Government National Mortgage Association (GNMA), the Federal Deposit Insurance Corporation (FDIC), and the National Credit Union Administration (NCUA). U.S. Government-sponsored agencies include, but are not limited to, such agencies as the Federal Home Loan Mortgage Corporation (FHLMC) and the Federal National Mortgage Association (FNMA). 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 21 of 86 RC-5 Schedule RC-B—Continued Held-to-maturity Available-for-sale (Column A) (Column B) (Column C) (Column D) Amortized Cost Fair Value Amortized Cost Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount 4. c.(2) Other commercial MBS: (a) Issued or guaranteed by U.S. Government agencies or sponsored .................................... K150 K151 K152 K153 agencies (1) 0 0 0 0 4.c.(2)(a) (b) All other commercial MBS……………………………….. K154 0 K155 0 K156 0 K157 0 4.c.(2)(b) 5. Asset-backed securities and structured financial products: a. Asset-backed securities (ABS)..............……..…........................ C026 0 C988 0 C989 0 C027 0 5.a. b. Structured financial products………………………………… HT58 0 HT59 0 HT60 0 HT61 0 5.b. 6. Other debt securities: a. Other domestic debt securities………………….…….......................... 1737 0 1738 0 1739 0 1741 0 6.a. b. Other foreign debt securities………………….…….......................... 1742 0 1743 0 1744 0 1746 0 6.b. 7. Unallocated portfolio layer fair value hedge adjustments MG95 basis (2)..……………………………………… NA 7. 8. Total (sum of items 1 1754 1771 1772 1773 through 7) (3)..……………………………………… 0 0 423,000 378,000 8. 1. U.S. Government agencies include, but are not limited to, such agencies as the Government National Mortgage Association (GNMA), the Federal Deposit Insurance Corporation (FDIC), and the National Credit Union Administration (NCUA). U.S. Government-sponsored agencies include, but are not limited to, such agencies as the Federal Home Loan Mortgage Corporation (FHLMC) and the Federal National Mortgage Association (FNMA). 2. This item is to be completed by institutions that have adopted ASU 2022-01, as applicable. 3. For institutions that have adopted ASU 2016-13, the total reported in column A must equal Schedule RC, item 2.a, plus Schedule RI-B, Part II, item 7, column B. For institutions that have not adopted ASU 2016-13, the total reported in column A must equal Schedule RC, item 2.a. For all institutions, the total reported in column D must equal Schedule RC, item 2.b. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 22 of 86 RC-6 Schedule RC-B—Continued Memoranda Dollar Amounts in Thousands RCON Amount . Pledged securities 0416 1 (1)…………………………………………………………………………………………………………............................ 0 M.1. 2. Maturity and repricing data for debt securities (excluding those in nonaccrual status): a. Securities issued by the U.S. Treasury, U.S. Government agencies, and states and political subdivisions in the U.S.; other non-mortgage debt securities; and mortgage pass-through securities other than those backed by closed-end first lien 1–4 family residential mortgages with a remaining maturity or next repricing date of: (2), (3) (1) Three months or less……………………………………………………………………………………………………………………… A549 0 M.2.a.(1) (2) Over three months through 12 months…………………………………………………………….………………………………………… A550 0 M.2.a.(2) (3) Over one year through three years………………………………………………………………..…………………………………………… A551 0 M.2.a.(3) (4) Over three years through five years……………………………………………………………………………………………………… A552 378,000 M.2.a.(4) (5) Over five years through 15 years………………………………………………………………….…………………………………………… A553 0 M.2.a.(5) (6) Over 15 years………………………………………………………………………………………………………………………… A554 0 M.2.a.(6) b. Mortgage pass-through securities backed by closed-end first lien 1–4 family residential mortgages with a remaining maturity or next repricing date of: (2), (4) (1) Three months or less………………………………………………………………………………………………………………………………… A555 0 M.2.b.(1) (2) Over three months through 12 months…………………………………………………………….……………………………………………… A556 0 M.2.b.(2) (3) Over one year through three years………………………………………………………………..…………………………………………… A557 0 M.2.b.(3) (4) Over three years through five years……………………………………………………………….…………………………………………… A558 0 M.2.b.(4) (5) Over five years through 15 years………………………………………………………………….…………………………………… A559 0 M.2.b.(5) (6) Over 15 years…………………………………………………………………………………………………………………………………… A560 0 M.2.b.(6) c. Other mortgage-backed securities (include CMOs, REMICs, and stripped MBS; exclude mortgage pass-through securities) with an expected average life of: (5) (1) Three years or less…………………………………………………………………………………..……………………………………… A561 0 M.2.c.(1) (2) Over three years……………………………………………………………………………………..…………………………………… A562 0 M.2.c.(2) d. Debt securities with a REMAINING MATURITY of one year or less (included in Memorandum items 2.a through 2.c above)………………………………………………………………………………............... A248 0 M.2.d. Memorandum item 3 is to be completed semiannually in the June and December reports only. 3. Amortized cost of held-to-maturity securities sold or transferred to available-for-sale or trading securities during the calendar year-to-date (report the amortized cost at date of sale or transfer)…………………….................. 1778 0 M.3. 4. Structured notes (included in the held-to-maturity and available-for-sale accounts in Schedule RC-B, items 2, 3, 5, and 6): a. Amortized cost……………………………………………………………………………………………………………….............. 8782 0 M.4.a. b. Fair value………………………………………………………………………………………………….………………….................. 8783 0 M.4.b. 1. Includes held-to-maturity securities at amortized cost, available-for-sale debt securities at fair value, and equity securities with readily determinable fair values not held for trading (reported in Schedule RC, item 2.c) at fair value. 2. Report fixed-rate debt securities by remaining maturity and floating-rate debt securities by next repricing date. 3. Sum of Memorandum items 2.a.(1) through 2.a.(6) plus any nonaccrual debt securities in the categories of debt securities reported in Memorandum item 2.a that are included in Schedule RC-N, item 10, column C, must equal Schedule RC-B, sum of items 1, 2, 3, 4.c.(1), 5, and 6, columns A and D, plus residential mortgage pass-through securities other than those backed by closed-end first lien 1–4 family residential mortgages included in Schedule RC-B, item 4.a, columns A and D. 4. Sum of Memorandum items 2.b.(1) through 2.b.(6) plus any nonaccrual mortgage pass-through securities backed by closed-end first lien 1–4 family residential mortgages included in Schedule RC-N, item 10, column C, must equal Schedule RC-B, item 4.a, sum of columns A and D, less the amount of residential mortgage pass-through securities other than those backed by closed-end first lien 1–4 family residential mortgages included in Schedule RC-B, item 4.a, columns A and D. 5. Sum of Memorandum items 2.c.(1) and 2.c.(2) plus any nonaccrual “Other mortgage-backed securities” included in Schedule RC-N, item 10, column C, must equal Schedule RC-B, sum of items 4.b and 4.c.(2), columns A and D. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 23 of 86 RC-7 Schedule RC-B—Continued Memoranda—Continued Held-to-maturity Available-for-sale (Column A) (Column B) (Column C) (Column D) Amortized Cost Fair Value Amortized Cost Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount Memorandum items 5.a through 5.f and 6.a through 6.g are to be completed by banks with $10 billion or more in total assets. (1) 5. Asset-backed securities (ABS) (for each column, sum of Memorandum items 5.a through 5.f must equal Schedule RC-B, item 5.a): a. Credit card receivables……………….……................ B838 0 B839 0 B840 0 B841 0 M.5.a. b. Home equity lines………………................. B842 0 B843 0 B844 0 B845 0 M.5.b. c. Automobile loans………….……................ B846 0 B847 0 B848 0 B849 0 M.5.c. d. Other consumer loans……………………................. B850 0 B851 0 B852 0 B853 0 M.5.d. e. Commercial and industrial loans…………….……............. B854 0 B855 0 B856 0 B857 0 M.5.e. f. Other………………………..……............... B858 0 B859 0 B860 0 B861 0 M.5.f. 6. Structured financial products by underlying collateral or reference assets (for each column, sum of Memorandum items 6.a through 6.g must equal Schedule RC-B, item 5.b: a. Trust preferred securities issued by financial institutions................................. G348 0 G349 0 G350 0 G351 0 M.6.a. b. Trust preferred securities issued by real estate investment trusts..................................... G352 0 G353 0 G354 0 G355 0 M.6.b. c. Corporate and similar loans........................................... G356 0 G357 0 G358 0 G359 0 M.6.c. d. 1-4 family residential MBS issued or guaranteed by U.S. Government-sponsored enterprises (GSEs)............................... G360 0 G361 0 G362 0 G363 0 M.6.d. e. 1-4 family residential MBS not issued or guaranteed by GSEs................................ G364 0 G365 0 G366 0 G367 0 M.6.e. f. Diversified (mixed) pools of structured financial products.................................. G368 0 G369 0 G370 0 G371 0 M.6.f. g. Other collateral or reference assets.................................... G372 0 G373 0 G374 0 G375 0 M.6.g. 1. The $10 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RC-C—Loans and Lease Financing Receivables FFIEC 041 Page 24 of 86 RC-8 Part I. Loans and Leases Do not deduct the allowance for loan and lease losses or the allocated transfer risk reserve from amounts reported in this schedule.(1) Report (1) loans and leases held for sale at the lower of cost or fair value, (2) loans and leases held for investment, net of unearned income, and (3) loans and leases accounted for at fair value under a fair value option. Exclude assets held for trading and commercial paper. (Column A) (Column B) To Be Completed To Be Completed by Banks with by All Banks $300 Million or More in Total Assets (2) Dollar Amounts in Thousands RCON Amount RCON Amount 1. Loans secured by real estate: a. Construction, land development, and other land loans: (1) 1–4 family residential construction loans…………………..……………….................. F158 0 1.a.(1) (2) Other construction loans and all land development and other land loans………………………………………….……………………………………….…………………………….. F159 77,000 1.a.(2) b. Secured by farmland (including farm residential and other improvements)……………………………………………………………………...…. 1420 0 1.b. c. Secured by 1–4 family residential properties: (1) Revolving, open-end loans secured by 1–4 family residential properties and extended under lines of credit…………………………....…............ 1797 264,000 1.c.(1) (2) Closed-end loans secured by 1–4 family residential properties: (a) Secured by first liens……………………………………….……………………….……………………………………….……………………………… 5367 1,898,000 1.c.(2)(a) (b) Secured by junior liens…………………………………………………….....…………………………… 5368 32,000 1.c.(2)(b) d. Secured by multifamily (5 or more) residential properties…………………........................ 1460 2,100,000 1.d. e. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties………………………………………………………………………………….……………………………………….………………………….….. F160 0 1.e.(1) (2) Loans secured by other nonfarm nonresidential properties…………………………………………… F161 2,352,000 1.e.(2) 2. Loans to depository institutions and acceptances of other banks…………………………………………….. 1288 1,065,000 2. a. To commercial banks in the U.S. …………………………….…………......................... B531 1,000 2.a. b. To other depository institutions in the U.S…………………………….…………............... B534 0 2.b. c. To banks in foreign countries B535 1,064,000 2.c. 3. Loans to finance agricultural production and other loans to farmers……………................. 1590 0 3. 4. Commercial and industrial loans………………………………………….……………………………………….……………………………………………..….... 1766 3,016,000 4. a. To U.S. addressees (domicile)………………………………………………….……………………………………….……………………………………..….... 1763 2,819,000 4.a. b. To non-U.S. addressees (domicile)………………………………….………….................1764 197,000 4.b. 5. Not applicable 6. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper): a. Credit cards………………………………………..…………..……………………................ B538 0 6.a. b. Other revolving credit plans…………………………………………….……………………………………….…………………………………………………….. B539 0 6.b. c. Automobile loans…………………………………………………………….………………….…………………..…........... K137 0 6.c. d. Other consumer loans (includes single payment and installment, loans other than automobile loans, and all student loans)………………………………………………….….………..…… K207 307,000 6.d. 7. Not applicable 8. Obligations (other than securities and leases) of states and political subdivisions in the U.S………………………………………………….……………………………………….……………………………………………………..... 2107 0 8. 1. Institutions that have adopted ASU 2016-13 should not deduct the allowance for credit losses on loans and leases or the allocated transfer risk reserve from amounts reported on this schedule. 2. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 25 of 86 RC-9 Schedule RC-C—Continued Part I—Continued (Column A) (Column B) To Be Completed To Be Completed by Banks with by All Banks $300 Million or More in Total Assets (1) Dollar Amounts in Thousands RCON Amount RCON Amount 9. Loans to nondepository financial institutions and other loans: a. Loans to nondepository financial institutions…………………………….............. J454 58,000 9.a. b. Other loans……………………………………………………………………....................... J464 5,178,000 9.b. (1) Loans for purchasing or carrying securities (secured and unsecured) ...................................................................................................................................................................................... 1545 2,302,000 9.b.(1) (2) All other loans (exclude consumer loans)................................................................................... J451 2,876,000 9.b.(2) 10. Lease financing receivables (net of unearned income).................................................. 2165 0 10. a. Leases to individuals for household, family, and other personal expenditures (i.e., consumer leases)……………………………................................. F162 0 10.a. b. All other leases………………………………………………………………............ F163 0 10.b. 11. LESS: Any unearned income on loans reflected in items 1-9 above.................................................... 2123 0 11. 12. Total loans and leases held for investment and held for sale (sum of items 1 through 10 minus item 11) (must equal Schedule RC, sum of items 4.a and 4.b)…...............…...............…...............…..... 2122 16,347,000 12. Memoranda Dollar Amounts in Thousands RCON Amount 1. Loans restructured in troubled debt restructurings that are in compliance with their modified terms (included in Schedule RC-C, Part I, and not reported as past due or nonaccrual in Schedule RC-N, Memorandum item 1): a. Construction, land development, and other land loans: (1) 1—4 family residential construction loans…………………………………………………...…………. K158 0 M.1.a.(1) (2) Other construction loans and all land development and other land loans…………………………………………………………………………………………. K159 0 M.1.a.(2) b. Loans secured by 1—4 family residential properties……………………...…………………………………………………………………………………… F576 0 M.1.b. c. Secured by multifamily (5 or more) residential properties……………………………………………………………………. K160 0 M.1.c. d. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties………………………………………………. K161 0 M.1.d.(1) (2) Loans secured by other nonfarm nonresidential properties………………………………………………………. K162 0 M.1.d.(2) e. Commercial and industrial loans……………………………………………………………..………………………………………. K256 0 M.1.e. Memorandum items 1.e.(1) and (2) are to be completed by banks with $300 million or more in total assets (1) (sum of Memorandum items 1.e(1) and (2) must equal Memorandum item 1.e): (1) To U.S. addressees (domicile)…………………………………..…................... K163 0 M.1.e.(1) (2) To non-U.S. addressees (domicile).................................................................................................................................. K164 0 M.1.e.(2) f. All other loans ( include loans to individuals for household, family, and other personal expenditures)……………………………………………………………………………………………………………… K165 0 M.1.f. Itemize loan categories included in Memorandum item 1.f, above that exceed 10 percent of total loans restructured in troubled debt restructurings that are in compliance with their modified terms (sum of Memorandum items 1.a through 1.e plus 1.f): (1) Loans secured by farmland…………………………………………………………………..……………..……..…… K166 0 M.1.f.(1) (2) and (3) Not applicable 1. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 26 of 86 Schedule RC-C—Continued RC-10 Part I—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount RCON Amount 1. f. (4) Loans to individuals for household, family, and other personal expenditures: (a) Credit cards……………..……………………………………………………………………………………............... K098 0 M.1.f.(4)(a) (b) Automobile loans…………………………………………………………………………………………….......................... K203 0 M.1.f.(4)(b) (c) Other (includes revolving credit plans other than credit cards and other consumer loans).................................................................................................................................................................................. K204 0 M.1.f.(4)(c) Memorandum item 1.f.(5) is to be completed by: (1) • Banks with $300 million or more in total assets • Banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans (5) Loans to finance agricultural production and other loans to farmers included in Schedule RC-C, Part I, Memorandum item 1.f, above……………………………………………………………………………. K168 0 M.1.f.(5) g.Total loans restructured in troubled debt restructurings that are in compliance with their modified terms (sum of Memorandum items 1.a.(1) through 1.e plus 1.f)………………………………………………………………………………………… HK25 0 M.1.g. 2. Maturity and repricing data for loans and leases (excluding those in nonaccrual status): a. Closed-end loans secured by first liens on 1–4 family residential properties (reported in Schedule RC-C, Part I, item 1.c.(2)(a), column B) with a remaining maturity or next repricing date of: (2), (3) (1) Three months or less………………………………………………………………………………………................................. A564 56,000 M.2.a.(1) (2) Over three months through 12 months……………………………………………………………………................................ A565 222,000 M.2.a.(2) (3) Over one year through three years……………………………………………………………………….................................. A566 222,000 M.2.a.(3) (4) Over three years through five years……………………………………………………………………........................................ A567 184,000 M.2.a.(4) (5) Over five years through 15 years………………………………………………………………………….................................. A568 876,000 M.2.a.(5) (6) Over 15 years………………………………………………………………………………………………......................................... A569 316,000 M.2.a.(6) b. All loans and leases (reported in Schedule RC-C, Part I, items 1 through 10, column B above) EXCLUDING closed-end loans secured by first liens on 1–4 family residential properties (reported in Schedule RC-C, Part I, item 1.c.(2)(a), column B, above) with a remaining maturity or next repricing date of: (2) , (4) (1) Three months or less…………………………………………………………………………........................................................... A570 13,412,000 M.2.b.(1) (2) Over three months through 12 months……………………….…………………………………....................................... A571 742,000 M.2.b.(2) (3) Over one year through three years……………….…………………………………........................................................ A572 5,000 M.2.b.(3) (4) Over three years through five years……………………...………………………………................................................. A573 11,000 M.2.b.(4) (5) Over five years through 15 years………………………………………………………………......................................... A574 13,000 M.2.b.(5) (6) Over 15 years………………………………………………………………………………....................................…………………………….................................... A575 262,000 M.2.b.(6) c. Loans and leases (reported in Schedule RC-C, Part I, items 1 through 10, column B, above) with a REMAINING MATURITY of one year or less (excluding those in nonaccrual status)………………................................................ A247 14,137,000 M.2.c. 1. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on theJune 30, 2022, Report of Condition. 2. Report fixed-rate loans and leases by remaining maturity and floating rate loans by next repricing date. 3. Sum of Memorandum items 2.a.(1) through 2.a.(6) plus total nonaccrual closed-end loans secured by first liens on 1–4 family residential properties included in Schedule RC-N, item 1.c.(2)(a), column C, must equal total closed-end loans secured by first liens on 1–4 family residential properties from Schedule RC-C, Part I, item 1.c.(2)(a), column B. 4. Sum of Memorandum items 2.b.(1) through 2.b.(6), plus total nonaccrual loans and leases from Schedule RC-N, item 9, column C, minus nonaccrual closed-end loans secured by first liens on 1–4 family residential properties included in Schedule RC-N, item 1.c.(2)(a), column C, must equal total loans and leases from Schedule RC-C, Part I, sum of items 1 through 10, column B, minus total closed-end loans secured by first liens on 1–4 family residential properties from Schedule RC-C, Part I, item 1.c.(2)(a), column B. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 27 of 86 RC-11 Schedule RC-C—Continued Part I—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount 3. Loans to finance commercial real estate, construction, and land development activities (not secured by real estate) included in Schedule RC-C, Part I, items 4 and 9, column B (1) 2746 52,000 M.3. 4. Adjustable-rate closed-end loans secured by first liens on 1–4 family residential properties (included in Schedule RC-C, Part I, item 1.c.(2)(a), column B)……………………………….......................................... 5370 1,887,000 M.4. 5. To be completed by banks with $300 million or more in total assets: (2) Loans secured by real estate to non-U.S. addressees (domicile) (included in Schedule RC-C, Part I, items 1.a through 1.e, column B) B837 108,000 M.5. Memorandum item 6 is to be completed by banks that (1) together with affiliated institutions, have outstanding credit card receivables (as defined in the instructions) that exceed $500 million as of the report date or (2) are credit card specialty banks as defined for Uniform Bank Performance Report purposes. 6. Outstanding credit card fees and finance charges included in Schedule RC-C, Part I, item 6.a. ……………………….…………………………………………………………………………………………………….......................... C391 NA M.6. Memorandum items 7.a, 7.b, and 8.a are to be completed by all banks semiannually in the June and December reports only. (3) 7. Purchased credit-impaired loans held for investment accounted for in accordance with FASB ASC 310-30 (former AICPA Statement of Position 03-3) (exclude loans held for sale): a. Outstanding balance………………………………………………………………………………………………......................... C779 NA M.7.a. b. Amount included in Schedule RC-C, Part I, items 1 through 9………………………………………........................... C780 NA M.7.b. 8. Closed-end loans with negative amortization features secured by 1–4 family residential properties: a. Total amount of closed-end loans with negative amortization features secured by 1–4 family residential properties (included in Schedule RC-C, Part I, items 1.c.(2)(a) and (b))................................. F230 0 M.8.a. Memorandum items 8.b and 8.c are to be completed semiannually in the June and December reports only by banks that had closed-end loans with negative amortization features secured by 1– 4 family residential properties (as reported in Schedule RC-C, Part I, Memorandum item 8.a) as of the preceding December 31 report date, that exceeded the lesser of $100 million or 5 percent of total loans and leases held for investment and held for sale (as reported in Schedule RC-C, Part I, item 12, column B). b. Total maximum remaining amount of negative amortization contractually permitted on closed-end loans secured by 1–4 family residential properties………………………………………………..................... F231 NA M.8.b. c. Total amount of negative amortization on closed-end loans secured by 1–4 family residential properties included in the amount reported in Memorandum item 8.a above……………........…........….............. F232 NA M.8.c 9. Loans secured by 1–4 family residential properties in process of foreclosure (included in Schedule RC-C, Part I, items 1.c.(1), 1.c.(2)(a), and 1.c.(2)(b))…………….................................................... F577 0 M.9. 10. and 11. Not applicable 1. Exclude loans secured by real estate that are included in Schedule RC-C, Part I, items 1.a through 1.e, column B. 2. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 3. Memorandum item 7 is to be completed only by institutions that have not yet adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 28 of 86 RC-12 Schedule RC-C—Continued Part I—Continued Memoranda—Continued (Column A) (Column B) (Column C) Fair Value of Acquired Gross Contractual Best Estimate at Loans and Leases at Amounts Receivable Acquisition Date of Acquisition Date at Acquisition Date Contractual Cash Flows Not Expected to be Collected Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount Memorandum items 12.a, 12.b, 12.c, and 12.d are to be completed semiannually in the June and December reports only. 12. Loans (not subject to the requirements of FASB ASC 310-30 (former AICPA Statement of Position 03-3)) and leases held for investment that were acquired in business combinations with acquisition dates in the current calendar year: (1) a. Loans secured by real estate………………….……………. G091 0 G092 0 G093 0 M.12.a. b. Commercial and industrial loans……………………………. G094 0 G095 0 G096 0 M.12.b. c. Loans to individuals for household, family, and other personal expenditures……………………………. G097 0 G098 0 G099 0 M.12.c. d. All other loans and all leases………………………………… G100 0 G101 0 G102 0 M.12.d. Dollar Amounts in Thousands RCON Amount Memorandum item 13 is to be completed by banks that had construction, land development, and other land loans (as reported in Schedule RC-C, Part I, item 1.a, column B) that exceeded the sum of tier 1 capital (as reported in Schedule RC-R, Part I, item 26) plus the allowance for loan and lease losses or the allowance for credit losses on loans and leases, as applicable (as reported in Schedule RC, item 4.c) as of the preceding December 31 report date. 13. Construction, land development, and other land loans with interest reserves: a. Amount of loans that provide for the use of interest reserves (included in Schedule RC-C, Part I, item 1.a, column B)................................................................................................................................................ G376 0 M.13.a. b. Amount of interest capitalized from interest reserves on construction, land development, and other land loans that is included in interest and fee income on loans during the quarter RIAD (included in Schedule RI, item 1.a.(1)(b))............................................................................................................... G377 0 M.13.b. Memorandum item 14 is to be completed by all banks. RCON 14. Pledged loans and leases...................................................................................................................................................... G378 297,000 M.14. Memorandum item 15 is to be completed for the December report only. 15. Reverse mortgages: a. Reverse mortgages outstanding that are held for investment (included in Schedule RC-C, item 1.c, above)........................................................................................................... PR04 0 M.15.a. b. Estimated number of reverse mortgage loan referrals to other lenders during the year from whom compensation has been received for services performed in Number connection with the origination of the reverse mortgages...................................................................................... PR05 0 M.15.b. RCON Amount c. Principal amount of reverse mortgage originations that have been sold during the year...................................................................................... PR06 0 M.15.c. 1. Institutions that have adopted ASU 2016-13 should report only loans held for investment not considered purchased credit-deteriorated in Memorandum item 12. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 29 of 86 RC-13 Schedule RC-C—Continued Part I—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount Memorandum item 16 is to be completed by all banks. 16. Revolving, open-end loans secured by 1–4 family residential properties and extended under lines of credit that have converted to non-revolving closed-end status (included in item 1.c.(1) above)................................................................................................................................................................................................................ LE75 0 M.16. Amounts reported in Memorandum items 17.a and 17.b will not be made available to the public on an individual institution basis. 17. Eligible loan modifications under Section 4013,Temporary Relief from Troubled Debt Restructurings, of the 2020 Coronavirus Aid, Relief, and Economic Security Act: Number a. Number of Section 4013 loans outstanding........................................................................................................ LG24 0 M.17.a. Amount b. Outstanding balance of Section 4013 loans......................................................................................................... LG25 0 M.17.b. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 30 of 86 RC-14 Schedule RC-C—Continued Part II. Loans to Small Businesses and Small Farms Report the number and amount currently outstanding as of the report date of business loans with “original amounts” of $1,000,000 or less and farm loans with “original amounts” of $500,000 or less. The following guidelines should be used to determine the “original amount” of a loan: (1) For loans drawn down under lines of credit or loan commitments, the “original amount” of the loan is the size of the line of credit or loan commitment when the line of credit or loan commitment was most recently approved, extended, or renewed prior to the report date. However, if the amount currently outstanding as of the report date exceeds this size, the “original amount” is the amount currently outstanding on the report date. (2) For loan participations and syndications, the “original amount” of the loan participation or syndication is the entire amount of the credit originated by the lead lender. (3) For all other loans, the “original amount” is the total amount of the loan at origination or the amount currently outstanding as of the report date, whichever is larger. Loans to Small Businesses 1. Indicate in the appropriate box at the right whether all or substantially all of the dollar volume of your bank’s “Loans secured by nonfarm nonresidential properties” reported in Schedule RC-C, Part I, items 1.e.(1) and 1.e.(2), and all or substantially all of the dollar volume of your bank’s “Commercial and industrial loans” reported in Schedule RC-C, Part I, item 4, (1) have original amounts of $100,000 or less (If your bank has no loans outstanding in both of these two loan categories, place an “X” in the RCON Yes No box marked “NO.”) ..................................................................................................................................................................................................... 6999 x 1. If YES, complete items 2.a and 2.b below, skip items 3 and 4, and go to item 5. If NO and your bank has loans outstanding in either loan category, skip items 2.a and 2.b, complete items 3 and 4 below, and go to item 5. If NO and your bank has no loans outstanding in both loan categories, skip items 2 through 4, and go to item 5. 2. Report the total number of loans currently outstanding for each of the following Schedule RC-C, Part Number of Loans I, loan categories: RCON Number a. “Loans secured by nonfarm nonresidential properties” reported in Schedule RC-C, Part I, items 1.e.(1) and 1.e.(2) (Note: Sum of items 1.e.(1) and 1.e.(2) divided by the number of loans should NOT exceed $100,000.) ............................................................................................................................................................. 5562 NA 2.a. b. “Commercial and industrial loans” reported in Schedule RC-C, Part I, item 4 (1) (Note: Item 4, 5563 (1) divided by the number of loans should NOT exceed $100,000.) NA 2.b. (Column A) (Column B) Number of Loans Amount Currently Dollar Amounts in Thousands Outstanding 3. Number and amount currently outstanding of “Loans secured by nonfarm RCON Number RCON Amount nonresidential properties” reported in Schedule RC-C, Part I, items 1.e.(1) and 1.e.(2) (sum of items 3.a through 3.c must be less than or equal to Schedule RC-C, Part I, sum of items 1.e.(1) and 1.e.(2)): a. With original amounts of $100,000 or less ........................................................................................................................... 5564 0 5565 0 3.a. b. With original amounts of more than $100,000 through $250,000 ................................................................................................ 5566 0 5567 0 3.b. c. With original amounts of more than $250,000 through $1,000,000 ............................................................................................. 5568 0 5569 0 3.c. 4. Number and amount currently outstanding of “Commercial and industrial loans” reported in Schedule RC-C, Part I, item 4 (1) (sum of items 4.a through 4.c must be less than or equal to Schedule RC-C, Part I, item 4 (1)): a. With original amounts of $100,000 or less ........................................................................................................................... 5570 0 5571 0 4.a. b. With original amounts of more than $100,000 through $250,000 ................................................................................................ 5572 1 5573 0 4.b. c. With original amounts of more than $250,000 through $1,000,000 ............................................................................................. 5574 0 5575 0 4.c. 1. Banks with $300 million or more in total assets should provide the requested information for “Commercial and industrial loans” based on the loans reported in Schedule RC-C, Part I, item 4.a, column A, “Commercial and industrial loans to U.S. addressees.” 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 31 of 86 RC-15 Schedule RC-C—Continued Part II—Continued Agricultural Loans to Small Farms 5. Indicate in the appropriate box at the right whether all or substantially all of the dollar volume of your bank’s “Loans secured by farmland (including farm residential and other improvements)” reported in Schedule RC-C, Part I, item 1.b, and all or substantially all of the dollar volume of your bank’s “Loans to finance agricultural production and other loans to farmers” in reported in Schedule RC-C, Part I, item 3, have original amounts of $100,000 or less (If your bank has no loans outstanding inboth of these two RCON Yes No loan categories, place an “X” in the box marked “NO.”) ............................................................................................................. 6860 x 5. If YES, complete items 6.a and 6.b below, and do not complete items 7 and 8. If NO and your bank has loans outstanding in either loan category, skip items 6.a and 6.b and complete items 7 and 8 below. If NO and your bank has no loans outstanding in both loan categories, do not complete items 6 through 8. 6. Report the total number of loans currently outstanding for each of the following Schedule RC-C, Part I, loan categories: a. “Loans secured by farmland (including farm residential and other improvements)” reported in Schedule RC-C, Part I, item 1.b (Note: Item 1.b, divided by the number of loans should NOT exceed $100,000.) .......................................................................................................................................................... b. “Loans to finance agricultural production and other loans to farmers” in reported in Schedule RC-C, Part I, item 3 (Note: Item 3 divided by the number of loans should NOT exceed $100,000.) Currently Dollar Amounts in Thousands Outstanding 7. Number and amount currently outstanding of “Loans secured by farmland RCON Number RCON Amount (including farm residential and other improvements)” reported in Schedule RC-C, Part I, item 1.b (sum of items 7.a through 7.c must be less than or equal to Schedule RC-C, Part I, item 1.b): a. With original amounts of $100,000 or less......................................................................................................................... 5578 NA 5579 NA 7.a. b. With original amounts of more than $100,000 through $250,000 ....................................................................................... 5580 NA 5581 NA 7.b. c. With original amounts of more than $250,000 through $500,000 .................................................................................. 5582 NA 5583 NA 7.c. 8. Number and amount currently outstanding of “Loans to finance agricultural production and other loans to farmers” reported in Schedule RC-C, Part I, item 3 (sum of items 8.a through 8.c must be less than or equal to Schedule RC-C, Part I, item 3): a. With original amounts of $100,000 or less.......................................................................................................................... 5584 NA 5585 NA 8.a. b. With original amounts of more than $100,000 through $250,000 ....................................................................................... 5586 NA 5587 NA 8.b. c. With original amounts of more than $250,000 through $500,000 ........................................................................................ 5588 NA 5589 NA 8.c. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 32 of 86 RC-16 Schedule RC-D—Trading Assets and Liabilities Schedule RC-D is to be completed by banks that (1) reported total trading assets of $10 million or more in any of the four preceding calendar quarters, or (2) meet the FDIC’s definition of a large or highly complex institution for deposit insurance assessment purposes. Dollar Amounts in Thousands RCON Amount Assets 1. U.S. Treasury securities.............................................................................................................................................................................................................................................. 3531 0 1. 2. U.S. Government agency obligations (exclude mortgage-backed securities) 3532 0 2. 3. Securities issued by states and political subdivisions in the U.S....................................................................................................................... 3533 0 3. 4. Mortgage-backed securities (MBS): a. Residential mortgage pass-through securities issued or guaranteed by FNMA, FHLMC, or GNMA……………………………………..…………..................................................................................................... G379 0 4.a. b. Other residential MBS issued or guaranteed by U.S. Government agencies or sponsored G380 agencies (1) (include CMOs, REMICs, and stripped MBS).................................................................................................................................. 0 4.b. c. All other residential MBS................................................................................................................................................................ G381 0 4.c. d. Commercial MBS issued or guaranteed by U.S. Government agencies or sponsored K197 agencies (1) ..................................................................................................................................................................................................................................................................... 0 4.d. e. All other commercial MBS................................................................................................................................................................................................... K198 0 4.e. 5. Other debt securities: a. Structured financial products HT62 0 5.a. b. All other debt securities.............................................................................................................................................................................................................................................. G386 0 5.b. 6. Loans: a. Loans secured by real estate: (1) Loans secured by 1-4 family residential properties.................................................................................................... HT63 0 6.a.(1) (2) All other loans secured by real estate....................................................................................................................... HT64 0 6.a.(2) b. Commercial and industrial loans F614 0 6.b. c. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper)........................................................................................................ HT65 0 6.c. d. Other loans.............................................................................................................................................................................................................................................. F618 0 6.d. 7. and 8. Not applicable 9. Other trading assets.............................................................................................................................................................................................................................................. 3541 0 9. 10. Not applicable 11. Derivatives with a positive fair value 3543 0 11. 12. Total trading assets (sum of items 1 through 11) (must equal Schedule RC, item 5)....................................................................................................................... 3545 0 12. Liabilities 13. a. Liability for short positions.............................................................................................................................................................................................................................................. 3546 0 13.a. b. Other trading liabilities.............................................................................................................................................................................................................................................. F624 0 13.b. 14. Derivatives with a negative fair value 3547 0 14. 15. Total trading liabilities (sum of items 13.a through 14) (must equal Schedule RC, item 15).............................................................. 3548 0 15. _______________ 1. U.S. Government agencies include, but are not limited to, such agencies as the Government National Mortgage Association (GNMA), the Federal Deposit Insurance Corporation (FDIC), and the National Credit Union Administration (NCUA). U.S. Government-sponsored agencies include, but are not limited to, such agencies as the Federal Home Loan Mortgage Corporation (FHLMC) and the Federal National Mortgage Association (FNMA). Memoranda Dollar Amounts in Thousands RCON Amount 1. Unpaid principal balance of loans measured at fair value (reported in Schedule RC-D, items 6.a through 6.d): a. Loans secured by real estate: (1) Loans secured by 1-4 family residential properties……………………………………………..….……......... HT66 0 M.1.a.(1) (2) All other loans secured by real estate………………………………………………………………................... HT67 0 M.1.a.(2) b. Commercial and industrial loans………………………………………………………………………………………………………. F632 0 M.1.b. c. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper)…………………………………………………………........... HT68 0 M.1.c. d. Other loans…………………………………………………………………………......................................…………………………................... F636 0 M.1.d. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 33 of 86 RC-17 Schedule RC-E—Deposit Liabilities Nontransaction Transaction Accounts Accounts (Column A) (Column B) (Column C) Total Transaction Memo: Total Total Accounts (Including Demand Deposits (1) Nontransaction Total Demand (Included in Accounts Deposits) Column A) (Including MMDAs) Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount Deposits of: 1. Individuals, partnerships, and corporations…………………………………………………………… B549 14,670,000 B550 2,832,000 1. 2. U.S. Government………………………………………………................. 2202 0 2520 0 2. 3. States and political subdivisions in the U.S. ………………………. 2203 68,000 2530 0 3. 4. Commercial banks and other depository institutions in the U.S. …………………………………………............. B551 340,000 B552 190,000 4. 5. Banks in foreign countries……………………………………............... 2213 7,778,000 2236 117,000 5. 6. Foreign governments and official institutions (including foreign central banks)……………………………................. 2216 283,000 2377 0 6. 7. Total (sum of items 1 through 6) (sum of columns A and C must equal Schedule RC, item 13.a)………………………………………………………................. 2215 23,139,000 2210 23,137,000 2385 3,139,000 7. Memoranda Dollar Amounts in Thousands RCON Amount 1. Selected components of total deposits (i.e., sum of item 7, columns A and C): a. Total Individual Retirement Accounts (IRAs) and Keogh Plan accounts…………………………………….…….......................... 6835 48,000 M.1.a. b. Total brokered deposits………………………………………………………………………………………….……............................. 2365 319,000 M.1.b. c. Brokered deposits of $250,000 or less (fully insured brokered deposits) HK05 (2) ……………………………... 312,000 M.1.c. d. Maturity data for brokered deposits: (1) Brokered deposits of $250,000 or less with a remaining maturity of one year or less (included in Memorandum item 1.c above)….............................................................................................................................. HK06 312,000 M.1.d.(1) (2) Not applicable (3) Brokered deposits of more than $250,000 with a remaining maturity of one year or less (included in Memorandum item 1.b above)……………………………………………………………….…………………………………….. K220 7,000 M.1.d.(3) e. Preferred deposits (uninsured deposits of states and political subdivisions in the U.S. reported in item 3 above which are secured or collateralized as required under state law) (to be completed for the December report only)………………………………………………………………........................... 5590 0 M.1.e. f. Estimated amount of deposits obtained through the use of deposit listing services that are not brokered deposits ............................................................................................................................................................ K223 0 M.1.f. g. Total reciprocal deposits........................................................................................................................................................................ JH83 0 M.1.g. h. Sweep deposits: (1) Fully insured, affiliate sweep deposits .............................................................................................................................................................. MT87 110,000 M.1.h.(1) (2) Not fully insured, affiliate sweep deposits ............................................................................................................................................................... MT89 462,000 M.1.h.(2) (3) Fully insured, non-affiliate sweep deposits .............................................................................................................................................................. MT91 0 M.1.h.(3) (4) Not fully insured, non-affiliate sweep deposits .............................................................................................................................................................. MT93 0 M.1.h.(4) i. Total sweep deposits that are not brokered deposits .............................................................................................................................................................. MT95 536,000 M.1.i. 1. Includes interest-bearing and noninterest-bearing demand deposits. 2. The dollar amount used as the basis for reporting in Memorandum item 1.c reflects the deposit insurance limits in effect on the report date. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 34 of 86 RC-18 Schedule RC-E—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount 2. Components of total nontransaction accounts (sum of Memorandum items 2.a through 2.d must equal item 7, column C above): a. Savings deposits: (1) Money market deposit accounts (MMDAs)…………………………………………………………………….......................... 6810 2,922,000 M.2.a.(1) (2) Other savings deposits (excludes MMDAs)……………………………………………………………….…............................. 0352 0 M.2.a.(2) b. Total time deposits of less than $100,000…………………………………………………………………………................................ 6648 0 M.2.b. c. Total time deposits of $100,000 through $250,000…………………………………………………………………………………………….... J473 0 M.2.c. d. Total time deposits of more than $250,000 …………………………………………………………………………………………….... J474 217,000 M.2.d. e. Individual Retirement Accounts (IRAs) and Keogh Plan accounts of $100,000 or more included in Memorandum items 2.c and 2.d above …………………………………………………………………………………………….... F233 0 M.2.e. 3. Maturity and repricing data for time deposits of $250,000 or less: a. Time deposits of $250,000 or less with a remaining maturity or next repricing date of: (1), (2) (1) Three months or less………………………………………………………………………………………………………….... HK07 0 M.3.a.(1) (2) Over three months through 12 months……………………………………………………………………………………….. HK08 0 M.3.a.(2) (3) Over one year through three years…………………………………………………………………………………………..... HK09 0 M.3.a.(3) (4) Over three years……………………………………………………………………………………………………………….... HK10 0 M.3.a.(4) b. Time deposits of $250,000 or less with a REMAINING MATURITY of one year or less in Memorandum items 3.a.(1) and 3.a.(2) above) HK11 (included (3)……………………………………………………………...... 0 M.3.b. 4. Maturity and repricing data for time deposits of more than $250,000: a. Time deposits of more than $250,000 with a remaining maturity or next repricing date of: (1), (4) (1) Three months or less………………………………………………………………………………………………………….... HK12 217,000 M.4.a.(1) (2) Over three months through 12 months……………………………………………………………………………………….. HK13 0 M.4.a.(2) (3) Over one year through three years…………………………………………………………………………………………..... HK14 0 M.4.a.(3) (4) Over three years……………………………………………………………………………………………………………….... HK15 0 M.4.a.(4) b. Time deposits of more than $250,000 with a REMAINING MATURITY of one year or less in Memorandum items 4.a.(1) and 4.a.(2) above) K222 (included (3) ………………….………………............... 217,000 M.4.b. 5. Does your institution offer one or more consumer deposit account products, i.e., transaction account or nontransaction savings account deposit products intended primarily for RCON Yes No individuals for personal, household, or family use?……………………………………………………………………………………………………………….... P752 x M.5. Memorandum items 6 and 7 are to be completed by institutions with $1 billion or more in total assets (5) that answered “Yes” to Memorandum item 5 above. Dollar Amounts in Thousands RCON Amount 6. Components of total transaction account deposits of individuals, partnerships, and corporations (sum of Memorandum items 6.a and 6.b must be less than or equal to item 1, column A above): a. Total deposits in those noninterest-bearing transaction account deposit products intended primarily for individuals for personal, household, or family use P753 NA M.6.a. b. Total deposits in those interest-bearing transaction account deposit products intended primarily for individuals for personal, household, or family use P754 NA M.6.b. 1. Report fixed-rate time deposits by remaining maturity and floating rate time deposits by next repricing date. 2. Sum of Memorandum items 3.a.(1) through 3.a.(4) must equal Schedule RC-E, sum of Memorandum items 2.b and 2.c. 3. Report both fixed- and floating-rate time deposits by remaining maturity. Exclude floating-rate time deposits with a next repricing date of one year or less that have a remaining maturity of over one year. 4. Sum of Memorandum items 4.a.(1) through 4.a.(4) must equal Schedule RC-E, Memorandum item 2.d. 5. The $1 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 35 of 86 RC-19 Schedule RC-E—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount 7. Components of total nontransaction account deposits of individuals, partnerships, and corporations (sum of Memorandum items 7.a.(1), 7.a.(2), 7.b.(1), and 7.b.(2) plus all time deposits of individuals, partnerships, and corporations must equal item 1, column C, above): a. Money market deposit accounts (MMDAs) of individuals, partnerships, and corporations (sum of Memorandum items 7.a.(1) and 7.a.(2) must be less than or equal to Memorandum item 2.a.(1) above): (1) Total deposits in those MMDA deposit products intended primarily for individuals for personal, household, or family use P756 NA M.7.a.(1) (2) Deposits in all other MMDAs of individuals, partnerships, and corporations P757 NA M.7.a.(2) b. Other savings deposit accounts of individuals, partnerships, and corporations (sum of Memorandum items 7.b.(1) and 7.b.(2) must be less than or equal to Memorandum item 2.a.(2) above): (1) Total deposits in those other savings deposit account deposit products intended primarily for individuals for personal, household, or family use P758 NA M.7.b.(1) (2) Deposits in all other savings deposit accounts of individuals, partnerships, and corporations P759 NA M.7.b.(2) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 36 of 86 RC-20 Schedule RC-F—Other Assets (1) Dollar Amounts in Thousands RCON Amount . Accrued interest receivable B556 1 (2)……………………………………………………………………………….............................................. 112,000 1. . Net deferred tax assets 2148 2 (3)……………………………………………………………………………….............................................. 456,000 2. 3. Interest-only strips receivable (not in the form of a security) HT80 (4) ……………………………………………… 0 3. . Equity investments without readily determinable fair values 1752 4 (5)………………………………...................................... 97,000 4. 5. Life insurance assets: a. General account life insurance assets………………………………………………………………………….. K201 0 5.a. b. Separate account life insurance assets………………………………………………………………………………… K202 0 5.b. c. Hybrid account life insurance assets……………………………………………………………………………….. K270 0 5.c. 6. All other assets (itemize and describe amounts greater than $100,000 that exceed 25 percent of this item) 2168 1,825,000 6. a. Prepaid expenses…………....................................................................................................................................... 2166 0 6.a. b. Repossessed personal property (including vehicles)………………….................................................. 1578 0 6.b. c. Derivatives with a positive fair value held for purposes other than trading…………………………………………………..……………..................................................... C010 0 6.c. d. Not applicable e. Computer software.............................................................................................................................................................. FT33 0 6.e. f. Accounts receivable.............................................................................................................................................................. FT34 1,353,000 6.f. g. Receivables from foreclosed government-guaranteed mortgage loans.................................................................................................. FT35 0 6.g. TEXT h. 3549 . 3549 0 6.h TEXT i. 3550 . 3550 0 6.i TEXT j. 3551 j 3551 0 6. . 7. Total (sum of items 1 through 6) (must equal Schedule RC, item 11)…………………………………………….. 2160 2,490,000 7. 1. Institutions that have adopted ASU 2016-13 should report asset amounts in Schedule RC-F net of any applicable allowance for credit losses. 2. Include accrued interest receivable on loans, leases, debt securities, and other interest-bearing assets. Exclude accrued interest receivable on interest-bearing assets that is reported elsewhere on the balance sheet. 3. See discussion of deferred income taxes in Glossary entry on “income taxes.” 4. Report interest-only strips receivable in the form of a security as available-for-sale securities in Schedule RC, item 2.b, or as trading assets in Schedule RC, item 5, as appropriate. 5. Include Federal Reserve stock, Federal Home Loan Bank stock, and bankers’ bank stock. Schedule RC-G—Other Liabilities Dollar Amounts in Thousands RCON Amount . a. Interest accrued and unpaid on deposits 3645 1 (1) …………………………………………………………….……………………....51,000 1.a. b. Other expenses accrued and unpaid (includes accrued income taxes payable)…………………………………………………… 3646 650,000 1.b. . Net deferred tax liabilities 3049 2 (2)………………………………………………………………………………………………………………..0 2. . Allowance for credit losses on off-balance-sheet credit exposures B557 3 (3)…………………………………………….………………………. 2,000 3. 4. All other liabilities (itemize and describe amounts greater than $100,000 that exceed 25 percent of this item) 2938 2,079,000 4. a. Accounts payable…………………………………………………..…………………………………… 3066 989,000 4.a. b. Deferred compensation liabilities……………………………………………………………………… C011 0 4.b. c. Dividends declared but not yet payable………………………………….……………………………. 2932 0 4.c. d. Derivatives with a negative fair value held for purposes other than trading C012 0 4.d. e. Operating lease liabilities.................................................................................................................................. LB56 0 4.e. TEXT f. 3552 f 3552 0 4. . TEXT g. 3553 . 3553 0 4.g TEXT h. 3554 h 3554 0 4. . 5. Total (sum of items 1 through 4) (must equal Schedule RC, item 20)…………………………………………………………………. 2930 2,782,000 5. 1. For savings banks, include “dividends” accrued and unpaid on deposits. 2. See discussion of deferred income taxes in Glossary entry on “income taxes.” 3. Institutions that have adopted ASU 2016-13 should report in item 3 the allowance for credit losses on those off-balance sheet credit exposures that fall within the scope of the standard. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 37 of 86 RC-21 Schedule RC-K—Quarterly Averages (1) Dollar Amounts in Thousands RCON Amount Assets 1. Interest-bearing balances due from depository institutions………………………………………....................................... 3381 12,551,000 1. 2. U.S. Treasury securities and U.S. Government agency obligations (2) (excluding mortgage-backed securities)……………………………………………………………………………………...................................... B558 368,000 2. . Mortgage-backed securities B559 3 (2)…………………………………………………………………………....................................... 0 3. 4. All other debt securities (2) and equity securities with readily determinable fair values not held trading B560 for (3) ………………………………………………………………………………………………........................................ 0 4. 5. Federal funds sold and securities purchased under agreements to resell…………………….......................................... 3365 5,920,000 5. 6. Loans: a. Total loans……………………………………………………………………………………...................................... 3360 15,014,000 6.a. b. Loans secured by real estate: (1) Loans secured by 1–4 family residential properties…………………………………...................................3465 2,197,000 6.b.(1) (2) All other loans secured by real estate…………………………………………………...................................... 3466 4,045,000 6.b.(2) c. Commercial and industrial loans……………………………………………………………......................................... 3387 2,054,000 6.c. d. Loans to individuals for household, family, and other personal expenditures: (1) Credit cards………………………………………………………………………………..................................... B561 0 6.d.(1) (2) Other (includes revolving credit plans other than credit cards, automobile loans, and other consumer loans)………………………...…………………..……….……………...................................... B562 298,000 6.d.(2) Item 7 is to be completed by (1) banks that reported total trading assets of $10 million or more in any of the four preceding calendar quarters and (2) all banks meeting the FDIC’s definition of a large or highly complex institution for deposit insurance assessment purposes. 7. Trading assets………………………………………………………………...……………….......................................... 3401 0 7. 8. Lease financing receivables (net of unearned income)……………………...………………........................................ 3484 0 8. . Total assets 3368 9 (4) ……………………………………………………………………………………..……………………...... 36,263,000 9. Liabilities 10. Interest-bearing transaction accounts (interest-bearing demand deposits, NOW accounts, ATS accounts, and telephone and preauthorized transfer accounts)…………………….…………..................................... 3485 6,621,000 10. 11. Nontransaction accounts: a. Savings deposits (includes MMDAs)……………………………………………………………...................................... B563 3,204,000 11.a. b. Time deposits of $250,000 or less……………………………………………………………........................................ HK16 0 11.b. c. Time deposits of more than $250,000……………………………………………………………........................................ HK17 177,000 11.c. 12. Federal funds purchased and securities sold under agreements to repurchase……….......................................... 3353 0 12. 13. To be completed by banks with $100 million or more in total assets: (5) Other borrowed money (includes mortgage indebtedness)....................................................………………………………......................................... 3355 90,000 13. 1. For all items, banks have the option of reporting either (1) an average of DAILY figures for the quarter, or (2) an average of WEEKLY figures (i.e., the Wednesday of each week of the quarter). 2. Quarterly averages for all debt securities should be based on amortized cost. 3. Quarterly averages for equity securities with readily determinable fair values should be based on fair value. 4. The quarterly average for total assets should reflect securities not held for trading as follows: a) Debt securities at amortized cost. b) Equity securities with readily determinable fair values at fair value. c) Equity investments without readily determinable fair values at their balance sheet carrying values (i.e., fair value or, if elected, cost minus impairment, if any, plus or minus changes resulting from observable price changes). 5. The $100 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 38 of 86 RC-22 Schedule RC-K—Quarterly Averages (1) —Continued Memorandum Dollar Amounts in Thousands RCON Amount Memorandum item 1 is to be completed by: (2) • banks with $300 million or more in total assets, and • banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part 1, item 3) exceeding 5 percent of total loans. 1. Loans to finance agricultural production and other loans to farmers .......................................................................... 3386 0 M.1. 1. For all items, banks have the option of reporting either (1) an average of DAILY figures for the quarter, or (2) an average of WEEKLY figures (i.e., the Wednesday of each week of the quarter). 2. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RC-L—Derivatives and Off-Balance-Sheet Items FFIEC 041 Page 39 of 86 RC-23 Please read carefully the instructions for the preparation of Schedule RC-L. Some of the amounts reported in Schedule RC-L are regarded as volume indicators and not necessarily as measures of risk. Dollar Amounts in Thousands RCON Amount 1. Unused commitments: a. Revolving, open-end lines secured by 1–4 family residential properties, e.g., home equity lines........................................................................................................................................................................................................................................ 3814 170,000 1.a. Item 1.a.(1) is to be completed for the December report only. (1) Unused commitments for reverse mortgages outstanding that are held for investment (included in item 1.a. above)............................................................................................................................................................................................................ HT72 0 1.a.(1) b. Credit card lines..................................................................................................................................................................................................................... 3815 0 1.b. Items 1.b.(1) and 1.b.(2) are to be completed semiannually in the June and December reports only by banks with either $300 million or more in total assets or $300 million or more in credit card lines (1) (sum of items 1.b.(1) and 1.b.(2) must equal item 1.b). (1) Unused consumer credit card lines............................................................................................................................................................................. J455 0 1.b.(1) (2) Other unused credit card lines..................................................................................................................................................................................... J456 0 1.b.(2) c. Commitments to fund commercial real estate, construction, and land development loans: (1) Secured by real estate: (a) 1–4 family residential construction loan commitments............................................................................................................................................ F164 0 1.c.(1)(a) (b) Commercial real estate, other construction loan, and land development loan commitments.............................................................................................................................................................................................................. F165 254,000 1.c.(1)(b) (2) NOT secured by real estate.......................................................................................................................................................................................... 6550 0 1.c.(2) d. Securities underwriting........................................................................................................................................................................................................... 3817 0 1.d. e. Other unused commitments: (1) Commercial and industrial loans................................................................................................................................................................................. J457 282,000 1.e.(1) (2) Loans to financial institutions...................................................................................................................................................................................... J458 308,000 1.e.(2) (3) All other unused commitments.................................................................................................................................................................................... J459 6,867,000 1.e.(3) 2. Financial standby letters of credit…………………………………………………………..…….................................................................................................... 3819 241,000 2. Item 2.a is to be completed by banks with $1 billion or more in total assets. (1) 3820 a. Amount of financial standby letters of credit conveyed to others………………………………........................................ 0 2.a. 3. Performance standby letters of credit…………………………………………………….……..................................................................................................... 3821 104,000 3. Item 3.a is to be completed by banks with $1 billion or more in total assets. (1) 3822 a. Amount of performance standby letters of credit conveyed to others…………………………........................................ 0 3.a. 4. Commercial and similar letters of credit………………………….…………………………………………………………….……..................................................... 3411 0 4. 5. Not applicable 6. Securities lent and borrowed: a. Securities lent (including customers’ securities lent where the customer is indemnified against loss by the reporting bank)………………………………………………………….………………………………………….…….......................... 3433 0 6.a. b. Securities borrowed...................................................................................................................................................................................... 3432 0 6.b. (Column A) (Column B) Sold Protection Purchased Protection 7. Credit derivatives: RCON Amount RCON Amount a. Notional amounts: (1) Credit default swaps………………………………………….... C968 0 C969 0 7.a.(1) (2) Total return swaps…………………………………………….... C970 0 C971 0 7.a.(2) (3) Credit options……………………………………………………. C972 0 C973 0 7.a.(3) (4) Other credit derivatives……………………………………….... C974 0 C975 0 7.a.(4) 1. The asset-size tests and the $300 million credit card lines test are based on the total assets and credit card lines reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 40 of 86 Schedule RC-L—Continued RC-24 (Column A) (Column B) Sold Protection Purchased Protection Dollar Amounts in Thousands RCON Amount RCON Amount 7. b. Gross fair values: (1) Gross positive fair value……………………………………….. C219 0 C221 0 7.b.(1) (2) Gross negative fair value……………………………………..... C220 0 C222 0 7.b.(2) . c. Notional amounts by regulatory capital treatment: RCON Amount 7 (1) (1) Positions covered under the Market Risk Rule: (a) Sold protection…………………………………………………………………….…………………………...……....................................... G401 0 7.c.(1)(a) (b) Purchased protection………………………………………………………………………………………………........................................ G402 0 7.c.(1)(b) (2) All other positions: (a) Sold protection………………………………………………………………………………………………………....................................... G403 0 7.c.(2)(a) (b) Purchased protection that is recognized as a guarantee for regulatory capital purposes G404 0 7.c.(2)(b) (c) Purchased protection that is not recognized as a guarantee for regulatory capital purposes……………………….………………………………………………………………………………..……....................................... G405 0 7.c.(2)(c) Remaining Maturity of: (Column A) (Column B) (Column C) One Year or Less Over One Year Over Five Years Through Five Years Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 7. d. Notional amounts by remaining maturity: (1) Sold credit protection: (2) (a) Investment grade................................................................................... G406 0 G407 0 G408 0 7.d.(1)(a) (b) Subinvestment grade........................................................................... G409 0 G410 0 G411 0 7.d.(1)(b) (2) Purchased credit protection: (3) (a) Investment grade................................................................................... G412 0 G413 0 G414 0 7.d.(2)(a) (b) Subinvestment grade............................................................................ G415 0 G416 0 G417 0 7.d.(2)(b) RCON Amount 8. Not applicable 9. All other off-balance-sheet liabilities (exclude derivatives) (itemize and describe each component of this item over 25 percent of Schedule RC, item 27.a, “Total bank equity capital”) 3430 0 9. a. Not applicable b. Commitments to purchase when-issued securities..................................................................................... 3434 0 9.b. c. Standby letters of credit issued byanother party (e.g., a Federal Home Loan Bank) on the bank’s behalf...................................................................................................................................................... C978 0 9.c. TEXT 3555 d d. 3555 0 9. . TEXT 3556 . e. 3556 0 9.e TEXT f. 3557 . 3557 0 9.f 10. All other off-balance-sheet assets (exclude derivatives) (itemize and describe each component of this item over 25 percent of Schedule RC, item 27.a, “Total bank equity capital”):..................................................................................................... 5591 0 10. a. Commitments to sell when-issued securities............................................................................................... 3435 0 10.a. TEXT 5592 . b. 5592 0 10.b TEXT 5593 . c. 5593 0 10.c TEXT d. 5594 . 5594 0 10.d TEXT e. 5595 e 5595 0 10. . 1. Sum of items 7.c.(1)(a) and 7.c.(2)(a), must equal sum of items 7.a.(1) through (4), column A. Sum of items 7.c.(1)(b), 7.c.(2)(b), and 7.c.(2)(c) must equal sum of items 7.a.(1) through (4), column B. 2. Sum of items 7.d.(1)(a) and (b), columns A through C, must equal sum of items 7.a.(1) through (4), column A. 3. Sum of items 7.d.(2)(a) and (b), columns A through C, must equal sum of items 7.a.(1) through (4), column B. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 41 of 86 RC-25 Schedule RC-L—Continued Dollar Amounts in Thousands RCON Amount Items 11.a and 11.b are to be completed semiannually in the June and December reports only. 11. Year-to-date merchant credit card sales volume: a. Sales for which the reporting bank is the acquiring bank....................................................................................................................................... C223 0 11.a. b. Sales for which the reporting bank is the agent bank with risk.............................................................................................................................. C224 0 11.b. (Column A) (Column B) (Column C) (Column D) Interest Rate Foreign Exchange Equity Derivative Commodity and Other Dollar Amounts in Thousands Contracts Contracts Contracts Contracts Derivatives Position Indicators Amount Amount Amount Amount 12. Gross amounts (e.g., notional amounts) (for each column, sum of items 12.a through 12.e must equal sum of items 13 and 14): RCON 8693 RCON 8694 RCON 8695 RCON 8696 a. Futures contracts……………………… 0 0 0 0 12.a. RCON 8697 RCON 8698 RCON 8699 RCON 8700 b. Forward contracts…………………….. 0 0 0 0 12.b. c. Exchange-traded option contracts: RCON 8701 RCON 8702 RCON 8703 RCON 8704 (1) Written options……………………. 0 0 0 0 12.c.(1) RCON 8705 RCON 8706 RCON 8707 RCON 8708 (2) Purchased options………………… 24,000 0 0 0 12.c.(2) d. Over-the-counter option contracts: RCON 8709 RCON 8710 RCON 8711 RCON8712 (1) Written options…………………….. 0 0 0 0 12.d.(1) RCON 8713 RCON 8714 RCON 8715 RCON 8716 (2) Purchased options………………… 0 0 0 0 12.d.(2) RCON 3450 RCON 3826 RCON 8719 RCON 8720 e. Swaps………………………………….. 22,744,000 0 0 0 12.e. 13. Total gross notional amount of derivative RCON A126 RCON A127 RCON 8723 RCON 8724 contracts held for trading………..……..……..……..……..….. 0 0 0 0 13. 14. Total gross notional amount of derivative contracts held for purposes other than RCON 8725 RCON 8726 RCON 8727 RCON 8728 trading…………….……………………… 22,768,000 0 0 0 14. a. Interest rate swaps where the bank has agreed to pay a fixed RCON A589 rate…………………………………………………. 0 14.a. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 42 of 86 RC-26 Schedule RC-L—Continued (Column A) (Column B) (Column C) (Column D) Interest Rate Foreign Exchange Equity Derivative Commodity and Other Dollar Amounts in Thousands Contracts Contracts Contracts Contracts Derivatives Position Indicators Amount Amount Amount Amount 15. Gross fair values of derivative contracts: a. Contracts held for trading: (1) Gross positive fair RCON 8733 RCON 8734 RCON 8735 RCON 8736 value………………………………………………………… 0 0 0 0 15.a.(1) (2) Gross negative fair RCON 8737 RCON 8738 RCON 8739 RCON 8740 value……………………………………………………………… 0 0 0 0 15.a.(2) b. Contracts held for purposes other than trading: (1) Gross positive fair RCON 8741 RCON 8742 RCON 8743 RCON 8744 value………………………………………… 392,000 0 0 0 15.b.(1) (2) Gross negative fair RCON 8745 RCON 8746 RCON 8747 RCON 8748 value…………………………………………………………………………… 460,000 0 0 0 15.b.(2) (Column A) (Columns B-D) (Column E) Banks and Securities Not applicable Corporations and All Firms Other Counterparties Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount Item 16 is to be completed only by banks with total assets of $10 billion or more. (1) 16. Over-the-counter derivatives: a. Net current credit exposure………………..…............ G418 12,000 G422 375,000 16.a. b. Fair value of collateral: (1) Cash—U.S. dollar……………………………............G423 13,000 G427 0 16.b.(1) (2) Cash—Other currencies…………………............... G428 0 G432 0 16.b.(2) (3) U.S. Treasury securities………………….............. G433 0 G437 0 16.b.(3) (4) through (6) Not Applicable (7) All other collateral…………………………................. G453 0 G457 0 16.b.(7) (8) Total fair value of collateral (sum of items 16.b.(1) through (7))………………............... G458 13,000 G462 0 16.b.(8) 1. The $10 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 43 of 86 RC-27 Schedule RC-M—Memoranda Dollar Amounts in Thousands RCON Amount 1. Extensions of credit by the reporting bank to its executive officers, directors, principal shareholders, and their related interests as of the report date: a. Aggregate amount of all extensions of credit to all executive officers, directors, principal shareholders, and their related interests……………………………………………………………………………………………… 6164 0 1.a. b. Number of executive officers, directors, and principal shareholders to whom the amount of all extensions of credit by the reporting bank (including extensions of credit to related interests) equals or exceeds the lesser of $500,000 or 5 Number percent of total capital as defined for this purpose in agency regulations………………………………… 6165 0 1.b. 2. Intangible assets: a. Mortgage servicing assets……………………………………………………………………………………………………………. 3164 0 2.a. (1) Estimated fair value of mortgage servicing assets……………………………………………… A590 0 2.a.(1) b. Goodwill………………………….……………………………….…….……………………………….…….……………………………….…….………………………………. 3163 0 2.b. c. All other intangible assets………………………………………………………………………………………………… JF76 2,000 2.c. d. Total (sum of items 2.a, 2.b, and 2.c) (must equal Schedule RC, item 10)…………………………………………………….. 2143 2,000 2.d. 3. Other real estate owned: a. Construction, land development, and other land………………………………………………………………....................... 5508 0 3.a. b. Farmland………………………………………………………………………………………………………….................... 5509 0 3.b. c. 1–4 family residential properties………………………………………………………………………………................. 5510 4,000 3.c. d. Multifamily (5 or more) residential properties…………………………………………………………………........................ 5511 0 3.d. e. Nonfarm nonresidential properties……………………………………………………………………………........................... 5512 0 3.e. f. Total (sum of items 3.a through 3.e) (must equal Schedule RC, item 7) 2150 4,000 3.f. 4. Cost of equity securities with readily determinable fair values not held for trading fair value of which is reported in Schedule RC, item 2.c) JA29 (the (1) ……………………………………… 0 4. 5. Other borrowed money: a. Federal Home Loan Bank advances: (1) Advances with a remaining maturity or next repricing date of: (2) (a) One year or less……………………………………………………………………………………………………………….. F055 0 5.a.(1)(a) (b) Over one year through three years…………………………………………………………………………………………… F056 0 5.a.(1)(b) (c) Over three years through five years………………………………………………………………………………………….. F057 0 5.a.(1)(c) (d) Over five years…………………………………………………………………………………………………………………. F058 0 5.a.(1)(d) (2) Advances with a REMAINING MATURITY of one year or less in item 5.a.(1)(a) above) 2651 (included (3)…………………………………………………………………………………………………………………………………. 0 5.a.(2) (3) Structured advances (included in items 5.a.(1)(a)–(d) above)……………………………………………………………….. F059 0 5.a.(3) b. Other borrowings: (1) Other borrowings with a remaining maturity or next repricing date of: (4) (a) One year or less………………………………………………………………………………..………………………………. F060 0 5.b.(1)(a) (b) Over one year through three years……………………………………………………………………………………………. F061 0 5.b.(1)(b) (c) Over three years through five years………………………………………………………………………………………….. F062 0 5.b.(1)(c) (d) Over five years…………………………………………………………………………………………………………………. F063 0 5.b.(1)(d) (2) Other borrowings with a REMAINING MATURITY of one year or less in item 5.b.(1)(a) above) B571 (included (5).............................................................................................................................................. 0 5.b.(2) c. Total (sum of items 5.a.(1)(a)–(d) and items 5.b.(1)(a)–(d)) (must equal Schedule RC, item 16) 3190 0 5.c. 1. Item 4 is to be completed only by insured state banks that have been approved by the FDIC to hold grandfathered equity investments. See instructions for this item and the Glossary entry for “Securities Activities” for further detail on accounting for investments in equity securities. 2. Report fixed-rate advances by remaining maturity and floating-rate advances by next repricing date. 3. Report both fixed- and floating-rate advances by remaining maturity. Exclude floating-rate advances with a next repricing date of one year or less that have a remaining maturity of over one year. 4. Report fixed-rate other borrowings by remaining maturity and floating-rate other borrowings by next repricing date. 5. Report both fixed- and floating-rate other borrowings by remaining maturity. Exclude floating-rate other borrowings with a next repricing date of one year or less that have a remaining maturity of over one year. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 44 of 86 Schedule RC-M—Continued RC-28 Dollar Amounts in Thousands RCON Yes No 6. Does the reporting bank sell private label or third-party mutual funds and annuities?..................................................................... B569 x 6. RCON Amount 7. Assets under the reporting bank’s management in proprietary mutual funds and annuities B570 0 7. 8. Internet website addresses and physical office trade names: a. Uniform Resource Locator (URL) of the reporting institution’s primary Internet website (home page), if any (Example: www.examplebank.com): TEXT 4087 http:// http://www.db.com 8.a. b. URLs of all other public-facing Internet websites that the reporting institution uses to accept or solicit deposits from the public, if any (Example: www.examplebank.biz): (1) TE01 N528 (1) http:// 8.b.(1) TE02 N528 (2) http:// 8.b.(2) TE03 N528 (3) http:// 8.b.(3) TE04 N528 (4) http:// 8.b.(4) TE05 N528 (5) http:// 8.b.(5) TE06 N528 (6) http:// 8.b.(6) TE07 N528 (7) http:// 8.b.(7) TE08 N528 (8) http:// 8.b.(8) TE09 N528 (9) http:// 8.b.(9) TE10 N528 (10) http:// 8.b.(10) c. Trade names other than the reporting institution’s legal title used to identify one or more of the institution’s physical offices at which deposits are accepted or solicited from the public, if any: TE01 N529 (1) 8.c.(1) TE02 N529 (2) 8.c.(2) TE03 N529 (3) 8.c.(3) TE04 N529 (4) 8.c.(4) TE05 N529 (5) 8.c.(5) TE06 N529 (6) 8.c.(6) Item 9 is to be completed annually in the December report only. 9. Do any of the bank’s Internet websites have transactional capability, i.e., allow the RCON Yes No bank’s customers to execute transactions on their accounts through the website?................................................................................... 4088 x 9. 10. Secured liabilities: a. Amount of “Federal funds purchased” that are secured RCON Amount (included in Schedule RC, item 14.a)............................................................................................................................................................ F064 0 10.a. b. Amount of “Other borrowings” that are secured (included in Schedule RC-M, items 5.b.(1)(a)–(d)).......................................................................................................................................................... F065 0 10.b. 11. Does the bank act as trustee or custodian for Individual Retirement Accounts, Health RCON Yes No Savings Accounts, and other similar accounts?.......................................................................................................................................................... G463 x 11. 12. Does the bank provide custody, safekeeping, or other services involving the acceptance of orders for the sale or purchase of securities?..................................................................................................................................................................... G464 x 12. 1. Report only highest level URLs (for example, report www.examplebank.biz, but do not also report www.examplebank.biz/checking). Report each top level domain name used (for example, report both www.examplebank.biz and www.examplebank.net). 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 45 of 86 RC-29 Schedule RC-M—Continued Dollar Amounts in Thousands RCON Amount 13. Portion of covered other real estate owned that is protected by FDIC loss-sharing agreements (included in Schedule RC, item 7)................................................................................................................................................ K192 0 13. Items 14.a and 14.b are to be completed annually in the December report only. 14.Captive insurance and reinsurance subsidiaries: a. assets of captive insurance subsidiaries K193 . Total (1) ................................................................................................................................................... 0 14.a b. Total assets of captive reinsurance subsidiaries K194 (1) .............................................................................................................................................. 0 14.b. Item 15 is to be completed by institutions that are required or have elected to be treated as a Qualified Thrift Lender. 15.Qualified Thrift Lender (QTL) test: a. Does the institution use the Home Owners’ Loan Act (HOLA) QTL test or the Internal Revenue Service Domestic Building and Loan Association (IRS DBLA) test to determine RCON Number its QTL compliance? (for the HOLA QTL test, enter 1; for the IRS DBLA test, enter 2).............................................................................................................................. L133 NA 15.a. b. Has the institution been in compliance with the HOLA QTL test as of each month end Yes No during the quarter or the IRS DBLA test for its most recent taxable year, as applicable? L135 15.b. Item 16.a and, if appropriate, items 16.b.(1) through 16.b.(3) are to be completed annually in the December report only. 16. International remittance transfers offered to consumers: (2) a. Estimated number of international remittance transfers provided by your institution during the calendar year ending on the report date............................................................................................................................... N523 1,469 16.a. Items 16.b.(1) through 16.b.(3) are to be completed by institutions that reported 501 or more international remittance transfers in item 16.a in either or both of the current report or the most recent prior report in which item 16.a was required to be completed. b. Estimated dollar value of remittance transfers provided by your institution and usage of regulatory exceptions during the calendar year ending on the report date: Amount (1) Estimated dollar value of international remittance transfers................................................................................................................................................................................... N524 130,000 16.b.(1) (2) Estimated number of international remittance transfers for which your institution Number applied the permanent exchange rate exception.................................................................................................................................................................................. MM07 0 16.b.(2) (3) Estimated number of international remittance transfers for which your institution applied the permanent covered third-party fee exception.................................................................................................................................................................................. MQ52 0 16.b.(3) 17. U.S. Small Business Administration Paycheck Protection Program (PPP) loans (3) and the Federal Reserve PPP Liquidity Facility (PPPLF): a. Number of PPP loans outstanding............................................................................................................................................ LG26 0 17.a. Amount b. Outstanding balance of PPP loans............................................................................................................................................. LG27 0 17.b. c. Outstanding balance of PPP loans pledged to the PPPLF............................................................................................................... LG28 0 17.c. d. Outstanding balance of borrowings from Federal Reserve Banks under the PPPLF with a remaining maturity of: (1) One year or less.................................................................................................................................................................. LL59 0 17.d.(1) (2) More than one year....................................................................................................................................................... LL60 0 17.d.(2) e. Quarterly average amount of PPP loans pledged to the PPPLF and excluded from “Total assets for the leverage ratio” reported in Schedule RC-R, Part I, item 30................................................................................ LL57 0 17.e. 1. Report total assets before eliminating intercompany transactions between the consolidated insurance or reinsurance subsidiary and other offices or consolidated subsidiaries of the reporting bank. 2. Report information about international electronic transfers of funds offered to consumers in the United States that: (a) are “remittance transfers” as defined by subpart B of Regulation E (12 CFR § 1005.30(e)), or (b) would qualify as “remittance transfers” under subpart B of Regulation E (12 CFR § 1005.30(e)) but are excluded from that definition only because the provider is not providing those transfers in the normal course of its business. See 12 CFR § 1005.30(f). For purposes of this item 16, such transfers are referred to as international remittance transfers. Exclude transfers sent by your institution as a correspondent bank for other providers. Report information only about transfers for which the reporting institution is the provider. 3. Paycheck Protection Program (PPP) covered loans as defined in sections 7(a)(36) and 7(a)(37) of the Small Business Act (15 U.S.C. 636(a)(36) and (37)). 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 46 of 86 RC-30 Schedule RC-N—Past Due and Nonaccrual Loans, Leases, and Other Assets (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. Loans secured by real estate: a. Construction, land development, and other land loans: (1) 1–4 family residential construction loans..................................................................................... F172 0 F174 0 F176 0 1.a.(1) (2) Other construction loans and all land development and other land loans…........................................ F173 0 F175 0 F177 0 1.a.(2) b. Secured by farmland....................................................... 3493 0 3494 0 3495 0 1.b. c. Secured by 1– 4 family residential properties: (1) Revolving, open-end loans secured by 1– 4 family residential properties and extended under lines of credit..................................... 5398 1,000 5399 0 5400 3,000 1.c.(1) (2) Closed-end loans secured by 1-4 family residential properties: (a) Secured by first liens.............................................. C236 10,000 C237 2,000 C229 22,000 1.c.(2)(a) (b) Secured by junior liens.............................................. C238 0 C239 0 C230 0 1.c.(2)(b) d. Secured by multifamily (5 or more) residential properties.............................................................................. 3499 0 3500 0 3501 0 1.d. e. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties......................................................... F178 0 F180 0 F182 0 1.e.(1) (2) Loans secured by other nonfarm nonresidential properties................................................. F179 0 F181 0 F183 0 1.e.(2) 2. Loans to depository institutions and acceptances of other banks........................................................... B834 0 B835 0 B836 0 2. 3. Not applicable 4. Commercial and industrial loans…….................................................. 1606 0 1607 0 1608 0 4. 5. Loans to individuals for household, family, and other personal expenditures: a. Credit cards............................................................................... B575 0 B576 0 B577 0 5.a. b. Automobile loans.......................................................................... K213 0 K214 0 K215 0 5.b. c. Other (includes revolving credit plans other than credit cards and other consumer loans)............................................................................ K216 0 K217 0 K218 0 5.c. 6. Not applicable . All other 5459 5460 5461 . 7 loans (1)......................................................................................... 0 0 1,000 7 8. Lease financing receivables........................................................................................ 1226 0 1227 0 1228 0 8. 9. Total loans and leases (sum of items 1 through 8)………… 1406 11,000 1407 2,000 1403 26,000 9. 10. Debt securities and other assets (exclude other real estate owned and other repossessed assets).............................................................................................. 3505 0 3506 0 3507 0 10. __________ 1. Includes past due and nonaccrual “Loans to finance agricultural productions and other loans to farmers,” “Obligations (other than securities and leases) of states and political subdivisions in the U.S.,” and “Loans to nondepository financial institutions and other loans.” 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 47 of 86 RC-31 Schedule RC-N—Continued Amounts reported by loan and lease category in Schedule RC-N, items 1 through 8, include guaranteed and unguaranteed portions of past due and nonaccrual loans and leases. Report in items 11 and 12 below certain guaranteed loans and leases that have already been included in the amounts reported in items 1 through 8. (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 11. Loans and leases reported in items 1 through 8 above that are wholly or partially guaranteed by the U.S. Government, excluding loans and leases covered by loss-sharing agreements with the FDIC.......................................................................................................................................... K036 0 K037 0 K038 0 11. a. Guaranteed portion of loans and leases included in item 11 above, excluding rebooked “GNMA loans”.......................................................................................................... K039 0 K040 0 K041 0 11.a. b. Rebooked “GNMA loans” that have been repurchased or are eligible for repurchase included in item 11 above............................................................................................................... K042 0 K043 0 K044 0 11.b. 12. Portion of covered loans and leases reported in item 9 above that is protected by FDIC loss-sharing agreements............................................................................................................... K102 0 K103 0 K104 0 12. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 48 of 86 RC-32 Schedule RC-N—Continued Memoranda (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. Loans restructured in troubled debt restructurings included in Schedule RC-N, items 1 through 7, above (and not reported in Schedule RC-C, Part I, Memorandum item 1): a. Construction, land development, and other land loans: (1) 1–4 family residential construction loans ............................................................................................ K105 0 K106 0 K107 0 M.1.a.(1) (2) Other construction loans and all land development and other land loans ........................ K108 0 K109 0 K110 0 M.1.a.(2) b. Loans secured by 1–4 family residential properties…………………………………………................. F661 0 F662 0 F663 2,000 M.1.b. c. Secured by multifamily (5 or more) residential properties ........................................................................................... K111 0 K112 0 K113 0 M.1.c. d. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties.................................. K114 0 K115 0 K116 0 M.1.d.(1) (2) Loans secured by other nonfarm nonresidential properties ........................................................... K117 0 K118 0 K119 0 M.1.d.(2) e. Commercial and industrial loans ................................. K257 0 K258 0 K259 0 M.1.e. Memorandum items 1.e.(1) and (2) are to be completed by banks with $300 million or more in total assets (sum of Memorandum items 1.e.(1) and (2) must equal ‘Memorandum item 1.e): (1) (1) To U.S. addressees (domicile) ............................... K120 0 K121 0 K122 0 M.1.e.(1) (2) To non-U.S. addressees (domicile) .................................... K123 0 K124 0 K125 0 M.1.e.(2) f. All other loans ( include loans to individuals for household, family, and other personal expenditures) ............................................................. K126 0 K127 0 K128 0 M.1.f. Itemize loan categories included in Memorandum item 1.f, above that exceed 10 percent of total loans restructured in troubled debt restructurings that are past due 30 days or more or in nonaccrual status (sum of Memorandum items 1.a through 1.e plus 1.f, columns A through C): (1) Loans secured by farmland ..................................................... K130 0 K131 0 K132 0 M.1.f.(1) (2) and (3) Not applicable 1. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 49 of 86 RC-33 Schedule RC-N—Continued Memoranda—Continued (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. f. (4) Loans to individuals for household, family, and other personal expenditures: (a) Credit cards .......................................................... K274 0 K275 0 K276 0 M.1.f.(4)(a) (b) Automobile loans ............................................... K277 0 K278 0 K279 0 M.1.f.(4)(b) (c) Other (includes revolving credit plans other than credit cards and other consumer loans) .............................................. K280 0 K281 0 K282 0 M.1.f.(4)(c) Memorandum item 1.f.(5) is to be completed by: (1) • Banks with $300 million or more in total assets • Banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans (5) Loans to finance agricultural production and other loans to farmers included in Schedule RC-N, Memorandum item 1.f, above ................................................................. K138 0 K139 0 K140 0 M.1.f.(5) 1. g.Total loans restructured in troubled debt restructurings included in Schedule RC-N, items 1 through 7, above (sum of Memorandum items 1.a(1) through 1.e 1.f) HK26 HK27 HK28 plus (2)……………………………………………………………………………………………………………………… 0 0 2,000 M.1.g. 2. Loans to finance commercial real estate, construction, and land development activities (not secured by real estate) included in Schedule RC-N, items 4 and 7, above.................................... 6558 0 6559 0 6560 0 M.2. 3. Memorandum items 3.a through 3.d are to be completed by banks with $300 million or more in total assets: (1) a.Loans secured by real estate to non-U.S. addressees (domicile) (included in Schedule RC-N, item 1, above).................................. 1248 0 1249 0 1250 0 M.3.a. b.Loans to and acceptances of foreign banks (included in Schedule RC-N, item 2, above) .................................................................................................................................................. 5380 0 5381 0 5382 0 M.3.b. c. Commercial and industrial loans to non-U.S. addressees (domicile) included in Schedule RC-N, item 4, above................................... 1254 0 1255 0 1256 0 M.3.c. 1. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 2. Exclude amounts reported in Memorandum items 1.e.(1), 1.e.(2), and 1.f.(1) through 1.f.(5) when calculating the total in Memorandum item 1.g. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 50 of 86 Schedule RC-N—Continued RC-34 Memoranda—Continued (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 3. d. Leases to individuals for household, family, and other personal expenditures (included in Schedule RC-N, item 8, above) ..............................F166 0 F167 0 F168 0 M.3.d. Memorandum item 4 is to be completed by: (1) • banks with $300 million or more in total assets • banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans: 4. Loans to finance agricultural production and other loans to farmers (included in Schedule RC-N, item 7, above) ................................................................... 1594 0 1597 0 1583 0 M.4. 5. Loans and leases held for sale (included in Schedule RC-N, items 1 through 8, above)……………………. C240 0 C241 0 C226 0 M.5. RCON Amount 6. Not applicable Memorandum items 7, 8, 9.a, and 9.b are to be completed semiannually in the June and December reports only. 7. Additions to nonaccrual assets during the previous six months ...................................................................................................................... C410 0 M.7. 8. Nonaccrual assets sold during the previous six months................................................................................................................................. C411 0 M.8. (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 9. Purchased credit-impaired loans accounted for in accordance with FASB ASC 310-30 (former AICPA Statement of Position 03-3): (2) a. Outstanding balance......................................................................... L183 NA L184 NA L185 NA M.9.a. b. Amount included in Schedule RC-N, items 1 through 7, above..................................................................... L186 NA L187 NA L188 NA M.9.b. 1. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 2. Memorandum items 9.a and 9.b should be completed only by institutions that have not yet adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 51 of 86 RC-35 Schedule RC-O—Other Data for Deposit Insurance Assessments All FDIC-insured depository institutions must complete items 1 and 2, 4 through 9,10, and 11, Memorandum item 1, and, if applicable, item 9.a, Memorandum items 2, 3, and 5 through 18 each quarter. Unless otherwise indicated, complete items 1 through 11 and Memorandum items 1 through 3 on an “unconsolidated single FDIC certificate number basis” (see instructions) and complete Memorandum items 5 through 18 on a fully consolidated basis. Dollar Amounts in Thousands RCON Amount 1. Total deposit liabilities before exclusions (gross) as defined in Section 3(l) of the Federal Deposit Insurance Act and FDIC regulations............................................................................................................. F236 26,567,000 1. 2. Total allowable exclusions, including interest accrued and unpaid on allowable exclusions............................... F237 0 2. 3. Not applicable 4. Average consolidated total assets for the calendar quarter .............................................................................................................................. K652 36,263,000 4. a. Averaging method used Number (for daily averaging, enter 1, for weekly averaging, enter 2) .......................................................................................................................................... K653 1 4.a. Amount 5. Average tangible equity for the calendar quarter K654 (1) ........................................................................................................................................... 9,542,000 5. 6. Holdings of long-term unsecured debt issued by other FDIC-insured depository institutions………………………………………………………..…….... K655 0 6. 7. Unsecured “Other borrowings” with a remaining maturity of (sum of items 7.a through 7.d must be less than or equal to Schedule RC-M, items 5.b.(1)(a)–(d) minus item 10.b): a. One year or less........................................................................................................................................................... G465 0 7.a. b. Over one year through three years....................................................................................................................... G466 0 7.b. c. Over three years through five years......................................................................................................................... G467 0 7.c. d. Over five years.............................................................................................................................................................. G468 0 7.d. 8. Subordinated notes and debentures with a remaining maturity of (sum of items 8.a. through 8.d. must equal Schedule RC, item 19): a. One year or less............................................................................................................................................................ G469 0 8.a. b. Over one year through three years........................................................................................................................ G470 0 8.b. c. Over three years through five years........................................................................................................................... G471 0 8.c. d. Over five years............................................................................................................................................................. G472 0 8.d. 9. Brokered reciprocal deposits (included in Schedule RC-E, Memorandum item 1.b)....................................G803 0 9. Item 9.a is to be completed on a fully consolidated basis by all institutions that own another insured depository institution. a. Fully consolidated brokered reciprocal deposits................................................................................................................. L190 NA 9.a. 10. Banker’s bank certification: Does the reporting institution meet both the statutory definition of a banker’s bank and the business Yes No conduct test set forth in FDIC regulations? ................................................................................................................................................................. K656 x 10. If the answer to item 10 is “YES,” complete items 10.a and 10.b. Amount a. Banker’s bank deduction.................................................................................................................................... K657 NA 10.a. b. Banker’s bank deduction limit .............................................................................................................................. K658 NA 10.b. 11.Custodial bank certification: Yes No Does the reporting institution meet the definition of a custodial bank set forth in FDIC regulations? K659 x 11. If the answer to item 11 is “YES,” complete items 11.a and 11.b. (2) Amount a. Custodial bank deduction ....................................................................................................................................... K660 12,934,000 11.a. b. Custodial bank deduction limit ............................................................................................................................. K661 6,471,000 11.b. 1. See instructions for averaging methods. For deposit insurance assessment purposes, tangible equity is defined as Tier 1 capital as set forth in the banking agencies’ regulatory capital standards and reported in Schedule RC-R, Part I, item 26, except as described in the instructions. 2. If the amount reported in item 11.b is zero, item 11.a may be left blank. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 52 of 86 RC-36 Schedule RC-O—Continued Memoranda Dollar Amounts in Thousands RCON Amount 1. Total deposit liabilities of the bank, including related interest accrued and unpaid, less allowable exclusions, including related interest accrued and unpaid (sum of Memorandum items 1.a.(1), 1.b.(1), 1.c.(1), and 1.d.(1) must equal Schedule RC-O, item 1 less item 2): a. Deposit accounts (excluding retirement accounts) of $250,000 or less: (1) (1)Amount of deposit accounts (excluding retirement accounts) of $250,000 or less................................................................. F049 134,000 M.1.a.(1) (2)Number of deposit accounts (excluding retirement accounts) Number of $250,000 or less......................................................................................................................................... F050 5,836 M.1.a.(2) b. Deposit accounts (excluding retirement accounts) of more than $250,000: (1) (1)Amount of deposit accounts (excluding retirement accounts) of more than $250,000............................................................ F051 26,385,000 M.1.b.(1) (2)Number of deposit accounts (excluding retirement accounts) Number of more than $250,000........................................................................................................................ F052 3,294 M.1.b.(2) c. Retirement deposit accounts of $250,000 or less: (1) (1)Amount of retirement deposit accounts of $250,000 or less.................................................................................................... F045 47,000 M.1.c.(1) Number (2)Number of retirement deposit accounts of $250,000 or less........................................................... F046 143 M.1.c.(2) d. Retirement deposit accounts of more than $250,000: (1) (1)Amount of retirement deposit accounts of more than $250,000............................................................................................... F047 1,000 M.1.d.(1) Number (2)Number of retirement deposit accounts of more than $250,000........................................................ F048 2 M.1.d.(2) Memorandum item 2 is to be completed by banks with $1 billion or more in total assets. (2) 2. Estimated amount of uninsured deposits including related interest accrued and unpaid instructions) 5597 (see (3)..................................................................................................................................................................... 25,562,000 M.2. 3. Has the reporting institution been consolidated with a parent bank or savings association in that parent bank’s or parent savings association’s Call Report? If so, report the legal title and FDIC Certificate Number of the parent bank or parent savings association: RCON FDIC Cert. No. TEXT A545 A545 0 M.3. 4. Not applicable 1. The dollar amounts used as the basis for reporting in Memorandum items 1.a through 1.d reflect the deposit insurance limits in effect on the report date. 2. The $1 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 3. Uninsured deposits should be estimated based on the deposit insurance limits set forth in Memorandum items 1.a through 1.d. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 53 of 86 RC-37 Schedule RC-O—Continued Amounts reported in Memorandum items 6 through 9, 14, and 15 will not be made available to the public on an individual institution basis. Memoranda—Continued Dollar Amounts in Thousands RCON Amount Memorandum items 5 through 12 are to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. 5. Applicable portion of the CECL transitional amount or modified CECL transitional amount that has been added to retained earnings for regulatory capital purposes as of the current report date and is attributable to loans and leases held for investment................................................................................................................................... MW53 0 M.5. 6. Criticized and classified items: a. Special mention ......................................................................................................................................................................... K663 1,850,000 M.6.a. b. Substandard...................................................................................................................................................................................... K664 172,000 M.6.b. c. Doubtful ............................................................................................................................................................................................. K665 5,000 M.6.c. d. Loss ................................................................................................................................................................................................... K666 0 M.6.d. 7. “Nontraditional 1–4 family residential mortgage loans” as defined for assessment purposes only in FDIC regulations: a. Nontraditional 1-4 family residential mortgage loans................................................................................................................................................... N025 1,705,000 M.7.a. b. Securitizations of nontraditional 1-4 family residential mortgage loans N026 0 M.7.b. 8. “Higher-risk consumer loans” as defined for assessment purposes only in FDIC regulations: a. Higher-risk consumer loans……........................................................................................................................................................................ N027 35,000 M.8.a. b. Securitizations of higher-risk consumer loans…........................................................................................................................................................................ N028 0 M.8.b. 9. “Higher-risk commercial and industrial loans and securities” as defined for assessment purposes only in FDIC regulations: a. Higher-risk commercial and industrial loans and securities............................................................................................................................................................ N029 0 M.9.a. b. Securitizations of higher-risk commercial and industrial loans and securities N030 0 M.9.b. 10. Commitments to fund construction, land development, and other land loans secured by real estate: a. Total unfunded commitments ....................................................................................................................................... K676 254,000 M.10.a. b. Portion of unfunded commitments guaranteed or insured by the U.S. government (including the FDIC) .......................................................................................................................................................................... K677 0 M.10.b. 11. Amount of other real estate owned recoverable from the U.S. government under guarantee or insurance provisions (excluding FDIC loss-sharing agreements) .......................................................... K669 0 M.11. 12. Nonbrokered time deposits of more than $250,000 in domestic offices (included in Schedule RC-E, Part I, Memorandum item 2.d) K678 217,000 M.12. Memorandum item 13.a is to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. Memorandum items 13.b through 13.h are to be completed by “large institutions” only. 13. Portion of funded loans and securities guaranteed or insured by the U.S. government (including FDIC loss-sharing agreements): a. Construction, land development, and other land loans secured by real estate .......................................................... N177 0 M.13.a. b. Loans secured by multifamily residential and nonfarm nonresidential properties ...............................N178 0 M.13.b. c. Closed-end loans secured by first liens on 1–4 family residential properties ............................................................ N179 0 M.13.c. d. Closed-end loans secured by junior liens on 1–4 family residential properties and revolving, open-end loans secured by 1–4 family residential properties and extended under lines of credit ................................................................................................................................................... N180 0 M.13.d. e. Commercial and industrial loans ................................................................................................................................ N181 0 M.13.e. f. Credit card loans to individuals for household, family, and other personal expenditures …....................................... N182 0 M.13.f. g. All other loans to individuals for household, family, and other personal expenditures N183 0 M.13.g. h. Non-agency residential mortgage-backed securities............................................................................................................................... M963 0 M.13.h. Memorandum items 14 and 15 are to be completed by “highly complex institutions” as defined in FDIC regulations. 14. Amount of the institution’s largest counterparty exposure ............................................................................................. K673 NA M.14. 15. Total amount of the institution’s 20 largest counterparty exposures ................................................................................ K674 NA M.15. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 54 of 86 RC-38 Schedule RC-O—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount Memorandum item 16 is to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. 16. Portion of loans restructured in troubled debt restructurings that are in compliance with their modified terms and are guaranteed or insured by the U.S. government (including the FDIC) (included in Schedule RC-C, Part I, Memorandum item 1)....................................................................................................................................................................... L189 0 M.16. Memorandum item 17 is to be completed on a fully consolidated basis by those “large institutions” and “highly complex institutions” as defined in FDIC regulations that own another insured depository institution. 17. Selected fully consolidated data for deposit insurance assessment purposes: a. Total deposit liabilities before exclusions (gross) as defined in Section 3(I) of the Federal Deposit Insurance Act and FDIC regulations....................................................................................................................................................................... L194 NA M.17.a. b. Total allowable exclusions, including interest accrued and unpaid on allowable exclusions............................. L195 NA M.17.b. c. Unsecured “Other borrowings” with a remaining maturity of one year or less L196 NA M.17.c. d. Estimated amount of uninsured deposits, including related interest accrued and unpaid L197 NA M.17.d. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 55 of 86 RC-39 Schedule RC-O—Continued Memorandum item 18 is to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. Amounts reported in Memorandum item 18 will not be made available to the public on an individual institution basis. Two-Year Probability of Default (PD) (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) < 1% 1.01–4% 4.01–7% 7.01–10% 10.01–14% 14.01–16% 16.01–18% 18.01–20% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount 18. Outstanding balance of 1-4 family residential mortgage loans, consumer loans, and consumer leases by two-year probability of default: a. “Nontraditional 1-4 family residential mortgage loans” as defined for assessment purposes RCON M964 RCON M965 RCON M966 RCON M967 RCON M968 RCON M969 RCON M970 RCON M971 only in FDIC regulations………………………………………………………………………………… 400,000 616,000 351,000 179,000 54,000 4,000 0 3,000 M.18.a. b. Closed-end loans secured by first liens on 1-4 family RCON M979 RCON M980 RCON M981 RCON M982 RCON M983 RCON M984 RCON M985 RCON M986 residential properties…………………………… 44,000 86,000 40,000 3,000 5,000 0 0 0 M.18.b. c. Closed-end loans secured by junior liens on 1-4 family RCON M994 RCON M995 RCON M996 RCON M997 RCON M998 RCON M999 RCON N001 RCON N002 residential properties………………………………………………………………………………… 6,000 13,000 2,000 1,000 10,000 0 0 0 M.18.c. d. Revolving, open-end loans secured by 1-4 family residential properties RCON N010 RCON N011 RCON N012 RCON N013 RCON N014 RCON N015 RCON N016 RCON N017 and extended under lines of credit 27,000 75,000 95,000 10,000 7,000 0 3,000 0 M.18.d. RCON N040 RCON N041 RCON N042 RCON N043 RCON N044 RCON N045 RCON N046 RCON N047 e. Credit cards………………………………………………………………………………… 0 0 0 0 0 0 0 0 M.18.e. RCON N055 RCON N056 RCON N057 RCON N058 RCON N059 RCON N060 RCON N061 RCON N062 f. Automobile loans………………………………………………………………………………… 0 0 0 0 0 0 0 0 M.18.f. RCON N070 RCON N071 RCON N072 RCON N073 RCON N074 RCON N075 RCON N076 RCON N077 g. Student loans…………………………………………………………………………… 0 0 0 0 0 0 0 0 M.18.g. h. Other consumer loans and revolving credit plans other RCON N085 RCON N086 RCON N087 RCON N088 RCON N089 RCON N090 RCON N091 RCON N092 than credit cards………………………………………………………………………………… 112,000 112,000 67,000 1,000 0 0 0 0 M.18.h. RCON N100 RCON N101 RCON N102 RCON N103 RCON N104 RCON N105 RCON N106 RCON N107 i. Consumer leases………………………………………………………………………………… 0 0 0 0 0 0 0 0 M.18.i. RCON N115 RCON N116 RCON N117 RCON N118 RCON N119 RCON N120 RCON N121 RCON N122 j. Total………………………………………………………………………………… 589,000 902,000 555,000 194,000 76,000 4,000 3,000 3,000 M.18.j. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RC-O—Continued Memorandum item 18 is to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. Amounts reported in Memorandum item 18 will not be made available to the public on an individual institution basis. Two-Year Probability of Default (PD) (Column O) PDs Were (Column I) (Column J) (Column K) (Column L) (Column M) (Column N) Derived 20.01–22% 22.01–26% 26.01–30% > 30% Unscoreable Total Using (1) Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Number 18. Outstanding balance of 1-4 family residential mortgage loans, consumer loans, and consumer leases by two-year probability of default: a.“Nontraditional 1-4 family residential mortgage loans” as defined for assessment purposes RCON M972 RCON M973 RCON M974 RCON M975 RCON M976 RCON M977 RCON M978 only in FDIC regulations………………………………………………………………………………… 5,000 2,000 2,000 0 89,000 1,705,000 1 M.18.a. b.Closed-end loans secured by first liens on 1-4 family RCON M987 RCON M988 RCON M989 RCON M990 RCON M991 RCON M992 RCON M993 residential properties………………………………………………………………… 0 0 0 0 11,000 189,000 1 M.18.b. c. Closed-end loans secured by junior liens on 1-4 family RCON N003 RCON N004 RCON N005 RCON N006 RCON N007 RCON N008 RCON N009 residential properties………………………………………………………………………………… 0 0 0 0 0 32,000 1 M.18.c. d.Revolving, open-end loans secured by 1-4 family residential properties RCON N018 RCON N019 RCON N020 RCON N021 RCON N022 RCON N023 RCON N024 and extended under lines of credit………………………………………………………………………………… 0 0 0 0 47,000 264,000 1 M.18.d. RCON N048 RCON N049 RCON N050 RCON N051 RCON N052 RCON N053 RCON N054 e.Credit cards………………………………………………………………………………… 0 0 0 0 0 0 0 M.18.e. RCON N063 RCON N064 RCON N065 RCON N066 RCON N067 RCON N068 RCON N069 f. Automobile loans………………………………………………………………………………… 0 0 0 0 0 0 0 M.18.f. RCON N078 RCON N079 RCON N080 RCON N081 RCON N082 RCON N083 RCON N084 g.Student loans…………………………………………………………………………… 0 0 0 0 0 0 0 M.18.g. h.Other consumer loans and revolving credit plans other RCON N093 RCON N094 RCON N095 RCON N096 RCON N097 RCON N098 RCON N099 than credit cards………………………………………………………………………………… 0 0 0 0 15,000 307,000 1 M.18.h. RCON N108 RCON N109 RCON N110 RCON N111 RCON N112 RCON N113 RCON N114 i. Consumer leases………………………………………………………………………………… 0 0 0 0 0 0 0 M.18.i. RCON N123 RCON N124 RCON N125 RCON N126 RCON N127 RCON N128 j. Total………………………………………………………………………………… 5,000 2,000 2,000 0 162,000 2,497,000 M.18.j. 1. For PDs derived using scores and default rate mappings provided by a third-party vendor, enter 1; for PDs derived using an internal approach, enter 2; for PDs derived using third-party vendor mappings for some loans within a product type and an internal approach for other loans within the same product type, enter 3. If the total reported in Column N for a product type is zero, enter 0. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 57 of 86 RC-41 Schedule RC-P—1–4 Family Residential Mortgage Banking Activities Schedule RC-P is to be completed by banks at which either 1–4 family residential mortgage loan originations and purchases for resale (1) from all sources, loan sales, or quarter-end loans held for sale or trading exceed $10 million for two consecutive quarters. Dollar Amounts in Thousands RCON Amount 1. Retail originations during the quarter of 1–4 family residential mortgage loans for sale HT81 (1) .............................. 0 1. 2. Wholesale originations and purchases during the quarter of 1–4 family residential mortgage loans sale HT82 for (1)................................................................................................................................................................................................................................................................... 0 2. 3. 1–4 family residential mortgage loans sold during the quarter................................................................................ FT04 0 3. 4. 1–4 family residential mortgage loans held for sale or trading at quarter-end 4. (included in Schedule RC, items 4.a and 5)............................................................................................................ FT05 0 5. Noninterest income for the quarter from the sale, securitization, and servicing of 1–4 family RIAD residential mortgage loans (included in Schedule RI, items 5.c, 5.f, 5.g, and 5.i)................................................. HT85 0 5. RCON 6. Repurchases and indemnifications of 1–4 family residential mortgage loans during the quarter.................................. HT86 0 6. 7. Representation and warranty reserves for 1–4 family residential mortgage loans sold: a. For representations and warranties made to U.S. government agencies and government-sponsored agencies................................................................................................................................................. L191 0 7.a. b. For representations and warranties made to other parties................................................................................................................................................. L192 0 7.b. c. Total representation and warranty reserves (sum of items 7.a and 7.b) M288 0 7.c. 1. Exclude originations and purchases of 1–4 family residential mortgage loans that are held for investment. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RC-Q—Assets and Liabilities Measured at Fair Value on a Recurring Basis FFIEC 041 Page 58 of 86 RC-42 Schedule RC-Q is to be completed by banks that: (1) Have elected to report financial instruments or servicing assets and liabilities at fair value under a fair value option with changes in fair value recognized in earnings, or (2) Are required to complete Schedule RC-D, Trading Assets and Liabilities. (Column A) (Column B) (Column C) (Column D) (Column E) Total Fair Value LESS: Amounts Netted Level 1 Fair Value Level 2 Fair Value Level 3 Fair Value Reported on in the Determination of Measurements Measurements Measurements Schedule RC Total Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount RCON Amount Assets 1. Available-for-sale debt securities and equity securities with readily determinable fair values trading JA36 G474 G475 G476 G477 not held for (1)…………………………………………………… 378,000 0 378,000 0 0 1. 2. Not applicable 3. Loans and leases held for sale........................................................................................................................... G483 0 G484 0 G485 0 G486 0 G487 0 3. 4. Loans and leases held for investment........................................................................................................................... G488 0 G489 0 G490 0 G491 0 G492 0 4. 5. Trading assets: a. Derivative assets........................................................................................................................... 3543 0 G493 0 G494 0 G495 0 G496 0 5.a. b. Other trading assets........................................................................................................................... G497 0 G498 0 G499 0 G500 0 G501 0 5.b. (1) Nontrading securities at fair value with changes in fair value reported in current earnings (included in Schedule RC-Q, item 5.b above)........................................................................................................................... F240 0 F684 0 F692 0 F241 0 F242 0 5.b.(1) 6. All other assets........................................................................................................................... G391 393,000 G392 4,000 G395 0 G396 397,000 G804 0 6. 7. Total assets measured at fair value on a recurring basis (sum of items 1 through 5.b plus item 6)................................................................................................................................... G502 771,000 G503 4,000 G504 378,000 G505 397,000 G506 0 7. Liabilities 8. Deposits........................................................................................................................... F252 0 F686 0 F694 0 F253 0 F254 0 8. 9. Not applicable 10. Trading liabilities: a. Derivative liabilities........................................................................................................................... 3547 0 G512 0 G513 0 G514 0 G515 0 10.a. b. Other trading liabilities........................................................................................................................... G516 0 G517 0 G518 0 G519 0 G520 0 10.b. 11. and 12. Not applicable 13. All other liabilities........................................................................................................................... G805 457,000 G806 4,000 G807 0 G808 461,000 G809 0 13. 14. Total liabilities measured at fair value on a recurring basis (sum of items 8 through 13).................................. G531 457,000 G532 4,000 G533 0 G534 461,000 G535 0 14. 1. The amount reported in item 1, column A, must equal the sum of Schedule RC, items 2.b and 2.c. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 59 of 86 RC-43 Schedule RC-Q—Continued (Column A) (Column B) (Column C) (Column D) (Column E) Total Fair Value LESS: Amounts Netted Level 1 Fair Value Level 2 Fair Value Level 3 Fair Value Reported on in the Determination Measurements Measurements Measurements Schedule RC of Total Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount RCON Amount Memoranda 1. All other assets (itemize and describe amounts included in Schedule RC-Q, item 6, that are greater than $100,000 and exceed 25 percent of item 6): a. Mortgage servicing assets……………………………………… G536 0 G537 0 G538 0 G539 0 G540 0 M.1.a. b. Nontrading derivative assets…………………………………… G541 388,000 G542 4,000 G543 0 G544 392,000 G545 0 M.1.b. TEXT c. G546 0 G547 0 G548 0 G549 0 G550 0 M.1.c. G546 TEXT d. G551 0 G552 0 G553 0 G554 0 G555 0 M.1.d. G551 TEXT e. G556 0 G557 0 G558 0 G559 0 G560 0 M.1.e. G556 TEXT f. G561 0 G562 0 G563 0 G564 0 G565 0 M.1.f. G561 2. All other liabilities (itemize and describe amounts included in Schedule RC-Q, item 13, that are greater than $100,000 and exceed 25 percent of item 13): a. Loan commitments (not accounted for as derivatives)…………………………………………………… F261 0 F689 0 F697 0 F262 0 F263 0 M.2.a. b. Nontrading derivative liabilities………………………………… G566 457,000 G567 4,000 G568 0 G569 461,000 G570 0 M.2.b. TEXT c. G571 0 G572 0 G573 0 G574 0 G575 0 M.2.c. G571 TEXT d. G576 0 G577 0 G578 0 G579 0 G580 0 M.2.d. G576 TEXT e. G581 0 G582 0 G583 0 G584 0 G585 0 M.2.e. G581 TEXT f. G586 0 G587 0 G588 0 G589 0 G590 0 M.2.f. G586 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 60 of 86 RC-44 Schedule RC-Q—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount 3. Loans measured at fair value (included in Schedule RC-C, Part I, items 1 through 9): a. Loans secured by real estate: (1) Secured by 1–4 family residential properties…………………………………………....................... HT87 0 M.3.a.(1) (2) All other loans secured by real estate……………………...…………………...…………………...…… HT88 0 M.3.a.(2) b. Commercial and industrial loans………………………………………….……….......................................... F585 0 M.3.b. c. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper)……………………….…………………….……………………. HT89 0 M.3.c. d. Other loans…………………………..………………………….…………………………..................................................... F589 0 M.3.d. 4. Unpaid principal balance of loans measured at fair value (reported in Schedule RC-Q, Memorandum item 3): a. Loans secured by real estate: (1) Secured by 1–4 family residential properties…....…………………....…....…………………....……….... HT91 0 M.4.a.(1) (2) All other loans secured by real estate…………………………….…………………....………………….... HT92 0 M.4.a.(2) b. Commercial and industrial loans………………………………………………..............................…………………… F597 0 M.4.b. c. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper)………………………………………..………..……….. HT93 0 M.4.c. d. Other loans………………………………….…………………………………………………............................................ F601 0 M.4.d. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 61 of 86 RC-45 Schedule RC-R—Regulatory Capital Part I. Regulatory Capital Components and Ratios Part I is to be completed on a consolidated basis. Dollar Amounts in Thousands RCOA Amount Common Equity Tier 1 Capital 1. Common stock plus related surplus, net of treasury stock and unearned employee stock ownership plan (ESOP) shares............................................................................................................................... P742 3,063,000 1. . Retained earnings KW00 2 (1)........................................................................................................................................................ 6,637,000 2. a. To be completed only by institutions that have adopted ASU 2016-13: Does your institution have a CECL transition election in effect as of the quarter-end report date? (enter “0” for No; enter “1” for Yes with a 3-year CECL transition election; RCOA enter “2” for Yes with a 5-year 2020 CECL transition election.) JJ29 0 2.a. RCOA Amount 3. Accumulated other comprehensive income (AOCI)................................................................................................................................................................... B530 (34,000) 3. 0=No RCOA a. AOCI opt-out election (enter “1” for Yes; enter “0” for No.) 1=Yes P838 0 3.a. RCOA Amount 4. Common equity tier 1 minority interest includable in common equity tier 1 capital.................................................................... P839 0 4. 5. Common equity tier 1 capital before adjustments and deductions (sum of items 1 through 4) P840 9,666,000 5. Common Equity Tier 1 Capital: Adjustments and Deductions 6. LESS: Goodwill net of associated deferred tax liabilities (DTLs)............................................................................................................................ P841 0 6. 7. LESS: Intangible assets (other than goodwill and mortgage servicing assets (MSAs)), net of associated DTLs.................................................................................................................................................................................................. P842 2,000 7. 8. LESS: Deferred tax assets (DTAs) that arise from net operating loss and tax credit carryforwards, net of any related valuation allowances and net of DTLs................................................................................................. P843 1,000 8. 9. AOCI-related adjustments (if entered “1” for Yes in item 3.a, complete only items 9.a through 9.e; if entered “0” for No in item 3.a, complete only item 9.f): a. LESS: Net unrealized gains (losses) on available-for-sale debt securities (if a gain, report as a positive value; if a loss, report as a negative value) P844 NA 9.a. b. Not applicable c. LESS: Accumulated net gains (losses) on cash flow hedges (if a gain, report as a positive value; if a loss, report as a negative value)............................................................................................................................................................................................................. P846 NA 9.c. d. LESS: Amounts recorded in AOCI attributed to defined benefit postretirement plans resulting from the initial and subsequent application of the relevant GAAP standards that pertain to such plans (if a gain, report as a positive value; if a loss, report as a negative value)........................... P847 NA 9.d. e. LESS: Net unrealized gains (losses) on held-to-maturity securities that are included in AOCI (if a gain, report as a positive value; if a loss, report as a negative value) P848 NA 9.e. f. To be completed only by institutions that entered “0” for No in item 3.a: LESS: Accumulated net gain (loss) on cash flow hedges included in AOCI, net of applicable income taxes, that relates to the hedging of items that are not recognized at fair value on the balance sheet (if a gain, report as a positive value; if a loss, report as a negative value)...................................................................... P849 0 9.f. 1. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should include the applicable portion of the CECL transitional amount or the modified CECL transitional amount, respectively, in this item. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 62 of 86 RC-46 Schedule RC-R—Continued Part I—Continued Dollar Amounts in Thousands RCOA Amount 10. Other deductions from (additions to) common equity tier 1 capital before threshold-based deductions: a. LESS: Unrealized net gain (loss) related to changes in the fair value of liabilities that are due to changes in own credit risk (if a gain, report as a positive value; if a loss, report as a negative value)........................................................................................................................................................................................................................................................ Q258 0 10.a. b. LESS: All other deductions from (additions to) common equity tier 1 capital before threshold-based deductions..................................................................................................................................................................................... P850 0 10.b. 11. Not applicable 12. Subtotal (item 5 minus items 6 through 10.b)..................................................................................................................................................... P852 9,663,000 12. 13. LESS: Investments in the capital of unconsolidated financial institutions, net of associated DTLs, that exceed 25 percent of item 12....................................................................................................................................................................................................................................... LB58 0 13. 14. LESS: MSAs, net of associated DTLs, that exceed 25 percent of item 12 LB59 0 14. 15. LESS: DTAs arising from temporary differences that could not be realized through net operating loss carrybacks, net of related valuation allowances and net of DTLs, that exceed 25 percent of item 12................................................................................................................................................................................................................. LB60 0 15. 16. Not applicable 17. LESS: Deductions applied to common equity tier 1 capital due to insufficient amounts of additional tier 1 capital and tier 2 P857 . capital (1) to cover deductions.......................................................................................................................... 0 17 18. Total adjustments and deductions for common equity tier 1 capital (sum of items 13 through 17).............................................................................................. P858 0 18. 19. Common equity tier 1 capital (item 12 minus item 18) P859 9,663,000 19. Additional Tier 1 Capital 20. Additional tier 1 capital instruments plus related surplus.............................................................................................................................................. P860 0 20. 21. Non-qualifying capital instruments subject to phase-out from additional tier 1 capital................................................................................................................................... P861 0 21. 22. Tier 1 minority interest not included in common equity tier 1 capital........................................................................................................... P862 0 22. 23. Additional tier 1 capital before deductions (sum of items 20, 21, and 22)..................................................................................................................................... P863 0 23. 24. LESS: Additional tier 1 capital deductions...................................................................................................................................................................... P864 0 24. 25. Additional tier 1 capital (greater of item 23 minus item 24, or zero)............................................................................................................................ P865 0 25. Tier 1 Capital 26. Tier 1 capital (sum of items 19 and 25)....................................................................................................................................................................................................................... 8274 9,663,000 26. Total Assets for the Leverage Ratio 27. Average total consolidated assets KW03 27 (2).............................................................................................................................................................................................................. 36,263,000 . 28. LESS: Deductions from common equity tier 1 capital and additional tier 1 capital (sum of items 6, 7, 8, 10.b, 13 through 15, 17, and certain elements of item 24—see instructions)........................................ P875 3,000 28. 29. LESS: Other deductions from (additions to) assets for leverage ratio purposes......................................................................................................................................... B596 0 29. 30. Total assets for the leverage ratio (item 27 minus items 28 and 29)......................................................................................................................................... A224 36,260,000 30. 1. An institution that has a CBLR framework election in effect as of the quarter-end report date is neither required to calculate tier 2 capital nor make any deductions that would have been taken from tier 2 capital as of the report date. 2. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should include the applicable portion of the CECL transitional amount or the modified CECL transitional amount, respectively, in item 27. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 63 of 86 RC-47 Schedule RC-R—Continued Part I—Continued Leverage Ratio* RCOA Percentage 31. Leverage ratio (item 26 divided by item 30) 7204 26.6492% 31. a. Does your institution have a community bank leverage ratio (CBLR) framework election in effect as 0=No RCOA of the quarter-end report date? (enter “1” for Yes; enter “0” for No)............................................................................................................. 1=Yes LE74 0 31.a. If your institution entered “1” for Yes in item 31.a: • Complete items 32 through 37 and, if applicable, items 38.a through 38.c, • Do not complete items 39 through 55.b, and • Do not complete Part II of Schedule RC-R. If your institution entered “0” for No in item 31.a: • Skip (do not complete) items 32 through 38.c, • Complete items 39 through 55.b, as applicable, and • Complete Part II of Schedule RC-R. Item 31.b is to be completed only by non-advanced approaches institutions that elect to use the Standardized Approach for Counterparty Credit Risk (SA-CCR) for purposes of the standardized approach and supplementary leverage ratio. b. Standardized Approach for Counterparty Credit Risk opt-in election RCOA (enter “1” for Yes; leave blank for No)............................................................................................................................................................... 1=Yes NC99 31.b. Qualifying Criteria and Other Information for CBLR Institutions* Column A Column B Dollar Amounts in Thousands RCOA Amount RCOA Percentage 32. Total assets (Schedule RC, item 12); (must be less than $10 billion) 2170 NA 32. 33. Trading assets and trading liabilities (Schedule RC, sum of items 5 and 15). Report as a dollar amount in column A and as a percentage of total assets (5% limit) in column B........................................................................................................................................................................................................................... KX77 NA KX78 NA 33. 34. Off-balance sheet exposures: a. Unused portion of conditionally cancellable commitments KX79 NA 34.a. b. Securities lent and borrowed (Schedule RC-L, sum of items 6.a and 6.b)................................................................................................................................................................................................................. KX80 NA 34.b. c. Other off-balance sheet exposures KX81 NA 34.c. d. Total off-balance sheet exposures (sum of items 34.a through 34.c). Report as a dollar amount in column A and as a percentage of total assets (25% limit) in column B KX82 NA KX83 NA 34.d Dollar Amounts in Thousands RCOA Amount 35. Unconditionally cancellable commitments.......................................................................................................................................................................................................... S540 NA 35. 36. Investments in the tier 2 capital of unconsolidated financial institutions LB61 NA 36. 37. Allocated transfer risk reserve.......................................................................................................................................................................................................... 3128 NA 37 38. Amount of allowances for credit losses on purchased credit-deteriorated assets: (1) a. Loans and leases held for investment.......................................................................................................................................................................................................... JJ30 NA 38.a. b. Held-to-maturity debt securities.......................................................................................................................................................................................................... JJ31 NA 38.b. c. Other financial assets measured at amortized cost JJ32 NA 38.c. * Report each ratio as a percentage, rounded to four decimal places, e.g., 12.3456. 1. Items 38.a through 38.c should be completed only by institutions that have adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 64 of 86 RC-48 Schedule RC-R—Continued Part I—Continued If your institution entered “0” for No in item 31.a, complete items 39 through 55.b, as applicable, and Part II of Schedule RC-R. If your institution entered “1” for Yes in item 31.a, do not complete items 39 through 55.b or Part II of Schedule RC-R. Dollar Amounts in Thousands RCOA Amount Tier 2 Capital (1) 39. Tier 2 capital instruments plus related surplus..................................................................................................................................................................................................... P866 0 39. 40. Non-qualifying capital instruments subject to phase-out from tier 2 capital.............................................................................................. P867 0 40. 41. Total capital minority interest that is not included in tier 1 capital P868 0 41. . Allowance for loan and lease losses includable in tier 2 capital 5310 42 (2, 3)............................................................................................................................... 18,000 42. 43. Not applicable 44. Tier 2 capital before deductions (sum of items 39 through 42)....................................................................................... P870 18,000 44. 45. LESS: Tier 2 capital deductions......................................................................................................................................... P872 0 45. 46. Tier 2 capital (greater of item 44 minus item 45, or zero)......................................................................................................................................... 5311 18,000 46. Total Capital 47. Total capital (sum of items 26 and 46)......................................................................................................................................... 3792 9,681,000 47. Total Risk-Weighted Assets 48. Total risk-weighted assets (from Schedule RC-R, Part II, item 31)......................................................................................................................................... A223 18,490,000 48. Risk-Based Capital Ratios * RCOA Percentage 49. Common equity tier 1 capital ratio (item 19 divided by item 48).............................................................................................................................. P793 52.2607% 49. 50. Tier 1 capital ratio (item 26 divided by item 48).............................................................................................................................. 7206 52.2607% 50. 51. Total capital ratio (item 47 divided by item 48).............................................................................................................................. 7205 52.3580% 51. Capital Buffer* 52. Institution-specific capital buffer necessary to avoid limitations on distributions and discretionary bonus payments: a. Capital conservation buffer H311 44.3580% 52.a. RCOW b. Institutions subject to Category III capital standards only: Total applicable capital buffer............................................................................... H312 2.5000% 52.b. RCOA Amount 53. Eligible income H313 retained (4) NA 53. 54 Distributions and discretionary bonus payments during the quarter H314 . (5) NA 54. Supplementary Leverage Ratio* 55. Institutions subject to Category III capital standards only: Supplementary leverage ratio information: a. Total exposure H015 leverage (6) .................................................................................................................................................................... 38,942,000 55.a. Percentage b. Supplementary leverage ratio................................................................................................................................................................... H036 24.8138% 55.b. * Report each ratio as a percentage, rounded to four decimal places, e.g., 12.3456. 1. An institution that has a CBLR framework election in effect as of the quarter-end report date is neither required to calculate tier 2 capital nor make any deductions that would have been taken from tier 2 capital as of the report date. 2. Institutions that have adopted ASU 2016-13 should report the amount of adjusted allowances for credit losses (AACL), as defined in the regu- latory capital rule, includable in tier 2 capital in item 42. 3. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should subtract the applicable portion of the AACL transitional amount or the modified AACL transitional amount, respectively, from the AACL, as defined in the regulatory capital rule, before determining the amount of AACL includable in tier 2 capital. See instructions for further detail on the CECL transition provisions. 4. Non-advanced approaches institutions other than Category III institutions must complete item 53 only if the amount reported in item 52.a above is less than or equal to 2.5000 percent. Category III institutions must complete item 53 only if the amount reported in item 52.a above is less than or equal to the amount reported in item 52.b above. 5. Non-advanced approaches institutions other than Category III institutions must complete item 54 only if the amount reported in Schedule RC- R, Part I, item 52.a, in the Call Report for the previous calendar quarter-end report date was less than or equal to 2.5000 percent. Category III institutions must complete item 54 only if the amount reported in Schedule RC-R, Part I, item 52.a, in the Call Report for the previous calendar quarter-end report date was less than or equal to the amount reported in Schedule RC-R, Part I, item 52.b, in the Call Report for that previous report date. 6. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should include the applicable portion of the CECL transitional amount or the modified CECL transitional amount, respectively, in item 55.a. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 65 of 86 Schedule RC-R—Continued RC-49 Part II. Risk-Weighted Assets Institutions that entered “1” for Yes in Schedule RC-R, Part I, item 31.a, do not have to complete Schedule RC-R, Part II. Institutions are required to assign a 100 percent risk weight to all assets not specifically assigned a risk weight under Subpart D of the federal banking agencies’ regulatory capital rules (1) and not deducted from tier 1 or tier 2 capital. (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Totals From Adjustments Allocation by Risk-Weight Category Schedule to Totals RC Reported in 0% 2% 4% 10% 20% 50% 100% 150% Column A Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount Balance Sheet Asset Categories (2) 1. Cash and balances due from depository RCON D957 RCON S396 RCON D958 RCON D959 RCON S397 RCON D960 RCON S398 institutions……………………………… 13,597,000 0 13,553,000 44,000 0 0 0 1. 2. Securities: a. Held-to-maturity RCON D961 RCON S399 RCON D962 RCON HJ74 RCON HJ75 RCON D963 RCON D964 RCON D965 RCON S400 securities (3)……………………………………………… 0 0 0 0 0 0 0 0 0 2.a. b. Available-for-sale debt securities and equity securities with readily determinable fair values RCON JA21 RCON S402 RCON D967 RCON HJ76 RCON HJ77 RCON D968 RCON D969 RCON D970 RCON S403 not held for trading……………………………………… 378,000 0 378,000 0 0 0 0 0 0 2.b. 3. Federal funds sold and securities purchased under agreements to resell: RCON D971 RCON D972 RCON D973 RCON S410 RCON D974 RCON S411 a. Federal funds sold………………. 0 0 0 0 0 0 3.a b. Securities purchased under agreements to RCON H171 RCON H172 resell……………………………………………….. 5,923,000 5,923,000 3.b 4. Loans and leases held for sale: a. Residential mortgage RCON S413 RCON S414 RCON H173 RCON S415 RCON S416 RCON S417 exposures……………………………………….. 0 0 0 0 0 0 4.a. b. High volatility commercial real estate RCON S419 RCON S420 RCON H174 RCON H175 RCON H176 RCON H177 RCON S421 exposures………………………… 0 0 0 0 0 0 0 4.b. 1. For national banks and federal savings associations, 12 CFR Part 3; for state member banks, 12 CFR Part 217; and for state nonmember banks and state savings associations 12 CFR Part 324. 2. All securitization exposures held as on-balance sheet assets of the reporting institution are to be excluded from items 1 through 8 and are to be reported instead in item 9. 3. Institutions that have adopted ASU 2016-13 and have reported held-to-maturity securities net of allowances for credit losses in item 2.a, column A, should report as a negative number in item 2.a, column B, those allowances for credit losses eligible for inclusion in tier 2 capital, which excludes allowances for credit losses on purchased credit-deteriorated assets. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 66 of 86 RC-50 Schedule RC-R—Continued Part II—Continued (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) (Column R) (Column S) Allocation by Risk-Weight Category Application of Other Risk- Weighting Approaches (1) 250% 300% 400% 600% 625% 937.5% 1250% Exposure Risk-Weighted Amount Asset Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Balance Sheet Asset Categories (continued) 1. Cash and balances due from depository institutions…………………………………….. 1. 2. Securities: a. Held-to-maturity securities…………………………………………. 2.a. b. Available-for-sale debt securities and equity securities with readily determinable fair values RCON S405 RCON S406 RCON H271 RCON H272 not held for trading .................................................. 0 0 0 0 2.b. 3. Federal funds sold and securities purchased under agreements to resell: a. Federal funds sold…………………….. 3.a. b. Securities purchased under agreements to resell..……………………………………. 3.b 4. Loans and leases held for sale: a. Residential mortgage RCON H273 RCON H274 exposures………………………………………. 0 0 4.a. b. High volatility commercial real estate RCON H275 RCON H276 exposures…………………………………………. 0 0 4.b. 1. Includes, for example, investments in mutual funds/investment funds, exposures collateralized by securitization exposures or mutual funds, separate account bank-owned life insurance, and default fund contributions to central counterparties. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 67 of 86 RC-51 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Totals From Adjustments Allocation by Risk-Weight Category Schedule to Totals RC Reported in 0% 2% 4% 10% 20% 50% 100% 150% Column A Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount 4. Loans and leases held for sale (continued): c. Exposures past due 90 days or more or RCON S423 RCON S424 RCON S425 RCON HJ78 RCON HJ79 RCON S426 RCON S427 RCON S428 RCON S429 on nonaccrual (1)……………………………………….. 0 0 0 0 0 0 0 0 0 4.c. d. All other RCON S431 RCON S432 RCON S433 RCON HJ80 RCON HJ81 RCON S434 RCON S435 RCON S436 RCON S437 exposures………………………………. 0 0 0 0 0 0 0 0 0 4.d. 5. Loans and leases held for investment: (2) a. Residential mortgage RCON S439 RCON S440 RCON H178 RCON S441 RCON S442 RCON S443 exposures……………………………………….. 2,417,000 0 1,000 0 2,309,000 107,000 5.a. b. High volatility commercial real estate RCON S445 RCON S446 RCON H179 RCON H180 RCON H181 RCON H182 RCON S447 exposures……………………….. 0 0 0 0 0 0 0 5.b. c. Exposures past due 90 days or more or on RCON S449 RCON S450 RCON S451 RCON HJ82 RCON HJ83 RCON S452 RCON S453 RCON S454 RCON S455 nonaccrual (3)……………………………………….. 0 0 0 0 0 0 0 0 0 5.c. RCON S457 RCON S458 RCON S459 RCON HJ84 RCON HJ85 RCON S460 RCON S461 RCON S462 RCON S463 d. All other exposures………………………….. 13,930,000 0 114,000 0 0 545,000 135,000 12,160,000 976,000 5.d. 6. LESS: Allowance for loan RCON 3123 RCON 3123 and lease losses (4)………………………………….. 16,000 16,000 6. 1. For loans and leases held for sale, exclude residential mortgage exposures, high volatility commercial real estate exposures, or sovereign exposures that are past due 90 days or more or on nonaccrual. 2. Institutions that have adopted ASU 2016-13 should report as a positive number in column B of items 5.a through 5.d, as appropriate, any allowances for credit losses on purchased credit- deteriorated assets reported in column A of items 5.a through 5.d, as appropriate. 3. For loans and leases held for investment, exclude residential mortgage exposures, high volatility commercial real estate exposures, or sovereign exposures that are past due 90 days or more or on nonaccrual. 4. Institutions that have adopted ASU 2016-13 should report the allowance for credit losses on loans and leases in item 6, columns A and B. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 68 of 86 RC-52 Schedule RC-R—Continued Part II—Continued (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) (Column R) (Column S) Allocation by Risk-Weight Category Application of Other Risk- Weighting Approaches (1) Exposure Risk-Weighted 250% 300% 400% 600% 625% 937.5% 1250% Amount Asset Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount 4. Loans and leases held for sale (continued): c. Exposures past due 90 days or more or RCON H277 RCON H278 nonaccrual on (2)…………………………………….. 0 0 4.c. d. All other RCON H279 RCON H280 exposures………………………………… 0 0 4.d. 5. Loans and leases held for investment: a. Residential mortgage RCON H281 RCON H282 exposures……………………………………….. 0 0 5.a. b. High volatility commercial real estate RCON H283 RCON H284 exposures…………………………………………………………………………….. 0 0 5.b. c. Exposures past due 90 days or more or on RCON H285 RCON H286 nonaccrual (3)……………………………………….. 0 0 5.c. RCON H287 RCON H288 d. All other exposures………………………….. 0 0 5.d. 6. LESS: Allowance for loan and lease losses………………………………….. 6. 1. Includes, for example, investments in mutual funds/investment funds, exposures collateralized by securitization exposures or mutual funds, separate account bank-owned life insurance, and default fund contributions to central counterparties. 2. For loans and leases held for sale, exclude residential mortgage exposures, high volatility commercial real estate exposures, or sovereign exposures that are past due 90 days or more or on nonaccrual. 3. For loans and leases held for investment, exclude residential mortgage exposures, high volatility commercial real estate exposures, or sovereign exposures that are past due 90 days or more or on nonaccrual. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 69 of 86 RC-53 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Totals From Adjustments Allocation by Risk-Weight Category Schedule to Totals RC Reported in 0% 2% 4% 10% 20% 50% 100% 150% Column A Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount RCON D976 RCON S466 RCON D977 RCON HJ86 RCON HJ87 RCON D978 RCON D979 RCON D980 RCON S467 7. Trading assets…………………………………. 0 0 0 0 0 0 0 0 0 7. RCON D981 RCON S469 RCON D982 RCON HJ88 RCON HJ89 RCON D983 RCON D984 RCON D985 RCON H185 8. All other assets (1, 2, 3)…………………………………… 2,496,000 728,000 105,000 0 0 53,000 1,000 1,144,000 9,000 8. a. Separate account bank-owned life insurance…………………………. 8.a. b. Default fund contributions to central counterparties……………………. 8.b. 1. Includes premises and fixed assets; other real estate owned; investments in unconsolidated subsidiaries and associated companies; direct and indirect investments in real estate ventures; intangible assets; and other assets. 2. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should report as a positive number in item 8, column B, the applicable portion of the DTA transitional amount as determined in accordance with the 3-year or the 5-year 2020 CECL transitional amount, respectively. 3. Institutions that have adopted ASU 2016-13 and have reported any assets net of allowances for credit losses in item 8, column A, should report as a negative number in item 8, column B, those allowances for credit losses eligible for inclusion in tier 2 capital, which excludes allowances for credit losses on purchased credit-deteriorated assets. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 70 of 86 RC-54 Schedule RC-R—Continued Part II—Continued (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) (Column R) (Column S) Allocation by Risk-Weight Category Application of Other Risk- Weighting Approaches (1) Exposure Risk-Weighted 250% 300% 400% 600% 625% 937.5% 1250% Amount Asset Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount RCON H186 RCON H290 RCON H187 RCON H291 RCON H292 7. Trading assets…………………………………. 0 0 0 0 0 7. RCON H293 RCON H188 RCON S470 RCON S471 RCON H294 RCON H295 8. All other assets (2)…………………………………… 456,000 0 0 0 0 0 8. a. Separate account bank-owned life RCON H296 RCON H297 insurance……….…………..…………… 0 0 8.a. b. Default fund contributions to central RCON H298 RCON H299 counterparties………………………….. 0 0 8.b. 1. Includes, for example, investments in mutual funds/investment funds, exposures collateralized by securitization exposures or mutual funds, separate account bank-owned life insurance, and default fund contributions to central counterparties. 2. Includes premises and fixed assets; other real estate owned; investments in unconsolidated subsidiaries and associated companies; direct and indirect investments in real estate ventures; intangible assets; and other assets. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 71 of 86 RC-55 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column Q) (Column T) (Column U) Totals Adjustments Allocation by Total Risk-Weighted Asset to Totals Risk-Weight Amount by Calculation Reported in Category Methodology Column A (Exposure Amount) 1250% SSFA (1) Gross-Up Dollar Amounts in Thousands Amount Amount Amount Amount Amount Securitization Exposures: On- and Off-Balance Sheet 9. On-balance sheet securitization exposures: RCON S475 RCON S476 RCON S477 RCON S478 RCON S479 a. Held-to-maturity securities (2)…………………………………………………………………………………………………………………..………... 0 0 0 0 0 9.a. RCON S480 RCON S481 RCON S482 RCON S483 RCON S484 b. Available-for-sale securities…………………………………………………………………………………………………………………………… 0 0 0 0 0 9.b. RCON S485 RCON S486 RCON S487 RCON S488 RCON S489 c. Trading assets……………………………………………………………………………………………………………………………………………………….. 0 0 0 0 0 9.c RCON S490 RCON S491 RCON S492 RCON S493 RCON S494 d. All other on-balance sheet securitization exposures……………………………………………………………………………………………………………….. 0 0 0 0 0 9.d RCON S495 RCON S496 RCON S497 RCON S498 RCON S499 10. Off-balance sheet securitization exposures……………………………………………………………………………………………………………………………………… 0 0 0 0 0 10. 1. Simplified Supervisory Formula Approach. 2. Institutions that have adopted ASU 2016-13 and have reported held-to-maturity securities net of allowances for credit losses in item 9.a, column A, should report as a negative number in item 9.a, column B, those allowances for credit losses eligible for inclusion in tier 2 capital, which excludes allowances for credit losses on purchased credit-deteriorated assets. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 72 of 86 RC-56 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Totals From Adjustments Allocation by Risk-Weight Category Schedule to Totals RC Reported in 0% 2% 4% 10% 20% 50% 100% 150% Column A Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount 11. Total balance sheet RCON 2170 RCON S500 RCON D987 RCON HJ90 RCON HJ91 RCON D988 RCON D989 RCON D990 RCON S503 assets (1)………………………………………………………………… 38,725,000 6,635,000 14,151,000 0 0 642,000 2,445,000 13,411,000 985,000 11. (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) (Column R) Application of Other Risk-Allocation by Risk-Weight Category Weighting Approaches Exposure 250% 300% 400% 600% 625% 937.5% 1250% Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount 11. Total balance sheet RCON S504 RCON S505 RCON S506 RCON S507 RCON S510 RCON H300 assets (1)…………...………………………………………………………… 456,000 0 0 0 0 0 11. 1. For each of columns A through R of item 11, report the sum of items 1 through 9. For item 11, the sum of columns B through R must equal column A. Item 11, column A, must equal Schedule RC, item 12. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 73 of 86 RC-57 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Face, Notional, CCF (1) Credit or Other Equivalent Allocation by Risk-Weight Category Amount Amount (2) 0% 2% 4% 10% 20% 50% 100% 150% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount Derivatives, Off-Balance Sheet Items, and Other Items Subject to Risk Weighting (Excluding Securitization Exposures) (3) 12. Financial standby RCON D991 RCON D992 RCON D993 RCON HJ92 RCON HJ93 RCON D994 RCON D995 RCON D996 RCON S511 letters of credit…………………………………………………………………… 241,000 1.0 241,000 0 0 0 4,000 3,000 234,000 0 12. 13. Performance standby letters of credit and transaction-related RCON D997 RCON D998 RCON D999 RCON G603 RCON G604 RCON G605 RCON S512 contingent items…………………………………………………………………… 102,000 0.5 51,000 0 0 1,000 50,000 0 13. 14. Commercial and similar letters of credit with an original maturity of one year RCON G606 RCON G607 RCON G608 RCON HJ94 RCON HJ95 RCON G609 RCON G610 RCON G611 RCON S513 or less…………………………………………………………………… 0 0.2 0 0 0 0 0 0 0 0 14. 15. Retained recourse on small business obligations sold RCON G612 RCON G613 RCON G614 RCON G615 RCON G616 RCON G617 RCON S514 with recourse…………………………………………………………………… 0 1.0 0 0 0 0 0 0 15. 1. Credit conversion factor. 2. Column A multiplied by credit conversion factor. For each of items 12 through 21, the sum of columns C through J plus column R must equal column B. 3. All derivatives and off-balance sheet items that are securitization exposures are to be excluded from items 12 through 21 and are to be reported instead in item 10. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 74 of 86 RC-58 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Face, Notional, CCF (1) Credit Allocation by Risk-Weight Category or Other Equivalent Amount Amount (2) 0% 2% 4% 10% 20% 50% 100% 150% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount 16. Repo-style RCON S515 RCON S516 RCON S517 RCON S518 RCON S519 RCON S520 RCON S521 RCON S522 RCON S523 transactions (3)……………………………………47,000 1.0 47,000 0 0 0 0 0 47,000 0 16. 17. All other off-balance RCON G618 RCON G619 RCON G620 RCON G621 RCON G622 RCON G623 RCON S524 sheet liabilities……………………………………………………………………0 1.0 0 0 0 0 0 0 17. 18. Unused commitments (exclude unused commitments to asset-backed commercial paper conduits): a. Original maturity of RCON S525 RCON S526 RCON S527 RCON HJ96 RCON HJ97 RCON S528 RCON S529 RCON S530 RCON S531 one year or less………………………………………………………65,000 0.2 13,000 0 0 0 0 0 13,000 0 18.a. b. Original maturity exceeding one RCON G624 RCON G625 RCON G626 RCON HJ98 RCON HJ99 RCON G627 RCON G628 RCON G629 RCON S539 year……………………………………………………………………1,908,000 0.5 954,000 84,000 0 0 103,000 88,000 679,000 0 18.b. 19. Unconditionally cancelable RCON S540 RCON S541 commitments……………………………………………………………………0 0.0 0 19. 20. Over-the-counter RCON S542 RCON S543 RCON HK00 RCON HK01 RCON S544 RCON S545 RCON S546 RCON S547 RCON S548 derivatives…………………………………………………………………… 15,000 0 0 0 0 15,000 0 0 0 20. 21. Centrally cleared RCON S549 RCON S550 RCON S551 RCON S552 RCON S554 RCON S555 RCON S556 RCON S557 derivatives…………………………………………………………………… 796,000 0 796,000 0 0 0 0 0 21. 22. Unsettled transactions RCON H191 RCON H193 RCON H194 RCON H195 RCON H196 RCON H197 (failed trades) (4)……………………………………………………………………0 0 0 0 0 0 22. 06/2012 1. Credit conversion factor. 2. For items 16 through 19, column A multiplied by credit conversion factor. 3. Includes securities purchased under agreements to resell (reverse repos), securities sold under agreements to repurchase (repos), securities borrowed, and securities lent. 4. For item 22, the sum of columns C through Q must equal column A.
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 75 of 86 RC-59 Schedule RC-R—Continued Part II—Continued (Column O) (Column P) (Column Q) (Column R) (Column S) Application of Other Risk-Allocation by Risk-Weight Category Weighting Approaches (1) Credit Equivalent Risk-Weighted 625% 937.5% 1250% Amount Asset Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount 16. Repo-style RCON H301 RCON H302 transactions (2)……….…………………………...……………………...…………….…………...…………….….… 0 0 16. 17. All other off-balance sheet liabilities……………..…….…………………...…………….………………………… 17. 18. Unused commitments (exclude unused commitments to asset-backed commercial paper conduits): a. Original maturity of RCON H303 RCON H304 one year or less………………….…………………………...…………….……………………. 0 0 18.a. b. Original maturity exceeding one RCON H307 RCON H308 year…………………….…………………………...…………….……………………. 0 0 18.b. 19. Unconditionally cancelable commitments………………………………………….…………...…………….…………… 19. 20. Over-the-counter RCON H309 RCON H310 derivatives…………………………………………………...…………….………………...… 0 0 20. 21. Centrally cleared derivatives………………………………………………………………...…………….….… 21. 22. Unsettled transactions RCON H198 RCON H199 RCON H200 (failed trades) (3)………………………………………………...…………….……………… 0 0 0 22. 1. Includes, for example, exposures collateralized by securitization exposures or mutual funds. 2. Includes securities purchased under agreements to resell (reverse repos), securities sold under agreements to repurchase (repos), securities borrowed, and securities lent. 3. For item 22, the sum of columns C through Q must equal column A. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 76 of 86 RC-60 Schedule RC-R—Continued Part II—Continued (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Allocation by Risk-Weight Category 0% 2% 4% 10% 20% 50% 100% 150% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount 23. Total assets, derivatives, off-balance sheet items, and other items subject to risk weighting by risk-weight category (for each of columns C through P, sum of items 11 through 22; for column Q, sum of items RCON G630 RCON S558 RCON S559 RCON S560 RCON G631 RCON G632 RCON G633 RCON S561 10 through 22)…………………………………………………………………… 14,235,000 796,000 0 0 764,000 2,537,000 14,434,000 985,000 23. 24. Risk-weight factor…………………………………………………………………… X 0% X 2% X 4% X 10% X 20% X 50% X 100% X 150% 24. 25. Risk-weighted assets by risk-weight category (for each column, item 23 multiplied by RCON G634 RCON S569 RCON S570 RCON S571 RCON G635 RCON G636 RCON G637 RCON S572 item 24)…………………………………………………………………… 0 16,000 0 0 153,000 1,269,000 14,434,000 1,478,000 25. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 77 of 86 RC-61 Schedule RC-R—Continued Part II—Continued (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) Allocation by Risk-Weight Category 250% 300% 400% 600% 625% 937.5% 1250% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount 23. Total assets, derivatives, off-balance sheet items, and other items subject to risk weighting by risk- weight category (for each of columns C through P, sum of items 11 through 22; for column Q, sum of items RCON S562 RCON S563 RCON S564 RCON S565 RCON S566 RCON S567 RCON S568 10 through 22) …………………………………………………………………………………………. 456,000 0 0 0 0 0 0 23. 24. Risk-weight factor……………………………………………………………………………………… X 250% X 300% X 400% X 600% X 625% X 937.5% X 1250% 24. 25. Risk-weighted assets by risk-weight category (for each column, item 23 multiplied by RCON S573 RCON S574 RCON S575 RCON S576 RCON S577 RCON S578 RCON S579 item 24)…………………………………………………………………………………………………. 1,140,000 0 0 0 0 0 0 25. Totals Dollar Amounts in Thousands RCON Amount 26. Risk-weighted assets base for purposes of calculating the allowance for loan and lease losses 1.25 percent threshold (1)………………………………….………………………… S580 18,490,000 26. 27. Standardized market-risk weighted assets (applicable only to banks that are covered by the market risk capital rules)……………………………...……………………...….………… S581 0 27. 28. Risk-weighted assets before deductions for excess allowance for loan and lease losses and allocated transfer risk reserve (2, 3)………………………..…………………….. B704 18,490,000 28. 29. LESS: Excess allowance for loan and lease losses (4, 5)……………………………………………………………………………………………………………………………………………….. A222 0 29. 30. LESS: Allocated transfer risk reserve………………………………………………………………………………………………………………………………………………………………… 3128 0 30. 31. Total risk-weighted assets (item 28 minus items 29 and 30)……………………………………………………………………………………………………………………………………. G641 18,490,000 31. 1. For institutions that have adopted ASU 2016-13, the risk-weighted assets base reported in item 26 is for purposes of calculating the adjusted allowances for credit losses (AACL) 1.25 percent threshold. 2. Sum of items 2.b through 20, column S; items 9.a, 9.b, 9.c, 9.d, and 10, columns T and U; item 25, columns C through Q; and item 27 (if applicable). 3. For institutions that have adopted ASU 2016-13, the risk-weighted assets reported in item 28 represents the amount of risk-weighted assets before deductions for excess AACL and allocated transfer risk reserve. 4. Institutions that have adopted ASU 2016-13 should report the excess AACL. 5. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should subtract the applicable portion of the AACL transitional amount or the modified AACL transitional amount, respectively, from the AACL, as defined in the regulatory capital rule, before determining the amount of excess AACL. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 78 of 86 RC-62 Schedule RC-R—Continued Part II—Continued Memoranda Dollar Amounts in Thousands RCON Amount 1. Current credit exposure across all derivative contracts covered by the regulatory capital rules……………………………………………………. G642 388,000 M.1. With a remaining maturity of (Column A) (Column B) (Column C) One year or less Over one year Over five years through five years Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 2. Notional principal amounts of over-the-counter derivative contracts: a. Interest rate…………………………………………………………………………………………………………… S582 168,000 S583 228,000 S584 104,000 M.2.a. b. Foreign exchange rate and gold………………………………………………………………………………………………………… S585 0 S586 0 S587 0 M.2.b. c. Credit (investment grade reference asset)…………………………………………………………………………………………………………… S588 0 S589 0 S590 0 M.2.c. d. Credit (non-investment grade reference asset)…………………………………………………………………………………………………………… S591 0 S592 0 S593 0 M.2.d. e. Equity…………………………………………………………………………………………………………… S594 0 S595 0 S596 0 M.2.e. f. Precious metals (except gold)………………………………………………………………. S597 0 S598 0 S599 0 M.2.f. g. Other…………………………………………………………………………………………………………… S600 0 S601 0 S602 0 M.2.g. 3. Notional principal amounts of centrally cleared derivative contracts: a. Interest rate…………………………………………………………………… S603 5,796,000 S604 13,317,000 S605 3,155,000 M.3.a. b. Foreign exchange rate and gold…………………………………………………………… S606 0 S607 0 S608 0 M.3.b. c. Credit (investment grade reference asset)…………………………………………………………………………………………………………… S609 0 S610 0 S611 0 M.3.c. d. Credit (non-investment grade reference asset)…………………………………………. S612 0 S613 0 S614 0 M.3.d. e. Equity…………………………………………………………………………………………………………… S615 0 S616 0 S617 0 M.3.e. f. Precious metals (except gold)…………………………………………………………………………………………………………… S618 0 S619 0 S620 0 M.3.f. g. Other………………………………………………………………………………………… S621 0 S622 0 S623 0 M.3.g. Dollar Amounts in Thousands RCON Amount 4. Amount of allowances for credit losses on purchased credit-deteriorated assets: (1) a. Loans and leases held for investment............................................................................................................................................................................................................................................ JJ30 0 M.4.a. b. Held-to-maturity debt securities................................................................................................................................................................................................................................. JJ31 0 M.4.b. c. Other financial assets measured at amortized cost JJ32 0 M.4.c. 1. Memorandum items 4.a through 4.c should be completed only by institutions that have adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 79 of 86 Schedule RC-S—Servicing, Securitization, and Asset Sale Activities RC-63 (Column A) (Column B to Column F) (Column G) 1–4 Family Not applicable All Other Loans, Residential All Leases, and Loans All Other Assets Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount Bank Securitization Activities 1. Outstanding principal balance of assets sold and securitized by the reporting bank with servicing retained or with recourse or other seller-provided credit enhancements ................................................................................................................... B705 0 B711 0 1. 2. Maximum amount of credit exposure arising from recourse or other seller-provided credit enhancements provided to structures reported in item 1………………………………………………… HU09 0 HU15 0 2. 3. Not applicable 4. Past due loan amounts included in item 1: a. 30–89 days past due .............................................................................................................. B733 0 B739 0 4.a. b. 90 days or more past due............................................................................................................................... B740 0 B746 0 4.b. 5. Charge-offs and recoveries on assets sold and securitized with servicing retained or with recourse or other seller-provided credit enhancements (calendar year-to-date): RIAD RIAD a. Charge-offs ................................................................................................................................. B747 0 B753 0 5.a. b. Recoveries ................................................................................................................................ B754 0 B760 0 5.b. Item 6 is to be completed by banks with $10 billion or more in total assets. (1) 6. Total amount of ownership (or seller’s) interest RCON carried as securities or loans…………………………………………………………………………… HU19 0 6. 7. and 8. Not applicable For Securitization Facilities Sponsored By or Otherwise Established By Other Institutions 9. Maximum amount of credit exposure arising from credit enhancements provided by the reporting bank to other institutions’ securitization structures in the form of standby letters of credit, purchased RCON subordinated securities, and other enhancements................................................................................................................. B776 0 B782 0 9. Item 10 is to be completed by banks with $10 billion or more in total assets (1) 10. Reporting bank’s unused commitments to provide liquidity to other institutions’ securitization structures .................................................................................................. B783 0 B789 0 10. Bank Asset Sales 11. Assets sold with recourse or other seller-provided credit enhancements and not securitized by the reporting bank...............................................................................................B790 0 B796 0 11. 12. Maximum amount of credit exposure arising from recourse or other seller-provided credit enhancements provided to assets reported in item 11.............................................................................................................................................. B797 0 B803 0 12. 1. The $10 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 80 of 86 Schedule RC-S—Continued RC-64 Memoranda Dollar Amounts in Thousands RCON Amount 1. Not applicable 2. Outstanding principal balance of assets serviced for others (includes participations serviced for others): a. Closed-end 1–4 family residential mortgages serviced with recourse or other servicer-provided credit enhancement...................................................................................................................................... B804 0 M.2.a. b. Closed-end 1–4 family residential mortgages serviced with no recourse or other servicer-provided credit enhancement............................................................................................................................................ B805 0 M.2.b. c. Other financial assets (includes home equity lines) A591 (1)............................................................................................................................................................................................ 0 M.2.c. d. 1–4 family residential mortgages serviced for others that are in process of foreclosure at quarter-end (includes closed-end and open-end loans) F699 0 M.2.d. Memorandum item 3 is to be completed by banks with $10 billion or more in total assets. (2) 3. Asset-backed commercial paper conduits: a. Maximum amount of credit exposure arising from credit enhancements provided to conduit structures in the form of standby letters of credit, subordinated securities, and other enhancements: (1) Conduits sponsored by the bank, a bank affiliate, or the bank’s holding company........................................................................................................................ B806 0 M.3.a.(1) (2) Conduits sponsored by other unrelated institutions.............................................................................................................................................................................................. B807 0 M.3.a.(2) b. Unused commitments to provide liquidity to conduit structures: (1) Conduits sponsored by the bank, a bank affiliate, or the bank’s holding company............................................................................................................... B808 0 M.3.b.(1) (2) Conduits sponsored by other unrelated institutions.............................................................................................................................................................................................. B809 0 M.3.b.(2) 4. Outstanding credit card fees and finance charges included in Schedule RC-S, item 1, column G C407 (2), (3)........................................................................................................................................................................................... 0 M.4. __________ 1. Memorandum item 2.c is to be completed if the principal balance of other financial assets serviced for others is more than $10 million. 2. The $10 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 3. Memorandum item 4 is to be completed by banks with $10 billion or more in total assets that (1) together with affiliated institutions, have outstanding credit card receivables (as defined in the instructions) that exceed $500 million as of the report date, or (2) are credit card specialty banks as defined for Uniform Bank Performance Report purposes. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 81 of 86 RC-65 Schedule RC-T—Fiduciary and Related Services RCON Yes No 1. Does the institution have fiduciary powers? (If “NO,” do not complete Schedule RC-T.) A345 x 1. 2. Does the institution exercise the fiduciary powers it has been granted? A346 x 2. 3. Does the institution have any fiduciary or related activity (in the form of assets or accounts) to report in this schedule? (If “NO,” do not complete the rest of Schedule RC-T.) B867 x 3. If the answer to item 3 is “YES,” complete the applicable items of Schedule RC-T, as follows: Institutions with total fiduciary assets (item 10, sum of columns A and B) greater than $250 million (as of the preceding December 31 report date) or with gross fiduciary and related services income greater than 10 percent of revenue (net interest income plus noninterest income) for the preceding calendar year must complete: • Items 4 through 22 and Memorandum item 3 quarterly, • Items 23 through 26 annually with the December report, and • Memorandum items 1, 2, and 4 annually with the December report. Institutions with total fiduciary assets (item 10, sum of columns A and B) less than or equal to $250 million (as of the preceding December 31 report date) that do not meet the fiduciary income test for quarterly reporting must complete: • Items 4 through 13 annually with the December report, and • Memorandum items 1 through 3 annually with the December report. • Institutions with total fiduciary assets greater than $100 million but less than or equal to $250 million (as of the preceding December 31 report date) that do not meet the fiduciary income test for quarterly reporting must also complete Memorandum item 4 annually with the December report. (Column A) (Column B) (Column C) (Column D) Managed Non-Managed Number of Number of Assets Assets Managed Non-Managed Accounts Accounts Dollar Amounts in Thousands Amount Amount Number Number Fiduciary and Related Assets RCON B868 RCON B869 RCON B870 RCON B871 4. Personal trust and agency accounts........................... 0 4,000 2 2 4. 5. Employee benefit and retirement-related trust and agency accounts: a. Employee benefit—defined RCON B872 RCON B873 RCON B874 RCON B875 contribution........................................................................................................................... 2,000 0 1 0 5.a. b. Employee benefit—defined RCON B876 RCON B877 RCON B878 RCON B879 benefit........................................................................................................................... 8,000 0 3 0 5.b. c. Other employee benefit and retirement- RCON B880 RCON B881 RCON B882 RCON B883 related accounts........................................................................................................................... 133,000 0 124 1 5.c. RCON B884 RCON B885 RCON C001 RCON C002 6. Corporate trust and agency accounts........................................................................................................................... 0 82,131,000 0 17,830 6. 7. Investment management and investment RCON B886 RCON J253 RCON B888 RCON J254 advisory agency accounts........................................................................................................................... 13,461,000 61,000 2,722 28 7. 8. Foundation and endowment trust and RCON J255 RCON J256 RCON J257 RCON J258 agency accounts..................................................................... 613,000 0 39 0 8. RCON B890 RCON B891 RCON B892 RCON B893 9. Other fiduciary accounts........................................................................................................................... 0 0 0 0 9. 10. Total fiduciary accounts RCON B894 RCON B895 RCON B896 RCON B897 (sum of items 4 through 9)............................................................ 14,217,000 82,196,000 2,891 17,861 10. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 82 of 86 RC-66 Schedule RC-T—Continued (Column A) (Column B) (Column C) (Column D) Managed Non-Managed Number of Number of Assets Assets Managed Non-Managed Accounts Accounts Dollar Amounts in Thousands Amount Amount Number Number RCON B898 RCON B899 11. Custody and safekeeping accounts............... 27,067,000 3,299 11. 12. Not applicable 13. Individual Retirement Accounts, Health Savings Accounts, and other similar ac- RCON J259 RCON J260 RCON J261 RCON J262 counts (included in items 5.c and 11)............................................................... 129,000 390,000 122 479 13. Dollar Amounts in Thousands RIAD Amount Fiduciary and Related Services Income 14. Personal trust and agency accounts.............................................................................................................................................................................................. B904 0 14. 15. Employee benefit and retirement-related trust and agency accounts: a. Employee benefit—defined contribution................................................................................................................................ B905 0 15.a. b. Employee benefit—defined benefit...................................................................................................................................... B906 0 15.b. c. Other employee benefit and retirement-related accounts............................................................................................... B907 1,000 15.c. 16. Corporate trust and agency accounts............................................................................................................................. A479 244,000 16. 17. Investment management and investment advisory agency accounts............................................................................................... J315 23,000 17. 18. Foundation and endowment trust and agency accounts........................................................................................................ J316 2,000 18. 19. Other fiduciary accounts............................................................................................................................................. A480 0 19. 20. Custody and safekeeping accounts........................................................................................................................................... B909 9,000 20. 21. Other fiduciary and related services income............................................................................................................................ B910 0 21. 22. Total gross fiduciary and related services income (sum of items 14 through 21) (must equal Schedule RI, item 5.a)............................................................................................................................................................ 4070 279,000 22. 23. Less: Expenses.............................................................................................................................................................................................. C058 143,000 23. 24. Less: Net losses from fiduciary and related services............................................................................................... A488 0 24. 25. Plus: Intracompany income credits for fiduciary and related services............................................................................................... B911 0 25. 26. Net fiduciary and related services income.............................................................................................................................................................................................. A491 136,000 26. (Column A) (Column B) (Column C) Personal Trust and Employee Benefit All Other Accounts Memoranda Agency and Investment and Retirement-Related Management Agency Trust and Agency Accounts Accounts Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. Managed assets held in fiduciary accounts: a. Noninterest-bearing deposits............................................................................................... J263 (28,000) J264 0 J265 0 M.1.a. b. Interest-bearing deposits............................................................................................... J266 318,000 J267 3,000 J268 5,000 M.1.b. c. U.S. Treasury and U.S. Government agency obligations............................................................................................... J269 737,000 J270 14,000 J271 67,000 M.1.c. d. State, county, and municipal obligations............................................................................................... J272 1,854,000 J273 0 J274 12,000 M.1.d. e. Money market mutual funds............................................................................................... J275 570,000 J276 3,000 J277 26,000 M.1.e. f. Equity mutual funds............................................................................................... J278 1,153,000 J279 35,000 J280 57,000 M.1.f. g. Other mutual funds............................................................................................... J281 638,000 J282 18,000 J283 23,000 M.1.g. h. Common trust funds and collective investment funds............................................................................................... J284 845,000 J285 0 J286 0 M.1.h. i. Other short-term obligations........................................................................................... J287 660,000 J288 2,000 J289 18,000 M.1.i. j. Other notes and bonds................................................................................. J290 1,945,000 J291 24,000 J292 212,000 M.1.j. k. Investments in unregistered funds and private equity investments........................................................................ J293 64,000 J294 1,000 J295 1,000 M.1.k. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 83 of 86 RC-67 Schedule RC-T—Continued Memoranda—Continued (Column A) (Column B) (Column C) Personal Trust and Employee Benefit All Other Accounts Agency and Investment and Retirement-Related Management Agency Trust and Agency Accounts Accounts Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. l. Other common and preferred stocks…………………………………………………..…… J296 4,253,000 J297 43,000 J298 192,000 M.1.l. m. Real estate mortgages…….……………………….……..................................... J299 0 J300 0 J301 0 M.1.m. n. Real estate……………………………………………………………………..…… J302 44,000 J303 0 J304 0 M.1.n. o. Miscellaneous assets……………………………………………………………………..…… J305 408,000 J306 0 J307 0 M.1.o. p. Total managed assets held in fiduciary accounts (for each column, sum of Memorandum items 1.a through 1.o)............................................ J308 13,461,000 J309 143,000 J310 613,000 M.1.p. (Column A) (Column B) Managed Assets Number of Managed Accounts Dollar Amounts in Thousands RCON Amount RCON Number 1. q. Investments of managed fiduciary accounts in advised or sponsored mutual funds…………………………………………………………………………............................. J311 226,000 J312 2,036 M.1.q. (Column A) (Column B) Number of Principal Amount Issues Outstanding Dollar Amounts in Thousands RCON Number Amount 2. Corporate trust and agency accounts: RCON B928 a. Corporate and municipal trusteeships………………………………………………………..……............................. B927 6,102 1,179,867,000 M.2.a. RCON J314 (1) Issues reported in Memorandum item 2.a that are in default............................................................... J313 322 25,636,000 M.2.a.(1) b. Transfer agent, registrar, paying agent, and other corporate agency…………………….……..................... B929 21,482 M.2.b. Memorandum items 3.a through 3.h are to be completed by banks with collective investment funds and common trust funds with a total market value of $1 billion or more as of the preceding December 31 report date. Memorandum item 3.h only is to be completed by banks with collective investment funds and common trust funds with a total market value of less than $1 billion as of the preceding December 31 report date. (Column A) (Column B) Number of Funds Market Value of Fund Assets Dollar Amounts in Thousands RCON Number RCON Amount 3. Collective investment funds and common trust funds a. Domestic equity………………………………………………………………………..……............................ B931 3 B932 396,000 M.3.a. b. International/Global equity…………………………………………………………….……............................ B933 1 B934 165,000 M.3.b. c. Stock/Bond blend……………………………………………………………………………............................... B935 0 B936 0 M.3.c. d. Taxable bond…………………………………………………………………………..……................................ B937 1 B938 99,000 M.3.d. e. Municipal bond………………………………………………………………………………................................... B939 1 B940 184,000 M.3.e. f. Short-term investments/Money market…………………………………………………….................................. B941 0 B942 0 M.3.f. g. Specialty/Other………………………………………………………………………..…….............................. B943 0 B944 0 M.3.g. h. Total collective investment funds (sum of Memorandum items 3.a through 3.g)…………………………………………………………………………….…….............................. B945 6 B946 844,000 M.3.h. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 84 of 86 RC-68 Schedule RC-T—Continued Memoranda—Continued (Column A) (Column B) (Column C) Gross Losses Gross Losses Recoveries Managed Non-Managed Accounts Accounts Dollar Amounts in Thousands RIAD Amount RIAD Amount RIAD Amount 4. Fiduciary settlements, surcharges, and other losses: a. Personal trust and agency accounts……………………….…………........................................ B947 0 B948 0 B949 0 M.4.a. b. Employee benefit and retirement-related trust and agency accounts……………..…………..…………..…………..…………............................... B950 0 B951 0 B952 0 M.4.b. c. Investment management and investment advisory agency accounts……………..…………..…………..…………..…………................................... B953 0 B954 0 B955 0 M.4.c. d. Other fiduciary accounts and related services……………………….…................................ B956 0 B957 0 B958 0 M.4.d. e. Total fiduciary settlements, surcharges, and other losses (sum of Memorandum items 4.a through 4.d) (sum of columns A and B minus column C must equal Schedule RC-T, item 24)……………………………………..…………........................................ B959 0 B960 0 B961 0 M.4.e. Person to whom questions about Schedule RC-T—Fiduciary and Related Services should be directed: Scott Iacono, Director Name and Title (TEXT B962) Scott.Iacono@db.com E-mail Address (TEXT B926) 212-250-8948 Area Code / Phone Number / Extension (TEXT B963) 212-797-0541 Area Code / FAX Number (TEXT B964) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 85 of 86 RC-69 Schedule RC-V—Variable Interest Entities (1) (Column A) (Column B) Securitization Vehicles Other VIEs Dollar Amounts in Thousands RCON Amount RCON Amount 1. Assets of consolidated variable interest entities (VIEs) that can be used only to settle obligations of the consolidated VIEs: a. Cash and balances due from depository institutions ........................................................................ J981 0 JF84 0 1.a. b. Securities not held for trading ...................................................................................................... HU20 0 HU21 0 1.b. c. Loans and leases held for investment, net of allowance, and held for sale……………………………….......................................... HU22 0 HU23 0 1.c. d. Other real estate owned………………..………..………............................................ K009 0 JF89 0 1.d. e. Other assets .................................................................................................................................. JF91 0 JF90 0 1.e. 2. Liabilities of consolidated VIEs for which creditors do not have recourse to the general credit of the reporting bank: a. Other borrowed money ................................................................................................................. JF92 0 JF85 0 2.a. b. Other liabilities .......................................................................................................................... JF93 0 JF86 0 2.b. 3. All other assets of consolidated VIEs (not included in items 1.a through 1.e above) ............................................................................................................ K030 0 JF87 0 3. 4. All other liabilities of consolidated VIEs (not included in items 2.a and 2.b above) ......................................................................................... K033 0 JF88 0 4. Dollar Amounts in Thousands RCON Amount 5. Total assets of asset-backed commercial paper (ABCP) conduit VIEs............................................................................................. JF77 0 5. 6. Total liabilities of ABCP conduit VIEs....................................................................................................................................... JF78 0 6. 1. Institutions that have adopted ASU 2016-13 should report assets net of any applicable allowance for credit losses. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 86 of 86 RC-70 Optional Narrative Statement Concerning the Amounts Reported in the Consolidated Reports of Condition and Income The management of the reporting bank may, if it wishes, submit a brief narrative statement on the amounts reported in the Consolidated Reports of Condition and Income. This optional statement will be made available to the public, along with the publicly available data in the Consolidated Reports of Condition and Income, in response to any request for individual bank report data. However, the information reported in Schedule RI-E, item 2.g; Schedule RC-C, Part I, Memorandum items 17.a and 17.b; Schedule RC-O, Memorandum items 6 through 9, 14, 15, and 18; and Schedule RC-P, items 7.a and 7.b, is regarded as confidential and will not be made available to the public on an individual institution basis. BANKS CHOOSING TO SUBMIT THE NARRATIVE STATEMENT SHOULD ENSURE THAT THE STATEMENT DOES NOT CONTAIN THE NAMES OR OTHER IDENTIFICATIONS OF INDIVIDUAL BANK CUSTOMERS, REFERENCES TO THE AMOUNTS REPORTED IN THE CONFIDENTIAL ITEMS IDENTIFIED ABOVE, OR ANY OTHER INFORMATION THAT THEY ARE NOT WILLING TO HAVE MADE PUBLIC OR THAT WOULD COMPROMISE THE PRIVACY OF THEIR CUSTOMERS. Banks choosing not to make a statement may check the “No comment” box below and should make no entries of any kind in the space provided for the narrative statement; i.e., DO NOT enter in this space such phrases as “No statement,” “Not applicable,” “N/A,” “No comment,” and “None.” The optional statement must be entered on this sheet. The statement should not exceed 100 words. Further, regardless of the number of words, the statement must not exceed 750 characters, including punctuation, indentation, and standard spacing between words and sentences. If any submission should exceed 750 characters, as defined, it will be truncated at 750 characters with no notice to the submitting bank and the truncated statement will appear as the bank’s statement both on agency computerized records and in computer-file releases to the public. All information furnished by the bank in the narrative statement must be accurate and not misleading. Appropriate efforts shall be taken by the submitting bank to ensure the statement’s accuracy. If, subsequent to the original submission, material changes are submitted for the data reported in the Consolidated Reports of Condition and Income, the existing narrative statement will be deleted from the files, and from disclosure; the bank, at its option, may replace it with a statement appropriate to the amended data. The optional narrative statement will appear in agency records and in release to the public exactly as submitted (or amended as described in the preceding paragraph) by the management of the bank (except for the truncation of statements exceeding the 750-character limit described above). THE STATEMENT WILL NOT BE EDITED OR SCREENED IN ANY WAY BY THE SUPERVISORY AGENCIES FOR ACCURACY OR RELEVANCE. DISCLOSURE OF THE STATEMENT SHALL NOT SIGNIFY THAT ANY FEDERAL SUPERVISORY AGENCY HAS VERIFIED OR CONFIRMED THE ACCURACY OF THE INFORMATION CONTAINED THEREIN. A STATEMENT TO THIS EFFECT WILL APPEAR ON ANY PUBLIC RELEASE OF THE OPTIONAL STATEMENT SUBMITTED BY THE MANAGEMENT OF THE REPORTING BANK. Comments? RCON Yes No 6979 x BANK MANAGEMENT STATEMENT (please type or print clearly; 750 character limit): (TEXT 6980) 06/2012
Exhibit 25.2
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM T-1
STATEMENT OF ELIGIBILITY
UNDER THE TRUST INDENTURE ACT OF 1939
OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE
| ☐ | CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) |
DEUTSCHE BANK TRUST COMPANY AMERICAS
(formerly BANKERS TRUST COMPANY)
(Exact name of trustee as specified in its charter)
| NEW YORK | 13-4941247 | |
| (Jurisdiction of Incorporation or organization if not a U.S. national bank) |
(I.R.S. Employer Identification no.) | |
| 1 COLUMBUS CIRCLE NEW YORK, NEW YORK |
10019 | |
| (Address of principal executive offices) | (Zip Code) | |
Deutsche Bank Trust Company Americas
1 Columbus Circle
New York, New York 10019
(212) 250 – 2500
(Name, address and telephone number of agent for service)
GlaxoSmithKline Capital Inc.
(Exact name of Obligor as specified in its charter)
Delaware
(State or other jurisdiction of incorporation or organization)
51-0332587
(I.R.S. Employer Identification No.)
1100 North Market Street, 4th Floor, Suite 4056
Wilmington, Delaware 19890
+1 (302) 651-8319
(Address and telephone number of Obligor’s principal executive offices)
GUARANTEED DEBT SECURITIES OF GLAXOSMITHKLINE CAPITAL INC.
GUARANTEE OF GSK PLC IN CONNECTION WITH GUARANTEED DEBT SECURITIES OF GLAXOSMITHKLINE CAPITAL INC.
(Title of the Indenture securities)
| Item 1. | General Information. |
Furnish the following information as to the trustee.
| (a) | Name and address of each examining or supervising authority to which it is subject. |
| Name |
Address | |
| Federal Reserve Bank (2nd District) | New York, NY | |
| Federal Deposit Insurance Corporation | Washington, D.C. | |
| New York State Banking Department | Albany, NY | |
| (b) | Whether it is authorized to exercise corporate trust powers. |
Yes.
| Item 2. | Affiliations with Obligor. |
If the obligor is an affiliate of the Trustee, describe each such affiliation.
NA
| Item 3. -15. | Not Applicable |
| Item 16. | List of Exhibits. |
| Exhibit 1 - | Restated Organization Certificate of Bankers Trust Company dated August 31, 1998; Certificate of Amendment of the Organization Certificate of Bankers Trust Company dated September 25, 1998; Certificate of Amendment of the Organization Certificate of Bankers Trust Company dated December 18, 1998;Certificate of Amendment of the Organization Certificate of Bankers Trust Company dated September 3, 1999; and Certificate of Amendment of the Organization Certificate of Bankers Trust Company dated March 14, 2002, incorporated herein by reference to Exhibit 1 filed with Form T-1 Statement, Registration No. 333-201810. | |
| Exhibit 2 - | Certificate of Authority to commence business, incorporated herein by reference to Exhibit 2 filed with Form T-1 Statement, Registration No. 333-201810. | |
| Exhibit 3 - | Authorization of the Trustee to exercise corporate trust powers, incorporated herein by reference to Exhibit 3 filed with Form T-1 Statement, Registration No. 333-201810. | |
| Exhibit 4 - | A copy of existing By-Laws of Deutsche Bank Trust Company Americas, dated March 2, 2023 (see attached). | |
| Exhibit 5 - | Not applicable. | |
| Exhibit 6 - | Consent of Bankers Trust Company required by Section 321(b) of the Act, incorporated herein by reference to Exhibit 6 filed with Form T-1 Statement, Registration No. 333-201810. | |
| Exhibit 7 - | A copy of the latest report of condition of the trustee published pursuant to law or the requirements of its supervising or examining authority. | |
| Exhibit 8 - | Not Applicable. | |
| Exhibit 9 - | Not Applicable. | |
SIGNATURE
Pursuant to the requirements of the Trust Indenture Act of 1939, as amended, the trustee, Deutsche Bank Trust Company Americas, a corporation organized and existing under the laws of the State of New York, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in The City of New York, and State of New York, on this 20th day of March, 2024.
| DEUTSCHE BANK TRUST COMPANY AMERICAS | ||||
| By: | /s/ Irina Golovashchuk | |||
| Name: | Irina Golovashchuk | |||
| Title: | Vice President | |||
Exhibit 4
AMENDED AND RESTATED
BY-LAWS
OF
DEUTSCHE BANK TRUST COMPANY AMERICAS
ARTICLE I
STOCKHOLDERS
Section 1.01. Annual Meeting. The annual meeting of the stockholders of Deutsche Bank Trust Company Americas (the “Company”) shall be held in the City of New York within the State of New York within the first four months of the Company’s fiscal year, on such date and at such time and place as the board of directors of the Company (“Board of Directors” or “Board”) may designate in the call or in a waiver of notice thereof, for the purpose of electing directors and for the transaction of such other business as may properly be brought before the meeting.
Section 1.02. Special Meetings. Special meetings of the stockholders of the Company may be called by the Board of Directors or by the President, and shall be called by the President or by the Secretary upon the written request of the holders of record of at least twenty-five percent (25%) of the shares of stock of the Company issued and outstanding and entitled to vote, at such times. If for a period of thirteen months after the last annual meeting, there is a failure to elect a sufficient number of directors to conduct the business of the Company, the Board of Directors shall call a special meeting for the election of directors within two weeks after the expiration of such period; otherwise, holders of record of ten percent (10%) of the shares of stock of the Company entitled to vote in an election of directors may, in writing, demand the call of a special meeting at the office of the Company for the election of directors, specifying the date and month thereof, but not less than two nor more than three months from the date of such call. At any such special meeting called on demand of stockholders, the stockholders attending, in person or by proxy, and entitled to vote in an election of directors shall constitute a quorum for the purpose of electing directors, but not for the transaction of any other business.
Section 1.03. Notice of Meetings. Notice of the time, place and purpose of every meeting of stockholders shall be delivered personally or mailed not less than 10 nor more than 50 days before the date of such meeting (or any other action) to each stockholder of record entitled to vote, at his post office address appearing upon the records of the Company or at such other address as shall be furnished in writing by him to the Secretary of the Company for such purpose. Such further notice shall be given as may be required by law or by these By-Laws. Any meeting may be held without notice if all stockholders entitled to vote are present in person or by proxy, or if notice is waived in writing, either before or after the meeting, by those not present.
Section 1.04. Quorum. The holders of record of at least a majority of the shares of the stock of the Company issued and outstanding and entitled to vote, present in person or by proxy, shall, except as otherwise provided by law, by the Company’s Organization Certificate or by these By-Laws, constitute a quorum at all meetings of the stockholders; if there be no such quorum, the holders of a majority of such shares so present or represented may adjourn the meeting from time to time until a quorum shall have been obtained.
Section 1.05. Organization of Meetings. Meetings of the stockholders shall be presided over by the Chairman of the Board or, if he is not present, by the President or, if he is not present, by a chairman to be chosen at the meeting. The Secretary of the Company, or in his absence an Assistant Secretary, shall act as secretary of the meeting, if present.
- 1 -
Section 1.06. Voting. At each meeting of stockholders, except as otherwise provided by statute, the Company’s Organization Certificate or these By-Laws, every holder of record of stock entitled to vote shall be entitled to one vote in person or by proxy for each share of such stock standing in his name on the records of the Company. Elections of directors shall be determined by a plurality of the votes cast thereat and, except as otherwise provided by statute, the Company’s Organization Certificate or these By-Laws, all other action shall be determined by a majority of the votes cast at such meeting.
At all elections of directors, the voting shall be by ballot or in such other manner as may be determined by the stockholders present in person or by proxy entitled to vote at such election.
Section 1.07. Action by Consent. Except as may otherwise be provided in the Company’s Organization Certificate, any action required or permitted to be taken at any meeting of stockholders may be taken without a meeting, without prior notice and without a vote if, prior to such action, a written consent or consents thereto, setting forth such action, is signed by all the holders of record of shares of the stock of the Company, issued and outstanding and entitled to vote thereon, having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted.
ARTICLE II
DIRECTORS
Section 2.01. Chairman of the Board. Following the election of the Board of Directors at each annual meeting, the elected Board shall appoint one of its members as Chairman. The Chairman of the Board shall preside at all meetings of the Board of Directors and of the stockholders, and he shall perform such other duties and have such other powers as from time to time may be prescribed by the Board of Directors.
Section 2.02. Lead Independent Director. Following the election of the Board of Directors at each annual meeting, the elected Board may appoint one of its independent members as its Lead Independent Director. When the Chairman of the Board is not present at a meeting of the Board of Directors, the Lead Independent Director, if there be one, shall preside.
Section 2.03. Director Emeritus. The Board of Directors may from time to time elect one or more Directors Emeritus. Each Director Emeritus shall be elected for a term expiring on the date of the regular meeting of the Board of Directors following the next annual meeting. No Director Emeritus shall be considered a “director” for purposes of these By-Laws or for any other purpose.
Section 2.04. Powers, Number, Quorum, Term, Vacancies, Removal. The business and affairs of the Company shall be managed by or under the direction of the Board of Directors which may exercise all such powers of the Company and do all such lawful acts and things as are not by statute or by the Company’s Organization Certificate or by these By-Laws required to be exercised or done by the stockholders.
The number of directors may be changed by a resolution passed by a majority of the members of the Board of Directors or by a vote of the holders of record of at least a majority of the shares of stock of the Company issued and outstanding and entitled to vote, but at all times the Board of Directors must consist of not less than seven nor more than thirty directors. No more than one-third of the directors shall be active officers or employees of the Company. At least one-half of the directors must be citizens of the United States at the time of their election and during their continuance in office.
- 2 -
Except as otherwise required by law, rule or regulation, or by the Company’s Organization Certificate, at all meetings of the Board of Directors or any committee thereof, a majority of the entire Board of Directors or a majority of the directors constituting such committee, as the case may be, shall constitute a quorum for the transaction of business and the act of a majority of the directors or committee members present at any meeting at which there is a quorum shall be the act of the Board of Directors, or such committee, as applicable. Any one or more members of the Board may participate in a meeting of the Board by means of a conference telephone or video, or other similar communications equipment allowing all persons participating in the meeting to hear each other at the same time. Participation by such means shall constitute presence in person at a meeting. Whether or not a quorum shall be present at any meeting of the Board of Directors or a committee thereof, a majority of the directors present thereat may adjourn the meeting from time to time; notice of the adjourned meeting shall be given to the directors who were not present at the time of the adjournment, but if the time and place of the adjourned meeting are announced, no additional notice shall be required to be given to the directors present at the time of adjournment.
Directors shall hold office until the next annual election and until their successors shall have been elected and shall have qualified. Director vacancies not exceeding one-third of the whole number of the Board of Directors may be filled by the affirmative vote of a majority of the directors then in office, and the directors so elected shall hold office for the balance of the unexpired term.
Any one or more of the directors of the Company may be removed either with or without cause at any time by a vote of the holders of record of at least a majority of the shares of stock of the Company, issued and outstanding and entitled to vote, and thereupon the term of the director or directors who shall have been so removed shall forthwith terminate and there shall be a vacancy or vacancies in the Board of Directors, to be filled by a vote of the stockholders as provided in these By-Laws.
Section 2.05. Meetings, Notice. Meetings of the Board of Directors shall be held at such place either within or without the State of New York, as may from time to time be fixed by resolution of the Board, or as may be specified in the call or in a waiver of notice thereof. Regular meetings of the Board of Directors and its Executive Committee shall be held as often as may be required under applicable law, and special meetings may be held at any time upon the call of two directors, the Chairman of the Board or the President, by oral, telegraphic or written notice duly served on or sent or mailed to each director not less than two days before such meeting. Any meeting may be held without notice, if all directors are present, or if notice is waived in writing, either before or after the meeting, by those not present.
Section 2.06. Compensation. The Board of Directors may determine, from time to time, the amount of compensation, which shall be paid to its members. The Board of Directors shall also have power, in its discretion, to allow a fixed sum and expenses for attendance at each regular or special meeting of the Board, or of any committee of the Board. The Board of Directors shall also have power, in its discretion, to provide for and pay to directors rendering services to the Company not ordinarily rendered by directors, as such, special compensation appropriate to the value of such services, as determined by the Board from time to time.
ARTICLE III
COMMITTEES
Section 3.01. Executive Committee. There shall be an Executive Committee of the Board who shall be appointed annually by resolution adopted by the majority of the entire Board of Directors. The Chairman of the Board shall preside at meetings of the Executive Committee. In his absence, the Chief Executive Officer or, in his absence, the President or any Co-President or, in their absence, such other member of the Executive Committee as the Executive Committee from time to time may designate shall preside at such meetings.
- 3 -
Section 3.02. Audit and Fiduciary Committee. There shall be an Audit and Fiduciary Committee appointed annually by resolution adopted by a majority of the entire Board of Directors which shall consist of such number of independent directors, as may from time to time be fixed by the Audit and Fiduciary Committee charter adopted by the Board of Directors.
Section 3.03. Other Committees. The Board of Directors shall have the power to appoint any other Committees as may seem necessary, and from time to time to suspend or continue the powers and duties of such Committees. Each Committee appointed pursuant to this Article shall serve at the pleasure of the Board of Directors.
Section 3.04. Limitations. No committee shall have the authority as to the following matters: (i) the submission to stockholders of any action that needs stockholders’ authorization under New York Banking Law; (ii) the filling of vacancies in the Board of Directors or in any such committee; (iii) the fixing of compensation of the directors for serving on the Board of Directors or on any committee; (iv) the amendment or repeal of these By-Laws, or the adoption of new by-laws; (v) the amendment or repeal of any resolution of the Board of Directors which by its terms shall not be so amendable or repealable; or (vi) the taking of action which is expressly required by any provision of New York Banking Law to be taken at a meeting of the Board of Directors or by a specified proportion of the directors.
ARTICLE IV
OFFICERS
Section 4.01. Titles and Election. The officers of the Company, who shall be chosen by the Board of Directors within twenty-five days after each annual meeting of stockholders, shall be a President, Chief Executive Officer, Chief Risk Officer, Chief Financial Officer, Treasurer, Secretary, and a General Auditor. The Board of Directors from time to time may elect one or more Managing Directors, Directors, Vice Presidents, Assistant Secretaries, Assistant Treasurers and such other officers and agents as it shall deem necessary, and may define their powers and duties. Any number of offices may be held by the same person, except the offices of President and Secretary.
Section 4.02. Terms of Office. Each officer shall hold office for the term for which he is elected or appointed, and until his successor has been elected or appointed and qualified.
Section 4.03. Removal. Any officer may be removed, either with or without cause, at any time, by the affirmative vote of a majority of the Board of Directors.
Section 4.04. Resignations. Any officer may resign at any time by giving written notice to the Board of Directors or to the Secretary. Such resignation shall take effect at the time specified therein and, unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective.
Section 4.05. Vacancies. If the office of any officer or agent becomes vacant by reason of death, resignation, retirement, disqualification, removal from office or otherwise, the Board of Directors may choose a successor, who shall hold office for the unexpired term in respect of which such vacancy occurred.
- 4 -
Section 4.06. President. The President shall have general authority to exercise all the powers necessary for the President of the Company. In the absence of the Chairman and the Lead Independent Director, the President shall preside at all meetings of the Board of Directors and of the stockholders. The President shall have the power to execute bonds, mortgages and other contracts, agreements and instruments of the Company, and he shall perform such other duties and have such other powers as may be incident to the office of the president of a corporation and as from time to time may otherwise be prescribed by the Board of Directors.
Section 4.07. Chief Executive Officer. Unless otherwise determined by the Board of Directors, the President shall be the Chief Executive Officer of the Company. The Chief Executive Officer shall exercise the powers and perform the duties usual to the chief executive officer and, subject to the control of the Board of Directors, shall have general management and control of the affairs and business of the Company; he shall appoint and discharge employees and agents of the Company (other than officers elected by the Board of Directors); he shall see that all orders and resolutions of the Board of Directors are carried into effect; he shall have the power to execute bonds, mortgages and other contracts, agreements and instruments of the Company, and he shall perform such other duties and have such other powers as may be incident to the office of the chief executive officer of a corporation and as from time to time may otherwise be prescribed by the Board of Directors.
Section 4.08. Chief Risk Officer. The Chief Risk Officer shall have the responsibility for the risk management and monitoring of the Company. The Chief Risk Officer shall have the power to execute bonds, notes, mortgages and other contracts, agreements and instruments of the Company, and he shall perform such other duties and have such other powers as may be incident to his office and as from time to time may otherwise be prescribed by the Board of Directors.
Section 4.09. Chief Financial Officer. The Chief Financial Officer shall have the responsibility for reporting to the Board of Directors on the financial condition of the Company, preparing and submitting all financial reports required by applicable law, and preparing annual financial statements of the Company and coordinating with qualified third party auditors to ensure such financial statements are audited in accordance with applicable law.
Section 4.10. Treasurer. The Treasurer shall have the custody of the corporate funds and securities and shall keep full and accurate accounts of receipts and disbursements in books belonging to the Company and shall deposit all moneys, and other valuable effects in the name and to the credit of the Company, in such depositories as may be designated by the Board of Directors. He shall disburse the funds of the Company as may be ordered by the Board, taking proper vouchers for such disbursements, and shall render to the directors whenever they may require it an account of all his transactions as Treasurer and of the financial condition of the Company.
Section 4.11. Secretary. The Secretary shall attend all sessions of the Board of Directors and all meetings of the stockholders and record all votes and the minutes of proceedings in records or books to be kept for that purpose. He shall give, or cause to be given, notice of all meetings of the stockholders and of the Board of Directors and shall perform such other duties and have such other powers as may be incident to the office of the secretary of a corporation and as from time to time may otherwise be prescribed by the Board of Directors. The Secretary shall have and be the custodian of the stock records and all other books, records and papers of the Company (other than financial) and shall see that all books, reports, statements, certificates and other documents and records required by law are properly kept and filed.
- 5 -
Section 4.12. General Auditor. The General Auditor shall be responsible, through the Audit and Fiduciary Committee, to the Board of Directors for the determination of the program of the internal audit function and the evaluation of the adequacy of the system of internal controls. Subject to the Board of Directors, the General Auditor shall have and may exercise all the powers and shall perform all the duties usual to such office and shall have such other powers as may be prescribed or assigned to him from time to time by the Board of Directors or vested in him by law or by these By-Laws. He shall perform such other duties and shall make such investigations, examinations and reports as may be prescribed or required by the Audit and Fiduciary Committee. The General Auditor shall have unrestricted access to all records and premises of the Company and shall delegate such authority to his subordinates. He shall have the duty to report to the Audit and Fiduciary Committee on all matters concerning the internal audit program and the adequacy of the system of internal controls of the Company which he deems advisable or which the Audit and Fiduciary Committee may request.
Section 4.13. Managing Directors, Directors and Vice Presidents. If chosen, the Managing Directors, Directors and Vice Presidents, in the order of their seniority, shall, in the absence or disability of the President, exercise all of the powers and duties of the President. Such Managing Directors, Directors and Vice Presidents shall have the power to execute bonds, notes, mortgages and other contracts, agreements and instruments of the Company, and they shall perform such other duties and have such other powers as may be incident to their respective offices and as from time to time may be prescribed by the Board of Directors or the President.
Section 4.14. Duties of Officers may be Delegated. In case of the absence or disability of any officer of the Company, or for any other reason that the Board may deem sufficient, the Board may delegate, for the time being, the powers or duties, or any of them, of such officer to any other officer.
ARTICLE V
INDEMNIFICATION OF DIRECTORS, OFFICERS AND OTHERS
Section 5.01. Power to Indemnify in Actions, Suits or Proceedings other than Those by or in the Right of the Company. Subject to the other provisions of this Article V, and subject to applicable law, the Company shall indemnify any person made or threatened to be made a party to an action or proceeding (other than one by or in the right of the Company to procure a judgment in its favor), whether civil or criminal, including an action by or in the right of any other corporation of any type or kind, domestic or foreign, or any partnership, joint venture, trust, employee benefit plan or other enterprise, which any director or officer of the Company served in any capacity at the request of the Company, by reason of the fact that such person, his or her testator or intestate, was a director or officer of the Company, or served such other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise in any capacity, against judgments, fines, amounts paid in settlement and reasonable expenses, including attorneys’ fees actually and necessarily incurred as a result of such action or proceeding, or any appeal therein, if such director or officer acted, in good faith, for a purpose which such person reasonably believed to be in, or, in the case of service for any other corporation or any partnership, joint venture, trust, employee benefit plan or other enterprise, not opposed to, the best interests of the Company, and had no reasonable cause to believe that such person’s conduct was unlawful.
Section 5.02. Power to Indemnify in Actions, Suits or Proceedings by or in the Right of the Company. Subject to the other provisions of this Article V, and subject to applicable law, the Company shall indemnify any person made, or threatened to be made, a party to an action by or in the right of the Company to procure a judgment in its favor by reason of the fact that such person, his or her testator or intestate, is or was a director or officer of the Company, or is or was serving at the request of the Company as a director or officer of any other corporation of any type or kind, domestic or foreign, of any partnership, joint venture, trust, employee benefit plan or other enterprise, against amounts paid in settlement and reasonable
- 6 -
expenses, including attorneys’ fees, actually and necessarily incurred by such person in connection with the defense or settlement of such action, or in connection with an appeal therein, if such director or officer acted, in good faith, for a purpose which he reasonably believed to be in, or, in the case of service for any other corporation or any partnership, joint venture, trust, employee benefit plan or other enterprise, not opposed to, the best interests of the Company, except that no indemnification under this Section 5.02 shall be made in respect of (a) a threatened action, or a pending action which is settled or otherwise disposed of, or (b) any claim, issue or matter as to which such person shall have been adjudged to be liable to the Company, unless and only to the extent that the court in which the action was brought, or, if no action was brought, any court of competent jurisdiction, determines upon application that, in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such portion of the settlement amount and expenses as the court deems proper.
Section 5.03. Authorization of Indemnification. Any indemnification under this Article V (unless ordered by a court) shall be made by the Company only if authorized in the specific case (i) by the Board acting by a quorum consisting of directors who are not parties to such action or proceeding upon a finding that the director or officer has met the standard of conduct set forth in Section 5.01 or Section 5.02, as the case may be; or (ii) if a quorum is not obtainable or, even if obtainable, a quorum of disinterested directors so directs, (x) by the Board upon the opinion in writing of independent legal counsel that indemnification is proper in the circumstances because the applicable standard of conduct set forth in Section 5.01 or Section 5.02, as the case may be, has been met by such director or officer; or (y) by the stockholders upon a finding that the director or officer has met the applicable standard of conduct set forth in Section 5.01 or Section 5.02, as the case may be. A person who has been successful on the merits or otherwise, in the defense of a civil or criminal action or proceeding of the character described in Sections 5.01 or 5.02, shall be entitled to indemnification as authorized in such section.
Section 5.04. Good Faith Defined. For purposes of any determination under Section 5.03, a person shall be deemed to have acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Company, or to have had no reasonable cause to believe such person’s conduct was unlawful, if such person’s action is based on the records or books of account of the Company or another enterprise, or on information supplied to such person by the officers of the Company or another enterprise in the course of their duties, or on the advice of legal counsel for the Company or another enterprise or on information or records given or reports made to the Company or another enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by the Company or another enterprise. The provisions of this Section 5.04 shall not be deemed to be exclusive or to limit in any way the circumstances in which a person may be deemed to have met the applicable standard of conduct set forth in Section 5.01 or Section 5.02, as the case may be.
Section 5.05. Serving an Employee Benefit Plan on behalf of the Company. For the purpose of this Article V, the Company shall be deemed to have requested a person to serve an employee benefit plan where the performance by such person of his duties to the Company also imposes duties on, or otherwise involves services by, such person to the plan or participants or beneficiaries of the plan; excise taxes assessed on a person with respect to an employee benefit plan pursuant to applicable law shall be considered fines; and action taken or omitted by a person with respect to an employee benefit plan in the performance of such person’s duties for a purpose reasonably believed by such person to be in the interest of the participants and beneficiaries of the plan shall be deemed to be for a purpose which is not opposed to the best interests of the Company.
- 7 -
Section 5.06. Indemnification upon Application to a Court. Notwithstanding the failure of the Company to provide indemnification and despite any contrary resolution of the Board or stockholders under Section 5.03, or in the event that no determination has been made within ninety days after receipt of the Company of a written claim therefor, upon application to a court by a director or officer, indemnification shall be awarded by a court to the extent authorized in Section 5.01 or Section 5.02. Such application shall be upon notice to the Company. Neither a contrary determination in the specific case under Section 5.03 nor the absence of any determination thereunder shall be a defense to such application or create a presumption that the director or officer seeking indemnification has not met any applicable standard of conduct.
Section 5.07. Expenses Payable in Advance. Subject to the other provisions of this Article V, and subject to applicable law, expenses incurred in defending a civil or criminal action or proceeding may be paid by the Company in advance of the final disposition of such action or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount (i) if it shall ultimately be determined that such person is not entitled to be indemnified by the Company as authorized in this Article V, (ii) where indemnification is granted, to the extent expenses so advanced by the Company or allowed by a court exceed the indemnification to which such person is entitled and (iii) upon such other terms and conditions, if any, as the Company deems appropriate. Any such advancement of expenses shall be made in the sole and absolute discretion of the Company only as authorized in the specific case upon a determination made, with respect to a person who is a director or officer at the time of such determination, (i) by the Board acting by a quorum consisting of directors who are not parties to such action or proceeding, or (ii) if a quorum is not obtainable or, even if obtainable, if a quorum of disinterested directors so directs, (x) by the Board upon the opinion in writing of independent legal counsel or (y) by the stockholders and, with respect to former directors and officers, by any person or persons having the authority to act on the matter on behalf of the Company. Without limiting the foregoing, the Company reserves the right in its sole and absolute discretion to revoke at any time any approval previously granted in respect of any such request for the advancement of expenses or to, in its sole and absolute discretion, impose limits or conditions in respect of any such approval.
Section 5.08. Nonexclusivity of Indemnification and Advancement of Expenses. The indemnification and advancement of expenses granted pursuant to, or provided by, this Article V shall not be deemed exclusive of any other rights to which a director or officer seeking indemnification or advancement of expenses may be entitled whether contained in the Company’s Organization Certificate, these By-Laws or, when authorized by the Organization Certificate or these By-Laws, (i) a resolution of stockholders, (ii) a resolution of directors, or (iii) an agreement providing for such indemnification, provided that no indemnification may be made to or on behalf of any director or officer if a judgment or other final adjudication adverse to the director or officer establishes that his acts were committed in bad faith or were the result of active and deliberate dishonesty and were material to the cause of action so adjudicated, or that he personally gained in fact a financial profit or other advantage to which he was not legally entitled. Nothing contained in this Article V shall affect any rights to indemnification to which corporate personnel other than directors and officers may be entitled by contract or otherwise under law.
Section 5.09. Insurance. Subject to the other provisions of this Article V, the Company may purchase and maintain insurance (in a single contract or supplement thereto, but not in a retrospective rated contract): (i) to indemnify the Company for any obligation which it incurs as a result of the indemnification of directors and officers under the provisions of this Article V, (ii) to indemnify directors and officers in instances in which they may be indemnified by the Company under the provisions of this Article V and applicable law, and (iii) to indemnify directors and officers in instances in which they may not otherwise be indemnified by the Company under the provisions of this Article V, provided the contract of insurance covering such directors and officers provides, in a manner acceptable to the New York Superintendent of Financial Services, for a retention amount and for co-insurance. Notwithstanding the foregoing, any such insurance shall be subject to the provisions of, and the Company shall comply with the requirements set forth in, Section 7023 of the New York State Banking Law.
- 8 -
Section 5.10. Limitations on Indemnification and Insurance. All indemnification and insurance provisions contained in this Article V are subject to any limitations and prohibitions under applicable law, including but not limited to Section 7022 (with respect to indemnification, advancement or allowance) and Section 7023 (with respect to insurance) of the New York State Banking Law and the Federal Deposit Insurance Act (with respect to administrative proceedings or civil actions initiated by any federal banking agency). Notwithstanding anything contained in this Article V to the contrary, no indemnification, advancement or allowance shall be made (i) to or on behalf of any director or officer if a judgment or other final adjudication adverse to the director or officer establishes that his acts were committed in bad faith or were the result of active and deliberate dishonesty and were material to the cause of action so adjudicated, or that he personally gained in fact a financial profit or other advantage to which he was not legally entitled, or (ii) in any circumstance where it appears (a) that the indemnification would be inconsistent with a provision of the Company’s Organization Certificate, these By-Laws, a resolution of the Board or of the stockholders, an agreement or other proper corporate action, in effect at the time of the accrual of the alleged cause of action asserted in the threatened or pending action or proceeding in which the expenses were incurred or other amounts were paid, which prohibits or otherwise limits indemnification; or (b) if there has been a settlement approved by the court, that the indemnification would be inconsistent with any condition with respect to indemnification expressly imposed by the court in approving the settlement.
Notwithstanding anything contained in this Article V to the contrary, but subject to any requirements of applicable law, (i) except for proceedings to enforce rights to indemnification (which shall be governed by Section 5.06), the Company shall not be obligated to indemnify any director or officer (or his testators intestate) or advance expenses in connection with a proceeding (or part thereof) initiated by such person unless such proceeding (or part thereof) was authorized or consented to by the Board of Directors of the Company, (ii) with respect to indemnification or advancement of expenses relating to attorneys’ fees under this Article V, counsel for the present or former director or officer must be reasonably acceptable to the Company (and the Company may, in its sole and absolute discretion, establish a panel of approved law firms for such purpose, out of which the present or former director or officer could be required to select an approved law firm to represent him), (iii) indemnification in respect of amounts paid in settlement shall be subject to the prior consent of the Company (not to be unreasonably withheld), (iv) any and all obligations of the Corporation under this Article V shall be subject to applicable law, (v) in no event shall any payments pursuant to this Article V be made if duplicative of any indemnification or advancement of expenses or other reimbursement available to the applicable director or officer (other than for coverage maintained by such person in his individual capacity), and (vi) no indemnification or advancement of expenses shall be provided under these By-Laws to any person in respect of any expenses, judgments, fines or amounts paid in settlement to the extent incurred by such person in his capacity or position with another entity (including, without limitation, an entity that is a stockholder of the Company or any of the branches or affiliates of such stockholder), except as expressly provided in these By-Laws in respect of such person’s capacity and position as a director or officer of the Company or such person is a director or officer of the Company serving at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise.
Section 5.11. Indemnification of Other Persons. The Company may, to the extent authorized from time to time by the Board of Directors, provide rights to indemnification and to the advancement of expenses (whether pursuant to an adoption of a policy or otherwise) to employees and agents of the Company (whether similar to those conferred in this Article V upon directors and officers of the Company or on other terms and conditions authorized from time to time by the Board of Directors), as well as to employees of direct and indirect subsidiaries of the Company and to other persons (or categories of persons) approved from time to time by the Board of Directors.
- 9 -
Section 5.12. Repeal. Any repeal or modification of this Article V shall not adversely affect any rights to indemnification and to the advancement of expenses of a director, officer, employee or agent of the Company existing at the time of such repeal or modification with respect to any acts or omissions occurring prior to such repeal or modification.
ARTICLE VI
CAPITAL STOCK
Section 6.01. Certificates. The interest of each stockholder of the Company shall be evidenced by certificates for shares of stock in such form as the Board of Directors may from time to time prescribe. The certificates of stock shall be signed by the Chairman of the Board or the President or a Managing Director or a Director or a Vice President and by the Secretary, or the Treasurer, or an Assistant Secretary, or an Assistant Treasurer, sealed with the seal of the Company or a facsimile thereof, and countersigned and registered in such manner, if any, as the Board of Directors may by resolution prescribe. Where any such certificate is countersigned by a transfer agent other than the Company or its employee, or registered by a registrar other than the Company or its employee, the signature of any such officer may be a facsimile signature. In case any officer or officers who shall have signed, or whose facsimile signature or signatures shall have been used on, any such certificate or certificates shall cease to be such officer or officers of the Company, whether because of death, resignation, retirement, disqualification, removal or otherwise, before such certificate or certificates shall have been delivered by the Company, such certificate or certificates may nevertheless be adopted by the Company and be issued and delivered as though the person or persons who signed such certificate or certificates or whose facsimile signature or signatures shall have been used thereon had not ceased to be such officer or officers of the Company.
Section 6.02. Transfer. The shares of stock of the Company shall be transferred only upon the books of the Company by the holder thereof in person or by his attorney, upon surrender for cancellation of certificates for the same number of shares, with an assignment and power of transfer endorsed thereon or attached thereto, duly executed, with such proof of the authenticity of the signature as the Company or its agents may reasonably require.
Section 6.03. Record Dates. The Board of Directors may fix in advance a date, not less than 10 nor more than 50 days preceding the date of any meeting of stockholders, or the date for the payment of any dividend, or the date for the distribution or allotment of any rights, or the date when any change, conversion or exchange of capital stock shall go into effect, as a record date for the determination of the stockholders entitled to notice of, and to vote at, any such meeting, or entitled to receive payment of any such dividend, or to receive any distribution or allotment of such rights, or to exercise the rights in respect of any such change, conversion or exchange of capital stock, and in such case only such stockholders as shall be stockholders of record on the date so fixed shall be entitled to such notice of, and to vote at, such meeting, or to receive payment of such dividend, or to receive such distribution or allotment or rights or to exercise such rights, as the case may be, notwithstanding any transfer of any stock on the books of the Company after any such record date fixed as aforesaid.
Section 6.04. Lost Certificates. In the event that any certificate of stock is lost, stolen, destroyed or mutilated, the Board of Directors may authorize the issuance of a new certificate of the same tenor and for the same number of shares in lieu thereof. The Board may in its discretion, before the issuance of such new certificate, require the owner of the lost, stolen, destroyed or mutilated certificate or the legal representative of the owner to make an affidavit or affirmation setting forth such facts as to the loss, destruction or mutilation as it deems necessary and to give the Company a bond in such reasonable sum as it directs to indemnify the Company.
- 10 -
ARTICLE VII
CHECKS, NOTES, ETC.
Section 7.01. Checks, Notes, Etc. All checks and drafts on the Company’s bank accounts and all bills of exchange and promissory notes, and all acceptances, obligations and other instruments for the payment of money, may be signed by the President or any Managing Director or any Director or any Vice President and may also be signed by such other officer or officers, agent or agents, as shall be thereunto authorized from time to time by the Board of Directors.
ARTICLE VIII
MISCELLANEOUS PROVISIONS
Section 8.01. Fiscal Year. The fiscal year of the Company shall be from January 1 to December 31, unless changed by the Board of Directors.
Section 8.02. Books. There shall be kept at such office of the Company as the Board of Directors shall determine, within or without the State of New York, correct books and records of account of all its business and transactions, minutes of the proceedings of its stockholders, Board of Directors and committees, and the stock book, containing the names and addresses of the stockholders, the number of shares held by them, respectively, and the dates when they respectively became the owners of record thereof, and in which the transfer of stock shall be registered, and such other books and records as the Board of Directors may from time to time determine.
Section 8.03. Voting of Stock. Unless otherwise specifically authorized by the Board of Directors, all stock owned by the Company, other than stock of the Company, shall be voted, in person or by proxy, by the President or any Managing Director or any Director or any Vice President of the Company on behalf of the Company.
ARTICLE IX
AMENDMENTS
Section 9.01. Amendments. The vote of the holders of at least a majority of the shares of stock of the Company issued and outstanding and entitled to vote shall be necessary at any meeting of stockholders to amend or repeal these By-Laws or to adopt new by-laws. These By-Laws may also be amended or repealed, or new by-laws adopted, at any meeting of the Board of Directors by the vote of at least a majority of the entire Board, provided that any by-law adopted by the Board may be amended or repealed by the stockholders in the manner set forth above.
Any proposal to amend or repeal these By-Laws or to adopt new by-laws shall be stated in the notice of the meeting of the Board of Directors or the stockholders or in the waiver of notice thereof, as the case may be, unless all of the directors or the holders of record of all of the shares of stock of the Company issued and outstanding and entitled to vote are present at such meeting.
- 11 -
Exhibit 7
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Board of Governors of the Federal Reserve System OMB Number 7100-0036 Federal Deposit Insurance Corporation OMB Number 3064-0052 Office of the Comptroller of the Currency OMB Number 1557-0081 Approval expires August 31, 2026 Page 1 of 86 Federal Financial Institutions Examination Council Consolidated Reports of Condition and Income for a Bank with Domestic Offices Only—FFIEC 041 Report at the close of business December 31, 2023 20231231 (RCON 9999) This report is required by law: 12 U.S.C. § 324 (State member This report form is to be filed by banks with domestic offices only banks); 12 U.S.C. §1817 (State nonmember banks); 12 U.S.C. §161 and total consolidated assets of less than $100 billion, except (National banks); and 12 U.S.C. §1464 (Savings associations). those banks that file the FFIEC 051, and those banks that are advanced approaches institutions for regulatory capital purposes Unless the context indicates otherwise, the term “bank” in this that are required to file the FFIEC 031. report form refers to both banks and savings associations. NOTE: Each bank’s board of directors and senior management are responsible for establishing and maintaining an effective system of internal control, including controls over the Reports of Condition and Income. The Reports of Condition and Income are to be prepared in accordance with federal regulatory authority instructions. The Reports of Condition and Income must be signed by the Chief Financial Officer (CFO) of the reporting bank (or by the individual performing an equivalent function) and attested to by not less than two directors (trustees) for state nonmember banks and three directors for state member banks, national banks, and savings associations. I, the undersigned CFO (or equivalent) of the named bank, attest that the Reports of Condition and Income (including the supporting Signature of Chief Financial Officer (or Equivalent) 01/30/2024 Date of Signature schedules) for this report date have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true and correct to the best of my knowledge and belief. We, the undersigned directors (trustees), attest to the correctness of the Reports of Condition and Income (including the supporting schedules) for this report date and declare that the Reports of Condition and Income have been examined by us and to the best of our knowledge and belief have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true and correct. Director (Trustee) Director (Trustee) Director (Trustee) Submission of Reports Each bank must file its Reports of Condition and Income (Call To fulfill the signature and attestation requirement for the Reports Report) data by either: of Condition and Income for this report date, attach your bank’s completed signature page (or a photocopy or a computer gener-(a) Using computer software to prepare its Call Report and then ated version of this page) to the hard-copy record of the data file submitting the report data directly to the FFIEC’s Central Data submitted to the CDR that your bank must place in its files. Repository (CDR), an Internet-based system for data collection (https://cdr.ffiec.gov/cdr/), or The appearance of your bank’s hard-copy record of the submitted (b) Completing its Call Report in paper form and arranging with a data file need not match exactly the appearance of the FFIEC’s software vendor or another party to convert the data into the sample report forms, but should show at least the caption of each electronic format that can be processed by the CDR. The Call Report item and the reported amount. software vendor or other party then must electronically submit the bank’s data file to the CDR. DEUTSCHE BANK TRUST COMPANY AMERICAS Legal Title of Bank (RSSD 9017) For technical assistance with submissions to the CDR, please contact the CDR Help Desk by telephone at (888) CDR-3111, by New York fax at (703) 774-3946, or by e-mail at cdr.help@cdr.ffiec.gov. City (RSSD 9130) FDIC Certificate Number 623 NY 10019 (RSSD 9050) State Abbreviation (RSSD 9200) Zip Code (RSSD 9220) Legal Entity Identifier (LEI) 8EWQ2UQKS07AKK8ANH81 (Report only if your institution already has an LEI.) (RCON 9224) The estimated average burden associated with this information collection is 54.60 hours per respondent and is expected to vary by institution, depending on individual circumstances. Burden estimates include the time for reviewing instructions, gathering and maintaining data in the required form, and completing the information collection, but exclude the time for compiling and maintaining business records in the normal course of a respondent’s activities. A Federal agency may not conduct or sponsor, and an organization (or a person) is not required to respond to a collection of information, unless it displays a currently valid OMB control number. Comments concerning the accuracy of this burden estimate and suggestions for reducing this burden should be directed to the Office of Information and Regulatory Affairs, Office of Management and Budget, Washington, DC 20503, and to one of the following: Secretary, Board of Governors of the Federal Reserve System, 20th and C Streets, NW, Washington, DC 20551; Legislative and Regulatory Analysis Division, Office of the Comptroller of the Currency, Washington, DC 20219; Assistant Executive Secretary, Federal Deposit Insurance Corporation, Washington, DC 20429. 12/2023 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 2 of 86 Consolidated Reports of Condition and Income for a Bank with Domestic Offices Only Table of Contents Signature Page...................................................................................................................................................................1 Contact Information.................................................................................................... 3, 4 Report of Income Schedule RI—Income Statement........................................RI-1, 2, 3, 4 Schedule RI-A—Changes in Bank Equity Capital......................RI-5 Schedule RI-B—Charge-offs and Recoveries on Loans and Leases and Changes in Allowances for Credit Losses Part I. Charge-offs and Recoveries on Loans and Leases............................................................................................RI-6, 7 Part II. Changes in Allowances for Credit Losses..................RI-8 Schedule RI-C—Disaggregated Data on the Allowance for Loan and Lease Losses (to be completed only by selected banks) Part I. Disaggregated Data on the Allowance for Loan and Lease Losses......................................................................................RI-9 Part II. Disaggregated Data on the Allowances for Credit Losses..........................................................................................RI-10 Schedule RI-E—Explanations..............................................................................................RI-11, 12 Report of Condition Schedule RC—Balance Sheet.......................................................................................................RC-1, 2 Schedule RC-A—Cash and Balances Due from Depository Institutions (to be completed only by selected banks)...........................RC-3 Schedule RC-B—Securities.............................................RC-3, 4, 5, 6, 7 Schedule RC-C—Loans and Lease Financing Receivables: Part I. Loans and Leases........................RC-8, 9, 10, 11, 12, 13 Part II. Loans to Small Businesses and Small Farms................................................................. RC-14,15 Schedule RC-D—Trading Assets and Liabilities (to be completed only by selected banks)...............................................................................……...............RC-16 Schedule RC-E—Deposit Liabilities ............................... .................................................... RC-17, 18, 19 Schedule RC-F—Other Assets.................................................................................RC-20 Schedule RC-G—Other Liabilities..........................................................................................................................RC-20 Schedule RC-K—Quarterly Averages.......................................................................................................................RC-21, 22 Schedule RC-L—Derivatives and Off-Balance-Sheet Items...................................................RC-23, 24, 25, 26 Schedule RC-M—Memoranda.............................................RC-27, 28, 29 Schedule RC-N—Past Due and Nonaccrual Loans, Leases, and Other Assets.....................RC-30, 31, 32, 33, 34 Schedule RC-O—Other Data for Deposit Insurance Assessments..................RC-35, 36, 37, 38, 39, 40 Schedule RC-P—1–4 Family Residential Mortgage Banking Activities (to be completed only by selected banks)........................................................................................................................................................................RC-41 Schedule RC-Q—Assets and Liabilities Measured at Fair Value on a Recurring Basis (to be completed only by selected banks)..........................................................................................................RC-42, 43, 44 Schedule RC-R—Regulatory Capital: Part I. Regulatory Capital Components and Ratios..........................................................................................RC-45, 46, 47, 48 Part II. Risk-Weighted Assets....................................RC-49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62 Schedule RC-S—Servicing, Securitization, and Asset Sale Activities.................................................RC-63, 64 Schedule RC-T—Fiduciary and Related Services..........................................................RC-65, 66, 67, 68 Schedule RC-V—Variable Interest Entities ....................RC-69 Optional Narrative Statement Concerning the Amounts Reported in the Consolidated Reports of Condition and Income..........................................................................RC-70 For information or assistance, national banks, state nonmember banks, and savings associations should contact the FDIC’s Data Collection and Analysis Section, 550 17th Street, NW, Washington, DC 20429, toll free on (800) 688-FDIC(3342), Monday through Friday between 8:00 a.m. and 5:00 p.m., Eastern Time. State member banks should contact their Federal Reserve District Bank. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 3 of 86 Contact Information for the Reports of Condition and Income To facilitate communication between the Agencies and the bank concerning the Reports of Condition and Income, please provide contact information for (1) the Chief Financial Officer (or equivalent) of the bank signing the reports for this quarter, and (2) the person at the bank —other than the Chief Financial Officer (or equivalent) — to whom questions about the reports should be directed. If the Chief Financial Officer (or equivalent) is the primary contact for questions about the reports, please provide contact information for another person at the bank who will serve as a secondary contact for communications between the Agencies and the bank concerning the Reports of Condition and Income. Enter “none” for the contact’s e-mail address or fax number if not available. Contact information for the Reports of Condition and Income is for the confidential use of the Agencies and will not be released to the public. Chief Financial Officer (or Equivalent) Other Person to Whom Questions about the Signing the Reports Reports Should be Directed Mona Nag Scott Iacono Name (TEXT C490) Name (TEXT C495) CFO Director Title (TEXT C491) Title (TEXT C496) mona.nag@db.com Scott.Iacono@db.com E-mail Address (TEXT C492) E-mail Address (TEXT 4086) 212-250-0302 212-250-8948 Area Code / Phone Number / Extension (TEXT C493) Area Code / Phone Number / Extension (TEXT 8902) 212-797-5376 212-797-5376 Area Code / FAX Number (TEXT C494) Area Code / FAX Number (TEXT 9116) Chief Executive Officer Contact Information This information is being requested so the Agencies can distribute notifications about policy initiatives, deposit insurance assessments, and other matters directly to the Chief Executive Officers of reporting institutions. Notifications about other matters may include emergency notifications that may or may not also be sent to the institution’s emergency contacts listed below. Please provide contact information for the Chief Executive Officer of the reporting institution. Enter “none” for the Chief Executive Officer’s e-mail address or fax number if not available. Chief Executive Officer contact information is for the confidential use of the Agencies and will not be released to the public. Chief Executive Officer Arjun Nagarkatti 442075450031 Name (TEXT FT42) Area Code / Phone Number / Extension (TEXT FT43) arjun.nagarkatti@db.com 212-797-4932 E-mail Address (TEXT FT44) Area Code / FAX Number (TEXT FT45) Emergency Contact Information This information is being requested so the Agencies can distribute critical, time-sensitive information to emergency contacts at banks. Please provide primary contact information for a senior official of the bank who has decision-making authority. Also provide information for a secondary contact if available. Enter “none” for the contact’s e-mail address or fax number if not available. Emergency contact information is for the confidential use of the Agencies and will not be released to the public. Primary Contact Secondary Contact Arjun Nagarkatti Michael Connolly Name (TEXT C366) Name (TEXT C371) Managing Director Managing Director Title (TEXT C367) Title (TEXT C372) Arjun.Nagarkatti@db.com Michael.Connolly@db.com E-mail Address (TEXT C368) E-mail Address (TEXT C373) 442075450031 212-250-1483 Area Code / Phone Number / Extension (TEXT C369) Area Code / Phone Number / Extension (TEXT C374) 212-797-4932 212-797-4932 Area Code / FAX Number (TEXT C370) Area Code / FAX Number (TEXT C375) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 4 of 86 USA PATRIOT Act Section 314(a) Anti-Money Laundering Contact Information This information is being requested to identify points-of-contact who are in charge of your bank’s USA PATRIOT Act Section 314(a) information requests. Bank personnel listed could be contacted by law enforcement officers or the Financial Crimes Enforcement Network (FinCEN) for additional information related to specific Section 314(a) search requests or other anti-terrorist financing and anti-money-laundering matters. Communications sent by FinCEN to the bank for purposes other than Section 314(a) notifications will state the intended purpose and should be directed to the appropriate bank personnel for review. Any disclosure of customer records to law enforcement officers or FinCEN must be done in compliance with applicable law, including the Right to Financial Privacy Act (12 U.S.C. 3401 et seq.). Please provide information for a primary and secondary contact. Information for a third and fourth contact may be provided at the bank’s option. Enter “none” for the contact’s e-mail address if not available. This contact information is for the confidential use of the Agencies, FinCEN, and law enforcement officers and will not be released to the public. Primary Contact Secondary Contact Paul Khareyn Joe Evans Name (TEXT C437) Name (TEXT C442) Director Managing Director Title (TEXT C438) Title (TEXT C443) Paul.Khareyn@db.com Joe.Evans@db.com E-mail Address (TEXT C439) E-mail Address (TEXT C444) 212-250-6774 212-250-1213 Area Code / Phone Number / Extension (TEXT C440) Area Code / Phone Number / Extension (TEXT C445) Third Contact Fourth Contact Hatton Hillin Cristian Ilut Name (TEXT C870) Name (TEXT C875) Assistant Vice President Assistant Vice President Title (TEXT C871) Title (TEXT C876) Hatton.Hillin@db.com Cristian.Ilut@db.com E-mail Address (TEXT C872) E-mail Address (TEXT C877) 904-520-5106 347-863-0715 Area Code / Phone Number / Extension (TEXT C873) Area Code / Phone Number / Extension (TEXT C878) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 5 of 86 RI-1 Consolidated Report of Income for the period January 1, 2023–December 31, 2023 Schedule RI—Income Statement Dollar Amounts in Thousands RIAD Amount 1. Interest income: a. Interest and fee income on loans: (1) Loans secured by real estate: (a) Loans secured by 1–4 family residential properties……………………………………….............................. 4435 80,000 1.a.(1)(a) (b) All other loans secured by real estate……………………………………………………….............................. 4436 290,000 1.a.(1)(b) (2) Commercial and industrial loans…………………………………………………………………......................... 4012 122,000 1.a.(2) (3) Loans to individuals for household, family, and other personal expenditures: (a) Credit cards………………………………………………………………………………………….................... B485 0 1.a.(3)(a) (b) Other (includes revolving credit plans other than credit cards, automobile loans, and other consumer loans)……………………………………………………………………..……………………….................. B486 21,000 1.a.(3)(b) (4) Not applicable All other loans 4058 (5) (1)…………………………………………………………............................................................ 436,000 1.a.(5) (6) Total interest and fee income on loans (sum of items 1.a.(1)(a) through 1.a.(5))…………………........................... 4010 949,000 1.a.(6) b. Income from lease financing receivables……………………………………..………..….………............................ 4065 0 1.b. . Interest income on balances due from depository institutions 4115 c (2)……………………………………..................... 712,000 1.c. d. Interest and dividend income on securities: (1) U.S. Treasury securities and U.S. Government agency obligations (excluding mortgage-backed securities)………………………………………………………………………………........................ B488 5,000 1.d.(1) (2) Mortgage-backed securities………………………………………………………………………………......................... B489 0 1.d.(2) (3) All other securities (includes securities issued by states and political subdivisions in the U.S.)……………………………………………………………………………………………....…......................... 4060 0 1.d.(3) e. Not applicable f. Interest income on federal funds sold and securities purchased under agreements to resell………….............. 4020 306,000 1.f. g. Other interest income………………………………………………………………………………............................... 4518 5,000 1.g. h. Total interest income (sum of items 1.a.(6) through 1.g)…………………………………………........................... 4107 1,977,000 1.h. 2. Interest expense: a. Interest on deposits: (1) Transaction accounts (interest-bearing demand deposits, NOW accounts, ATS accounts, and telephone and preauthorized transfer accounts)………………………………………………………………............................ 4508 545,000 2.a.(1) (2) Nontransaction accounts: (a) Savings deposits (includes MMDAs)………………………………………………….............................. 0093 82,000 2.a.(2)(a) (b) Time deposits of $250,000 or less………………………………………………………............................. HK03 0 2.a.(2)(b) (c) Time deposits of more than $250,000………………………………………………………………................. HK04 7,000 2.a.(2)(c) b. Expense of federal funds purchased and securities sold under agreements to repurchase…………............... 4180 0 2.b. c. Interest on trading liabilities and other borrowed money…………………………………...………....................... 4185 29,000 2.c. d. Interest on subordinated notes and debentures............................................................................................................................................................................................. 4200 0 2.d. e. Total interest expense (sum of items 2.a through 2.d)............................................................................................................................................... 4073 663,000 2.e. 3. Net interest income (item 1.h minus 2.e)....................................................................................................................... 4074 1,314,000 3. . Provision for loan and lease losses JJ33 4 (3)..................................................................................................................... (2,000) 4. __________ 1. Includes interest and fee income on “Loans to depository institutions and acceptances of other banks,” “Loans to finance agricultural production and other loans to farmers,” “Obligations (other than securities and leases) of states and political subdivisions in the U.S.,” and “Loans to nondepository financial institutions and other loans.” 2. Includes interest income on time certificates of deposit not held for trading. 3. Institutions that have adopted ASU 2016-13 should report in item 4 the provisions for credit losses on all financial assets and off-balance-sheet credit exposures that fall within the scope of the standard. 12/2023 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 6 of 86 RI-2 Schedule RI—Continued Year-to-date Dollar Amounts in Thousands RIAD Amount 5. Noninterest income: . Income from fiduciary activities 4070 a (1).................................................................................................................................................... 279,000 5.a. b. Service charges on deposit accounts...................................................................................................................……………………………. 4080 140,000 5.b. c. Trading revenue.................................................................................................................................................................…………. A220 0 5.c. d. Income from securities-related and insurance activities: (1)Fees and commissions from securities brokerage..........................................................................................................................................… C886 0 5.d.(1) (2)Investment banking, advisory, and underwriting fees and commissions C888 0 5.d.(2) (3)Fees and commissions from annuity sales.......................................................................................................................................... C887 0 5.d.(3) (4)Underwriting income from insurance and reinsurance activities.......................................................................................................................................... C386 0 5.d.(4) (5)Income from other insurance activities................................................................................................................... C387 0 5.d.(5) e. Venture capital revenue........................................................................................................................................................................................ B491 0 5.e. f. Net servicing fees.................................................................................................................................................................… B492 0 5.f. g. Net securitization income..........................................................................................................................................................................................................................…........… B493 0 5.g. h. Not applicable i. Net gains (losses) on sales of loans and leases....................................................................................................................................… 5416 0 5.i. j. Net gains (losses) on sales of other real estate owned....................................................................................................................................… 5415 0 5.j. . Net gains (losses) on sales of other assets B496 k (2)....................................................................................................................................… 0 5.k. l. Other noninterest income*..............................................................................................................................................................................................................................................… B497 139,000 5.l. m.Total noninterest income (sum of items 5.a through 5.l)………………….…..…..…………….. 4079 558,000 5.m. 6. a. Realized gains (losses) on held-to-maturity securities………………………………..………… 3521 0 6.a. b. Realized gains (losses) on available-for-sale debt securities………………..…..…………………… 3196 0 6.b. 7. Noninterest expense: a. Salaries and employee benefits 4135 122,000 7.a. b. Expenses of premises and fixed assets (net of rental income) (excluding salaries and employee benefits and mortgage interest)....................................................................................................................................… 4217 28,000 7.b. c. (1)Goodwill impairment losses....................................................................................................................................… C216 0 7.c.(1) (2)Amortization expense and impairment losses for other intangible assets....................................................................................................................................… C232 2,000 7.c.(2) d. Other noninterest expense*....................................................................................................................................… 4092 873,000 7.d. e. Total noninterest expense (sum of items 7.a through 7.d)....................................................................................................................................… 4093 1,025,000 7.e. 8. a. Income (loss) before change in net unrealized holding gains (losses) on equity securities not held for trading, applicable income taxes, and discontinued operations (item 3 plus or minus items 4, 5.m, 6.a, 6.b, and 7.e)……..…..…………………………..… HT69 849,000 8.a. b. Change in net unrealized holding gains (losses) on equity securities held for trading HT70 not (3)..…..…………………………..…..…………………………..…..……………………..…..…………………………..…..…………………………..…..…………………… 1,000 8.b c. Income (loss) before applicable income taxes and discontinued operations (sum of items 8.a and 8.b)……..…..…………………………..…..…………………………..…..…………………… 4301 850,000 8.c. 9. Applicable income taxes (on item 8.c)....................................................................................................................................… 4302 219,000 9. 10. Income (loss) before discontinued operations (item 8.c minus item 9)......................................................................................... 4300 631,000 10. 11. Discontinued operations, net of applicable income taxes*........................................................................................................... FT28 0 11. 12. Net income (loss) attributable to bank and noncontrolling (minority) interests (sum of items 10 and 11)....................................................................................................................................… G104 631,000 12. 13. LESS: Net income (loss) attributable to noncontrolling (minority) interests (if net income, report as a positive value; if net loss, report as a negative value)....................................................................................................................................…....................................................................................................................................… G103 0 13. 14. Net income (loss) attributable to bank (item 12 minus item 13)....................................................................................................................................… 4340 631,000 14. __________ * Describe on Schedule RI-E—Explanations. 1. For banks required to complete Schedule RC-T, items 14 through 22, income from fiduciary activities reported in Schedule RI, item 5.a, must equal the amount reported in Schedule RC-T, item 22. 2. Exclude net gains (losses) on sales of trading assets and held-to-maturity and available-for-sale debt securities. 3. Item 8.b is to be completed by all institutions. See the instructions for this item and the Glossary entry for “Securities Activities” for further detail on accounting for investments in equity securities. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 7 of 86 Schedule RI—Continued RI-3 Memoranda Year-to-date Dollar Amounts in Thousands RIAD Amount 1. Interest expense incurred to carry tax-exempt securities, loans, and leases acquired after August 7, 1986, that is not deductible for federal income tax purposes…………………………………................ 4513 0 M.1. Memorandum item 2 is to be completed by banks with $1 billion or more in total assets (1) 2. Income from the sale and servicing of mutual funds and annuities (included in Schedule RI, item 8)……………………………………………………………………………………..................................................... 8431 0 M.2. 3. Income on tax-exempt loans and leases to states and political subdivisions in the U.S. (included in Schedule RI, items 1.a and 1.b)………………………………………………………………………................................... 4313 0 M.3. 4. Income on tax-exempt securities issued by states and political subdivisions in the U.S. (included in Schedule RI, item 1.d.(3))…………………………………………………………………………….................................... 4507 0 M.4. 5. Number of full-time equivalent employees at end of current period Number (round to nearest whole number)………………………………………………………………………………………………………................................... 4150 384 M.5. Memorandum item 6 is to be completed by: (1) • banks with $300 million or more in total assets, and • banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans 6. Interest and fee income on loans to finance agricultural production and other loans to farmers Amount (included in Schedule RI, item 1.a.(5))......................................................................................................................... 4024 0 M.6. 7. If the reporting institution has applied push down accounting this calendar year, report the date RIAD Date the institution’s acquisition (see instructions) 9106 of (2)…………………………......................………..................................... 00000000 M.7. 8. Not applicable Memorandum items 9.a and 9.b are to be completed by banks with $10 billion or more in total assets. (1) 9. Net gains (losses) recognized in earnings on credit derivatives that economically hedge credit exposures held outside the trading account: Amount a. Net gains (losses) on credit derivatives held for trading…………………………………………………….................................. C889 0 M.9.a. b. Net gains (losses) on credit derivatives held for purposes other than trading……………………………................................. C890 0 M.9.b. Memorandum item 10 is to be completed by banks with $300 million or more in total assets. (1) 10. Credit losses on derivatives (see instructions)…………………………………………………………………................................. A251 0 M.10. 11. Does the reporting bank have a Subchapter S election in effect for federal income tax purposes RIAD Yes No for the current tax year?................................................................................................................................................ A530 x M.11. 12. Not applicable __________ 1. The asset-size tests and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 2. Report the date in YYYYMMDD format. For example, a bank acquired on March 1, 2023, would report 20230301. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 8 of 86 Schedule RI—Continued RI-4 Memoranda—Continued Dollar Amounts in Thousands Year-to-date RIAD Amount Memorandum item 13 is to be completed by banks that have elected to account for assets and liabilities under a fair value option. 13. Net gains (losses) recognized in earnings on assets and liabilities that are reported at fair value under a fair value option: a. Net gains (losses) on assets............................................................................................................................................................ F551 0 M.13.a. (1) Estimated net gains (losses) on loans attributable to changes in instrument-specific credit risk................................................................................................................................................................................ F552 0 M.13.a.(1) b. Net gains (losses) on liabilities............................................................................................................................................................ F553 0 M.13.b. (1) Estimated net gains (losses) on liabilities attributable to changes in instrument-specific credit risk................................................................................................................................................................................ F554 0 M.13.b.(1) 14. Other-than-temporary impairment losses on held-to-maturity and available-for-sale debt recognized in earnings (included in Schedule RI, items 6.a and 6.b) J321 securities (1)................................................................................................... NA M.14. Memorandum item 15 is to be completed by institutions with $1 billion or more in total assets (2) that answered “Yes” to Schedule RC-E, Memorandum item 5. 15. Components of service charges on deposit accounts (sum of Memorandum items 15.a through 15.d must equal Schedule RI, item 5.b): a. Consumer overdraft-related service charges levied on those transaction account and nontransaction savings account deposit products intended primarily for individuals for personal, household, or family use H032 NA M.15.a. b. Consumer account periodic maintenance charges levied on those transaction account and nontransaction savings account deposit products intended primarily for individuals for personal, household, or family use H033 NA M.15.b. c. Consumer customer automated teller machine (ATM) fees levied on those transaction account and nontransaction savings account deposit products intended primarily for individuals for personal, household, or family use H034 NA M.15.c. d. All other service charges on deposit accounts ................................................................................................................................................................................................ H035 NA M.15.d. 1. Memorandum item 14 is to be completed only by institutions that have not adopted ASU 2016-13. 2. The $1 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 9 of 86 RI-5 Schedule RI-A—Changes in Bank Equity Capital RIAD Amount Dollar Amounts in Thousands 1. Total bank equity capital most recently reported for the December 31, 2022, Reports of Condition and Income (i.e., after adjustments from amended Reports of Income) 3217 9,479,000 1. 2. Cumulative effect of changes in accounting principles and corrections of material accounting errors*............................................................................................................................................................................................................. B507 0 2. 3. Balance end of previous calendar year as restated (sum of items 1 and 2) B508 9,479,000 3. 4. Net income (loss) attributable to bank (must equal Schedule RI, item 14) 4340 631,000 4. 5. Sale, conversion, acquisition, or retirement of capital stock, net (excluding treasury stock transactions)............................................................................................................................................................ B509 (4,000) 5. 6. Treasury stock transactions, net............................................................................................................................................................ B510 0 6. 7. Changes incident to business combinations, net............................................................................................................................................................ 4356 0 7. 8. LESS: Cash dividends declared on preferred stock............................................................................................................................................................ 4470 0 8. 9. LESS: Cash dividends declared on common stock............................................................................................................................................................ 4460 456,000 9. . Other comprehensive income B511 10 (1)............................................................................................................................................................ 15,000 10. 11. Other transactions with stockholders (including a parent holding company)* (not included in items 5, 6, 8, or 9 above)............................................................................................................................................................ 4415 0 11. 12. Total bank equity capital end of current period (sum of items 3 through 11) (must equal Schedule RC, item 27.a)............................................................................................................................................................ 3210 9,665,000 12. __________ * Describe on Schedule RI-E—Explanations. 1. Includes, but is not limited to, changes in net unrealized holding gains (losses) on available-for-sale debt securities, changes in accumulated net gains (losses) on cash flow hedges, and pension and other postretirement plan-related changes other than net periodic benefit cost. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 10 of 86 Schedule RI-B—Charge-offs and Recoveries on Loans and Leases RI-6 and Changes in Allowances for Credit Losses Part I. Charge-offs and Recoveries on Loans and Leases Part I includes charge-offs and recoveries through (Column A) (Column B) the allocated transfer risk reserve. Charge-offs (1) Recoveries Calendar Year-to-date Dollar Amounts in Thousands RIAD Amount RIAD Amount 1. Loans secured by real estate: a. Construction, land development, and other land loans: (1) 1–4 family residential construction loans………………………………............................. C891 0 C892 0 1.a.(1) (2) Other construction loans and all land development and other land loans………………………………………………………………….............................. C893 0 C894 0 1.a.(2) b. Secured by farmland …………………………………….............................................................. 3584 0 3585 0 1.b. c. Secured by 1–4 family residential properties: (1) Revolving, open-end loans secured by 1–4 family residential properties and extended under lines of credit…………………………............................ 5411 0 5412 0 1.c.(1) (2) Closed-end loans secured by 1–4 family residential properties: (a) Secured by first liens…………………………………………………......................... C234 0 C217 2,000 1.c.(2)(a) (b) Secured by junior liens……………………………………………….......................... C235 0 C218 0 1.c.(2)(b) d. Secured by multifamily (5 or more) residential properties………………………………………………………………… 3588 0 3589 0 1.d. e. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties…………………………………………………………………................................ C895 0 C896 0 1.e.(1) (2) Loans secured by other nonfarm nonresidential properties........................................ C897 0 C898 0 1.e.(2) 2. and 3. Not applicable 4. Commercial and industrial loans………………………………………………………… 4638 0 4608 0 4. 5. Loans to individuals for household, family, and other personal expenditures: a. Credit cards…................................................................................................................................................... B514 0 B515 0 5.a. b. Automobile loans…................................................................................................................................................... K129 0 K133 0 5.b. c. Other (includes revolving credit plans other than credit cards and other consumer loans)…................................................................................................................................................... K205 0 K206 0 5.c. 6. Not applicable . All other loans 4644 4628 7 (2)…................................................................................................................................................... 0 0 7. 8. Lease financing receivables…................................................................................................................................................... 4266 0 4267 0 8. 9. Total (sum of items 1 through 8)…................................................................................................................................................... 4635 0 4605 2,000 9. 1. Include write-downs arising from transfers of loans to a held-for-sale account. 2. Includes charge-offs and recoveries on ”Loans to depository institutions and acceptances of other banks,“ “Loans to finance agricultural production and other loans to farmers,” “Obligations (other than securities and leases) of states and political subdivisions in the U.S.,” and “Loans to nondepository financial institutions and other loans.” 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 11 of 86 RI-7 Schedule RI-B—Continued Memoranda (Column A) (Column B) Charge-offs (1) Recoveries Calendar Year-to-date RIAD Amount RIAD Amount Dollar Amounts in Thousands 1. Loans to finance commercial real estate, construction, and land development activities (not secured by real estate) included in Schedule RI-B, Part I, items 4 and 7, above…................................................................................................................................................... 5409 0 5410 0 M.1. 2. Memorandum items 2.a. through 2.d. are to be completed by banks with $300 million or more in total assets: (2) a. Loans secured by real estate to non-U.S. addressees (domicile) (included in Schedule RI-B, Part I, item 1, above)…................................................................................................................................................... 4652 0 4662 0 M.2.a. b. Not applicable c. Commercial and industrial loans to non-U.S. addressees (domicile) (included in Schedule RI-B, Part I, item 4 above) ......................................................... 4646 0 4618 0 M.2.c. d. Leases to individuals for household, family, and other personal expenditures (included in Schedule RI-B, Part I, item 8, above)…................................................................................................................................................... F185 0 F187 0 M.2.d. Memorandum item 3 is to be completed by: (2) • banks with $300 million or more in total assets, and • banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans: 3. Loans to finance agricultural production and other loans to farmers (included in Schedule RI-B, Part I, item 7, above) ......................................................... 4655 0 4665 0 M.3. Memorandum item 4 is to be completed by banks that (1) together with affiliated institutions, have outstanding credit card receivables (as defined in the instructions) that exceed $500 million as of the report date, or (2) are credit card specialty banks as defined for Uniform Bank Performance Report purposes. Calendar Year-to-date 4. Uncollectible retail credit card fees and finance charges reversed against income RIAD Amount .e., not included in charge-offs against the allowance for loan and lease losses) C388 . (i (3) NA M.4 __________ 1. Include write-downs arising from transfers of loans to a held-for-sale account. 2. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 3. Institutions that have adopted ASU 2016-13 should report in Memorandum item 4 uncollectible retail credit card fees and finance charges reversed against income (i.e., not included in charge-offs against the allowance for credit losses on loans and leases). 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 12 of 86 RI-8 Schedule RI-B—Continued Part II. Changes in Allowances for Credit Losses (1) (Column A) (Column B) (Column C) Loans and Leases Held Held-to-Maturity Available-for-Sale for Investment Debt Securities (2) Debt Securities (2) Dollar Amounts in Thousands RIAD Amount RIAD Amount RIAD Amount 1. Balance most recently reported for the December 31, 2022, Reports of Condition and Income (i.e., after adjustments from amended Reports of Income)........................................................................................................................................ B522 16,000 JH88 0 JH94 0 1. 2. Recoveries (column A must equal Part I, item 9, column B, above) .......................................................................................................................... 4605 2,000 JH89 0 JH95 0 2. 3. LESS: Charge-offs (column A must equal Part I, item 9, column A, above less Schedule RI-B, Part II, item 4, column A) ..................................................................................................................................................................................................................... C079 0 JH92 0 JH98 0 3. 4. LESS: Write-downs arising from transfers of assets 5523 JJ00 JJ01 financial (3).............................................................................................................................................................................................................0 0 0 4. 5. Provisions for credit losses (4, 5)........................................................................................................................................................................ 4230 (2,000) JH90 0 JH96 0 5. 6. Adjustments* (see instructions for this schedule) C233 0 JH91 0 JH97 0 6. 7. Balance end of current period (sum of items 1, 2, 5, and 6, less items 3 and 4) (column A must equal Schedule RC, item 4.c).................................................................................................................................................................. 3123 16,000 JH93 0 JH99 0 7. * Describe on Schedule RI-E—Explanations. 1. Institutions that have not adopted ASU 2016-13 should report changes in the allowance for loan and lease losses in column A. 2. Columns B and C are to be completed only by institutions that have adopted ASU 2016-13. 3. Institutions that have not yet adopted ASU 2016-13 should report write-downs arising from transfers of loans to a held-for-sale account in item 4, column A. 4. Institutions that have not yet adopted ASU 2016-13 should report the provision for loan and lease losses in item 5, column A, and the amount reported must equal Schedule RI, item 4. 5. For institutions that have adopted ASU 2016-13, the sum of item 5, columns A through C, plus schedule RI-B, Part II, Memorandum items 5 and 7, below, must equal Schedule RI, item 4. Memoranda Dollar Amounts in Thousands RIAD Amount 1. Allocated transfer risk reserve included in Schedule RI-B, Part II, item 7,column A, above...................................................................................................................... C435 0 M.1. Memorandum items 2 and 3 are to be completed by banks that (1) together with affiliated institutions, have outstanding credit card receivables (as defined in the instructions) that exceed $500 million as of the report date, or (2) are credit card specialty banks as defined for Uniform Bank Performance Report purposes. 2. Separate valuation allowance for uncollectible retail credit card fees and finance charges......................................................................................... C389 NA M.2. 3. Amount of allowance for loan and lease losses attributable to retail credit card fees and finance C390 charges (1).................................................................................................................................................................................................................................... NA M.3. 4. Amount of allowance for post-acquisition credit losses on purchased credit-impaired loans accounted for in accordance with FASB ASC 310-30 (former AICPA Statement of Position 03-3) in Schedule RI-B, Part II, item 7, column A , above) C781 (included (2).............................................................................................................................................................................. NA M.4. 5. Provisions for credit losses on other financial assets measured at amortized cost (not included in 5, above) JJ02 item (3) 0 M.5. 6. Allowance for credit losses on other financial assets measured at amortized cost (not included in RCON 7, above) JJ03 item (3) 0 M.6. RIAD 7. Provisions for credit losses on off-balance-sheet credit exposures MG93 (3)....................................................................................................................................................................... 0 M.7. 8. Estimated amount of expected recoveries of amounts previously written off included within the allowance for credit losses on loans and leases held for investment (included in item 7, column A, end of current period,” above) MG94 “Balance (3)....................................................................................................................................................................... 0 M.8. 1. Institutions that have adopted ASU 2016-13 should report in Memorandum item 3 the amount of allowance for credit losses on loans and leases attributable to retail credit card fees and finance changes. 2. Memorandum item 4 is to be completed only by institutions that have not yet adopted ASU 2016-13. 3. Memorandum items 5, 6, 7, and 8 are to be completed only by institutions that have adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RI-C—Disaggregated Data on the Allowance for Loan and Lease Losses FFIEC 041 Page 13 of 86 RI-9 Part I. Disaggregated Data on the Allowance for Loan and Lease Losses (1) Schedule RI-C. Part I, is to be completed by institutions with $1 billion or more in total assets. (2) (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) Recorded Investment: Allowance Balance: Recorded Investment: Allowance Balance: Recorded Investment: Allowance Balance: Individually Evaluated Individually Evaluated Collectively Evaluated Collectively Evaluated Purchased Purchased for Impairment and for Impairment and for Impairment for Impairment Credit-Impaired Loans Credit-Impaired Loans Determined to be Impaired Determined to be Impaired (ASC 450-20) (ASC 450-20) (ASC 310-30) (ASC 310-30) (ASC 310-10-35) (ASC 310-10-35) Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount RCON Amount RCON Amount Real estate loans: a. Construction loans………………………………………………………………………….............. M708 NA M709 NA M710 NA M711 NA M712 NA M713 NA 1.a. b. Commercial real estate loans………………………………………………………………………….............. M714 NA M715 NA M716 NA M717 NA M719 NA M720 NA 1.b. c. Residential real estate loans………………………………………………………………………….............. M721 NA M722 NA M723 NA M724 NA M725 NA M726 NA 1.c. M727 M728 M729 M730 M731 M732 Commercial loans (3)………………………………………………………………………….............. NA NA NA NA NA NA 2. Credit cards………………………………………………………………………….............. M733 NA M734 NA M735 NA M736 NA M737 NA M738 NA 3. Other consumer loans………………………………………………………………………….............. M739 NA M740 NA M741 NA M742 NA M743 NA M744 NA 4. Unallocated, if any………………………………………………………………………….............. M745 NA 5. Total (sum of . through 5) M746 M747 M748 M749 M750 M751 items 1.a (4)………………………………………………………………………….............. NA NA NA NA NA NA 6. 1. Only institutions that have not yet adopted ASU 2016-13 are to complete Schedule RI-C, Part I. 2. The $1 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 3. Include all loans and leases not reported as real estate loans, credit cards, or other consumer loans in items 1, 3, or 4 of Schedule RI-C. 4. The sum of item 6, columns B, D, and F, must equal Schedule RC, item 4.c. Item 6, column E, must equal Schedule RC-C, Part I, Memorandum item 7.b. Item 6, column F, must equal Schedule RI-B, Part II, Memorandum item 4. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 14 of 86 RI-10 Schedule RI-C—Continued Part II. Disaggregated Data on the Allowances for Credit Losses (1) Schedule RI-C, Part II, is to be completed by institutions with $1 billion or more in total assets. (2) (Column A) (Column B) Amortized Cost Allowance Balance Dollar Amounts in Thousands RCON Amount RCON Amount Loans and Leases Held for Investment: 1. Real estate loans: a. Construction loans.................................................................................................... JJ04 77,000 JJ12 0 1.a. b. Commercial real estate loans................................................................................................ JJ05 4,452,000 JJ13 3,000 1.b. c. Residential real estate loans................................................................................................ JJ06 2,194,000 JJ14 4,000 1.c. . JJ07 JJ15 2 Commercial loans (3)................................................................................................................................................................................... 9,317,000 8,000 2. 3. Credit cards................................................................................................................................................ JJ08 0 JJ16 0 3. 4. Other consumer loans................................................................................................................................................ JJ09 307,000 JJ17 1,000 4. 5. Unallocated, if any................................................................................................................................................ JJ18 0 5. . Total (sum of items 1 a. through 5) JJ11 JJ19 6 . (4)................................................................................................................................... 16,347,000 16,000 6. Allowance Balance Dollar Amounts in Thousands RCON Amount Held-to-Maturity Securities: 7. Securities issued by states and political subdivisions in the U.S.................................................................... JJ20 0 7. 8. Mortgage-backed securities (MBS) (including CMOs, REMICs, and stripped MBS) JJ21 0 8. 9. Asset-backed securities and structured financial products JJ23 0 9. 10. Other debt securities JJ24 0 10. 11. Total (sum of items 7 through 10) JJ25 (5) 0 11. 1. Only institutions that have adopted ASU 2016-13 are to complete Schedule RI-C, Part II. 2. The $1 billion asset-size test is based on the total assets reported on theJune 30, 2022, Report of Condition. 3. Include all loans and leases not reported as real estate loans, credit cards, or other consumer loans in items 1, 3, or 4 of Schedule RI-C, Part II. 4. Item 6, column B, must equal Schedule RC, item 4.c. 5. Item 11 must equal Schedule RI-B, Part II, item 7, column B. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 15 of 86 RI-11 Schedule RI-E—Explanations Schedule RI-E is to be completed each quarter on a calendar year-to-date basis. Detail all adjustments in Schedule RI-A and RI-B, all discontinued operations in Schedule RI, and all significant items of other noninterest income and other noninterest expense in Schedule RI. (See instructions for details.) Year-to-date Dollar Amounts in Thousands RIAD Amount 1. Other noninterest income (from Schedule RI, item 5.l) Itemize and describe amounts greater than $100,000 that exceed 7 percent of Schedule RI, item 5.l: a. Income and fees from the printing and sale of checks............................................................................................................................................ C013 0 1.a. b. Earnings on/increase in value of cash surrender value of life insurance.................................................................................... C014 0 1.b. c. Income and fees from automated teller machines (ATMs)................................................................................................................ C016 0 1.c. d. Rent and other income from other real estate owned................................................................................................................ 4042 0 1.d. e. Safe deposit box rent........................................................................................................................................................................ C015 0 1.e. f. Bank card and credit card interchange fees................................................................................................................ F555 0 1.f. g. Income and fees from wire transfers not reportable as service charges on deposit accounts……………….T047 0 1.g. TEXT 4461 h. 4461 Revenue from Services rendered to affiliates 165,000 1.h. . TEXT 4462 . i 4462 Net gains (losses) on non-trading derivatives (59,000) 1.i TEXT 4463 j. 4463 Commissions and fees 30,000 1.j. 2. Other noninterest expense (from Schedule RI, item 7.d) Itemize and describe amounts greater than $100,000 that exceed 7 percent of Schedule RI, item 7.d: a. Data processing expenses………………………………………………….…………………………………………............. C017 0 2.a. b. Advertising and marketing expenses………………………………………………….……….……………………................ 0497 0 2.b. c. Directors’ fees………………………………………………….……….………………………………………………............. 4136 0 2.c. d. Printing, stationery, and supplies………………………………………………….……….…………………………............... C018 0 2.d. e. Postage………………………………………………….……….………………………………………………….…................... 8403 0 2.e. f. Legal fees and expenses………………………………………………….……….………………………………….............. 4141 0 2.f. g. FDIC deposit insurance assessments………………………………………………….……….…………………….............. 4146 0 2.g. h. Accounting and auditing expenses………………………………………………….……….………………………................ F556 0 2.h. i. Consulting and advisory expenses………………………………………………….……….……………………….............. F557 0 2.i. j. Automated teller machine (ATM) and interchange expenses………………………………………………….……................. F558 0 2.j. k. Telecommunications expenses………………………………………………….……….……………………………................. F559 0 2.k. l. Other real estate owned expenses..................................................................................................................................... Y923 0 2.l. m. Insurance expenses (not included in employee expenses, premises and fixed asset expenses, and other real estate owned expenses)................................................................................................................................................................................ Y924 0 2.m. . TEXT 4464 . n 4464 Services rendered by affiliates 627,000 2.n o. TEXT 4467 4467 Litigation Expenses 98,000 2.o. p. TEXT 4468 p 4468 0 2. . 3. Discontinued operations and applicable income tax effect (from Schedule RI, item 11) (itemize and describe each discontinued operation): TEXT FT29 a. (1) FT29 0 3.a.(1) (2) Applicable income tax effect………………………………………………….................................. FT30 0 3.a.(2) TEXT FT31 b. (1) FT31 0 3.b.(1) (2) Applicable income tax effect…………………………………………………................................... FT32 0 3.b.(2) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 16 of 86 RI-12 Schedule RI-E—Continued Year-to-date Dollar Amounts in Thousands RIAD Amount 4. Cumulative effect of changes in accounting principles and corrections of material accounting errors (from Schedule RI-A, item 2) (itemize and describe all such effects): a. Effect of adoption of current expected credit losses methodology—ASU 2016-13 (1, 2).............................................................. JJ26 NA 4.a. b. Not applicable TEXT c. B526 . B526 0 4.c TEXT d. B527 d B527 0 4. . 5. Other transactions with stockholders (including a parent holding company) (from Schedule RI-A, item 11) (itemize and describe all such transactions): TEXT a. 4498 . 4498 0 5.a TEXT b. 4499 b 4499 0 5. . 6. Adjustments to allowances for credit losses (3) (from Schedule RI-B, Part II, item 6) (itemize and describe all adjustments): a. Initial allowances for credit losses recognized upon the acquisition of purchased credit-deteriorated assets on or after the effective date of ASU 2016-13 (1).......................................................... JJ27 NA 6.a. b. Effect of adoption of current expected credit losses methodology on allowances for losses JJ28 credit (1, 2)........................................................................................................................................................................................................... 0 6.b. TEXT c. 4521 c 4521 0 6. . TEXT d. 4522 d 4522 0 6. . 7. Other explanations (the space below is provided for the bank to briefly describe, at its option, any other significant items affecting the Report of Income): RIAD Yes No Comments?.................................................................................................................................................................. 4769 x 7. Other explanations (please type or print clearly; 750 character limit): (TEXT 4769) 1. Only institutions that have adopted ASU 2016-13 should report amounts in items 4.a, 6.a, and 6.b, if applicable. 2. An institution should complete item 4.a and item 6.b in the quarter that it adopts ASU 2016-13 and in the quarter-end Call Reports for the remainder of that calendar year only. 3. Institutions that have not adopted ASU 2016-13 should report adjustments to the allowance for loan and lease losses in items 6.c and 6.d, if applicable. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 17 of 86 RC-1 Consolidated Report of Condition for Insured Banks and Savings Associations for December 31, 2023 All schedules are to be reported in thousands of dollars. Unless otherwise indicated, report the amount outstanding as of the last business day of the quarter. Schedule RC—Balance Sheet Dollar Amounts in Thousands RCON Amount Assets 1. Cash and balances due from depository institutions (from Schedule RC-A): . Noninterest-bearing balances and currency and coin 0081 a (1)…………………………….…….…........................ 41,000 1.a. . Interest-bearing balances 0071 b (2)……………………………………………………….................................... 13,556,000 1.b. 2. Securities: a. Held-to-maturity securities (from Schedule RC-B, column A) JJ34 (3)……………………………............................... 0 2.a. b. Available-for-sale debt securities (from Schedule RC-B, column D)…………………….……................................... 1773 378,000 2.b. . Equity securities with readily determinable fair values not held for trading JA22 c (4)…………………………. 0 2.c. 3. Federal funds sold and securities purchased under agreements to resell: a. Federal funds sold………………………………………………………......................................................... B987 0 3.a. . Securities purchased under agreements to resell B989 b (5, 6)………………………….......................................... 5,923,000 3.b. 4. Loans and lease financing receivables (from Schedule RC-C): a. Loans and leases held for sale………………………………………………………..……................................... 5369 0 4.a. b. Loans and leases held for investment……………….................................... B528 16,347,000 4.b. c. LESS: Allowance for loan and lease losses……………....................................... 3123 16,000 4.c. . Loans and leases held for investment, net of allowance (item 4.b minus 4.c) B529 d (7)………............................... 16,331,000 4.d. 5. Trading assets (from Schedule RC-D)…………………………………………………….…….................................. 3545 0 5. 6. Premises and fixed assets (including capitalized leases)…………………………………….................................. 2145 0 6. 7. Other real estate owned (from Schedule RC-M)………………………………………………............................... 2150 4,000 7. 8. Investments in unconsolidated subsidiaries and associated companies……………………............................... 2130 0 8. 9. Direct and indirect investments in real estate ventures...................................……...................................... 3656 0 9. 10. Intangible assets (from Schedule RC-M)………………………………………………………………………………………………………… 2143 2,000 10. . Other assets (from Schedule RC-F) 2160 11 (6)…………………………………………………………….................................. 2,490,000 11. 12. Total assets (sum of items 1 through 11)………………………………………………………....................................... 2170 38,725,000 12. Liabilities 13. Deposits: a. In domestic offices (sum of totals of columns A and C from Schedule RC-E)………………………………................... 2200 26,278,000 13.a. -bearing 6631 (1) Noninterest (8)………………………………………………..………….. 9,337,000 13.a.(1) (2) Interest-bearing……………………………………………………..…………….. 6636 16,941,000 13.a.(2) b. Not applicable 14. Federal funds purchased and securities sold under agreements to repurchase: . Federal funds purchased B993 a (9)………………………………………..…………......................................... 0 14.a. .. Securities sold under agreements to repurchase B995 b (10)………………………………………………..................................... 0 14.b. 15. Trading liabilities (from Schedule RC-D)…………………………………………………..………….............................................. 3548 0 15. 16. Other borrowed money (includes mortgage indebtedness) (from Schedule RC-M)................................. 3190 0 16. 17. and 18. Not applicable 19 Subordinated notes and debentures 3200 . (11)……………………………………………………………………..……………….................. 0 19. __________ 1. Includes cash items in process of collection and unposted debits. 2. Includes time certificates of deposit not held for trading. 3. Institutions that have adopted ASU 2016-13 should report in item 2.a amounts net of any applicable allowance for credit losses, and item 2.a should equal Schedule RC-B, item 8, column A, less Schedule RI-B, Part II, item 7, column B. 4. Item 2.c is to be completed by all institutions. See the instructions for this item and the Glossary entry for “Securities Activities” for further detail on accounting for investments in equity securities. 5. Includes all securities resale agreements, regardless of maturity. 6. Institutions that have adopted ASU 2016-13 should report in items 3.b and 11 amounts net of any applicable allowance for credit losses. 7. Institutions that have adopted ASU 2016-13 should report in item 4.c the allowance for credit losses on loans and leases. 8. Includes noninterest-bearing demand, time, and savings deposits. 9. Report overnight Federal Home Loan Bank advances in Schedule RC, item 16, “Other borrowed money.” 10. Includes all securities repurchase agreements, regardless of maturity. 11. Includes limited-life preferred stock and related surplus. 12/2023 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 18 of 86 RC-2 Schedule RC—Continued Dollar Amounts in Thousands RCON Amount Liabilities—continued 20. Other liabilities (from Schedule RC-G)…………………………………………………………………….………………..................... 2930 2,782,000 20. 21. Total liabilities (sum of items 13 through 20)……………………………………………………………………………….................. 2948 29,060,000 21. 22. Not applicable Equity Capital Bank Equity Capital 23. Perpetual preferred stock and related surplus…………………………………………………………………………….............. 3838 0 23. 24. Common stock……………………………………………………………………………………………….……………….............. 3230 2,127,000 24. 25. Surplus (exclude all surplus related to preferred stock)………………………………………………..………………............... 3839 935,000 25. 26. a.Retained earnings………………………………………………………………………………………..………………............... 3632 6,637,000 26.a. .Accumulated other comprehensive income B530 b (1)………………………………………………………….………………...................... (34,000) 26.b. . Other equity capital components A130 c (2)………………………………………………………………………………………................. 0 26.c. 27. a.Total bank equity capital (sum of items 23 through 26.c)…………………………………………………..…………....................... 3210 9,665,000 27.a. b.Noncontrolling (minority) interests in consolidated subsidiaries…………………………………….……............................ 3000 0 27.b. 28. Total equity capital (sum of items 27.a and 27.b)………………………………………………………..…………....................... G105 9,665,000 28. 29. Total liabilities and equity capital (sum of items 21 and 28)……………………………………………..……….......................... 3300 38,725,000 29. Memoranda To be reported with the March Report of Condition. 1. Indicate in the box at the right the number of the statement below that best describes the most comprehensive level of auditing work performed for the bank by independent external auditors as of RCON Number any date during 2022……………………………………………………………………………………......................... 6724 NA M.1. 1a = An integrated audit of the reporting institution’s financial statements and its internal control over financial reporting conducted in accordance with the standards of the American Institute of Certified Public Accountants (AICPA) or Public Company Accounting Oversight Board (PCAOB) by an independent public accountant that submits a report on the institution 1b =An audit of the reporting institution’s financial statements only conducted in accordance with the auditing standards of the AICPA or the PCAOB by an independent public accountant that submits a report on the institution 2a =An integrated audit of the reporting institution’s parent holding company’s consolidated financial statements and its internal control over financial reporting conducted in accordance with the standards of the AICPA or the PCAOB by an independent public accountant that submits a report on the consolidated holding company (but not on the institution separately) 2b = 3 = 4 = 5 = 6 = 7 = 8 = 9 = An audit of the reporting institution’s parent holding company’s consolidated financial statements only conducted in accordance with the auditing standards of the AICPA or the PCAOB by an independent public accountant that submits a report on the consolidated holding company (but not on the institution separately) This number is not to be used Directors’ examination of the bank conducted in accordance with generally accepted auditing standards by a certified public accounting firm (may be required by state-chartering authority) Directors’ examination of the bank performed by other external auditors (may be required by state-chartering authority) Review of the bank’s financial statements by external auditors Compilation of the bank’s financial statements by external auditors Other audit procedures (excluding tax preparation work) No external audit work To be reported with the March Report of Condition. RCON Date 2. Bank’s fiscal year-end date (report the date in MMDD format)............................................................................................................................................................... 8678 NA M.2. 1. Includes, but is not limited to, net unrealized holding gains (losses) on available-for-sale securities, accumulated net gains (losses) on cash flow hedges, and accumulated defined benefit pension and other postretirement plan adjustments. 2. Includes treasury stock and unearned Employee Stock Ownership Plan shares. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 19 of 86 RC-3 Schedule RC-A—Cash and Balances Due from Depository Institutions Schedule RC-A is to be completed only by banks with $300 million or more in total assets. (1) Exclude assets held for trading. Dollar Amounts in Thousands RCON Amount 1. Cash items in process of collection, unposted debits, and currency and coin: a. Cash items in process of collection and unposted debits...................................................................................... 0020 41,000 1.a. b. Currency and coin............................................................................................................................................................. 0080 0 1.b. 2. Balances due from depository institutions in the U.S............................................................................................... 0082 3,000 2. 3. Balances due from banks in foreign countries and foreign central banks........................................................................................ 0070 0 3. 4. Balances due from Federal Reserve Banks......................................................................................................................... 0090 13,553,000 4. 5. Total (sum of items 1 through 4) (must equal Schedule RC, sum of items 1.a and 1.b)…........................................ 0010 13,597,000 5. __________ 1. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. Schedule RC-B—Securities Exclude assets held for trading. Held-to-maturity Available-for-sale (Column A) (Column B) (Column C) (Column D) Amortized Cost Fair Value Amortized Cost Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount 1. U.S. Treasury securities……................. 0211 0 0213 0 1286 423,000 1287 378,000 1. 2. U.S. Government agency and sponsored agency obligations (exclude mort—backed securities) ………………… HT50 0 HT51 0 HT52 HT53 gage (1) 0 0 2. 3. Securities issued by states and political subdivisions in the U.S 8496 0 8497 0 8498 0 8499 0 3. 1. Includes Small Business Administration “Guaranteed Loan Pool Certificates”; U.S. Maritime Administration obligations; Export-Import Bank participation certificates; and obligations (other than mortgage-backed securities) issued by the Farm Credit System, the Federal Home Loan Bank System, the Federal Home Loan Mortgage Corporation, the Federal National Mortgage Association, the Resolution Funding Corporation, the Student Loan Marketing Association, and the Tennessee Valley Authority. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 20 of 86 RC-4 Schedule RC-B—Continued Held-to-maturity Available-for-sale (Column A) (Column B) (Column C) (Column D) Amortized Cost Fair Value Amortized Cost Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount 4. Mortgage-backed securities (MBS): a. Residential mortgage pass-through securities: (1) Guaranteed by GNMA…………………..……......................... G300 0 G301 0 G302 0 G303 0 4.a.(1) (2) Issued by FNMA and FHLMC…………………........................ G304 0 G305 0 G306 0 G307 0 4.a.(2) (3) Other pass-through securities…………….................... G308 0 G309 0 G310 0 G311 0 4.a.(3) b. Other residential mortgage-backed securities (include CMOs, REMICs, and stripped MBS): (1) Issued or guaranteed by U.S. Government agencies or sponsored G312 G313 G314 G315 agencies (1) ………………………………………………………… 0 0 0 0 4.b.(1) (2) Collateralized by MBS issued or guaranteed by U.S. Government agencies or sponsored G316 G317 G318 G319 agencies (1) ..................................................................... 0 0 0 0 4.b.(2) (3) All other residential MBS................................................. G320 0 G321 0 G322 0 G323 0 4.b.(3) c. Commercial MBS (1) Commercial mortgage pass-through securities: (a) Issued or guaranteed by FNMA, FHLMC, or GNMA…………………… K142 0 K143 0 K144 0 K145 0 4.c.(1)(a) (b) Other pass-through securities………… K146 0 K147 0 K148 0 K149 0 4.c.(1)(b) 1. U.S. Government agencies include, but are not limited to, such agencies as the Government National Mortgage Association (GNMA), the Federal Deposit Insurance Corporation (FDIC), and the National Credit Union Administration (NCUA). U.S. Government-sponsored agencies include, but are not limited to, such agencies as the Federal Home Loan Mortgage Corporation (FHLMC) and the Federal National Mortgage Association (FNMA). 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 21 of 86 RC-5 Schedule RC-B—Continued Held-to-maturity Available-for-sale (Column A) (Column B) (Column C) (Column D) Amortized Cost Fair Value Amortized Cost Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount 4. c.(2) Other commercial MBS: (a) Issued or guaranteed by U.S. Government agencies or sponsored .................................... K150 K151 K152 K153 agencies (1) 0 0 0 0 4.c.(2)(a) (b) All other commercial MBS……………………………….. K154 0 K155 0 K156 0 K157 0 4.c.(2)(b) 5. Asset-backed securities and structured financial products: a. Asset-backed securities (ABS)..............……..…........................ C026 0 C988 0 C989 0 C027 0 5.a. b. Structured financial products………………………………… HT58 0 HT59 0 HT60 0 HT61 0 5.b. 6. Other debt securities: a. Other domestic debt securities………………….…….......................... 1737 0 1738 0 1739 0 1741 0 6.a. b. Other foreign debt securities………………….…….......................... 1742 0 1743 0 1744 0 1746 0 6.b. 7. Unallocated portfolio layer fair value hedge adjustments MG95 basis (2)..……………………………………… NA 7. 8. Total (sum of items 1 1754 1771 1772 1773 through 7) (3)..……………………………………… 0 0 423,000 378,000 8. 1. U.S. Government agencies include, but are not limited to, such agencies as the Government National Mortgage Association (GNMA), the Federal Deposit Insurance Corporation (FDIC), and the National Credit Union Administration (NCUA). U.S. Government-sponsored agencies include, but are not limited to, such agencies as the Federal Home Loan Mortgage Corporation (FHLMC) and the Federal National Mortgage Association (FNMA). 2. This item is to be completed by institutions that have adopted ASU 2022-01, as applicable. 3. For institutions that have adopted ASU 2016-13, the total reported in column A must equal Schedule RC, item 2.a, plus Schedule RI-B, Part II, item 7, column B. For institutions that have not adopted ASU 2016-13, the total reported in column A must equal Schedule RC, item 2.a. For all institutions, the total reported in column D must equal Schedule RC, item 2.b. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 22 of 86 RC-6 Schedule RC-B—Continued Memoranda Dollar Amounts in Thousands RCON Amount . Pledged securities 0416 1 (1)…………………………………………………………………………………………………………............................ 0 M.1. 2. Maturity and repricing data for debt securities (excluding those in nonaccrual status): a. Securities issued by the U.S. Treasury, U.S. Government agencies, and states and political subdivisions in the U.S.; other non-mortgage debt securities; and mortgage pass-through securities other than those backed by closed-end first lien 1–4 family residential mortgages with a remaining maturity or next repricing date of: (2), (3) (1) Three months or less……………………………………………………………………………………………………………………… A549 0 M.2.a.(1) (2) Over three months through 12 months…………………………………………………………….………………………………………… A550 0 M.2.a.(2) (3) Over one year through three years………………………………………………………………..…………………………………………… A551 0 M.2.a.(3) (4) Over three years through five years……………………………………………………………………………………………………… A552 378,000 M.2.a.(4) (5) Over five years through 15 years………………………………………………………………….…………………………………………… A553 0 M.2.a.(5) (6) Over 15 years………………………………………………………………………………………………………………………… A554 0 M.2.a.(6) b. Mortgage pass-through securities backed by closed-end first lien 1–4 family residential mortgages with a remaining maturity or next repricing date of: (2), (4) (1) Three months or less………………………………………………………………………………………………………………………………… A555 0 M.2.b.(1) (2) Over three months through 12 months…………………………………………………………….……………………………………………… A556 0 M.2.b.(2) (3) Over one year through three years………………………………………………………………..…………………………………………… A557 0 M.2.b.(3) (4) Over three years through five years……………………………………………………………….…………………………………………… A558 0 M.2.b.(4) (5) Over five years through 15 years………………………………………………………………….…………………………………… A559 0 M.2.b.(5) (6) Over 15 years…………………………………………………………………………………………………………………………………… A560 0 M.2.b.(6) c. Other mortgage-backed securities (include CMOs, REMICs, and stripped MBS; exclude mortgage pass-through securities) with an expected average life of: (5) (1) Three years or less…………………………………………………………………………………..……………………………………… A561 0 M.2.c.(1) (2) Over three years……………………………………………………………………………………..…………………………………… A562 0 M.2.c.(2) d. Debt securities with a REMAINING MATURITY of one year or less (included in Memorandum items 2.a through 2.c above)………………………………………………………………………………............... A248 0 M.2.d. Memorandum item 3 is to be completed semiannually in the June and December reports only. 3. Amortized cost of held-to-maturity securities sold or transferred to available-for-sale or trading securities during the calendar year-to-date (report the amortized cost at date of sale or transfer)…………………….................. 1778 0 M.3. 4. Structured notes (included in the held-to-maturity and available-for-sale accounts in Schedule RC-B, items 2, 3, 5, and 6): a. Amortized cost……………………………………………………………………………………………………………….............. 8782 0 M.4.a. b. Fair value………………………………………………………………………………………………….………………….................. 8783 0 M.4.b. 1. Includes held-to-maturity securities at amortized cost, available-for-sale debt securities at fair value, and equity securities with readily determinable fair values not held for trading (reported in Schedule RC, item 2.c) at fair value. 2. Report fixed-rate debt securities by remaining maturity and floating-rate debt securities by next repricing date. 3. Sum of Memorandum items 2.a.(1) through 2.a.(6) plus any nonaccrual debt securities in the categories of debt securities reported in Memorandum item 2.a that are included in Schedule RC-N, item 10, column C, must equal Schedule RC-B, sum of items 1, 2, 3, 4.c.(1), 5, and 6, columns A and D, plus residential mortgage pass-through securities other than those backed by closed-end first lien 1–4 family residential mortgages included in Schedule RC-B, item 4.a, columns A and D. 4. Sum of Memorandum items 2.b.(1) through 2.b.(6) plus any nonaccrual mortgage pass-through securities backed by closed-end first lien 1–4 family residential mortgages included in Schedule RC-N, item 10, column C, must equal Schedule RC-B, item 4.a, sum of columns A and D, less the amount of residential mortgage pass-through securities other than those backed by closed-end first lien 1–4 family residential mortgages included in Schedule RC-B, item 4.a, columns A and D. 5. Sum of Memorandum items 2.c.(1) and 2.c.(2) plus any nonaccrual “Other mortgage-backed securities” included in Schedule RC-N, item 10, column C, must equal Schedule RC-B, sum of items 4.b and 4.c.(2), columns A and D. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 23 of 86 RC-7 Schedule RC-B—Continued Memoranda—Continued Held-to-maturity Available-for-sale (Column A) (Column B) (Column C) (Column D) Amortized Cost Fair Value Amortized Cost Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount Memorandum items 5.a through 5.f and 6.a through 6.g are to be completed by banks with $10 billion or more in total assets. (1) 5. Asset-backed securities (ABS) (for each column, sum of Memorandum items 5.a through 5.f must equal Schedule RC-B, item 5.a): a. Credit card receivables……………….……................ B838 0 B839 0 B840 0 B841 0 M.5.a. b. Home equity lines………………................. B842 0 B843 0 B844 0 B845 0 M.5.b. c. Automobile loans………….……................ B846 0 B847 0 B848 0 B849 0 M.5.c. d. Other consumer loans……………………................. B850 0 B851 0 B852 0 B853 0 M.5.d. e. Commercial and industrial loans…………….……............. B854 0 B855 0 B856 0 B857 0 M.5.e. f. Other………………………..……............... B858 0 B859 0 B860 0 B861 0 M.5.f. 6. Structured financial products by underlying collateral or reference assets (for each column, sum of Memorandum items 6.a through 6.g must equal Schedule RC-B, item 5.b: a. Trust preferred securities issued by financial institutions................................. G348 0 G349 0 G350 0 G351 0 M.6.a. b. Trust preferred securities issued by real estate investment trusts..................................... G352 0 G353 0 G354 0 G355 0 M.6.b. c. Corporate and similar loans........................................... G356 0 G357 0 G358 0 G359 0 M.6.c. d. 1-4 family residential MBS issued or guaranteed by U.S. Government-sponsored enterprises (GSEs)............................... G360 0 G361 0 G362 0 G363 0 M.6.d. e. 1-4 family residential MBS not issued or guaranteed by GSEs................................ G364 0 G365 0 G366 0 G367 0 M.6.e. f. Diversified (mixed) pools of structured financial products.................................. G368 0 G369 0 G370 0 G371 0 M.6.f. g. Other collateral or reference assets.................................... G372 0 G373 0 G374 0 G375 0 M.6.g. 1. The $10 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RC-C—Loans and Lease Financing Receivables FFIEC 041 Page 24 of 86 RC-8 Part I. Loans and Leases Do not deduct the allowance for loan and lease losses or the allocated transfer risk reserve from amounts reported in this schedule.(1) Report (1) loans and leases held for sale at the lower of cost or fair value, (2) loans and leases held for investment, net of unearned income, and (3) loans and leases accounted for at fair value under a fair value option. Exclude assets held for trading and commercial paper. (Column A) (Column B) To Be Completed To Be Completed by Banks with by All Banks $300 Million or More in Total Assets (2) Dollar Amounts in Thousands RCON Amount RCON Amount 1. Loans secured by real estate: a. Construction, land development, and other land loans: (1) 1–4 family residential construction loans…………………..……………….................. F158 0 1.a.(1) (2) Other construction loans and all land development and other land loans………………………………………….……………………………………….…………………………….. F159 77,000 1.a.(2) b. Secured by farmland (including farm residential and other improvements)……………………………………………………………………...…. 1420 0 1.b. c. Secured by 1–4 family residential properties: (1) Revolving, open-end loans secured by 1–4 family residential properties and extended under lines of credit…………………………....…............ 1797 264,000 1.c.(1) (2) Closed-end loans secured by 1–4 family residential properties: (a) Secured by first liens……………………………………….……………………….……………………………………….……………………………… 5367 1,898,000 1.c.(2)(a) (b) Secured by junior liens…………………………………………………….....…………………………… 5368 32,000 1.c.(2)(b) d. Secured by multifamily (5 or more) residential properties…………………........................ 1460 2,100,000 1.d. e. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties………………………………………………………………………………….……………………………………….………………………….….. F160 0 1.e.(1) (2) Loans secured by other nonfarm nonresidential properties…………………………………………… F161 2,352,000 1.e.(2) 2. Loans to depository institutions and acceptances of other banks…………………………………………….. 1288 1,065,000 2. a. To commercial banks in the U.S. …………………………….…………......................... B531 1,000 2.a. b. To other depository institutions in the U.S…………………………….…………............... B534 0 2.b. c. To banks in foreign countries B535 1,064,000 2.c. 3. Loans to finance agricultural production and other loans to farmers……………................. 1590 0 3. 4. Commercial and industrial loans………………………………………….……………………………………….……………………………………………..….... 1766 3,016,000 4. a. To U.S. addressees (domicile)………………………………………………….……………………………………….……………………………………..….... 1763 2,819,000 4.a. b. To non-U.S. addressees (domicile)………………………………….………….................1764 197,000 4.b. 5. Not applicable 6. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper): a. Credit cards………………………………………..…………..……………………................ B538 0 6.a. b. Other revolving credit plans…………………………………………….……………………………………….…………………………………………………….. B539 0 6.b. c. Automobile loans…………………………………………………………….………………….…………………..…........... K137 0 6.c. d. Other consumer loans (includes single payment and installment, loans other than automobile loans, and all student loans)………………………………………………….….………..…… K207 307,000 6.d. 7. Not applicable 8. Obligations (other than securities and leases) of states and political subdivisions in the U.S………………………………………………….……………………………………….……………………………………………………..... 2107 0 8. 1. Institutions that have adopted ASU 2016-13 should not deduct the allowance for credit losses on loans and leases or the allocated transfer risk reserve from amounts reported on this schedule. 2. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 25 of 86 RC-9 Schedule RC-C—Continued Part I—Continued (Column A) (Column B) To Be Completed To Be Completed by Banks with by All Banks $300 Million or More in Total Assets (1) Dollar Amounts in Thousands RCON Amount RCON Amount 9. Loans to nondepository financial institutions and other loans: a. Loans to nondepository financial institutions…………………………….............. J454 58,000 9.a. b. Other loans……………………………………………………………………....................... J464 5,178,000 9.b. (1) Loans for purchasing or carrying securities (secured and unsecured) ...................................................................................................................................................................................... 1545 2,302,000 9.b.(1) (2) All other loans (exclude consumer loans)................................................................................... J451 2,876,000 9.b.(2) 10. Lease financing receivables (net of unearned income).................................................. 2165 0 10. a. Leases to individuals for household, family, and other personal expenditures (i.e., consumer leases)……………………………................................. F162 0 10.a. b. All other leases………………………………………………………………............ F163 0 10.b. 11. LESS: Any unearned income on loans reflected in items 1-9 above.................................................... 2123 0 11. 12. Total loans and leases held for investment and held for sale (sum of items 1 through 10 minus item 11) (must equal Schedule RC, sum of items 4.a and 4.b)…...............…...............…...............…..... 2122 16,347,000 12. Memoranda Dollar Amounts in Thousands RCON Amount 1. Loans restructured in troubled debt restructurings that are in compliance with their modified terms (included in Schedule RC-C, Part I, and not reported as past due or nonaccrual in Schedule RC-N, Memorandum item 1): a. Construction, land development, and other land loans: (1) 1—4 family residential construction loans…………………………………………………...…………. K158 0 M.1.a.(1) (2) Other construction loans and all land development and other land loans…………………………………………………………………………………………. K159 0 M.1.a.(2) b. Loans secured by 1—4 family residential properties……………………...…………………………………………………………………………………… F576 0 M.1.b. c. Secured by multifamily (5 or more) residential properties……………………………………………………………………. K160 0 M.1.c. d. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties………………………………………………. K161 0 M.1.d.(1) (2) Loans secured by other nonfarm nonresidential properties………………………………………………………. K162 0 M.1.d.(2) e. Commercial and industrial loans……………………………………………………………..………………………………………. K256 0 M.1.e. Memorandum items 1.e.(1) and (2) are to be completed by banks with $300 million or more in total assets (1) (sum of Memorandum items 1.e(1) and (2) must equal Memorandum item 1.e): (1) To U.S. addressees (domicile)…………………………………..…................... K163 0 M.1.e.(1) (2) To non-U.S. addressees (domicile).................................................................................................................................. K164 0 M.1.e.(2) f. All other loans ( include loans to individuals for household, family, and other personal expenditures)……………………………………………………………………………………………………………… K165 0 M.1.f. Itemize loan categories included in Memorandum item 1.f, above that exceed 10 percent of total loans restructured in troubled debt restructurings that are in compliance with their modified terms (sum of Memorandum items 1.a through 1.e plus 1.f): (1) Loans secured by farmland…………………………………………………………………..……………..……..…… K166 0 M.1.f.(1) (2) and (3) Not applicable 1. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 26 of 86 Schedule RC-C—Continued RC-10 Part I—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount RCON Amount 1. f. (4) Loans to individuals for household, family, and other personal expenditures: (a) Credit cards……………..……………………………………………………………………………………............... K098 0 M.1.f.(4)(a) (b) Automobile loans…………………………………………………………………………………………….......................... K203 0 M.1.f.(4)(b) (c) Other (includes revolving credit plans other than credit cards and other consumer loans).................................................................................................................................................................................. K204 0 M.1.f.(4)(c) Memorandum item 1.f.(5) is to be completed by: (1) • Banks with $300 million or more in total assets • Banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans (5) Loans to finance agricultural production and other loans to farmers included in Schedule RC-C, Part I, Memorandum item 1.f, above……………………………………………………………………………. K168 0 M.1.f.(5) g.Total loans restructured in troubled debt restructurings that are in compliance with their modified terms (sum of Memorandum items 1.a.(1) through 1.e plus 1.f)………………………………………………………………………………………… HK25 0 M.1.g. 2. Maturity and repricing data for loans and leases (excluding those in nonaccrual status): a. Closed-end loans secured by first liens on 1–4 family residential properties (reported in Schedule RC-C, Part I, item 1.c.(2)(a), column B) with a remaining maturity or next repricing date of: (2), (3) (1) Three months or less………………………………………………………………………………………................................. A564 56,000 M.2.a.(1) (2) Over three months through 12 months……………………………………………………………………................................ A565 222,000 M.2.a.(2) (3) Over one year through three years……………………………………………………………………….................................. A566 222,000 M.2.a.(3) (4) Over three years through five years……………………………………………………………………........................................ A567 184,000 M.2.a.(4) (5) Over five years through 15 years………………………………………………………………………….................................. A568 876,000 M.2.a.(5) (6) Over 15 years………………………………………………………………………………………………......................................... A569 316,000 M.2.a.(6) b. All loans and leases (reported in Schedule RC-C, Part I, items 1 through 10, column B above) EXCLUDING closed-end loans secured by first liens on 1–4 family residential properties (reported in Schedule RC-C, Part I, item 1.c.(2)(a), column B, above) with a remaining maturity or next repricing date of: (2) , (4) (1) Three months or less…………………………………………………………………………........................................................... A570 13,412,000 M.2.b.(1) (2) Over three months through 12 months……………………….…………………………………....................................... A571 742,000 M.2.b.(2) (3) Over one year through three years……………….…………………………………........................................................ A572 5,000 M.2.b.(3) (4) Over three years through five years……………………...………………………………................................................. A573 11,000 M.2.b.(4) (5) Over five years through 15 years………………………………………………………………......................................... A574 13,000 M.2.b.(5) (6) Over 15 years………………………………………………………………………………....................................…………………………….................................... A575 262,000 M.2.b.(6) c. Loans and leases (reported in Schedule RC-C, Part I, items 1 through 10, column B, above) with a REMAINING MATURITY of one year or less (excluding those in nonaccrual status)………………................................................ A247 14,137,000 M.2.c. 1. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on theJune 30, 2022, Report of Condition. 2. Report fixed-rate loans and leases by remaining maturity and floating rate loans by next repricing date. 3. Sum of Memorandum items 2.a.(1) through 2.a.(6) plus total nonaccrual closed-end loans secured by first liens on 1–4 family residential properties included in Schedule RC-N, item 1.c.(2)(a), column C, must equal total closed-end loans secured by first liens on 1–4 family residential properties from Schedule RC-C, Part I, item 1.c.(2)(a), column B. 4. Sum of Memorandum items 2.b.(1) through 2.b.(6), plus total nonaccrual loans and leases from Schedule RC-N, item 9, column C, minus nonaccrual closed-end loans secured by first liens on 1–4 family residential properties included in Schedule RC-N, item 1.c.(2)(a), column C, must equal total loans and leases from Schedule RC-C, Part I, sum of items 1 through 10, column B, minus total closed-end loans secured by first liens on 1–4 family residential properties from Schedule RC-C, Part I, item 1.c.(2)(a), column B. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 27 of 86 RC-11 Schedule RC-C—Continued Part I—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount 3. Loans to finance commercial real estate, construction, and land development activities (not secured by real estate) included in Schedule RC-C, Part I, items 4 and 9, column B (1) 2746 52,000 M.3. 4. Adjustable-rate closed-end loans secured by first liens on 1–4 family residential properties (included in Schedule RC-C, Part I, item 1.c.(2)(a), column B)……………………………….......................................... 5370 1,887,000 M.4. 5. To be completed by banks with $300 million or more in total assets: (2) Loans secured by real estate to non-U.S. addressees (domicile) (included in Schedule RC-C, Part I, items 1.a through 1.e, column B) B837 108,000 M.5. Memorandum item 6 is to be completed by banks that (1) together with affiliated institutions, have outstanding credit card receivables (as defined in the instructions) that exceed $500 million as of the report date or (2) are credit card specialty banks as defined for Uniform Bank Performance Report purposes. 6. Outstanding credit card fees and finance charges included in Schedule RC-C, Part I, item 6.a. ……………………….…………………………………………………………………………………………………….......................... C391 NA M.6. Memorandum items 7.a, 7.b, and 8.a are to be completed by all banks semiannually in the June and December reports only. (3) 7. Purchased credit-impaired loans held for investment accounted for in accordance with FASB ASC 310-30 (former AICPA Statement of Position 03-3) (exclude loans held for sale): a. Outstanding balance………………………………………………………………………………………………......................... C779 NA M.7.a. b. Amount included in Schedule RC-C, Part I, items 1 through 9………………………………………........................... C780 NA M.7.b. 8. Closed-end loans with negative amortization features secured by 1–4 family residential properties: a. Total amount of closed-end loans with negative amortization features secured by 1–4 family residential properties (included in Schedule RC-C, Part I, items 1.c.(2)(a) and (b))................................. F230 0 M.8.a. Memorandum items 8.b and 8.c are to be completed semiannually in the June and December reports only by banks that had closed-end loans with negative amortization features secured by 1– 4 family residential properties (as reported in Schedule RC-C, Part I, Memorandum item 8.a) as of the preceding December 31 report date, that exceeded the lesser of $100 million or 5 percent of total loans and leases held for investment and held for sale (as reported in Schedule RC-C, Part I, item 12, column B). b. Total maximum remaining amount of negative amortization contractually permitted on closed-end loans secured by 1–4 family residential properties………………………………………………..................... F231 NA M.8.b. c. Total amount of negative amortization on closed-end loans secured by 1–4 family residential properties included in the amount reported in Memorandum item 8.a above……………........…........….............. F232 NA M.8.c 9. Loans secured by 1–4 family residential properties in process of foreclosure (included in Schedule RC-C, Part I, items 1.c.(1), 1.c.(2)(a), and 1.c.(2)(b))…………….................................................... F577 0 M.9. 10. and 11. Not applicable 1. Exclude loans secured by real estate that are included in Schedule RC-C, Part I, items 1.a through 1.e, column B. 2. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 3. Memorandum item 7 is to be completed only by institutions that have not yet adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 28 of 86 RC-12 Schedule RC-C—Continued Part I—Continued Memoranda—Continued (Column A) (Column B) (Column C) Fair Value of Acquired Gross Contractual Best Estimate at Loans and Leases at Amounts Receivable Acquisition Date of Acquisition Date at Acquisition Date Contractual Cash Flows Not Expected to be Collected Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount Memorandum items 12.a, 12.b, 12.c, and 12.d are to be completed semiannually in the June and December reports only. 12. Loans (not subject to the requirements of FASB ASC 310-30 (former AICPA Statement of Position 03-3)) and leases held for investment that were acquired in business combinations with acquisition dates in the current calendar year: (1) a. Loans secured by real estate………………….……………. G091 0 G092 0 G093 0 M.12.a. b. Commercial and industrial loans……………………………. G094 0 G095 0 G096 0 M.12.b. c. Loans to individuals for household, family, and other personal expenditures……………………………. G097 0 G098 0 G099 0 M.12.c. d. All other loans and all leases………………………………… G100 0 G101 0 G102 0 M.12.d. Dollar Amounts in Thousands RCON Amount Memorandum item 13 is to be completed by banks that had construction, land development, and other land loans (as reported in Schedule RC-C, Part I, item 1.a, column B) that exceeded the sum of tier 1 capital (as reported in Schedule RC-R, Part I, item 26) plus the allowance for loan and lease losses or the allowance for credit losses on loans and leases, as applicable (as reported in Schedule RC, item 4.c) as of the preceding December 31 report date. 13. Construction, land development, and other land loans with interest reserves: a. Amount of loans that provide for the use of interest reserves (included in Schedule RC-C, Part I, item 1.a, column B)................................................................................................................................................ G376 0 M.13.a. b. Amount of interest capitalized from interest reserves on construction, land development, and other land loans that is included in interest and fee income on loans during the quarter RIAD (included in Schedule RI, item 1.a.(1)(b))............................................................................................................... G377 0 M.13.b. Memorandum item 14 is to be completed by all banks. RCON 14. Pledged loans and leases...................................................................................................................................................... G378 297,000 M.14. Memorandum item 15 is to be completed for the December report only. 15. Reverse mortgages: a. Reverse mortgages outstanding that are held for investment (included in Schedule RC-C, item 1.c, above)........................................................................................................... PR04 0 M.15.a. b. Estimated number of reverse mortgage loan referrals to other lenders during the year from whom compensation has been received for services performed in Number connection with the origination of the reverse mortgages...................................................................................... PR05 0 M.15.b. RCON Amount c. Principal amount of reverse mortgage originations that have been sold during the year...................................................................................... PR06 0 M.15.c. 1. Institutions that have adopted ASU 2016-13 should report only loans held for investment not considered purchased credit-deteriorated in Memorandum item 12. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 29 of 86 RC-13 Schedule RC-C—Continued Part I—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount Memorandum item 16 is to be completed by all banks. 16. Revolving, open-end loans secured by 1–4 family residential properties and extended under lines of credit that have converted to non-revolving closed-end status (included in item 1.c.(1) above)................................................................................................................................................................................................................ LE75 0 M.16. Amounts reported in Memorandum items 17.a and 17.b will not be made available to the public on an individual institution basis. 17. Eligible loan modifications under Section 4013,Temporary Relief from Troubled Debt Restructurings, of the 2020 Coronavirus Aid, Relief, and Economic Security Act: Number a. Number of Section 4013 loans outstanding........................................................................................................ LG24 0 M.17.a. Amount b. Outstanding balance of Section 4013 loans......................................................................................................... LG25 0 M.17.b. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 30 of 86 RC-14 Schedule RC-C—Continued Part II. Loans to Small Businesses and Small Farms Report the number and amount currently outstanding as of the report date of business loans with “original amounts” of $1,000,000 or less and farm loans with “original amounts” of $500,000 or less. The following guidelines should be used to determine the “original amount” of a loan: (1) For loans drawn down under lines of credit or loan commitments, the “original amount” of the loan is the size of the line of credit or loan commitment when the line of credit or loan commitment was most recently approved, extended, or renewed prior to the report date. However, if the amount currently outstanding as of the report date exceeds this size, the “original amount” is the amount currently outstanding on the report date. (2) For loan participations and syndications, the “original amount” of the loan participation or syndication is the entire amount of the credit originated by the lead lender. (3) For all other loans, the “original amount” is the total amount of the loan at origination or the amount currently outstanding as of the report date, whichever is larger. Loans to Small Businesses 1. Indicate in the appropriate box at the right whether all or substantially all of the dollar volume of your bank’s “Loans secured by nonfarm nonresidential properties” reported in Schedule RC-C, Part I, items 1.e.(1) and 1.e.(2), and all or substantially all of the dollar volume of your bank’s “Commercial and industrial loans” reported in Schedule RC-C, Part I, item 4, (1) have original amounts of $100,000 or less (If your bank has no loans outstanding in both of these two loan categories, place an “X” in the RCON Yes No box marked “NO.”) ..................................................................................................................................................................................................... 6999 x 1. If YES, complete items 2.a and 2.b below, skip items 3 and 4, and go to item 5. If NO and your bank has loans outstanding in either loan category, skip items 2.a and 2.b, complete items 3 and 4 below, and go to item 5. If NO and your bank has no loans outstanding in both loan categories, skip items 2 through 4, and go to item 5. 2. Report the total number of loans currently outstanding for each of the following Schedule RC-C, Part Number of Loans I, loan categories: RCON Number a. “Loans secured by nonfarm nonresidential properties” reported in Schedule RC-C, Part I, items 1.e.(1) and 1.e.(2) (Note: Sum of items 1.e.(1) and 1.e.(2) divided by the number of loans should NOT exceed $100,000.) ............................................................................................................................................................. 5562 NA 2.a. b. “Commercial and industrial loans” reported in Schedule RC-C, Part I, item 4 (1) (Note: Item 4, 5563 (1) divided by the number of loans should NOT exceed $100,000.) NA 2.b. (Column A) (Column B) Number of Loans Amount Currently Dollar Amounts in Thousands Outstanding 3. Number and amount currently outstanding of “Loans secured by nonfarm RCON Number RCON Amount nonresidential properties” reported in Schedule RC-C, Part I, items 1.e.(1) and 1.e.(2) (sum of items 3.a through 3.c must be less than or equal to Schedule RC-C, Part I, sum of items 1.e.(1) and 1.e.(2)): a. With original amounts of $100,000 or less ........................................................................................................................... 5564 0 5565 0 3.a. b. With original amounts of more than $100,000 through $250,000 ................................................................................................ 5566 0 5567 0 3.b. c. With original amounts of more than $250,000 through $1,000,000 ............................................................................................. 5568 0 5569 0 3.c. 4. Number and amount currently outstanding of “Commercial and industrial loans” reported in Schedule RC-C, Part I, item 4 (1) (sum of items 4.a through 4.c must be less than or equal to Schedule RC-C, Part I, item 4 (1)): a. With original amounts of $100,000 or less ........................................................................................................................... 5570 0 5571 0 4.a. b. With original amounts of more than $100,000 through $250,000 ................................................................................................ 5572 1 5573 0 4.b. c. With original amounts of more than $250,000 through $1,000,000 ............................................................................................. 5574 0 5575 0 4.c. 1. Banks with $300 million or more in total assets should provide the requested information for “Commercial and industrial loans” based on the loans reported in Schedule RC-C, Part I, item 4.a, column A, “Commercial and industrial loans to U.S. addressees.” 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 31 of 86 RC-15 Schedule RC-C—Continued Part II—Continued Agricultural Loans to Small Farms 5. Indicate in the appropriate box at the right whether all or substantially all of the dollar volume of your bank’s “Loans secured by farmland (including farm residential and other improvements)” reported in Schedule RC-C, Part I, item 1.b, and all or substantially all of the dollar volume of your bank’s “Loans to finance agricultural production and other loans to farmers” in reported in Schedule RC-C, Part I, item 3, have original amounts of $100,000 or less (If your bank has no loans outstanding inboth of these two RCON Yes No loan categories, place an “X” in the box marked “NO.”) ............................................................................................................. 6860 x 5. If YES, complete items 6.a and 6.b below, and do not complete items 7 and 8. If NO and your bank has loans outstanding in either loan category, skip items 6.a and 6.b and complete items 7 and 8 below. If NO and your bank has no loans outstanding in both loan categories, do not complete items 6 through 8. 6. Report the total number of loans currently outstanding for each of the following Schedule RC-C, Part I, loan categories: a. “Loans secured by farmland (including farm residential and other improvements)” reported in Schedule RC-C, Part I, item 1.b (Note: Item 1.b, divided by the number of loans should NOT exceed $100,000.) .......................................................................................................................................................... b. “Loans to finance agricultural production and other loans to farmers” in reported in Schedule RC-C, Part I, item 3 (Note: Item 3 divided by the number of loans should NOT exceed $100,000.) Currently Dollar Amounts in Thousands Outstanding 7. Number and amount currently outstanding of “Loans secured by farmland RCON Number RCON Amount (including farm residential and other improvements)” reported in Schedule RC-C, Part I, item 1.b (sum of items 7.a through 7.c must be less than or equal to Schedule RC-C, Part I, item 1.b): a. With original amounts of $100,000 or less......................................................................................................................... 5578 NA 5579 NA 7.a. b. With original amounts of more than $100,000 through $250,000 ....................................................................................... 5580 NA 5581 NA 7.b. c. With original amounts of more than $250,000 through $500,000 .................................................................................. 5582 NA 5583 NA 7.c. 8. Number and amount currently outstanding of “Loans to finance agricultural production and other loans to farmers” reported in Schedule RC-C, Part I, item 3 (sum of items 8.a through 8.c must be less than or equal to Schedule RC-C, Part I, item 3): a. With original amounts of $100,000 or less.......................................................................................................................... 5584 NA 5585 NA 8.a. b. With original amounts of more than $100,000 through $250,000 ....................................................................................... 5586 NA 5587 NA 8.b. c. With original amounts of more than $250,000 through $500,000 ........................................................................................ 5588 NA 5589 NA 8.c. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 32 of 86 RC-16 Schedule RC-D—Trading Assets and Liabilities Schedule RC-D is to be completed by banks that (1) reported total trading assets of $10 million or more in any of the four preceding calendar quarters, or (2) meet the FDIC’s definition of a large or highly complex institution for deposit insurance assessment purposes. Dollar Amounts in Thousands RCON Amount Assets 1. U.S. Treasury securities.............................................................................................................................................................................................................................................. 3531 0 1. 2. U.S. Government agency obligations (exclude mortgage-backed securities) 3532 0 2. 3. Securities issued by states and political subdivisions in the U.S....................................................................................................................... 3533 0 3. 4. Mortgage-backed securities (MBS): a. Residential mortgage pass-through securities issued or guaranteed by FNMA, FHLMC, or GNMA……………………………………..…………..................................................................................................... G379 0 4.a. b. Other residential MBS issued or guaranteed by U.S. Government agencies or sponsored G380 agencies (1) (include CMOs, REMICs, and stripped MBS).................................................................................................................................. 0 4.b. c. All other residential MBS................................................................................................................................................................ G381 0 4.c. d. Commercial MBS issued or guaranteed by U.S. Government agencies or sponsored K197 agencies (1) ..................................................................................................................................................................................................................................................................... 0 4.d. e. All other commercial MBS................................................................................................................................................................................................... K198 0 4.e. 5. Other debt securities: a. Structured financial products HT62 0 5.a. b. All other debt securities.............................................................................................................................................................................................................................................. G386 0 5.b. 6. Loans: a. Loans secured by real estate: (1) Loans secured by 1-4 family residential properties.................................................................................................... HT63 0 6.a.(1) (2) All other loans secured by real estate....................................................................................................................... HT64 0 6.a.(2) b. Commercial and industrial loans F614 0 6.b. c. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper)........................................................................................................ HT65 0 6.c. d. Other loans.............................................................................................................................................................................................................................................. F618 0 6.d. 7. and 8. Not applicable 9. Other trading assets.............................................................................................................................................................................................................................................. 3541 0 9. 10. Not applicable 11. Derivatives with a positive fair value 3543 0 11. 12. Total trading assets (sum of items 1 through 11) (must equal Schedule RC, item 5)....................................................................................................................... 3545 0 12. Liabilities 13. a. Liability for short positions.............................................................................................................................................................................................................................................. 3546 0 13.a. b. Other trading liabilities.............................................................................................................................................................................................................................................. F624 0 13.b. 14. Derivatives with a negative fair value 3547 0 14. 15. Total trading liabilities (sum of items 13.a through 14) (must equal Schedule RC, item 15).............................................................. 3548 0 15. _______________ 1. U.S. Government agencies include, but are not limited to, such agencies as the Government National Mortgage Association (GNMA), the Federal Deposit Insurance Corporation (FDIC), and the National Credit Union Administration (NCUA). U.S. Government-sponsored agencies include, but are not limited to, such agencies as the Federal Home Loan Mortgage Corporation (FHLMC) and the Federal National Mortgage Association (FNMA). Memoranda Dollar Amounts in Thousands RCON Amount 1. Unpaid principal balance of loans measured at fair value (reported in Schedule RC-D, items 6.a through 6.d): a. Loans secured by real estate: (1) Loans secured by 1-4 family residential properties……………………………………………..….……......... HT66 0 M.1.a.(1) (2) All other loans secured by real estate………………………………………………………………................... HT67 0 M.1.a.(2) b. Commercial and industrial loans………………………………………………………………………………………………………. F632 0 M.1.b. c. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper)…………………………………………………………........... HT68 0 M.1.c. d. Other loans…………………………………………………………………………......................................…………………………................... F636 0 M.1.d. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 33 of 86 RC-17 Schedule RC-E—Deposit Liabilities Nontransaction Transaction Accounts Accounts (Column A) (Column B) (Column C) Total Transaction Memo: Total Total Accounts (Including Demand Deposits (1) Nontransaction Total Demand (Included in Accounts Deposits) Column A) (Including MMDAs) Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount Deposits of: 1. Individuals, partnerships, and corporations…………………………………………………………… B549 14,670,000 B550 2,832,000 1. 2. U.S. Government………………………………………………................. 2202 0 2520 0 2. 3. States and political subdivisions in the U.S. ………………………. 2203 68,000 2530 0 3. 4. Commercial banks and other depository institutions in the U.S. …………………………………………............. B551 340,000 B552 190,000 4. 5. Banks in foreign countries……………………………………............... 2213 7,778,000 2236 117,000 5. 6. Foreign governments and official institutions (including foreign central banks)……………………………................. 2216 283,000 2377 0 6. 7. Total (sum of items 1 through 6) (sum of columns A and C must equal Schedule RC, item 13.a)………………………………………………………................. 2215 23,139,000 2210 23,137,000 2385 3,139,000 7. Memoranda Dollar Amounts in Thousands RCON Amount 1. Selected components of total deposits (i.e., sum of item 7, columns A and C): a. Total Individual Retirement Accounts (IRAs) and Keogh Plan accounts…………………………………….…….......................... 6835 48,000 M.1.a. b. Total brokered deposits………………………………………………………………………………………….……............................. 2365 319,000 M.1.b. c. Brokered deposits of $250,000 or less (fully insured brokered deposits) HK05 (2) ……………………………... 312,000 M.1.c. d. Maturity data for brokered deposits: (1) Brokered deposits of $250,000 or less with a remaining maturity of one year or less (included in Memorandum item 1.c above)….............................................................................................................................. HK06 312,000 M.1.d.(1) (2) Not applicable (3) Brokered deposits of more than $250,000 with a remaining maturity of one year or less (included in Memorandum item 1.b above)……………………………………………………………….…………………………………….. K220 7,000 M.1.d.(3) e. Preferred deposits (uninsured deposits of states and political subdivisions in the U.S. reported in item 3 above which are secured or collateralized as required under state law) (to be completed for the December report only)………………………………………………………………........................... 5590 0 M.1.e. f. Estimated amount of deposits obtained through the use of deposit listing services that are not brokered deposits ............................................................................................................................................................ K223 0 M.1.f. g. Total reciprocal deposits........................................................................................................................................................................ JH83 0 M.1.g. h. Sweep deposits: (1) Fully insured, affiliate sweep deposits .............................................................................................................................................................. MT87 110,000 M.1.h.(1) (2) Not fully insured, affiliate sweep deposits ............................................................................................................................................................... MT89 462,000 M.1.h.(2) (3) Fully insured, non-affiliate sweep deposits .............................................................................................................................................................. MT91 0 M.1.h.(3) (4) Not fully insured, non-affiliate sweep deposits .............................................................................................................................................................. MT93 0 M.1.h.(4) i. Total sweep deposits that are not brokered deposits .............................................................................................................................................................. MT95 536,000 M.1.i. 1. Includes interest-bearing and noninterest-bearing demand deposits. 2. The dollar amount used as the basis for reporting in Memorandum item 1.c reflects the deposit insurance limits in effect on the report date. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 34 of 86 RC-18 Schedule RC-E—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount 2. Components of total nontransaction accounts (sum of Memorandum items 2.a through 2.d must equal item 7, column C above): a. Savings deposits: (1) Money market deposit accounts (MMDAs)…………………………………………………………………….......................... 6810 2,922,000 M.2.a.(1) (2) Other savings deposits (excludes MMDAs)……………………………………………………………….…............................. 0352 0 M.2.a.(2) b. Total time deposits of less than $100,000…………………………………………………………………………................................ 6648 0 M.2.b. c. Total time deposits of $100,000 through $250,000…………………………………………………………………………………………….... J473 0 M.2.c. d. Total time deposits of more than $250,000 …………………………………………………………………………………………….... J474 217,000 M.2.d. e. Individual Retirement Accounts (IRAs) and Keogh Plan accounts of $100,000 or more included in Memorandum items 2.c and 2.d above …………………………………………………………………………………………….... F233 0 M.2.e. 3. Maturity and repricing data for time deposits of $250,000 or less: a. Time deposits of $250,000 or less with a remaining maturity or next repricing date of: (1), (2) (1) Three months or less………………………………………………………………………………………………………….... HK07 0 M.3.a.(1) (2) Over three months through 12 months……………………………………………………………………………………….. HK08 0 M.3.a.(2) (3) Over one year through three years…………………………………………………………………………………………..... HK09 0 M.3.a.(3) (4) Over three years……………………………………………………………………………………………………………….... HK10 0 M.3.a.(4) b. Time deposits of $250,000 or less with a REMAINING MATURITY of one year or less in Memorandum items 3.a.(1) and 3.a.(2) above) HK11 (included (3)……………………………………………………………...... 0 M.3.b. 4. Maturity and repricing data for time deposits of more than $250,000: a. Time deposits of more than $250,000 with a remaining maturity or next repricing date of: (1), (4) (1) Three months or less………………………………………………………………………………………………………….... HK12 217,000 M.4.a.(1) (2) Over three months through 12 months……………………………………………………………………………………….. HK13 0 M.4.a.(2) (3) Over one year through three years…………………………………………………………………………………………..... HK14 0 M.4.a.(3) (4) Over three years……………………………………………………………………………………………………………….... HK15 0 M.4.a.(4) b. Time deposits of more than $250,000 with a REMAINING MATURITY of one year or less in Memorandum items 4.a.(1) and 4.a.(2) above) K222 (included (3) ………………….………………............... 217,000 M.4.b. 5. Does your institution offer one or more consumer deposit account products, i.e., transaction account or nontransaction savings account deposit products intended primarily for RCON Yes No individuals for personal, household, or family use?……………………………………………………………………………………………………………….... P752 x M.5. Memorandum items 6 and 7 are to be completed by institutions with $1 billion or more in total assets (5) that answered “Yes” to Memorandum item 5 above. Dollar Amounts in Thousands RCON Amount 6. Components of total transaction account deposits of individuals, partnerships, and corporations (sum of Memorandum items 6.a and 6.b must be less than or equal to item 1, column A above): a. Total deposits in those noninterest-bearing transaction account deposit products intended primarily for individuals for personal, household, or family use P753 NA M.6.a. b. Total deposits in those interest-bearing transaction account deposit products intended primarily for individuals for personal, household, or family use P754 NA M.6.b. 1. Report fixed-rate time deposits by remaining maturity and floating rate time deposits by next repricing date. 2. Sum of Memorandum items 3.a.(1) through 3.a.(4) must equal Schedule RC-E, sum of Memorandum items 2.b and 2.c. 3. Report both fixed- and floating-rate time deposits by remaining maturity. Exclude floating-rate time deposits with a next repricing date of one year or less that have a remaining maturity of over one year. 4. Sum of Memorandum items 4.a.(1) through 4.a.(4) must equal Schedule RC-E, Memorandum item 2.d. 5. The $1 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 35 of 86 RC-19 Schedule RC-E—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount 7. Components of total nontransaction account deposits of individuals, partnerships, and corporations (sum of Memorandum items 7.a.(1), 7.a.(2), 7.b.(1), and 7.b.(2) plus all time deposits of individuals, partnerships, and corporations must equal item 1, column C, above): a. Money market deposit accounts (MMDAs) of individuals, partnerships, and corporations (sum of Memorandum items 7.a.(1) and 7.a.(2) must be less than or equal to Memorandum item 2.a.(1) above): (1) Total deposits in those MMDA deposit products intended primarily for individuals for personal, household, or family use P756 NA M.7.a.(1) (2) Deposits in all other MMDAs of individuals, partnerships, and corporations P757 NA M.7.a.(2) b. Other savings deposit accounts of individuals, partnerships, and corporations (sum of Memorandum items 7.b.(1) and 7.b.(2) must be less than or equal to Memorandum item 2.a.(2) above): (1) Total deposits in those other savings deposit account deposit products intended primarily for individuals for personal, household, or family use P758 NA M.7.b.(1) (2) Deposits in all other savings deposit accounts of individuals, partnerships, and corporations P759 NA M.7.b.(2) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 36 of 86 RC-20 Schedule RC-F—Other Assets (1) Dollar Amounts in Thousands RCON Amount . Accrued interest receivable B556 1 (2)……………………………………………………………………………….............................................. 112,000 1. . Net deferred tax assets 2148 2 (3)……………………………………………………………………………….............................................. 456,000 2. 3. Interest-only strips receivable (not in the form of a security) HT80 (4) ……………………………………………… 0 3. . Equity investments without readily determinable fair values 1752 4 (5)………………………………...................................... 97,000 4. 5. Life insurance assets: a. General account life insurance assets………………………………………………………………………….. K201 0 5.a. b. Separate account life insurance assets………………………………………………………………………………… K202 0 5.b. c. Hybrid account life insurance assets……………………………………………………………………………….. K270 0 5.c. 6. All other assets (itemize and describe amounts greater than $100,000 that exceed 25 percent of this item) 2168 1,825,000 6. a. Prepaid expenses…………....................................................................................................................................... 2166 0 6.a. b. Repossessed personal property (including vehicles)………………….................................................. 1578 0 6.b. c. Derivatives with a positive fair value held for purposes other than trading…………………………………………………..……………..................................................... C010 0 6.c. d. Not applicable e. Computer software.............................................................................................................................................................. FT33 0 6.e. f. Accounts receivable.............................................................................................................................................................. FT34 1,353,000 6.f. g. Receivables from foreclosed government-guaranteed mortgage loans.................................................................................................. FT35 0 6.g. TEXT h. 3549 . 3549 0 6.h TEXT i. 3550 . 3550 0 6.i TEXT j. 3551 j 3551 0 6. . 7. Total (sum of items 1 through 6) (must equal Schedule RC, item 11)…………………………………………….. 2160 2,490,000 7. 1. Institutions that have adopted ASU 2016-13 should report asset amounts in Schedule RC-F net of any applicable allowance for credit losses. 2. Include accrued interest receivable on loans, leases, debt securities, and other interest-bearing assets. Exclude accrued interest receivable on interest-bearing assets that is reported elsewhere on the balance sheet. 3. See discussion of deferred income taxes in Glossary entry on “income taxes.” 4. Report interest-only strips receivable in the form of a security as available-for-sale securities in Schedule RC, item 2.b, or as trading assets in Schedule RC, item 5, as appropriate. 5. Include Federal Reserve stock, Federal Home Loan Bank stock, and bankers’ bank stock. Schedule RC-G—Other Liabilities Dollar Amounts in Thousands RCON Amount . a. Interest accrued and unpaid on deposits 3645 1 (1) …………………………………………………………….……………………....51,000 1.a. b. Other expenses accrued and unpaid (includes accrued income taxes payable)…………………………………………………… 3646 650,000 1.b. . Net deferred tax liabilities 3049 2 (2)………………………………………………………………………………………………………………..0 2. . Allowance for credit losses on off-balance-sheet credit exposures B557 3 (3)…………………………………………….………………………. 2,000 3. 4. All other liabilities (itemize and describe amounts greater than $100,000 that exceed 25 percent of this item) 2938 2,079,000 4. a. Accounts payable…………………………………………………..…………………………………… 3066 989,000 4.a. b. Deferred compensation liabilities……………………………………………………………………… C011 0 4.b. c. Dividends declared but not yet payable………………………………….……………………………. 2932 0 4.c. d. Derivatives with a negative fair value held for purposes other than trading C012 0 4.d. e. Operating lease liabilities.................................................................................................................................. LB56 0 4.e. TEXT f. 3552 f 3552 0 4. . TEXT g. 3553 . 3553 0 4.g TEXT h. 3554 h 3554 0 4. . 5. Total (sum of items 1 through 4) (must equal Schedule RC, item 20)…………………………………………………………………. 2930 2,782,000 5. 1. For savings banks, include “dividends” accrued and unpaid on deposits. 2. See discussion of deferred income taxes in Glossary entry on “income taxes.” 3. Institutions that have adopted ASU 2016-13 should report in item 3 the allowance for credit losses on those off-balance sheet credit exposures that fall within the scope of the standard. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 37 of 86 RC-21 Schedule RC-K—Quarterly Averages (1) Dollar Amounts in Thousands RCON Amount Assets 1. Interest-bearing balances due from depository institutions………………………………………....................................... 3381 12,551,000 1. 2. U.S. Treasury securities and U.S. Government agency obligations (2) (excluding mortgage-backed securities)……………………………………………………………………………………...................................... B558 368,000 2. . Mortgage-backed securities B559 3 (2)…………………………………………………………………………....................................... 0 3. 4. All other debt securities (2) and equity securities with readily determinable fair values not held trading B560 for (3) ………………………………………………………………………………………………........................................ 0 4. 5. Federal funds sold and securities purchased under agreements to resell…………………….......................................... 3365 5,920,000 5. 6. Loans: a. Total loans……………………………………………………………………………………...................................... 3360 15,014,000 6.a. b. Loans secured by real estate: (1) Loans secured by 1–4 family residential properties…………………………………...................................3465 2,197,000 6.b.(1) (2) All other loans secured by real estate…………………………………………………...................................... 3466 4,045,000 6.b.(2) c. Commercial and industrial loans……………………………………………………………......................................... 3387 2,054,000 6.c. d. Loans to individuals for household, family, and other personal expenditures: (1) Credit cards………………………………………………………………………………..................................... B561 0 6.d.(1) (2) Other (includes revolving credit plans other than credit cards, automobile loans, and other consumer loans)………………………...…………………..……….……………...................................... B562 298,000 6.d.(2) Item 7 is to be completed by (1) banks that reported total trading assets of $10 million or more in any of the four preceding calendar quarters and (2) all banks meeting the FDIC’s definition of a large or highly complex institution for deposit insurance assessment purposes. 7. Trading assets………………………………………………………………...……………….......................................... 3401 0 7. 8. Lease financing receivables (net of unearned income)……………………...………………........................................ 3484 0 8. . Total assets 3368 9 (4) ……………………………………………………………………………………..……………………...... 36,263,000 9. Liabilities 10. Interest-bearing transaction accounts (interest-bearing demand deposits, NOW accounts, ATS accounts, and telephone and preauthorized transfer accounts)…………………….…………..................................... 3485 6,621,000 10. 11. Nontransaction accounts: a. Savings deposits (includes MMDAs)……………………………………………………………...................................... B563 3,204,000 11.a. b. Time deposits of $250,000 or less……………………………………………………………........................................ HK16 0 11.b. c. Time deposits of more than $250,000……………………………………………………………........................................ HK17 177,000 11.c. 12. Federal funds purchased and securities sold under agreements to repurchase……….......................................... 3353 0 12. 13. To be completed by banks with $100 million or more in total assets: (5) Other borrowed money (includes mortgage indebtedness)....................................................………………………………......................................... 3355 90,000 13. 1. For all items, banks have the option of reporting either (1) an average of DAILY figures for the quarter, or (2) an average of WEEKLY figures (i.e., the Wednesday of each week of the quarter). 2. Quarterly averages for all debt securities should be based on amortized cost. 3. Quarterly averages for equity securities with readily determinable fair values should be based on fair value. 4. The quarterly average for total assets should reflect securities not held for trading as follows: a) Debt securities at amortized cost. b) Equity securities with readily determinable fair values at fair value. c) Equity investments without readily determinable fair values at their balance sheet carrying values (i.e., fair value or, if elected, cost minus impairment, if any, plus or minus changes resulting from observable price changes). 5. The $100 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 38 of 86 RC-22 Schedule RC-K—Quarterly Averages (1) —Continued Memorandum Dollar Amounts in Thousands RCON Amount Memorandum item 1 is to be completed by: (2) • banks with $300 million or more in total assets, and • banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part 1, item 3) exceeding 5 percent of total loans. 1. Loans to finance agricultural production and other loans to farmers .......................................................................... 3386 0 M.1. 1. For all items, banks have the option of reporting either (1) an average of DAILY figures for the quarter, or (2) an average of WEEKLY figures (i.e., the Wednesday of each week of the quarter). 2. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RC-L—Derivatives and Off-Balance-Sheet Items FFIEC 041 Page 39 of 86 RC-23 Please read carefully the instructions for the preparation of Schedule RC-L. Some of the amounts reported in Schedule RC-L are regarded as volume indicators and not necessarily as measures of risk. Dollar Amounts in Thousands RCON Amount 1. Unused commitments: a. Revolving, open-end lines secured by 1–4 family residential properties, e.g., home equity lines........................................................................................................................................................................................................................................ 3814 170,000 1.a. Item 1.a.(1) is to be completed for the December report only. (1) Unused commitments for reverse mortgages outstanding that are held for investment (included in item 1.a. above)............................................................................................................................................................................................................ HT72 0 1.a.(1) b. Credit card lines..................................................................................................................................................................................................................... 3815 0 1.b. Items 1.b.(1) and 1.b.(2) are to be completed semiannually in the June and December reports only by banks with either $300 million or more in total assets or $300 million or more in credit card lines (1) (sum of items 1.b.(1) and 1.b.(2) must equal item 1.b). (1) Unused consumer credit card lines............................................................................................................................................................................. J455 0 1.b.(1) (2) Other unused credit card lines..................................................................................................................................................................................... J456 0 1.b.(2) c. Commitments to fund commercial real estate, construction, and land development loans: (1) Secured by real estate: (a) 1–4 family residential construction loan commitments............................................................................................................................................ F164 0 1.c.(1)(a) (b) Commercial real estate, other construction loan, and land development loan commitments.............................................................................................................................................................................................................. F165 254,000 1.c.(1)(b) (2) NOT secured by real estate.......................................................................................................................................................................................... 6550 0 1.c.(2) d. Securities underwriting........................................................................................................................................................................................................... 3817 0 1.d. e. Other unused commitments: (1) Commercial and industrial loans................................................................................................................................................................................. J457 282,000 1.e.(1) (2) Loans to financial institutions...................................................................................................................................................................................... J458 308,000 1.e.(2) (3) All other unused commitments.................................................................................................................................................................................... J459 6,867,000 1.e.(3) 2. Financial standby letters of credit…………………………………………………………..…….................................................................................................... 3819 241,000 2. Item 2.a is to be completed by banks with $1 billion or more in total assets. (1) 3820 a. Amount of financial standby letters of credit conveyed to others………………………………........................................ 0 2.a. 3. Performance standby letters of credit…………………………………………………….……..................................................................................................... 3821 104,000 3. Item 3.a is to be completed by banks with $1 billion or more in total assets. (1) 3822 a. Amount of performance standby letters of credit conveyed to others…………………………........................................ 0 3.a. 4. Commercial and similar letters of credit………………………….…………………………………………………………….……..................................................... 3411 0 4. 5. Not applicable 6. Securities lent and borrowed: a. Securities lent (including customers’ securities lent where the customer is indemnified against loss by the reporting bank)………………………………………………………….………………………………………….…….......................... 3433 0 6.a. b. Securities borrowed...................................................................................................................................................................................... 3432 0 6.b. (Column A) (Column B) Sold Protection Purchased Protection 7. Credit derivatives: RCON Amount RCON Amount a. Notional amounts: (1) Credit default swaps………………………………………….... C968 0 C969 0 7.a.(1) (2) Total return swaps…………………………………………….... C970 0 C971 0 7.a.(2) (3) Credit options……………………………………………………. C972 0 C973 0 7.a.(3) (4) Other credit derivatives……………………………………….... C974 0 C975 0 7.a.(4) 1. The asset-size tests and the $300 million credit card lines test are based on the total assets and credit card lines reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 40 of 86 Schedule RC-L—Continued RC-24 (Column A) (Column B) Sold Protection Purchased Protection Dollar Amounts in Thousands RCON Amount RCON Amount 7. b. Gross fair values: (1) Gross positive fair value……………………………………….. C219 0 C221 0 7.b.(1) (2) Gross negative fair value……………………………………..... C220 0 C222 0 7.b.(2) . c. Notional amounts by regulatory capital treatment: RCON Amount 7 (1) (1) Positions covered under the Market Risk Rule: (a) Sold protection…………………………………………………………………….…………………………...……....................................... G401 0 7.c.(1)(a) (b) Purchased protection………………………………………………………………………………………………........................................ G402 0 7.c.(1)(b) (2) All other positions: (a) Sold protection………………………………………………………………………………………………………....................................... G403 0 7.c.(2)(a) (b) Purchased protection that is recognized as a guarantee for regulatory capital purposes G404 0 7.c.(2)(b) (c) Purchased protection that is not recognized as a guarantee for regulatory capital purposes……………………….………………………………………………………………………………..……....................................... G405 0 7.c.(2)(c) Remaining Maturity of: (Column A) (Column B) (Column C) One Year or Less Over One Year Over Five Years Through Five Years Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 7. d. Notional amounts by remaining maturity: (1) Sold credit protection: (2) (a) Investment grade................................................................................... G406 0 G407 0 G408 0 7.d.(1)(a) (b) Subinvestment grade........................................................................... G409 0 G410 0 G411 0 7.d.(1)(b) (2) Purchased credit protection: (3) (a) Investment grade................................................................................... G412 0 G413 0 G414 0 7.d.(2)(a) (b) Subinvestment grade............................................................................ G415 0 G416 0 G417 0 7.d.(2)(b) RCON Amount 8. Not applicable 9. All other off-balance-sheet liabilities (exclude derivatives) (itemize and describe each component of this item over 25 percent of Schedule RC, item 27.a, “Total bank equity capital”) 3430 0 9. a. Not applicable b. Commitments to purchase when-issued securities..................................................................................... 3434 0 9.b. c. Standby letters of credit issued byanother party (e.g., a Federal Home Loan Bank) on the bank’s behalf...................................................................................................................................................... C978 0 9.c. TEXT 3555 d d. 3555 0 9. . TEXT 3556 . e. 3556 0 9.e TEXT f. 3557 . 3557 0 9.f 10. All other off-balance-sheet assets (exclude derivatives) (itemize and describe each component of this item over 25 percent of Schedule RC, item 27.a, “Total bank equity capital”):..................................................................................................... 5591 0 10. a. Commitments to sell when-issued securities............................................................................................... 3435 0 10.a. TEXT 5592 . b. 5592 0 10.b TEXT 5593 . c. 5593 0 10.c TEXT d. 5594 . 5594 0 10.d TEXT e. 5595 e 5595 0 10. . 1. Sum of items 7.c.(1)(a) and 7.c.(2)(a), must equal sum of items 7.a.(1) through (4), column A. Sum of items 7.c.(1)(b), 7.c.(2)(b), and 7.c.(2)(c) must equal sum of items 7.a.(1) through (4), column B. 2. Sum of items 7.d.(1)(a) and (b), columns A through C, must equal sum of items 7.a.(1) through (4), column A. 3. Sum of items 7.d.(2)(a) and (b), columns A through C, must equal sum of items 7.a.(1) through (4), column B. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 41 of 86 RC-25 Schedule RC-L—Continued Dollar Amounts in Thousands RCON Amount Items 11.a and 11.b are to be completed semiannually in the June and December reports only. 11. Year-to-date merchant credit card sales volume: a. Sales for which the reporting bank is the acquiring bank....................................................................................................................................... C223 0 11.a. b. Sales for which the reporting bank is the agent bank with risk.............................................................................................................................. C224 0 11.b. (Column A) (Column B) (Column C) (Column D) Interest Rate Foreign Exchange Equity Derivative Commodity and Other Dollar Amounts in Thousands Contracts Contracts Contracts Contracts Derivatives Position Indicators Amount Amount Amount Amount 12. Gross amounts (e.g., notional amounts) (for each column, sum of items 12.a through 12.e must equal sum of items 13 and 14): RCON 8693 RCON 8694 RCON 8695 RCON 8696 a. Futures contracts……………………… 0 0 0 0 12.a. RCON 8697 RCON 8698 RCON 8699 RCON 8700 b. Forward contracts…………………….. 0 0 0 0 12.b. c. Exchange-traded option contracts: RCON 8701 RCON 8702 RCON 8703 RCON 8704 (1) Written options……………………. 0 0 0 0 12.c.(1) RCON 8705 RCON 8706 RCON 8707 RCON 8708 (2) Purchased options………………… 24,000 0 0 0 12.c.(2) d. Over-the-counter option contracts: RCON 8709 RCON 8710 RCON 8711 RCON8712 (1) Written options…………………….. 0 0 0 0 12.d.(1) RCON 8713 RCON 8714 RCON 8715 RCON 8716 (2) Purchased options………………… 0 0 0 0 12.d.(2) RCON 3450 RCON 3826 RCON 8719 RCON 8720 e. Swaps………………………………….. 22,744,000 0 0 0 12.e. 13. Total gross notional amount of derivative RCON A126 RCON A127 RCON 8723 RCON 8724 contracts held for trading………..……..……..……..……..….. 0 0 0 0 13. 14. Total gross notional amount of derivative contracts held for purposes other than RCON 8725 RCON 8726 RCON 8727 RCON 8728 trading…………….……………………… 22,768,000 0 0 0 14. a. Interest rate swaps where the bank has agreed to pay a fixed RCON A589 rate…………………………………………………. 0 14.a. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 42 of 86 RC-26 Schedule RC-L—Continued (Column A) (Column B) (Column C) (Column D) Interest Rate Foreign Exchange Equity Derivative Commodity and Other Dollar Amounts in Thousands Contracts Contracts Contracts Contracts Derivatives Position Indicators Amount Amount Amount Amount 15. Gross fair values of derivative contracts: a. Contracts held for trading: (1) Gross positive fair RCON 8733 RCON 8734 RCON 8735 RCON 8736 value………………………………………………………… 0 0 0 0 15.a.(1) (2) Gross negative fair RCON 8737 RCON 8738 RCON 8739 RCON 8740 value……………………………………………………………… 0 0 0 0 15.a.(2) b. Contracts held for purposes other than trading: (1) Gross positive fair RCON 8741 RCON 8742 RCON 8743 RCON 8744 value………………………………………… 392,000 0 0 0 15.b.(1) (2) Gross negative fair RCON 8745 RCON 8746 RCON 8747 RCON 8748 value…………………………………………………………………………… 460,000 0 0 0 15.b.(2) (Column A) (Columns B-D) (Column E) Banks and Securities Not applicable Corporations and All Firms Other Counterparties Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount Item 16 is to be completed only by banks with total assets of $10 billion or more. (1) 16. Over-the-counter derivatives: a. Net current credit exposure………………..…............ G418 12,000 G422 375,000 16.a. b. Fair value of collateral: (1) Cash—U.S. dollar……………………………............G423 13,000 G427 0 16.b.(1) (2) Cash—Other currencies…………………............... G428 0 G432 0 16.b.(2) (3) U.S. Treasury securities………………….............. G433 0 G437 0 16.b.(3) (4) through (6) Not Applicable (7) All other collateral…………………………................. G453 0 G457 0 16.b.(7) (8) Total fair value of collateral (sum of items 16.b.(1) through (7))………………............... G458 13,000 G462 0 16.b.(8) 1. The $10 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 43 of 86 RC-27 Schedule RC-M—Memoranda Dollar Amounts in Thousands RCON Amount 1. Extensions of credit by the reporting bank to its executive officers, directors, principal shareholders, and their related interests as of the report date: a. Aggregate amount of all extensions of credit to all executive officers, directors, principal shareholders, and their related interests……………………………………………………………………………………………… 6164 0 1.a. b. Number of executive officers, directors, and principal shareholders to whom the amount of all extensions of credit by the reporting bank (including extensions of credit to related interests) equals or exceeds the lesser of $500,000 or 5 Number percent of total capital as defined for this purpose in agency regulations………………………………… 6165 0 1.b. 2. Intangible assets: a. Mortgage servicing assets……………………………………………………………………………………………………………. 3164 0 2.a. (1) Estimated fair value of mortgage servicing assets……………………………………………… A590 0 2.a.(1) b. Goodwill………………………….……………………………….…….……………………………….…….……………………………….…….………………………………. 3163 0 2.b. c. All other intangible assets………………………………………………………………………………………………… JF76 2,000 2.c. d. Total (sum of items 2.a, 2.b, and 2.c) (must equal Schedule RC, item 10)…………………………………………………….. 2143 2,000 2.d. 3. Other real estate owned: a. Construction, land development, and other land………………………………………………………………....................... 5508 0 3.a. b. Farmland………………………………………………………………………………………………………….................... 5509 0 3.b. c. 1–4 family residential properties………………………………………………………………………………................. 5510 4,000 3.c. d. Multifamily (5 or more) residential properties…………………………………………………………………........................ 5511 0 3.d. e. Nonfarm nonresidential properties……………………………………………………………………………........................... 5512 0 3.e. f. Total (sum of items 3.a through 3.e) (must equal Schedule RC, item 7) 2150 4,000 3.f. 4. Cost of equity securities with readily determinable fair values not held for trading fair value of which is reported in Schedule RC, item 2.c) JA29 (the (1) ……………………………………… 0 4. 5. Other borrowed money: a. Federal Home Loan Bank advances: (1) Advances with a remaining maturity or next repricing date of: (2) (a) One year or less……………………………………………………………………………………………………………….. F055 0 5.a.(1)(a) (b) Over one year through three years…………………………………………………………………………………………… F056 0 5.a.(1)(b) (c) Over three years through five years………………………………………………………………………………………….. F057 0 5.a.(1)(c) (d) Over five years…………………………………………………………………………………………………………………. F058 0 5.a.(1)(d) (2) Advances with a REMAINING MATURITY of one year or less in item 5.a.(1)(a) above) 2651 (included (3)…………………………………………………………………………………………………………………………………. 0 5.a.(2) (3) Structured advances (included in items 5.a.(1)(a)–(d) above)……………………………………………………………….. F059 0 5.a.(3) b. Other borrowings: (1) Other borrowings with a remaining maturity or next repricing date of: (4) (a) One year or less………………………………………………………………………………..………………………………. F060 0 5.b.(1)(a) (b) Over one year through three years……………………………………………………………………………………………. F061 0 5.b.(1)(b) (c) Over three years through five years………………………………………………………………………………………….. F062 0 5.b.(1)(c) (d) Over five years…………………………………………………………………………………………………………………. F063 0 5.b.(1)(d) (2) Other borrowings with a REMAINING MATURITY of one year or less in item 5.b.(1)(a) above) B571 (included (5).............................................................................................................................................. 0 5.b.(2) c. Total (sum of items 5.a.(1)(a)–(d) and items 5.b.(1)(a)–(d)) (must equal Schedule RC, item 16) 3190 0 5.c. 1. Item 4 is to be completed only by insured state banks that have been approved by the FDIC to hold grandfathered equity investments. See instructions for this item and the Glossary entry for “Securities Activities” for further detail on accounting for investments in equity securities. 2. Report fixed-rate advances by remaining maturity and floating-rate advances by next repricing date. 3. Report both fixed- and floating-rate advances by remaining maturity. Exclude floating-rate advances with a next repricing date of one year or less that have a remaining maturity of over one year. 4. Report fixed-rate other borrowings by remaining maturity and floating-rate other borrowings by next repricing date. 5. Report both fixed- and floating-rate other borrowings by remaining maturity. Exclude floating-rate other borrowings with a next repricing date of one year or less that have a remaining maturity of over one year. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 44 of 86 Schedule RC-M—Continued RC-28 Dollar Amounts in Thousands RCON Yes No 6. Does the reporting bank sell private label or third-party mutual funds and annuities?..................................................................... B569 x 6. RCON Amount 7. Assets under the reporting bank’s management in proprietary mutual funds and annuities B570 0 7. 8. Internet website addresses and physical office trade names: a. Uniform Resource Locator (URL) of the reporting institution’s primary Internet website (home page), if any (Example: www.examplebank.com): TEXT 4087 http:// http://www.db.com 8.a. b. URLs of all other public-facing Internet websites that the reporting institution uses to accept or solicit deposits from the public, if any (Example: www.examplebank.biz): (1) TE01 N528 (1) http:// 8.b.(1) TE02 N528 (2) http:// 8.b.(2) TE03 N528 (3) http:// 8.b.(3) TE04 N528 (4) http:// 8.b.(4) TE05 N528 (5) http:// 8.b.(5) TE06 N528 (6) http:// 8.b.(6) TE07 N528 (7) http:// 8.b.(7) TE08 N528 (8) http:// 8.b.(8) TE09 N528 (9) http:// 8.b.(9) TE10 N528 (10) http:// 8.b.(10) c. Trade names other than the reporting institution’s legal title used to identify one or more of the institution’s physical offices at which deposits are accepted or solicited from the public, if any: TE01 N529 (1) 8.c.(1) TE02 N529 (2) 8.c.(2) TE03 N529 (3) 8.c.(3) TE04 N529 (4) 8.c.(4) TE05 N529 (5) 8.c.(5) TE06 N529 (6) 8.c.(6) Item 9 is to be completed annually in the December report only. 9. Do any of the bank’s Internet websites have transactional capability, i.e., allow the RCON Yes No bank’s customers to execute transactions on their accounts through the website?................................................................................... 4088 x 9. 10. Secured liabilities: a. Amount of “Federal funds purchased” that are secured RCON Amount (included in Schedule RC, item 14.a)............................................................................................................................................................ F064 0 10.a. b. Amount of “Other borrowings” that are secured (included in Schedule RC-M, items 5.b.(1)(a)–(d)).......................................................................................................................................................... F065 0 10.b. 11. Does the bank act as trustee or custodian for Individual Retirement Accounts, Health RCON Yes No Savings Accounts, and other similar accounts?.......................................................................................................................................................... G463 x 11. 12. Does the bank provide custody, safekeeping, or other services involving the acceptance of orders for the sale or purchase of securities?..................................................................................................................................................................... G464 x 12. 1. Report only highest level URLs (for example, report www.examplebank.biz, but do not also report www.examplebank.biz/checking). Report each top level domain name used (for example, report both www.examplebank.biz and www.examplebank.net). 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 45 of 86 RC-29 Schedule RC-M—Continued Dollar Amounts in Thousands RCON Amount 13. Portion of covered other real estate owned that is protected by FDIC loss-sharing agreements (included in Schedule RC, item 7)................................................................................................................................................ K192 0 13. Items 14.a and 14.b are to be completed annually in the December report only. 14.Captive insurance and reinsurance subsidiaries: a. assets of captive insurance subsidiaries K193 . Total (1) ................................................................................................................................................... 0 14.a b. Total assets of captive reinsurance subsidiaries K194 (1) .............................................................................................................................................. 0 14.b. Item 15 is to be completed by institutions that are required or have elected to be treated as a Qualified Thrift Lender. 15.Qualified Thrift Lender (QTL) test: a. Does the institution use the Home Owners’ Loan Act (HOLA) QTL test or the Internal Revenue Service Domestic Building and Loan Association (IRS DBLA) test to determine RCON Number its QTL compliance? (for the HOLA QTL test, enter 1; for the IRS DBLA test, enter 2).............................................................................................................................. L133 NA 15.a. b. Has the institution been in compliance with the HOLA QTL test as of each month end Yes No during the quarter or the IRS DBLA test for its most recent taxable year, as applicable? L135 15.b. Item 16.a and, if appropriate, items 16.b.(1) through 16.b.(3) are to be completed annually in the December report only. 16. International remittance transfers offered to consumers: (2) a. Estimated number of international remittance transfers provided by your institution during the calendar year ending on the report date............................................................................................................................... N523 1,469 16.a. Items 16.b.(1) through 16.b.(3) are to be completed by institutions that reported 501 or more international remittance transfers in item 16.a in either or both of the current report or the most recent prior report in which item 16.a was required to be completed. b. Estimated dollar value of remittance transfers provided by your institution and usage of regulatory exceptions during the calendar year ending on the report date: Amount (1) Estimated dollar value of international remittance transfers................................................................................................................................................................................... N524 130,000 16.b.(1) (2) Estimated number of international remittance transfers for which your institution Number applied the permanent exchange rate exception.................................................................................................................................................................................. MM07 0 16.b.(2) (3) Estimated number of international remittance transfers for which your institution applied the permanent covered third-party fee exception.................................................................................................................................................................................. MQ52 0 16.b.(3) 17. U.S. Small Business Administration Paycheck Protection Program (PPP) loans (3) and the Federal Reserve PPP Liquidity Facility (PPPLF): a. Number of PPP loans outstanding............................................................................................................................................ LG26 0 17.a. Amount b. Outstanding balance of PPP loans............................................................................................................................................. LG27 0 17.b. c. Outstanding balance of PPP loans pledged to the PPPLF............................................................................................................... LG28 0 17.c. d. Outstanding balance of borrowings from Federal Reserve Banks under the PPPLF with a remaining maturity of: (1) One year or less.................................................................................................................................................................. LL59 0 17.d.(1) (2) More than one year....................................................................................................................................................... LL60 0 17.d.(2) e. Quarterly average amount of PPP loans pledged to the PPPLF and excluded from “Total assets for the leverage ratio” reported in Schedule RC-R, Part I, item 30................................................................................ LL57 0 17.e. 1. Report total assets before eliminating intercompany transactions between the consolidated insurance or reinsurance subsidiary and other offices or consolidated subsidiaries of the reporting bank. 2. Report information about international electronic transfers of funds offered to consumers in the United States that: (a) are “remittance transfers” as defined by subpart B of Regulation E (12 CFR § 1005.30(e)), or (b) would qualify as “remittance transfers” under subpart B of Regulation E (12 CFR § 1005.30(e)) but are excluded from that definition only because the provider is not providing those transfers in the normal course of its business. See 12 CFR § 1005.30(f). For purposes of this item 16, such transfers are referred to as international remittance transfers. Exclude transfers sent by your institution as a correspondent bank for other providers. Report information only about transfers for which the reporting institution is the provider. 3. Paycheck Protection Program (PPP) covered loans as defined in sections 7(a)(36) and 7(a)(37) of the Small Business Act (15 U.S.C. 636(a)(36) and (37)). 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 46 of 86 RC-30 Schedule RC-N—Past Due and Nonaccrual Loans, Leases, and Other Assets (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. Loans secured by real estate: a. Construction, land development, and other land loans: (1) 1–4 family residential construction loans..................................................................................... F172 0 F174 0 F176 0 1.a.(1) (2) Other construction loans and all land development and other land loans…........................................ F173 0 F175 0 F177 0 1.a.(2) b. Secured by farmland....................................................... 3493 0 3494 0 3495 0 1.b. c. Secured by 1– 4 family residential properties: (1) Revolving, open-end loans secured by 1– 4 family residential properties and extended under lines of credit..................................... 5398 1,000 5399 0 5400 3,000 1.c.(1) (2) Closed-end loans secured by 1-4 family residential properties: (a) Secured by first liens.............................................. C236 10,000 C237 2,000 C229 22,000 1.c.(2)(a) (b) Secured by junior liens.............................................. C238 0 C239 0 C230 0 1.c.(2)(b) d. Secured by multifamily (5 or more) residential properties.............................................................................. 3499 0 3500 0 3501 0 1.d. e. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties......................................................... F178 0 F180 0 F182 0 1.e.(1) (2) Loans secured by other nonfarm nonresidential properties................................................. F179 0 F181 0 F183 0 1.e.(2) 2. Loans to depository institutions and acceptances of other banks........................................................... B834 0 B835 0 B836 0 2. 3. Not applicable 4. Commercial and industrial loans…….................................................. 1606 0 1607 0 1608 0 4. 5. Loans to individuals for household, family, and other personal expenditures: a. Credit cards............................................................................... B575 0 B576 0 B577 0 5.a. b. Automobile loans.......................................................................... K213 0 K214 0 K215 0 5.b. c. Other (includes revolving credit plans other than credit cards and other consumer loans)............................................................................ K216 0 K217 0 K218 0 5.c. 6. Not applicable . All other 5459 5460 5461 . 7 loans (1)......................................................................................... 0 0 1,000 7 8. Lease financing receivables........................................................................................ 1226 0 1227 0 1228 0 8. 9. Total loans and leases (sum of items 1 through 8)………… 1406 11,000 1407 2,000 1403 26,000 9. 10. Debt securities and other assets (exclude other real estate owned and other repossessed assets).............................................................................................. 3505 0 3506 0 3507 0 10. __________ 1. Includes past due and nonaccrual “Loans to finance agricultural productions and other loans to farmers,” “Obligations (other than securities and leases) of states and political subdivisions in the U.S.,” and “Loans to nondepository financial institutions and other loans.” 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 47 of 86 RC-31 Schedule RC-N—Continued Amounts reported by loan and lease category in Schedule RC-N, items 1 through 8, include guaranteed and unguaranteed portions of past due and nonaccrual loans and leases. Report in items 11 and 12 below certain guaranteed loans and leases that have already been included in the amounts reported in items 1 through 8. (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 11. Loans and leases reported in items 1 through 8 above that are wholly or partially guaranteed by the U.S. Government, excluding loans and leases covered by loss-sharing agreements with the FDIC.......................................................................................................................................... K036 0 K037 0 K038 0 11. a. Guaranteed portion of loans and leases included in item 11 above, excluding rebooked “GNMA loans”.......................................................................................................... K039 0 K040 0 K041 0 11.a. b. Rebooked “GNMA loans” that have been repurchased or are eligible for repurchase included in item 11 above............................................................................................................... K042 0 K043 0 K044 0 11.b. 12. Portion of covered loans and leases reported in item 9 above that is protected by FDIC loss-sharing agreements............................................................................................................... K102 0 K103 0 K104 0 12. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 48 of 86 RC-32 Schedule RC-N—Continued Memoranda (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. Loans restructured in troubled debt restructurings included in Schedule RC-N, items 1 through 7, above (and not reported in Schedule RC-C, Part I, Memorandum item 1): a. Construction, land development, and other land loans: (1) 1–4 family residential construction loans ............................................................................................ K105 0 K106 0 K107 0 M.1.a.(1) (2) Other construction loans and all land development and other land loans ........................ K108 0 K109 0 K110 0 M.1.a.(2) b. Loans secured by 1–4 family residential properties…………………………………………................. F661 0 F662 0 F663 2,000 M.1.b. c. Secured by multifamily (5 or more) residential properties ........................................................................................... K111 0 K112 0 K113 0 M.1.c. d. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties.................................. K114 0 K115 0 K116 0 M.1.d.(1) (2) Loans secured by other nonfarm nonresidential properties ........................................................... K117 0 K118 0 K119 0 M.1.d.(2) e. Commercial and industrial loans ................................. K257 0 K258 0 K259 0 M.1.e. Memorandum items 1.e.(1) and (2) are to be completed by banks with $300 million or more in total assets (sum of Memorandum items 1.e.(1) and (2) must equal ‘Memorandum item 1.e): (1) (1) To U.S. addressees (domicile) ............................... K120 0 K121 0 K122 0 M.1.e.(1) (2) To non-U.S. addressees (domicile) .................................... K123 0 K124 0 K125 0 M.1.e.(2) f. All other loans ( include loans to individuals for household, family, and other personal expenditures) ............................................................. K126 0 K127 0 K128 0 M.1.f. Itemize loan categories included in Memorandum item 1.f, above that exceed 10 percent of total loans restructured in troubled debt restructurings that are past due 30 days or more or in nonaccrual status (sum of Memorandum items 1.a through 1.e plus 1.f, columns A through C): (1) Loans secured by farmland ..................................................... K130 0 K131 0 K132 0 M.1.f.(1) (2) and (3) Not applicable 1. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 49 of 86 RC-33 Schedule RC-N—Continued Memoranda—Continued (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. f. (4) Loans to individuals for household, family, and other personal expenditures: (a) Credit cards .......................................................... K274 0 K275 0 K276 0 M.1.f.(4)(a) (b) Automobile loans ............................................... K277 0 K278 0 K279 0 M.1.f.(4)(b) (c) Other (includes revolving credit plans other than credit cards and other consumer loans) .............................................. K280 0 K281 0 K282 0 M.1.f.(4)(c) Memorandum item 1.f.(5) is to be completed by: (1) • Banks with $300 million or more in total assets • Banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans (5) Loans to finance agricultural production and other loans to farmers included in Schedule RC-N, Memorandum item 1.f, above ................................................................. K138 0 K139 0 K140 0 M.1.f.(5) 1. g.Total loans restructured in troubled debt restructurings included in Schedule RC-N, items 1 through 7, above (sum of Memorandum items 1.a(1) through 1.e 1.f) HK26 HK27 HK28 plus (2)……………………………………………………………………………………………………………………… 0 0 2,000 M.1.g. 2. Loans to finance commercial real estate, construction, and land development activities (not secured by real estate) included in Schedule RC-N, items 4 and 7, above.................................... 6558 0 6559 0 6560 0 M.2. 3. Memorandum items 3.a through 3.d are to be completed by banks with $300 million or more in total assets: (1) a.Loans secured by real estate to non-U.S. addressees (domicile) (included in Schedule RC-N, item 1, above).................................. 1248 0 1249 0 1250 0 M.3.a. b.Loans to and acceptances of foreign banks (included in Schedule RC-N, item 2, above) .................................................................................................................................................. 5380 0 5381 0 5382 0 M.3.b. c. Commercial and industrial loans to non-U.S. addressees (domicile) included in Schedule RC-N, item 4, above................................... 1254 0 1255 0 1256 0 M.3.c. 1. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 2. Exclude amounts reported in Memorandum items 1.e.(1), 1.e.(2), and 1.f.(1) through 1.f.(5) when calculating the total in Memorandum item 1.g. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 50 of 86 Schedule RC-N—Continued RC-34 Memoranda—Continued (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 3. d. Leases to individuals for household, family, and other personal expenditures (included in Schedule RC-N, item 8, above) ..............................F166 0 F167 0 F168 0 M.3.d. Memorandum item 4 is to be completed by: (1) • banks with $300 million or more in total assets • banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans: 4. Loans to finance agricultural production and other loans to farmers (included in Schedule RC-N, item 7, above) ................................................................... 1594 0 1597 0 1583 0 M.4. 5. Loans and leases held for sale (included in Schedule RC-N, items 1 through 8, above)……………………. C240 0 C241 0 C226 0 M.5. RCON Amount 6. Not applicable Memorandum items 7, 8, 9.a, and 9.b are to be completed semiannually in the June and December reports only. 7. Additions to nonaccrual assets during the previous six months ...................................................................................................................... C410 0 M.7. 8. Nonaccrual assets sold during the previous six months................................................................................................................................. C411 0 M.8. (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 9. Purchased credit-impaired loans accounted for in accordance with FASB ASC 310-30 (former AICPA Statement of Position 03-3): (2) a. Outstanding balance......................................................................... L183 NA L184 NA L185 NA M.9.a. b. Amount included in Schedule RC-N, items 1 through 7, above..................................................................... L186 NA L187 NA L188 NA M.9.b. 1. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 2. Memorandum items 9.a and 9.b should be completed only by institutions that have not yet adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 51 of 86 RC-35 Schedule RC-O—Other Data for Deposit Insurance Assessments All FDIC-insured depository institutions must complete items 1 and 2, 4 through 9,10, and 11, Memorandum item 1, and, if applicable, item 9.a, Memorandum items 2, 3, and 5 through 18 each quarter. Unless otherwise indicated, complete items 1 through 11 and Memorandum items 1 through 3 on an “unconsolidated single FDIC certificate number basis” (see instructions) and complete Memorandum items 5 through 18 on a fully consolidated basis. Dollar Amounts in Thousands RCON Amount 1. Total deposit liabilities before exclusions (gross) as defined in Section 3(l) of the Federal Deposit Insurance Act and FDIC regulations............................................................................................................. F236 26,567,000 1. 2. Total allowable exclusions, including interest accrued and unpaid on allowable exclusions............................... F237 0 2. 3. Not applicable 4. Average consolidated total assets for the calendar quarter .............................................................................................................................. K652 36,263,000 4. a. Averaging method used Number (for daily averaging, enter 1, for weekly averaging, enter 2) .......................................................................................................................................... K653 1 4.a. Amount 5. Average tangible equity for the calendar quarter K654 (1) ........................................................................................................................................... 9,542,000 5. 6. Holdings of long-term unsecured debt issued by other FDIC-insured depository institutions………………………………………………………..…….... K655 0 6. 7. Unsecured “Other borrowings” with a remaining maturity of (sum of items 7.a through 7.d must be less than or equal to Schedule RC-M, items 5.b.(1)(a)–(d) minus item 10.b): a. One year or less........................................................................................................................................................... G465 0 7.a. b. Over one year through three years....................................................................................................................... G466 0 7.b. c. Over three years through five years......................................................................................................................... G467 0 7.c. d. Over five years.............................................................................................................................................................. G468 0 7.d. 8. Subordinated notes and debentures with a remaining maturity of (sum of items 8.a. through 8.d. must equal Schedule RC, item 19): a. One year or less............................................................................................................................................................ G469 0 8.a. b. Over one year through three years........................................................................................................................ G470 0 8.b. c. Over three years through five years........................................................................................................................... G471 0 8.c. d. Over five years............................................................................................................................................................. G472 0 8.d. 9. Brokered reciprocal deposits (included in Schedule RC-E, Memorandum item 1.b)....................................G803 0 9. Item 9.a is to be completed on a fully consolidated basis by all institutions that own another insured depository institution. a. Fully consolidated brokered reciprocal deposits................................................................................................................. L190 NA 9.a. 10. Banker’s bank certification: Does the reporting institution meet both the statutory definition of a banker’s bank and the business Yes No conduct test set forth in FDIC regulations? ................................................................................................................................................................. K656 x 10. If the answer to item 10 is “YES,” complete items 10.a and 10.b. Amount a. Banker’s bank deduction.................................................................................................................................... K657 NA 10.a. b. Banker’s bank deduction limit .............................................................................................................................. K658 NA 10.b. 11.Custodial bank certification: Yes No Does the reporting institution meet the definition of a custodial bank set forth in FDIC regulations? K659 x 11. If the answer to item 11 is “YES,” complete items 11.a and 11.b. (2) Amount a. Custodial bank deduction ....................................................................................................................................... K660 12,934,000 11.a. b. Custodial bank deduction limit ............................................................................................................................. K661 6,471,000 11.b. 1. See instructions for averaging methods. For deposit insurance assessment purposes, tangible equity is defined as Tier 1 capital as set forth in the banking agencies’ regulatory capital standards and reported in Schedule RC-R, Part I, item 26, except as described in the instructions. 2. If the amount reported in item 11.b is zero, item 11.a may be left blank. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 52 of 86 RC-36 Schedule RC-O—Continued Memoranda Dollar Amounts in Thousands RCON Amount 1. Total deposit liabilities of the bank, including related interest accrued and unpaid, less allowable exclusions, including related interest accrued and unpaid (sum of Memorandum items 1.a.(1), 1.b.(1), 1.c.(1), and 1.d.(1) must equal Schedule RC-O, item 1 less item 2): a. Deposit accounts (excluding retirement accounts) of $250,000 or less: (1) (1)Amount of deposit accounts (excluding retirement accounts) of $250,000 or less................................................................. F049 134,000 M.1.a.(1) (2)Number of deposit accounts (excluding retirement accounts) Number of $250,000 or less......................................................................................................................................... F050 5,836 M.1.a.(2) b. Deposit accounts (excluding retirement accounts) of more than $250,000: (1) (1)Amount of deposit accounts (excluding retirement accounts) of more than $250,000............................................................ F051 26,385,000 M.1.b.(1) (2)Number of deposit accounts (excluding retirement accounts) Number of more than $250,000........................................................................................................................ F052 3,294 M.1.b.(2) c. Retirement deposit accounts of $250,000 or less: (1) (1)Amount of retirement deposit accounts of $250,000 or less.................................................................................................... F045 47,000 M.1.c.(1) Number (2)Number of retirement deposit accounts of $250,000 or less........................................................... F046 143 M.1.c.(2) d. Retirement deposit accounts of more than $250,000: (1) (1)Amount of retirement deposit accounts of more than $250,000............................................................................................... F047 1,000 M.1.d.(1) Number (2)Number of retirement deposit accounts of more than $250,000........................................................ F048 2 M.1.d.(2) Memorandum item 2 is to be completed by banks with $1 billion or more in total assets. (2) 2. Estimated amount of uninsured deposits including related interest accrued and unpaid instructions) 5597 (see (3)..................................................................................................................................................................... 25,562,000 M.2. 3. Has the reporting institution been consolidated with a parent bank or savings association in that parent bank’s or parent savings association’s Call Report? If so, report the legal title and FDIC Certificate Number of the parent bank or parent savings association: RCON FDIC Cert. No. TEXT A545 A545 0 M.3. 4. Not applicable 1. The dollar amounts used as the basis for reporting in Memorandum items 1.a through 1.d reflect the deposit insurance limits in effect on the report date. 2. The $1 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 3. Uninsured deposits should be estimated based on the deposit insurance limits set forth in Memorandum items 1.a through 1.d. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 53 of 86 RC-37 Schedule RC-O—Continued Amounts reported in Memorandum items 6 through 9, 14, and 15 will not be made available to the public on an individual institution basis. Memoranda—Continued Dollar Amounts in Thousands RCON Amount Memorandum items 5 through 12 are to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. 5. Applicable portion of the CECL transitional amount or modified CECL transitional amount that has been added to retained earnings for regulatory capital purposes as of the current report date and is attributable to loans and leases held for investment................................................................................................................................... MW53 0 M.5. 6. Criticized and classified items: a. Special mention ......................................................................................................................................................................... K663 1,850,000 M.6.a. b. Substandard...................................................................................................................................................................................... K664 172,000 M.6.b. c. Doubtful ............................................................................................................................................................................................. K665 5,000 M.6.c. d. Loss ................................................................................................................................................................................................... K666 0 M.6.d. 7. “Nontraditional 1–4 family residential mortgage loans” as defined for assessment purposes only in FDIC regulations: a. Nontraditional 1-4 family residential mortgage loans................................................................................................................................................... N025 1,705,000 M.7.a. b. Securitizations of nontraditional 1-4 family residential mortgage loans N026 0 M.7.b. 8. “Higher-risk consumer loans” as defined for assessment purposes only in FDIC regulations: a. Higher-risk consumer loans……........................................................................................................................................................................ N027 35,000 M.8.a. b. Securitizations of higher-risk consumer loans…........................................................................................................................................................................ N028 0 M.8.b. 9. “Higher-risk commercial and industrial loans and securities” as defined for assessment purposes only in FDIC regulations: a. Higher-risk commercial and industrial loans and securities............................................................................................................................................................ N029 0 M.9.a. b. Securitizations of higher-risk commercial and industrial loans and securities N030 0 M.9.b. 10. Commitments to fund construction, land development, and other land loans secured by real estate: a. Total unfunded commitments ....................................................................................................................................... K676 254,000 M.10.a. b. Portion of unfunded commitments guaranteed or insured by the U.S. government (including the FDIC) .......................................................................................................................................................................... K677 0 M.10.b. 11. Amount of other real estate owned recoverable from the U.S. government under guarantee or insurance provisions (excluding FDIC loss-sharing agreements) .......................................................... K669 0 M.11. 12. Nonbrokered time deposits of more than $250,000 in domestic offices (included in Schedule RC-E, Part I, Memorandum item 2.d) K678 217,000 M.12. Memorandum item 13.a is to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. Memorandum items 13.b through 13.h are to be completed by “large institutions” only. 13. Portion of funded loans and securities guaranteed or insured by the U.S. government (including FDIC loss-sharing agreements): a. Construction, land development, and other land loans secured by real estate .......................................................... N177 0 M.13.a. b. Loans secured by multifamily residential and nonfarm nonresidential properties ...............................N178 0 M.13.b. c. Closed-end loans secured by first liens on 1–4 family residential properties ............................................................ N179 0 M.13.c. d. Closed-end loans secured by junior liens on 1–4 family residential properties and revolving, open-end loans secured by 1–4 family residential properties and extended under lines of credit ................................................................................................................................................... N180 0 M.13.d. e. Commercial and industrial loans ................................................................................................................................ N181 0 M.13.e. f. Credit card loans to individuals for household, family, and other personal expenditures …....................................... N182 0 M.13.f. g. All other loans to individuals for household, family, and other personal expenditures N183 0 M.13.g. h. Non-agency residential mortgage-backed securities............................................................................................................................... M963 0 M.13.h. Memorandum items 14 and 15 are to be completed by “highly complex institutions” as defined in FDIC regulations. 14. Amount of the institution’s largest counterparty exposure ............................................................................................. K673 NA M.14. 15. Total amount of the institution’s 20 largest counterparty exposures ................................................................................ K674 NA M.15. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 54 of 86 RC-38 Schedule RC-O—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount Memorandum item 16 is to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. 16. Portion of loans restructured in troubled debt restructurings that are in compliance with their modified terms and are guaranteed or insured by the U.S. government (including the FDIC) (included in Schedule RC-C, Part I, Memorandum item 1)....................................................................................................................................................................... L189 0 M.16. Memorandum item 17 is to be completed on a fully consolidated basis by those “large institutions” and “highly complex institutions” as defined in FDIC regulations that own another insured depository institution. 17. Selected fully consolidated data for deposit insurance assessment purposes: a. Total deposit liabilities before exclusions (gross) as defined in Section 3(I) of the Federal Deposit Insurance Act and FDIC regulations....................................................................................................................................................................... L194 NA M.17.a. b. Total allowable exclusions, including interest accrued and unpaid on allowable exclusions............................. L195 NA M.17.b. c. Unsecured “Other borrowings” with a remaining maturity of one year or less L196 NA M.17.c. d. Estimated amount of uninsured deposits, including related interest accrued and unpaid L197 NA M.17.d. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 55 of 86 RC-39 Schedule RC-O—Continued Memorandum item 18 is to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. Amounts reported in Memorandum item 18 will not be made available to the public on an individual institution basis. Two-Year Probability of Default (PD) (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) < 1% 1.01–4% 4.01–7% 7.01–10% 10.01–14% 14.01–16% 16.01–18% 18.01–20% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount 18. Outstanding balance of 1-4 family residential mortgage loans, consumer loans, and consumer leases by two-year probability of default: a. “Nontraditional 1-4 family residential mortgage loans” as defined for assessment purposes RCON M964 RCON M965 RCON M966 RCON M967 RCON M968 RCON M969 RCON M970 RCON M971 only in FDIC regulations………………………………………………………………………………… 400,000 616,000 351,000 179,000 54,000 4,000 0 3,000 M.18.a. b. Closed-end loans secured by first liens on 1-4 family RCON M979 RCON M980 RCON M981 RCON M982 RCON M983 RCON M984 RCON M985 RCON M986 residential properties…………………………… 44,000 86,000 40,000 3,000 5,000 0 0 0 M.18.b. c. Closed-end loans secured by junior liens on 1-4 family RCON M994 RCON M995 RCON M996 RCON M997 RCON M998 RCON M999 RCON N001 RCON N002 residential properties………………………………………………………………………………… 6,000 13,000 2,000 1,000 10,000 0 0 0 M.18.c. d. Revolving, open-end loans secured by 1-4 family residential properties RCON N010 RCON N011 RCON N012 RCON N013 RCON N014 RCON N015 RCON N016 RCON N017 and extended under lines of credit 27,000 75,000 95,000 10,000 7,000 0 3,000 0 M.18.d. RCON N040 RCON N041 RCON N042 RCON N043 RCON N044 RCON N045 RCON N046 RCON N047 e. Credit cards………………………………………………………………………………… 0 0 0 0 0 0 0 0 M.18.e. RCON N055 RCON N056 RCON N057 RCON N058 RCON N059 RCON N060 RCON N061 RCON N062 f. Automobile loans………………………………………………………………………………… 0 0 0 0 0 0 0 0 M.18.f. RCON N070 RCON N071 RCON N072 RCON N073 RCON N074 RCON N075 RCON N076 RCON N077 g. Student loans…………………………………………………………………………… 0 0 0 0 0 0 0 0 M.18.g. h. Other consumer loans and revolving credit plans other RCON N085 RCON N086 RCON N087 RCON N088 RCON N089 RCON N090 RCON N091 RCON N092 than credit cards………………………………………………………………………………… 112,000 112,000 67,000 1,000 0 0 0 0 M.18.h. RCON N100 RCON N101 RCON N102 RCON N103 RCON N104 RCON N105 RCON N106 RCON N107 i. Consumer leases………………………………………………………………………………… 0 0 0 0 0 0 0 0 M.18.i. RCON N115 RCON N116 RCON N117 RCON N118 RCON N119 RCON N120 RCON N121 RCON N122 j. Total………………………………………………………………………………… 589,000 902,000 555,000 194,000 76,000 4,000 3,000 3,000 M.18.j. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RC-O—Continued Memorandum item 18 is to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. Amounts reported in Memorandum item 18 will not be made available to the public on an individual institution basis. Two-Year Probability of Default (PD) (Column O) PDs Were (Column I) (Column J) (Column K) (Column L) (Column M) (Column N) Derived 20.01–22% 22.01–26% 26.01–30% > 30% Unscoreable Total Using (1) Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Number 18. Outstanding balance of 1-4 family residential mortgage loans, consumer loans, and consumer leases by two-year probability of default: a.“Nontraditional 1-4 family residential mortgage loans” as defined for assessment purposes RCON M972 RCON M973 RCON M974 RCON M975 RCON M976 RCON M977 RCON M978 only in FDIC regulations………………………………………………………………………………… 5,000 2,000 2,000 0 89,000 1,705,000 1 M.18.a. b.Closed-end loans secured by first liens on 1-4 family RCON M987 RCON M988 RCON M989 RCON M990 RCON M991 RCON M992 RCON M993 residential properties………………………………………………………………… 0 0 0 0 11,000 189,000 1 M.18.b. c. Closed-end loans secured by junior liens on 1-4 family RCON N003 RCON N004 RCON N005 RCON N006 RCON N007 RCON N008 RCON N009 residential properties………………………………………………………………………………… 0 0 0 0 0 32,000 1 M.18.c. d.Revolving, open-end loans secured by 1-4 family residential properties RCON N018 RCON N019 RCON N020 RCON N021 RCON N022 RCON N023 RCON N024 and extended under lines of credit………………………………………………………………………………… 0 0 0 0 47,000 264,000 1 M.18.d. RCON N048 RCON N049 RCON N050 RCON N051 RCON N052 RCON N053 RCON N054 e.Credit cards………………………………………………………………………………… 0 0 0 0 0 0 0 M.18.e. RCON N063 RCON N064 RCON N065 RCON N066 RCON N067 RCON N068 RCON N069 f. Automobile loans………………………………………………………………………………… 0 0 0 0 0 0 0 M.18.f. RCON N078 RCON N079 RCON N080 RCON N081 RCON N082 RCON N083 RCON N084 g.Student loans…………………………………………………………………………… 0 0 0 0 0 0 0 M.18.g. h.Other consumer loans and revolving credit plans other RCON N093 RCON N094 RCON N095 RCON N096 RCON N097 RCON N098 RCON N099 than credit cards………………………………………………………………………………… 0 0 0 0 15,000 307,000 1 M.18.h. RCON N108 RCON N109 RCON N110 RCON N111 RCON N112 RCON N113 RCON N114 i. Consumer leases………………………………………………………………………………… 0 0 0 0 0 0 0 M.18.i. RCON N123 RCON N124 RCON N125 RCON N126 RCON N127 RCON N128 j. Total………………………………………………………………………………… 5,000 2,000 2,000 0 162,000 2,497,000 M.18.j. 1. For PDs derived using scores and default rate mappings provided by a third-party vendor, enter 1; for PDs derived using an internal approach, enter 2; for PDs derived using third-party vendor mappings for some loans within a product type and an internal approach for other loans within the same product type, enter 3. If the total reported in Column N for a product type is zero, enter 0. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 57 of 86 RC-41 Schedule RC-P—1–4 Family Residential Mortgage Banking Activities Schedule RC-P is to be completed by banks at which either 1–4 family residential mortgage loan originations and purchases for resale (1) from all sources, loan sales, or quarter-end loans held for sale or trading exceed $10 million for two consecutive quarters. Dollar Amounts in Thousands RCON Amount 1. Retail originations during the quarter of 1–4 family residential mortgage loans for sale HT81 (1) .............................. 0 1. 2. Wholesale originations and purchases during the quarter of 1–4 family residential mortgage loans sale HT82 for (1)................................................................................................................................................................................................................................................................... 0 2. 3. 1–4 family residential mortgage loans sold during the quarter................................................................................ FT04 0 3. 4. 1–4 family residential mortgage loans held for sale or trading at quarter-end 4. (included in Schedule RC, items 4.a and 5)............................................................................................................ FT05 0 5. Noninterest income for the quarter from the sale, securitization, and servicing of 1–4 family RIAD residential mortgage loans (included in Schedule RI, items 5.c, 5.f, 5.g, and 5.i)................................................. HT85 0 5. RCON 6. Repurchases and indemnifications of 1–4 family residential mortgage loans during the quarter.................................. HT86 0 6. 7. Representation and warranty reserves for 1–4 family residential mortgage loans sold: a. For representations and warranties made to U.S. government agencies and government-sponsored agencies................................................................................................................................................. L191 0 7.a. b. For representations and warranties made to other parties................................................................................................................................................. L192 0 7.b. c. Total representation and warranty reserves (sum of items 7.a and 7.b) M288 0 7.c. 1. Exclude originations and purchases of 1–4 family residential mortgage loans that are held for investment. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RC-Q—Assets and Liabilities Measured at Fair Value on a Recurring Basis FFIEC 041 Page 58 of 86 RC-42 Schedule RC-Q is to be completed by banks that: (1) Have elected to report financial instruments or servicing assets and liabilities at fair value under a fair value option with changes in fair value recognized in earnings, or (2) Are required to complete Schedule RC-D, Trading Assets and Liabilities. (Column A) (Column B) (Column C) (Column D) (Column E) Total Fair Value LESS: Amounts Netted Level 1 Fair Value Level 2 Fair Value Level 3 Fair Value Reported on in the Determination of Measurements Measurements Measurements Schedule RC Total Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount RCON Amount Assets 1. Available-for-sale debt securities and equity securities with readily determinable fair values trading JA36 G474 G475 G476 G477 not held for (1)…………………………………………………… 378,000 0 378,000 0 0 1. 2. Not applicable 3. Loans and leases held for sale........................................................................................................................... G483 0 G484 0 G485 0 G486 0 G487 0 3. 4. Loans and leases held for investment........................................................................................................................... G488 0 G489 0 G490 0 G491 0 G492 0 4. 5. Trading assets: a. Derivative assets........................................................................................................................... 3543 0 G493 0 G494 0 G495 0 G496 0 5.a. b. Other trading assets........................................................................................................................... G497 0 G498 0 G499 0 G500 0 G501 0 5.b. (1) Nontrading securities at fair value with changes in fair value reported in current earnings (included in Schedule RC-Q, item 5.b above)........................................................................................................................... F240 0 F684 0 F692 0 F241 0 F242 0 5.b.(1) 6. All other assets........................................................................................................................... G391 393,000 G392 4,000 G395 0 G396 397,000 G804 0 6. 7. Total assets measured at fair value on a recurring basis (sum of items 1 through 5.b plus item 6)................................................................................................................................... G502 771,000 G503 4,000 G504 378,000 G505 397,000 G506 0 7. Liabilities 8. Deposits........................................................................................................................... F252 0 F686 0 F694 0 F253 0 F254 0 8. 9. Not applicable 10. Trading liabilities: a. Derivative liabilities........................................................................................................................... 3547 0 G512 0 G513 0 G514 0 G515 0 10.a. b. Other trading liabilities........................................................................................................................... G516 0 G517 0 G518 0 G519 0 G520 0 10.b. 11. and 12. Not applicable 13. All other liabilities........................................................................................................................... G805 457,000 G806 4,000 G807 0 G808 461,000 G809 0 13. 14. Total liabilities measured at fair value on a recurring basis (sum of items 8 through 13).................................. G531 457,000 G532 4,000 G533 0 G534 461,000 G535 0 14. 1. The amount reported in item 1, column A, must equal the sum of Schedule RC, items 2.b and 2.c. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 59 of 86 RC-43 Schedule RC-Q—Continued (Column A) (Column B) (Column C) (Column D) (Column E) Total Fair Value LESS: Amounts Netted Level 1 Fair Value Level 2 Fair Value Level 3 Fair Value Reported on in the Determination Measurements Measurements Measurements Schedule RC of Total Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount RCON Amount Memoranda 1. All other assets (itemize and describe amounts included in Schedule RC-Q, item 6, that are greater than $100,000 and exceed 25 percent of item 6): a. Mortgage servicing assets……………………………………… G536 0 G537 0 G538 0 G539 0 G540 0 M.1.a. b. Nontrading derivative assets…………………………………… G541 388,000 G542 4,000 G543 0 G544 392,000 G545 0 M.1.b. TEXT c. G546 0 G547 0 G548 0 G549 0 G550 0 M.1.c. G546 TEXT d. G551 0 G552 0 G553 0 G554 0 G555 0 M.1.d. G551 TEXT e. G556 0 G557 0 G558 0 G559 0 G560 0 M.1.e. G556 TEXT f. G561 0 G562 0 G563 0 G564 0 G565 0 M.1.f. G561 2. All other liabilities (itemize and describe amounts included in Schedule RC-Q, item 13, that are greater than $100,000 and exceed 25 percent of item 13): a. Loan commitments (not accounted for as derivatives)…………………………………………………… F261 0 F689 0 F697 0 F262 0 F263 0 M.2.a. b. Nontrading derivative liabilities………………………………… G566 457,000 G567 4,000 G568 0 G569 461,000 G570 0 M.2.b. TEXT c. G571 0 G572 0 G573 0 G574 0 G575 0 M.2.c. G571 TEXT d. G576 0 G577 0 G578 0 G579 0 G580 0 M.2.d. G576 TEXT e. G581 0 G582 0 G583 0 G584 0 G585 0 M.2.e. G581 TEXT f. G586 0 G587 0 G588 0 G589 0 G590 0 M.2.f. G586 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 60 of 86 RC-44 Schedule RC-Q—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount 3. Loans measured at fair value (included in Schedule RC-C, Part I, items 1 through 9): a. Loans secured by real estate: (1) Secured by 1–4 family residential properties…………………………………………....................... HT87 0 M.3.a.(1) (2) All other loans secured by real estate……………………...…………………...…………………...…… HT88 0 M.3.a.(2) b. Commercial and industrial loans………………………………………….……….......................................... F585 0 M.3.b. c. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper)……………………….…………………….……………………. HT89 0 M.3.c. d. Other loans…………………………..………………………….…………………………..................................................... F589 0 M.3.d. 4. Unpaid principal balance of loans measured at fair value (reported in Schedule RC-Q, Memorandum item 3): a. Loans secured by real estate: (1) Secured by 1–4 family residential properties…....…………………....…....…………………....……….... HT91 0 M.4.a.(1) (2) All other loans secured by real estate…………………………….…………………....………………….... HT92 0 M.4.a.(2) b. Commercial and industrial loans………………………………………………..............................…………………… F597 0 M.4.b. c. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper)………………………………………..………..……….. HT93 0 M.4.c. d. Other loans………………………………….…………………………………………………............................................ F601 0 M.4.d. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 61 of 86 RC-45 Schedule RC-R—Regulatory Capital Part I. Regulatory Capital Components and Ratios Part I is to be completed on a consolidated basis. Dollar Amounts in Thousands RCOA Amount Common Equity Tier 1 Capital 1. Common stock plus related surplus, net of treasury stock and unearned employee stock ownership plan (ESOP) shares............................................................................................................................... P742 3,063,000 1. . Retained earnings KW00 2 (1)........................................................................................................................................................ 6,637,000 2. a. To be completed only by institutions that have adopted ASU 2016-13: Does your institution have a CECL transition election in effect as of the quarter-end report date? (enter “0” for No; enter “1” for Yes with a 3-year CECL transition election; RCOA enter “2” for Yes with a 5-year 2020 CECL transition election.) JJ29 0 2.a. RCOA Amount 3. Accumulated other comprehensive income (AOCI)................................................................................................................................................................... B530 (34,000) 3. 0=No RCOA a. AOCI opt-out election (enter “1” for Yes; enter “0” for No.) 1=Yes P838 0 3.a. RCOA Amount 4. Common equity tier 1 minority interest includable in common equity tier 1 capital.................................................................... P839 0 4. 5. Common equity tier 1 capital before adjustments and deductions (sum of items 1 through 4) P840 9,666,000 5. Common Equity Tier 1 Capital: Adjustments and Deductions 6. LESS: Goodwill net of associated deferred tax liabilities (DTLs)............................................................................................................................ P841 0 6. 7. LESS: Intangible assets (other than goodwill and mortgage servicing assets (MSAs)), net of associated DTLs.................................................................................................................................................................................................. P842 2,000 7. 8. LESS: Deferred tax assets (DTAs) that arise from net operating loss and tax credit carryforwards, net of any related valuation allowances and net of DTLs................................................................................................. P843 1,000 8. 9. AOCI-related adjustments (if entered “1” for Yes in item 3.a, complete only items 9.a through 9.e; if entered “0” for No in item 3.a, complete only item 9.f): a. LESS: Net unrealized gains (losses) on available-for-sale debt securities (if a gain, report as a positive value; if a loss, report as a negative value) P844 NA 9.a. b. Not applicable c. LESS: Accumulated net gains (losses) on cash flow hedges (if a gain, report as a positive value; if a loss, report as a negative value)............................................................................................................................................................................................................. P846 NA 9.c. d. LESS: Amounts recorded in AOCI attributed to defined benefit postretirement plans resulting from the initial and subsequent application of the relevant GAAP standards that pertain to such plans (if a gain, report as a positive value; if a loss, report as a negative value)........................... P847 NA 9.d. e. LESS: Net unrealized gains (losses) on held-to-maturity securities that are included in AOCI (if a gain, report as a positive value; if a loss, report as a negative value) P848 NA 9.e. f. To be completed only by institutions that entered “0” for No in item 3.a: LESS: Accumulated net gain (loss) on cash flow hedges included in AOCI, net of applicable income taxes, that relates to the hedging of items that are not recognized at fair value on the balance sheet (if a gain, report as a positive value; if a loss, report as a negative value)...................................................................... P849 0 9.f. 1. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should include the applicable portion of the CECL transitional amount or the modified CECL transitional amount, respectively, in this item. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 62 of 86 RC-46 Schedule RC-R—Continued Part I—Continued Dollar Amounts in Thousands RCOA Amount 10. Other deductions from (additions to) common equity tier 1 capital before threshold-based deductions: a. LESS: Unrealized net gain (loss) related to changes in the fair value of liabilities that are due to changes in own credit risk (if a gain, report as a positive value; if a loss, report as a negative value)........................................................................................................................................................................................................................................................ Q258 0 10.a. b. LESS: All other deductions from (additions to) common equity tier 1 capital before threshold-based deductions..................................................................................................................................................................................... P850 0 10.b. 11. Not applicable 12. Subtotal (item 5 minus items 6 through 10.b)..................................................................................................................................................... P852 9,663,000 12. 13. LESS: Investments in the capital of unconsolidated financial institutions, net of associated DTLs, that exceed 25 percent of item 12....................................................................................................................................................................................................................................... LB58 0 13. 14. LESS: MSAs, net of associated DTLs, that exceed 25 percent of item 12 LB59 0 14. 15. LESS: DTAs arising from temporary differences that could not be realized through net operating loss carrybacks, net of related valuation allowances and net of DTLs, that exceed 25 percent of item 12................................................................................................................................................................................................................. LB60 0 15. 16. Not applicable 17. LESS: Deductions applied to common equity tier 1 capital due to insufficient amounts of additional tier 1 capital and tier 2 P857 . capital (1) to cover deductions.......................................................................................................................... 0 17 18. Total adjustments and deductions for common equity tier 1 capital (sum of items 13 through 17).............................................................................................. P858 0 18. 19. Common equity tier 1 capital (item 12 minus item 18) P859 9,663,000 19. Additional Tier 1 Capital 20. Additional tier 1 capital instruments plus related surplus.............................................................................................................................................. P860 0 20. 21. Non-qualifying capital instruments subject to phase-out from additional tier 1 capital................................................................................................................................... P861 0 21. 22. Tier 1 minority interest not included in common equity tier 1 capital........................................................................................................... P862 0 22. 23. Additional tier 1 capital before deductions (sum of items 20, 21, and 22)..................................................................................................................................... P863 0 23. 24. LESS: Additional tier 1 capital deductions...................................................................................................................................................................... P864 0 24. 25. Additional tier 1 capital (greater of item 23 minus item 24, or zero)............................................................................................................................ P865 0 25. Tier 1 Capital 26. Tier 1 capital (sum of items 19 and 25)....................................................................................................................................................................................................................... 8274 9,663,000 26. Total Assets for the Leverage Ratio 27. Average total consolidated assets KW03 27 (2).............................................................................................................................................................................................................. 36,263,000 . 28. LESS: Deductions from common equity tier 1 capital and additional tier 1 capital (sum of items 6, 7, 8, 10.b, 13 through 15, 17, and certain elements of item 24—see instructions)........................................ P875 3,000 28. 29. LESS: Other deductions from (additions to) assets for leverage ratio purposes......................................................................................................................................... B596 0 29. 30. Total assets for the leverage ratio (item 27 minus items 28 and 29)......................................................................................................................................... A224 36,260,000 30. 1. An institution that has a CBLR framework election in effect as of the quarter-end report date is neither required to calculate tier 2 capital nor make any deductions that would have been taken from tier 2 capital as of the report date. 2. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should include the applicable portion of the CECL transitional amount or the modified CECL transitional amount, respectively, in item 27. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 63 of 86 RC-47 Schedule RC-R—Continued Part I—Continued Leverage Ratio* RCOA Percentage 31. Leverage ratio (item 26 divided by item 30) 7204 26.6492% 31. a. Does your institution have a community bank leverage ratio (CBLR) framework election in effect as 0=No RCOA of the quarter-end report date? (enter “1” for Yes; enter “0” for No)............................................................................................................. 1=Yes LE74 0 31.a. If your institution entered “1” for Yes in item 31.a: • Complete items 32 through 37 and, if applicable, items 38.a through 38.c, • Do not complete items 39 through 55.b, and • Do not complete Part II of Schedule RC-R. If your institution entered “0” for No in item 31.a: • Skip (do not complete) items 32 through 38.c, • Complete items 39 through 55.b, as applicable, and • Complete Part II of Schedule RC-R. Item 31.b is to be completed only by non-advanced approaches institutions that elect to use the Standardized Approach for Counterparty Credit Risk (SA-CCR) for purposes of the standardized approach and supplementary leverage ratio. b. Standardized Approach for Counterparty Credit Risk opt-in election RCOA (enter “1” for Yes; leave blank for No)............................................................................................................................................................... 1=Yes NC99 31.b. Qualifying Criteria and Other Information for CBLR Institutions* Column A Column B Dollar Amounts in Thousands RCOA Amount RCOA Percentage 32. Total assets (Schedule RC, item 12); (must be less than $10 billion) 2170 NA 32. 33. Trading assets and trading liabilities (Schedule RC, sum of items 5 and 15). Report as a dollar amount in column A and as a percentage of total assets (5% limit) in column B........................................................................................................................................................................................................................... KX77 NA KX78 NA 33. 34. Off-balance sheet exposures: a. Unused portion of conditionally cancellable commitments KX79 NA 34.a. b. Securities lent and borrowed (Schedule RC-L, sum of items 6.a and 6.b)................................................................................................................................................................................................................. KX80 NA 34.b. c. Other off-balance sheet exposures KX81 NA 34.c. d. Total off-balance sheet exposures (sum of items 34.a through 34.c). Report as a dollar amount in column A and as a percentage of total assets (25% limit) in column B KX82 NA KX83 NA 34.d Dollar Amounts in Thousands RCOA Amount 35. Unconditionally cancellable commitments.......................................................................................................................................................................................................... S540 NA 35. 36. Investments in the tier 2 capital of unconsolidated financial institutions LB61 NA 36. 37. Allocated transfer risk reserve.......................................................................................................................................................................................................... 3128 NA 37 38. Amount of allowances for credit losses on purchased credit-deteriorated assets: (1) a. Loans and leases held for investment.......................................................................................................................................................................................................... JJ30 NA 38.a. b. Held-to-maturity debt securities.......................................................................................................................................................................................................... JJ31 NA 38.b. c. Other financial assets measured at amortized cost JJ32 NA 38.c. * Report each ratio as a percentage, rounded to four decimal places, e.g., 12.3456. 1. Items 38.a through 38.c should be completed only by institutions that have adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 64 of 86 RC-48 Schedule RC-R—Continued Part I—Continued If your institution entered “0” for No in item 31.a, complete items 39 through 55.b, as applicable, and Part II of Schedule RC-R. If your institution entered “1” for Yes in item 31.a, do not complete items 39 through 55.b or Part II of Schedule RC-R. Dollar Amounts in Thousands RCOA Amount Tier 2 Capital (1) 39. Tier 2 capital instruments plus related surplus..................................................................................................................................................................................................... P866 0 39. 40. Non-qualifying capital instruments subject to phase-out from tier 2 capital.............................................................................................. P867 0 40. 41. Total capital minority interest that is not included in tier 1 capital P868 0 41. . Allowance for loan and lease losses includable in tier 2 capital 5310 42 (2, 3)............................................................................................................................... 18,000 42. 43. Not applicable 44. Tier 2 capital before deductions (sum of items 39 through 42)....................................................................................... P870 18,000 44. 45. LESS: Tier 2 capital deductions......................................................................................................................................... P872 0 45. 46. Tier 2 capital (greater of item 44 minus item 45, or zero)......................................................................................................................................... 5311 18,000 46. Total Capital 47. Total capital (sum of items 26 and 46)......................................................................................................................................... 3792 9,681,000 47. Total Risk-Weighted Assets 48. Total risk-weighted assets (from Schedule RC-R, Part II, item 31)......................................................................................................................................... A223 18,490,000 48. Risk-Based Capital Ratios * RCOA Percentage 49. Common equity tier 1 capital ratio (item 19 divided by item 48).............................................................................................................................. P793 52.2607% 49. 50. Tier 1 capital ratio (item 26 divided by item 48).............................................................................................................................. 7206 52.2607% 50. 51. Total capital ratio (item 47 divided by item 48).............................................................................................................................. 7205 52.3580% 51. Capital Buffer* 52. Institution-specific capital buffer necessary to avoid limitations on distributions and discretionary bonus payments: a. Capital conservation buffer H311 44.3580% 52.a. RCOW b. Institutions subject to Category III capital standards only: Total applicable capital buffer............................................................................... H312 2.5000% 52.b. RCOA Amount 53. Eligible income H313 retained (4) NA 53. 54 Distributions and discretionary bonus payments during the quarter H314 . (5) NA 54. Supplementary Leverage Ratio* 55. Institutions subject to Category III capital standards only: Supplementary leverage ratio information: a. Total exposure H015 leverage (6) .................................................................................................................................................................... 38,942,000 55.a. Percentage b. Supplementary leverage ratio................................................................................................................................................................... H036 24.8138% 55.b. * Report each ratio as a percentage, rounded to four decimal places, e.g., 12.3456. 1. An institution that has a CBLR framework election in effect as of the quarter-end report date is neither required to calculate tier 2 capital nor make any deductions that would have been taken from tier 2 capital as of the report date. 2. Institutions that have adopted ASU 2016-13 should report the amount of adjusted allowances for credit losses (AACL), as defined in the regu- latory capital rule, includable in tier 2 capital in item 42. 3. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should subtract the applicable portion of the AACL transitional amount or the modified AACL transitional amount, respectively, from the AACL, as defined in the regulatory capital rule, before determining the amount of AACL includable in tier 2 capital. See instructions for further detail on the CECL transition provisions. 4. Non-advanced approaches institutions other than Category III institutions must complete item 53 only if the amount reported in item 52.a above is less than or equal to 2.5000 percent. Category III institutions must complete item 53 only if the amount reported in item 52.a above is less than or equal to the amount reported in item 52.b above. 5. Non-advanced approaches institutions other than Category III institutions must complete item 54 only if the amount reported in Schedule RC- R, Part I, item 52.a, in the Call Report for the previous calendar quarter-end report date was less than or equal to 2.5000 percent. Category III institutions must complete item 54 only if the amount reported in Schedule RC-R, Part I, item 52.a, in the Call Report for the previous calendar quarter-end report date was less than or equal to the amount reported in Schedule RC-R, Part I, item 52.b, in the Call Report for that previous report date. 6. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should include the applicable portion of the CECL transitional amount or the modified CECL transitional amount, respectively, in item 55.a. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 65 of 86 Schedule RC-R—Continued RC-49 Part II. Risk-Weighted Assets Institutions that entered “1” for Yes in Schedule RC-R, Part I, item 31.a, do not have to complete Schedule RC-R, Part II. Institutions are required to assign a 100 percent risk weight to all assets not specifically assigned a risk weight under Subpart D of the federal banking agencies’ regulatory capital rules (1) and not deducted from tier 1 or tier 2 capital. (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Totals From Adjustments Allocation by Risk-Weight Category Schedule to Totals RC Reported in 0% 2% 4% 10% 20% 50% 100% 150% Column A Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount Balance Sheet Asset Categories (2) 1. Cash and balances due from depository RCON D957 RCON S396 RCON D958 RCON D959 RCON S397 RCON D960 RCON S398 institutions……………………………… 13,597,000 0 13,553,000 44,000 0 0 0 1. 2. Securities: a. Held-to-maturity RCON D961 RCON S399 RCON D962 RCON HJ74 RCON HJ75 RCON D963 RCON D964 RCON D965 RCON S400 securities (3)……………………………………………… 0 0 0 0 0 0 0 0 0 2.a. b. Available-for-sale debt securities and equity securities with readily determinable fair values RCON JA21 RCON S402 RCON D967 RCON HJ76 RCON HJ77 RCON D968 RCON D969 RCON D970 RCON S403 not held for trading……………………………………… 378,000 0 378,000 0 0 0 0 0 0 2.b. 3. Federal funds sold and securities purchased under agreements to resell: RCON D971 RCON D972 RCON D973 RCON S410 RCON D974 RCON S411 a. Federal funds sold………………. 0 0 0 0 0 0 3.a b. Securities purchased under agreements to RCON H171 RCON H172 resell……………………………………………….. 5,923,000 5,923,000 3.b 4. Loans and leases held for sale: a. Residential mortgage RCON S413 RCON S414 RCON H173 RCON S415 RCON S416 RCON S417 exposures……………………………………….. 0 0 0 0 0 0 4.a. b. High volatility commercial real estate RCON S419 RCON S420 RCON H174 RCON H175 RCON H176 RCON H177 RCON S421 exposures………………………… 0 0 0 0 0 0 0 4.b. 1. For national banks and federal savings associations, 12 CFR Part 3; for state member banks, 12 CFR Part 217; and for state nonmember banks and state savings associations 12 CFR Part 324. 2. All securitization exposures held as on-balance sheet assets of the reporting institution are to be excluded from items 1 through 8 and are to be reported instead in item 9. 3. Institutions that have adopted ASU 2016-13 and have reported held-to-maturity securities net of allowances for credit losses in item 2.a, column A, should report as a negative number in item 2.a, column B, those allowances for credit losses eligible for inclusion in tier 2 capital, which excludes allowances for credit losses on purchased credit-deteriorated assets. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 66 of 86 RC-50 Schedule RC-R—Continued Part II—Continued (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) (Column R) (Column S) Allocation by Risk-Weight Category Application of Other Risk- Weighting Approaches (1) 250% 300% 400% 600% 625% 937.5% 1250% Exposure Risk-Weighted Amount Asset Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Balance Sheet Asset Categories (continued) 1. Cash and balances due from depository institutions…………………………………….. 1. 2. Securities: a. Held-to-maturity securities…………………………………………. 2.a. b. Available-for-sale debt securities and equity securities with readily determinable fair values RCON S405 RCON S406 RCON H271 RCON H272 not held for trading .................................................. 0 0 0 0 2.b. 3. Federal funds sold and securities purchased under agreements to resell: a. Federal funds sold…………………….. 3.a. b. Securities purchased under agreements to resell..……………………………………. 3.b 4. Loans and leases held for sale: a. Residential mortgage RCON H273 RCON H274 exposures………………………………………. 0 0 4.a. b. High volatility commercial real estate RCON H275 RCON H276 exposures…………………………………………. 0 0 4.b. 1. Includes, for example, investments in mutual funds/investment funds, exposures collateralized by securitization exposures or mutual funds, separate account bank-owned life insurance, and default fund contributions to central counterparties. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 67 of 86 RC-51 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Totals From Adjustments Allocation by Risk-Weight Category Schedule to Totals RC Reported in 0% 2% 4% 10% 20% 50% 100% 150% Column A Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount 4. Loans and leases held for sale (continued): c. Exposures past due 90 days or more or RCON S423 RCON S424 RCON S425 RCON HJ78 RCON HJ79 RCON S426 RCON S427 RCON S428 RCON S429 on nonaccrual (1)……………………………………….. 0 0 0 0 0 0 0 0 0 4.c. d. All other RCON S431 RCON S432 RCON S433 RCON HJ80 RCON HJ81 RCON S434 RCON S435 RCON S436 RCON S437 exposures………………………………. 0 0 0 0 0 0 0 0 0 4.d. 5. Loans and leases held for investment: (2) a. Residential mortgage RCON S439 RCON S440 RCON H178 RCON S441 RCON S442 RCON S443 exposures……………………………………….. 2,417,000 0 1,000 0 2,309,000 107,000 5.a. b. High volatility commercial real estate RCON S445 RCON S446 RCON H179 RCON H180 RCON H181 RCON H182 RCON S447 exposures……………………….. 0 0 0 0 0 0 0 5.b. c. Exposures past due 90 days or more or on RCON S449 RCON S450 RCON S451 RCON HJ82 RCON HJ83 RCON S452 RCON S453 RCON S454 RCON S455 nonaccrual (3)……………………………………….. 0 0 0 0 0 0 0 0 0 5.c. RCON S457 RCON S458 RCON S459 RCON HJ84 RCON HJ85 RCON S460 RCON S461 RCON S462 RCON S463 d. All other exposures………………………….. 13,930,000 0 114,000 0 0 545,000 135,000 12,160,000 976,000 5.d. 6. LESS: Allowance for loan RCON 3123 RCON 3123 and lease losses (4)………………………………….. 16,000 16,000 6. 1. For loans and leases held for sale, exclude residential mortgage exposures, high volatility commercial real estate exposures, or sovereign exposures that are past due 90 days or more or on nonaccrual. 2. Institutions that have adopted ASU 2016-13 should report as a positive number in column B of items 5.a through 5.d, as appropriate, any allowances for credit losses on purchased credit- deteriorated assets reported in column A of items 5.a through 5.d, as appropriate. 3. For loans and leases held for investment, exclude residential mortgage exposures, high volatility commercial real estate exposures, or sovereign exposures that are past due 90 days or more or on nonaccrual. 4. Institutions that have adopted ASU 2016-13 should report the allowance for credit losses on loans and leases in item 6, columns A and B. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 68 of 86 RC-52 Schedule RC-R—Continued Part II—Continued (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) (Column R) (Column S) Allocation by Risk-Weight Category Application of Other Risk- Weighting Approaches (1) Exposure Risk-Weighted 250% 300% 400% 600% 625% 937.5% 1250% Amount Asset Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount 4. Loans and leases held for sale (continued): c. Exposures past due 90 days or more or RCON H277 RCON H278 nonaccrual on (2)…………………………………….. 0 0 4.c. d. All other RCON H279 RCON H280 exposures………………………………… 0 0 4.d. 5. Loans and leases held for investment: a. Residential mortgage RCON H281 RCON H282 exposures……………………………………….. 0 0 5.a. b. High volatility commercial real estate RCON H283 RCON H284 exposures…………………………………………………………………………….. 0 0 5.b. c. Exposures past due 90 days or more or on RCON H285 RCON H286 nonaccrual (3)……………………………………….. 0 0 5.c. RCON H287 RCON H288 d. All other exposures………………………….. 0 0 5.d. 6. LESS: Allowance for loan and lease losses………………………………….. 6. 1. Includes, for example, investments in mutual funds/investment funds, exposures collateralized by securitization exposures or mutual funds, separate account bank-owned life insurance, and default fund contributions to central counterparties. 2. For loans and leases held for sale, exclude residential mortgage exposures, high volatility commercial real estate exposures, or sovereign exposures that are past due 90 days or more or on nonaccrual. 3. For loans and leases held for investment, exclude residential mortgage exposures, high volatility commercial real estate exposures, or sovereign exposures that are past due 90 days or more or on nonaccrual. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 69 of 86 RC-53 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Totals From Adjustments Allocation by Risk-Weight Category Schedule to Totals RC Reported in 0% 2% 4% 10% 20% 50% 100% 150% Column A Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount RCON D976 RCON S466 RCON D977 RCON HJ86 RCON HJ87 RCON D978 RCON D979 RCON D980 RCON S467 7. Trading assets…………………………………. 0 0 0 0 0 0 0 0 0 7. RCON D981 RCON S469 RCON D982 RCON HJ88 RCON HJ89 RCON D983 RCON D984 RCON D985 RCON H185 8. All other assets (1, 2, 3)…………………………………… 2,496,000 728,000 105,000 0 0 53,000 1,000 1,144,000 9,000 8. a. Separate account bank-owned life insurance…………………………. 8.a. b. Default fund contributions to central counterparties……………………. 8.b. 1. Includes premises and fixed assets; other real estate owned; investments in unconsolidated subsidiaries and associated companies; direct and indirect investments in real estate ventures; intangible assets; and other assets. 2. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should report as a positive number in item 8, column B, the applicable portion of the DTA transitional amount as determined in accordance with the 3-year or the 5-year 2020 CECL transitional amount, respectively. 3. Institutions that have adopted ASU 2016-13 and have reported any assets net of allowances for credit losses in item 8, column A, should report as a negative number in item 8, column B, those allowances for credit losses eligible for inclusion in tier 2 capital, which excludes allowances for credit losses on purchased credit-deteriorated assets. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 70 of 86 RC-54 Schedule RC-R—Continued Part II—Continued (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) (Column R) (Column S) Allocation by Risk-Weight Category Application of Other Risk- Weighting Approaches (1) Exposure Risk-Weighted 250% 300% 400% 600% 625% 937.5% 1250% Amount Asset Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount RCON H186 RCON H290 RCON H187 RCON H291 RCON H292 7. Trading assets…………………………………. 0 0 0 0 0 7. RCON H293 RCON H188 RCON S470 RCON S471 RCON H294 RCON H295 8. All other assets (2)…………………………………… 456,000 0 0 0 0 0 8. a. Separate account bank-owned life RCON H296 RCON H297 insurance……….…………..…………… 0 0 8.a. b. Default fund contributions to central RCON H298 RCON H299 counterparties………………………….. 0 0 8.b. 1. Includes, for example, investments in mutual funds/investment funds, exposures collateralized by securitization exposures or mutual funds, separate account bank-owned life insurance, and default fund contributions to central counterparties. 2. Includes premises and fixed assets; other real estate owned; investments in unconsolidated subsidiaries and associated companies; direct and indirect investments in real estate ventures; intangible assets; and other assets. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 71 of 86 RC-55 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column Q) (Column T) (Column U) Totals Adjustments Allocation by Total Risk-Weighted Asset to Totals Risk-Weight Amount by Calculation Reported in Category Methodology Column A (Exposure Amount) 1250% SSFA (1) Gross-Up Dollar Amounts in Thousands Amount Amount Amount Amount Amount Securitization Exposures: On- and Off-Balance Sheet 9. On-balance sheet securitization exposures: RCON S475 RCON S476 RCON S477 RCON S478 RCON S479 a. Held-to-maturity securities (2)…………………………………………………………………………………………………………………..………... 0 0 0 0 0 9.a. RCON S480 RCON S481 RCON S482 RCON S483 RCON S484 b. Available-for-sale securities…………………………………………………………………………………………………………………………… 0 0 0 0 0 9.b. RCON S485 RCON S486 RCON S487 RCON S488 RCON S489 c. Trading assets……………………………………………………………………………………………………………………………………………………….. 0 0 0 0 0 9.c RCON S490 RCON S491 RCON S492 RCON S493 RCON S494 d. All other on-balance sheet securitization exposures……………………………………………………………………………………………………………….. 0 0 0 0 0 9.d RCON S495 RCON S496 RCON S497 RCON S498 RCON S499 10. Off-balance sheet securitization exposures……………………………………………………………………………………………………………………………………… 0 0 0 0 0 10. 1. Simplified Supervisory Formula Approach. 2. Institutions that have adopted ASU 2016-13 and have reported held-to-maturity securities net of allowances for credit losses in item 9.a, column A, should report as a negative number in item 9.a, column B, those allowances for credit losses eligible for inclusion in tier 2 capital, which excludes allowances for credit losses on purchased credit-deteriorated assets. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 72 of 86 RC-56 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Totals From Adjustments Allocation by Risk-Weight Category Schedule to Totals RC Reported in 0% 2% 4% 10% 20% 50% 100% 150% Column A Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount 11. Total balance sheet RCON 2170 RCON S500 RCON D987 RCON HJ90 RCON HJ91 RCON D988 RCON D989 RCON D990 RCON S503 assets (1)………………………………………………………………… 38,725,000 6,635,000 14,151,000 0 0 642,000 2,445,000 13,411,000 985,000 11. (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) (Column R) Application of Other Risk-Allocation by Risk-Weight Category Weighting Approaches Exposure 250% 300% 400% 600% 625% 937.5% 1250% Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount 11. Total balance sheet RCON S504 RCON S505 RCON S506 RCON S507 RCON S510 RCON H300 assets (1)…………...………………………………………………………… 456,000 0 0 0 0 0 11. 1. For each of columns A through R of item 11, report the sum of items 1 through 9. For item 11, the sum of columns B through R must equal column A. Item 11, column A, must equal Schedule RC, item 12. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 73 of 86 RC-57 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Face, Notional, CCF (1) Credit or Other Equivalent Allocation by Risk-Weight Category Amount Amount (2) 0% 2% 4% 10% 20% 50% 100% 150% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount Derivatives, Off-Balance Sheet Items, and Other Items Subject to Risk Weighting (Excluding Securitization Exposures) (3) 12. Financial standby RCON D991 RCON D992 RCON D993 RCON HJ92 RCON HJ93 RCON D994 RCON D995 RCON D996 RCON S511 letters of credit…………………………………………………………………… 241,000 1.0 241,000 0 0 0 4,000 3,000 234,000 0 12. 13. Performance standby letters of credit and transaction-related RCON D997 RCON D998 RCON D999 RCON G603 RCON G604 RCON G605 RCON S512 contingent items…………………………………………………………………… 102,000 0.5 51,000 0 0 1,000 50,000 0 13. 14. Commercial and similar letters of credit with an original maturity of one year RCON G606 RCON G607 RCON G608 RCON HJ94 RCON HJ95 RCON G609 RCON G610 RCON G611 RCON S513 or less…………………………………………………………………… 0 0.2 0 0 0 0 0 0 0 0 14. 15. Retained recourse on small business obligations sold RCON G612 RCON G613 RCON G614 RCON G615 RCON G616 RCON G617 RCON S514 with recourse…………………………………………………………………… 0 1.0 0 0 0 0 0 0 15. 1. Credit conversion factor. 2. Column A multiplied by credit conversion factor. For each of items 12 through 21, the sum of columns C through J plus column R must equal column B. 3. All derivatives and off-balance sheet items that are securitization exposures are to be excluded from items 12 through 21 and are to be reported instead in item 10. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 74 of 86 RC-58 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Face, Notional, CCF (1) Credit Allocation by Risk-Weight Category or Other Equivalent Amount Amount (2) 0% 2% 4% 10% 20% 50% 100% 150% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount 16. Repo-style RCON S515 RCON S516 RCON S517 RCON S518 RCON S519 RCON S520 RCON S521 RCON S522 RCON S523 transactions (3)……………………………………47,000 1.0 47,000 0 0 0 0 0 47,000 0 16. 17. All other off-balance RCON G618 RCON G619 RCON G620 RCON G621 RCON G622 RCON G623 RCON S524 sheet liabilities……………………………………………………………………0 1.0 0 0 0 0 0 0 17. 18. Unused commitments (exclude unused commitments to asset-backed commercial paper conduits): a. Original maturity of RCON S525 RCON S526 RCON S527 RCON HJ96 RCON HJ97 RCON S528 RCON S529 RCON S530 RCON S531 one year or less………………………………………………………65,000 0.2 13,000 0 0 0 0 0 13,000 0 18.a. b. Original maturity exceeding one RCON G624 RCON G625 RCON G626 RCON HJ98 RCON HJ99 RCON G627 RCON G628 RCON G629 RCON S539 year……………………………………………………………………1,908,000 0.5 954,000 84,000 0 0 103,000 88,000 679,000 0 18.b. 19. Unconditionally cancelable RCON S540 RCON S541 commitments……………………………………………………………………0 0.0 0 19. 20. Over-the-counter RCON S542 RCON S543 RCON HK00 RCON HK01 RCON S544 RCON S545 RCON S546 RCON S547 RCON S548 derivatives…………………………………………………………………… 15,000 0 0 0 0 15,000 0 0 0 20. 21. Centrally cleared RCON S549 RCON S550 RCON S551 RCON S552 RCON S554 RCON S555 RCON S556 RCON S557 derivatives…………………………………………………………………… 796,000 0 796,000 0 0 0 0 0 21. 22. Unsettled transactions RCON H191 RCON H193 RCON H194 RCON H195 RCON H196 RCON H197 (failed trades) (4)……………………………………………………………………0 0 0 0 0 0 22. 06/2012 1. Credit conversion factor. 2. For items 16 through 19, column A multiplied by credit conversion factor. 3. Includes securities purchased under agreements to resell (reverse repos), securities sold under agreements to repurchase (repos), securities borrowed, and securities lent. 4. For item 22, the sum of columns C through Q must equal column A.
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 75 of 86 RC-59 Schedule RC-R—Continued Part II—Continued (Column O) (Column P) (Column Q) (Column R) (Column S) Application of Other Risk-Allocation by Risk-Weight Category Weighting Approaches (1) Credit Equivalent Risk-Weighted 625% 937.5% 1250% Amount Asset Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount 16. Repo-style RCON H301 RCON H302 transactions (2)……….…………………………...……………………...…………….…………...…………….….… 0 0 16. 17. All other off-balance sheet liabilities……………..…….…………………...…………….………………………… 17. 18. Unused commitments (exclude unused commitments to asset-backed commercial paper conduits): a. Original maturity of RCON H303 RCON H304 one year or less………………….…………………………...…………….……………………. 0 0 18.a. b. Original maturity exceeding one RCON H307 RCON H308 year…………………….…………………………...…………….……………………. 0 0 18.b. 19. Unconditionally cancelable commitments………………………………………….…………...…………….…………… 19. 20. Over-the-counter RCON H309 RCON H310 derivatives…………………………………………………...…………….………………...… 0 0 20. 21. Centrally cleared derivatives………………………………………………………………...…………….….… 21. 22. Unsettled transactions RCON H198 RCON H199 RCON H200 (failed trades) (3)………………………………………………...…………….……………… 0 0 0 22. 1. Includes, for example, exposures collateralized by securitization exposures or mutual funds. 2. Includes securities purchased under agreements to resell (reverse repos), securities sold under agreements to repurchase (repos), securities borrowed, and securities lent. 3. For item 22, the sum of columns C through Q must equal column A. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 76 of 86 RC-60 Schedule RC-R—Continued Part II—Continued (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Allocation by Risk-Weight Category 0% 2% 4% 10% 20% 50% 100% 150% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount 23. Total assets, derivatives, off-balance sheet items, and other items subject to risk weighting by risk-weight category (for each of columns C through P, sum of items 11 through 22; for column Q, sum of items RCON G630 RCON S558 RCON S559 RCON S560 RCON G631 RCON G632 RCON G633 RCON S561 10 through 22)…………………………………………………………………… 14,235,000 796,000 0 0 764,000 2,537,000 14,434,000 985,000 23. 24. Risk-weight factor…………………………………………………………………… X 0% X 2% X 4% X 10% X 20% X 50% X 100% X 150% 24. 25. Risk-weighted assets by risk-weight category (for each column, item 23 multiplied by RCON G634 RCON S569 RCON S570 RCON S571 RCON G635 RCON G636 RCON G637 RCON S572 item 24)…………………………………………………………………… 0 16,000 0 0 153,000 1,269,000 14,434,000 1,478,000 25. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 77 of 86 RC-61 Schedule RC-R—Continued Part II—Continued (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) Allocation by Risk-Weight Category 250% 300% 400% 600% 625% 937.5% 1250% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount 23. Total assets, derivatives, off-balance sheet items, and other items subject to risk weighting by risk- weight category (for each of columns C through P, sum of items 11 through 22; for column Q, sum of items RCON S562 RCON S563 RCON S564 RCON S565 RCON S566 RCON S567 RCON S568 10 through 22) …………………………………………………………………………………………. 456,000 0 0 0 0 0 0 23. 24. Risk-weight factor……………………………………………………………………………………… X 250% X 300% X 400% X 600% X 625% X 937.5% X 1250% 24. 25. Risk-weighted assets by risk-weight category (for each column, item 23 multiplied by RCON S573 RCON S574 RCON S575 RCON S576 RCON S577 RCON S578 RCON S579 item 24)…………………………………………………………………………………………………. 1,140,000 0 0 0 0 0 0 25. Totals Dollar Amounts in Thousands RCON Amount 26. Risk-weighted assets base for purposes of calculating the allowance for loan and lease losses 1.25 percent threshold (1)………………………………….………………………… S580 18,490,000 26. 27. Standardized market-risk weighted assets (applicable only to banks that are covered by the market risk capital rules)……………………………...……………………...….………… S581 0 27. 28. Risk-weighted assets before deductions for excess allowance for loan and lease losses and allocated transfer risk reserve (2, 3)………………………..…………………….. B704 18,490,000 28. 29. LESS: Excess allowance for loan and lease losses (4, 5)……………………………………………………………………………………………………………………………………………….. A222 0 29. 30. LESS: Allocated transfer risk reserve………………………………………………………………………………………………………………………………………………………………… 3128 0 30. 31. Total risk-weighted assets (item 28 minus items 29 and 30)……………………………………………………………………………………………………………………………………. G641 18,490,000 31. 1. For institutions that have adopted ASU 2016-13, the risk-weighted assets base reported in item 26 is for purposes of calculating the adjusted allowances for credit losses (AACL) 1.25 percent threshold. 2. Sum of items 2.b through 20, column S; items 9.a, 9.b, 9.c, 9.d, and 10, columns T and U; item 25, columns C through Q; and item 27 (if applicable). 3. For institutions that have adopted ASU 2016-13, the risk-weighted assets reported in item 28 represents the amount of risk-weighted assets before deductions for excess AACL and allocated transfer risk reserve. 4. Institutions that have adopted ASU 2016-13 should report the excess AACL. 5. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should subtract the applicable portion of the AACL transitional amount or the modified AACL transitional amount, respectively, from the AACL, as defined in the regulatory capital rule, before determining the amount of excess AACL. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 78 of 86 RC-62 Schedule RC-R—Continued Part II—Continued Memoranda Dollar Amounts in Thousands RCON Amount 1. Current credit exposure across all derivative contracts covered by the regulatory capital rules……………………………………………………. G642 388,000 M.1. With a remaining maturity of (Column A) (Column B) (Column C) One year or less Over one year Over five years through five years Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 2. Notional principal amounts of over-the-counter derivative contracts: a. Interest rate…………………………………………………………………………………………………………… S582 168,000 S583 228,000 S584 104,000 M.2.a. b. Foreign exchange rate and gold………………………………………………………………………………………………………… S585 0 S586 0 S587 0 M.2.b. c. Credit (investment grade reference asset)…………………………………………………………………………………………………………… S588 0 S589 0 S590 0 M.2.c. d. Credit (non-investment grade reference asset)…………………………………………………………………………………………………………… S591 0 S592 0 S593 0 M.2.d. e. Equity…………………………………………………………………………………………………………… S594 0 S595 0 S596 0 M.2.e. f. Precious metals (except gold)………………………………………………………………. S597 0 S598 0 S599 0 M.2.f. g. Other…………………………………………………………………………………………………………… S600 0 S601 0 S602 0 M.2.g. 3. Notional principal amounts of centrally cleared derivative contracts: a. Interest rate…………………………………………………………………… S603 5,796,000 S604 13,317,000 S605 3,155,000 M.3.a. b. Foreign exchange rate and gold…………………………………………………………… S606 0 S607 0 S608 0 M.3.b. c. Credit (investment grade reference asset)…………………………………………………………………………………………………………… S609 0 S610 0 S611 0 M.3.c. d. Credit (non-investment grade reference asset)…………………………………………. S612 0 S613 0 S614 0 M.3.d. e. Equity…………………………………………………………………………………………………………… S615 0 S616 0 S617 0 M.3.e. f. Precious metals (except gold)…………………………………………………………………………………………………………… S618 0 S619 0 S620 0 M.3.f. g. Other………………………………………………………………………………………… S621 0 S622 0 S623 0 M.3.g. Dollar Amounts in Thousands RCON Amount 4. Amount of allowances for credit losses on purchased credit-deteriorated assets: (1) a. Loans and leases held for investment............................................................................................................................................................................................................................................ JJ30 0 M.4.a. b. Held-to-maturity debt securities................................................................................................................................................................................................................................. JJ31 0 M.4.b. c. Other financial assets measured at amortized cost JJ32 0 M.4.c. 1. Memorandum items 4.a through 4.c should be completed only by institutions that have adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 79 of 86 Schedule RC-S—Servicing, Securitization, and Asset Sale Activities RC-63 (Column A) (Column B to Column F) (Column G) 1–4 Family Not applicable All Other Loans, Residential All Leases, and Loans All Other Assets Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount Bank Securitization Activities 1. Outstanding principal balance of assets sold and securitized by the reporting bank with servicing retained or with recourse or other seller-provided credit enhancements ................................................................................................................... B705 0 B711 0 1. 2. Maximum amount of credit exposure arising from recourse or other seller-provided credit enhancements provided to structures reported in item 1………………………………………………… HU09 0 HU15 0 2. 3. Not applicable 4. Past due loan amounts included in item 1: a. 30–89 days past due .............................................................................................................. B733 0 B739 0 4.a. b. 90 days or more past due............................................................................................................................... B740 0 B746 0 4.b. 5. Charge-offs and recoveries on assets sold and securitized with servicing retained or with recourse or other seller-provided credit enhancements (calendar year-to-date): RIAD RIAD a. Charge-offs ................................................................................................................................. B747 0 B753 0 5.a. b. Recoveries ................................................................................................................................ B754 0 B760 0 5.b. Item 6 is to be completed by banks with $10 billion or more in total assets. (1) 6. Total amount of ownership (or seller’s) interest RCON carried as securities or loans…………………………………………………………………………… HU19 0 6. 7. and 8. Not applicable For Securitization Facilities Sponsored By or Otherwise Established By Other Institutions 9. Maximum amount of credit exposure arising from credit enhancements provided by the reporting bank to other institutions’ securitization structures in the form of standby letters of credit, purchased RCON subordinated securities, and other enhancements................................................................................................................. B776 0 B782 0 9. Item 10 is to be completed by banks with $10 billion or more in total assets (1) 10. Reporting bank’s unused commitments to provide liquidity to other institutions’ securitization structures .................................................................................................. B783 0 B789 0 10. Bank Asset Sales 11. Assets sold with recourse or other seller-provided credit enhancements and not securitized by the reporting bank...............................................................................................B790 0 B796 0 11. 12. Maximum amount of credit exposure arising from recourse or other seller-provided credit enhancements provided to assets reported in item 11.............................................................................................................................................. B797 0 B803 0 12. 1. The $10 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 80 of 86 Schedule RC-S—Continued RC-64 Memoranda Dollar Amounts in Thousands RCON Amount 1. Not applicable 2. Outstanding principal balance of assets serviced for others (includes participations serviced for others): a. Closed-end 1–4 family residential mortgages serviced with recourse or other servicer-provided credit enhancement...................................................................................................................................... B804 0 M.2.a. b. Closed-end 1–4 family residential mortgages serviced with no recourse or other servicer-provided credit enhancement............................................................................................................................................ B805 0 M.2.b. c. Other financial assets (includes home equity lines) A591 (1)............................................................................................................................................................................................ 0 M.2.c. d. 1–4 family residential mortgages serviced for others that are in process of foreclosure at quarter-end (includes closed-end and open-end loans) F699 0 M.2.d. Memorandum item 3 is to be completed by banks with $10 billion or more in total assets. (2) 3. Asset-backed commercial paper conduits: a. Maximum amount of credit exposure arising from credit enhancements provided to conduit structures in the form of standby letters of credit, subordinated securities, and other enhancements: (1) Conduits sponsored by the bank, a bank affiliate, or the bank’s holding company........................................................................................................................ B806 0 M.3.a.(1) (2) Conduits sponsored by other unrelated institutions.............................................................................................................................................................................................. B807 0 M.3.a.(2) b. Unused commitments to provide liquidity to conduit structures: (1) Conduits sponsored by the bank, a bank affiliate, or the bank’s holding company............................................................................................................... B808 0 M.3.b.(1) (2) Conduits sponsored by other unrelated institutions.............................................................................................................................................................................................. B809 0 M.3.b.(2) 4. Outstanding credit card fees and finance charges included in Schedule RC-S, item 1, column G C407 (2), (3)........................................................................................................................................................................................... 0 M.4. __________ 1. Memorandum item 2.c is to be completed if the principal balance of other financial assets serviced for others is more than $10 million. 2. The $10 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 3. Memorandum item 4 is to be completed by banks with $10 billion or more in total assets that (1) together with affiliated institutions, have outstanding credit card receivables (as defined in the instructions) that exceed $500 million as of the report date, or (2) are credit card specialty banks as defined for Uniform Bank Performance Report purposes. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 81 of 86 RC-65 Schedule RC-T—Fiduciary and Related Services RCON Yes No 1. Does the institution have fiduciary powers? (If “NO,” do not complete Schedule RC-T.) A345 x 1. 2. Does the institution exercise the fiduciary powers it has been granted? A346 x 2. 3. Does the institution have any fiduciary or related activity (in the form of assets or accounts) to report in this schedule? (If “NO,” do not complete the rest of Schedule RC-T.) B867 x 3. If the answer to item 3 is “YES,” complete the applicable items of Schedule RC-T, as follows: Institutions with total fiduciary assets (item 10, sum of columns A and B) greater than $250 million (as of the preceding December 31 report date) or with gross fiduciary and related services income greater than 10 percent of revenue (net interest income plus noninterest income) for the preceding calendar year must complete: • Items 4 through 22 and Memorandum item 3 quarterly, • Items 23 through 26 annually with the December report, and • Memorandum items 1, 2, and 4 annually with the December report. Institutions with total fiduciary assets (item 10, sum of columns A and B) less than or equal to $250 million (as of the preceding December 31 report date) that do not meet the fiduciary income test for quarterly reporting must complete: • Items 4 through 13 annually with the December report, and • Memorandum items 1 through 3 annually with the December report. • Institutions with total fiduciary assets greater than $100 million but less than or equal to $250 million (as of the preceding December 31 report date) that do not meet the fiduciary income test for quarterly reporting must also complete Memorandum item 4 annually with the December report. (Column A) (Column B) (Column C) (Column D) Managed Non-Managed Number of Number of Assets Assets Managed Non-Managed Accounts Accounts Dollar Amounts in Thousands Amount Amount Number Number Fiduciary and Related Assets RCON B868 RCON B869 RCON B870 RCON B871 4. Personal trust and agency accounts........................... 0 4,000 2 2 4. 5. Employee benefit and retirement-related trust and agency accounts: a. Employee benefit—defined RCON B872 RCON B873 RCON B874 RCON B875 contribution........................................................................................................................... 2,000 0 1 0 5.a. b. Employee benefit—defined RCON B876 RCON B877 RCON B878 RCON B879 benefit........................................................................................................................... 8,000 0 3 0 5.b. c. Other employee benefit and retirement- RCON B880 RCON B881 RCON B882 RCON B883 related accounts........................................................................................................................... 133,000 0 124 1 5.c. RCON B884 RCON B885 RCON C001 RCON C002 6. Corporate trust and agency accounts........................................................................................................................... 0 82,131,000 0 17,830 6. 7. Investment management and investment RCON B886 RCON J253 RCON B888 RCON J254 advisory agency accounts........................................................................................................................... 13,461,000 61,000 2,722 28 7. 8. Foundation and endowment trust and RCON J255 RCON J256 RCON J257 RCON J258 agency accounts..................................................................... 613,000 0 39 0 8. RCON B890 RCON B891 RCON B892 RCON B893 9. Other fiduciary accounts........................................................................................................................... 0 0 0 0 9. 10. Total fiduciary accounts RCON B894 RCON B895 RCON B896 RCON B897 (sum of items 4 through 9)............................................................ 14,217,000 82,196,000 2,891 17,861 10. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 82 of 86 RC-66 Schedule RC-T—Continued (Column A) (Column B) (Column C) (Column D) Managed Non-Managed Number of Number of Assets Assets Managed Non-Managed Accounts Accounts Dollar Amounts in Thousands Amount Amount Number Number RCON B898 RCON B899 11. Custody and safekeeping accounts............... 27,067,000 3,299 11. 12. Not applicable 13. Individual Retirement Accounts, Health Savings Accounts, and other similar ac- RCON J259 RCON J260 RCON J261 RCON J262 counts (included in items 5.c and 11)............................................................... 129,000 390,000 122 479 13. Dollar Amounts in Thousands RIAD Amount Fiduciary and Related Services Income 14. Personal trust and agency accounts.............................................................................................................................................................................................. B904 0 14. 15. Employee benefit and retirement-related trust and agency accounts: a. Employee benefit—defined contribution................................................................................................................................ B905 0 15.a. b. Employee benefit—defined benefit...................................................................................................................................... B906 0 15.b. c. Other employee benefit and retirement-related accounts............................................................................................... B907 1,000 15.c. 16. Corporate trust and agency accounts............................................................................................................................. A479 244,000 16. 17. Investment management and investment advisory agency accounts............................................................................................... J315 23,000 17. 18. Foundation and endowment trust and agency accounts........................................................................................................ J316 2,000 18. 19. Other fiduciary accounts............................................................................................................................................. A480 0 19. 20. Custody and safekeeping accounts........................................................................................................................................... B909 9,000 20. 21. Other fiduciary and related services income............................................................................................................................ B910 0 21. 22. Total gross fiduciary and related services income (sum of items 14 through 21) (must equal Schedule RI, item 5.a)............................................................................................................................................................ 4070 279,000 22. 23. Less: Expenses.............................................................................................................................................................................................. C058 143,000 23. 24. Less: Net losses from fiduciary and related services............................................................................................... A488 0 24. 25. Plus: Intracompany income credits for fiduciary and related services............................................................................................... B911 0 25. 26. Net fiduciary and related services income.............................................................................................................................................................................................. A491 136,000 26. (Column A) (Column B) (Column C) Personal Trust and Employee Benefit All Other Accounts Memoranda Agency and Investment and Retirement-Related Management Agency Trust and Agency Accounts Accounts Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. Managed assets held in fiduciary accounts: a. Noninterest-bearing deposits............................................................................................... J263 (28,000) J264 0 J265 0 M.1.a. b. Interest-bearing deposits............................................................................................... J266 318,000 J267 3,000 J268 5,000 M.1.b. c. U.S. Treasury and U.S. Government agency obligations............................................................................................... J269 737,000 J270 14,000 J271 67,000 M.1.c. d. State, county, and municipal obligations............................................................................................... J272 1,854,000 J273 0 J274 12,000 M.1.d. e. Money market mutual funds............................................................................................... J275 570,000 J276 3,000 J277 26,000 M.1.e. f. Equity mutual funds............................................................................................... J278 1,153,000 J279 35,000 J280 57,000 M.1.f. g. Other mutual funds............................................................................................... J281 638,000 J282 18,000 J283 23,000 M.1.g. h. Common trust funds and collective investment funds............................................................................................... J284 845,000 J285 0 J286 0 M.1.h. i. Other short-term obligations........................................................................................... J287 660,000 J288 2,000 J289 18,000 M.1.i. j. Other notes and bonds................................................................................. J290 1,945,000 J291 24,000 J292 212,000 M.1.j. k. Investments in unregistered funds and private equity investments........................................................................ J293 64,000 J294 1,000 J295 1,000 M.1.k. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 83 of 86 RC-67 Schedule RC-T—Continued Memoranda—Continued (Column A) (Column B) (Column C) Personal Trust and Employee Benefit All Other Accounts Agency and Investment and Retirement-Related Management Agency Trust and Agency Accounts Accounts Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. l. Other common and preferred stocks…………………………………………………..…… J296 4,253,000 J297 43,000 J298 192,000 M.1.l. m. Real estate mortgages…….……………………….……..................................... J299 0 J300 0 J301 0 M.1.m. n. Real estate……………………………………………………………………..…… J302 44,000 J303 0 J304 0 M.1.n. o. Miscellaneous assets……………………………………………………………………..…… J305 408,000 J306 0 J307 0 M.1.o. p. Total managed assets held in fiduciary accounts (for each column, sum of Memorandum items 1.a through 1.o)............................................ J308 13,461,000 J309 143,000 J310 613,000 M.1.p. (Column A) (Column B) Managed Assets Number of Managed Accounts Dollar Amounts in Thousands RCON Amount RCON Number 1. q. Investments of managed fiduciary accounts in advised or sponsored mutual funds…………………………………………………………………………............................. J311 226,000 J312 2,036 M.1.q. (Column A) (Column B) Number of Principal Amount Issues Outstanding Dollar Amounts in Thousands RCON Number Amount 2. Corporate trust and agency accounts: RCON B928 a. Corporate and municipal trusteeships………………………………………………………..……............................. B927 6,102 1,179,867,000 M.2.a. RCON J314 (1) Issues reported in Memorandum item 2.a that are in default............................................................... J313 322 25,636,000 M.2.a.(1) b. Transfer agent, registrar, paying agent, and other corporate agency…………………….……..................... B929 21,482 M.2.b. Memorandum items 3.a through 3.h are to be completed by banks with collective investment funds and common trust funds with a total market value of $1 billion or more as of the preceding December 31 report date. Memorandum item 3.h only is to be completed by banks with collective investment funds and common trust funds with a total market value of less than $1 billion as of the preceding December 31 report date. (Column A) (Column B) Number of Funds Market Value of Fund Assets Dollar Amounts in Thousands RCON Number RCON Amount 3. Collective investment funds and common trust funds a. Domestic equity………………………………………………………………………..……............................ B931 3 B932 396,000 M.3.a. b. International/Global equity…………………………………………………………….……............................ B933 1 B934 165,000 M.3.b. c. Stock/Bond blend……………………………………………………………………………............................... B935 0 B936 0 M.3.c. d. Taxable bond…………………………………………………………………………..……................................ B937 1 B938 99,000 M.3.d. e. Municipal bond………………………………………………………………………………................................... B939 1 B940 184,000 M.3.e. f. Short-term investments/Money market…………………………………………………….................................. B941 0 B942 0 M.3.f. g. Specialty/Other………………………………………………………………………..…….............................. B943 0 B944 0 M.3.g. h. Total collective investment funds (sum of Memorandum items 3.a through 3.g)…………………………………………………………………………….…….............................. B945 6 B946 844,000 M.3.h. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 84 of 86 RC-68 Schedule RC-T—Continued Memoranda—Continued (Column A) (Column B) (Column C) Gross Losses Gross Losses Recoveries Managed Non-Managed Accounts Accounts Dollar Amounts in Thousands RIAD Amount RIAD Amount RIAD Amount 4. Fiduciary settlements, surcharges, and other losses: a. Personal trust and agency accounts……………………….…………........................................ B947 0 B948 0 B949 0 M.4.a. b. Employee benefit and retirement-related trust and agency accounts……………..…………..…………..…………..…………............................... B950 0 B951 0 B952 0 M.4.b. c. Investment management and investment advisory agency accounts……………..…………..…………..…………..…………................................... B953 0 B954 0 B955 0 M.4.c. d. Other fiduciary accounts and related services……………………….…................................ B956 0 B957 0 B958 0 M.4.d. e. Total fiduciary settlements, surcharges, and other losses (sum of Memorandum items 4.a through 4.d) (sum of columns A and B minus column C must equal Schedule RC-T, item 24)……………………………………..…………........................................ B959 0 B960 0 B961 0 M.4.e. Person to whom questions about Schedule RC-T—Fiduciary and Related Services should be directed: Scott Iacono, Director Name and Title (TEXT B962) Scott.Iacono@db.com E-mail Address (TEXT B926) 212-250-8948 Area Code / Phone Number / Extension (TEXT B963) 212-797-0541 Area Code / FAX Number (TEXT B964) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 85 of 86 RC-69 Schedule RC-V—Variable Interest Entities (1) (Column A) (Column B) Securitization Vehicles Other VIEs Dollar Amounts in Thousands RCON Amount RCON Amount 1. Assets of consolidated variable interest entities (VIEs) that can be used only to settle obligations of the consolidated VIEs: a. Cash and balances due from depository institutions ........................................................................ J981 0 JF84 0 1.a. b. Securities not held for trading ...................................................................................................... HU20 0 HU21 0 1.b. c. Loans and leases held for investment, net of allowance, and held for sale……………………………….......................................... HU22 0 HU23 0 1.c. d. Other real estate owned………………..………..………............................................ K009 0 JF89 0 1.d. e. Other assets .................................................................................................................................. JF91 0 JF90 0 1.e. 2. Liabilities of consolidated VIEs for which creditors do not have recourse to the general credit of the reporting bank: a. Other borrowed money ................................................................................................................. JF92 0 JF85 0 2.a. b. Other liabilities .......................................................................................................................... JF93 0 JF86 0 2.b. 3. All other assets of consolidated VIEs (not included in items 1.a through 1.e above) ............................................................................................................ K030 0 JF87 0 3. 4. All other liabilities of consolidated VIEs (not included in items 2.a and 2.b above) ......................................................................................... K033 0 JF88 0 4. Dollar Amounts in Thousands RCON Amount 5. Total assets of asset-backed commercial paper (ABCP) conduit VIEs............................................................................................. JF77 0 5. 6. Total liabilities of ABCP conduit VIEs....................................................................................................................................... JF78 0 6. 1. Institutions that have adopted ASU 2016-13 should report assets net of any applicable allowance for credit losses. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 86 of 86 RC-70 Optional Narrative Statement Concerning the Amounts Reported in the Consolidated Reports of Condition and Income The management of the reporting bank may, if it wishes, submit a brief narrative statement on the amounts reported in the Consolidated Reports of Condition and Income. This optional statement will be made available to the public, along with the publicly available data in the Consolidated Reports of Condition and Income, in response to any request for individual bank report data. However, the information reported in Schedule RI-E, item 2.g; Schedule RC-C, Part I, Memorandum items 17.a and 17.b; Schedule RC-O, Memorandum items 6 through 9, 14, 15, and 18; and Schedule RC-P, items 7.a and 7.b, is regarded as confidential and will not be made available to the public on an individual institution basis. BANKS CHOOSING TO SUBMIT THE NARRATIVE STATEMENT SHOULD ENSURE THAT THE STATEMENT DOES NOT CONTAIN THE NAMES OR OTHER IDENTIFICATIONS OF INDIVIDUAL BANK CUSTOMERS, REFERENCES TO THE AMOUNTS REPORTED IN THE CONFIDENTIAL ITEMS IDENTIFIED ABOVE, OR ANY OTHER INFORMATION THAT THEY ARE NOT WILLING TO HAVE MADE PUBLIC OR THAT WOULD COMPROMISE THE PRIVACY OF THEIR CUSTOMERS. Banks choosing not to make a statement may check the “No comment” box below and should make no entries of any kind in the space provided for the narrative statement; i.e., DO NOT enter in this space such phrases as “No statement,” “Not applicable,” “N/A,” “No comment,” and “None.” The optional statement must be entered on this sheet. The statement should not exceed 100 words. Further, regardless of the number of words, the statement must not exceed 750 characters, including punctuation, indentation, and standard spacing between words and sentences. If any submission should exceed 750 characters, as defined, it will be truncated at 750 characters with no notice to the submitting bank and the truncated statement will appear as the bank’s statement both on agency computerized records and in computer-file releases to the public. All information furnished by the bank in the narrative statement must be accurate and not misleading. Appropriate efforts shall be taken by the submitting bank to ensure the statement’s accuracy. If, subsequent to the original submission, material changes are submitted for the data reported in the Consolidated Reports of Condition and Income, the existing narrative statement will be deleted from the files, and from disclosure; the bank, at its option, may replace it with a statement appropriate to the amended data. The optional narrative statement will appear in agency records and in release to the public exactly as submitted (or amended as described in the preceding paragraph) by the management of the bank (except for the truncation of statements exceeding the 750-character limit described above). THE STATEMENT WILL NOT BE EDITED OR SCREENED IN ANY WAY BY THE SUPERVISORY AGENCIES FOR ACCURACY OR RELEVANCE. DISCLOSURE OF THE STATEMENT SHALL NOT SIGNIFY THAT ANY FEDERAL SUPERVISORY AGENCY HAS VERIFIED OR CONFIRMED THE ACCURACY OF THE INFORMATION CONTAINED THEREIN. A STATEMENT TO THIS EFFECT WILL APPEAR ON ANY PUBLIC RELEASE OF THE OPTIONAL STATEMENT SUBMITTED BY THE MANAGEMENT OF THE REPORTING BANK. Comments? RCON Yes No 6979 x BANK MANAGEMENT STATEMENT (please type or print clearly; 750 character limit): (TEXT 6980) 06/2012
Exhibit 25.3
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM T-1
STATEMENT OF ELIGIBILITY
UNDER THE TRUST INDENTURE ACT OF 1939
OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE
| ☐ | CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) |
DEUTSCHE BANK TRUST COMPANY AMERICAS
(formerly BANKERS TRUST COMPANY)
(Exact name of trustee as specified in its charter)
| NEW YORK | 13-4941247 | |
| (Jurisdiction of Incorporation or organization if not a U.S. national bank) |
(I.R.S. Employer Identification no.) | |
| 1 COLUMBUS CIRCLE NEW YORK, NEW YORK |
10019 | |
| (Address of principal executive offices) | (Zip Code) | |
Deutsche Bank Trust Company Americas
1 Columbus Circle
New York, New York 10019
(212) 250 – 2500
(Name, address and telephone number of agent for service)
GlaxoSmithKline Capital plc
(Exact name of Obligor as specified in its charter)
England and Wales
(State or other jurisdiction of incorporation or organization)
Not Applicable
(I.R.S. Employer Identification No.)
980 Great West Road, Brentford
Middlesex TW8 9GS, England
+44 (0) 20 8047 5000
(Address and telephone number of Obligor’s principal executive offices)
GUARANTEED DEBT SECURITIES OF GLAXOSMITHKLINE CAPITAL PLC
GUARANTEE OF GSK PLC IN CONNECTION WITH GUARANTEED DEBT SECURITIES OF
GLAXOSMITHKLINE CAPITAL PLC
(Title of the Indenture securities)
| Item 1. | General Information. |
Furnish the following information as to the trustee.
| (a) | Name and address of each examining or supervising authority to which it is subject. |
| Name |
Address | |
| Federal Reserve Bank (2nd District) | New York, NY | |
| Federal Deposit Insurance Corporation | Washington, D.C. | |
| New York State Banking Department | Albany, NY | |
| (b) | Whether it is authorized to exercise corporate trust powers. |
Yes.
| Item 2. | Affiliations with Obligor. |
If the obligor is an affiliate of the Trustee, describe each such affiliation.
NA
| Item 3. -15. | Not Applicable |
| Item 16. | List of Exhibits. |
| Exhibit 1 - | Restated Organization Certificate of Bankers Trust Company dated August 31, 1998; Certificate of Amendment of the Organization Certificate of Bankers Trust Company dated September 25, 1998; Certificate of Amendment of the Organization Certificate of Bankers Trust Company dated December 18, 1998;Certificate of Amendment of the Organization Certificate of Bankers Trust Company dated September 3, 1999; and Certificate of Amendment of the Organization Certificate of Bankers Trust Company dated March 14, 2002, incorporated herein by reference to Exhibit 1 filed with Form T-1 Statement, Registration No. 333-201810. | |
| Exhibit 2 - | Certificate of Authority to commence business, incorporated herein by reference to Exhibit 2 filed with Form T-1 Statement, Registration No. 333-201810. | |
| Exhibit 3 - | Authorization of the Trustee to exercise corporate trust powers, incorporated herein by reference to Exhibit 3 filed with Form T-1 Statement, Registration No. 333-201810. | |
| Exhibit 4 - | A copy of existing By-Laws of Deutsche Bank Trust Company Americas, dated March 2, 2023 (see attached). | |
| Exhibit 5 - | Not applicable. | |
| Exhibit 6 - | Consent of Bankers Trust Company required by Section 321(b) of the Act, incorporated herein by reference to Exhibit 6 filed with Form T-1 Statement, Registration No. 333-201810. | |
| Exhibit 7 - | A copy of the latest report of condition of the trustee published pursuant to law or the requirements of its supervising or examining authority. | |
| Exhibit 8 - | Not Applicable. | |
| Exhibit 9 - | Not Applicable. | |
SIGNATURE
Pursuant to the requirements of the Trust Indenture Act of 1939, as amended, the trustee, Deutsche Bank Trust Company Americas, a corporation organized and existing under the laws of the State of New York, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in The City of New York, and State of New York, on this 20th day of March , 2024.
| DEUTSCHE BANK TRUST COMPANY AMERICAS | ||
| By: | /s/ Irina Golovashchuk | |
| Name: Irina Golovashchuk | ||
| Title: Vice President | ||
Exhibit 4
AMENDED AND RESTATED
BY-LAWS
OF
DEUTSCHE BANK TRUST COMPANY AMERICAS
ARTICLE I
STOCKHOLDERS
Section 1.01. Annual Meeting. The annual meeting of the stockholders of Deutsche Bank Trust Company Americas (the “Company”) shall be held in the City of New York within the State of New York within the first four months of the Company’s fiscal year, on such date and at such time and place as the board of directors of the Company (“Board of Directors” or “Board”) may designate in the call or in a waiver of notice thereof, for the purpose of electing directors and for the transaction of such other business as may properly be brought before the meeting.
Section 1.02. Special Meetings. Special meetings of the stockholders of the Company may be called by the Board of Directors or by the President, and shall be called by the President or by the Secretary upon the written request of the holders of record of at least twenty-five percent (25%) of the shares of stock of the Company issued and outstanding and entitled to vote, at such times. If for a period of thirteen months after the last annual meeting, there is a failure to elect a sufficient number of directors to conduct the business of the Company, the Board of Directors shall call a special meeting for the election of directors within two weeks after the expiration of such period; otherwise, holders of record of ten percent (10%) of the shares of stock of the Company entitled to vote in an election of directors may, in writing, demand the call of a special meeting at the office of the Company for the election of directors, specifying the date and month thereof, but not less than two nor more than three months from the date of such call. At any such special meeting called on demand of stockholders, the stockholders attending, in person or by proxy, and entitled to vote in an election of directors shall constitute a quorum for the purpose of electing directors, but not for the transaction of any other business.
Section 1.03. Notice of Meetings. Notice of the time, place and purpose of every meeting of stockholders shall be delivered personally or mailed not less than 10 nor more than 50 days before the date of such meeting (or any other action) to each stockholder of record entitled to vote, at his post office address appearing upon the records of the Company or at such other address as shall be furnished in writing by him to the Secretary of the Company for such purpose. Such further notice shall be given as may be required by law or by these By-Laws. Any meeting may be held without notice if all stockholders entitled to vote are present in person or by proxy, or if notice is waived in writing, either before or after the meeting, by those not present.
Section 1.04. Quorum. The holders of record of at least a majority of the shares of the stock of the Company issued and outstanding and entitled to vote, present in person or by proxy, shall, except as otherwise provided by law, by the Company’s Organization Certificate or by these By-Laws, constitute a quorum at all meetings of the stockholders; if there be no such quorum, the holders of a majority of such shares so present or represented may adjourn the meeting from time to time until a quorum shall have been obtained.
Section 1.05. Organization of Meetings. Meetings of the stockholders shall be presided over by the Chairman of the Board or, if he is not present, by the President or, if he is not present, by a chairman to be chosen at the meeting. The Secretary of the Company, or in his absence an Assistant Secretary, shall act as secretary of the meeting, if present.
- 1 -
Section 1.06. Voting. At each meeting of stockholders, except as otherwise provided by statute, the Company’s Organization Certificate or these By-Laws, every holder of record of stock entitled to vote shall be entitled to one vote in person or by proxy for each share of such stock standing in his name on the records of the Company. Elections of directors shall be determined by a plurality of the votes cast thereat and, except as otherwise provided by statute, the Company’s Organization Certificate or these By-Laws, all other action shall be determined by a majority of the votes cast at such meeting.
At all elections of directors, the voting shall be by ballot or in such other manner as may be determined by the stockholders present in person or by proxy entitled to vote at such election.
Section 1.07. Action by Consent. Except as may otherwise be provided in the Company’s Organization Certificate, any action required or permitted to be taken at any meeting of stockholders may be taken without a meeting, without prior notice and without a vote if, prior to such action, a written consent or consents thereto, setting forth such action, is signed by all the holders of record of shares of the stock of the Company, issued and outstanding and entitled to vote thereon, having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted.
ARTICLE II
DIRECTORS
Section 2.01. Chairman of the Board. Following the election of the Board of Directors at each annual meeting, the elected Board shall appoint one of its members as Chairman. The Chairman of the Board shall preside at all meetings of the Board of Directors and of the stockholders, and he shall perform such other duties and have such other powers as from time to time may be prescribed by the Board of Directors.
Section 2.02. Lead Independent Director. Following the election of the Board of Directors at each annual meeting, the elected Board may appoint one of its independent members as its Lead Independent Director. When the Chairman of the Board is not present at a meeting of the Board of Directors, the Lead Independent Director, if there be one, shall preside.
Section 2.03. Director Emeritus. The Board of Directors may from time to time elect one or more Directors Emeritus. Each Director Emeritus shall be elected for a term expiring on the date of the regular meeting of the Board of Directors following the next annual meeting. No Director Emeritus shall be considered a “director” for purposes of these By-Laws or for any other purpose.
Section 2.04. Powers, Number, Quorum, Term, Vacancies, Removal. The business and affairs of the Company shall be managed by or under the direction of the Board of Directors which may exercise all such powers of the Company and do all such lawful acts and things as are not by statute or by the Company’s Organization Certificate or by these By-Laws required to be exercised or done by the stockholders.
The number of directors may be changed by a resolution passed by a majority of the members of the Board of Directors or by a vote of the holders of record of at least a majority of the shares of stock of the Company issued and outstanding and entitled to vote, but at all times the Board of Directors must consist of not less than seven nor more than thirty directors. No more than one-third of the directors shall be active officers or employees of the Company. At least one-half of the directors must be citizens of the United States at the time of their election and during their continuance in office.
- 2 -
Except as otherwise required by law, rule or regulation, or by the Company’s Organization Certificate, at all meetings of the Board of Directors or any committee thereof, a majority of the entire Board of Directors or a majority of the directors constituting such committee, as the case may be, shall constitute a quorum for the transaction of business and the act of a majority of the directors or committee members present at any meeting at which there is a quorum shall be the act of the Board of Directors, or such committee, as applicable. Any one or more members of the Board may participate in a meeting of the Board by means of a conference telephone or video, or other similar communications equipment allowing all persons participating in the meeting to hear each other at the same time. Participation by such means shall constitute presence in person at a meeting. Whether or not a quorum shall be present at any meeting of the Board of Directors or a committee thereof, a majority of the directors present thereat may adjourn the meeting from time to time; notice of the adjourned meeting shall be given to the directors who were not present at the time of the adjournment, but if the time and place of the adjourned meeting are announced, no additional notice shall be required to be given to the directors present at the time of adjournment.
Directors shall hold office until the next annual election and until their successors shall have been elected and shall have qualified. Director vacancies not exceeding one-third of the whole number of the Board of Directors may be filled by the affirmative vote of a majority of the directors then in office, and the directors so elected shall hold office for the balance of the unexpired term.
Any one or more of the directors of the Company may be removed either with or without cause at any time by a vote of the holders of record of at least a majority of the shares of stock of the Company, issued and outstanding and entitled to vote, and thereupon the term of the director or directors who shall have been so removed shall forthwith terminate and there shall be a vacancy or vacancies in the Board of Directors, to be filled by a vote of the stockholders as provided in these By-Laws.
Section 2.05. Meetings, Notice. Meetings of the Board of Directors shall be held at such place either within or without the State of New York, as may from time to time be fixed by resolution of the Board, or as may be specified in the call or in a waiver of notice thereof. Regular meetings of the Board of Directors and its Executive Committee shall be held as often as may be required under applicable law, and special meetings may be held at any time upon the call of two directors, the Chairman of the Board or the President, by oral, telegraphic or written notice duly served on or sent or mailed to each director not less than two days before such meeting. Any meeting may be held without notice, if all directors are present, or if notice is waived in writing, either before or after the meeting, by those not present.
Section 2.06. Compensation. The Board of Directors may determine, from time to time, the amount of compensation, which shall be paid to its members. The Board of Directors shall also have power, in its discretion, to allow a fixed sum and expenses for attendance at each regular or special meeting of the Board, or of any committee of the Board. The Board of Directors shall also have power, in its discretion, to provide for and pay to directors rendering services to the Company not ordinarily rendered by directors, as such, special compensation appropriate to the value of such services, as determined by the Board from time to time.
ARTICLE III
COMMITTEES
Section 3.01. Executive Committee. There shall be an Executive Committee of the Board who shall be appointed annually by resolution adopted by the majority of the entire Board of Directors. The Chairman of the Board shall preside at meetings of the Executive Committee. In his absence, the Chief Executive Officer or, in his absence, the President or any Co-President or, in their absence, such other member of the Executive Committee as the Executive Committee from time to time may designate shall preside at such meetings.
- 3 -
Section 3.02. Audit and Fiduciary Committee. There shall be an Audit and Fiduciary Committee appointed annually by resolution adopted by a majority of the entire Board of Directors which shall consist of such number of independent directors, as may from time to time be fixed by the Audit and Fiduciary Committee charter adopted by the Board of Directors.
Section 3.03. Other Committees. The Board of Directors shall have the power to appoint any other Committees as may seem necessary, and from time to time to suspend or continue the powers and duties of such Committees. Each Committee appointed pursuant to this Article shall serve at the pleasure of the Board of Directors.
Section 3.04. Limitations. No committee shall have the authority as to the following matters: (i) the submission to stockholders of any action that needs stockholders’ authorization under New York Banking Law; (ii) the filling of vacancies in the Board of Directors or in any such committee; (iii) the fixing of compensation of the directors for serving on the Board of Directors or on any committee; (iv) the amendment or repeal of these By-Laws, or the adoption of new by-laws; (v) the amendment or repeal of any resolution of the Board of Directors which by its terms shall not be so amendable or repealable; or (vi) the taking of action which is expressly required by any provision of New York Banking Law to be taken at a meeting of the Board of Directors or by a specified proportion of the directors.
ARTICLE IV
OFFICERS
Section 4.01. Titles and Election. The officers of the Company, who shall be chosen by the Board of Directors within twenty-five days after each annual meeting of stockholders, shall be a President, Chief Executive Officer, Chief Risk Officer, Chief Financial Officer, Treasurer, Secretary, and a General Auditor. The Board of Directors from time to time may elect one or more Managing Directors, Directors, Vice Presidents, Assistant Secretaries, Assistant Treasurers and such other officers and agents as it shall deem necessary, and may define their powers and duties. Any number of offices may be held by the same person, except the offices of President and Secretary.
Section 4.02. Terms of Office. Each officer shall hold office for the term for which he is elected or appointed, and until his successor has been elected or appointed and qualified.
Section 4.03. Removal. Any officer may be removed, either with or without cause, at any time, by the affirmative vote of a majority of the Board of Directors.
Section 4.04. Resignations. Any officer may resign at any time by giving written notice to the Board of Directors or to the Secretary. Such resignation shall take effect at the time specified therein and, unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective.
Section 4.05. Vacancies. If the office of any officer or agent becomes vacant by reason of death, resignation, retirement, disqualification, removal from office or otherwise, the Board of Directors may choose a successor, who shall hold office for the unexpired term in respect of which such vacancy occurred.
- 4 -
Section 4.06. President. The President shall have general authority to exercise all the powers necessary for the President of the Company. In the absence of the Chairman and the Lead Independent Director, the President shall preside at all meetings of the Board of Directors and of the stockholders. The President shall have the power to execute bonds, mortgages and other contracts, agreements and instruments of the Company, and he shall perform such other duties and have such other powers as may be incident to the office of the president of a corporation and as from time to time may otherwise be prescribed by the Board of Directors.
Section 4.07. Chief Executive Officer. Unless otherwise determined by the Board of Directors, the President shall be the Chief Executive Officer of the Company. The Chief Executive Officer shall exercise the powers and perform the duties usual to the chief executive officer and, subject to the control of the Board of Directors, shall have general management and control of the affairs and business of the Company; he shall appoint and discharge employees and agents of the Company (other than officers elected by the Board of Directors); he shall see that all orders and resolutions of the Board of Directors are carried into effect; he shall have the power to execute bonds, mortgages and other contracts, agreements and instruments of the Company, and he shall perform such other duties and have such other powers as may be incident to the office of the chief executive officer of a corporation and as from time to time may otherwise be prescribed by the Board of Directors.
Section 4.08. Chief Risk Officer. The Chief Risk Officer shall have the responsibility for the risk management and monitoring of the Company. The Chief Risk Officer shall have the power to execute bonds, notes, mortgages and other contracts, agreements and instruments of the Company, and he shall perform such other duties and have such other powers as may be incident to his office and as from time to time may otherwise be prescribed by the Board of Directors.
Section 4.09. Chief Financial Officer. The Chief Financial Officer shall have the responsibility for reporting to the Board of Directors on the financial condition of the Company, preparing and submitting all financial reports required by applicable law, and preparing annual financial statements of the Company and coordinating with qualified third party auditors to ensure such financial statements are audited in accordance with applicable law.
Section 4.10. Treasurer. The Treasurer shall have the custody of the corporate funds and securities and shall keep full and accurate accounts of receipts and disbursements in books belonging to the Company and shall deposit all moneys, and other valuable effects in the name and to the credit of the Company, in such depositories as may be designated by the Board of Directors. He shall disburse the funds of the Company as may be ordered by the Board, taking proper vouchers for such disbursements, and shall render to the directors whenever they may require it an account of all his transactions as Treasurer and of the financial condition of the Company.
Section 4.11. Secretary. The Secretary shall attend all sessions of the Board of Directors and all meetings of the stockholders and record all votes and the minutes of proceedings in records or books to be kept for that purpose. He shall give, or cause to be given, notice of all meetings of the stockholders and of the Board of Directors and shall perform such other duties and have such other powers as may be incident to the office of the secretary of a corporation and as from time to time may otherwise be prescribed by the Board of Directors. The Secretary shall have and be the custodian of the stock records and all other books, records and papers of the Company (other than financial) and shall see that all books, reports, statements, certificates and other documents and records required by law are properly kept and filed.
- 5 -
Section 4.12. General Auditor. The General Auditor shall be responsible, through the Audit and Fiduciary Committee, to the Board of Directors for the determination of the program of the internal audit function and the evaluation of the adequacy of the system of internal controls. Subject to the Board of Directors, the General Auditor shall have and may exercise all the powers and shall perform all the duties usual to such office and shall have such other powers as may be prescribed or assigned to him from time to time by the Board of Directors or vested in him by law or by these By-Laws. He shall perform such other duties and shall make such investigations, examinations and reports as may be prescribed or required by the Audit and Fiduciary Committee. The General Auditor shall have unrestricted access to all records and premises of the Company and shall delegate such authority to his subordinates. He shall have the duty to report to the Audit and Fiduciary Committee on all matters concerning the internal audit program and the adequacy of the system of internal controls of the Company which he deems advisable or which the Audit and Fiduciary Committee may request.
Section 4.13. Managing Directors, Directors and Vice Presidents. If chosen, the Managing Directors, Directors and Vice Presidents, in the order of their seniority, shall, in the absence or disability of the President, exercise all of the powers and duties of the President. Such Managing Directors, Directors and Vice Presidents shall have the power to execute bonds, notes, mortgages and other contracts, agreements and instruments of the Company, and they shall perform such other duties and have such other powers as may be incident to their respective offices and as from time to time may be prescribed by the Board of Directors or the President.
Section 4.14. Duties of Officers may be Delegated. In case of the absence or disability of any officer of the Company, or for any other reason that the Board may deem sufficient, the Board may delegate, for the time being, the powers or duties, or any of them, of such officer to any other officer.
ARTICLE V
INDEMNIFICATION OF DIRECTORS, OFFICERS AND OTHERS
Section 5.01. Power to Indemnify in Actions, Suits or Proceedings other than Those by or in the Right of the Company. Subject to the other provisions of this Article V, and subject to applicable law, the Company shall indemnify any person made or threatened to be made a party to an action or proceeding (other than one by or in the right of the Company to procure a judgment in its favor), whether civil or criminal, including an action by or in the right of any other corporation of any type or kind, domestic or foreign, or any partnership, joint venture, trust, employee benefit plan or other enterprise, which any director or officer of the Company served in any capacity at the request of the Company, by reason of the fact that such person, his or her testator or intestate, was a director or officer of the Company, or served such other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise in any capacity, against judgments, fines, amounts paid in settlement and reasonable expenses, including attorneys’ fees actually and necessarily incurred as a result of such action or proceeding, or any appeal therein, if such director or officer acted, in good faith, for a purpose which such person reasonably believed to be in, or, in the case of service for any other corporation or any partnership, joint venture, trust, employee benefit plan or other enterprise, not opposed to, the best interests of the Company, and had no reasonable cause to believe that such person’s conduct was unlawful.
Section 5.02. Power to Indemnify in Actions, Suits or Proceedings by or in the Right of the Company. Subject to the other provisions of this Article V, and subject to applicable law, the Company shall indemnify any person made, or threatened to be made, a party to an action by or in the right of the Company to procure a judgment in its favor by reason of the fact that such person, his or her testator or intestate, is or was a director or officer of the Company, or is or was serving at the request of the Company as a director or officer of any other corporation of any type or kind, domestic or foreign, of any partnership, joint venture, trust, employee benefit plan or other enterprise, against amounts paid in settlement and reasonable
- 6 -
expenses, including attorneys’ fees, actually and necessarily incurred by such person in connection with the defense or settlement of such action, or in connection with an appeal therein, if such director or officer acted, in good faith, for a purpose which he reasonably believed to be in, or, in the case of service for any other corporation or any partnership, joint venture, trust, employee benefit plan or other enterprise, not opposed to, the best interests of the Company, except that no indemnification under this Section 5.02 shall be made in respect of (a) a threatened action, or a pending action which is settled or otherwise disposed of, or (b) any claim, issue or matter as to which such person shall have been adjudged to be liable to the Company, unless and only to the extent that the court in which the action was brought, or, if no action was brought, any court of competent jurisdiction, determines upon application that, in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such portion of the settlement amount and expenses as the court deems proper.
Section 5.03. Authorization of Indemnification. Any indemnification under this Article V (unless ordered by a court) shall be made by the Company only if authorized in the specific case (i) by the Board acting by a quorum consisting of directors who are not parties to such action or proceeding upon a finding that the director or officer has met the standard of conduct set forth in Section 5.01 or Section 5.02, as the case may be; or (ii) if a quorum is not obtainable or, even if obtainable, a quorum of disinterested directors so directs, (x) by the Board upon the opinion in writing of independent legal counsel that indemnification is proper in the circumstances because the applicable standard of conduct set forth in Section 5.01 or Section 5.02, as the case may be, has been met by such director or officer; or (y) by the stockholders upon a finding that the director or officer has met the applicable standard of conduct set forth in Section 5.01 or Section 5.02, as the case may be. A person who has been successful on the merits or otherwise, in the defense of a civil or criminal action or proceeding of the character described in Sections 5.01 or 5.02, shall be entitled to indemnification as authorized in such section.
Section 5.04. Good Faith Defined. For purposes of any determination under Section 5.03, a person shall be deemed to have acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Company, or to have had no reasonable cause to believe such person’s conduct was unlawful, if such person’s action is based on the records or books of account of the Company or another enterprise, or on information supplied to such person by the officers of the Company or another enterprise in the course of their duties, or on the advice of legal counsel for the Company or another enterprise or on information or records given or reports made to the Company or another enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by the Company or another enterprise. The provisions of this Section 5.04 shall not be deemed to be exclusive or to limit in any way the circumstances in which a person may be deemed to have met the applicable standard of conduct set forth in Section 5.01 or Section 5.02, as the case may be.
Section 5.05. Serving an Employee Benefit Plan on behalf of the Company. For the purpose of this Article V, the Company shall be deemed to have requested a person to serve an employee benefit plan where the performance by such person of his duties to the Company also imposes duties on, or otherwise involves services by, such person to the plan or participants or beneficiaries of the plan; excise taxes assessed on a person with respect to an employee benefit plan pursuant to applicable law shall be considered fines; and action taken or omitted by a person with respect to an employee benefit plan in the performance of such person’s duties for a purpose reasonably believed by such person to be in the interest of the participants and beneficiaries of the plan shall be deemed to be for a purpose which is not opposed to the best interests of the Company.
- 7 -
Section 5.06. Indemnification upon Application to a Court. Notwithstanding the failure of the Company to provide indemnification and despite any contrary resolution of the Board or stockholders under Section 5.03, or in the event that no determination has been made within ninety days after receipt of the Company of a written claim therefor, upon application to a court by a director or officer, indemnification shall be awarded by a court to the extent authorized in Section 5.01 or Section 5.02. Such application shall be upon notice to the Company. Neither a contrary determination in the specific case under Section 5.03 nor the absence of any determination thereunder shall be a defense to such application or create a presumption that the director or officer seeking indemnification has not met any applicable standard of conduct.
Section 5.07. Expenses Payable in Advance. Subject to the other provisions of this Article V, and subject to applicable law, expenses incurred in defending a civil or criminal action or proceeding may be paid by the Company in advance of the final disposition of such action or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount (i) if it shall ultimately be determined that such person is not entitled to be indemnified by the Company as authorized in this Article V, (ii) where indemnification is granted, to the extent expenses so advanced by the Company or allowed by a court exceed the indemnification to which such person is entitled and (iii) upon such other terms and conditions, if any, as the Company deems appropriate. Any such advancement of expenses shall be made in the sole and absolute discretion of the Company only as authorized in the specific case upon a determination made, with respect to a person who is a director or officer at the time of such determination, (i) by the Board acting by a quorum consisting of directors who are not parties to such action or proceeding, or (ii) if a quorum is not obtainable or, even if obtainable, if a quorum of disinterested directors so directs, (x) by the Board upon the opinion in writing of independent legal counsel or (y) by the stockholders and, with respect to former directors and officers, by any person or persons having the authority to act on the matter on behalf of the Company. Without limiting the foregoing, the Company reserves the right in its sole and absolute discretion to revoke at any time any approval previously granted in respect of any such request for the advancement of expenses or to, in its sole and absolute discretion, impose limits or conditions in respect of any such approval.
Section 5.08. Nonexclusivity of Indemnification and Advancement of Expenses. The indemnification and advancement of expenses granted pursuant to, or provided by, this Article V shall not be deemed exclusive of any other rights to which a director or officer seeking indemnification or advancement of expenses may be entitled whether contained in the Company’s Organization Certificate, these By-Laws or, when authorized by the Organization Certificate or these By-Laws, (i) a resolution of stockholders, (ii) a resolution of directors, or (iii) an agreement providing for such indemnification, provided that no indemnification may be made to or on behalf of any director or officer if a judgment or other final adjudication adverse to the director or officer establishes that his acts were committed in bad faith or were the result of active and deliberate dishonesty and were material to the cause of action so adjudicated, or that he personally gained in fact a financial profit or other advantage to which he was not legally entitled. Nothing contained in this Article V shall affect any rights to indemnification to which corporate personnel other than directors and officers may be entitled by contract or otherwise under law.
Section 5.09. Insurance. Subject to the other provisions of this Article V, the Company may purchase and maintain insurance (in a single contract or supplement thereto, but not in a retrospective rated contract): (i) to indemnify the Company for any obligation which it incurs as a result of the indemnification of directors and officers under the provisions of this Article V, (ii) to indemnify directors and officers in instances in which they may be indemnified by the Company under the provisions of this Article V and applicable law, and (iii) to indemnify directors and officers in instances in which they may not otherwise be indemnified by the Company under the provisions of this Article V, provided the contract of insurance covering such directors and officers provides, in a manner acceptable to the New York Superintendent of Financial Services, for a retention amount and for co-insurance. Notwithstanding the foregoing, any such insurance shall be subject to the provisions of, and the Company shall comply with the requirements set forth in, Section 7023 of the New York State Banking Law.
- 8 -
Section 5.10. Limitations on Indemnification and Insurance. All indemnification and insurance provisions contained in this Article V are subject to any limitations and prohibitions under applicable law, including but not limited to Section 7022 (with respect to indemnification, advancement or allowance) and Section 7023 (with respect to insurance) of the New York State Banking Law and the Federal Deposit Insurance Act (with respect to administrative proceedings or civil actions initiated by any federal banking agency). Notwithstanding anything contained in this Article V to the contrary, no indemnification, advancement or allowance shall be made (i) to or on behalf of any director or officer if a judgment or other final adjudication adverse to the director or officer establishes that his acts were committed in bad faith or were the result of active and deliberate dishonesty and were material to the cause of action so adjudicated, or that he personally gained in fact a financial profit or other advantage to which he was not legally entitled, or (ii) in any circumstance where it appears (a) that the indemnification would be inconsistent with a provision of the Company’s Organization Certificate, these By-Laws, a resolution of the Board or of the stockholders, an agreement or other proper corporate action, in effect at the time of the accrual of the alleged cause of action asserted in the threatened or pending action or proceeding in which the expenses were incurred or other amounts were paid, which prohibits or otherwise limits indemnification; or (b) if there has been a settlement approved by the court, that the indemnification would be inconsistent with any condition with respect to indemnification expressly imposed by the court in approving the settlement.
Notwithstanding anything contained in this Article V to the contrary, but subject to any requirements of applicable law, (i) except for proceedings to enforce rights to indemnification (which shall be governed by Section 5.06), the Company shall not be obligated to indemnify any director or officer (or his testators intestate) or advance expenses in connection with a proceeding (or part thereof) initiated by such person unless such proceeding (or part thereof) was authorized or consented to by the Board of Directors of the Company, (ii) with respect to indemnification or advancement of expenses relating to attorneys’ fees under this Article V, counsel for the present or former director or officer must be reasonably acceptable to the Company (and the Company may, in its sole and absolute discretion, establish a panel of approved law firms for such purpose, out of which the present or former director or officer could be required to select an approved law firm to represent him), (iii) indemnification in respect of amounts paid in settlement shall be subject to the prior consent of the Company (not to be unreasonably withheld), (iv) any and all obligations of the Corporation under this Article V shall be subject to applicable law, (v) in no event shall any payments pursuant to this Article V be made if duplicative of any indemnification or advancement of expenses or other reimbursement available to the applicable director or officer (other than for coverage maintained by such person in his individual capacity), and (vi) no indemnification or advancement of expenses shall be provided under these By-Laws to any person in respect of any expenses, judgments, fines or amounts paid in settlement to the extent incurred by such person in his capacity or position with another entity (including, without limitation, an entity that is a stockholder of the Company or any of the branches or affiliates of such stockholder), except as expressly provided in these By-Laws in respect of such person’s capacity and position as a director or officer of the Company or such person is a director or officer of the Company serving at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise.
Section 5.11. Indemnification of Other Persons. The Company may, to the extent authorized from time to time by the Board of Directors, provide rights to indemnification and to the advancement of expenses (whether pursuant to an adoption of a policy or otherwise) to employees and agents of the Company (whether similar to those conferred in this Article V upon directors and officers of the Company or on other terms and conditions authorized from time to time by the Board of Directors), as well as to employees of direct and indirect subsidiaries of the Company and to other persons (or categories of persons) approved from time to time by the Board of Directors.
- 9 -
Section 5.12. Repeal. Any repeal or modification of this Article V shall not adversely affect any rights to indemnification and to the advancement of expenses of a director, officer, employee or agent of the Company existing at the time of such repeal or modification with respect to any acts or omissions occurring prior to such repeal or modification.
ARTICLE VI
CAPITAL STOCK
Section 6.01. Certificates. The interest of each stockholder of the Company shall be evidenced by certificates for shares of stock in such form as the Board of Directors may from time to time prescribe. The certificates of stock shall be signed by the Chairman of the Board or the President or a Managing Director or a Director or a Vice President and by the Secretary, or the Treasurer, or an Assistant Secretary, or an Assistant Treasurer, sealed with the seal of the Company or a facsimile thereof, and countersigned and registered in such manner, if any, as the Board of Directors may by resolution prescribe. Where any such certificate is countersigned by a transfer agent other than the Company or its employee, or registered by a registrar other than the Company or its employee, the signature of any such officer may be a facsimile signature. In case any officer or officers who shall have signed, or whose facsimile signature or signatures shall have been used on, any such certificate or certificates shall cease to be such officer or officers of the Company, whether because of death, resignation, retirement, disqualification, removal or otherwise, before such certificate or certificates shall have been delivered by the Company, such certificate or certificates may nevertheless be adopted by the Company and be issued and delivered as though the person or persons who signed such certificate or certificates or whose facsimile signature or signatures shall have been used thereon had not ceased to be such officer or officers of the Company.
Section 6.02. Transfer. The shares of stock of the Company shall be transferred only upon the books of the Company by the holder thereof in person or by his attorney, upon surrender for cancellation of certificates for the same number of shares, with an assignment and power of transfer endorsed thereon or attached thereto, duly executed, with such proof of the authenticity of the signature as the Company or its agents may reasonably require.
Section 6.03. Record Dates. The Board of Directors may fix in advance a date, not less than 10 nor more than 50 days preceding the date of any meeting of stockholders, or the date for the payment of any dividend, or the date for the distribution or allotment of any rights, or the date when any change, conversion or exchange of capital stock shall go into effect, as a record date for the determination of the stockholders entitled to notice of, and to vote at, any such meeting, or entitled to receive payment of any such dividend, or to receive any distribution or allotment of such rights, or to exercise the rights in respect of any such change, conversion or exchange of capital stock, and in such case only such stockholders as shall be stockholders of record on the date so fixed shall be entitled to such notice of, and to vote at, such meeting, or to receive payment of such dividend, or to receive such distribution or allotment or rights or to exercise such rights, as the case may be, notwithstanding any transfer of any stock on the books of the Company after any such record date fixed as aforesaid.
Section 6.04. Lost Certificates. In the event that any certificate of stock is lost, stolen, destroyed or mutilated, the Board of Directors may authorize the issuance of a new certificate of the same tenor and for the same number of shares in lieu thereof. The Board may in its discretion, before the issuance of such new certificate, require the owner of the lost, stolen, destroyed or mutilated certificate or the legal representative of the owner to make an affidavit or affirmation setting forth such facts as to the loss, destruction or mutilation as it deems necessary and to give the Company a bond in such reasonable sum as it directs to indemnify the Company.
- 10 -
ARTICLE VII
CHECKS, NOTES, ETC.
Section 7.01. Checks, Notes, Etc. All checks and drafts on the Company’s bank accounts and all bills of exchange and promissory notes, and all acceptances, obligations and other instruments for the payment of money, may be signed by the President or any Managing Director or any Director or any Vice President and may also be signed by such other officer or officers, agent or agents, as shall be thereunto authorized from time to time by the Board of Directors.
ARTICLE VIII
MISCELLANEOUS PROVISIONS
Section 8.01. Fiscal Year. The fiscal year of the Company shall be from January 1 to December 31, unless changed by the Board of Directors.
Section 8.02. Books. There shall be kept at such office of the Company as the Board of Directors shall determine, within or without the State of New York, correct books and records of account of all its business and transactions, minutes of the proceedings of its stockholders, Board of Directors and committees, and the stock book, containing the names and addresses of the stockholders, the number of shares held by them, respectively, and the dates when they respectively became the owners of record thereof, and in which the transfer of stock shall be registered, and such other books and records as the Board of Directors may from time to time determine.
Section 8.03. Voting of Stock. Unless otherwise specifically authorized by the Board of Directors, all stock owned by the Company, other than stock of the Company, shall be voted, in person or by proxy, by the President or any Managing Director or any Director or any Vice President of the Company on behalf of the Company.
ARTICLE IX
AMENDMENTS
Section 9.01. Amendments. The vote of the holders of at least a majority of the shares of stock of the Company issued and outstanding and entitled to vote shall be necessary at any meeting of stockholders to amend or repeal these By-Laws or to adopt new by-laws. These By-Laws may also be amended or repealed, or new by-laws adopted, at any meeting of the Board of Directors by the vote of at least a majority of the entire Board, provided that any by-law adopted by the Board may be amended or repealed by the stockholders in the manner set forth above.
Any proposal to amend or repeal these By-Laws or to adopt new by-laws shall be stated in the notice of the meeting of the Board of Directors or the stockholders or in the waiver of notice thereof, as the case may be, unless all of the directors or the holders of record of all of the shares of stock of the Company issued and outstanding and entitled to vote are present at such meeting.
- 11 -
Exhibit 7
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Board of Governors of the Federal Reserve System OMB Number 7100-0036 Federal Deposit Insurance Corporation OMB Number 3064-0052 Office of the Comptroller of the Currency OMB Number 1557-0081 Approval expires August 31, 2026 Page 1 of 86 Federal Financial Institutions Examination Council Consolidated Reports of Condition and Income for a Bank with Domestic Offices Only—FFIEC 041 Report at the close of business December 31, 2023 20231231 (RCON 9999) This report is required by law: 12 U.S.C. § 324 (State member This report form is to be filed by banks with domestic offices only banks); 12 U.S.C. §1817 (State nonmember banks); 12 U.S.C. §161 and total consolidated assets of less than $100 billion, except (National banks); and 12 U.S.C. §1464 (Savings associations). those banks that file the FFIEC 051, and those banks that are advanced approaches institutions for regulatory capital purposes Unless the context indicates otherwise, the term “bank” in this that are required to file the FFIEC 031. report form refers to both banks and savings associations. NOTE: Each bank’s board of directors and senior management are responsible for establishing and maintaining an effective system of internal control, including controls over the Reports of Condition and Income. The Reports of Condition and Income are to be prepared in accordance with federal regulatory authority instructions. The Reports of Condition and Income must be signed by the Chief Financial Officer (CFO) of the reporting bank (or by the individual performing an equivalent function) and attested to by not less than two directors (trustees) for state nonmember banks and three directors for state member banks, national banks, and savings associations. I, the undersigned CFO (or equivalent) of the named bank, attest that the Reports of Condition and Income (including the supporting Signature of Chief Financial Officer (or Equivalent) 01/30/2024 Date of Signature schedules) for this report date have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true and correct to the best of my knowledge and belief. We, the undersigned directors (trustees), attest to the correctness of the Reports of Condition and Income (including the supporting schedules) for this report date and declare that the Reports of Condition and Income have been examined by us and to the best of our knowledge and belief have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true and correct. Director (Trustee) Director (Trustee) Director (Trustee) Submission of Reports Each bank must file its Reports of Condition and Income (Call To fulfill the signature and attestation requirement for the Reports Report) data by either: of Condition and Income for this report date, attach your bank’s completed signature page (or a photocopy or a computer gener-(a) Using computer software to prepare its Call Report and then ated version of this page) to the hard-copy record of the data file submitting the report data directly to the FFIEC’s Central Data submitted to the CDR that your bank must place in its files. Repository (CDR), an Internet-based system for data collection (https://cdr.ffiec.gov/cdr/), or The appearance of your bank’s hard-copy record of the submitted (b) Completing its Call Report in paper form and arranging with a data file need not match exactly the appearance of the FFIEC’s software vendor or another party to convert the data into the sample report forms, but should show at least the caption of each electronic format that can be processed by the CDR. The Call Report item and the reported amount. software vendor or other party then must electronically submit the bank’s data file to the CDR. DEUTSCHE BANK TRUST COMPANY AMERICAS Legal Title of Bank (RSSD 9017) For technical assistance with submissions to the CDR, please contact the CDR Help Desk by telephone at (888) CDR-3111, by New York fax at (703) 774-3946, or by e-mail at cdr.help@cdr.ffiec.gov. City (RSSD 9130) FDIC Certificate Number 623 NY 10019 (RSSD 9050) State Abbreviation (RSSD 9200) Zip Code (RSSD 9220) Legal Entity Identifier (LEI) 8EWQ2UQKS07AKK8ANH81 (Report only if your institution already has an LEI.) (RCON 9224) The estimated average burden associated with this information collection is 54.60 hours per respondent and is expected to vary by institution, depending on individual circumstances. Burden estimates include the time for reviewing instructions, gathering and maintaining data in the required form, and completing the information collection, but exclude the time for compiling and maintaining business records in the normal course of a respondent’s activities. A Federal agency may not conduct or sponsor, and an organization (or a person) is not required to respond to a collection of information, unless it displays a currently valid OMB control number. Comments concerning the accuracy of this burden estimate and suggestions for reducing this burden should be directed to the Office of Information and Regulatory Affairs, Office of Management and Budget, Washington, DC 20503, and to one of the following: Secretary, Board of Governors of the Federal Reserve System, 20th and C Streets, NW, Washington, DC 20551; Legislative and Regulatory Analysis Division, Office of the Comptroller of the Currency, Washington, DC 20219; Assistant Executive Secretary, Federal Deposit Insurance Corporation, Washington, DC 20429. 12/2023 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 2 of 86 Consolidated Reports of Condition and Income for a Bank with Domestic Offices Only Table of Contents Signature Page...................................................................................................................................................................1 Contact Information.................................................................................................... 3, 4 Report of Income Schedule RI—Income Statement........................................RI-1, 2, 3, 4 Schedule RI-A—Changes in Bank Equity Capital......................RI-5 Schedule RI-B—Charge-offs and Recoveries on Loans and Leases and Changes in Allowances for Credit Losses Part I. Charge-offs and Recoveries on Loans and Leases............................................................................................RI-6, 7 Part II. Changes in Allowances for Credit Losses..................RI-8 Schedule RI-C—Disaggregated Data on the Allowance for Loan and Lease Losses (to be completed only by selected banks) Part I. Disaggregated Data on the Allowance for Loan and Lease Losses......................................................................................RI-9 Part II. Disaggregated Data on the Allowances for Credit Losses..........................................................................................RI-10 Schedule RI-E—Explanations..............................................................................................RI-11, 12 Report of Condition Schedule RC—Balance Sheet.......................................................................................................RC-1, 2 Schedule RC-A—Cash and Balances Due from Depository Institutions (to be completed only by selected banks)...........................RC-3 Schedule RC-B—Securities.............................................RC-3, 4, 5, 6, 7 Schedule RC-C—Loans and Lease Financing Receivables: Part I. Loans and Leases........................RC-8, 9, 10, 11, 12, 13 Part II. Loans to Small Businesses and Small Farms................................................................. RC-14,15 Schedule RC-D—Trading Assets and Liabilities (to be completed only by selected banks)...............................................................................……...............RC-16 Schedule RC-E—Deposit Liabilities ............................... .................................................... RC-17, 18, 19 Schedule RC-F—Other Assets.................................................................................RC-20 Schedule RC-G—Other Liabilities..........................................................................................................................RC-20 Schedule RC-K—Quarterly Averages.......................................................................................................................RC-21, 22 Schedule RC-L—Derivatives and Off-Balance-Sheet Items...................................................RC-23, 24, 25, 26 Schedule RC-M—Memoranda.............................................RC-27, 28, 29 Schedule RC-N—Past Due and Nonaccrual Loans, Leases, and Other Assets.....................RC-30, 31, 32, 33, 34 Schedule RC-O—Other Data for Deposit Insurance Assessments..................RC-35, 36, 37, 38, 39, 40 Schedule RC-P—1–4 Family Residential Mortgage Banking Activities (to be completed only by selected banks)........................................................................................................................................................................RC-41 Schedule RC-Q—Assets and Liabilities Measured at Fair Value on a Recurring Basis (to be completed only by selected banks)..........................................................................................................RC-42, 43, 44 Schedule RC-R—Regulatory Capital: Part I. Regulatory Capital Components and Ratios..........................................................................................RC-45, 46, 47, 48 Part II. Risk-Weighted Assets....................................RC-49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62 Schedule RC-S—Servicing, Securitization, and Asset Sale Activities.................................................RC-63, 64 Schedule RC-T—Fiduciary and Related Services..........................................................RC-65, 66, 67, 68 Schedule RC-V—Variable Interest Entities ....................RC-69 Optional Narrative Statement Concerning the Amounts Reported in the Consolidated Reports of Condition and Income..........................................................................RC-70 For information or assistance, national banks, state nonmember banks, and savings associations should contact the FDIC’s Data Collection and Analysis Section, 550 17th Street, NW, Washington, DC 20429, toll free on (800) 688-FDIC(3342), Monday through Friday between 8:00 a.m. and 5:00 p.m., Eastern Time. State member banks should contact their Federal Reserve District Bank. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 3 of 86 Contact Information for the Reports of Condition and Income To facilitate communication between the Agencies and the bank concerning the Reports of Condition and Income, please provide contact information for (1) the Chief Financial Officer (or equivalent) of the bank signing the reports for this quarter, and (2) the person at the bank —other than the Chief Financial Officer (or equivalent) — to whom questions about the reports should be directed. If the Chief Financial Officer (or equivalent) is the primary contact for questions about the reports, please provide contact information for another person at the bank who will serve as a secondary contact for communications between the Agencies and the bank concerning the Reports of Condition and Income. Enter “none” for the contact’s e-mail address or fax number if not available. Contact information for the Reports of Condition and Income is for the confidential use of the Agencies and will not be released to the public. Chief Financial Officer (or Equivalent) Other Person to Whom Questions about the Signing the Reports Reports Should be Directed Mona Nag Scott Iacono Name (TEXT C490) Name (TEXT C495) CFO Director Title (TEXT C491) Title (TEXT C496) mona.nag@db.com Scott.Iacono@db.com E-mail Address (TEXT C492) E-mail Address (TEXT 4086) 212-250-0302 212-250-8948 Area Code / Phone Number / Extension (TEXT C493) Area Code / Phone Number / Extension (TEXT 8902) 212-797-5376 212-797-5376 Area Code / FAX Number (TEXT C494) Area Code / FAX Number (TEXT 9116) Chief Executive Officer Contact Information This information is being requested so the Agencies can distribute notifications about policy initiatives, deposit insurance assessments, and other matters directly to the Chief Executive Officers of reporting institutions. Notifications about other matters may include emergency notifications that may or may not also be sent to the institution’s emergency contacts listed below. Please provide contact information for the Chief Executive Officer of the reporting institution. Enter “none” for the Chief Executive Officer’s e-mail address or fax number if not available. Chief Executive Officer contact information is for the confidential use of the Agencies and will not be released to the public. Chief Executive Officer Arjun Nagarkatti 442075450031 Name (TEXT FT42) Area Code / Phone Number / Extension (TEXT FT43) arjun.nagarkatti@db.com 212-797-4932 E-mail Address (TEXT FT44) Area Code / FAX Number (TEXT FT45) Emergency Contact Information This information is being requested so the Agencies can distribute critical, time-sensitive information to emergency contacts at banks. Please provide primary contact information for a senior official of the bank who has decision-making authority. Also provide information for a secondary contact if available. Enter “none” for the contact’s e-mail address or fax number if not available. Emergency contact information is for the confidential use of the Agencies and will not be released to the public. Primary Contact Secondary Contact Arjun Nagarkatti Michael Connolly Name (TEXT C366) Name (TEXT C371) Managing Director Managing Director Title (TEXT C367) Title (TEXT C372) Arjun.Nagarkatti@db.com Michael.Connolly@db.com E-mail Address (TEXT C368) E-mail Address (TEXT C373) 442075450031 212-250-1483 Area Code / Phone Number / Extension (TEXT C369) Area Code / Phone Number / Extension (TEXT C374) 212-797-4932 212-797-4932 Area Code / FAX Number (TEXT C370) Area Code / FAX Number (TEXT C375) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 4 of 86 USA PATRIOT Act Section 314(a) Anti-Money Laundering Contact Information This information is being requested to identify points-of-contact who are in charge of your bank’s USA PATRIOT Act Section 314(a) information requests. Bank personnel listed could be contacted by law enforcement officers or the Financial Crimes Enforcement Network (FinCEN) for additional information related to specific Section 314(a) search requests or other anti-terrorist financing and anti-money-laundering matters. Communications sent by FinCEN to the bank for purposes other than Section 314(a) notifications will state the intended purpose and should be directed to the appropriate bank personnel for review. Any disclosure of customer records to law enforcement officers or FinCEN must be done in compliance with applicable law, including the Right to Financial Privacy Act (12 U.S.C. 3401 et seq.). Please provide information for a primary and secondary contact. Information for a third and fourth contact may be provided at the bank’s option. Enter “none” for the contact’s e-mail address if not available. This contact information is for the confidential use of the Agencies, FinCEN, and law enforcement officers and will not be released to the public. Primary Contact Secondary Contact Paul Khareyn Joe Evans Name (TEXT C437) Name (TEXT C442) Director Managing Director Title (TEXT C438) Title (TEXT C443) Paul.Khareyn@db.com Joe.Evans@db.com E-mail Address (TEXT C439) E-mail Address (TEXT C444) 212-250-6774 212-250-1213 Area Code / Phone Number / Extension (TEXT C440) Area Code / Phone Number / Extension (TEXT C445) Third Contact Fourth Contact Hatton Hillin Cristian Ilut Name (TEXT C870) Name (TEXT C875) Assistant Vice President Assistant Vice President Title (TEXT C871) Title (TEXT C876) Hatton.Hillin@db.com Cristian.Ilut@db.com E-mail Address (TEXT C872) E-mail Address (TEXT C877) 904-520-5106 347-863-0715 Area Code / Phone Number / Extension (TEXT C873) Area Code / Phone Number / Extension (TEXT C878) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 5 of 86 RI-1 Consolidated Report of Income for the period January 1, 2023–December 31, 2023 Schedule RI—Income Statement Dollar Amounts in Thousands RIAD Amount 1. Interest income: a. Interest and fee income on loans: (1) Loans secured by real estate: (a) Loans secured by 1–4 family residential properties……………………………………….............................. 4435 80,000 1.a.(1)(a) (b) All other loans secured by real estate……………………………………………………….............................. 4436 290,000 1.a.(1)(b) (2) Commercial and industrial loans…………………………………………………………………......................... 4012 122,000 1.a.(2) (3) Loans to individuals for household, family, and other personal expenditures: (a) Credit cards………………………………………………………………………………………….................... B485 0 1.a.(3)(a) (b) Other (includes revolving credit plans other than credit cards, automobile loans, and other consumer loans)……………………………………………………………………..……………………….................. B486 21,000 1.a.(3)(b) (4) Not applicable All other loans 4058 (5) (1)…………………………………………………………............................................................ 436,000 1.a.(5) (6) Total interest and fee income on loans (sum of items 1.a.(1)(a) through 1.a.(5))…………………........................... 4010 949,000 1.a.(6) b. Income from lease financing receivables……………………………………..………..….………............................ 4065 0 1.b. . Interest income on balances due from depository institutions 4115 c (2)……………………………………..................... 712,000 1.c. d. Interest and dividend income on securities: (1) U.S. Treasury securities and U.S. Government agency obligations (excluding mortgage-backed securities)………………………………………………………………………………........................ B488 5,000 1.d.(1) (2) Mortgage-backed securities………………………………………………………………………………......................... B489 0 1.d.(2) (3) All other securities (includes securities issued by states and political subdivisions in the U.S.)……………………………………………………………………………………………....…......................... 4060 0 1.d.(3) e. Not applicable f. Interest income on federal funds sold and securities purchased under agreements to resell………….............. 4020 306,000 1.f. g. Other interest income………………………………………………………………………………............................... 4518 5,000 1.g. h. Total interest income (sum of items 1.a.(6) through 1.g)…………………………………………........................... 4107 1,977,000 1.h. 2. Interest expense: a. Interest on deposits: (1) Transaction accounts (interest-bearing demand deposits, NOW accounts, ATS accounts, and telephone and preauthorized transfer accounts)………………………………………………………………............................ 4508 545,000 2.a.(1) (2) Nontransaction accounts: (a) Savings deposits (includes MMDAs)………………………………………………….............................. 0093 82,000 2.a.(2)(a) (b) Time deposits of $250,000 or less………………………………………………………............................. HK03 0 2.a.(2)(b) (c) Time deposits of more than $250,000………………………………………………………………................. HK04 7,000 2.a.(2)(c) b. Expense of federal funds purchased and securities sold under agreements to repurchase…………............... 4180 0 2.b. c. Interest on trading liabilities and other borrowed money…………………………………...………....................... 4185 29,000 2.c. d. Interest on subordinated notes and debentures............................................................................................................................................................................................. 4200 0 2.d. e. Total interest expense (sum of items 2.a through 2.d)............................................................................................................................................... 4073 663,000 2.e. 3. Net interest income (item 1.h minus 2.e)....................................................................................................................... 4074 1,314,000 3. . Provision for loan and lease losses JJ33 4 (3)..................................................................................................................... (2,000) 4. __________ 1. Includes interest and fee income on “Loans to depository institutions and acceptances of other banks,” “Loans to finance agricultural production and other loans to farmers,” “Obligations (other than securities and leases) of states and political subdivisions in the U.S.,” and “Loans to nondepository financial institutions and other loans.” 2. Includes interest income on time certificates of deposit not held for trading. 3. Institutions that have adopted ASU 2016-13 should report in item 4 the provisions for credit losses on all financial assets and off-balance-sheet credit exposures that fall within the scope of the standard. 12/2023 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 6 of 86 RI-2 Schedule RI—Continued Year-to-date Dollar Amounts in Thousands RIAD Amount 5. Noninterest income: . Income from fiduciary activities 4070 a (1).................................................................................................................................................... 279,000 5.a. b. Service charges on deposit accounts...................................................................................................................……………………………. 4080 140,000 5.b. c. Trading revenue.................................................................................................................................................................…………. A220 0 5.c. d. Income from securities-related and insurance activities: (1)Fees and commissions from securities brokerage..........................................................................................................................................… C886 0 5.d.(1) (2)Investment banking, advisory, and underwriting fees and commissions C888 0 5.d.(2) (3)Fees and commissions from annuity sales.......................................................................................................................................... C887 0 5.d.(3) (4)Underwriting income from insurance and reinsurance activities.......................................................................................................................................... C386 0 5.d.(4) (5)Income from other insurance activities................................................................................................................... C387 0 5.d.(5) e. Venture capital revenue........................................................................................................................................................................................ B491 0 5.e. f. Net servicing fees.................................................................................................................................................................… B492 0 5.f. g. Net securitization income..........................................................................................................................................................................................................................…........… B493 0 5.g. h. Not applicable i. Net gains (losses) on sales of loans and leases....................................................................................................................................… 5416 0 5.i. j. Net gains (losses) on sales of other real estate owned....................................................................................................................................… 5415 0 5.j. . Net gains (losses) on sales of other assets B496 k (2)....................................................................................................................................… 0 5.k. l. Other noninterest income*..............................................................................................................................................................................................................................................… B497 139,000 5.l. m.Total noninterest income (sum of items 5.a through 5.l)………………….…..…..…………….. 4079 558,000 5.m. 6. a. Realized gains (losses) on held-to-maturity securities………………………………..………… 3521 0 6.a. b. Realized gains (losses) on available-for-sale debt securities………………..…..…………………… 3196 0 6.b. 7. Noninterest expense: a. Salaries and employee benefits 4135 122,000 7.a. b. Expenses of premises and fixed assets (net of rental income) (excluding salaries and employee benefits and mortgage interest)....................................................................................................................................… 4217 28,000 7.b. c. (1)Goodwill impairment losses....................................................................................................................................… C216 0 7.c.(1) (2)Amortization expense and impairment losses for other intangible assets....................................................................................................................................… C232 2,000 7.c.(2) d. Other noninterest expense*....................................................................................................................................… 4092 873,000 7.d. e. Total noninterest expense (sum of items 7.a through 7.d)....................................................................................................................................… 4093 1,025,000 7.e. 8. a. Income (loss) before change in net unrealized holding gains (losses) on equity securities not held for trading, applicable income taxes, and discontinued operations (item 3 plus or minus items 4, 5.m, 6.a, 6.b, and 7.e)……..…..…………………………..… HT69 849,000 8.a. b. Change in net unrealized holding gains (losses) on equity securities held for trading HT70 not (3)..…..…………………………..…..…………………………..…..……………………..…..…………………………..…..…………………………..…..…………………… 1,000 8.b c. Income (loss) before applicable income taxes and discontinued operations (sum of items 8.a and 8.b)……..…..…………………………..…..…………………………..…..…………………… 4301 850,000 8.c. 9. Applicable income taxes (on item 8.c)....................................................................................................................................… 4302 219,000 9. 10. Income (loss) before discontinued operations (item 8.c minus item 9)......................................................................................... 4300 631,000 10. 11. Discontinued operations, net of applicable income taxes*........................................................................................................... FT28 0 11. 12. Net income (loss) attributable to bank and noncontrolling (minority) interests (sum of items 10 and 11)....................................................................................................................................… G104 631,000 12. 13. LESS: Net income (loss) attributable to noncontrolling (minority) interests (if net income, report as a positive value; if net loss, report as a negative value)....................................................................................................................................…....................................................................................................................................… G103 0 13. 14. Net income (loss) attributable to bank (item 12 minus item 13)....................................................................................................................................… 4340 631,000 14. __________ * Describe on Schedule RI-E—Explanations. 1. For banks required to complete Schedule RC-T, items 14 through 22, income from fiduciary activities reported in Schedule RI, item 5.a, must equal the amount reported in Schedule RC-T, item 22. 2. Exclude net gains (losses) on sales of trading assets and held-to-maturity and available-for-sale debt securities. 3. Item 8.b is to be completed by all institutions. See the instructions for this item and the Glossary entry for “Securities Activities” for further detail on accounting for investments in equity securities. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 7 of 86 Schedule RI—Continued RI-3 Memoranda Year-to-date Dollar Amounts in Thousands RIAD Amount 1. Interest expense incurred to carry tax-exempt securities, loans, and leases acquired after August 7, 1986, that is not deductible for federal income tax purposes…………………………………................ 4513 0 M.1. Memorandum item 2 is to be completed by banks with $1 billion or more in total assets (1) 2. Income from the sale and servicing of mutual funds and annuities (included in Schedule RI, item 8)……………………………………………………………………………………..................................................... 8431 0 M.2. 3. Income on tax-exempt loans and leases to states and political subdivisions in the U.S. (included in Schedule RI, items 1.a and 1.b)………………………………………………………………………................................... 4313 0 M.3. 4. Income on tax-exempt securities issued by states and political subdivisions in the U.S. (included in Schedule RI, item 1.d.(3))…………………………………………………………………………….................................... 4507 0 M.4. 5. Number of full-time equivalent employees at end of current period Number (round to nearest whole number)………………………………………………………………………………………………………................................... 4150 384 M.5. Memorandum item 6 is to be completed by: (1) • banks with $300 million or more in total assets, and • banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans 6. Interest and fee income on loans to finance agricultural production and other loans to farmers Amount (included in Schedule RI, item 1.a.(5))......................................................................................................................... 4024 0 M.6. 7. If the reporting institution has applied push down accounting this calendar year, report the date RIAD Date the institution’s acquisition (see instructions) 9106 of (2)…………………………......................………..................................... 00000000 M.7. 8. Not applicable Memorandum items 9.a and 9.b are to be completed by banks with $10 billion or more in total assets. (1) 9. Net gains (losses) recognized in earnings on credit derivatives that economically hedge credit exposures held outside the trading account: Amount a. Net gains (losses) on credit derivatives held for trading…………………………………………………….................................. C889 0 M.9.a. b. Net gains (losses) on credit derivatives held for purposes other than trading……………………………................................. C890 0 M.9.b. Memorandum item 10 is to be completed by banks with $300 million or more in total assets. (1) 10. Credit losses on derivatives (see instructions)…………………………………………………………………................................. A251 0 M.10. 11. Does the reporting bank have a Subchapter S election in effect for federal income tax purposes RIAD Yes No for the current tax year?................................................................................................................................................ A530 x M.11. 12. Not applicable __________ 1. The asset-size tests and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 2. Report the date in YYYYMMDD format. For example, a bank acquired on March 1, 2023, would report 20230301. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 8 of 86 Schedule RI—Continued RI-4 Memoranda—Continued Dollar Amounts in Thousands Year-to-date RIAD Amount Memorandum item 13 is to be completed by banks that have elected to account for assets and liabilities under a fair value option. 13. Net gains (losses) recognized in earnings on assets and liabilities that are reported at fair value under a fair value option: a. Net gains (losses) on assets............................................................................................................................................................ F551 0 M.13.a. (1) Estimated net gains (losses) on loans attributable to changes in instrument-specific credit risk................................................................................................................................................................................ F552 0 M.13.a.(1) b. Net gains (losses) on liabilities............................................................................................................................................................ F553 0 M.13.b. (1) Estimated net gains (losses) on liabilities attributable to changes in instrument-specific credit risk................................................................................................................................................................................ F554 0 M.13.b.(1) 14. Other-than-temporary impairment losses on held-to-maturity and available-for-sale debt recognized in earnings (included in Schedule RI, items 6.a and 6.b) J321 securities (1)................................................................................................... NA M.14. Memorandum item 15 is to be completed by institutions with $1 billion or more in total assets (2) that answered “Yes” to Schedule RC-E, Memorandum item 5. 15. Components of service charges on deposit accounts (sum of Memorandum items 15.a through 15.d must equal Schedule RI, item 5.b): a. Consumer overdraft-related service charges levied on those transaction account and nontransaction savings account deposit products intended primarily for individuals for personal, household, or family use H032 NA M.15.a. b. Consumer account periodic maintenance charges levied on those transaction account and nontransaction savings account deposit products intended primarily for individuals for personal, household, or family use H033 NA M.15.b. c. Consumer customer automated teller machine (ATM) fees levied on those transaction account and nontransaction savings account deposit products intended primarily for individuals for personal, household, or family use H034 NA M.15.c. d. All other service charges on deposit accounts ................................................................................................................................................................................................ H035 NA M.15.d. 1. Memorandum item 14 is to be completed only by institutions that have not adopted ASU 2016-13. 2. The $1 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 9 of 86 RI-5 Schedule RI-A—Changes in Bank Equity Capital RIAD Amount Dollar Amounts in Thousands 1. Total bank equity capital most recently reported for the December 31, 2022, Reports of Condition and Income (i.e., after adjustments from amended Reports of Income) 3217 9,479,000 1. 2. Cumulative effect of changes in accounting principles and corrections of material accounting errors*............................................................................................................................................................................................................. B507 0 2. 3. Balance end of previous calendar year as restated (sum of items 1 and 2) B508 9,479,000 3. 4. Net income (loss) attributable to bank (must equal Schedule RI, item 14) 4340 631,000 4. 5. Sale, conversion, acquisition, or retirement of capital stock, net (excluding treasury stock transactions)............................................................................................................................................................ B509 (4,000) 5. 6. Treasury stock transactions, net............................................................................................................................................................ B510 0 6. 7. Changes incident to business combinations, net............................................................................................................................................................ 4356 0 7. 8. LESS: Cash dividends declared on preferred stock............................................................................................................................................................ 4470 0 8. 9. LESS: Cash dividends declared on common stock............................................................................................................................................................ 4460 456,000 9. . Other comprehensive income B511 10 (1)............................................................................................................................................................ 15,000 10. 11. Other transactions with stockholders (including a parent holding company)* (not included in items 5, 6, 8, or 9 above)............................................................................................................................................................ 4415 0 11. 12. Total bank equity capital end of current period (sum of items 3 through 11) (must equal Schedule RC, item 27.a)............................................................................................................................................................ 3210 9,665,000 12. __________ * Describe on Schedule RI-E—Explanations. 1. Includes, but is not limited to, changes in net unrealized holding gains (losses) on available-for-sale debt securities, changes in accumulated net gains (losses) on cash flow hedges, and pension and other postretirement plan-related changes other than net periodic benefit cost. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 10 of 86 Schedule RI-B—Charge-offs and Recoveries on Loans and Leases RI-6 and Changes in Allowances for Credit Losses Part I. Charge-offs and Recoveries on Loans and Leases Part I includes charge-offs and recoveries through (Column A) (Column B) the allocated transfer risk reserve. Charge-offs (1) Recoveries Calendar Year-to-date Dollar Amounts in Thousands RIAD Amount RIAD Amount 1. Loans secured by real estate: a. Construction, land development, and other land loans: (1) 1–4 family residential construction loans………………………………............................. C891 0 C892 0 1.a.(1) (2) Other construction loans and all land development and other land loans………………………………………………………………….............................. C893 0 C894 0 1.a.(2) b. Secured by farmland …………………………………….............................................................. 3584 0 3585 0 1.b. c. Secured by 1–4 family residential properties: (1) Revolving, open-end loans secured by 1–4 family residential properties and extended under lines of credit…………………………............................ 5411 0 5412 0 1.c.(1) (2) Closed-end loans secured by 1–4 family residential properties: (a) Secured by first liens…………………………………………………......................... C234 0 C217 2,000 1.c.(2)(a) (b) Secured by junior liens……………………………………………….......................... C235 0 C218 0 1.c.(2)(b) d. Secured by multifamily (5 or more) residential properties………………………………………………………………… 3588 0 3589 0 1.d. e. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties…………………………………………………………………................................ C895 0 C896 0 1.e.(1) (2) Loans secured by other nonfarm nonresidential properties........................................ C897 0 C898 0 1.e.(2) 2. and 3. Not applicable 4. Commercial and industrial loans………………………………………………………… 4638 0 4608 0 4. 5. Loans to individuals for household, family, and other personal expenditures: a. Credit cards…................................................................................................................................................... B514 0 B515 0 5.a. b. Automobile loans…................................................................................................................................................... K129 0 K133 0 5.b. c. Other (includes revolving credit plans other than credit cards and other consumer loans)…................................................................................................................................................... K205 0 K206 0 5.c. 6. Not applicable . All other loans 4644 4628 7 (2)…................................................................................................................................................... 0 0 7. 8. Lease financing receivables…................................................................................................................................................... 4266 0 4267 0 8. 9. Total (sum of items 1 through 8)…................................................................................................................................................... 4635 0 4605 2,000 9. 1. Include write-downs arising from transfers of loans to a held-for-sale account. 2. Includes charge-offs and recoveries on ”Loans to depository institutions and acceptances of other banks,“ “Loans to finance agricultural production and other loans to farmers,” “Obligations (other than securities and leases) of states and political subdivisions in the U.S.,” and “Loans to nondepository financial institutions and other loans.” 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 11 of 86 RI-7 Schedule RI-B—Continued Memoranda (Column A) (Column B) Charge-offs (1) Recoveries Calendar Year-to-date RIAD Amount RIAD Amount Dollar Amounts in Thousands 1. Loans to finance commercial real estate, construction, and land development activities (not secured by real estate) included in Schedule RI-B, Part I, items 4 and 7, above…................................................................................................................................................... 5409 0 5410 0 M.1. 2. Memorandum items 2.a. through 2.d. are to be completed by banks with $300 million or more in total assets: (2) a. Loans secured by real estate to non-U.S. addressees (domicile) (included in Schedule RI-B, Part I, item 1, above)…................................................................................................................................................... 4652 0 4662 0 M.2.a. b. Not applicable c. Commercial and industrial loans to non-U.S. addressees (domicile) (included in Schedule RI-B, Part I, item 4 above) ......................................................... 4646 0 4618 0 M.2.c. d. Leases to individuals for household, family, and other personal expenditures (included in Schedule RI-B, Part I, item 8, above)…................................................................................................................................................... F185 0 F187 0 M.2.d. Memorandum item 3 is to be completed by: (2) • banks with $300 million or more in total assets, and • banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans: 3. Loans to finance agricultural production and other loans to farmers (included in Schedule RI-B, Part I, item 7, above) ......................................................... 4655 0 4665 0 M.3. Memorandum item 4 is to be completed by banks that (1) together with affiliated institutions, have outstanding credit card receivables (as defined in the instructions) that exceed $500 million as of the report date, or (2) are credit card specialty banks as defined for Uniform Bank Performance Report purposes. Calendar Year-to-date 4. Uncollectible retail credit card fees and finance charges reversed against income RIAD Amount .e., not included in charge-offs against the allowance for loan and lease losses) C388 . (i (3) NA M.4 __________ 1. Include write-downs arising from transfers of loans to a held-for-sale account. 2. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 3. Institutions that have adopted ASU 2016-13 should report in Memorandum item 4 uncollectible retail credit card fees and finance charges reversed against income (i.e., not included in charge-offs against the allowance for credit losses on loans and leases). 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 12 of 86 RI-8 Schedule RI-B—Continued Part II. Changes in Allowances for Credit Losses (1) (Column A) (Column B) (Column C) Loans and Leases Held Held-to-Maturity Available-for-Sale for Investment Debt Securities (2) Debt Securities (2) Dollar Amounts in Thousands RIAD Amount RIAD Amount RIAD Amount 1. Balance most recently reported for the December 31, 2022, Reports of Condition and Income (i.e., after adjustments from amended Reports of Income)........................................................................................................................................ B522 16,000 JH88 0 JH94 0 1. 2. Recoveries (column A must equal Part I, item 9, column B, above) .......................................................................................................................... 4605 2,000 JH89 0 JH95 0 2. 3. LESS: Charge-offs (column A must equal Part I, item 9, column A, above less Schedule RI-B, Part II, item 4, column A) ..................................................................................................................................................................................................................... C079 0 JH92 0 JH98 0 3. 4. LESS: Write-downs arising from transfers of assets 5523 JJ00 JJ01 financial (3).............................................................................................................................................................................................................0 0 0 4. 5. Provisions for credit losses (4, 5)........................................................................................................................................................................ 4230 (2,000) JH90 0 JH96 0 5. 6. Adjustments* (see instructions for this schedule) C233 0 JH91 0 JH97 0 6. 7. Balance end of current period (sum of items 1, 2, 5, and 6, less items 3 and 4) (column A must equal Schedule RC, item 4.c).................................................................................................................................................................. 3123 16,000 JH93 0 JH99 0 7. * Describe on Schedule RI-E—Explanations. 1. Institutions that have not adopted ASU 2016-13 should report changes in the allowance for loan and lease losses in column A. 2. Columns B and C are to be completed only by institutions that have adopted ASU 2016-13. 3. Institutions that have not yet adopted ASU 2016-13 should report write-downs arising from transfers of loans to a held-for-sale account in item 4, column A. 4. Institutions that have not yet adopted ASU 2016-13 should report the provision for loan and lease losses in item 5, column A, and the amount reported must equal Schedule RI, item 4. 5. For institutions that have adopted ASU 2016-13, the sum of item 5, columns A through C, plus schedule RI-B, Part II, Memorandum items 5 and 7, below, must equal Schedule RI, item 4. Memoranda Dollar Amounts in Thousands RIAD Amount 1. Allocated transfer risk reserve included in Schedule RI-B, Part II, item 7,column A, above...................................................................................................................... C435 0 M.1. Memorandum items 2 and 3 are to be completed by banks that (1) together with affiliated institutions, have outstanding credit card receivables (as defined in the instructions) that exceed $500 million as of the report date, or (2) are credit card specialty banks as defined for Uniform Bank Performance Report purposes. 2. Separate valuation allowance for uncollectible retail credit card fees and finance charges......................................................................................... C389 NA M.2. 3. Amount of allowance for loan and lease losses attributable to retail credit card fees and finance C390 charges (1).................................................................................................................................................................................................................................... NA M.3. 4. Amount of allowance for post-acquisition credit losses on purchased credit-impaired loans accounted for in accordance with FASB ASC 310-30 (former AICPA Statement of Position 03-3) in Schedule RI-B, Part II, item 7, column A , above) C781 (included (2).............................................................................................................................................................................. NA M.4. 5. Provisions for credit losses on other financial assets measured at amortized cost (not included in 5, above) JJ02 item (3) 0 M.5. 6. Allowance for credit losses on other financial assets measured at amortized cost (not included in RCON 7, above) JJ03 item (3) 0 M.6. RIAD 7. Provisions for credit losses on off-balance-sheet credit exposures MG93 (3)....................................................................................................................................................................... 0 M.7. 8. Estimated amount of expected recoveries of amounts previously written off included within the allowance for credit losses on loans and leases held for investment (included in item 7, column A, end of current period,” above) MG94 “Balance (3)....................................................................................................................................................................... 0 M.8. 1. Institutions that have adopted ASU 2016-13 should report in Memorandum item 3 the amount of allowance for credit losses on loans and leases attributable to retail credit card fees and finance changes. 2. Memorandum item 4 is to be completed only by institutions that have not yet adopted ASU 2016-13. 3. Memorandum items 5, 6, 7, and 8 are to be completed only by institutions that have adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RI-C—Disaggregated Data on the Allowance for Loan and Lease Losses FFIEC 041 Page 13 of 86 RI-9 Part I. Disaggregated Data on the Allowance for Loan and Lease Losses (1) Schedule RI-C. Part I, is to be completed by institutions with $1 billion or more in total assets. (2) (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) Recorded Investment: Allowance Balance: Recorded Investment: Allowance Balance: Recorded Investment: Allowance Balance: Individually Evaluated Individually Evaluated Collectively Evaluated Collectively Evaluated Purchased Purchased for Impairment and for Impairment and for Impairment for Impairment Credit-Impaired Loans Credit-Impaired Loans Determined to be Impaired Determined to be Impaired (ASC 450-20) (ASC 450-20) (ASC 310-30) (ASC 310-30) (ASC 310-10-35) (ASC 310-10-35) Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount RCON Amount RCON Amount Real estate loans: a. Construction loans………………………………………………………………………….............. M708 NA M709 NA M710 NA M711 NA M712 NA M713 NA 1.a. b. Commercial real estate loans………………………………………………………………………….............. M714 NA M715 NA M716 NA M717 NA M719 NA M720 NA 1.b. c. Residential real estate loans………………………………………………………………………….............. M721 NA M722 NA M723 NA M724 NA M725 NA M726 NA 1.c. M727 M728 M729 M730 M731 M732 Commercial loans (3)………………………………………………………………………….............. NA NA NA NA NA NA 2. Credit cards………………………………………………………………………….............. M733 NA M734 NA M735 NA M736 NA M737 NA M738 NA 3. Other consumer loans………………………………………………………………………….............. M739 NA M740 NA M741 NA M742 NA M743 NA M744 NA 4. Unallocated, if any………………………………………………………………………….............. M745 NA 5. Total (sum of . through 5) M746 M747 M748 M749 M750 M751 items 1.a (4)………………………………………………………………………….............. NA NA NA NA NA NA 6. 1. Only institutions that have not yet adopted ASU 2016-13 are to complete Schedule RI-C, Part I. 2. The $1 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 3. Include all loans and leases not reported as real estate loans, credit cards, or other consumer loans in items 1, 3, or 4 of Schedule RI-C. 4. The sum of item 6, columns B, D, and F, must equal Schedule RC, item 4.c. Item 6, column E, must equal Schedule RC-C, Part I, Memorandum item 7.b. Item 6, column F, must equal Schedule RI-B, Part II, Memorandum item 4. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 14 of 86 RI-10 Schedule RI-C—Continued Part II. Disaggregated Data on the Allowances for Credit Losses (1) Schedule RI-C, Part II, is to be completed by institutions with $1 billion or more in total assets. (2) (Column A) (Column B) Amortized Cost Allowance Balance Dollar Amounts in Thousands RCON Amount RCON Amount Loans and Leases Held for Investment: 1. Real estate loans: a. Construction loans.................................................................................................... JJ04 77,000 JJ12 0 1.a. b. Commercial real estate loans................................................................................................ JJ05 4,452,000 JJ13 3,000 1.b. c. Residential real estate loans................................................................................................ JJ06 2,194,000 JJ14 4,000 1.c. . JJ07 JJ15 2 Commercial loans (3)................................................................................................................................................................................... 9,317,000 8,000 2. 3. Credit cards................................................................................................................................................ JJ08 0 JJ16 0 3. 4. Other consumer loans................................................................................................................................................ JJ09 307,000 JJ17 1,000 4. 5. Unallocated, if any................................................................................................................................................ JJ18 0 5. . Total (sum of items 1 a. through 5) JJ11 JJ19 6 . (4)................................................................................................................................... 16,347,000 16,000 6. Allowance Balance Dollar Amounts in Thousands RCON Amount Held-to-Maturity Securities: 7. Securities issued by states and political subdivisions in the U.S.................................................................... JJ20 0 7. 8. Mortgage-backed securities (MBS) (including CMOs, REMICs, and stripped MBS) JJ21 0 8. 9. Asset-backed securities and structured financial products JJ23 0 9. 10. Other debt securities JJ24 0 10. 11. Total (sum of items 7 through 10) JJ25 (5) 0 11. 1. Only institutions that have adopted ASU 2016-13 are to complete Schedule RI-C, Part II. 2. The $1 billion asset-size test is based on the total assets reported on theJune 30, 2022, Report of Condition. 3. Include all loans and leases not reported as real estate loans, credit cards, or other consumer loans in items 1, 3, or 4 of Schedule RI-C, Part II. 4. Item 6, column B, must equal Schedule RC, item 4.c. 5. Item 11 must equal Schedule RI-B, Part II, item 7, column B. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 15 of 86 RI-11 Schedule RI-E—Explanations Schedule RI-E is to be completed each quarter on a calendar year-to-date basis. Detail all adjustments in Schedule RI-A and RI-B, all discontinued operations in Schedule RI, and all significant items of other noninterest income and other noninterest expense in Schedule RI. (See instructions for details.) Year-to-date Dollar Amounts in Thousands RIAD Amount 1. Other noninterest income (from Schedule RI, item 5.l) Itemize and describe amounts greater than $100,000 that exceed 7 percent of Schedule RI, item 5.l: a. Income and fees from the printing and sale of checks............................................................................................................................................ C013 0 1.a. b. Earnings on/increase in value of cash surrender value of life insurance.................................................................................... C014 0 1.b. c. Income and fees from automated teller machines (ATMs)................................................................................................................ C016 0 1.c. d. Rent and other income from other real estate owned................................................................................................................ 4042 0 1.d. e. Safe deposit box rent........................................................................................................................................................................ C015 0 1.e. f. Bank card and credit card interchange fees................................................................................................................ F555 0 1.f. g. Income and fees from wire transfers not reportable as service charges on deposit accounts……………….T047 0 1.g. TEXT 4461 h. 4461 Revenue from Services rendered to affiliates 165,000 1.h. . TEXT 4462 . i 4462 Net gains (losses) on non-trading derivatives (59,000) 1.i TEXT 4463 j. 4463 Commissions and fees 30,000 1.j. 2. Other noninterest expense (from Schedule RI, item 7.d) Itemize and describe amounts greater than $100,000 that exceed 7 percent of Schedule RI, item 7.d: a. Data processing expenses………………………………………………….…………………………………………............. C017 0 2.a. b. Advertising and marketing expenses………………………………………………….……….……………………................ 0497 0 2.b. c. Directors’ fees………………………………………………….……….………………………………………………............. 4136 0 2.c. d. Printing, stationery, and supplies………………………………………………….……….…………………………............... C018 0 2.d. e. Postage………………………………………………….……….………………………………………………….…................... 8403 0 2.e. f. Legal fees and expenses………………………………………………….……….………………………………….............. 4141 0 2.f. g. FDIC deposit insurance assessments………………………………………………….……….…………………….............. 4146 0 2.g. h. Accounting and auditing expenses………………………………………………….……….………………………................ F556 0 2.h. i. Consulting and advisory expenses………………………………………………….……….……………………….............. F557 0 2.i. j. Automated teller machine (ATM) and interchange expenses………………………………………………….……................. F558 0 2.j. k. Telecommunications expenses………………………………………………….……….……………………………................. F559 0 2.k. l. Other real estate owned expenses..................................................................................................................................... Y923 0 2.l. m. Insurance expenses (not included in employee expenses, premises and fixed asset expenses, and other real estate owned expenses)................................................................................................................................................................................ Y924 0 2.m. . TEXT 4464 . n 4464 Services rendered by affiliates 627,000 2.n o. TEXT 4467 4467 Litigation Expenses 98,000 2.o. p. TEXT 4468 p 4468 0 2. . 3. Discontinued operations and applicable income tax effect (from Schedule RI, item 11) (itemize and describe each discontinued operation): TEXT FT29 a. (1) FT29 0 3.a.(1) (2) Applicable income tax effect………………………………………………….................................. FT30 0 3.a.(2) TEXT FT31 b. (1) FT31 0 3.b.(1) (2) Applicable income tax effect…………………………………………………................................... FT32 0 3.b.(2) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 16 of 86 RI-12 Schedule RI-E—Continued Year-to-date Dollar Amounts in Thousands RIAD Amount 4. Cumulative effect of changes in accounting principles and corrections of material accounting errors (from Schedule RI-A, item 2) (itemize and describe all such effects): a. Effect of adoption of current expected credit losses methodology—ASU 2016-13 (1, 2).............................................................. JJ26 NA 4.a. b. Not applicable TEXT c. B526 . B526 0 4.c TEXT d. B527 d B527 0 4. . 5. Other transactions with stockholders (including a parent holding company) (from Schedule RI-A, item 11) (itemize and describe all such transactions): TEXT a. 4498 . 4498 0 5.a TEXT b. 4499 b 4499 0 5. . 6. Adjustments to allowances for credit losses (3) (from Schedule RI-B, Part II, item 6) (itemize and describe all adjustments): a. Initial allowances for credit losses recognized upon the acquisition of purchased credit-deteriorated assets on or after the effective date of ASU 2016-13 (1).......................................................... JJ27 NA 6.a. b. Effect of adoption of current expected credit losses methodology on allowances for losses JJ28 credit (1, 2)........................................................................................................................................................................................................... 0 6.b. TEXT c. 4521 c 4521 0 6. . TEXT d. 4522 d 4522 0 6. . 7. Other explanations (the space below is provided for the bank to briefly describe, at its option, any other significant items affecting the Report of Income): RIAD Yes No Comments?.................................................................................................................................................................. 4769 x 7. Other explanations (please type or print clearly; 750 character limit): (TEXT 4769) 1. Only institutions that have adopted ASU 2016-13 should report amounts in items 4.a, 6.a, and 6.b, if applicable. 2. An institution should complete item 4.a and item 6.b in the quarter that it adopts ASU 2016-13 and in the quarter-end Call Reports for the remainder of that calendar year only. 3. Institutions that have not adopted ASU 2016-13 should report adjustments to the allowance for loan and lease losses in items 6.c and 6.d, if applicable. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 17 of 86 RC-1 Consolidated Report of Condition for Insured Banks and Savings Associations for December 31, 2023 All schedules are to be reported in thousands of dollars. Unless otherwise indicated, report the amount outstanding as of the last business day of the quarter. Schedule RC—Balance Sheet Dollar Amounts in Thousands RCON Amount Assets 1. Cash and balances due from depository institutions (from Schedule RC-A): . Noninterest-bearing balances and currency and coin 0081 a (1)…………………………….…….…........................ 41,000 1.a. . Interest-bearing balances 0071 b (2)……………………………………………………….................................... 13,556,000 1.b. 2. Securities: a. Held-to-maturity securities (from Schedule RC-B, column A) JJ34 (3)……………………………............................... 0 2.a. b. Available-for-sale debt securities (from Schedule RC-B, column D)…………………….……................................... 1773 378,000 2.b. . Equity securities with readily determinable fair values not held for trading JA22 c (4)…………………………. 0 2.c. 3. Federal funds sold and securities purchased under agreements to resell: a. Federal funds sold………………………………………………………......................................................... B987 0 3.a. . Securities purchased under agreements to resell B989 b (5, 6)………………………….......................................... 5,923,000 3.b. 4. Loans and lease financing receivables (from Schedule RC-C): a. Loans and leases held for sale………………………………………………………..……................................... 5369 0 4.a. b. Loans and leases held for investment……………….................................... B528 16,347,000 4.b. c. LESS: Allowance for loan and lease losses……………....................................... 3123 16,000 4.c. . Loans and leases held for investment, net of allowance (item 4.b minus 4.c) B529 d (7)………............................... 16,331,000 4.d. 5. Trading assets (from Schedule RC-D)…………………………………………………….…….................................. 3545 0 5. 6. Premises and fixed assets (including capitalized leases)…………………………………….................................. 2145 0 6. 7. Other real estate owned (from Schedule RC-M)………………………………………………............................... 2150 4,000 7. 8. Investments in unconsolidated subsidiaries and associated companies……………………............................... 2130 0 8. 9. Direct and indirect investments in real estate ventures...................................……...................................... 3656 0 9. 10. Intangible assets (from Schedule RC-M)………………………………………………………………………………………………………… 2143 2,000 10. . Other assets (from Schedule RC-F) 2160 11 (6)…………………………………………………………….................................. 2,490,000 11. 12. Total assets (sum of items 1 through 11)………………………………………………………....................................... 2170 38,725,000 12. Liabilities 13. Deposits: a. In domestic offices (sum of totals of columns A and C from Schedule RC-E)………………………………................... 2200 26,278,000 13.a. -bearing 6631 (1) Noninterest (8)………………………………………………..………….. 9,337,000 13.a.(1) (2) Interest-bearing……………………………………………………..…………….. 6636 16,941,000 13.a.(2) b. Not applicable 14. Federal funds purchased and securities sold under agreements to repurchase: . Federal funds purchased B993 a (9)………………………………………..…………......................................... 0 14.a. .. Securities sold under agreements to repurchase B995 b (10)………………………………………………..................................... 0 14.b. 15. Trading liabilities (from Schedule RC-D)…………………………………………………..………….............................................. 3548 0 15. 16. Other borrowed money (includes mortgage indebtedness) (from Schedule RC-M)................................. 3190 0 16. 17. and 18. Not applicable 19 Subordinated notes and debentures 3200 . (11)……………………………………………………………………..……………….................. 0 19. __________ 1. Includes cash items in process of collection and unposted debits. 2. Includes time certificates of deposit not held for trading. 3. Institutions that have adopted ASU 2016-13 should report in item 2.a amounts net of any applicable allowance for credit losses, and item 2.a should equal Schedule RC-B, item 8, column A, less Schedule RI-B, Part II, item 7, column B. 4. Item 2.c is to be completed by all institutions. See the instructions for this item and the Glossary entry for “Securities Activities” for further detail on accounting for investments in equity securities. 5. Includes all securities resale agreements, regardless of maturity. 6. Institutions that have adopted ASU 2016-13 should report in items 3.b and 11 amounts net of any applicable allowance for credit losses. 7. Institutions that have adopted ASU 2016-13 should report in item 4.c the allowance for credit losses on loans and leases. 8. Includes noninterest-bearing demand, time, and savings deposits. 9. Report overnight Federal Home Loan Bank advances in Schedule RC, item 16, “Other borrowed money.” 10. Includes all securities repurchase agreements, regardless of maturity. 11. Includes limited-life preferred stock and related surplus. 12/2023 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 18 of 86 RC-2 Schedule RC—Continued Dollar Amounts in Thousands RCON Amount Liabilities—continued 20. Other liabilities (from Schedule RC-G)…………………………………………………………………….………………..................... 2930 2,782,000 20. 21. Total liabilities (sum of items 13 through 20)……………………………………………………………………………….................. 2948 29,060,000 21. 22. Not applicable Equity Capital Bank Equity Capital 23. Perpetual preferred stock and related surplus…………………………………………………………………………….............. 3838 0 23. 24. Common stock……………………………………………………………………………………………….……………….............. 3230 2,127,000 24. 25. Surplus (exclude all surplus related to preferred stock)………………………………………………..………………............... 3839 935,000 25. 26. a.Retained earnings………………………………………………………………………………………..………………............... 3632 6,637,000 26.a. .Accumulated other comprehensive income B530 b (1)………………………………………………………….………………...................... (34,000) 26.b. . Other equity capital components A130 c (2)………………………………………………………………………………………................. 0 26.c. 27. a.Total bank equity capital (sum of items 23 through 26.c)…………………………………………………..…………....................... 3210 9,665,000 27.a. b.Noncontrolling (minority) interests in consolidated subsidiaries…………………………………….……............................ 3000 0 27.b. 28. Total equity capital (sum of items 27.a and 27.b)………………………………………………………..…………....................... G105 9,665,000 28. 29. Total liabilities and equity capital (sum of items 21 and 28)……………………………………………..……….......................... 3300 38,725,000 29. Memoranda To be reported with the March Report of Condition. 1. Indicate in the box at the right the number of the statement below that best describes the most comprehensive level of auditing work performed for the bank by independent external auditors as of RCON Number any date during 2022……………………………………………………………………………………......................... 6724 NA M.1. 1a = An integrated audit of the reporting institution’s financial statements and its internal control over financial reporting conducted in accordance with the standards of the American Institute of Certified Public Accountants (AICPA) or Public Company Accounting Oversight Board (PCAOB) by an independent public accountant that submits a report on the institution 1b =An audit of the reporting institution’s financial statements only conducted in accordance with the auditing standards of the AICPA or the PCAOB by an independent public accountant that submits a report on the institution 2a =An integrated audit of the reporting institution’s parent holding company’s consolidated financial statements and its internal control over financial reporting conducted in accordance with the standards of the AICPA or the PCAOB by an independent public accountant that submits a report on the consolidated holding company (but not on the institution separately) 2b = 3 = 4 = 5 = 6 = 7 = 8 = 9 = An audit of the reporting institution’s parent holding company’s consolidated financial statements only conducted in accordance with the auditing standards of the AICPA or the PCAOB by an independent public accountant that submits a report on the consolidated holding company (but not on the institution separately) This number is not to be used Directors’ examination of the bank conducted in accordance with generally accepted auditing standards by a certified public accounting firm (may be required by state-chartering authority) Directors’ examination of the bank performed by other external auditors (may be required by state-chartering authority) Review of the bank’s financial statements by external auditors Compilation of the bank’s financial statements by external auditors Other audit procedures (excluding tax preparation work) No external audit work To be reported with the March Report of Condition. RCON Date 2. Bank’s fiscal year-end date (report the date in MMDD format)............................................................................................................................................................... 8678 NA M.2. 1. Includes, but is not limited to, net unrealized holding gains (losses) on available-for-sale securities, accumulated net gains (losses) on cash flow hedges, and accumulated defined benefit pension and other postretirement plan adjustments. 2. Includes treasury stock and unearned Employee Stock Ownership Plan shares. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 19 of 86 RC-3 Schedule RC-A—Cash and Balances Due from Depository Institutions Schedule RC-A is to be completed only by banks with $300 million or more in total assets. (1) Exclude assets held for trading. Dollar Amounts in Thousands RCON Amount 1. Cash items in process of collection, unposted debits, and currency and coin: a. Cash items in process of collection and unposted debits...................................................................................... 0020 41,000 1.a. b. Currency and coin............................................................................................................................................................. 0080 0 1.b. 2. Balances due from depository institutions in the U.S............................................................................................... 0082 3,000 2. 3. Balances due from banks in foreign countries and foreign central banks........................................................................................ 0070 0 3. 4. Balances due from Federal Reserve Banks......................................................................................................................... 0090 13,553,000 4. 5. Total (sum of items 1 through 4) (must equal Schedule RC, sum of items 1.a and 1.b)…........................................ 0010 13,597,000 5. __________ 1. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. Schedule RC-B—Securities Exclude assets held for trading. Held-to-maturity Available-for-sale (Column A) (Column B) (Column C) (Column D) Amortized Cost Fair Value Amortized Cost Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount 1. U.S. Treasury securities……................. 0211 0 0213 0 1286 423,000 1287 378,000 1. 2. U.S. Government agency and sponsored agency obligations (exclude mort—backed securities) ………………… HT50 0 HT51 0 HT52 HT53 gage (1) 0 0 2. 3. Securities issued by states and political subdivisions in the U.S 8496 0 8497 0 8498 0 8499 0 3. 1. Includes Small Business Administration “Guaranteed Loan Pool Certificates”; U.S. Maritime Administration obligations; Export-Import Bank participation certificates; and obligations (other than mortgage-backed securities) issued by the Farm Credit System, the Federal Home Loan Bank System, the Federal Home Loan Mortgage Corporation, the Federal National Mortgage Association, the Resolution Funding Corporation, the Student Loan Marketing Association, and the Tennessee Valley Authority. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 20 of 86 RC-4 Schedule RC-B—Continued Held-to-maturity Available-for-sale (Column A) (Column B) (Column C) (Column D) Amortized Cost Fair Value Amortized Cost Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount 4. Mortgage-backed securities (MBS): a. Residential mortgage pass-through securities: (1) Guaranteed by GNMA…………………..……......................... G300 0 G301 0 G302 0 G303 0 4.a.(1) (2) Issued by FNMA and FHLMC…………………........................ G304 0 G305 0 G306 0 G307 0 4.a.(2) (3) Other pass-through securities…………….................... G308 0 G309 0 G310 0 G311 0 4.a.(3) b. Other residential mortgage-backed securities (include CMOs, REMICs, and stripped MBS): (1) Issued or guaranteed by U.S. Government agencies or sponsored G312 G313 G314 G315 agencies (1) ………………………………………………………… 0 0 0 0 4.b.(1) (2) Collateralized by MBS issued or guaranteed by U.S. Government agencies or sponsored G316 G317 G318 G319 agencies (1) ..................................................................... 0 0 0 0 4.b.(2) (3) All other residential MBS................................................. G320 0 G321 0 G322 0 G323 0 4.b.(3) c. Commercial MBS (1) Commercial mortgage pass-through securities: (a) Issued or guaranteed by FNMA, FHLMC, or GNMA…………………… K142 0 K143 0 K144 0 K145 0 4.c.(1)(a) (b) Other pass-through securities………… K146 0 K147 0 K148 0 K149 0 4.c.(1)(b) 1. U.S. Government agencies include, but are not limited to, such agencies as the Government National Mortgage Association (GNMA), the Federal Deposit Insurance Corporation (FDIC), and the National Credit Union Administration (NCUA). U.S. Government-sponsored agencies include, but are not limited to, such agencies as the Federal Home Loan Mortgage Corporation (FHLMC) and the Federal National Mortgage Association (FNMA). 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 21 of 86 RC-5 Schedule RC-B—Continued Held-to-maturity Available-for-sale (Column A) (Column B) (Column C) (Column D) Amortized Cost Fair Value Amortized Cost Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount 4. c.(2) Other commercial MBS: (a) Issued or guaranteed by U.S. Government agencies or sponsored .................................... K150 K151 K152 K153 agencies (1) 0 0 0 0 4.c.(2)(a) (b) All other commercial MBS……………………………….. K154 0 K155 0 K156 0 K157 0 4.c.(2)(b) 5. Asset-backed securities and structured financial products: a. Asset-backed securities (ABS)..............……..…........................ C026 0 C988 0 C989 0 C027 0 5.a. b. Structured financial products………………………………… HT58 0 HT59 0 HT60 0 HT61 0 5.b. 6. Other debt securities: a. Other domestic debt securities………………….…….......................... 1737 0 1738 0 1739 0 1741 0 6.a. b. Other foreign debt securities………………….…….......................... 1742 0 1743 0 1744 0 1746 0 6.b. 7. Unallocated portfolio layer fair value hedge adjustments MG95 basis (2)..……………………………………… NA 7. 8. Total (sum of items 1 1754 1771 1772 1773 through 7) (3)..……………………………………… 0 0 423,000 378,000 8. 1. U.S. Government agencies include, but are not limited to, such agencies as the Government National Mortgage Association (GNMA), the Federal Deposit Insurance Corporation (FDIC), and the National Credit Union Administration (NCUA). U.S. Government-sponsored agencies include, but are not limited to, such agencies as the Federal Home Loan Mortgage Corporation (FHLMC) and the Federal National Mortgage Association (FNMA). 2. This item is to be completed by institutions that have adopted ASU 2022-01, as applicable. 3. For institutions that have adopted ASU 2016-13, the total reported in column A must equal Schedule RC, item 2.a, plus Schedule RI-B, Part II, item 7, column B. For institutions that have not adopted ASU 2016-13, the total reported in column A must equal Schedule RC, item 2.a. For all institutions, the total reported in column D must equal Schedule RC, item 2.b. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 22 of 86 RC-6 Schedule RC-B—Continued Memoranda Dollar Amounts in Thousands RCON Amount . Pledged securities 0416 1 (1)…………………………………………………………………………………………………………............................ 0 M.1. 2. Maturity and repricing data for debt securities (excluding those in nonaccrual status): a. Securities issued by the U.S. Treasury, U.S. Government agencies, and states and political subdivisions in the U.S.; other non-mortgage debt securities; and mortgage pass-through securities other than those backed by closed-end first lien 1–4 family residential mortgages with a remaining maturity or next repricing date of: (2), (3) (1) Three months or less……………………………………………………………………………………………………………………… A549 0 M.2.a.(1) (2) Over three months through 12 months…………………………………………………………….………………………………………… A550 0 M.2.a.(2) (3) Over one year through three years………………………………………………………………..…………………………………………… A551 0 M.2.a.(3) (4) Over three years through five years……………………………………………………………………………………………………… A552 378,000 M.2.a.(4) (5) Over five years through 15 years………………………………………………………………….…………………………………………… A553 0 M.2.a.(5) (6) Over 15 years………………………………………………………………………………………………………………………… A554 0 M.2.a.(6) b. Mortgage pass-through securities backed by closed-end first lien 1–4 family residential mortgages with a remaining maturity or next repricing date of: (2), (4) (1) Three months or less………………………………………………………………………………………………………………………………… A555 0 M.2.b.(1) (2) Over three months through 12 months…………………………………………………………….……………………………………………… A556 0 M.2.b.(2) (3) Over one year through three years………………………………………………………………..…………………………………………… A557 0 M.2.b.(3) (4) Over three years through five years……………………………………………………………….…………………………………………… A558 0 M.2.b.(4) (5) Over five years through 15 years………………………………………………………………….…………………………………… A559 0 M.2.b.(5) (6) Over 15 years…………………………………………………………………………………………………………………………………… A560 0 M.2.b.(6) c. Other mortgage-backed securities (include CMOs, REMICs, and stripped MBS; exclude mortgage pass-through securities) with an expected average life of: (5) (1) Three years or less…………………………………………………………………………………..……………………………………… A561 0 M.2.c.(1) (2) Over three years……………………………………………………………………………………..…………………………………… A562 0 M.2.c.(2) d. Debt securities with a REMAINING MATURITY of one year or less (included in Memorandum items 2.a through 2.c above)………………………………………………………………………………............... A248 0 M.2.d. Memorandum item 3 is to be completed semiannually in the June and December reports only. 3. Amortized cost of held-to-maturity securities sold or transferred to available-for-sale or trading securities during the calendar year-to-date (report the amortized cost at date of sale or transfer)…………………….................. 1778 0 M.3. 4. Structured notes (included in the held-to-maturity and available-for-sale accounts in Schedule RC-B, items 2, 3, 5, and 6): a. Amortized cost……………………………………………………………………………………………………………….............. 8782 0 M.4.a. b. Fair value………………………………………………………………………………………………….………………….................. 8783 0 M.4.b. 1. Includes held-to-maturity securities at amortized cost, available-for-sale debt securities at fair value, and equity securities with readily determinable fair values not held for trading (reported in Schedule RC, item 2.c) at fair value. 2. Report fixed-rate debt securities by remaining maturity and floating-rate debt securities by next repricing date. 3. Sum of Memorandum items 2.a.(1) through 2.a.(6) plus any nonaccrual debt securities in the categories of debt securities reported in Memorandum item 2.a that are included in Schedule RC-N, item 10, column C, must equal Schedule RC-B, sum of items 1, 2, 3, 4.c.(1), 5, and 6, columns A and D, plus residential mortgage pass-through securities other than those backed by closed-end first lien 1–4 family residential mortgages included in Schedule RC-B, item 4.a, columns A and D. 4. Sum of Memorandum items 2.b.(1) through 2.b.(6) plus any nonaccrual mortgage pass-through securities backed by closed-end first lien 1–4 family residential mortgages included in Schedule RC-N, item 10, column C, must equal Schedule RC-B, item 4.a, sum of columns A and D, less the amount of residential mortgage pass-through securities other than those backed by closed-end first lien 1–4 family residential mortgages included in Schedule RC-B, item 4.a, columns A and D. 5. Sum of Memorandum items 2.c.(1) and 2.c.(2) plus any nonaccrual “Other mortgage-backed securities” included in Schedule RC-N, item 10, column C, must equal Schedule RC-B, sum of items 4.b and 4.c.(2), columns A and D. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 23 of 86 RC-7 Schedule RC-B—Continued Memoranda—Continued Held-to-maturity Available-for-sale (Column A) (Column B) (Column C) (Column D) Amortized Cost Fair Value Amortized Cost Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount Memorandum items 5.a through 5.f and 6.a through 6.g are to be completed by banks with $10 billion or more in total assets. (1) 5. Asset-backed securities (ABS) (for each column, sum of Memorandum items 5.a through 5.f must equal Schedule RC-B, item 5.a): a. Credit card receivables……………….……................ B838 0 B839 0 B840 0 B841 0 M.5.a. b. Home equity lines………………................. B842 0 B843 0 B844 0 B845 0 M.5.b. c. Automobile loans………….……................ B846 0 B847 0 B848 0 B849 0 M.5.c. d. Other consumer loans……………………................. B850 0 B851 0 B852 0 B853 0 M.5.d. e. Commercial and industrial loans…………….……............. B854 0 B855 0 B856 0 B857 0 M.5.e. f. Other………………………..……............... B858 0 B859 0 B860 0 B861 0 M.5.f. 6. Structured financial products by underlying collateral or reference assets (for each column, sum of Memorandum items 6.a through 6.g must equal Schedule RC-B, item 5.b: a. Trust preferred securities issued by financial institutions................................. G348 0 G349 0 G350 0 G351 0 M.6.a. b. Trust preferred securities issued by real estate investment trusts..................................... G352 0 G353 0 G354 0 G355 0 M.6.b. c. Corporate and similar loans........................................... G356 0 G357 0 G358 0 G359 0 M.6.c. d. 1-4 family residential MBS issued or guaranteed by U.S. Government-sponsored enterprises (GSEs)............................... G360 0 G361 0 G362 0 G363 0 M.6.d. e. 1-4 family residential MBS not issued or guaranteed by GSEs................................ G364 0 G365 0 G366 0 G367 0 M.6.e. f. Diversified (mixed) pools of structured financial products.................................. G368 0 G369 0 G370 0 G371 0 M.6.f. g. Other collateral or reference assets.................................... G372 0 G373 0 G374 0 G375 0 M.6.g. 1. The $10 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RC-C—Loans and Lease Financing Receivables FFIEC 041 Page 24 of 86 RC-8 Part I. Loans and Leases Do not deduct the allowance for loan and lease losses or the allocated transfer risk reserve from amounts reported in this schedule.(1) Report (1) loans and leases held for sale at the lower of cost or fair value, (2) loans and leases held for investment, net of unearned income, and (3) loans and leases accounted for at fair value under a fair value option. Exclude assets held for trading and commercial paper. (Column A) (Column B) To Be Completed To Be Completed by Banks with by All Banks $300 Million or More in Total Assets (2) Dollar Amounts in Thousands RCON Amount RCON Amount 1. Loans secured by real estate: a. Construction, land development, and other land loans: (1) 1–4 family residential construction loans…………………..……………….................. F158 0 1.a.(1) (2) Other construction loans and all land development and other land loans………………………………………….……………………………………….…………………………….. F159 77,000 1.a.(2) b. Secured by farmland (including farm residential and other improvements)……………………………………………………………………...…. 1420 0 1.b. c. Secured by 1–4 family residential properties: (1) Revolving, open-end loans secured by 1–4 family residential properties and extended under lines of credit…………………………....…............ 1797 264,000 1.c.(1) (2) Closed-end loans secured by 1–4 family residential properties: (a) Secured by first liens……………………………………….……………………….……………………………………….……………………………… 5367 1,898,000 1.c.(2)(a) (b) Secured by junior liens…………………………………………………….....…………………………… 5368 32,000 1.c.(2)(b) d. Secured by multifamily (5 or more) residential properties…………………........................ 1460 2,100,000 1.d. e. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties………………………………………………………………………………….……………………………………….………………………….….. F160 0 1.e.(1) (2) Loans secured by other nonfarm nonresidential properties…………………………………………… F161 2,352,000 1.e.(2) 2. Loans to depository institutions and acceptances of other banks…………………………………………….. 1288 1,065,000 2. a. To commercial banks in the U.S. …………………………….…………......................... B531 1,000 2.a. b. To other depository institutions in the U.S…………………………….…………............... B534 0 2.b. c. To banks in foreign countries B535 1,064,000 2.c. 3. Loans to finance agricultural production and other loans to farmers……………................. 1590 0 3. 4. Commercial and industrial loans………………………………………….……………………………………….……………………………………………..….... 1766 3,016,000 4. a. To U.S. addressees (domicile)………………………………………………….……………………………………….……………………………………..….... 1763 2,819,000 4.a. b. To non-U.S. addressees (domicile)………………………………….………….................1764 197,000 4.b. 5. Not applicable 6. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper): a. Credit cards………………………………………..…………..……………………................ B538 0 6.a. b. Other revolving credit plans…………………………………………….……………………………………….…………………………………………………….. B539 0 6.b. c. Automobile loans…………………………………………………………….………………….…………………..…........... K137 0 6.c. d. Other consumer loans (includes single payment and installment, loans other than automobile loans, and all student loans)………………………………………………….….………..…… K207 307,000 6.d. 7. Not applicable 8. Obligations (other than securities and leases) of states and political subdivisions in the U.S………………………………………………….……………………………………….……………………………………………………..... 2107 0 8. 1. Institutions that have adopted ASU 2016-13 should not deduct the allowance for credit losses on loans and leases or the allocated transfer risk reserve from amounts reported on this schedule. 2. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 25 of 86 RC-9 Schedule RC-C—Continued Part I—Continued (Column A) (Column B) To Be Completed To Be Completed by Banks with by All Banks $300 Million or More in Total Assets (1) Dollar Amounts in Thousands RCON Amount RCON Amount 9. Loans to nondepository financial institutions and other loans: a. Loans to nondepository financial institutions…………………………….............. J454 58,000 9.a. b. Other loans……………………………………………………………………....................... J464 5,178,000 9.b. (1) Loans for purchasing or carrying securities (secured and unsecured) ...................................................................................................................................................................................... 1545 2,302,000 9.b.(1) (2) All other loans (exclude consumer loans)................................................................................... J451 2,876,000 9.b.(2) 10. Lease financing receivables (net of unearned income).................................................. 2165 0 10. a. Leases to individuals for household, family, and other personal expenditures (i.e., consumer leases)……………………………................................. F162 0 10.a. b. All other leases………………………………………………………………............ F163 0 10.b. 11. LESS: Any unearned income on loans reflected in items 1-9 above.................................................... 2123 0 11. 12. Total loans and leases held for investment and held for sale (sum of items 1 through 10 minus item 11) (must equal Schedule RC, sum of items 4.a and 4.b)…...............…...............…...............…..... 2122 16,347,000 12. Memoranda Dollar Amounts in Thousands RCON Amount 1. Loans restructured in troubled debt restructurings that are in compliance with their modified terms (included in Schedule RC-C, Part I, and not reported as past due or nonaccrual in Schedule RC-N, Memorandum item 1): a. Construction, land development, and other land loans: (1) 1—4 family residential construction loans…………………………………………………...…………. K158 0 M.1.a.(1) (2) Other construction loans and all land development and other land loans…………………………………………………………………………………………. K159 0 M.1.a.(2) b. Loans secured by 1—4 family residential properties……………………...…………………………………………………………………………………… F576 0 M.1.b. c. Secured by multifamily (5 or more) residential properties……………………………………………………………………. K160 0 M.1.c. d. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties………………………………………………. K161 0 M.1.d.(1) (2) Loans secured by other nonfarm nonresidential properties………………………………………………………. K162 0 M.1.d.(2) e. Commercial and industrial loans……………………………………………………………..………………………………………. K256 0 M.1.e. Memorandum items 1.e.(1) and (2) are to be completed by banks with $300 million or more in total assets (1) (sum of Memorandum items 1.e(1) and (2) must equal Memorandum item 1.e): (1) To U.S. addressees (domicile)…………………………………..…................... K163 0 M.1.e.(1) (2) To non-U.S. addressees (domicile).................................................................................................................................. K164 0 M.1.e.(2) f. All other loans ( include loans to individuals for household, family, and other personal expenditures)……………………………………………………………………………………………………………… K165 0 M.1.f. Itemize loan categories included in Memorandum item 1.f, above that exceed 10 percent of total loans restructured in troubled debt restructurings that are in compliance with their modified terms (sum of Memorandum items 1.a through 1.e plus 1.f): (1) Loans secured by farmland…………………………………………………………………..……………..……..…… K166 0 M.1.f.(1) (2) and (3) Not applicable 1. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 26 of 86 Schedule RC-C—Continued RC-10 Part I—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount RCON Amount 1. f. (4) Loans to individuals for household, family, and other personal expenditures: (a) Credit cards……………..……………………………………………………………………………………............... K098 0 M.1.f.(4)(a) (b) Automobile loans…………………………………………………………………………………………….......................... K203 0 M.1.f.(4)(b) (c) Other (includes revolving credit plans other than credit cards and other consumer loans).................................................................................................................................................................................. K204 0 M.1.f.(4)(c) Memorandum item 1.f.(5) is to be completed by: (1) • Banks with $300 million or more in total assets • Banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans (5) Loans to finance agricultural production and other loans to farmers included in Schedule RC-C, Part I, Memorandum item 1.f, above……………………………………………………………………………. K168 0 M.1.f.(5) g.Total loans restructured in troubled debt restructurings that are in compliance with their modified terms (sum of Memorandum items 1.a.(1) through 1.e plus 1.f)………………………………………………………………………………………… HK25 0 M.1.g. 2. Maturity and repricing data for loans and leases (excluding those in nonaccrual status): a. Closed-end loans secured by first liens on 1–4 family residential properties (reported in Schedule RC-C, Part I, item 1.c.(2)(a), column B) with a remaining maturity or next repricing date of: (2), (3) (1) Three months or less………………………………………………………………………………………................................. A564 56,000 M.2.a.(1) (2) Over three months through 12 months……………………………………………………………………................................ A565 222,000 M.2.a.(2) (3) Over one year through three years……………………………………………………………………….................................. A566 222,000 M.2.a.(3) (4) Over three years through five years……………………………………………………………………........................................ A567 184,000 M.2.a.(4) (5) Over five years through 15 years………………………………………………………………………….................................. A568 876,000 M.2.a.(5) (6) Over 15 years………………………………………………………………………………………………......................................... A569 316,000 M.2.a.(6) b. All loans and leases (reported in Schedule RC-C, Part I, items 1 through 10, column B above) EXCLUDING closed-end loans secured by first liens on 1–4 family residential properties (reported in Schedule RC-C, Part I, item 1.c.(2)(a), column B, above) with a remaining maturity or next repricing date of: (2) , (4) (1) Three months or less…………………………………………………………………………........................................................... A570 13,412,000 M.2.b.(1) (2) Over three months through 12 months……………………….…………………………………....................................... A571 742,000 M.2.b.(2) (3) Over one year through three years……………….…………………………………........................................................ A572 5,000 M.2.b.(3) (4) Over three years through five years……………………...………………………………................................................. A573 11,000 M.2.b.(4) (5) Over five years through 15 years………………………………………………………………......................................... A574 13,000 M.2.b.(5) (6) Over 15 years………………………………………………………………………………....................................…………………………….................................... A575 262,000 M.2.b.(6) c. Loans and leases (reported in Schedule RC-C, Part I, items 1 through 10, column B, above) with a REMAINING MATURITY of one year or less (excluding those in nonaccrual status)………………................................................ A247 14,137,000 M.2.c. 1. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on theJune 30, 2022, Report of Condition. 2. Report fixed-rate loans and leases by remaining maturity and floating rate loans by next repricing date. 3. Sum of Memorandum items 2.a.(1) through 2.a.(6) plus total nonaccrual closed-end loans secured by first liens on 1–4 family residential properties included in Schedule RC-N, item 1.c.(2)(a), column C, must equal total closed-end loans secured by first liens on 1–4 family residential properties from Schedule RC-C, Part I, item 1.c.(2)(a), column B. 4. Sum of Memorandum items 2.b.(1) through 2.b.(6), plus total nonaccrual loans and leases from Schedule RC-N, item 9, column C, minus nonaccrual closed-end loans secured by first liens on 1–4 family residential properties included in Schedule RC-N, item 1.c.(2)(a), column C, must equal total loans and leases from Schedule RC-C, Part I, sum of items 1 through 10, column B, minus total closed-end loans secured by first liens on 1–4 family residential properties from Schedule RC-C, Part I, item 1.c.(2)(a), column B. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 27 of 86 RC-11 Schedule RC-C—Continued Part I—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount 3. Loans to finance commercial real estate, construction, and land development activities (not secured by real estate) included in Schedule RC-C, Part I, items 4 and 9, column B (1) 2746 52,000 M.3. 4. Adjustable-rate closed-end loans secured by first liens on 1–4 family residential properties (included in Schedule RC-C, Part I, item 1.c.(2)(a), column B)……………………………….......................................... 5370 1,887,000 M.4. 5. To be completed by banks with $300 million or more in total assets: (2) Loans secured by real estate to non-U.S. addressees (domicile) (included in Schedule RC-C, Part I, items 1.a through 1.e, column B) B837 108,000 M.5. Memorandum item 6 is to be completed by banks that (1) together with affiliated institutions, have outstanding credit card receivables (as defined in the instructions) that exceed $500 million as of the report date or (2) are credit card specialty banks as defined for Uniform Bank Performance Report purposes. 6. Outstanding credit card fees and finance charges included in Schedule RC-C, Part I, item 6.a. ……………………….…………………………………………………………………………………………………….......................... C391 NA M.6. Memorandum items 7.a, 7.b, and 8.a are to be completed by all banks semiannually in the June and December reports only. (3) 7. Purchased credit-impaired loans held for investment accounted for in accordance with FASB ASC 310-30 (former AICPA Statement of Position 03-3) (exclude loans held for sale): a. Outstanding balance………………………………………………………………………………………………......................... C779 NA M.7.a. b. Amount included in Schedule RC-C, Part I, items 1 through 9………………………………………........................... C780 NA M.7.b. 8. Closed-end loans with negative amortization features secured by 1–4 family residential properties: a. Total amount of closed-end loans with negative amortization features secured by 1–4 family residential properties (included in Schedule RC-C, Part I, items 1.c.(2)(a) and (b))................................. F230 0 M.8.a. Memorandum items 8.b and 8.c are to be completed semiannually in the June and December reports only by banks that had closed-end loans with negative amortization features secured by 1– 4 family residential properties (as reported in Schedule RC-C, Part I, Memorandum item 8.a) as of the preceding December 31 report date, that exceeded the lesser of $100 million or 5 percent of total loans and leases held for investment and held for sale (as reported in Schedule RC-C, Part I, item 12, column B). b. Total maximum remaining amount of negative amortization contractually permitted on closed-end loans secured by 1–4 family residential properties………………………………………………..................... F231 NA M.8.b. c. Total amount of negative amortization on closed-end loans secured by 1–4 family residential properties included in the amount reported in Memorandum item 8.a above……………........…........….............. F232 NA M.8.c 9. Loans secured by 1–4 family residential properties in process of foreclosure (included in Schedule RC-C, Part I, items 1.c.(1), 1.c.(2)(a), and 1.c.(2)(b))…………….................................................... F577 0 M.9. 10. and 11. Not applicable 1. Exclude loans secured by real estate that are included in Schedule RC-C, Part I, items 1.a through 1.e, column B. 2. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 3. Memorandum item 7 is to be completed only by institutions that have not yet adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 28 of 86 RC-12 Schedule RC-C—Continued Part I—Continued Memoranda—Continued (Column A) (Column B) (Column C) Fair Value of Acquired Gross Contractual Best Estimate at Loans and Leases at Amounts Receivable Acquisition Date of Acquisition Date at Acquisition Date Contractual Cash Flows Not Expected to be Collected Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount Memorandum items 12.a, 12.b, 12.c, and 12.d are to be completed semiannually in the June and December reports only. 12. Loans (not subject to the requirements of FASB ASC 310-30 (former AICPA Statement of Position 03-3)) and leases held for investment that were acquired in business combinations with acquisition dates in the current calendar year: (1) a. Loans secured by real estate………………….……………. G091 0 G092 0 G093 0 M.12.a. b. Commercial and industrial loans……………………………. G094 0 G095 0 G096 0 M.12.b. c. Loans to individuals for household, family, and other personal expenditures……………………………. G097 0 G098 0 G099 0 M.12.c. d. All other loans and all leases………………………………… G100 0 G101 0 G102 0 M.12.d. Dollar Amounts in Thousands RCON Amount Memorandum item 13 is to be completed by banks that had construction, land development, and other land loans (as reported in Schedule RC-C, Part I, item 1.a, column B) that exceeded the sum of tier 1 capital (as reported in Schedule RC-R, Part I, item 26) plus the allowance for loan and lease losses or the allowance for credit losses on loans and leases, as applicable (as reported in Schedule RC, item 4.c) as of the preceding December 31 report date. 13. Construction, land development, and other land loans with interest reserves: a. Amount of loans that provide for the use of interest reserves (included in Schedule RC-C, Part I, item 1.a, column B)................................................................................................................................................ G376 0 M.13.a. b. Amount of interest capitalized from interest reserves on construction, land development, and other land loans that is included in interest and fee income on loans during the quarter RIAD (included in Schedule RI, item 1.a.(1)(b))............................................................................................................... G377 0 M.13.b. Memorandum item 14 is to be completed by all banks. RCON 14. Pledged loans and leases...................................................................................................................................................... G378 297,000 M.14. Memorandum item 15 is to be completed for the December report only. 15. Reverse mortgages: a. Reverse mortgages outstanding that are held for investment (included in Schedule RC-C, item 1.c, above)........................................................................................................... PR04 0 M.15.a. b. Estimated number of reverse mortgage loan referrals to other lenders during the year from whom compensation has been received for services performed in Number connection with the origination of the reverse mortgages...................................................................................... PR05 0 M.15.b. RCON Amount c. Principal amount of reverse mortgage originations that have been sold during the year...................................................................................... PR06 0 M.15.c. 1. Institutions that have adopted ASU 2016-13 should report only loans held for investment not considered purchased credit-deteriorated in Memorandum item 12. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 29 of 86 RC-13 Schedule RC-C—Continued Part I—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount Memorandum item 16 is to be completed by all banks. 16. Revolving, open-end loans secured by 1–4 family residential properties and extended under lines of credit that have converted to non-revolving closed-end status (included in item 1.c.(1) above)................................................................................................................................................................................................................ LE75 0 M.16. Amounts reported in Memorandum items 17.a and 17.b will not be made available to the public on an individual institution basis. 17. Eligible loan modifications under Section 4013,Temporary Relief from Troubled Debt Restructurings, of the 2020 Coronavirus Aid, Relief, and Economic Security Act: Number a. Number of Section 4013 loans outstanding........................................................................................................ LG24 0 M.17.a. Amount b. Outstanding balance of Section 4013 loans......................................................................................................... LG25 0 M.17.b. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 30 of 86 RC-14 Schedule RC-C—Continued Part II. Loans to Small Businesses and Small Farms Report the number and amount currently outstanding as of the report date of business loans with “original amounts” of $1,000,000 or less and farm loans with “original amounts” of $500,000 or less. The following guidelines should be used to determine the “original amount” of a loan: (1) For loans drawn down under lines of credit or loan commitments, the “original amount” of the loan is the size of the line of credit or loan commitment when the line of credit or loan commitment was most recently approved, extended, or renewed prior to the report date. However, if the amount currently outstanding as of the report date exceeds this size, the “original amount” is the amount currently outstanding on the report date. (2) For loan participations and syndications, the “original amount” of the loan participation or syndication is the entire amount of the credit originated by the lead lender. (3) For all other loans, the “original amount” is the total amount of the loan at origination or the amount currently outstanding as of the report date, whichever is larger. Loans to Small Businesses 1. Indicate in the appropriate box at the right whether all or substantially all of the dollar volume of your bank’s “Loans secured by nonfarm nonresidential properties” reported in Schedule RC-C, Part I, items 1.e.(1) and 1.e.(2), and all or substantially all of the dollar volume of your bank’s “Commercial and industrial loans” reported in Schedule RC-C, Part I, item 4, (1) have original amounts of $100,000 or less (If your bank has no loans outstanding in both of these two loan categories, place an “X” in the RCON Yes No box marked “NO.”) ..................................................................................................................................................................................................... 6999 x 1. If YES, complete items 2.a and 2.b below, skip items 3 and 4, and go to item 5. If NO and your bank has loans outstanding in either loan category, skip items 2.a and 2.b, complete items 3 and 4 below, and go to item 5. If NO and your bank has no loans outstanding in both loan categories, skip items 2 through 4, and go to item 5. 2. Report the total number of loans currently outstanding for each of the following Schedule RC-C, Part Number of Loans I, loan categories: RCON Number a. “Loans secured by nonfarm nonresidential properties” reported in Schedule RC-C, Part I, items 1.e.(1) and 1.e.(2) (Note: Sum of items 1.e.(1) and 1.e.(2) divided by the number of loans should NOT exceed $100,000.) ............................................................................................................................................................. 5562 NA 2.a. b. “Commercial and industrial loans” reported in Schedule RC-C, Part I, item 4 (1) (Note: Item 4, 5563 (1) divided by the number of loans should NOT exceed $100,000.) NA 2.b. (Column A) (Column B) Number of Loans Amount Currently Dollar Amounts in Thousands Outstanding 3. Number and amount currently outstanding of “Loans secured by nonfarm RCON Number RCON Amount nonresidential properties” reported in Schedule RC-C, Part I, items 1.e.(1) and 1.e.(2) (sum of items 3.a through 3.c must be less than or equal to Schedule RC-C, Part I, sum of items 1.e.(1) and 1.e.(2)): a. With original amounts of $100,000 or less ........................................................................................................................... 5564 0 5565 0 3.a. b. With original amounts of more than $100,000 through $250,000 ................................................................................................ 5566 0 5567 0 3.b. c. With original amounts of more than $250,000 through $1,000,000 ............................................................................................. 5568 0 5569 0 3.c. 4. Number and amount currently outstanding of “Commercial and industrial loans” reported in Schedule RC-C, Part I, item 4 (1) (sum of items 4.a through 4.c must be less than or equal to Schedule RC-C, Part I, item 4 (1)): a. With original amounts of $100,000 or less ........................................................................................................................... 5570 0 5571 0 4.a. b. With original amounts of more than $100,000 through $250,000 ................................................................................................ 5572 1 5573 0 4.b. c. With original amounts of more than $250,000 through $1,000,000 ............................................................................................. 5574 0 5575 0 4.c. 1. Banks with $300 million or more in total assets should provide the requested information for “Commercial and industrial loans” based on the loans reported in Schedule RC-C, Part I, item 4.a, column A, “Commercial and industrial loans to U.S. addressees.” 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 31 of 86 RC-15 Schedule RC-C—Continued Part II—Continued Agricultural Loans to Small Farms 5. Indicate in the appropriate box at the right whether all or substantially all of the dollar volume of your bank’s “Loans secured by farmland (including farm residential and other improvements)” reported in Schedule RC-C, Part I, item 1.b, and all or substantially all of the dollar volume of your bank’s “Loans to finance agricultural production and other loans to farmers” in reported in Schedule RC-C, Part I, item 3, have original amounts of $100,000 or less (If your bank has no loans outstanding inboth of these two RCON Yes No loan categories, place an “X” in the box marked “NO.”) ............................................................................................................. 6860 x 5. If YES, complete items 6.a and 6.b below, and do not complete items 7 and 8. If NO and your bank has loans outstanding in either loan category, skip items 6.a and 6.b and complete items 7 and 8 below. If NO and your bank has no loans outstanding in both loan categories, do not complete items 6 through 8. 6. Report the total number of loans currently outstanding for each of the following Schedule RC-C, Part I, loan categories: a. “Loans secured by farmland (including farm residential and other improvements)” reported in Schedule RC-C, Part I, item 1.b (Note: Item 1.b, divided by the number of loans should NOT exceed $100,000.) .......................................................................................................................................................... b. “Loans to finance agricultural production and other loans to farmers” in reported in Schedule RC-C, Part I, item 3 (Note: Item 3 divided by the number of loans should NOT exceed $100,000.) Currently Dollar Amounts in Thousands Outstanding 7. Number and amount currently outstanding of “Loans secured by farmland RCON Number RCON Amount (including farm residential and other improvements)” reported in Schedule RC-C, Part I, item 1.b (sum of items 7.a through 7.c must be less than or equal to Schedule RC-C, Part I, item 1.b): a. With original amounts of $100,000 or less......................................................................................................................... 5578 NA 5579 NA 7.a. b. With original amounts of more than $100,000 through $250,000 ....................................................................................... 5580 NA 5581 NA 7.b. c. With original amounts of more than $250,000 through $500,000 .................................................................................. 5582 NA 5583 NA 7.c. 8. Number and amount currently outstanding of “Loans to finance agricultural production and other loans to farmers” reported in Schedule RC-C, Part I, item 3 (sum of items 8.a through 8.c must be less than or equal to Schedule RC-C, Part I, item 3): a. With original amounts of $100,000 or less.......................................................................................................................... 5584 NA 5585 NA 8.a. b. With original amounts of more than $100,000 through $250,000 ....................................................................................... 5586 NA 5587 NA 8.b. c. With original amounts of more than $250,000 through $500,000 ........................................................................................ 5588 NA 5589 NA 8.c. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 32 of 86 RC-16 Schedule RC-D—Trading Assets and Liabilities Schedule RC-D is to be completed by banks that (1) reported total trading assets of $10 million or more in any of the four preceding calendar quarters, or (2) meet the FDIC’s definition of a large or highly complex institution for deposit insurance assessment purposes. Dollar Amounts in Thousands RCON Amount Assets 1. U.S. Treasury securities.............................................................................................................................................................................................................................................. 3531 0 1. 2. U.S. Government agency obligations (exclude mortgage-backed securities) 3532 0 2. 3. Securities issued by states and political subdivisions in the U.S....................................................................................................................... 3533 0 3. 4. Mortgage-backed securities (MBS): a. Residential mortgage pass-through securities issued or guaranteed by FNMA, FHLMC, or GNMA……………………………………..…………..................................................................................................... G379 0 4.a. b. Other residential MBS issued or guaranteed by U.S. Government agencies or sponsored G380 agencies (1) (include CMOs, REMICs, and stripped MBS).................................................................................................................................. 0 4.b. c. All other residential MBS................................................................................................................................................................ G381 0 4.c. d. Commercial MBS issued or guaranteed by U.S. Government agencies or sponsored K197 agencies (1) ..................................................................................................................................................................................................................................................................... 0 4.d. e. All other commercial MBS................................................................................................................................................................................................... K198 0 4.e. 5. Other debt securities: a. Structured financial products HT62 0 5.a. b. All other debt securities.............................................................................................................................................................................................................................................. G386 0 5.b. 6. Loans: a. Loans secured by real estate: (1) Loans secured by 1-4 family residential properties.................................................................................................... HT63 0 6.a.(1) (2) All other loans secured by real estate....................................................................................................................... HT64 0 6.a.(2) b. Commercial and industrial loans F614 0 6.b. c. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper)........................................................................................................ HT65 0 6.c. d. Other loans.............................................................................................................................................................................................................................................. F618 0 6.d. 7. and 8. Not applicable 9. Other trading assets.............................................................................................................................................................................................................................................. 3541 0 9. 10. Not applicable 11. Derivatives with a positive fair value 3543 0 11. 12. Total trading assets (sum of items 1 through 11) (must equal Schedule RC, item 5)....................................................................................................................... 3545 0 12. Liabilities 13. a. Liability for short positions.............................................................................................................................................................................................................................................. 3546 0 13.a. b. Other trading liabilities.............................................................................................................................................................................................................................................. F624 0 13.b. 14. Derivatives with a negative fair value 3547 0 14. 15. Total trading liabilities (sum of items 13.a through 14) (must equal Schedule RC, item 15).............................................................. 3548 0 15. _______________ 1. U.S. Government agencies include, but are not limited to, such agencies as the Government National Mortgage Association (GNMA), the Federal Deposit Insurance Corporation (FDIC), and the National Credit Union Administration (NCUA). U.S. Government-sponsored agencies include, but are not limited to, such agencies as the Federal Home Loan Mortgage Corporation (FHLMC) and the Federal National Mortgage Association (FNMA). Memoranda Dollar Amounts in Thousands RCON Amount 1. Unpaid principal balance of loans measured at fair value (reported in Schedule RC-D, items 6.a through 6.d): a. Loans secured by real estate: (1) Loans secured by 1-4 family residential properties……………………………………………..….……......... HT66 0 M.1.a.(1) (2) All other loans secured by real estate………………………………………………………………................... HT67 0 M.1.a.(2) b. Commercial and industrial loans………………………………………………………………………………………………………. F632 0 M.1.b. c. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper)…………………………………………………………........... HT68 0 M.1.c. d. Other loans…………………………………………………………………………......................................…………………………................... F636 0 M.1.d. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 33 of 86 RC-17 Schedule RC-E—Deposit Liabilities Nontransaction Transaction Accounts Accounts (Column A) (Column B) (Column C) Total Transaction Memo: Total Total Accounts (Including Demand Deposits (1) Nontransaction Total Demand (Included in Accounts Deposits) Column A) (Including MMDAs) Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount Deposits of: 1. Individuals, partnerships, and corporations…………………………………………………………… B549 14,670,000 B550 2,832,000 1. 2. U.S. Government………………………………………………................. 2202 0 2520 0 2. 3. States and political subdivisions in the U.S. ………………………. 2203 68,000 2530 0 3. 4. Commercial banks and other depository institutions in the U.S. …………………………………………............. B551 340,000 B552 190,000 4. 5. Banks in foreign countries……………………………………............... 2213 7,778,000 2236 117,000 5. 6. Foreign governments and official institutions (including foreign central banks)……………………………................. 2216 283,000 2377 0 6. 7. Total (sum of items 1 through 6) (sum of columns A and C must equal Schedule RC, item 13.a)………………………………………………………................. 2215 23,139,000 2210 23,137,000 2385 3,139,000 7. Memoranda Dollar Amounts in Thousands RCON Amount 1. Selected components of total deposits (i.e., sum of item 7, columns A and C): a. Total Individual Retirement Accounts (IRAs) and Keogh Plan accounts…………………………………….…….......................... 6835 48,000 M.1.a. b. Total brokered deposits………………………………………………………………………………………….……............................. 2365 319,000 M.1.b. c. Brokered deposits of $250,000 or less (fully insured brokered deposits) HK05 (2) ……………………………... 312,000 M.1.c. d. Maturity data for brokered deposits: (1) Brokered deposits of $250,000 or less with a remaining maturity of one year or less (included in Memorandum item 1.c above)….............................................................................................................................. HK06 312,000 M.1.d.(1) (2) Not applicable (3) Brokered deposits of more than $250,000 with a remaining maturity of one year or less (included in Memorandum item 1.b above)……………………………………………………………….…………………………………….. K220 7,000 M.1.d.(3) e. Preferred deposits (uninsured deposits of states and political subdivisions in the U.S. reported in item 3 above which are secured or collateralized as required under state law) (to be completed for the December report only)………………………………………………………………........................... 5590 0 M.1.e. f. Estimated amount of deposits obtained through the use of deposit listing services that are not brokered deposits ............................................................................................................................................................ K223 0 M.1.f. g. Total reciprocal deposits........................................................................................................................................................................ JH83 0 M.1.g. h. Sweep deposits: (1) Fully insured, affiliate sweep deposits .............................................................................................................................................................. MT87 110,000 M.1.h.(1) (2) Not fully insured, affiliate sweep deposits ............................................................................................................................................................... MT89 462,000 M.1.h.(2) (3) Fully insured, non-affiliate sweep deposits .............................................................................................................................................................. MT91 0 M.1.h.(3) (4) Not fully insured, non-affiliate sweep deposits .............................................................................................................................................................. MT93 0 M.1.h.(4) i. Total sweep deposits that are not brokered deposits .............................................................................................................................................................. MT95 536,000 M.1.i. 1. Includes interest-bearing and noninterest-bearing demand deposits. 2. The dollar amount used as the basis for reporting in Memorandum item 1.c reflects the deposit insurance limits in effect on the report date. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 34 of 86 RC-18 Schedule RC-E—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount 2. Components of total nontransaction accounts (sum of Memorandum items 2.a through 2.d must equal item 7, column C above): a. Savings deposits: (1) Money market deposit accounts (MMDAs)…………………………………………………………………….......................... 6810 2,922,000 M.2.a.(1) (2) Other savings deposits (excludes MMDAs)……………………………………………………………….…............................. 0352 0 M.2.a.(2) b. Total time deposits of less than $100,000…………………………………………………………………………................................ 6648 0 M.2.b. c. Total time deposits of $100,000 through $250,000…………………………………………………………………………………………….... J473 0 M.2.c. d. Total time deposits of more than $250,000 …………………………………………………………………………………………….... J474 217,000 M.2.d. e. Individual Retirement Accounts (IRAs) and Keogh Plan accounts of $100,000 or more included in Memorandum items 2.c and 2.d above …………………………………………………………………………………………….... F233 0 M.2.e. 3. Maturity and repricing data for time deposits of $250,000 or less: a. Time deposits of $250,000 or less with a remaining maturity or next repricing date of: (1), (2) (1) Three months or less………………………………………………………………………………………………………….... HK07 0 M.3.a.(1) (2) Over three months through 12 months……………………………………………………………………………………….. HK08 0 M.3.a.(2) (3) Over one year through three years…………………………………………………………………………………………..... HK09 0 M.3.a.(3) (4) Over three years……………………………………………………………………………………………………………….... HK10 0 M.3.a.(4) b. Time deposits of $250,000 or less with a REMAINING MATURITY of one year or less in Memorandum items 3.a.(1) and 3.a.(2) above) HK11 (included (3)……………………………………………………………...... 0 M.3.b. 4. Maturity and repricing data for time deposits of more than $250,000: a. Time deposits of more than $250,000 with a remaining maturity or next repricing date of: (1), (4) (1) Three months or less………………………………………………………………………………………………………….... HK12 217,000 M.4.a.(1) (2) Over three months through 12 months……………………………………………………………………………………….. HK13 0 M.4.a.(2) (3) Over one year through three years…………………………………………………………………………………………..... HK14 0 M.4.a.(3) (4) Over three years……………………………………………………………………………………………………………….... HK15 0 M.4.a.(4) b. Time deposits of more than $250,000 with a REMAINING MATURITY of one year or less in Memorandum items 4.a.(1) and 4.a.(2) above) K222 (included (3) ………………….………………............... 217,000 M.4.b. 5. Does your institution offer one or more consumer deposit account products, i.e., transaction account or nontransaction savings account deposit products intended primarily for RCON Yes No individuals for personal, household, or family use?……………………………………………………………………………………………………………….... P752 x M.5. Memorandum items 6 and 7 are to be completed by institutions with $1 billion or more in total assets (5) that answered “Yes” to Memorandum item 5 above. Dollar Amounts in Thousands RCON Amount 6. Components of total transaction account deposits of individuals, partnerships, and corporations (sum of Memorandum items 6.a and 6.b must be less than or equal to item 1, column A above): a. Total deposits in those noninterest-bearing transaction account deposit products intended primarily for individuals for personal, household, or family use P753 NA M.6.a. b. Total deposits in those interest-bearing transaction account deposit products intended primarily for individuals for personal, household, or family use P754 NA M.6.b. 1. Report fixed-rate time deposits by remaining maturity and floating rate time deposits by next repricing date. 2. Sum of Memorandum items 3.a.(1) through 3.a.(4) must equal Schedule RC-E, sum of Memorandum items 2.b and 2.c. 3. Report both fixed- and floating-rate time deposits by remaining maturity. Exclude floating-rate time deposits with a next repricing date of one year or less that have a remaining maturity of over one year. 4. Sum of Memorandum items 4.a.(1) through 4.a.(4) must equal Schedule RC-E, Memorandum item 2.d. 5. The $1 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 35 of 86 RC-19 Schedule RC-E—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount 7. Components of total nontransaction account deposits of individuals, partnerships, and corporations (sum of Memorandum items 7.a.(1), 7.a.(2), 7.b.(1), and 7.b.(2) plus all time deposits of individuals, partnerships, and corporations must equal item 1, column C, above): a. Money market deposit accounts (MMDAs) of individuals, partnerships, and corporations (sum of Memorandum items 7.a.(1) and 7.a.(2) must be less than or equal to Memorandum item 2.a.(1) above): (1) Total deposits in those MMDA deposit products intended primarily for individuals for personal, household, or family use P756 NA M.7.a.(1) (2) Deposits in all other MMDAs of individuals, partnerships, and corporations P757 NA M.7.a.(2) b. Other savings deposit accounts of individuals, partnerships, and corporations (sum of Memorandum items 7.b.(1) and 7.b.(2) must be less than or equal to Memorandum item 2.a.(2) above): (1) Total deposits in those other savings deposit account deposit products intended primarily for individuals for personal, household, or family use P758 NA M.7.b.(1) (2) Deposits in all other savings deposit accounts of individuals, partnerships, and corporations P759 NA M.7.b.(2) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 36 of 86 RC-20 Schedule RC-F—Other Assets (1) Dollar Amounts in Thousands RCON Amount . Accrued interest receivable B556 1 (2)……………………………………………………………………………….............................................. 112,000 1. . Net deferred tax assets 2148 2 (3)……………………………………………………………………………….............................................. 456,000 2. 3. Interest-only strips receivable (not in the form of a security) HT80 (4) ……………………………………………… 0 3. . Equity investments without readily determinable fair values 1752 4 (5)………………………………...................................... 97,000 4. 5. Life insurance assets: a. General account life insurance assets………………………………………………………………………….. K201 0 5.a. b. Separate account life insurance assets………………………………………………………………………………… K202 0 5.b. c. Hybrid account life insurance assets……………………………………………………………………………….. K270 0 5.c. 6. All other assets (itemize and describe amounts greater than $100,000 that exceed 25 percent of this item) 2168 1,825,000 6. a. Prepaid expenses…………....................................................................................................................................... 2166 0 6.a. b. Repossessed personal property (including vehicles)………………….................................................. 1578 0 6.b. c. Derivatives with a positive fair value held for purposes other than trading…………………………………………………..……………..................................................... C010 0 6.c. d. Not applicable e. Computer software.............................................................................................................................................................. FT33 0 6.e. f. Accounts receivable.............................................................................................................................................................. FT34 1,353,000 6.f. g. Receivables from foreclosed government-guaranteed mortgage loans.................................................................................................. FT35 0 6.g. TEXT h. 3549 . 3549 0 6.h TEXT i. 3550 . 3550 0 6.i TEXT j. 3551 j 3551 0 6. . 7. Total (sum of items 1 through 6) (must equal Schedule RC, item 11)…………………………………………….. 2160 2,490,000 7. 1. Institutions that have adopted ASU 2016-13 should report asset amounts in Schedule RC-F net of any applicable allowance for credit losses. 2. Include accrued interest receivable on loans, leases, debt securities, and other interest-bearing assets. Exclude accrued interest receivable on interest-bearing assets that is reported elsewhere on the balance sheet. 3. See discussion of deferred income taxes in Glossary entry on “income taxes.” 4. Report interest-only strips receivable in the form of a security as available-for-sale securities in Schedule RC, item 2.b, or as trading assets in Schedule RC, item 5, as appropriate. 5. Include Federal Reserve stock, Federal Home Loan Bank stock, and bankers’ bank stock. Schedule RC-G—Other Liabilities Dollar Amounts in Thousands RCON Amount . a. Interest accrued and unpaid on deposits 3645 1 (1) …………………………………………………………….……………………....51,000 1.a. b. Other expenses accrued and unpaid (includes accrued income taxes payable)…………………………………………………… 3646 650,000 1.b. . Net deferred tax liabilities 3049 2 (2)………………………………………………………………………………………………………………..0 2. . Allowance for credit losses on off-balance-sheet credit exposures B557 3 (3)…………………………………………….………………………. 2,000 3. 4. All other liabilities (itemize and describe amounts greater than $100,000 that exceed 25 percent of this item) 2938 2,079,000 4. a. Accounts payable…………………………………………………..…………………………………… 3066 989,000 4.a. b. Deferred compensation liabilities……………………………………………………………………… C011 0 4.b. c. Dividends declared but not yet payable………………………………….……………………………. 2932 0 4.c. d. Derivatives with a negative fair value held for purposes other than trading C012 0 4.d. e. Operating lease liabilities.................................................................................................................................. LB56 0 4.e. TEXT f. 3552 f 3552 0 4. . TEXT g. 3553 . 3553 0 4.g TEXT h. 3554 h 3554 0 4. . 5. Total (sum of items 1 through 4) (must equal Schedule RC, item 20)…………………………………………………………………. 2930 2,782,000 5. 1. For savings banks, include “dividends” accrued and unpaid on deposits. 2. See discussion of deferred income taxes in Glossary entry on “income taxes.” 3. Institutions that have adopted ASU 2016-13 should report in item 3 the allowance for credit losses on those off-balance sheet credit exposures that fall within the scope of the standard. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 37 of 86 RC-21 Schedule RC-K—Quarterly Averages (1) Dollar Amounts in Thousands RCON Amount Assets 1. Interest-bearing balances due from depository institutions………………………………………....................................... 3381 12,551,000 1. 2. U.S. Treasury securities and U.S. Government agency obligations (2) (excluding mortgage-backed securities)……………………………………………………………………………………...................................... B558 368,000 2. . Mortgage-backed securities B559 3 (2)…………………………………………………………………………....................................... 0 3. 4. All other debt securities (2) and equity securities with readily determinable fair values not held trading B560 for (3) ………………………………………………………………………………………………........................................ 0 4. 5. Federal funds sold and securities purchased under agreements to resell…………………….......................................... 3365 5,920,000 5. 6. Loans: a. Total loans……………………………………………………………………………………...................................... 3360 15,014,000 6.a. b. Loans secured by real estate: (1) Loans secured by 1–4 family residential properties…………………………………...................................3465 2,197,000 6.b.(1) (2) All other loans secured by real estate…………………………………………………...................................... 3466 4,045,000 6.b.(2) c. Commercial and industrial loans……………………………………………………………......................................... 3387 2,054,000 6.c. d. Loans to individuals for household, family, and other personal expenditures: (1) Credit cards………………………………………………………………………………..................................... B561 0 6.d.(1) (2) Other (includes revolving credit plans other than credit cards, automobile loans, and other consumer loans)………………………...…………………..……….……………...................................... B562 298,000 6.d.(2) Item 7 is to be completed by (1) banks that reported total trading assets of $10 million or more in any of the four preceding calendar quarters and (2) all banks meeting the FDIC’s definition of a large or highly complex institution for deposit insurance assessment purposes. 7. Trading assets………………………………………………………………...……………….......................................... 3401 0 7. 8. Lease financing receivables (net of unearned income)……………………...………………........................................ 3484 0 8. . Total assets 3368 9 (4) ……………………………………………………………………………………..……………………...... 36,263,000 9. Liabilities 10. Interest-bearing transaction accounts (interest-bearing demand deposits, NOW accounts, ATS accounts, and telephone and preauthorized transfer accounts)…………………….…………..................................... 3485 6,621,000 10. 11. Nontransaction accounts: a. Savings deposits (includes MMDAs)……………………………………………………………...................................... B563 3,204,000 11.a. b. Time deposits of $250,000 or less……………………………………………………………........................................ HK16 0 11.b. c. Time deposits of more than $250,000……………………………………………………………........................................ HK17 177,000 11.c. 12. Federal funds purchased and securities sold under agreements to repurchase……….......................................... 3353 0 12. 13. To be completed by banks with $100 million or more in total assets: (5) Other borrowed money (includes mortgage indebtedness)....................................................………………………………......................................... 3355 90,000 13. 1. For all items, banks have the option of reporting either (1) an average of DAILY figures for the quarter, or (2) an average of WEEKLY figures (i.e., the Wednesday of each week of the quarter). 2. Quarterly averages for all debt securities should be based on amortized cost. 3. Quarterly averages for equity securities with readily determinable fair values should be based on fair value. 4. The quarterly average for total assets should reflect securities not held for trading as follows: a) Debt securities at amortized cost. b) Equity securities with readily determinable fair values at fair value. c) Equity investments without readily determinable fair values at their balance sheet carrying values (i.e., fair value or, if elected, cost minus impairment, if any, plus or minus changes resulting from observable price changes). 5. The $100 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 38 of 86 RC-22 Schedule RC-K—Quarterly Averages (1) —Continued Memorandum Dollar Amounts in Thousands RCON Amount Memorandum item 1 is to be completed by: (2) • banks with $300 million or more in total assets, and • banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part 1, item 3) exceeding 5 percent of total loans. 1. Loans to finance agricultural production and other loans to farmers .......................................................................... 3386 0 M.1. 1. For all items, banks have the option of reporting either (1) an average of DAILY figures for the quarter, or (2) an average of WEEKLY figures (i.e., the Wednesday of each week of the quarter). 2. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RC-L—Derivatives and Off-Balance-Sheet Items FFIEC 041 Page 39 of 86 RC-23 Please read carefully the instructions for the preparation of Schedule RC-L. Some of the amounts reported in Schedule RC-L are regarded as volume indicators and not necessarily as measures of risk. Dollar Amounts in Thousands RCON Amount 1. Unused commitments: a. Revolving, open-end lines secured by 1–4 family residential properties, e.g., home equity lines........................................................................................................................................................................................................................................ 3814 170,000 1.a. Item 1.a.(1) is to be completed for the December report only. (1) Unused commitments for reverse mortgages outstanding that are held for investment (included in item 1.a. above)............................................................................................................................................................................................................ HT72 0 1.a.(1) b. Credit card lines..................................................................................................................................................................................................................... 3815 0 1.b. Items 1.b.(1) and 1.b.(2) are to be completed semiannually in the June and December reports only by banks with either $300 million or more in total assets or $300 million or more in credit card lines (1) (sum of items 1.b.(1) and 1.b.(2) must equal item 1.b). (1) Unused consumer credit card lines............................................................................................................................................................................. J455 0 1.b.(1) (2) Other unused credit card lines..................................................................................................................................................................................... J456 0 1.b.(2) c. Commitments to fund commercial real estate, construction, and land development loans: (1) Secured by real estate: (a) 1–4 family residential construction loan commitments............................................................................................................................................ F164 0 1.c.(1)(a) (b) Commercial real estate, other construction loan, and land development loan commitments.............................................................................................................................................................................................................. F165 254,000 1.c.(1)(b) (2) NOT secured by real estate.......................................................................................................................................................................................... 6550 0 1.c.(2) d. Securities underwriting........................................................................................................................................................................................................... 3817 0 1.d. e. Other unused commitments: (1) Commercial and industrial loans................................................................................................................................................................................. J457 282,000 1.e.(1) (2) Loans to financial institutions...................................................................................................................................................................................... J458 308,000 1.e.(2) (3) All other unused commitments.................................................................................................................................................................................... J459 6,867,000 1.e.(3) 2. Financial standby letters of credit…………………………………………………………..…….................................................................................................... 3819 241,000 2. Item 2.a is to be completed by banks with $1 billion or more in total assets. (1) 3820 a. Amount of financial standby letters of credit conveyed to others………………………………........................................ 0 2.a. 3. Performance standby letters of credit…………………………………………………….……..................................................................................................... 3821 104,000 3. Item 3.a is to be completed by banks with $1 billion or more in total assets. (1) 3822 a. Amount of performance standby letters of credit conveyed to others…………………………........................................ 0 3.a. 4. Commercial and similar letters of credit………………………….…………………………………………………………….……..................................................... 3411 0 4. 5. Not applicable 6. Securities lent and borrowed: a. Securities lent (including customers’ securities lent where the customer is indemnified against loss by the reporting bank)………………………………………………………….………………………………………….…….......................... 3433 0 6.a. b. Securities borrowed...................................................................................................................................................................................... 3432 0 6.b. (Column A) (Column B) Sold Protection Purchased Protection 7. Credit derivatives: RCON Amount RCON Amount a. Notional amounts: (1) Credit default swaps………………………………………….... C968 0 C969 0 7.a.(1) (2) Total return swaps…………………………………………….... C970 0 C971 0 7.a.(2) (3) Credit options……………………………………………………. C972 0 C973 0 7.a.(3) (4) Other credit derivatives……………………………………….... C974 0 C975 0 7.a.(4) 1. The asset-size tests and the $300 million credit card lines test are based on the total assets and credit card lines reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 40 of 86 Schedule RC-L—Continued RC-24 (Column A) (Column B) Sold Protection Purchased Protection Dollar Amounts in Thousands RCON Amount RCON Amount 7. b. Gross fair values: (1) Gross positive fair value……………………………………….. C219 0 C221 0 7.b.(1) (2) Gross negative fair value……………………………………..... C220 0 C222 0 7.b.(2) . c. Notional amounts by regulatory capital treatment: RCON Amount 7 (1) (1) Positions covered under the Market Risk Rule: (a) Sold protection…………………………………………………………………….…………………………...……....................................... G401 0 7.c.(1)(a) (b) Purchased protection………………………………………………………………………………………………........................................ G402 0 7.c.(1)(b) (2) All other positions: (a) Sold protection………………………………………………………………………………………………………....................................... G403 0 7.c.(2)(a) (b) Purchased protection that is recognized as a guarantee for regulatory capital purposes G404 0 7.c.(2)(b) (c) Purchased protection that is not recognized as a guarantee for regulatory capital purposes……………………….………………………………………………………………………………..……....................................... G405 0 7.c.(2)(c) Remaining Maturity of: (Column A) (Column B) (Column C) One Year or Less Over One Year Over Five Years Through Five Years Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 7. d. Notional amounts by remaining maturity: (1) Sold credit protection: (2) (a) Investment grade................................................................................... G406 0 G407 0 G408 0 7.d.(1)(a) (b) Subinvestment grade........................................................................... G409 0 G410 0 G411 0 7.d.(1)(b) (2) Purchased credit protection: (3) (a) Investment grade................................................................................... G412 0 G413 0 G414 0 7.d.(2)(a) (b) Subinvestment grade............................................................................ G415 0 G416 0 G417 0 7.d.(2)(b) RCON Amount 8. Not applicable 9. All other off-balance-sheet liabilities (exclude derivatives) (itemize and describe each component of this item over 25 percent of Schedule RC, item 27.a, “Total bank equity capital”) 3430 0 9. a. Not applicable b. Commitments to purchase when-issued securities..................................................................................... 3434 0 9.b. c. Standby letters of credit issued byanother party (e.g., a Federal Home Loan Bank) on the bank’s behalf...................................................................................................................................................... C978 0 9.c. TEXT 3555 d d. 3555 0 9. . TEXT 3556 . e. 3556 0 9.e TEXT f. 3557 . 3557 0 9.f 10. All other off-balance-sheet assets (exclude derivatives) (itemize and describe each component of this item over 25 percent of Schedule RC, item 27.a, “Total bank equity capital”):..................................................................................................... 5591 0 10. a. Commitments to sell when-issued securities............................................................................................... 3435 0 10.a. TEXT 5592 . b. 5592 0 10.b TEXT 5593 . c. 5593 0 10.c TEXT d. 5594 . 5594 0 10.d TEXT e. 5595 e 5595 0 10. . 1. Sum of items 7.c.(1)(a) and 7.c.(2)(a), must equal sum of items 7.a.(1) through (4), column A. Sum of items 7.c.(1)(b), 7.c.(2)(b), and 7.c.(2)(c) must equal sum of items 7.a.(1) through (4), column B. 2. Sum of items 7.d.(1)(a) and (b), columns A through C, must equal sum of items 7.a.(1) through (4), column A. 3. Sum of items 7.d.(2)(a) and (b), columns A through C, must equal sum of items 7.a.(1) through (4), column B. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 41 of 86 RC-25 Schedule RC-L—Continued Dollar Amounts in Thousands RCON Amount Items 11.a and 11.b are to be completed semiannually in the June and December reports only. 11. Year-to-date merchant credit card sales volume: a. Sales for which the reporting bank is the acquiring bank....................................................................................................................................... C223 0 11.a. b. Sales for which the reporting bank is the agent bank with risk.............................................................................................................................. C224 0 11.b. (Column A) (Column B) (Column C) (Column D) Interest Rate Foreign Exchange Equity Derivative Commodity and Other Dollar Amounts in Thousands Contracts Contracts Contracts Contracts Derivatives Position Indicators Amount Amount Amount Amount 12. Gross amounts (e.g., notional amounts) (for each column, sum of items 12.a through 12.e must equal sum of items 13 and 14): RCON 8693 RCON 8694 RCON 8695 RCON 8696 a. Futures contracts……………………… 0 0 0 0 12.a. RCON 8697 RCON 8698 RCON 8699 RCON 8700 b. Forward contracts…………………….. 0 0 0 0 12.b. c. Exchange-traded option contracts: RCON 8701 RCON 8702 RCON 8703 RCON 8704 (1) Written options……………………. 0 0 0 0 12.c.(1) RCON 8705 RCON 8706 RCON 8707 RCON 8708 (2) Purchased options………………… 24,000 0 0 0 12.c.(2) d. Over-the-counter option contracts: RCON 8709 RCON 8710 RCON 8711 RCON8712 (1) Written options…………………….. 0 0 0 0 12.d.(1) RCON 8713 RCON 8714 RCON 8715 RCON 8716 (2) Purchased options………………… 0 0 0 0 12.d.(2) RCON 3450 RCON 3826 RCON 8719 RCON 8720 e. Swaps………………………………….. 22,744,000 0 0 0 12.e. 13. Total gross notional amount of derivative RCON A126 RCON A127 RCON 8723 RCON 8724 contracts held for trading………..……..……..……..……..….. 0 0 0 0 13. 14. Total gross notional amount of derivative contracts held for purposes other than RCON 8725 RCON 8726 RCON 8727 RCON 8728 trading…………….……………………… 22,768,000 0 0 0 14. a. Interest rate swaps where the bank has agreed to pay a fixed RCON A589 rate…………………………………………………. 0 14.a. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 42 of 86 RC-26 Schedule RC-L—Continued (Column A) (Column B) (Column C) (Column D) Interest Rate Foreign Exchange Equity Derivative Commodity and Other Dollar Amounts in Thousands Contracts Contracts Contracts Contracts Derivatives Position Indicators Amount Amount Amount Amount 15. Gross fair values of derivative contracts: a. Contracts held for trading: (1) Gross positive fair RCON 8733 RCON 8734 RCON 8735 RCON 8736 value………………………………………………………… 0 0 0 0 15.a.(1) (2) Gross negative fair RCON 8737 RCON 8738 RCON 8739 RCON 8740 value……………………………………………………………… 0 0 0 0 15.a.(2) b. Contracts held for purposes other than trading: (1) Gross positive fair RCON 8741 RCON 8742 RCON 8743 RCON 8744 value………………………………………… 392,000 0 0 0 15.b.(1) (2) Gross negative fair RCON 8745 RCON 8746 RCON 8747 RCON 8748 value…………………………………………………………………………… 460,000 0 0 0 15.b.(2) (Column A) (Columns B-D) (Column E) Banks and Securities Not applicable Corporations and All Firms Other Counterparties Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount Item 16 is to be completed only by banks with total assets of $10 billion or more. (1) 16. Over-the-counter derivatives: a. Net current credit exposure………………..…............ G418 12,000 G422 375,000 16.a. b. Fair value of collateral: (1) Cash—U.S. dollar……………………………............G423 13,000 G427 0 16.b.(1) (2) Cash—Other currencies…………………............... G428 0 G432 0 16.b.(2) (3) U.S. Treasury securities………………….............. G433 0 G437 0 16.b.(3) (4) through (6) Not Applicable (7) All other collateral…………………………................. G453 0 G457 0 16.b.(7) (8) Total fair value of collateral (sum of items 16.b.(1) through (7))………………............... G458 13,000 G462 0 16.b.(8) 1. The $10 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 43 of 86 RC-27 Schedule RC-M—Memoranda Dollar Amounts in Thousands RCON Amount 1. Extensions of credit by the reporting bank to its executive officers, directors, principal shareholders, and their related interests as of the report date: a. Aggregate amount of all extensions of credit to all executive officers, directors, principal shareholders, and their related interests……………………………………………………………………………………………… 6164 0 1.a. b. Number of executive officers, directors, and principal shareholders to whom the amount of all extensions of credit by the reporting bank (including extensions of credit to related interests) equals or exceeds the lesser of $500,000 or 5 Number percent of total capital as defined for this purpose in agency regulations………………………………… 6165 0 1.b. 2. Intangible assets: a. Mortgage servicing assets……………………………………………………………………………………………………………. 3164 0 2.a. (1) Estimated fair value of mortgage servicing assets……………………………………………… A590 0 2.a.(1) b. Goodwill………………………….……………………………….…….……………………………….…….……………………………….…….………………………………. 3163 0 2.b. c. All other intangible assets………………………………………………………………………………………………… JF76 2,000 2.c. d. Total (sum of items 2.a, 2.b, and 2.c) (must equal Schedule RC, item 10)…………………………………………………….. 2143 2,000 2.d. 3. Other real estate owned: a. Construction, land development, and other land………………………………………………………………....................... 5508 0 3.a. b. Farmland………………………………………………………………………………………………………….................... 5509 0 3.b. c. 1–4 family residential properties………………………………………………………………………………................. 5510 4,000 3.c. d. Multifamily (5 or more) residential properties…………………………………………………………………........................ 5511 0 3.d. e. Nonfarm nonresidential properties……………………………………………………………………………........................... 5512 0 3.e. f. Total (sum of items 3.a through 3.e) (must equal Schedule RC, item 7) 2150 4,000 3.f. 4. Cost of equity securities with readily determinable fair values not held for trading fair value of which is reported in Schedule RC, item 2.c) JA29 (the (1) ……………………………………… 0 4. 5. Other borrowed money: a. Federal Home Loan Bank advances: (1) Advances with a remaining maturity or next repricing date of: (2) (a) One year or less……………………………………………………………………………………………………………….. F055 0 5.a.(1)(a) (b) Over one year through three years…………………………………………………………………………………………… F056 0 5.a.(1)(b) (c) Over three years through five years………………………………………………………………………………………….. F057 0 5.a.(1)(c) (d) Over five years…………………………………………………………………………………………………………………. F058 0 5.a.(1)(d) (2) Advances with a REMAINING MATURITY of one year or less in item 5.a.(1)(a) above) 2651 (included (3)…………………………………………………………………………………………………………………………………. 0 5.a.(2) (3) Structured advances (included in items 5.a.(1)(a)–(d) above)……………………………………………………………….. F059 0 5.a.(3) b. Other borrowings: (1) Other borrowings with a remaining maturity or next repricing date of: (4) (a) One year or less………………………………………………………………………………..………………………………. F060 0 5.b.(1)(a) (b) Over one year through three years……………………………………………………………………………………………. F061 0 5.b.(1)(b) (c) Over three years through five years………………………………………………………………………………………….. F062 0 5.b.(1)(c) (d) Over five years…………………………………………………………………………………………………………………. F063 0 5.b.(1)(d) (2) Other borrowings with a REMAINING MATURITY of one year or less in item 5.b.(1)(a) above) B571 (included (5).............................................................................................................................................. 0 5.b.(2) c. Total (sum of items 5.a.(1)(a)–(d) and items 5.b.(1)(a)–(d)) (must equal Schedule RC, item 16) 3190 0 5.c. 1. Item 4 is to be completed only by insured state banks that have been approved by the FDIC to hold grandfathered equity investments. See instructions for this item and the Glossary entry for “Securities Activities” for further detail on accounting for investments in equity securities. 2. Report fixed-rate advances by remaining maturity and floating-rate advances by next repricing date. 3. Report both fixed- and floating-rate advances by remaining maturity. Exclude floating-rate advances with a next repricing date of one year or less that have a remaining maturity of over one year. 4. Report fixed-rate other borrowings by remaining maturity and floating-rate other borrowings by next repricing date. 5. Report both fixed- and floating-rate other borrowings by remaining maturity. Exclude floating-rate other borrowings with a next repricing date of one year or less that have a remaining maturity of over one year. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 44 of 86 Schedule RC-M—Continued RC-28 Dollar Amounts in Thousands RCON Yes No 6. Does the reporting bank sell private label or third-party mutual funds and annuities?..................................................................... B569 x 6. RCON Amount 7. Assets under the reporting bank’s management in proprietary mutual funds and annuities B570 0 7. 8. Internet website addresses and physical office trade names: a. Uniform Resource Locator (URL) of the reporting institution’s primary Internet website (home page), if any (Example: www.examplebank.com): TEXT 4087 http:// http://www.db.com 8.a. b. URLs of all other public-facing Internet websites that the reporting institution uses to accept or solicit deposits from the public, if any (Example: www.examplebank.biz): (1) TE01 N528 (1) http:// 8.b.(1) TE02 N528 (2) http:// 8.b.(2) TE03 N528 (3) http:// 8.b.(3) TE04 N528 (4) http:// 8.b.(4) TE05 N528 (5) http:// 8.b.(5) TE06 N528 (6) http:// 8.b.(6) TE07 N528 (7) http:// 8.b.(7) TE08 N528 (8) http:// 8.b.(8) TE09 N528 (9) http:// 8.b.(9) TE10 N528 (10) http:// 8.b.(10) c. Trade names other than the reporting institution’s legal title used to identify one or more of the institution’s physical offices at which deposits are accepted or solicited from the public, if any: TE01 N529 (1) 8.c.(1) TE02 N529 (2) 8.c.(2) TE03 N529 (3) 8.c.(3) TE04 N529 (4) 8.c.(4) TE05 N529 (5) 8.c.(5) TE06 N529 (6) 8.c.(6) Item 9 is to be completed annually in the December report only. 9. Do any of the bank’s Internet websites have transactional capability, i.e., allow the RCON Yes No bank’s customers to execute transactions on their accounts through the website?................................................................................... 4088 x 9. 10. Secured liabilities: a. Amount of “Federal funds purchased” that are secured RCON Amount (included in Schedule RC, item 14.a)............................................................................................................................................................ F064 0 10.a. b. Amount of “Other borrowings” that are secured (included in Schedule RC-M, items 5.b.(1)(a)–(d)).......................................................................................................................................................... F065 0 10.b. 11. Does the bank act as trustee or custodian for Individual Retirement Accounts, Health RCON Yes No Savings Accounts, and other similar accounts?.......................................................................................................................................................... G463 x 11. 12. Does the bank provide custody, safekeeping, or other services involving the acceptance of orders for the sale or purchase of securities?..................................................................................................................................................................... G464 x 12. 1. Report only highest level URLs (for example, report www.examplebank.biz, but do not also report www.examplebank.biz/checking). Report each top level domain name used (for example, report both www.examplebank.biz and www.examplebank.net). 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 45 of 86 RC-29 Schedule RC-M—Continued Dollar Amounts in Thousands RCON Amount 13. Portion of covered other real estate owned that is protected by FDIC loss-sharing agreements (included in Schedule RC, item 7)................................................................................................................................................ K192 0 13. Items 14.a and 14.b are to be completed annually in the December report only. 14.Captive insurance and reinsurance subsidiaries: a. assets of captive insurance subsidiaries K193 . Total (1) ................................................................................................................................................... 0 14.a b. Total assets of captive reinsurance subsidiaries K194 (1) .............................................................................................................................................. 0 14.b. Item 15 is to be completed by institutions that are required or have elected to be treated as a Qualified Thrift Lender. 15.Qualified Thrift Lender (QTL) test: a. Does the institution use the Home Owners’ Loan Act (HOLA) QTL test or the Internal Revenue Service Domestic Building and Loan Association (IRS DBLA) test to determine RCON Number its QTL compliance? (for the HOLA QTL test, enter 1; for the IRS DBLA test, enter 2).............................................................................................................................. L133 NA 15.a. b. Has the institution been in compliance with the HOLA QTL test as of each month end Yes No during the quarter or the IRS DBLA test for its most recent taxable year, as applicable? L135 15.b. Item 16.a and, if appropriate, items 16.b.(1) through 16.b.(3) are to be completed annually in the December report only. 16. International remittance transfers offered to consumers: (2) a. Estimated number of international remittance transfers provided by your institution during the calendar year ending on the report date............................................................................................................................... N523 1,469 16.a. Items 16.b.(1) through 16.b.(3) are to be completed by institutions that reported 501 or more international remittance transfers in item 16.a in either or both of the current report or the most recent prior report in which item 16.a was required to be completed. b. Estimated dollar value of remittance transfers provided by your institution and usage of regulatory exceptions during the calendar year ending on the report date: Amount (1) Estimated dollar value of international remittance transfers................................................................................................................................................................................... N524 130,000 16.b.(1) (2) Estimated number of international remittance transfers for which your institution Number applied the permanent exchange rate exception.................................................................................................................................................................................. MM07 0 16.b.(2) (3) Estimated number of international remittance transfers for which your institution applied the permanent covered third-party fee exception.................................................................................................................................................................................. MQ52 0 16.b.(3) 17. U.S. Small Business Administration Paycheck Protection Program (PPP) loans (3) and the Federal Reserve PPP Liquidity Facility (PPPLF): a. Number of PPP loans outstanding............................................................................................................................................ LG26 0 17.a. Amount b. Outstanding balance of PPP loans............................................................................................................................................. LG27 0 17.b. c. Outstanding balance of PPP loans pledged to the PPPLF............................................................................................................... LG28 0 17.c. d. Outstanding balance of borrowings from Federal Reserve Banks under the PPPLF with a remaining maturity of: (1) One year or less.................................................................................................................................................................. LL59 0 17.d.(1) (2) More than one year....................................................................................................................................................... LL60 0 17.d.(2) e. Quarterly average amount of PPP loans pledged to the PPPLF and excluded from “Total assets for the leverage ratio” reported in Schedule RC-R, Part I, item 30................................................................................ LL57 0 17.e. 1. Report total assets before eliminating intercompany transactions between the consolidated insurance or reinsurance subsidiary and other offices or consolidated subsidiaries of the reporting bank. 2. Report information about international electronic transfers of funds offered to consumers in the United States that: (a) are “remittance transfers” as defined by subpart B of Regulation E (12 CFR § 1005.30(e)), or (b) would qualify as “remittance transfers” under subpart B of Regulation E (12 CFR § 1005.30(e)) but are excluded from that definition only because the provider is not providing those transfers in the normal course of its business. See 12 CFR § 1005.30(f). For purposes of this item 16, such transfers are referred to as international remittance transfers. Exclude transfers sent by your institution as a correspondent bank for other providers. Report information only about transfers for which the reporting institution is the provider. 3. Paycheck Protection Program (PPP) covered loans as defined in sections 7(a)(36) and 7(a)(37) of the Small Business Act (15 U.S.C. 636(a)(36) and (37)). 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 46 of 86 RC-30 Schedule RC-N—Past Due and Nonaccrual Loans, Leases, and Other Assets (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. Loans secured by real estate: a. Construction, land development, and other land loans: (1) 1–4 family residential construction loans..................................................................................... F172 0 F174 0 F176 0 1.a.(1) (2) Other construction loans and all land development and other land loans…........................................ F173 0 F175 0 F177 0 1.a.(2) b. Secured by farmland....................................................... 3493 0 3494 0 3495 0 1.b. c. Secured by 1– 4 family residential properties: (1) Revolving, open-end loans secured by 1– 4 family residential properties and extended under lines of credit..................................... 5398 1,000 5399 0 5400 3,000 1.c.(1) (2) Closed-end loans secured by 1-4 family residential properties: (a) Secured by first liens.............................................. C236 10,000 C237 2,000 C229 22,000 1.c.(2)(a) (b) Secured by junior liens.............................................. C238 0 C239 0 C230 0 1.c.(2)(b) d. Secured by multifamily (5 or more) residential properties.............................................................................. 3499 0 3500 0 3501 0 1.d. e. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties......................................................... F178 0 F180 0 F182 0 1.e.(1) (2) Loans secured by other nonfarm nonresidential properties................................................. F179 0 F181 0 F183 0 1.e.(2) 2. Loans to depository institutions and acceptances of other banks........................................................... B834 0 B835 0 B836 0 2. 3. Not applicable 4. Commercial and industrial loans…….................................................. 1606 0 1607 0 1608 0 4. 5. Loans to individuals for household, family, and other personal expenditures: a. Credit cards............................................................................... B575 0 B576 0 B577 0 5.a. b. Automobile loans.......................................................................... K213 0 K214 0 K215 0 5.b. c. Other (includes revolving credit plans other than credit cards and other consumer loans)............................................................................ K216 0 K217 0 K218 0 5.c. 6. Not applicable . All other 5459 5460 5461 . 7 loans (1)......................................................................................... 0 0 1,000 7 8. Lease financing receivables........................................................................................ 1226 0 1227 0 1228 0 8. 9. Total loans and leases (sum of items 1 through 8)………… 1406 11,000 1407 2,000 1403 26,000 9. 10. Debt securities and other assets (exclude other real estate owned and other repossessed assets).............................................................................................. 3505 0 3506 0 3507 0 10. __________ 1. Includes past due and nonaccrual “Loans to finance agricultural productions and other loans to farmers,” “Obligations (other than securities and leases) of states and political subdivisions in the U.S.,” and “Loans to nondepository financial institutions and other loans.” 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 47 of 86 RC-31 Schedule RC-N—Continued Amounts reported by loan and lease category in Schedule RC-N, items 1 through 8, include guaranteed and unguaranteed portions of past due and nonaccrual loans and leases. Report in items 11 and 12 below certain guaranteed loans and leases that have already been included in the amounts reported in items 1 through 8. (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 11. Loans and leases reported in items 1 through 8 above that are wholly or partially guaranteed by the U.S. Government, excluding loans and leases covered by loss-sharing agreements with the FDIC.......................................................................................................................................... K036 0 K037 0 K038 0 11. a. Guaranteed portion of loans and leases included in item 11 above, excluding rebooked “GNMA loans”.......................................................................................................... K039 0 K040 0 K041 0 11.a. b. Rebooked “GNMA loans” that have been repurchased or are eligible for repurchase included in item 11 above............................................................................................................... K042 0 K043 0 K044 0 11.b. 12. Portion of covered loans and leases reported in item 9 above that is protected by FDIC loss-sharing agreements............................................................................................................... K102 0 K103 0 K104 0 12. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 48 of 86 RC-32 Schedule RC-N—Continued Memoranda (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. Loans restructured in troubled debt restructurings included in Schedule RC-N, items 1 through 7, above (and not reported in Schedule RC-C, Part I, Memorandum item 1): a. Construction, land development, and other land loans: (1) 1–4 family residential construction loans ............................................................................................ K105 0 K106 0 K107 0 M.1.a.(1) (2) Other construction loans and all land development and other land loans ........................ K108 0 K109 0 K110 0 M.1.a.(2) b. Loans secured by 1–4 family residential properties…………………………………………................. F661 0 F662 0 F663 2,000 M.1.b. c. Secured by multifamily (5 or more) residential properties ........................................................................................... K111 0 K112 0 K113 0 M.1.c. d. Secured by nonfarm nonresidential properties: (1) Loans secured by owner-occupied nonfarm nonresidential properties.................................. K114 0 K115 0 K116 0 M.1.d.(1) (2) Loans secured by other nonfarm nonresidential properties ........................................................... K117 0 K118 0 K119 0 M.1.d.(2) e. Commercial and industrial loans ................................. K257 0 K258 0 K259 0 M.1.e. Memorandum items 1.e.(1) and (2) are to be completed by banks with $300 million or more in total assets (sum of Memorandum items 1.e.(1) and (2) must equal ‘Memorandum item 1.e): (1) (1) To U.S. addressees (domicile) ............................... K120 0 K121 0 K122 0 M.1.e.(1) (2) To non-U.S. addressees (domicile) .................................... K123 0 K124 0 K125 0 M.1.e.(2) f. All other loans ( include loans to individuals for household, family, and other personal expenditures) ............................................................. K126 0 K127 0 K128 0 M.1.f. Itemize loan categories included in Memorandum item 1.f, above that exceed 10 percent of total loans restructured in troubled debt restructurings that are past due 30 days or more or in nonaccrual status (sum of Memorandum items 1.a through 1.e plus 1.f, columns A through C): (1) Loans secured by farmland ..................................................... K130 0 K131 0 K132 0 M.1.f.(1) (2) and (3) Not applicable 1. The $300 million asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 49 of 86 RC-33 Schedule RC-N—Continued Memoranda—Continued (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. f. (4) Loans to individuals for household, family, and other personal expenditures: (a) Credit cards .......................................................... K274 0 K275 0 K276 0 M.1.f.(4)(a) (b) Automobile loans ............................................... K277 0 K278 0 K279 0 M.1.f.(4)(b) (c) Other (includes revolving credit plans other than credit cards and other consumer loans) .............................................. K280 0 K281 0 K282 0 M.1.f.(4)(c) Memorandum item 1.f.(5) is to be completed by: (1) • Banks with $300 million or more in total assets • Banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans (5) Loans to finance agricultural production and other loans to farmers included in Schedule RC-N, Memorandum item 1.f, above ................................................................. K138 0 K139 0 K140 0 M.1.f.(5) 1. g.Total loans restructured in troubled debt restructurings included in Schedule RC-N, items 1 through 7, above (sum of Memorandum items 1.a(1) through 1.e 1.f) HK26 HK27 HK28 plus (2)……………………………………………………………………………………………………………………… 0 0 2,000 M.1.g. 2. Loans to finance commercial real estate, construction, and land development activities (not secured by real estate) included in Schedule RC-N, items 4 and 7, above.................................... 6558 0 6559 0 6560 0 M.2. 3. Memorandum items 3.a through 3.d are to be completed by banks with $300 million or more in total assets: (1) a.Loans secured by real estate to non-U.S. addressees (domicile) (included in Schedule RC-N, item 1, above).................................. 1248 0 1249 0 1250 0 M.3.a. b.Loans to and acceptances of foreign banks (included in Schedule RC-N, item 2, above) .................................................................................................................................................. 5380 0 5381 0 5382 0 M.3.b. c. Commercial and industrial loans to non-U.S. addressees (domicile) included in Schedule RC-N, item 4, above................................... 1254 0 1255 0 1256 0 M.3.c. 1. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 2. Exclude amounts reported in Memorandum items 1.e.(1), 1.e.(2), and 1.f.(1) through 1.f.(5) when calculating the total in Memorandum item 1.g. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 50 of 86 Schedule RC-N—Continued RC-34 Memoranda—Continued (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 3. d. Leases to individuals for household, family, and other personal expenditures (included in Schedule RC-N, item 8, above) ..............................F166 0 F167 0 F168 0 M.3.d. Memorandum item 4 is to be completed by: (1) • banks with $300 million or more in total assets • banks with less than $300 million in total assets that have loans to finance agricultural production and other loans to farmers (Schedule RC-C, Part I, item 3) exceeding 5 percent of total loans: 4. Loans to finance agricultural production and other loans to farmers (included in Schedule RC-N, item 7, above) ................................................................... 1594 0 1597 0 1583 0 M.4. 5. Loans and leases held for sale (included in Schedule RC-N, items 1 through 8, above)……………………. C240 0 C241 0 C226 0 M.5. RCON Amount 6. Not applicable Memorandum items 7, 8, 9.a, and 9.b are to be completed semiannually in the June and December reports only. 7. Additions to nonaccrual assets during the previous six months ...................................................................................................................... C410 0 M.7. 8. Nonaccrual assets sold during the previous six months................................................................................................................................. C411 0 M.8. (Column A) (Column B) (Column C) Past due Past due 90 Nonaccrual 30 through 89 days or more days and still and still accruing accruing Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 9. Purchased credit-impaired loans accounted for in accordance with FASB ASC 310-30 (former AICPA Statement of Position 03-3): (2) a. Outstanding balance......................................................................... L183 NA L184 NA L185 NA M.9.a. b. Amount included in Schedule RC-N, items 1 through 7, above..................................................................... L186 NA L187 NA L188 NA M.9.b. 1. The $300 million asset-size test and the 5 percent of total loans test are based on the total assets and total loans reported on the June 30, 2022, Report of Condition. 2. Memorandum items 9.a and 9.b should be completed only by institutions that have not yet adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 51 of 86 RC-35 Schedule RC-O—Other Data for Deposit Insurance Assessments All FDIC-insured depository institutions must complete items 1 and 2, 4 through 9,10, and 11, Memorandum item 1, and, if applicable, item 9.a, Memorandum items 2, 3, and 5 through 18 each quarter. Unless otherwise indicated, complete items 1 through 11 and Memorandum items 1 through 3 on an “unconsolidated single FDIC certificate number basis” (see instructions) and complete Memorandum items 5 through 18 on a fully consolidated basis. Dollar Amounts in Thousands RCON Amount 1. Total deposit liabilities before exclusions (gross) as defined in Section 3(l) of the Federal Deposit Insurance Act and FDIC regulations............................................................................................................. F236 26,567,000 1. 2. Total allowable exclusions, including interest accrued and unpaid on allowable exclusions............................... F237 0 2. 3. Not applicable 4. Average consolidated total assets for the calendar quarter .............................................................................................................................. K652 36,263,000 4. a. Averaging method used Number (for daily averaging, enter 1, for weekly averaging, enter 2) .......................................................................................................................................... K653 1 4.a. Amount 5. Average tangible equity for the calendar quarter K654 (1) ........................................................................................................................................... 9,542,000 5. 6. Holdings of long-term unsecured debt issued by other FDIC-insured depository institutions………………………………………………………..…….... K655 0 6. 7. Unsecured “Other borrowings” with a remaining maturity of (sum of items 7.a through 7.d must be less than or equal to Schedule RC-M, items 5.b.(1)(a)–(d) minus item 10.b): a. One year or less........................................................................................................................................................... G465 0 7.a. b. Over one year through three years....................................................................................................................... G466 0 7.b. c. Over three years through five years......................................................................................................................... G467 0 7.c. d. Over five years.............................................................................................................................................................. G468 0 7.d. 8. Subordinated notes and debentures with a remaining maturity of (sum of items 8.a. through 8.d. must equal Schedule RC, item 19): a. One year or less............................................................................................................................................................ G469 0 8.a. b. Over one year through three years........................................................................................................................ G470 0 8.b. c. Over three years through five years........................................................................................................................... G471 0 8.c. d. Over five years............................................................................................................................................................. G472 0 8.d. 9. Brokered reciprocal deposits (included in Schedule RC-E, Memorandum item 1.b)....................................G803 0 9. Item 9.a is to be completed on a fully consolidated basis by all institutions that own another insured depository institution. a. Fully consolidated brokered reciprocal deposits................................................................................................................. L190 NA 9.a. 10. Banker’s bank certification: Does the reporting institution meet both the statutory definition of a banker’s bank and the business Yes No conduct test set forth in FDIC regulations? ................................................................................................................................................................. K656 x 10. If the answer to item 10 is “YES,” complete items 10.a and 10.b. Amount a. Banker’s bank deduction.................................................................................................................................... K657 NA 10.a. b. Banker’s bank deduction limit .............................................................................................................................. K658 NA 10.b. 11.Custodial bank certification: Yes No Does the reporting institution meet the definition of a custodial bank set forth in FDIC regulations? K659 x 11. If the answer to item 11 is “YES,” complete items 11.a and 11.b. (2) Amount a. Custodial bank deduction ....................................................................................................................................... K660 12,934,000 11.a. b. Custodial bank deduction limit ............................................................................................................................. K661 6,471,000 11.b. 1. See instructions for averaging methods. For deposit insurance assessment purposes, tangible equity is defined as Tier 1 capital as set forth in the banking agencies’ regulatory capital standards and reported in Schedule RC-R, Part I, item 26, except as described in the instructions. 2. If the amount reported in item 11.b is zero, item 11.a may be left blank. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 52 of 86 RC-36 Schedule RC-O—Continued Memoranda Dollar Amounts in Thousands RCON Amount 1. Total deposit liabilities of the bank, including related interest accrued and unpaid, less allowable exclusions, including related interest accrued and unpaid (sum of Memorandum items 1.a.(1), 1.b.(1), 1.c.(1), and 1.d.(1) must equal Schedule RC-O, item 1 less item 2): a. Deposit accounts (excluding retirement accounts) of $250,000 or less: (1) (1)Amount of deposit accounts (excluding retirement accounts) of $250,000 or less................................................................. F049 134,000 M.1.a.(1) (2)Number of deposit accounts (excluding retirement accounts) Number of $250,000 or less......................................................................................................................................... F050 5,836 M.1.a.(2) b. Deposit accounts (excluding retirement accounts) of more than $250,000: (1) (1)Amount of deposit accounts (excluding retirement accounts) of more than $250,000............................................................ F051 26,385,000 M.1.b.(1) (2)Number of deposit accounts (excluding retirement accounts) Number of more than $250,000........................................................................................................................ F052 3,294 M.1.b.(2) c. Retirement deposit accounts of $250,000 or less: (1) (1)Amount of retirement deposit accounts of $250,000 or less.................................................................................................... F045 47,000 M.1.c.(1) Number (2)Number of retirement deposit accounts of $250,000 or less........................................................... F046 143 M.1.c.(2) d. Retirement deposit accounts of more than $250,000: (1) (1)Amount of retirement deposit accounts of more than $250,000............................................................................................... F047 1,000 M.1.d.(1) Number (2)Number of retirement deposit accounts of more than $250,000........................................................ F048 2 M.1.d.(2) Memorandum item 2 is to be completed by banks with $1 billion or more in total assets. (2) 2. Estimated amount of uninsured deposits including related interest accrued and unpaid instructions) 5597 (see (3)..................................................................................................................................................................... 25,562,000 M.2. 3. Has the reporting institution been consolidated with a parent bank or savings association in that parent bank’s or parent savings association’s Call Report? If so, report the legal title and FDIC Certificate Number of the parent bank or parent savings association: RCON FDIC Cert. No. TEXT A545 A545 0 M.3. 4. Not applicable 1. The dollar amounts used as the basis for reporting in Memorandum items 1.a through 1.d reflect the deposit insurance limits in effect on the report date. 2. The $1 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 3. Uninsured deposits should be estimated based on the deposit insurance limits set forth in Memorandum items 1.a through 1.d. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 53 of 86 RC-37 Schedule RC-O—Continued Amounts reported in Memorandum items 6 through 9, 14, and 15 will not be made available to the public on an individual institution basis. Memoranda—Continued Dollar Amounts in Thousands RCON Amount Memorandum items 5 through 12 are to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. 5. Applicable portion of the CECL transitional amount or modified CECL transitional amount that has been added to retained earnings for regulatory capital purposes as of the current report date and is attributable to loans and leases held for investment................................................................................................................................... MW53 0 M.5. 6. Criticized and classified items: a. Special mention ......................................................................................................................................................................... K663 1,850,000 M.6.a. b. Substandard...................................................................................................................................................................................... K664 172,000 M.6.b. c. Doubtful ............................................................................................................................................................................................. K665 5,000 M.6.c. d. Loss ................................................................................................................................................................................................... K666 0 M.6.d. 7. “Nontraditional 1–4 family residential mortgage loans” as defined for assessment purposes only in FDIC regulations: a. Nontraditional 1-4 family residential mortgage loans................................................................................................................................................... N025 1,705,000 M.7.a. b. Securitizations of nontraditional 1-4 family residential mortgage loans N026 0 M.7.b. 8. “Higher-risk consumer loans” as defined for assessment purposes only in FDIC regulations: a. Higher-risk consumer loans……........................................................................................................................................................................ N027 35,000 M.8.a. b. Securitizations of higher-risk consumer loans…........................................................................................................................................................................ N028 0 M.8.b. 9. “Higher-risk commercial and industrial loans and securities” as defined for assessment purposes only in FDIC regulations: a. Higher-risk commercial and industrial loans and securities............................................................................................................................................................ N029 0 M.9.a. b. Securitizations of higher-risk commercial and industrial loans and securities N030 0 M.9.b. 10. Commitments to fund construction, land development, and other land loans secured by real estate: a. Total unfunded commitments ....................................................................................................................................... K676 254,000 M.10.a. b. Portion of unfunded commitments guaranteed or insured by the U.S. government (including the FDIC) .......................................................................................................................................................................... K677 0 M.10.b. 11. Amount of other real estate owned recoverable from the U.S. government under guarantee or insurance provisions (excluding FDIC loss-sharing agreements) .......................................................... K669 0 M.11. 12. Nonbrokered time deposits of more than $250,000 in domestic offices (included in Schedule RC-E, Part I, Memorandum item 2.d) K678 217,000 M.12. Memorandum item 13.a is to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. Memorandum items 13.b through 13.h are to be completed by “large institutions” only. 13. Portion of funded loans and securities guaranteed or insured by the U.S. government (including FDIC loss-sharing agreements): a. Construction, land development, and other land loans secured by real estate .......................................................... N177 0 M.13.a. b. Loans secured by multifamily residential and nonfarm nonresidential properties ...............................N178 0 M.13.b. c. Closed-end loans secured by first liens on 1–4 family residential properties ............................................................ N179 0 M.13.c. d. Closed-end loans secured by junior liens on 1–4 family residential properties and revolving, open-end loans secured by 1–4 family residential properties and extended under lines of credit ................................................................................................................................................... N180 0 M.13.d. e. Commercial and industrial loans ................................................................................................................................ N181 0 M.13.e. f. Credit card loans to individuals for household, family, and other personal expenditures …....................................... N182 0 M.13.f. g. All other loans to individuals for household, family, and other personal expenditures N183 0 M.13.g. h. Non-agency residential mortgage-backed securities............................................................................................................................... M963 0 M.13.h. Memorandum items 14 and 15 are to be completed by “highly complex institutions” as defined in FDIC regulations. 14. Amount of the institution’s largest counterparty exposure ............................................................................................. K673 NA M.14. 15. Total amount of the institution’s 20 largest counterparty exposures ................................................................................ K674 NA M.15. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 54 of 86 RC-38 Schedule RC-O—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount Memorandum item 16 is to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. 16. Portion of loans restructured in troubled debt restructurings that are in compliance with their modified terms and are guaranteed or insured by the U.S. government (including the FDIC) (included in Schedule RC-C, Part I, Memorandum item 1)....................................................................................................................................................................... L189 0 M.16. Memorandum item 17 is to be completed on a fully consolidated basis by those “large institutions” and “highly complex institutions” as defined in FDIC regulations that own another insured depository institution. 17. Selected fully consolidated data for deposit insurance assessment purposes: a. Total deposit liabilities before exclusions (gross) as defined in Section 3(I) of the Federal Deposit Insurance Act and FDIC regulations....................................................................................................................................................................... L194 NA M.17.a. b. Total allowable exclusions, including interest accrued and unpaid on allowable exclusions............................. L195 NA M.17.b. c. Unsecured “Other borrowings” with a remaining maturity of one year or less L196 NA M.17.c. d. Estimated amount of uninsured deposits, including related interest accrued and unpaid L197 NA M.17.d. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 55 of 86 RC-39 Schedule RC-O—Continued Memorandum item 18 is to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. Amounts reported in Memorandum item 18 will not be made available to the public on an individual institution basis. Two-Year Probability of Default (PD) (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) < 1% 1.01–4% 4.01–7% 7.01–10% 10.01–14% 14.01–16% 16.01–18% 18.01–20% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount 18. Outstanding balance of 1-4 family residential mortgage loans, consumer loans, and consumer leases by two-year probability of default: a. “Nontraditional 1-4 family residential mortgage loans” as defined for assessment purposes RCON M964 RCON M965 RCON M966 RCON M967 RCON M968 RCON M969 RCON M970 RCON M971 only in FDIC regulations………………………………………………………………………………… 400,000 616,000 351,000 179,000 54,000 4,000 0 3,000 M.18.a. b. Closed-end loans secured by first liens on 1-4 family RCON M979 RCON M980 RCON M981 RCON M982 RCON M983 RCON M984 RCON M985 RCON M986 residential properties…………………………… 44,000 86,000 40,000 3,000 5,000 0 0 0 M.18.b. c. Closed-end loans secured by junior liens on 1-4 family RCON M994 RCON M995 RCON M996 RCON M997 RCON M998 RCON M999 RCON N001 RCON N002 residential properties………………………………………………………………………………… 6,000 13,000 2,000 1,000 10,000 0 0 0 M.18.c. d. Revolving, open-end loans secured by 1-4 family residential properties RCON N010 RCON N011 RCON N012 RCON N013 RCON N014 RCON N015 RCON N016 RCON N017 and extended under lines of credit 27,000 75,000 95,000 10,000 7,000 0 3,000 0 M.18.d. RCON N040 RCON N041 RCON N042 RCON N043 RCON N044 RCON N045 RCON N046 RCON N047 e. Credit cards………………………………………………………………………………… 0 0 0 0 0 0 0 0 M.18.e. RCON N055 RCON N056 RCON N057 RCON N058 RCON N059 RCON N060 RCON N061 RCON N062 f. Automobile loans………………………………………………………………………………… 0 0 0 0 0 0 0 0 M.18.f. RCON N070 RCON N071 RCON N072 RCON N073 RCON N074 RCON N075 RCON N076 RCON N077 g. Student loans…………………………………………………………………………… 0 0 0 0 0 0 0 0 M.18.g. h. Other consumer loans and revolving credit plans other RCON N085 RCON N086 RCON N087 RCON N088 RCON N089 RCON N090 RCON N091 RCON N092 than credit cards………………………………………………………………………………… 112,000 112,000 67,000 1,000 0 0 0 0 M.18.h. RCON N100 RCON N101 RCON N102 RCON N103 RCON N104 RCON N105 RCON N106 RCON N107 i. Consumer leases………………………………………………………………………………… 0 0 0 0 0 0 0 0 M.18.i. RCON N115 RCON N116 RCON N117 RCON N118 RCON N119 RCON N120 RCON N121 RCON N122 j. Total………………………………………………………………………………… 589,000 902,000 555,000 194,000 76,000 4,000 3,000 3,000 M.18.j. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RC-O—Continued Memorandum item 18 is to be completed by “large institutions” and “highly complex institutions” as defined in FDIC regulations. Amounts reported in Memorandum item 18 will not be made available to the public on an individual institution basis. Two-Year Probability of Default (PD) (Column O) PDs Were (Column I) (Column J) (Column K) (Column L) (Column M) (Column N) Derived 20.01–22% 22.01–26% 26.01–30% > 30% Unscoreable Total Using (1) Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Number 18. Outstanding balance of 1-4 family residential mortgage loans, consumer loans, and consumer leases by two-year probability of default: a.“Nontraditional 1-4 family residential mortgage loans” as defined for assessment purposes RCON M972 RCON M973 RCON M974 RCON M975 RCON M976 RCON M977 RCON M978 only in FDIC regulations………………………………………………………………………………… 5,000 2,000 2,000 0 89,000 1,705,000 1 M.18.a. b.Closed-end loans secured by first liens on 1-4 family RCON M987 RCON M988 RCON M989 RCON M990 RCON M991 RCON M992 RCON M993 residential properties………………………………………………………………… 0 0 0 0 11,000 189,000 1 M.18.b. c. Closed-end loans secured by junior liens on 1-4 family RCON N003 RCON N004 RCON N005 RCON N006 RCON N007 RCON N008 RCON N009 residential properties………………………………………………………………………………… 0 0 0 0 0 32,000 1 M.18.c. d.Revolving, open-end loans secured by 1-4 family residential properties RCON N018 RCON N019 RCON N020 RCON N021 RCON N022 RCON N023 RCON N024 and extended under lines of credit………………………………………………………………………………… 0 0 0 0 47,000 264,000 1 M.18.d. RCON N048 RCON N049 RCON N050 RCON N051 RCON N052 RCON N053 RCON N054 e.Credit cards………………………………………………………………………………… 0 0 0 0 0 0 0 M.18.e. RCON N063 RCON N064 RCON N065 RCON N066 RCON N067 RCON N068 RCON N069 f. Automobile loans………………………………………………………………………………… 0 0 0 0 0 0 0 M.18.f. RCON N078 RCON N079 RCON N080 RCON N081 RCON N082 RCON N083 RCON N084 g.Student loans…………………………………………………………………………… 0 0 0 0 0 0 0 M.18.g. h.Other consumer loans and revolving credit plans other RCON N093 RCON N094 RCON N095 RCON N096 RCON N097 RCON N098 RCON N099 than credit cards………………………………………………………………………………… 0 0 0 0 15,000 307,000 1 M.18.h. RCON N108 RCON N109 RCON N110 RCON N111 RCON N112 RCON N113 RCON N114 i. Consumer leases………………………………………………………………………………… 0 0 0 0 0 0 0 M.18.i. RCON N123 RCON N124 RCON N125 RCON N126 RCON N127 RCON N128 j. Total………………………………………………………………………………… 5,000 2,000 2,000 0 162,000 2,497,000 M.18.j. 1. For PDs derived using scores and default rate mappings provided by a third-party vendor, enter 1; for PDs derived using an internal approach, enter 2; for PDs derived using third-party vendor mappings for some loans within a product type and an internal approach for other loans within the same product type, enter 3. If the total reported in Column N for a product type is zero, enter 0. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 57 of 86 RC-41 Schedule RC-P—1–4 Family Residential Mortgage Banking Activities Schedule RC-P is to be completed by banks at which either 1–4 family residential mortgage loan originations and purchases for resale (1) from all sources, loan sales, or quarter-end loans held for sale or trading exceed $10 million for two consecutive quarters. Dollar Amounts in Thousands RCON Amount 1. Retail originations during the quarter of 1–4 family residential mortgage loans for sale HT81 (1) .............................. 0 1. 2. Wholesale originations and purchases during the quarter of 1–4 family residential mortgage loans sale HT82 for (1)................................................................................................................................................................................................................................................................... 0 2. 3. 1–4 family residential mortgage loans sold during the quarter................................................................................ FT04 0 3. 4. 1–4 family residential mortgage loans held for sale or trading at quarter-end 4. (included in Schedule RC, items 4.a and 5)............................................................................................................ FT05 0 5. Noninterest income for the quarter from the sale, securitization, and servicing of 1–4 family RIAD residential mortgage loans (included in Schedule RI, items 5.c, 5.f, 5.g, and 5.i)................................................. HT85 0 5. RCON 6. Repurchases and indemnifications of 1–4 family residential mortgage loans during the quarter.................................. HT86 0 6. 7. Representation and warranty reserves for 1–4 family residential mortgage loans sold: a. For representations and warranties made to U.S. government agencies and government-sponsored agencies................................................................................................................................................. L191 0 7.a. b. For representations and warranties made to other parties................................................................................................................................................. L192 0 7.b. c. Total representation and warranty reserves (sum of items 7.a and 7.b) M288 0 7.c. 1. Exclude originations and purchases of 1–4 family residential mortgage loans that are held for investment. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 Schedule RC-Q—Assets and Liabilities Measured at Fair Value on a Recurring Basis FFIEC 041 Page 58 of 86 RC-42 Schedule RC-Q is to be completed by banks that: (1) Have elected to report financial instruments or servicing assets and liabilities at fair value under a fair value option with changes in fair value recognized in earnings, or (2) Are required to complete Schedule RC-D, Trading Assets and Liabilities. (Column A) (Column B) (Column C) (Column D) (Column E) Total Fair Value LESS: Amounts Netted Level 1 Fair Value Level 2 Fair Value Level 3 Fair Value Reported on in the Determination of Measurements Measurements Measurements Schedule RC Total Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount RCON Amount Assets 1. Available-for-sale debt securities and equity securities with readily determinable fair values trading JA36 G474 G475 G476 G477 not held for (1)…………………………………………………… 378,000 0 378,000 0 0 1. 2. Not applicable 3. Loans and leases held for sale........................................................................................................................... G483 0 G484 0 G485 0 G486 0 G487 0 3. 4. Loans and leases held for investment........................................................................................................................... G488 0 G489 0 G490 0 G491 0 G492 0 4. 5. Trading assets: a. Derivative assets........................................................................................................................... 3543 0 G493 0 G494 0 G495 0 G496 0 5.a. b. Other trading assets........................................................................................................................... G497 0 G498 0 G499 0 G500 0 G501 0 5.b. (1) Nontrading securities at fair value with changes in fair value reported in current earnings (included in Schedule RC-Q, item 5.b above)........................................................................................................................... F240 0 F684 0 F692 0 F241 0 F242 0 5.b.(1) 6. All other assets........................................................................................................................... G391 393,000 G392 4,000 G395 0 G396 397,000 G804 0 6. 7. Total assets measured at fair value on a recurring basis (sum of items 1 through 5.b plus item 6)................................................................................................................................... G502 771,000 G503 4,000 G504 378,000 G505 397,000 G506 0 7. Liabilities 8. Deposits........................................................................................................................... F252 0 F686 0 F694 0 F253 0 F254 0 8. 9. Not applicable 10. Trading liabilities: a. Derivative liabilities........................................................................................................................... 3547 0 G512 0 G513 0 G514 0 G515 0 10.a. b. Other trading liabilities........................................................................................................................... G516 0 G517 0 G518 0 G519 0 G520 0 10.b. 11. and 12. Not applicable 13. All other liabilities........................................................................................................................... G805 457,000 G806 4,000 G807 0 G808 461,000 G809 0 13. 14. Total liabilities measured at fair value on a recurring basis (sum of items 8 through 13).................................. G531 457,000 G532 4,000 G533 0 G534 461,000 G535 0 14. 1. The amount reported in item 1, column A, must equal the sum of Schedule RC, items 2.b and 2.c. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 59 of 86 RC-43 Schedule RC-Q—Continued (Column A) (Column B) (Column C) (Column D) (Column E) Total Fair Value LESS: Amounts Netted Level 1 Fair Value Level 2 Fair Value Level 3 Fair Value Reported on in the Determination Measurements Measurements Measurements Schedule RC of Total Fair Value Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount RCON Amount RCON Amount Memoranda 1. All other assets (itemize and describe amounts included in Schedule RC-Q, item 6, that are greater than $100,000 and exceed 25 percent of item 6): a. Mortgage servicing assets……………………………………… G536 0 G537 0 G538 0 G539 0 G540 0 M.1.a. b. Nontrading derivative assets…………………………………… G541 388,000 G542 4,000 G543 0 G544 392,000 G545 0 M.1.b. TEXT c. G546 0 G547 0 G548 0 G549 0 G550 0 M.1.c. G546 TEXT d. G551 0 G552 0 G553 0 G554 0 G555 0 M.1.d. G551 TEXT e. G556 0 G557 0 G558 0 G559 0 G560 0 M.1.e. G556 TEXT f. G561 0 G562 0 G563 0 G564 0 G565 0 M.1.f. G561 2. All other liabilities (itemize and describe amounts included in Schedule RC-Q, item 13, that are greater than $100,000 and exceed 25 percent of item 13): a. Loan commitments (not accounted for as derivatives)…………………………………………………… F261 0 F689 0 F697 0 F262 0 F263 0 M.2.a. b. Nontrading derivative liabilities………………………………… G566 457,000 G567 4,000 G568 0 G569 461,000 G570 0 M.2.b. TEXT c. G571 0 G572 0 G573 0 G574 0 G575 0 M.2.c. G571 TEXT d. G576 0 G577 0 G578 0 G579 0 G580 0 M.2.d. G576 TEXT e. G581 0 G582 0 G583 0 G584 0 G585 0 M.2.e. G581 TEXT f. G586 0 G587 0 G588 0 G589 0 G590 0 M.2.f. G586 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 60 of 86 RC-44 Schedule RC-Q—Continued Memoranda—Continued Dollar Amounts in Thousands RCON Amount 3. Loans measured at fair value (included in Schedule RC-C, Part I, items 1 through 9): a. Loans secured by real estate: (1) Secured by 1–4 family residential properties…………………………………………....................... HT87 0 M.3.a.(1) (2) All other loans secured by real estate……………………...…………………...…………………...…… HT88 0 M.3.a.(2) b. Commercial and industrial loans………………………………………….……….......................................... F585 0 M.3.b. c. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper)……………………….…………………….……………………. HT89 0 M.3.c. d. Other loans…………………………..………………………….…………………………..................................................... F589 0 M.3.d. 4. Unpaid principal balance of loans measured at fair value (reported in Schedule RC-Q, Memorandum item 3): a. Loans secured by real estate: (1) Secured by 1–4 family residential properties…....…………………....…....…………………....……….... HT91 0 M.4.a.(1) (2) All other loans secured by real estate…………………………….…………………....………………….... HT92 0 M.4.a.(2) b. Commercial and industrial loans………………………………………………..............................…………………… F597 0 M.4.b. c. Loans to individuals for household, family, and other personal expenditures (i.e., consumer loans) (includes purchased paper)………………………………………..………..……….. HT93 0 M.4.c. d. Other loans………………………………….…………………………………………………............................................ F601 0 M.4.d. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 61 of 86 RC-45 Schedule RC-R—Regulatory Capital Part I. Regulatory Capital Components and Ratios Part I is to be completed on a consolidated basis. Dollar Amounts in Thousands RCOA Amount Common Equity Tier 1 Capital 1. Common stock plus related surplus, net of treasury stock and unearned employee stock ownership plan (ESOP) shares............................................................................................................................... P742 3,063,000 1. . Retained earnings KW00 2 (1)........................................................................................................................................................ 6,637,000 2. a. To be completed only by institutions that have adopted ASU 2016-13: Does your institution have a CECL transition election in effect as of the quarter-end report date? (enter “0” for No; enter “1” for Yes with a 3-year CECL transition election; RCOA enter “2” for Yes with a 5-year 2020 CECL transition election.) JJ29 0 2.a. RCOA Amount 3. Accumulated other comprehensive income (AOCI)................................................................................................................................................................... B530 (34,000) 3. 0=No RCOA a. AOCI opt-out election (enter “1” for Yes; enter “0” for No.) 1=Yes P838 0 3.a. RCOA Amount 4. Common equity tier 1 minority interest includable in common equity tier 1 capital.................................................................... P839 0 4. 5. Common equity tier 1 capital before adjustments and deductions (sum of items 1 through 4) P840 9,666,000 5. Common Equity Tier 1 Capital: Adjustments and Deductions 6. LESS: Goodwill net of associated deferred tax liabilities (DTLs)............................................................................................................................ P841 0 6. 7. LESS: Intangible assets (other than goodwill and mortgage servicing assets (MSAs)), net of associated DTLs.................................................................................................................................................................................................. P842 2,000 7. 8. LESS: Deferred tax assets (DTAs) that arise from net operating loss and tax credit carryforwards, net of any related valuation allowances and net of DTLs................................................................................................. P843 1,000 8. 9. AOCI-related adjustments (if entered “1” for Yes in item 3.a, complete only items 9.a through 9.e; if entered “0” for No in item 3.a, complete only item 9.f): a. LESS: Net unrealized gains (losses) on available-for-sale debt securities (if a gain, report as a positive value; if a loss, report as a negative value) P844 NA 9.a. b. Not applicable c. LESS: Accumulated net gains (losses) on cash flow hedges (if a gain, report as a positive value; if a loss, report as a negative value)............................................................................................................................................................................................................. P846 NA 9.c. d. LESS: Amounts recorded in AOCI attributed to defined benefit postretirement plans resulting from the initial and subsequent application of the relevant GAAP standards that pertain to such plans (if a gain, report as a positive value; if a loss, report as a negative value)........................... P847 NA 9.d. e. LESS: Net unrealized gains (losses) on held-to-maturity securities that are included in AOCI (if a gain, report as a positive value; if a loss, report as a negative value) P848 NA 9.e. f. To be completed only by institutions that entered “0” for No in item 3.a: LESS: Accumulated net gain (loss) on cash flow hedges included in AOCI, net of applicable income taxes, that relates to the hedging of items that are not recognized at fair value on the balance sheet (if a gain, report as a positive value; if a loss, report as a negative value)...................................................................... P849 0 9.f. 1. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should include the applicable portion of the CECL transitional amount or the modified CECL transitional amount, respectively, in this item. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 62 of 86 RC-46 Schedule RC-R—Continued Part I—Continued Dollar Amounts in Thousands RCOA Amount 10. Other deductions from (additions to) common equity tier 1 capital before threshold-based deductions: a. LESS: Unrealized net gain (loss) related to changes in the fair value of liabilities that are due to changes in own credit risk (if a gain, report as a positive value; if a loss, report as a negative value)........................................................................................................................................................................................................................................................ Q258 0 10.a. b. LESS: All other deductions from (additions to) common equity tier 1 capital before threshold-based deductions..................................................................................................................................................................................... P850 0 10.b. 11. Not applicable 12. Subtotal (item 5 minus items 6 through 10.b)..................................................................................................................................................... P852 9,663,000 12. 13. LESS: Investments in the capital of unconsolidated financial institutions, net of associated DTLs, that exceed 25 percent of item 12....................................................................................................................................................................................................................................... LB58 0 13. 14. LESS: MSAs, net of associated DTLs, that exceed 25 percent of item 12 LB59 0 14. 15. LESS: DTAs arising from temporary differences that could not be realized through net operating loss carrybacks, net of related valuation allowances and net of DTLs, that exceed 25 percent of item 12................................................................................................................................................................................................................. LB60 0 15. 16. Not applicable 17. LESS: Deductions applied to common equity tier 1 capital due to insufficient amounts of additional tier 1 capital and tier 2 P857 . capital (1) to cover deductions.......................................................................................................................... 0 17 18. Total adjustments and deductions for common equity tier 1 capital (sum of items 13 through 17).............................................................................................. P858 0 18. 19. Common equity tier 1 capital (item 12 minus item 18) P859 9,663,000 19. Additional Tier 1 Capital 20. Additional tier 1 capital instruments plus related surplus.............................................................................................................................................. P860 0 20. 21. Non-qualifying capital instruments subject to phase-out from additional tier 1 capital................................................................................................................................... P861 0 21. 22. Tier 1 minority interest not included in common equity tier 1 capital........................................................................................................... P862 0 22. 23. Additional tier 1 capital before deductions (sum of items 20, 21, and 22)..................................................................................................................................... P863 0 23. 24. LESS: Additional tier 1 capital deductions...................................................................................................................................................................... P864 0 24. 25. Additional tier 1 capital (greater of item 23 minus item 24, or zero)............................................................................................................................ P865 0 25. Tier 1 Capital 26. Tier 1 capital (sum of items 19 and 25)....................................................................................................................................................................................................................... 8274 9,663,000 26. Total Assets for the Leverage Ratio 27. Average total consolidated assets KW03 27 (2).............................................................................................................................................................................................................. 36,263,000 . 28. LESS: Deductions from common equity tier 1 capital and additional tier 1 capital (sum of items 6, 7, 8, 10.b, 13 through 15, 17, and certain elements of item 24—see instructions)........................................ P875 3,000 28. 29. LESS: Other deductions from (additions to) assets for leverage ratio purposes......................................................................................................................................... B596 0 29. 30. Total assets for the leverage ratio (item 27 minus items 28 and 29)......................................................................................................................................... A224 36,260,000 30. 1. An institution that has a CBLR framework election in effect as of the quarter-end report date is neither required to calculate tier 2 capital nor make any deductions that would have been taken from tier 2 capital as of the report date. 2. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should include the applicable portion of the CECL transitional amount or the modified CECL transitional amount, respectively, in item 27. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 63 of 86 RC-47 Schedule RC-R—Continued Part I—Continued Leverage Ratio* RCOA Percentage 31. Leverage ratio (item 26 divided by item 30) 7204 26.6492% 31. a. Does your institution have a community bank leverage ratio (CBLR) framework election in effect as 0=No RCOA of the quarter-end report date? (enter “1” for Yes; enter “0” for No)............................................................................................................. 1=Yes LE74 0 31.a. If your institution entered “1” for Yes in item 31.a: • Complete items 32 through 37 and, if applicable, items 38.a through 38.c, • Do not complete items 39 through 55.b, and • Do not complete Part II of Schedule RC-R. If your institution entered “0” for No in item 31.a: • Skip (do not complete) items 32 through 38.c, • Complete items 39 through 55.b, as applicable, and • Complete Part II of Schedule RC-R. Item 31.b is to be completed only by non-advanced approaches institutions that elect to use the Standardized Approach for Counterparty Credit Risk (SA-CCR) for purposes of the standardized approach and supplementary leverage ratio. b. Standardized Approach for Counterparty Credit Risk opt-in election RCOA (enter “1” for Yes; leave blank for No)............................................................................................................................................................... 1=Yes NC99 31.b. Qualifying Criteria and Other Information for CBLR Institutions* Column A Column B Dollar Amounts in Thousands RCOA Amount RCOA Percentage 32. Total assets (Schedule RC, item 12); (must be less than $10 billion) 2170 NA 32. 33. Trading assets and trading liabilities (Schedule RC, sum of items 5 and 15). Report as a dollar amount in column A and as a percentage of total assets (5% limit) in column B........................................................................................................................................................................................................................... KX77 NA KX78 NA 33. 34. Off-balance sheet exposures: a. Unused portion of conditionally cancellable commitments KX79 NA 34.a. b. Securities lent and borrowed (Schedule RC-L, sum of items 6.a and 6.b)................................................................................................................................................................................................................. KX80 NA 34.b. c. Other off-balance sheet exposures KX81 NA 34.c. d. Total off-balance sheet exposures (sum of items 34.a through 34.c). Report as a dollar amount in column A and as a percentage of total assets (25% limit) in column B KX82 NA KX83 NA 34.d Dollar Amounts in Thousands RCOA Amount 35. Unconditionally cancellable commitments.......................................................................................................................................................................................................... S540 NA 35. 36. Investments in the tier 2 capital of unconsolidated financial institutions LB61 NA 36. 37. Allocated transfer risk reserve.......................................................................................................................................................................................................... 3128 NA 37 38. Amount of allowances for credit losses on purchased credit-deteriorated assets: (1) a. Loans and leases held for investment.......................................................................................................................................................................................................... JJ30 NA 38.a. b. Held-to-maturity debt securities.......................................................................................................................................................................................................... JJ31 NA 38.b. c. Other financial assets measured at amortized cost JJ32 NA 38.c. * Report each ratio as a percentage, rounded to four decimal places, e.g., 12.3456. 1. Items 38.a through 38.c should be completed only by institutions that have adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 64 of 86 RC-48 Schedule RC-R—Continued Part I—Continued If your institution entered “0” for No in item 31.a, complete items 39 through 55.b, as applicable, and Part II of Schedule RC-R. If your institution entered “1” for Yes in item 31.a, do not complete items 39 through 55.b or Part II of Schedule RC-R. Dollar Amounts in Thousands RCOA Amount Tier 2 Capital (1) 39. Tier 2 capital instruments plus related surplus..................................................................................................................................................................................................... P866 0 39. 40. Non-qualifying capital instruments subject to phase-out from tier 2 capital.............................................................................................. P867 0 40. 41. Total capital minority interest that is not included in tier 1 capital P868 0 41. . Allowance for loan and lease losses includable in tier 2 capital 5310 42 (2, 3)............................................................................................................................... 18,000 42. 43. Not applicable 44. Tier 2 capital before deductions (sum of items 39 through 42)....................................................................................... P870 18,000 44. 45. LESS: Tier 2 capital deductions......................................................................................................................................... P872 0 45. 46. Tier 2 capital (greater of item 44 minus item 45, or zero)......................................................................................................................................... 5311 18,000 46. Total Capital 47. Total capital (sum of items 26 and 46)......................................................................................................................................... 3792 9,681,000 47. Total Risk-Weighted Assets 48. Total risk-weighted assets (from Schedule RC-R, Part II, item 31)......................................................................................................................................... A223 18,490,000 48. Risk-Based Capital Ratios * RCOA Percentage 49. Common equity tier 1 capital ratio (item 19 divided by item 48).............................................................................................................................. P793 52.2607% 49. 50. Tier 1 capital ratio (item 26 divided by item 48).............................................................................................................................. 7206 52.2607% 50. 51. Total capital ratio (item 47 divided by item 48).............................................................................................................................. 7205 52.3580% 51. Capital Buffer* 52. Institution-specific capital buffer necessary to avoid limitations on distributions and discretionary bonus payments: a. Capital conservation buffer H311 44.3580% 52.a. RCOW b. Institutions subject to Category III capital standards only: Total applicable capital buffer............................................................................... H312 2.5000% 52.b. RCOA Amount 53. Eligible income H313 retained (4) NA 53. 54 Distributions and discretionary bonus payments during the quarter H314 . (5) NA 54. Supplementary Leverage Ratio* 55. Institutions subject to Category III capital standards only: Supplementary leverage ratio information: a. Total exposure H015 leverage (6) .................................................................................................................................................................... 38,942,000 55.a. Percentage b. Supplementary leverage ratio................................................................................................................................................................... H036 24.8138% 55.b. * Report each ratio as a percentage, rounded to four decimal places, e.g., 12.3456. 1. An institution that has a CBLR framework election in effect as of the quarter-end report date is neither required to calculate tier 2 capital nor make any deductions that would have been taken from tier 2 capital as of the report date. 2. Institutions that have adopted ASU 2016-13 should report the amount of adjusted allowances for credit losses (AACL), as defined in the regu- latory capital rule, includable in tier 2 capital in item 42. 3. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should subtract the applicable portion of the AACL transitional amount or the modified AACL transitional amount, respectively, from the AACL, as defined in the regulatory capital rule, before determining the amount of AACL includable in tier 2 capital. See instructions for further detail on the CECL transition provisions. 4. Non-advanced approaches institutions other than Category III institutions must complete item 53 only if the amount reported in item 52.a above is less than or equal to 2.5000 percent. Category III institutions must complete item 53 only if the amount reported in item 52.a above is less than or equal to the amount reported in item 52.b above. 5. Non-advanced approaches institutions other than Category III institutions must complete item 54 only if the amount reported in Schedule RC- R, Part I, item 52.a, in the Call Report for the previous calendar quarter-end report date was less than or equal to 2.5000 percent. Category III institutions must complete item 54 only if the amount reported in Schedule RC-R, Part I, item 52.a, in the Call Report for the previous calendar quarter-end report date was less than or equal to the amount reported in Schedule RC-R, Part I, item 52.b, in the Call Report for that previous report date. 6. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should include the applicable portion of the CECL transitional amount or the modified CECL transitional amount, respectively, in item 55.a. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 65 of 86 Schedule RC-R—Continued RC-49 Part II. Risk-Weighted Assets Institutions that entered “1” for Yes in Schedule RC-R, Part I, item 31.a, do not have to complete Schedule RC-R, Part II. Institutions are required to assign a 100 percent risk weight to all assets not specifically assigned a risk weight under Subpart D of the federal banking agencies’ regulatory capital rules (1) and not deducted from tier 1 or tier 2 capital. (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Totals From Adjustments Allocation by Risk-Weight Category Schedule to Totals RC Reported in 0% 2% 4% 10% 20% 50% 100% 150% Column A Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount Balance Sheet Asset Categories (2) 1. Cash and balances due from depository RCON D957 RCON S396 RCON D958 RCON D959 RCON S397 RCON D960 RCON S398 institutions……………………………… 13,597,000 0 13,553,000 44,000 0 0 0 1. 2. Securities: a. Held-to-maturity RCON D961 RCON S399 RCON D962 RCON HJ74 RCON HJ75 RCON D963 RCON D964 RCON D965 RCON S400 securities (3)……………………………………………… 0 0 0 0 0 0 0 0 0 2.a. b. Available-for-sale debt securities and equity securities with readily determinable fair values RCON JA21 RCON S402 RCON D967 RCON HJ76 RCON HJ77 RCON D968 RCON D969 RCON D970 RCON S403 not held for trading……………………………………… 378,000 0 378,000 0 0 0 0 0 0 2.b. 3. Federal funds sold and securities purchased under agreements to resell: RCON D971 RCON D972 RCON D973 RCON S410 RCON D974 RCON S411 a. Federal funds sold………………. 0 0 0 0 0 0 3.a b. Securities purchased under agreements to RCON H171 RCON H172 resell……………………………………………….. 5,923,000 5,923,000 3.b 4. Loans and leases held for sale: a. Residential mortgage RCON S413 RCON S414 RCON H173 RCON S415 RCON S416 RCON S417 exposures……………………………………….. 0 0 0 0 0 0 4.a. b. High volatility commercial real estate RCON S419 RCON S420 RCON H174 RCON H175 RCON H176 RCON H177 RCON S421 exposures………………………… 0 0 0 0 0 0 0 4.b. 1. For national banks and federal savings associations, 12 CFR Part 3; for state member banks, 12 CFR Part 217; and for state nonmember banks and state savings associations 12 CFR Part 324. 2. All securitization exposures held as on-balance sheet assets of the reporting institution are to be excluded from items 1 through 8 and are to be reported instead in item 9. 3. Institutions that have adopted ASU 2016-13 and have reported held-to-maturity securities net of allowances for credit losses in item 2.a, column A, should report as a negative number in item 2.a, column B, those allowances for credit losses eligible for inclusion in tier 2 capital, which excludes allowances for credit losses on purchased credit-deteriorated assets. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 66 of 86 RC-50 Schedule RC-R—Continued Part II—Continued (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) (Column R) (Column S) Allocation by Risk-Weight Category Application of Other Risk- Weighting Approaches (1) 250% 300% 400% 600% 625% 937.5% 1250% Exposure Risk-Weighted Amount Asset Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Balance Sheet Asset Categories (continued) 1. Cash and balances due from depository institutions…………………………………….. 1. 2. Securities: a. Held-to-maturity securities…………………………………………. 2.a. b. Available-for-sale debt securities and equity securities with readily determinable fair values RCON S405 RCON S406 RCON H271 RCON H272 not held for trading .................................................. 0 0 0 0 2.b. 3. Federal funds sold and securities purchased under agreements to resell: a. Federal funds sold…………………….. 3.a. b. Securities purchased under agreements to resell..……………………………………. 3.b 4. Loans and leases held for sale: a. Residential mortgage RCON H273 RCON H274 exposures………………………………………. 0 0 4.a. b. High volatility commercial real estate RCON H275 RCON H276 exposures…………………………………………. 0 0 4.b. 1. Includes, for example, investments in mutual funds/investment funds, exposures collateralized by securitization exposures or mutual funds, separate account bank-owned life insurance, and default fund contributions to central counterparties. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 67 of 86 RC-51 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Totals From Adjustments Allocation by Risk-Weight Category Schedule to Totals RC Reported in 0% 2% 4% 10% 20% 50% 100% 150% Column A Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount 4. Loans and leases held for sale (continued): c. Exposures past due 90 days or more or RCON S423 RCON S424 RCON S425 RCON HJ78 RCON HJ79 RCON S426 RCON S427 RCON S428 RCON S429 on nonaccrual (1)……………………………………….. 0 0 0 0 0 0 0 0 0 4.c. d. All other RCON S431 RCON S432 RCON S433 RCON HJ80 RCON HJ81 RCON S434 RCON S435 RCON S436 RCON S437 exposures………………………………. 0 0 0 0 0 0 0 0 0 4.d. 5. Loans and leases held for investment: (2) a. Residential mortgage RCON S439 RCON S440 RCON H178 RCON S441 RCON S442 RCON S443 exposures……………………………………….. 2,417,000 0 1,000 0 2,309,000 107,000 5.a. b. High volatility commercial real estate RCON S445 RCON S446 RCON H179 RCON H180 RCON H181 RCON H182 RCON S447 exposures……………………….. 0 0 0 0 0 0 0 5.b. c. Exposures past due 90 days or more or on RCON S449 RCON S450 RCON S451 RCON HJ82 RCON HJ83 RCON S452 RCON S453 RCON S454 RCON S455 nonaccrual (3)……………………………………….. 0 0 0 0 0 0 0 0 0 5.c. RCON S457 RCON S458 RCON S459 RCON HJ84 RCON HJ85 RCON S460 RCON S461 RCON S462 RCON S463 d. All other exposures………………………….. 13,930,000 0 114,000 0 0 545,000 135,000 12,160,000 976,000 5.d. 6. LESS: Allowance for loan RCON 3123 RCON 3123 and lease losses (4)………………………………….. 16,000 16,000 6. 1. For loans and leases held for sale, exclude residential mortgage exposures, high volatility commercial real estate exposures, or sovereign exposures that are past due 90 days or more or on nonaccrual. 2. Institutions that have adopted ASU 2016-13 should report as a positive number in column B of items 5.a through 5.d, as appropriate, any allowances for credit losses on purchased credit- deteriorated assets reported in column A of items 5.a through 5.d, as appropriate. 3. For loans and leases held for investment, exclude residential mortgage exposures, high volatility commercial real estate exposures, or sovereign exposures that are past due 90 days or more or on nonaccrual. 4. Institutions that have adopted ASU 2016-13 should report the allowance for credit losses on loans and leases in item 6, columns A and B. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 68 of 86 RC-52 Schedule RC-R—Continued Part II—Continued (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) (Column R) (Column S) Allocation by Risk-Weight Category Application of Other Risk- Weighting Approaches (1) Exposure Risk-Weighted 250% 300% 400% 600% 625% 937.5% 1250% Amount Asset Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount 4. Loans and leases held for sale (continued): c. Exposures past due 90 days or more or RCON H277 RCON H278 nonaccrual on (2)…………………………………….. 0 0 4.c. d. All other RCON H279 RCON H280 exposures………………………………… 0 0 4.d. 5. Loans and leases held for investment: a. Residential mortgage RCON H281 RCON H282 exposures……………………………………….. 0 0 5.a. b. High volatility commercial real estate RCON H283 RCON H284 exposures…………………………………………………………………………….. 0 0 5.b. c. Exposures past due 90 days or more or on RCON H285 RCON H286 nonaccrual (3)……………………………………….. 0 0 5.c. RCON H287 RCON H288 d. All other exposures………………………….. 0 0 5.d. 6. LESS: Allowance for loan and lease losses………………………………….. 6. 1. Includes, for example, investments in mutual funds/investment funds, exposures collateralized by securitization exposures or mutual funds, separate account bank-owned life insurance, and default fund contributions to central counterparties. 2. For loans and leases held for sale, exclude residential mortgage exposures, high volatility commercial real estate exposures, or sovereign exposures that are past due 90 days or more or on nonaccrual. 3. For loans and leases held for investment, exclude residential mortgage exposures, high volatility commercial real estate exposures, or sovereign exposures that are past due 90 days or more or on nonaccrual. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 69 of 86 RC-53 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Totals From Adjustments Allocation by Risk-Weight Category Schedule to Totals RC Reported in 0% 2% 4% 10% 20% 50% 100% 150% Column A Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount RCON D976 RCON S466 RCON D977 RCON HJ86 RCON HJ87 RCON D978 RCON D979 RCON D980 RCON S467 7. Trading assets…………………………………. 0 0 0 0 0 0 0 0 0 7. RCON D981 RCON S469 RCON D982 RCON HJ88 RCON HJ89 RCON D983 RCON D984 RCON D985 RCON H185 8. All other assets (1, 2, 3)…………………………………… 2,496,000 728,000 105,000 0 0 53,000 1,000 1,144,000 9,000 8. a. Separate account bank-owned life insurance…………………………. 8.a. b. Default fund contributions to central counterparties……………………. 8.b. 1. Includes premises and fixed assets; other real estate owned; investments in unconsolidated subsidiaries and associated companies; direct and indirect investments in real estate ventures; intangible assets; and other assets. 2. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should report as a positive number in item 8, column B, the applicable portion of the DTA transitional amount as determined in accordance with the 3-year or the 5-year 2020 CECL transitional amount, respectively. 3. Institutions that have adopted ASU 2016-13 and have reported any assets net of allowances for credit losses in item 8, column A, should report as a negative number in item 8, column B, those allowances for credit losses eligible for inclusion in tier 2 capital, which excludes allowances for credit losses on purchased credit-deteriorated assets. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 70 of 86 RC-54 Schedule RC-R—Continued Part II—Continued (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) (Column R) (Column S) Allocation by Risk-Weight Category Application of Other Risk- Weighting Approaches (1) Exposure Risk-Weighted 250% 300% 400% 600% 625% 937.5% 1250% Amount Asset Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount RCON H186 RCON H290 RCON H187 RCON H291 RCON H292 7. Trading assets…………………………………. 0 0 0 0 0 7. RCON H293 RCON H188 RCON S470 RCON S471 RCON H294 RCON H295 8. All other assets (2)…………………………………… 456,000 0 0 0 0 0 8. a. Separate account bank-owned life RCON H296 RCON H297 insurance……….…………..…………… 0 0 8.a. b. Default fund contributions to central RCON H298 RCON H299 counterparties………………………….. 0 0 8.b. 1. Includes, for example, investments in mutual funds/investment funds, exposures collateralized by securitization exposures or mutual funds, separate account bank-owned life insurance, and default fund contributions to central counterparties. 2. Includes premises and fixed assets; other real estate owned; investments in unconsolidated subsidiaries and associated companies; direct and indirect investments in real estate ventures; intangible assets; and other assets. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 71 of 86 RC-55 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column Q) (Column T) (Column U) Totals Adjustments Allocation by Total Risk-Weighted Asset to Totals Risk-Weight Amount by Calculation Reported in Category Methodology Column A (Exposure Amount) 1250% SSFA (1) Gross-Up Dollar Amounts in Thousands Amount Amount Amount Amount Amount Securitization Exposures: On- and Off-Balance Sheet 9. On-balance sheet securitization exposures: RCON S475 RCON S476 RCON S477 RCON S478 RCON S479 a. Held-to-maturity securities (2)…………………………………………………………………………………………………………………..………... 0 0 0 0 0 9.a. RCON S480 RCON S481 RCON S482 RCON S483 RCON S484 b. Available-for-sale securities…………………………………………………………………………………………………………………………… 0 0 0 0 0 9.b. RCON S485 RCON S486 RCON S487 RCON S488 RCON S489 c. Trading assets……………………………………………………………………………………………………………………………………………………….. 0 0 0 0 0 9.c RCON S490 RCON S491 RCON S492 RCON S493 RCON S494 d. All other on-balance sheet securitization exposures……………………………………………………………………………………………………………….. 0 0 0 0 0 9.d RCON S495 RCON S496 RCON S497 RCON S498 RCON S499 10. Off-balance sheet securitization exposures……………………………………………………………………………………………………………………………………… 0 0 0 0 0 10. 1. Simplified Supervisory Formula Approach. 2. Institutions that have adopted ASU 2016-13 and have reported held-to-maturity securities net of allowances for credit losses in item 9.a, column A, should report as a negative number in item 9.a, column B, those allowances for credit losses eligible for inclusion in tier 2 capital, which excludes allowances for credit losses on purchased credit-deteriorated assets. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 72 of 86 RC-56 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Totals From Adjustments Allocation by Risk-Weight Category Schedule to Totals RC Reported in 0% 2% 4% 10% 20% 50% 100% 150% Column A Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount 11. Total balance sheet RCON 2170 RCON S500 RCON D987 RCON HJ90 RCON HJ91 RCON D988 RCON D989 RCON D990 RCON S503 assets (1)………………………………………………………………… 38,725,000 6,635,000 14,151,000 0 0 642,000 2,445,000 13,411,000 985,000 11. (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) (Column R) Application of Other Risk-Allocation by Risk-Weight Category Weighting Approaches Exposure 250% 300% 400% 600% 625% 937.5% 1250% Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount 11. Total balance sheet RCON S504 RCON S505 RCON S506 RCON S507 RCON S510 RCON H300 assets (1)…………...………………………………………………………… 456,000 0 0 0 0 0 11. 1. For each of columns A through R of item 11, report the sum of items 1 through 9. For item 11, the sum of columns B through R must equal column A. Item 11, column A, must equal Schedule RC, item 12. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 73 of 86 RC-57 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Face, Notional, CCF (1) Credit or Other Equivalent Allocation by Risk-Weight Category Amount Amount (2) 0% 2% 4% 10% 20% 50% 100% 150% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount Derivatives, Off-Balance Sheet Items, and Other Items Subject to Risk Weighting (Excluding Securitization Exposures) (3) 12. Financial standby RCON D991 RCON D992 RCON D993 RCON HJ92 RCON HJ93 RCON D994 RCON D995 RCON D996 RCON S511 letters of credit…………………………………………………………………… 241,000 1.0 241,000 0 0 0 4,000 3,000 234,000 0 12. 13. Performance standby letters of credit and transaction-related RCON D997 RCON D998 RCON D999 RCON G603 RCON G604 RCON G605 RCON S512 contingent items…………………………………………………………………… 102,000 0.5 51,000 0 0 1,000 50,000 0 13. 14. Commercial and similar letters of credit with an original maturity of one year RCON G606 RCON G607 RCON G608 RCON HJ94 RCON HJ95 RCON G609 RCON G610 RCON G611 RCON S513 or less…………………………………………………………………… 0 0.2 0 0 0 0 0 0 0 0 14. 15. Retained recourse on small business obligations sold RCON G612 RCON G613 RCON G614 RCON G615 RCON G616 RCON G617 RCON S514 with recourse…………………………………………………………………… 0 1.0 0 0 0 0 0 0 15. 1. Credit conversion factor. 2. Column A multiplied by credit conversion factor. For each of items 12 through 21, the sum of columns C through J plus column R must equal column B. 3. All derivatives and off-balance sheet items that are securitization exposures are to be excluded from items 12 through 21 and are to be reported instead in item 10. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 74 of 86 RC-58 Schedule RC-R—Continued Part II—Continued (Column A) (Column B) (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Face, Notional, CCF (1) Credit Allocation by Risk-Weight Category or Other Equivalent Amount Amount (2) 0% 2% 4% 10% 20% 50% 100% 150% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount Amount Amount 16. Repo-style RCON S515 RCON S516 RCON S517 RCON S518 RCON S519 RCON S520 RCON S521 RCON S522 RCON S523 transactions (3)……………………………………47,000 1.0 47,000 0 0 0 0 0 47,000 0 16. 17. All other off-balance RCON G618 RCON G619 RCON G620 RCON G621 RCON G622 RCON G623 RCON S524 sheet liabilities……………………………………………………………………0 1.0 0 0 0 0 0 0 17. 18. Unused commitments (exclude unused commitments to asset-backed commercial paper conduits): a. Original maturity of RCON S525 RCON S526 RCON S527 RCON HJ96 RCON HJ97 RCON S528 RCON S529 RCON S530 RCON S531 one year or less………………………………………………………65,000 0.2 13,000 0 0 0 0 0 13,000 0 18.a. b. Original maturity exceeding one RCON G624 RCON G625 RCON G626 RCON HJ98 RCON HJ99 RCON G627 RCON G628 RCON G629 RCON S539 year……………………………………………………………………1,908,000 0.5 954,000 84,000 0 0 103,000 88,000 679,000 0 18.b. 19. Unconditionally cancelable RCON S540 RCON S541 commitments……………………………………………………………………0 0.0 0 19. 20. Over-the-counter RCON S542 RCON S543 RCON HK00 RCON HK01 RCON S544 RCON S545 RCON S546 RCON S547 RCON S548 derivatives…………………………………………………………………… 15,000 0 0 0 0 15,000 0 0 0 20. 21. Centrally cleared RCON S549 RCON S550 RCON S551 RCON S552 RCON S554 RCON S555 RCON S556 RCON S557 derivatives…………………………………………………………………… 796,000 0 796,000 0 0 0 0 0 21. 22. Unsettled transactions RCON H191 RCON H193 RCON H194 RCON H195 RCON H196 RCON H197 (failed trades) (4)……………………………………………………………………0 0 0 0 0 0 22. 06/2012 1. Credit conversion factor. 2. For items 16 through 19, column A multiplied by credit conversion factor. 3. Includes securities purchased under agreements to resell (reverse repos), securities sold under agreements to repurchase (repos), securities borrowed, and securities lent. 4. For item 22, the sum of columns C through Q must equal column A.
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 75 of 86 RC-59 Schedule RC-R—Continued Part II—Continued (Column O) (Column P) (Column Q) (Column R) (Column S) Application of Other Risk-Allocation by Risk-Weight Category Weighting Approaches (1) Credit Equivalent Risk-Weighted 625% 937.5% 1250% Amount Asset Amount Dollar Amounts in Thousands Amount Amount Amount Amount Amount 16. Repo-style RCON H301 RCON H302 transactions (2)……….…………………………...……………………...…………….…………...…………….….… 0 0 16. 17. All other off-balance sheet liabilities……………..…….…………………...…………….………………………… 17. 18. Unused commitments (exclude unused commitments to asset-backed commercial paper conduits): a. Original maturity of RCON H303 RCON H304 one year or less………………….…………………………...…………….……………………. 0 0 18.a. b. Original maturity exceeding one RCON H307 RCON H308 year…………………….…………………………...…………….……………………. 0 0 18.b. 19. Unconditionally cancelable commitments………………………………………….…………...…………….…………… 19. 20. Over-the-counter RCON H309 RCON H310 derivatives…………………………………………………...…………….………………...… 0 0 20. 21. Centrally cleared derivatives………………………………………………………………...…………….….… 21. 22. Unsettled transactions RCON H198 RCON H199 RCON H200 (failed trades) (3)………………………………………………...…………….……………… 0 0 0 22. 1. Includes, for example, exposures collateralized by securitization exposures or mutual funds. 2. Includes securities purchased under agreements to resell (reverse repos), securities sold under agreements to repurchase (repos), securities borrowed, and securities lent. 3. For item 22, the sum of columns C through Q must equal column A. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 76 of 86 RC-60 Schedule RC-R—Continued Part II—Continued (Column C) (Column D) (Column E) (Column F) (Column G) (Column H) (Column I) (Column J) Allocation by Risk-Weight Category 0% 2% 4% 10% 20% 50% 100% 150% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount Amount 23. Total assets, derivatives, off-balance sheet items, and other items subject to risk weighting by risk-weight category (for each of columns C through P, sum of items 11 through 22; for column Q, sum of items RCON G630 RCON S558 RCON S559 RCON S560 RCON G631 RCON G632 RCON G633 RCON S561 10 through 22)…………………………………………………………………… 14,235,000 796,000 0 0 764,000 2,537,000 14,434,000 985,000 23. 24. Risk-weight factor…………………………………………………………………… X 0% X 2% X 4% X 10% X 20% X 50% X 100% X 150% 24. 25. Risk-weighted assets by risk-weight category (for each column, item 23 multiplied by RCON G634 RCON S569 RCON S570 RCON S571 RCON G635 RCON G636 RCON G637 RCON S572 item 24)…………………………………………………………………… 0 16,000 0 0 153,000 1,269,000 14,434,000 1,478,000 25. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 77 of 86 RC-61 Schedule RC-R—Continued Part II—Continued (Column K) (Column L) (Column M) (Column N) (Column O) (Column P) (Column Q) Allocation by Risk-Weight Category 250% 300% 400% 600% 625% 937.5% 1250% Dollar Amounts in Thousands Amount Amount Amount Amount Amount Amount Amount 23. Total assets, derivatives, off-balance sheet items, and other items subject to risk weighting by risk- weight category (for each of columns C through P, sum of items 11 through 22; for column Q, sum of items RCON S562 RCON S563 RCON S564 RCON S565 RCON S566 RCON S567 RCON S568 10 through 22) …………………………………………………………………………………………. 456,000 0 0 0 0 0 0 23. 24. Risk-weight factor……………………………………………………………………………………… X 250% X 300% X 400% X 600% X 625% X 937.5% X 1250% 24. 25. Risk-weighted assets by risk-weight category (for each column, item 23 multiplied by RCON S573 RCON S574 RCON S575 RCON S576 RCON S577 RCON S578 RCON S579 item 24)…………………………………………………………………………………………………. 1,140,000 0 0 0 0 0 0 25. Totals Dollar Amounts in Thousands RCON Amount 26. Risk-weighted assets base for purposes of calculating the allowance for loan and lease losses 1.25 percent threshold (1)………………………………….………………………… S580 18,490,000 26. 27. Standardized market-risk weighted assets (applicable only to banks that are covered by the market risk capital rules)……………………………...……………………...….………… S581 0 27. 28. Risk-weighted assets before deductions for excess allowance for loan and lease losses and allocated transfer risk reserve (2, 3)………………………..…………………….. B704 18,490,000 28. 29. LESS: Excess allowance for loan and lease losses (4, 5)……………………………………………………………………………………………………………………………………………….. A222 0 29. 30. LESS: Allocated transfer risk reserve………………………………………………………………………………………………………………………………………………………………… 3128 0 30. 31. Total risk-weighted assets (item 28 minus items 29 and 30)……………………………………………………………………………………………………………………………………. G641 18,490,000 31. 1. For institutions that have adopted ASU 2016-13, the risk-weighted assets base reported in item 26 is for purposes of calculating the adjusted allowances for credit losses (AACL) 1.25 percent threshold. 2. Sum of items 2.b through 20, column S; items 9.a, 9.b, 9.c, 9.d, and 10, columns T and U; item 25, columns C through Q; and item 27 (if applicable). 3. For institutions that have adopted ASU 2016-13, the risk-weighted assets reported in item 28 represents the amount of risk-weighted assets before deductions for excess AACL and allocated transfer risk reserve. 4. Institutions that have adopted ASU 2016-13 should report the excess AACL. 5. Institutions that have adopted ASU 2016-13 and have elected to apply the 3-year or the 5-year 2020 CECL transition provision should subtract the applicable portion of the AACL transitional amount or the modified AACL transitional amount, respectively, from the AACL, as defined in the regulatory capital rule, before determining the amount of excess AACL. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 78 of 86 RC-62 Schedule RC-R—Continued Part II—Continued Memoranda Dollar Amounts in Thousands RCON Amount 1. Current credit exposure across all derivative contracts covered by the regulatory capital rules……………………………………………………. G642 388,000 M.1. With a remaining maturity of (Column A) (Column B) (Column C) One year or less Over one year Over five years through five years Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 2. Notional principal amounts of over-the-counter derivative contracts: a. Interest rate…………………………………………………………………………………………………………… S582 168,000 S583 228,000 S584 104,000 M.2.a. b. Foreign exchange rate and gold………………………………………………………………………………………………………… S585 0 S586 0 S587 0 M.2.b. c. Credit (investment grade reference asset)…………………………………………………………………………………………………………… S588 0 S589 0 S590 0 M.2.c. d. Credit (non-investment grade reference asset)…………………………………………………………………………………………………………… S591 0 S592 0 S593 0 M.2.d. e. Equity…………………………………………………………………………………………………………… S594 0 S595 0 S596 0 M.2.e. f. Precious metals (except gold)………………………………………………………………. S597 0 S598 0 S599 0 M.2.f. g. Other…………………………………………………………………………………………………………… S600 0 S601 0 S602 0 M.2.g. 3. Notional principal amounts of centrally cleared derivative contracts: a. Interest rate…………………………………………………………………… S603 5,796,000 S604 13,317,000 S605 3,155,000 M.3.a. b. Foreign exchange rate and gold…………………………………………………………… S606 0 S607 0 S608 0 M.3.b. c. Credit (investment grade reference asset)…………………………………………………………………………………………………………… S609 0 S610 0 S611 0 M.3.c. d. Credit (non-investment grade reference asset)…………………………………………. S612 0 S613 0 S614 0 M.3.d. e. Equity…………………………………………………………………………………………………………… S615 0 S616 0 S617 0 M.3.e. f. Precious metals (except gold)…………………………………………………………………………………………………………… S618 0 S619 0 S620 0 M.3.f. g. Other………………………………………………………………………………………… S621 0 S622 0 S623 0 M.3.g. Dollar Amounts in Thousands RCON Amount 4. Amount of allowances for credit losses on purchased credit-deteriorated assets: (1) a. Loans and leases held for investment............................................................................................................................................................................................................................................ JJ30 0 M.4.a. b. Held-to-maturity debt securities................................................................................................................................................................................................................................. JJ31 0 M.4.b. c. Other financial assets measured at amortized cost JJ32 0 M.4.c. 1. Memorandum items 4.a through 4.c should be completed only by institutions that have adopted ASU 2016-13. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 79 of 86 Schedule RC-S—Servicing, Securitization, and Asset Sale Activities RC-63 (Column A) (Column B to Column F) (Column G) 1–4 Family Not applicable All Other Loans, Residential All Leases, and Loans All Other Assets Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount Bank Securitization Activities 1. Outstanding principal balance of assets sold and securitized by the reporting bank with servicing retained or with recourse or other seller-provided credit enhancements ................................................................................................................... B705 0 B711 0 1. 2. Maximum amount of credit exposure arising from recourse or other seller-provided credit enhancements provided to structures reported in item 1………………………………………………… HU09 0 HU15 0 2. 3. Not applicable 4. Past due loan amounts included in item 1: a. 30–89 days past due .............................................................................................................. B733 0 B739 0 4.a. b. 90 days or more past due............................................................................................................................... B740 0 B746 0 4.b. 5. Charge-offs and recoveries on assets sold and securitized with servicing retained or with recourse or other seller-provided credit enhancements (calendar year-to-date): RIAD RIAD a. Charge-offs ................................................................................................................................. B747 0 B753 0 5.a. b. Recoveries ................................................................................................................................ B754 0 B760 0 5.b. Item 6 is to be completed by banks with $10 billion or more in total assets. (1) 6. Total amount of ownership (or seller’s) interest RCON carried as securities or loans…………………………………………………………………………… HU19 0 6. 7. and 8. Not applicable For Securitization Facilities Sponsored By or Otherwise Established By Other Institutions 9. Maximum amount of credit exposure arising from credit enhancements provided by the reporting bank to other institutions’ securitization structures in the form of standby letters of credit, purchased RCON subordinated securities, and other enhancements................................................................................................................. B776 0 B782 0 9. Item 10 is to be completed by banks with $10 billion or more in total assets (1) 10. Reporting bank’s unused commitments to provide liquidity to other institutions’ securitization structures .................................................................................................. B783 0 B789 0 10. Bank Asset Sales 11. Assets sold with recourse or other seller-provided credit enhancements and not securitized by the reporting bank...............................................................................................B790 0 B796 0 11. 12. Maximum amount of credit exposure arising from recourse or other seller-provided credit enhancements provided to assets reported in item 11.............................................................................................................................................. B797 0 B803 0 12. 1. The $10 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 80 of 86 Schedule RC-S—Continued RC-64 Memoranda Dollar Amounts in Thousands RCON Amount 1. Not applicable 2. Outstanding principal balance of assets serviced for others (includes participations serviced for others): a. Closed-end 1–4 family residential mortgages serviced with recourse or other servicer-provided credit enhancement...................................................................................................................................... B804 0 M.2.a. b. Closed-end 1–4 family residential mortgages serviced with no recourse or other servicer-provided credit enhancement............................................................................................................................................ B805 0 M.2.b. c. Other financial assets (includes home equity lines) A591 (1)............................................................................................................................................................................................ 0 M.2.c. d. 1–4 family residential mortgages serviced for others that are in process of foreclosure at quarter-end (includes closed-end and open-end loans) F699 0 M.2.d. Memorandum item 3 is to be completed by banks with $10 billion or more in total assets. (2) 3. Asset-backed commercial paper conduits: a. Maximum amount of credit exposure arising from credit enhancements provided to conduit structures in the form of standby letters of credit, subordinated securities, and other enhancements: (1) Conduits sponsored by the bank, a bank affiliate, or the bank’s holding company........................................................................................................................ B806 0 M.3.a.(1) (2) Conduits sponsored by other unrelated institutions.............................................................................................................................................................................................. B807 0 M.3.a.(2) b. Unused commitments to provide liquidity to conduit structures: (1) Conduits sponsored by the bank, a bank affiliate, or the bank’s holding company............................................................................................................... B808 0 M.3.b.(1) (2) Conduits sponsored by other unrelated institutions.............................................................................................................................................................................................. B809 0 M.3.b.(2) 4. Outstanding credit card fees and finance charges included in Schedule RC-S, item 1, column G C407 (2), (3)........................................................................................................................................................................................... 0 M.4. __________ 1. Memorandum item 2.c is to be completed if the principal balance of other financial assets serviced for others is more than $10 million. 2. The $10 billion asset-size test is based on the total assets reported on the June 30, 2022, Report of Condition. 3. Memorandum item 4 is to be completed by banks with $10 billion or more in total assets that (1) together with affiliated institutions, have outstanding credit card receivables (as defined in the instructions) that exceed $500 million as of the report date, or (2) are credit card specialty banks as defined for Uniform Bank Performance Report purposes. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 81 of 86 RC-65 Schedule RC-T—Fiduciary and Related Services RCON Yes No 1. Does the institution have fiduciary powers? (If “NO,” do not complete Schedule RC-T.) A345 x 1. 2. Does the institution exercise the fiduciary powers it has been granted? A346 x 2. 3. Does the institution have any fiduciary or related activity (in the form of assets or accounts) to report in this schedule? (If “NO,” do not complete the rest of Schedule RC-T.) B867 x 3. If the answer to item 3 is “YES,” complete the applicable items of Schedule RC-T, as follows: Institutions with total fiduciary assets (item 10, sum of columns A and B) greater than $250 million (as of the preceding December 31 report date) or with gross fiduciary and related services income greater than 10 percent of revenue (net interest income plus noninterest income) for the preceding calendar year must complete: • Items 4 through 22 and Memorandum item 3 quarterly, • Items 23 through 26 annually with the December report, and • Memorandum items 1, 2, and 4 annually with the December report. Institutions with total fiduciary assets (item 10, sum of columns A and B) less than or equal to $250 million (as of the preceding December 31 report date) that do not meet the fiduciary income test for quarterly reporting must complete: • Items 4 through 13 annually with the December report, and • Memorandum items 1 through 3 annually with the December report. • Institutions with total fiduciary assets greater than $100 million but less than or equal to $250 million (as of the preceding December 31 report date) that do not meet the fiduciary income test for quarterly reporting must also complete Memorandum item 4 annually with the December report. (Column A) (Column B) (Column C) (Column D) Managed Non-Managed Number of Number of Assets Assets Managed Non-Managed Accounts Accounts Dollar Amounts in Thousands Amount Amount Number Number Fiduciary and Related Assets RCON B868 RCON B869 RCON B870 RCON B871 4. Personal trust and agency accounts........................... 0 4,000 2 2 4. 5. Employee benefit and retirement-related trust and agency accounts: a. Employee benefit—defined RCON B872 RCON B873 RCON B874 RCON B875 contribution........................................................................................................................... 2,000 0 1 0 5.a. b. Employee benefit—defined RCON B876 RCON B877 RCON B878 RCON B879 benefit........................................................................................................................... 8,000 0 3 0 5.b. c. Other employee benefit and retirement- RCON B880 RCON B881 RCON B882 RCON B883 related accounts........................................................................................................................... 133,000 0 124 1 5.c. RCON B884 RCON B885 RCON C001 RCON C002 6. Corporate trust and agency accounts........................................................................................................................... 0 82,131,000 0 17,830 6. 7. Investment management and investment RCON B886 RCON J253 RCON B888 RCON J254 advisory agency accounts........................................................................................................................... 13,461,000 61,000 2,722 28 7. 8. Foundation and endowment trust and RCON J255 RCON J256 RCON J257 RCON J258 agency accounts..................................................................... 613,000 0 39 0 8. RCON B890 RCON B891 RCON B892 RCON B893 9. Other fiduciary accounts........................................................................................................................... 0 0 0 0 9. 10. Total fiduciary accounts RCON B894 RCON B895 RCON B896 RCON B897 (sum of items 4 through 9)............................................................ 14,217,000 82,196,000 2,891 17,861 10. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 82 of 86 RC-66 Schedule RC-T—Continued (Column A) (Column B) (Column C) (Column D) Managed Non-Managed Number of Number of Assets Assets Managed Non-Managed Accounts Accounts Dollar Amounts in Thousands Amount Amount Number Number RCON B898 RCON B899 11. Custody and safekeeping accounts............... 27,067,000 3,299 11. 12. Not applicable 13. Individual Retirement Accounts, Health Savings Accounts, and other similar ac- RCON J259 RCON J260 RCON J261 RCON J262 counts (included in items 5.c and 11)............................................................... 129,000 390,000 122 479 13. Dollar Amounts in Thousands RIAD Amount Fiduciary and Related Services Income 14. Personal trust and agency accounts.............................................................................................................................................................................................. B904 0 14. 15. Employee benefit and retirement-related trust and agency accounts: a. Employee benefit—defined contribution................................................................................................................................ B905 0 15.a. b. Employee benefit—defined benefit...................................................................................................................................... B906 0 15.b. c. Other employee benefit and retirement-related accounts............................................................................................... B907 1,000 15.c. 16. Corporate trust and agency accounts............................................................................................................................. A479 244,000 16. 17. Investment management and investment advisory agency accounts............................................................................................... J315 23,000 17. 18. Foundation and endowment trust and agency accounts........................................................................................................ J316 2,000 18. 19. Other fiduciary accounts............................................................................................................................................. A480 0 19. 20. Custody and safekeeping accounts........................................................................................................................................... B909 9,000 20. 21. Other fiduciary and related services income............................................................................................................................ B910 0 21. 22. Total gross fiduciary and related services income (sum of items 14 through 21) (must equal Schedule RI, item 5.a)............................................................................................................................................................ 4070 279,000 22. 23. Less: Expenses.............................................................................................................................................................................................. C058 143,000 23. 24. Less: Net losses from fiduciary and related services............................................................................................... A488 0 24. 25. Plus: Intracompany income credits for fiduciary and related services............................................................................................... B911 0 25. 26. Net fiduciary and related services income.............................................................................................................................................................................................. A491 136,000 26. (Column A) (Column B) (Column C) Personal Trust and Employee Benefit All Other Accounts Memoranda Agency and Investment and Retirement-Related Management Agency Trust and Agency Accounts Accounts Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. Managed assets held in fiduciary accounts: a. Noninterest-bearing deposits............................................................................................... J263 (28,000) J264 0 J265 0 M.1.a. b. Interest-bearing deposits............................................................................................... J266 318,000 J267 3,000 J268 5,000 M.1.b. c. U.S. Treasury and U.S. Government agency obligations............................................................................................... J269 737,000 J270 14,000 J271 67,000 M.1.c. d. State, county, and municipal obligations............................................................................................... J272 1,854,000 J273 0 J274 12,000 M.1.d. e. Money market mutual funds............................................................................................... J275 570,000 J276 3,000 J277 26,000 M.1.e. f. Equity mutual funds............................................................................................... J278 1,153,000 J279 35,000 J280 57,000 M.1.f. g. Other mutual funds............................................................................................... J281 638,000 J282 18,000 J283 23,000 M.1.g. h. Common trust funds and collective investment funds............................................................................................... J284 845,000 J285 0 J286 0 M.1.h. i. Other short-term obligations........................................................................................... J287 660,000 J288 2,000 J289 18,000 M.1.i. j. Other notes and bonds................................................................................. J290 1,945,000 J291 24,000 J292 212,000 M.1.j. k. Investments in unregistered funds and private equity investments........................................................................ J293 64,000 J294 1,000 J295 1,000 M.1.k. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 83 of 86 RC-67 Schedule RC-T—Continued Memoranda—Continued (Column A) (Column B) (Column C) Personal Trust and Employee Benefit All Other Accounts Agency and Investment and Retirement-Related Management Agency Trust and Agency Accounts Accounts Dollar Amounts in Thousands RCON Amount RCON Amount RCON Amount 1. l. Other common and preferred stocks…………………………………………………..…… J296 4,253,000 J297 43,000 J298 192,000 M.1.l. m. Real estate mortgages…….……………………….……..................................... J299 0 J300 0 J301 0 M.1.m. n. Real estate……………………………………………………………………..…… J302 44,000 J303 0 J304 0 M.1.n. o. Miscellaneous assets……………………………………………………………………..…… J305 408,000 J306 0 J307 0 M.1.o. p. Total managed assets held in fiduciary accounts (for each column, sum of Memorandum items 1.a through 1.o)............................................ J308 13,461,000 J309 143,000 J310 613,000 M.1.p. (Column A) (Column B) Managed Assets Number of Managed Accounts Dollar Amounts in Thousands RCON Amount RCON Number 1. q. Investments of managed fiduciary accounts in advised or sponsored mutual funds…………………………………………………………………………............................. J311 226,000 J312 2,036 M.1.q. (Column A) (Column B) Number of Principal Amount Issues Outstanding Dollar Amounts in Thousands RCON Number Amount 2. Corporate trust and agency accounts: RCON B928 a. Corporate and municipal trusteeships………………………………………………………..……............................. B927 6,102 1,179,867,000 M.2.a. RCON J314 (1) Issues reported in Memorandum item 2.a that are in default............................................................... J313 322 25,636,000 M.2.a.(1) b. Transfer agent, registrar, paying agent, and other corporate agency…………………….……..................... B929 21,482 M.2.b. Memorandum items 3.a through 3.h are to be completed by banks with collective investment funds and common trust funds with a total market value of $1 billion or more as of the preceding December 31 report date. Memorandum item 3.h only is to be completed by banks with collective investment funds and common trust funds with a total market value of less than $1 billion as of the preceding December 31 report date. (Column A) (Column B) Number of Funds Market Value of Fund Assets Dollar Amounts in Thousands RCON Number RCON Amount 3. Collective investment funds and common trust funds a. Domestic equity………………………………………………………………………..……............................ B931 3 B932 396,000 M.3.a. b. International/Global equity…………………………………………………………….……............................ B933 1 B934 165,000 M.3.b. c. Stock/Bond blend……………………………………………………………………………............................... B935 0 B936 0 M.3.c. d. Taxable bond…………………………………………………………………………..……................................ B937 1 B938 99,000 M.3.d. e. Municipal bond………………………………………………………………………………................................... B939 1 B940 184,000 M.3.e. f. Short-term investments/Money market…………………………………………………….................................. B941 0 B942 0 M.3.f. g. Specialty/Other………………………………………………………………………..…….............................. B943 0 B944 0 M.3.g. h. Total collective investment funds (sum of Memorandum items 3.a through 3.g)…………………………………………………………………………….…….............................. B945 6 B946 844,000 M.3.h. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 84 of 86 RC-68 Schedule RC-T—Continued Memoranda—Continued (Column A) (Column B) (Column C) Gross Losses Gross Losses Recoveries Managed Non-Managed Accounts Accounts Dollar Amounts in Thousands RIAD Amount RIAD Amount RIAD Amount 4. Fiduciary settlements, surcharges, and other losses: a. Personal trust and agency accounts……………………….…………........................................ B947 0 B948 0 B949 0 M.4.a. b. Employee benefit and retirement-related trust and agency accounts……………..…………..…………..…………..…………............................... B950 0 B951 0 B952 0 M.4.b. c. Investment management and investment advisory agency accounts……………..…………..…………..…………..…………................................... B953 0 B954 0 B955 0 M.4.c. d. Other fiduciary accounts and related services……………………….…................................ B956 0 B957 0 B958 0 M.4.d. e. Total fiduciary settlements, surcharges, and other losses (sum of Memorandum items 4.a through 4.d) (sum of columns A and B minus column C must equal Schedule RC-T, item 24)……………………………………..…………........................................ B959 0 B960 0 B961 0 M.4.e. Person to whom questions about Schedule RC-T—Fiduciary and Related Services should be directed: Scott Iacono, Director Name and Title (TEXT B962) Scott.Iacono@db.com E-mail Address (TEXT B926) 212-250-8948 Area Code / Phone Number / Extension (TEXT B963) 212-797-0541 Area Code / FAX Number (TEXT B964) 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 85 of 86 RC-69 Schedule RC-V—Variable Interest Entities (1) (Column A) (Column B) Securitization Vehicles Other VIEs Dollar Amounts in Thousands RCON Amount RCON Amount 1. Assets of consolidated variable interest entities (VIEs) that can be used only to settle obligations of the consolidated VIEs: a. Cash and balances due from depository institutions ........................................................................ J981 0 JF84 0 1.a. b. Securities not held for trading ...................................................................................................... HU20 0 HU21 0 1.b. c. Loans and leases held for investment, net of allowance, and held for sale……………………………….......................................... HU22 0 HU23 0 1.c. d. Other real estate owned………………..………..………............................................ K009 0 JF89 0 1.d. e. Other assets .................................................................................................................................. JF91 0 JF90 0 1.e. 2. Liabilities of consolidated VIEs for which creditors do not have recourse to the general credit of the reporting bank: a. Other borrowed money ................................................................................................................. JF92 0 JF85 0 2.a. b. Other liabilities .......................................................................................................................... JF93 0 JF86 0 2.b. 3. All other assets of consolidated VIEs (not included in items 1.a through 1.e above) ............................................................................................................ K030 0 JF87 0 3. 4. All other liabilities of consolidated VIEs (not included in items 2.a and 2.b above) ......................................................................................... K033 0 JF88 0 4. Dollar Amounts in Thousands RCON Amount 5. Total assets of asset-backed commercial paper (ABCP) conduit VIEs............................................................................................. JF77 0 5. 6. Total liabilities of ABCP conduit VIEs....................................................................................................................................... JF78 0 6. 1. Institutions that have adopted ASU 2016-13 should report assets net of any applicable allowance for credit losses. 06/2012
DEUTSCHE BANK TRUST COMPANY AMERICAS 00623 New York, NY 10019 FFIEC 041 Page 86 of 86 RC-70 Optional Narrative Statement Concerning the Amounts Reported in the Consolidated Reports of Condition and Income The management of the reporting bank may, if it wishes, submit a brief narrative statement on the amounts reported in the Consolidated Reports of Condition and Income. This optional statement will be made available to the public, along with the publicly available data in the Consolidated Reports of Condition and Income, in response to any request for individual bank report data. However, the information reported in Schedule RI-E, item 2.g; Schedule RC-C, Part I, Memorandum items 17.a and 17.b; Schedule RC-O, Memorandum items 6 through 9, 14, 15, and 18; and Schedule RC-P, items 7.a and 7.b, is regarded as confidential and will not be made available to the public on an individual institution basis. BANKS CHOOSING TO SUBMIT THE NARRATIVE STATEMENT SHOULD ENSURE THAT THE STATEMENT DOES NOT CONTAIN THE NAMES OR OTHER IDENTIFICATIONS OF INDIVIDUAL BANK CUSTOMERS, REFERENCES TO THE AMOUNTS REPORTED IN THE CONFIDENTIAL ITEMS IDENTIFIED ABOVE, OR ANY OTHER INFORMATION THAT THEY ARE NOT WILLING TO HAVE MADE PUBLIC OR THAT WOULD COMPROMISE THE PRIVACY OF THEIR CUSTOMERS. Banks choosing not to make a statement may check the “No comment” box below and should make no entries of any kind in the space provided for the narrative statement; i.e., DO NOT enter in this space such phrases as “No statement,” “Not applicable,” “N/A,” “No comment,” and “None.” The optional statement must be entered on this sheet. The statement should not exceed 100 words. Further, regardless of the number of words, the statement must not exceed 750 characters, including punctuation, indentation, and standard spacing between words and sentences. If any submission should exceed 750 characters, as defined, it will be truncated at 750 characters with no notice to the submitting bank and the truncated statement will appear as the bank’s statement both on agency computerized records and in computer-file releases to the public. All information furnished by the bank in the narrative statement must be accurate and not misleading. Appropriate efforts shall be taken by the submitting bank to ensure the statement’s accuracy. If, subsequent to the original submission, material changes are submitted for the data reported in the Consolidated Reports of Condition and Income, the existing narrative statement will be deleted from the files, and from disclosure; the bank, at its option, may replace it with a statement appropriate to the amended data. The optional narrative statement will appear in agency records and in release to the public exactly as submitted (or amended as described in the preceding paragraph) by the management of the bank (except for the truncation of statements exceeding the 750-character limit described above). THE STATEMENT WILL NOT BE EDITED OR SCREENED IN ANY WAY BY THE SUPERVISORY AGENCIES FOR ACCURACY OR RELEVANCE. DISCLOSURE OF THE STATEMENT SHALL NOT SIGNIFY THAT ANY FEDERAL SUPERVISORY AGENCY HAS VERIFIED OR CONFIRMED THE ACCURACY OF THE INFORMATION CONTAINED THEREIN. A STATEMENT TO THIS EFFECT WILL APPEAR ON ANY PUBLIC RELEASE OF THE OPTIONAL STATEMENT SUBMITTED BY THE MANAGEMENT OF THE REPORTING BANK. Comments? RCON Yes No 6979 x BANK MANAGEMENT STATEMENT (please type or print clearly; 750 character limit): (TEXT 6980) 06/2012